A incidence 05 - USRDS · 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 ... Black 4,876 5,508...

Incidence of reported ESRD

AReferenceSec

tion

INCIDENCE OF REPORTED ESRDA

284

Reference section A

A.1 . 285Incident counts of reported ESRD: all patientsby demographic characteristics & primary diagnosis

A.2 . 289 Incident rates of reported ESRDper million population, by demographic characteristics & primary diagnosis

A.3 . 293 Incident rates of reported diabetic ESRDper million population, by demographic characteristics

A.4 . 295Incident counts of reported ESRD patients, 2001-2003by age, gender, & race

A.5 . 296 Incident rates of reported ESRD, 2001-2003per million population, by age, gender, & race

A.6 . 297 Mean age at start of ESRD therapy by demographic characteristics & primary diagnosis

A.7 . 299 Incidence of reported ESRD, by primary diagnosis: all patients999-2003 combined, by detailed primary diagnosis

A.8 . 301 Incident counts of reported ESRD patients, by diabetic status & state/territory

A.9 . 307 Incident rates of reported ESRD, by diabetic status & state, adjustedper million population

A.10 . 313 Incident counts of reported ESRD patients, by diabetic status & ESRD network

A.11 . 315 Incident rates of reported ESRD, by diabetic status & ESRD network, adjustedper million population

285

2005 Annual Data ReportAINCIDENCE OF REPORTED ESRD

ON OUR WEBSITE & CDIncident counts of reported ESRD, by primary diagnosis, (A.1.1-4), patients re-siding in Puerto Rico & U.S. territories (A.a).

Table A.1Incident counts of reported ESRD: all patientsby demographic characteristics & primary diagnosis

Table A.1Incident counts of reported ESRD: all patientsby demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 47 69 101 106 112 139 136 148 145 158 151 1825-9 97 97 105 88 110 103 122 115 106 131 154 12910-14 179 188 224 211 230 217 213 220 225 208 249 24815-19 433 476 456 444 431 442 457 484 522 526 548 49020-29 1,540 1,689 1,902 1,857 2,007 2,088 2,159 2,186 2,420 2,584 2,637 2,65130-39 2,222 2,484 2,768 2,851 3,077 3,313 3,673 3,834 4,297 4,652 4,893 5,14940-49 2,447 2,741 2,890 3,250 3,389 3,703 4,002 4,523 5,018 5,690 6,280 7,00350-59 3,759 4,375 4,690 4,853 5,129 5,510 5,813 6,290 7,206 7,733 8,362 9,01660-64 2,139 2,464 2,791 3,223 3,533 3,959 4,146 4,621 5,072 5,527 6,145 6,70265-69 2,187 2,273 2,602 3,335 3,522 3,934 4,460 5,117 5,670 6,544 7,254 8,03470-79 2,533 2,754 3,404 4,690 4,933 5,796 6,607 7,463 8,317 9,792 10,886 12,69780+ 434 491 646 1,017 1,099 1,383 1,669 1,944 2,289 2,907 3,359 3,869Unknown . * * * * 17 14 * * * * *

0-19 756 830 886 849 883 901 928 967 998 1,023 1,102 1,04920-44 4,877 5,471 6,024 6,226 6,654 7,151 7,736 8,209 9,137 9,905 10,651 11,21545-64 7,230 8,282 9,017 9,808 10,481 11,422 12,057 13,245 14,876 16,281 17,666 19,30665-74 3,795 4,024 4,764 6,208 6,462 7,427 8,291 9,488 10,451 12,067 13,528 15,32275+ 1,359 1,494 1,888 2,834 3,092 3,686 4,445 5,036 5,825 7,176 7,971 9,278Unknown . * * * * 17 14 * * * * *

Male 10,041 11,124 12,437 14,222 15,220 16,590 18,267 20,004 22,154 25,026 27,344 29,991Female 7,976 8,977 10,150 11,711 12,360 14,010 15,203 16,946 19,137 21,436 23,582 26,180Unknown . * . * * * * * * . . *

White 12,593 14,004 15,753 17,675 18,829 20,857 22,909 25,003 27,483 30,886 33,876 37,231Black 4,876 5,508 6,203 7,476 7,892 8,744 9,415 10,664 12,175 13,913 15,016 16,697Native American 122 144 186 275 286 300 372 424 507 545 596 641Asian 110 179 357 373 466 591 631 736 911 1,009 1,279 1,449Other/unknown 316 267 88 136 108 112 144 124 216 109 159 155

†Hispanic†Non-Hispanic

Diabetes 2,690 4,043 5,308 6,218 7,513 8,708 10,092 11,477 13,072 15,770 18,138 20,720Hypertension 3,141 4,528 5,838 6,349 7,152 8,241 8,924 10,342 11,937 13,878 15,301 16,982Glomerulonephritis 2,802 3,633 4,265 4,493 4,816 5,089 5,353 5,854 6,234 6,610 7,053 7,262Cystic kidney 765 944 1,081 1,105 1,148 1,228 1,311 1,362 1,400 1,417 1,573 1,624Other urologic 483 679 874 968 985 1,184 1,214 1,341 1,389 1,405 1,331 1,494Other cause 1,781 2,227 2,827 3,134 3,343 3,608 3,708 3,729 3,890 4,455 4,646 5,009Unknown cause 1,625 1,679 1,414 1,457 1,495 1,588 1,832 2,021 2,242 2,149 2,287 2,554Missing disease 4,730 2,369 980 2,211 1,129 958 1,037 825 1,128 778 597 528

U.S. 17,555 19,638 22,055 25,379 26,948 29,904 32,728 36,179 40,283 45,431 49,863 55,119U.S territories * 16 18 19 14 30 28 35 47 51 59 69Puerto Rico 235 245 299 300 377 387 403 425 489 576 583 665Foreign * 14 * 13 13 20 13 15 19 20 43 38Unknown 209 189 207 224 229 263 299 297 454 384 378 282

All 18,017 20,102 22,587 25,935 27,581 30,604 33,471 36,951 41,292 46,462 50,926 56,173

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.


286

Reference section A

Table A.1 (continued)Incident counts of reported ESRD: all patientsby demographic characteristics & primary diagnosis

Table A.1 (continued)Incident counts of reported ESRD: all patientsby demographic characteristics & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 153 187 146 168 186 176 175 182 197 205 184 2075-9 125 135 162 146 146 133 138 157 155 152 182 15310-14 248 243 260 281 270 281 270 300 311 312 345 34015-19 533 528 529 570 581 534 542 609 576 585 582 63720-29 2,795 2,827 2,826 2,705 2,715 2,660 2,741 2,656 2,701 2,712 2,604 2,54530-39 5,505 5,602 5,928 5,796 5,892 5,803 5,836 5,968 5,821 5,755 5,817 5,76040-49 7,543 8,020 8,477 9,036 9,727 9,728 10,523 10,746 10,991 11,018 11,360 11,63850-59 9,984 10,591 11,876 12,066 12,771 13,848 15,093 16,296 16,802 17,696 18,289 19,13360-64 7,033 7,398 7,844 8,121 8,540 8,992 9,515 9,734 10,055 10,428 10,669 11,26365-69 8,654 8,984 9,636 9,635 10,467 10,874 11,148 11,253 11,435 11,666 11,937 12,18070-79 14,198 15,013 16,635 17,142 19,344 20,795 21,895 23,246 23,721 24,014 25,146 24,87280+ 4,545 4,963 5,643 6,121 7,221 8,378 9,243 10,412 11,201 11,737 13,510 13,839Unknown * * * * . * * * . . . .

0-19 1,059 1,093 1,097 1,165 1,183 1,124 1,125 1,248 1,239 1,254 1,293 1,33720-44 11,919 12,150 12,546 12,614 12,979 12,734 13,212 13,241 13,267 13,163 13,175 13,17245-64 20,941 22,288 24,405 25,110 26,666 28,297 30,496 32,159 33,103 34,446 35,564 37,16765-74 16,820 17,625 19,163 19,337 21,305 22,231 22,854 23,326 23,733 24,122 24,765 24,59975+ 10,577 11,335 12,751 13,561 15,727 17,816 19,432 21,585 22,624 23,295 25,828 26,292Unknown * * * * . * * * . . . .

Male 32,447 34,359 37,056 37,852 41,561 43,792 46,397 48,954 50,268 51,805 54,628 55,584Female 28,870 30,129 32,911 33,932 36,298 38,411 40,724 42,604 43,697 44,475 45,995 46,955Unknown * * * * * . . * * . * 28

White 40,340 42,004 45,263 45,686 49,936 53,151 55,992 59,568 61,387 62,667 65,451 66,287Black 18,377 19,565 21,250 21,907 23,253 24,193 25,868 26,380 26,640 27,560 28,812 29,357Native American 760 753 823 877 927 960 1,064 1,126 1,144 1,131 1,134 1,097Asian 1,633 1,936 2,177 2,319 2,514 2,652 2,938 3,195 3,180 3,386 3,581 3,608Other/unknown 208 234 455 1,002 1,230 1,247 1,259 1,291 1,615 1,536 1,647 2,218

†Hispanic 8,829 9,094 9,722 10,516 11,347 11,706 12,579 13,258†Non-Hispanic 69,031 73,109 77,399 81,044 82,619 84,574 88,046 89,309

Diabetes 22,971 24,585 27,384 29,912 33,450 35,971 38,351 40,371 42,070 43,265 44,700 45,330Hypertension 18,963 19,681 21,350 19,174 20,342 21,857 23,041 24,420 24,853 25,779 27,335 28,319Glomerulonephritis 7,450 7,712 8,311 8,370 8,795 8,721 8,905 8,923 8,636 8,519 8,724 8,384Cystic kidney 1,738 1,807 1,863 1,941 1,895 1,985 2,157 2,192 2,188 2,248 2,250 2,291Other urologic 1,536 1,351 1,406 2,113 2,364 2,437 2,449 2,847 2,716 2,737 2,978 2,827Other cause 5,414 5,730 6,277 7,147 7,557 7,761 8,390 8,667 9,058 9,266 10,057 10,192Unknown cause 2,784 3,027 2,986 2,801 3,104 3,179 3,398 3,611 3,849 4,028 4,062 4,209Missing disease 462 599 391 333 353 292 430 529 596 438 519 1,015

U.S. 60,225 63,424 68,806 70,766 76,736 81,030 85,854 90,234 92,647 94,915 99,163 100,786U.S territories 97 76 89 103 119 139 139 144 137 150 174 175Puerto Rico 785 800 858 853 938 963 1,040 1,115 1,108 1,154 1,224 1,295Foreign 32 42 43 33 31 31 39 26 39 28 27 16Unknown 179 150 172 36 36 40 49 41 35 33 37 295

All 61,318 64,492 69,968 71,791 77,860 82,203 87,121 91,560 93,966 96,280 100,625 102,567

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

287


Table A.1 (continued) Incident counts of reported ESRD patients: U.S. only, with unknowns droppedby demographic characteristics & primary diagnosis

Table A.1 (continued)Incident counts of reported ESRD patients: U.S. only, with unknowns droppedby demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 46 67 100 105 107 132 131 140 138 149 142 1735-9 92 94 103 86 107 101 121 111 100 126 148 12210-14 174 180 217 207 220 208 204 214 215 197 241 23815-19 425 464 447 437 422 428 448 458 492 512 528 47420-29 1,480 1,646 1,851 1,790 1,939 2,029 2,091 2,117 2,310 2,501 2,559 2,56430-39 2,144 2,403 2,698 2,773 2,978 3,225 3,584 3,708 4,147 4,503 4,749 5,04440-49 2,353 2,652 2,790 3,148 3,298 3,589 3,864 4,383 4,814 5,523 6,081 6,79350-59 3,609 4,240 4,550 4,728 4,977 5,344 5,640 6,114 6,960 7,515 8,099 8,75060-64 2,029 2,377 2,711 3,125 3,448 3,850 4,037 4,528 4,955 5,373 5,986 6,55465-69 2,101 2,182 2,547 3,267 3,449 3,852 4,366 5,023 5,575 6,441 7,158 7,90370-79 2,405 2,627 3,329 4,602 4,828 5,686 6,488 7,363 8,167 9,657 10,743 12,54280+ 417 467 630 989 1,073 1,355 1,636 1,917 2,253 2,858 3,315 3,835

0-19 737 805 867 835 856 869 904 923 945 984 1,059 1,00720-44 4,694 5,311 5,861 6,031 6,448 6,937 7,506 7,945 8,774 9,597 10,332 10,92745-64 6,921 8,007 8,739 9,533 10,192 11,100 11,710 12,905 14,412 15,818 17,142 18,77865-74 3,624 3,850 4,663 6,083 6,329 7,280 8,124 9,332 10,277 11,894 13,348 15,09375+ 1,299 1,426 1,843 2,775 3,021 3,613 4,366 4,971 5,718 7,062 7,868 9,187

Male 9,636 10,726 12,093 13,848 14,792 16,164 17,787 19,490 21,520 24,375 26,674 29,316Female 7,639 8,673 9,880 11,409 12,054 13,635 14,823 16,586 18,606 20,980 23,075 25,676

White 12,256 13,661 15,373 17,268 18,372 20,365 22,394 24,477 26,798 30,160 33,152 36,452Black 4,793 5,424 6,082 7,364 7,754 8,577 9,250 10,483 11,993 13,721 14,824 16,548Native American 121 143 181 271 280 297 366 423 503 543 593 639Asian 105 171 337 354 440 560 600 693 832 931 1,180 1,353


Diabetes 2,569 3,901 5,164 6,057 7,303 8,473 9,794 11,175 12,695 15,342 17,675 20,196Hypertension 3,059 4,408 5,731 6,250 7,041 8,071 8,774 10,198 11,763 13,703 15,094 16,787Glomerulonephritis 2,710 3,528 4,146 4,352 4,660 4,946 5,213 5,712 6,062 6,421 6,866 7,090Cystic kidney 753 932 1,070 1,092 1,131 1,204 1,294 1,340 1,379 1,399 1,544 1,605Other urologic 462 653 839 938 947 1,149 1,181 1,316 1,334 1,352 1,278 1,455Other cause 1,732 2,191 2,778 3,090 3,297 3,554 3,646 3,674 3,813 4,378 4,579 4,913Unknown cause 1,511 1,575 1,351 1,370 1,425 1,520 1,757 1,935 2,162 2,089 2,206 2,473Missing disease 4,479 2,211 894 2,108 1,042 882 951 726 918 671 507 473

All 17,275 19,399 21,973 25,257 26,846 29,799 32,610 36,076 40,126 45,355 49,749 54,992

Patients dropped 742 703 614 678 735 805 861 875 1,166 1,107 1,177 1,181

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


288

Reference section A

Table A.1 (continued) Incident counts of reported ESRD patients: U.S. only, with unknowns droppedby demographic characteristics & primary diagnosis

Table A.1 (continued)Incident counts of reported ESRD patients: U.S. only, with unknowns droppedby demographic characteristics & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 149 181 140 160 172 166 165 175 190 186 166 1855-9 119 128 154 145 140 130 131 145 149 143 175 13210-14 242 239 249 266 265 269 263 292 298 297 328 30315-19 526 507 513 551 564 516 522 590 543 559 541 57920-29 2,719 2,770 2,737 2,624 2,625 2,569 2,642 2,567 2,558 2,586 2,439 2,36730-39 5,391 5,488 5,773 5,657 5,731 5,653 5,656 5,779 5,621 5,533 5,601 5,44040-49 7,358 7,842 8,266 8,779 9,416 9,455 10,237 10,458 10,643 10,712 10,992 11,15850-59 9,682 10,301 11,549 11,666 12,353 13,368 14,562 15,755 16,204 17,097 17,693 18,30460-64 6,875 7,216 7,649 7,890 8,261 8,703 9,219 9,442 9,698 10,094 10,321 10,80065-69 8,501 8,841 9,484 9,384 10,227 10,600 10,878 10,958 11,127 11,357 11,619 11,81270-79 14,003 14,817 16,432 16,875 18,999 20,422 21,505 22,863 23,274 23,557 24,674 24,33480+ 4,503 4,903 5,560 6,030 7,120 8,259 9,154 10,251 11,060 11,594 13,326 13,620

0-19 1,036 1,055 1,056 1,122 1,141 1,081 1,081 1,202 1,180 1,185 1,210 1,19920-44 11,651 11,889 12,209 12,283 12,600 12,393 12,801 12,844 12,764 12,685 12,638 12,47245-64 20,374 21,728 23,765 24,333 25,786 27,355 29,515 31,157 31,960 33,337 34,408 35,59765-74 16,540 17,366 18,886 18,933 20,872 21,749 22,348 22,812 23,160 23,561 24,171 23,93575+ 10,467 11,195 12,590 13,356 15,474 17,532 19,189 21,260 22,301 22,947 25,448 25,831

Male 31,768 33,649 36,199 36,842 40,443 42,626 45,122 47,645 48,745 50,270 52,986 53,566Female 28,300 29,584 32,307 33,185 35,430 37,484 39,812 41,630 42,620 43,445 44,889 45,468

White 39,566 41,233 44,462 45,113 49,390 52,516 55,301 58,816 60,610 61,877 64,623 65,266Black 18,216 19,409 21,116 21,796 23,137 24,085 25,735 26,249 26,538 27,434 28,664 29,202Native American 759 749 821 876 927 956 1,063 1,124 1,144 1,131 1,134 1,097Asian 1,527 1,842 2,107 2,242 2,419 2,553 2,835 3,086 3,073 3,273 3,454 3,469


Diabetes 22,378 24,035 26,701 29,019 32,367 34,831 37,190 39,111 40,703 41,864 43,219 43,589Hypertension 18,732 19,416 21,074 18,857 20,029 21,500 22,676 24,063 24,446 25,350 26,871 27,706Glomeruloneph. 7,299 7,560 8,132 8,169 8,595 8,492 8,659 8,694 8,373 8,262 8,444 8,076Cystic kidney 1,710 1,771 1,822 1,909 1,854 1,946 2,119 2,160 2,133 2,195 2,195 2,216Other urologic 1,497 1,330 1,384 2,038 2,313 2,375 2,395 2,763 2,641 2,678 2,898 2,765Other cause 5,321 5,617 6,136 7,021 7,399 7,621 8,232 8,507 8,837 9,079 9,833 9,957Unknown cause 2,713 2,950 2,909 2,716 3,018 3,087 3,302 3,518 3,725 3,913 3,958 4,050Missing disease 418 554 348 298 298 258 361 459 507 374 457 675

All 60,068 63,233 68,506 70,027 75,873 80,110 84,934 89,275 91,365 93,715 97,875 99,034

Patients dropped 1,250 1,259 1,462 1,764 1,987 2,093 2,187 2,285 2,601 2,565 2,750 3,533


289


ON OUR WEBSITE & CDIncident rates of reported ESRD: diabetes, hypertension, glomerulonephritis, & cystic kidney disease (A.2.1-4).

Table A.2Incident rates of reported ESRDper million population, by demographic characteristics & primary diagnosis

Table A.2Incident rates of reported ESRDper million population, by demographic characteristics & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 2.8 4.0 5.8 6.0 6.1 7.4 7.3 7.8 7.6 8.1 7.5 9.05-9 5.5 5.9 6.5 5.4 6.6 6.1 7.1 6.4 5.6 7.0 8.2 6.710-14 9.5 9.8 12.0 11.6 12.6 12.2 12.4 13.1 13.0 11.7 14.0 13.415-19 20.1 22.6 22.4 22.5 22.3 22.9 23.8 24.5 26.6 28.2 29.7 27.520-29 36.0 39.4 43.7 41.9 45.1 47.3 49.0 50.4 55.8 61.3 63.3 63.930-39 67.4 72.6 78.7 78.8 81.9 85.7 91.7 93.6 102.7 109.5 113.3 117.640-49 103.3 115.2 118.9 129.3 131.6 139.7 147.1 157.1 165.2 181.8 192.3 206.650-59 154.8 183.2 198.9 209.1 223.1 242.0 257.3 280.9 320.5 345.6 370.6 395.360-64 200.0 229.5 256.6 293.3 319.2 353.0 371.8 419.9 459.2 501.8 563.5 618.165-69 238.5 245.2 282.9 358.0 374.3 412.3 457.5 516.0 567.7 646.5 710.2 787.370-79 206.1 219.8 271.9 367.5 377.6 436.5 490.1 546.5 595.6 693.3 758.0 862.780+ 79.8 86.9 113.7 173.2 182.6 224.1 262.8 298.7 341.9 420.9 473.8 530.0

0-19 10.2 11.2 12.2 11.8 12.2 12.4 12.9 13.1 13.3 13.8 14.7 13.920-44 55.5 61.1 65.8 66.2 69.3 73.3 78.1 81.7 89.6 97.0 103.2 107.445-64 155.5 180.0 196.6 214.4 228.8 248.9 262.3 287.8 317.0 344.8 370.2 400.765-74 231.6 242.3 288.8 370.6 380.7 431.8 474.1 535.5 583.1 665.8 737.3 825.075+ 129.3 138.0 173.2 253.5 268.5 312.6 367.8 407.5 457.5 551.0 598.6 679.6

Male 87.3 96.2 107.4 121.9 129.0 139.7 152.2 165.2 180.7 202.7 219.2 237.5Female 65.4 73.5 83.0 95.0 99.5 111.6 120.3 133.4 148.4 165.8 180.4 198.2

White 62.8 69.5 77.6 86.6 91.5 100.8 110.1 119.5 130.0 145.3 158.3 172.3Black 179.0 199.9 221.1 264.3 274.8 300.2 319.6 357.5 403.5 455.2 483.7 528.9Native American 84.6 96.4 117.7 169.8 169.1 172.9 205.2 228.5 261.6 271.3 288.0 300.4Asian 27.4 40.6 73.6 72.1 83.8 99.9 100.4 109.3 123.7 130.5 156.3 170.0


Diabetes 11.3 17.0 22.3 25.9 31.0 35.6 40.8 46.1 51.9 62.2 70.8 79.8Hypertension 13.5 19.2 24.7 26.7 29.9 33.9 36.5 42.1 48.1 55.5 60.5 66.4Glomerulonephritis 11.9 15.4 17.9 18.6 19.8 20.8 21.7 23.6 24.8 26.0 27.5 28.0Cystic kidney 3.3 4.1 4.6 4.7 4.8 5.1 5.4 5.5 5.6 5.7 6.2 6.3Other urologic 2.0 2.9 3.6 4.0 4.0 4.8 4.9 5.4 5.5 5.5 5.1 5.8Other cause 7.6 9.6 12.0 13.2 14.0 14.9 15.2 15.2 15.6 17.7 18.3 19.4Unknown cause 6.7 6.9 5.8 5.9 6.0 6.4 7.3 8.0 8.8 8.5 8.8 9.8Missing disease 19.7 9.6 3.9 9.0 4.4 3.7 4.0 3.0 3.8 2.7 2.0 1.9

All 76.0 84.5 94.9 108.0 113.8 125.3 135.8 148.9 164.1 183.8 199.3 217.4



290

Reference section A

Table A.2 (continued)Incident rates of reported ESRDper million population, by demographic characteristics & primary diagnosis


UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 7.6 9.2 7.1 8.2 8.9 8.6 8.6 9.2 9.9 9.6 8.5 9.45-9 6.5 6.9 8.1 7.5 7.1 6.4 6.4 7.0 7.3 7.1 8.8 6.710-14 13.3 12.8 13.1 13.9 13.6 13.7 13.3 14.5 14.5 14.2 15.6 14.315-19 30.5 29.0 28.7 30.0 29.8 26.6 26.3 29.4 26.9 27.6 26.6 28.320-29 68.5 70.9 71.3 69.1 69.6 68.0 69.6 67.3 66.6 66.7 62.2 59.330-39 123.4 123.9 129.1 126.1 128.1 127.5 128.9 132.9 130.2 128.8 131.4 129.240-49 215.1 222.8 226.6 232.0 239.1 236.3 250.1 249.9 248.9 245.9 248.7 249.550-59 427.4 436.7 473.9 465.9 481.2 488.0 507.3 525.0 516.3 524.3 524.4 525.460-64 656.2 701.1 753.6 778.3 817.2 853.7 884.6 883.0 892.5 908.4 890.1 892.165-69 850.5 880.3 947.7 940.6 1026.4 1076.2 1124.1 1148.5 1167.8 1190.4 1212.2 1212.070-79 940.4 978.9 1068.8 1081.9 1205.2 1281.8 1334.0 1409.6 1429.6 1452.4 1528.6 1516.880+ 602.9 634.9 699.4 735.8 846.1 958.3 1037.8 1134.4 1192.8 1210.6 1348.7 1344.6

0-19 14.1 14.2 14.0 14.6 14.7 13.8 13.6 15.0 14.7 14.7 14.9 14.820-44 114.1 115.9 118.8 119.2 122.1 119.8 123.5 123.7 122.6 121.4 120.6 118.845-64 419.7 435.5 463.2 460.9 474.1 486.1 506.8 516.2 511.5 516.9 516.7 518.165-74 894.7 929.0 1005.1 1003.6 1108.8 1164.1 1203.4 1238.5 1260.5 1285.4 1321.3 1305.375+ 754.7 787.9 865.8 896.2 1010.2 1115.4 1195.7 1298.0 1334.7 1349.1 1469.8 1469.2

Male 253.6 265.0 281.5 282.9 306.8 319.4 333.9 348.3 352.1 359.1 374.4 374.5Female 215.6 222.5 240.2 243.9 257.5 269.3 282.9 292.7 296.6 299.4 306.5 307.7


†Hispanic 249.3 243.7 251.7 260.0 266.9 265.6 274.1 274.6†Non-Hispanic 285.6 300.2 315.4 328.2 332.0 338.2 350.0 351.0


All 234.2 243.3 260.4 263.0 281.6 293.8 307.9 319.9 323.8 328.7 339.9 340.5


291




ADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 2.7 3.9 5.7 5.9 5.9 7.3 7.2 7.6 7.4 7.9 7.4 8.85-9 5.4 5.7 6.5 5.3 6.5 6.0 7.1 6.2 5.6 6.9 8.0 6.610-14 9.2 9.6 12.2 11.6 12.5 12.2 12.3 12.8 12.9 11.6 13.8 13.315-19 19.8 22.5 22.6 22.1 21.8 22.6 23.6 24.1 25.9 27.5 28.9 26.820-29 36.6 39.7 44.2 42.4 45.5 47.4 48.9 49.9 55.2 60.4 62.3 62.530-39 71.4 77.3 83.7 83.5 86.2 90.4 95.9 97.9 107.3 113.6 117.0 121.440-49 110.8 123.3 128.2 141.5 144.3 152.4 160.8 173.1 183.1 202.7 211.9 229.350-59 170.6 203.0 221.7 233.1 248.0 268.8 284.2 311.5 356.3 381.7 410.2 439.460-64 223.0 255.3 289.7 338.5 364.3 406.2 419.9 474.5 518.8 569.1 632.4 687.765-69 261.6 270.9 317.3 402.1 424.2 467.5 521.2 590.8 641.7 727.6 812.8 892.870-79 224.0 243.3 306.9 426.3 439.0 500.1 566.1 624.5 690.2 805.7 880.2 999.080+ 92.6 103.0 141.3 216.4 232.9 289.0 325.3 365.1 429.1 521.9 590.8 672.4

0-19 9.3 10.4 11.7 11.2 11.7 12.0 12.5 12.7 13.0 13.5 14.5 13.920-44 62.4 68.8 73.6 74.5 77.0 80.8 85.2 88.6 96.1 102.8 108.2 111.445-64 172.4 199.5 219.3 241.8 256.7 280.0 293.4 324.1 360.5 393.0 423.6 459.065-74 253.0 268.8 323.8 421.9 434.4 494.3 542.8 614.9 666.0 761.0 848.5 943.675+ 129.6 141.9 188.7 281.2 299.7 352.4 406.2 446.8 516.1 620.3 685.9 782.7

Male 102.4 113.0 126.7 145.3 152.9 165.5 179.5 194.9 213.3 238.4 257.6 278.6Female 68.2 76.9 86.8 98.0 102.2 113.9 122.3 134.4 149.2 165.4 179.2 195.9




All 84.0 93.6 105.1 119.5 125.2 137.3 148.1 161.7 177.8 197.9 214.0 232.5

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race & ethnicity are adjusted for gender & age.The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


292

Reference section A



ADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 7.6 9.1 7.0 7.9 8.8 8.5 8.5 9.1 9.8 9.6 8.3 9.35-9 6.3 6.8 7.9 7.3 7.0 6.4 6.2 6.9 7.1 7.0 8.7 6.610-14 13.2 12.6 12.9 13.5 13.3 13.5 12.9 14.2 14.1 13.8 15.1 14.115-19 29.6 27.8 27.7 28.8 28.5 25.7 25.3 28.5 26.1 26.6 25.9 27.220-29 67.2 69.2 69.4 67.0 67.3 65.5 67.2 64.9 64.7 65.1 60.5 58.030-39 126.8 126.5 131.4 127.6 128.9 127.5 128.3 131.8 128.9 127.2 129.9 127.640-49 236.3 244.0 247.8 250.8 255.7 250.9 263.7 262.2 259.3 254.9 257.0 256.250-59 474.9 488.2 529.5 522.0 538.2 547.1 569.1 586.3 574.0 578.9 575.9 572.760-64 734.3 778.2 828.3 855.7 892.0 932.7 966.1 960.3 960.8 986.5 966.7 971.065-69 959.3 998.7 1,061.0 1,044.8 1,137.3 1,187.6 1,232.0 1,254.9 1,271.1 1,289.7 1,310.4 1,312.670-79 1,085.5 1,131.8 1,244.1 1,262.5 1,390.6 1,473.5 1,542.4 1,611.4 1,617.3 1,637.4 1,728.0 1,703.680+ 750.2 789.7 871.6 914.7 1,059.3 1,174.3 1,287.9 1,398.9 1,455.5 1,460.6 1,614.1 1,605.6

0-19 14.2 14.1 13.9 14.4 14.4 13.5 13.2 14.7 14.3 14.2 14.5 14.320-44 117.4 118.1 119.8 119.1 120.9 117.5 120.5 120.0 118.8 117.6 116.8 115.345-64 489.4 510.9 546.3 548.8 566.9 581.7 605.0 612.7 605.1 612.7 607.4 605.965-74 1,019.2 1,066.2 1,144.9 1,142.2 1,252.1 1,311.2 1,349.3 1,376.3 1,390.6 1,413.0 1,457.5 1,435.375+ 864.0 903.1 1,000.8 1,038.3 1,177.6 1,287.0 1,398.0 1,507.6 1,545.2 1,553.2 1,693.2 1,686.8

Male 296.1 308.0 327.6 327.2 353.4 366.2 381.6 396.1 397.1 402.0 416.9 413.4Female 212.4 218.8 234.4 237.2 248.5 257.3 268.6 276.1 277.2 278.0 281.6 280.4




All 249.4 258.3 275.5 276.9 294.3 304.9 317.5 327.7 328.9 331.5 339.9 337.6

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race & ethnicity are adjusted for gender & age.The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

293


Table A.3Incident rates of reported diabetic ESRDper million population, by demographic characteristics

Table A.3Incident rates of reported diabetic ESRDper million population, by demographic characteristics

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 . * . * * * * * * * * *5-9 . * . . . . . . * * * .10-14 . * * * * * * * * * . *15-19 0.5 0.6 * * * * * 0.6 0.6 0.8 0.8 0.720-29 5.2 7.6 9.8 10.1 10.6 12.5 12.7 13.0 13.2 15.7 15.3 16.130-39 16.3 20.0 23.4 24.2 28.3 30.0 32.0 31.5 33.5 37.2 37.3 38.140-49 17.7 26.3 31.5 36.5 41.0 46.2 51.6 56.6 57.9 69.4 74.4 80.850-59 26.7 42.7 56.3 65.7 77.8 89.2 100.1 113.1 132.7 153.0 176.0 191.260-64 31.8 49.4 71.3 86.0 106.8 118.9 136.3 163.4 182.7 218.5 262.8 300.165-69 29.4 49.7 63.6 79.2 99.0 121.7 147.3 175.0 207.1 245.0 283.2 338.570-79 17.7 28.1 43.7 54.5 68.4 82.2 104.0 122.8 141.4 183.1 220.5 262.680+ * 4.1 9.2 11.9 16.7 22.2 27.0 31.8 40.1 57.0 71.9 85.3

0-19 . . * * . . . . . . . .20-44 10.9 14.6 17.3 18.6 21.4 23.3 25.3 26.0 27.3 31.6 32.6 34.245-64 26.1 40.7 55.2 64.7 76.6 87.8 98.5 112.9 126.9 148.6 170.8 189.265-74 25.5 43.9 58.4 73.9 90.8 109.3 136.0 159.1 188.4 226.9 269.3 319.275+ 7.6 10.0 20.3 23.8 33.4 43.2 52.3 64.8 73.4 103.3 122.2 147.5

Male 12.2 17.0 22.3 25.5 30.9 35.9 40.2 44.7 50.2 59.5 67.6 75.5Female 10.5 17.1 22.3 26.3 31.1 35.4 41.4 47.5 53.6 64.7 73.9 84.0

White 9.6 14.0 18.3 20.9 25.0 28.4 33.0 36.7 41.4 49.8 56.1 63.3Black 24.1 38.6 50.0 59.6 72.0 83.6 92.9 108.2 120.9 144.4 167.6 188.4Native American 35.0 53.3 59.2 88.4 95.4 105.4 127.9 144.8 175.2 184.9 189.4 213.9Asian * 5.7 14.6 17.5 17.5 28.7 28.3 33.1 34.1 40.9 54.8 56.7


All 11.3 17.0 22.3 25.9 31.0 35.6 40.8 46.1 51.9 62.2 70.8 79.8

ADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 . * . * * * * * * * * *5-9 . * . . . . . . * * * .10-14 . * * * * * * * * * . *15-19 0.5 0.6 * * * * * 0.6 0.6 0.7 0.8 0.620-29 5.2 7.6 9.7 10.0 10.5 12.3 12.4 12.6 12.7 15.1 14.7 15.630-39 16.1 20.0 23.5 24.2 28.2 30.1 32.0 31.6 33.8 37.3 37.5 38.340-49 18.8 27.4 33.7 39.3 43.7 49.7 55.1 61.1 62.9 75.8 81.2 88.850-59 30.2 48.3 63.5 75.0 87.4 100.4 112.3 126.9 148.3 169.6 195.0 212.560-64 36.3 57.3 85.3 102.2 124.3 140.7 155.8 188.1 210.2 250.3 297.3 337.665-69 34.0 59.5 72.6 94.1 113.9 143.9 172.7 208.9 238.7 278.4 330.7 388.270-79 18.8 32.3 50.3 62.9 82.3 99.0 124.9 142.4 165.0 213.6 256.3 306.180+ * 3.8 12.5 14.5 22.6 31.3 32.9 36.1 48.9 69.9 90.0 105.5

0-19 0.1 0.2 * * 0.2 0.2 0.3 0.2 0.2 0.3 0.3 0.220-44 11.8 15.9 18.6 20.2 23.2 25.0 26.8 27.4 28.5 32.7 33.5 34.845-64 29.5 46.1 63.2 74.5 87.0 100.2 111.3 128.9 145.8 170.6 196.7 218.565-74 28.5 51.8 66.1 87.4 105.5 128.9 159.4 187.0 215.3 259.3 312.9 366.875+ 6.0 9.4 21.9 24.7 37.7 48.9 56.5 63.9 78.6 108.9 132.5 159.2

Male 14.0 19.5 25.9 30.0 35.7 41.8 46.4 51.7 58.2 68.4 78.4 87.1Female 11.1 18.1 23.6 27.6 32.3 36.8 42.8 48.6 54.5 65.6 74.5 84.4

White 10.1 14.7 19.0 21.5 25.6 28.9 33.4 37.0 41.5 49.6 55.9 62.8Black 32.3 51.8 68.0 81.0 97.5 114.1 127.7 147.7 165.1 198.9 231.4 261.5Native American 57.1 88.2 97.9 149.5 162.5 174.8 209.5 241.4 291.0 307.4 314.8 359.5Asian * 8.5 22.2 27.5 28.7 48.0 46.1 50.8 54.3 64.7 85.7 89.1


All 12.5 18.8 24.8 28.9 34.1 39.3 44.7 50.3 56.4 67.2 76.6 85.9

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race & ethnicity are adjusted for gender and age.The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.


294

Reference section A

Table A.3 (continued)Incident rates of reported diabetic ESRDper million population, by demographic characteristics

Table A.3 (continued)Incident rates of reported diabetic ESRDper million population, by demographic characteristics

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 * * * * * . * * * * * *5-9 . * * . . . . . . . * .10-14 * * . * * * * . . * * .15-19 0.8 0.7 0.6 * * * * 0.7 * * * *20-29 15.4 14.5 15.2 13.8 13.0 13.3 11.8 12.0 12.8 12.0 10.4 10.230-39 40.2 40.0 41.8 40.9 41.5 40.4 40.6 41.7 42.1 40.1 41.0 40.740-49 84.2 87.9 90.4 94.1 95.8 99.1 102.7 100.4 101.9 99.9 101.6 101.250-59 207.9 216.6 238.8 248.5 268.3 272.3 280.0 289.4 288.5 289.5 285.9 283.960-64 320.3 349.8 390.8 426.4 464.5 488.2 521.5 515.6 518.0 535.8 513.9 503.765-69 384.8 397.7 439.8 472.6 540.7 571.2 601.7 627.0 638.5 657.5 655.4 654.670-79 298.2 332.8 370.5 419.6 482.1 531.1 564.8 607.2 632.9 642.0 676.1 674.980+ 101.6 108.8 132.3 156.9 197.9 236.6 265.5 287.3 318.1 337.6 379.9 368.6

0-19 * * * * * * * * * * * *20-44 35.6 35.4 36.6 36.9 37.2 37.5 37.5 37.3 38.4 37.3 36.2 36.745-64 199.5 210.6 229.4 239.8 254.9 263.3 275.1 278.2 277.7 279.7 277.2 273.465-74 363.8 388.0 427.6 468.5 537.9 571.4 599.7 630.6 646.3 661.0 672.6 666.275+ 167.2 184.3 214.2 248.7 295.5 346.9 382.1 416.0 446.7 458.8 499.3 496.3

Male 82.5 88.8 96.5 104.4 116.5 125.7 132.9 139.8 145.0 149.5 155.4 155.7Female 91.8 96.0 106.2 113.3 123.6 129.7 136.7 140.5 143.5 144.3 145.0 144.3



All 87.2 92.5 101.5 109.0 120.2 127.8 134.8 140.2 144.3 146.8 150.1 149.9

ADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 * * * * * . * * * * * *5-9 . * * . . . . . . . * .10-14 * * . * * * * . . * * .15-19 0.8 0.7 0.6 * * * * 0.7 * * * *20-29 15.1 14.2 14.8 13.4 12.5 12.9 11.4 11.6 12.7 12.0 10.4 10.230-39 40.4 40.0 41.9 40.8 41.4 40.1 40.3 41.3 41.8 39.8 40.8 40.640-49 91.7 95.4 98.1 100.7 101.7 104.6 108.1 105.1 106.0 103.2 104.9 103.750-59 232.0 243.4 266.3 279.1 301.0 305.8 315.3 324.2 320.8 320.2 314.8 309.460-64 360.4 388.6 430.4 471.4 508.2 535.0 571.1 561.3 556.5 581.5 558.2 548.165-69 437.8 453.5 493.5 530.5 606.7 635.9 662.5 689.7 697.2 714.8 709.0 709.270-79 342.9 385.0 430.9 493.3 558.1 612.6 659.0 693.5 716.3 725.1 767.1 760.080+ 123.9 137.4 163.7 197.6 252.1 293.4 330.5 360.7 389.4 404.3 455.2 435.8

0-19 0.2 0.3 0.2 0.1 0.2 0.2 0.1 0.2 0.2 * 0.2 0.120-44 36.0 35.6 36.4 36.3 36.2 36.3 36.1 35.8 37.0 35.8 34.9 35.545-64 234.7 249.2 272.6 289.5 310.1 320.1 335.2 336.7 333.5 338.2 331.4 324.565-74 416.1 447.5 489.3 536.4 612.3 648.0 675.5 703.5 714.4 728.0 742.9 731.875+ 179.7 201.1 234.7 279.8 334.2 383.9 430.2 463.7 493.3 505.9 555.9 545.7

Male 94.9 101.8 110.7 119.5 132.7 142.2 149.7 156.4 160.6 164.5 169.8 168.4Female 91.9 95.8 105.3 112.0 121.0 125.6 131.3 134.1 135.5 135.0 134.1 132.2



All 93.5 98.8 108.1 115.6 126.5 133.4 139.7 144.1 146.8 148.3 150.1 148.3

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race & ethnicity are adjusted for gender and age.The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

295


ON OUR WEBSITE & CDIncident counts of reported ESRD patients, 1998-2000 (A.4.1).Incident counts of reported ESRD: by primary diagnosis, 2000-2003 (A.4.2).

Table A.4Incident counts of reported ESRD patients, 2001-2003by age, gender, & race

Table A.4Incident counts of reported ESRD patients, 2001-2003by age, gender, & race

Male Female AllWhite Black N Am Asian All White Black N Am Asian All White Black N Am Asian All

0-4 261 60 * 11 337 162 28 * * 200 423 88 * 17 5375-9 187 55 * * 249 165 34 . * 201 352 89 * * 45010-14 355 121 * 21 504 287 118 * * 424 642 239 16 31 92815-19 623 264 * 41 938 437 253 15 36 741 1,060 517 25 77 1,67920-29 2,252 1,519 61 207 4,039 1,689 1,438 60 166 3,353 3,941 2,957 121 373 7,39230-39 5,061 4,179 111 339 9,690 3,406 3,051 117 310 6,884 8,467 7,230 228 649 16,57440-49 10,647 7,844 287 561 19,339 6,926 5,849 261 487 13,523 17,573 13,693 548 1,048 32,86250-59 18,050 10,063 428 1,083 29,624 13,519 8,734 418 799 23,470 31,569 18,797 846 1,882 53,09460-64 10,943 4,631 197 642 16,413 8,972 5,119 252 459 14,802 19,915 9,750 449 1,101 31,21565-69 12,677 4,293 185 634 17,789 10,687 5,482 274 556 16,999 23,364 9,775 459 1,190 34,78870-79 30,061 6,414 213 1,212 37,900 23,924 9,118 326 1,297 34,665 53,985 15,532 539 2,509 72,56580+ 16,863 2,431 44 662 20,000 13,612 4,202 77 649 18,540 30,475 6,633 121 1,311 38,540

0-19 1,426 500 23 79 2,028 1,051 433 28 54 1,566 2,477 933 51 133 3,59420-44 11,768 9,119 313 754 21,954 7,902 6,958 292 689 15,841 19,670 16,077 605 1,443 37,79545-64 35,185 19,117 771 2,078 57,151 26,610 17,233 816 1,532 46,191 61,795 36,350 1,587 3,610 103,34265-74 27,508 7,871 312 1,265 36,956 22,542 10,453 464 1,252 34,711 50,050 18,324 776 2,517 71,66775+ 32,093 5,267 130 1,243 38,733 25,681 8,349 213 1,250 35,493 57,774 13,616 343 2,493 74,226

Diabetes 45,232 16,338 1,086 2,529 65,185 39,192 20,669 1,375 2,251 63,487 84,424 37,007 2,461 4,780 128,672Hypertension 27,865 15,369 153 1,440 44,827 19,932 13,858 133 1,177 35,100 47,797 29,227 286 2,617 79,927Glomerulonephritis 10,417 3,580 143 743 14,883 6,446 2,680 137 636 9,899 16,863 6,260 280 1,379 24,782Other cause 24,466 6,587 167 707 31,927 18,216 6,219 168 713 25,316 42,682 12,806 335 1,420 57,243

All 107,980 41,874 1,549 5,419 156,822 83,786 43,426 1,813 4,777 133,802 191,766 85,300 3,362 10,196 290,624

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.The age of the incident patient is determined as of the date of ESRD initiation. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.


296

Reference section A

ON OUR WEBSITE & CDIncident rates of reported ESRD, 1998-2000 (A.5.1).Incident rates of reported ESRD: by primary diagnosis (A.5.2).

Table A.5Incident rates of reported ESRD, 2001-2003per million population, by age, gender, & race

Table A.5Incident rates of reported ESRD, 2001-2003per million population, by age, gender, & race

Unadjusted rates Rates adjusted for:Male Female Gender Race Gender &

White Black N Am Asian White Black N Am Asian White Black N Am Asian Male Female race0-4 11 12 * 8 7 6 * * 9 9 * 6 11 7 95-9 8 11 * * 7 7 . * 8 9 * * 8 7 710-14 14 23 * 15 12 23 * * 13 23 18 12 15 13 1415-19 25 55 * 30 19 54 35 28 22 54 29 29 29 24 2720-29 47 183 79 64 38 164 84 51 43 177 83 57 67 56 6130-39 97 520 159 99 68 340 171 87 82 427 164 94 153 105 12840-49 195 1,029 447 203 127 672 388 159 162 859 420 183 311 204 25650-59 429 2,054 1,019 575 311 1,493 934 368 377 1,815 1,007 486 668 488 57660-64 764 3,060 1,566 1,075 579 2,647 1,852 682 670 2,851 1,719 877 1,087 868 97565-69 1,089 3,574 2,086 1,405 809 3,382 2,689 1,004 947 3,476 2,394 1,202 1,439 1,174 1,30470-79 1,618 4,125 2,021 2,087 988 3,740 2,423 1,627 1,309 3,946 2,226 1,884 1,994 1,395 1,69080+ 1,839 3,631 1,087 2,696 776 2,836 1,059 1,773 1,273 3,175 1,000 2,188 2,048 1,087 1,560

0-19 15 25 13 15 11 22 17 10 13 24 15 12 16 13 1420-44 92 447 172 93 64 312 166 82 75 379 172 88 138 96 11745-64 425 1,919 913 550 312 1,451 907 355 405 1,878 1,052 520 699 523 60965-74 1,255 3,742 2,052 1,605 872 3,525 2,589 1,237 1,067 3,652 2,315 1,448 1,618 1,258 1,43575+ 1,837 3,983 1,576 2,539 882 3,242 1,639 1,774 1,326 3,471 1,405 2,150 2,095 1,208 1,644

Diabetes 130 303 236 136 110 349 298 114 113 438 393 170 281 229 254Hypertension 80 285 33 77 56 234 29 60 63 349 51 101 255 150 201Glomerulonephritis 30 66 31 40 18 45 30 32 23 64 36 41 53 29 41Other cause 70 122 36 38 51 105 36 36 12 28 10 9 28 16 22

All 311 778 337 291 235 734 393 243 273 755 365 266 369 305 336All (age adjusted) 325 1,108 508 427 207 887 550 304 257 990 532 357 411 280 336

Rates by age are adjusted for gender & race.The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.The age of the incident patient is determined as of the date of ESRD initiation. *Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

297


ON OUR WEBSITE & CDMedian age at start of ESRD therapy; incident patients by demographic characteristics & primary diagnosis (A.c).

Table A.6Mean age at start of ESRD therapyby demographic characteristics & primary diagnosis

Table A.6Mean age at start of ESRD therapyby demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19920-4 2.4 2.4 2.1 2.1 2.0 1.8 1.8 1.8 1.6 2.0 1.7 1.6 1.65-9 7.9 7.9 7.5 7.9 7.8 7.6 7.7 7.7 7.8 7.8 7.8 7.6 7.610-14 12.6 12.9 12.9 12.7 12.8 12.9 12.7 12.6 12.7 13.0 12.7 12.8 12.815-19 17.7 17.8 17.7 17.8 17.8 17.7 17.8 17.7 17.7 17.8 17.8 17.9 17.920-29 25.5 25.6 25.6 25.8 25.7 25.7 25.9 25.8 25.8 26.0 25.9 25.9 25.830-39 34.9 35.0 34.9 35.0 35.0 35.2 35.2 35.2 35.3 35.2 35.3 35.3 35.440-49 45.3 45.2 45.2 45.3 45.3 45.2 45.2 45.2 45.1 45.2 45.1 45.2 45.250-59 55.3 55.4 55.3 55.4 55.4 55.5 55.4 55.4 55.4 55.4 55.4 55.4 55.360-64 62.5 62.5 62.5 62.5 62.5 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.665-69 67.4 67.5 67.5 67.5 67.5 67.4 67.4 67.4 67.5 67.5 67.5 67.5 67.570-79 74.1 74.1 74.1 74.2 74.3 74.3 74.5 74.4 74.5 74.6 74.5 74.5 74.580+ 83.4 83.5 84.1 83.6 83.6 83.6 83.7 83.5 83.6 83.7 83.8 83.8 83.8

0-19 14.3 14.2 13.5 13.6 13.2 13.0 13.0 12.9 13.2 13.1 13.0 12.6 13.120-44 33.7 33.9 33.7 34.1 34.0 34.2 34.4 34.7 34.7 34.8 35.1 35.3 35.345-64 56.0 56.1 56.2 56.4 56.5 56.6 56.5 56.5 56.5 56.4 56.5 56.5 56.365-74 69.5 69.6 69.7 69.7 69.7 69.8 69.8 69.7 69.8 69.7 69.8 69.8 69.975+ 79.2 79.3 79.5 79.5 79.5 79.6 79.7 79.7 79.8 79.9 80.0 80.0 80.1

Male 52.4 52.2 52.8 54.7 54.6 55.3 55.8 56.2 56.5 57.1 57.5 58.1 58.5Female 53.3 53.4 53.9 56.1 56.2 56.9 57.4 58.1 58.1 58.8 59.2 59.9 60.2Unknown . 33.1 . 46.4 30.6 34.9 45.9 35.7 42.3 . . 59.3 62.2

White 53.1 53.1 53.8 55.8 56.0 56.8 57.4 58.1 58.6 59.4 59.7 60.5 61.0Black 52.2 52.0 52.5 54.4 54.1 54.6 54.9 54.9 54.7 55.0 55.4 55.9 56.0Native American 49.4 50.8 50.8 53.0 52.2 53.0 53.5 54.5 55.2 56.4 55.4 56.2 56.2Asian 42.2 45.8 48.0 51.3 52.3 52.7 52.4 53.5 53.6 54.0 55.8 56.9 56.7Other/unknown 55.6 56.4 51.0 53.2 52.2 50.0 53.1 50.7 49.8 52.0 47.3 47.8 51.0


Diabetes 51.1 52.1 53.0 54.0 54.5 54.9 55.6 56.5 57.1 57.5 58.4 59.1 59.5Hypertension 56.4 58.3 59.4 60.9 61.0 61.9 62.6 63.2 63.0 63.7 64.1 64.4 64.5Glomerulonephritis 44.9 46.6 47.2 48.5 49.2 50.2 50.3 50.5 50.5 51.3 51.3 52.3 52.0Cystic kidney 51.7 52.6 52.9 53.6 53.6 53.7 53.6 54.1 53.9 53.3 54.3 53.7 54.6Other urologic 51.3 55.3 54.0 57.4 58.1 58.4 58.7 59.5 59.8 60.3 58.8 59.6 59.9Other cause 46.5 48.3 49.0 49.4 49.6 50.8 51.6 51.2 51.1 51.9 51.3 51.6 52.3Unknown cause 55.0 56.8 56.3 58.6 59.5 58.7 59.3 59.6 59.4 58.9 58.5 58.9 59.1Missing disease 58.0 53.3 53.1 63.2 62.0 61.1 58.8 55.0 52.9 53.6 51.5 53.6 52.3

U.S. 52.8 52.7 53.3 55.4 55.4 56.1 56.6 57.2 57.4 58.0 58.4 59.0 59.4U.S. territories 48.2 44.2 54.7 52.5 51.6 53.0 55.0 53.8 51.2 53.4 53.7 56.3 52.9Puerto Rico 54.4 54.7 52.1 55.0 55.0 56.1 55.9 55.5 57.3 58.7 57.6 56.8 58.8Foreign 52.3 47.9 52.0 51.0 55.9 50.5 54.7 58.9 45.6 49.7 49.5 45.1 48.9Unknown 53.0 55.3 53.0 50.3 48.8 49.8 51.1 44.1 44.1 44.9 47.7 49.3 49.3

All 52.8 52.8 53.3 55.3 55.3 56.0 56.5 57.1 57.2 57.9 58.3 59.0 59.3

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients with unknown age are excluded. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.


298

Reference section A

Table A.6 (continued)Mean age at start of ESRD therapyby demographic characteristics & primary diagnosis

Table A.6 (continued)Mean age at start of ESRD therapyby demographic characteristics & primary diagnosis

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 1.8 1.6 1.7 1.9 1.9 1.4 1.6 1.6 1.7 1.7 1.75-9 7.6 7.8 7.6 7.6 7.9 8.0 7.9 7.6 7.6 7.7 7.610-14 12.8 13.0 12.8 12.9 12.8 12.7 12.8 12.6 12.8 12.8 12.815-19 17.7 17.7 17.7 17.8 17.7 17.7 17.8 17.8 17.8 17.8 17.720-29 25.8 25.8 25.8 25.8 25.9 25.9 25.8 25.9 25.8 25.7 25.630-39 35.4 35.4 35.5 35.5 35.5 35.5 35.6 35.5 35.5 35.6 35.540-49 45.2 45.3 45.3 45.4 45.4 45.4 45.5 45.5 45.5 45.6 45.550-59 55.3 55.3 55.3 55.3 55.3 55.2 55.2 55.2 55.2 55.3 55.260-64 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.5 62.565-69 67.5 67.5 67.5 67.5 67.5 67.5 67.6 67.5 67.5 67.6 67.570-79 74.5 74.5 74.6 74.6 74.7 74.8 74.9 74.9 74.9 74.9 75.080+ 83.8 83.8 83.9 84.0 84.1 84.2 84.3 84.3 84.3 84.3 84.4

0-19 12.7 13.0 12.9 12.9 12.9 12.8 13.0 12.7 12.7 12.7 12.820-44 35.4 35.4 35.7 35.9 35.9 36.0 36.1 36.1 36.1 36.2 36.245-64 56.2 56.1 56.1 56.1 56.1 56.0 56.0 56.0 56.0 56.0 56.065-74 69.9 70.0 70.0 70.1 70.1 70.1 70.1 70.1 70.1 70.1 70.175+ 80.2 80.2 80.3 80.4 80.5 80.6 80.7 80.8 80.9 81.0 81.1

Male 58.6 59.1 59.2 60.1 60.7 60.9 61.4 61.4 61.6 62.1 62.1Female 60.5 60.9 61.2 61.6 62.3 62.4 62.6 63.0 63.1 63.6 63.5Unknown 53.0 58.5 58.7 67.3 . . 42.7 39.8 . 57.9 64.7

White 61.3 61.9 62.2 62.8 63.4 63.6 64.0 64.2 64.4 64.9 64.9Black 56.0 56.2 56.2 56.8 57.5 57.8 57.7 58.2 58.4 58.6 58.6Native American 57.2 55.8 56.1 56.1 57.6 57.1 57.6 58.0 56.4 57.4 58.0Asian 57.5 59.2 60.1 61.0 60.3 61.2 61.8 61.4 61.3 62.2 62.5Other/unknown 52.7 51.1 56.9 57.2 57.7 56.2 56.9 55.5 55.1 54.7 53.8


Diabetes 59.9 60.3 60.9 61.6 62.0 62.3 62.6 62.8 63.0 63.3 63.2Hypertension 65.0 65.1 65.4 65.8 66.5 66.6 66.9 67.1 67.1 67.6 67.5Glomerulonephritis 52.1 53.2 53.0 53.8 53.8 53.7 54.3 53.8 53.5 54.1 53.8Cystic kidney 54.3 55.1 54.2 54.8 55.0 54.6 55.1 55.1 54.9 55.3 54.4Other urologic 57.5 58.2 59.4 61.1 60.7 61.4 61.5 62.2 62.1 61.6 63.0Other cause 52.2 52.8 53.2 53.7 54.8 55.1 55.0 55.7 55.9 56.9 56.9Unknown cause 57.6 58.8 61.1 61.4 62.9 62.4 63.4 63.2 63.1 63.0 63.2Missing disease 59.8 49.8 50.6 49.6 51.2 50.1 49.1 49.7 48.7 55.7 55.4

U.S. 59.6 60.0 60.2 60.8 61.5 61.7 62.0 62.2 62.3 62.8 62.8U.S. territories 56.4 55.5 54.9 55.7 55.9 57.4 58.8 58.6 58.8 56.9 58.0Puerto Rico 58.8 58.4 58.0 59.5 60.5 59.6 60.9 60.1 60.6 60.7 61.1Foreign 45.1 48.4 48.5 48.9 51.1 53.0 61.0 54.9 63.9 58.0 71.8Unknown 48.4 48.2 47.0 36.6 41.7 44.1 36.2 44.1 40.7 38.1 41.1

All 59.5 59.9 60.1 60.8 61.4 61.6 62.0 62.2 62.3 62.8 62.7

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients with unknown age are excluded. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

299


ON OUR WEBSITE & CDIncidence of reported ESRD, by primary diagnosis: Hispanics & non-Hispanic (A.7.1-2). Incidence of reported ESRD: by detailed primary diagnosis, age <20, 20-64, & 65+ (A.7.3-5).

Table A.7Incidence of reported ESRD, by primary diagnosis: all patients999-2003 combined, by detailed primary diagnosis

Table A.7Incidence of reported ESRD, by primary diagnosis: all patients1999-2003 combined, by detailed primary diagnosis

Total Percent Median Percent Percent % Tx % DiedROW PERCENT Patients Incident Age Male White Black N Am Asian 1st yr 1st yrAll ESRD (reference) 484,998 100.0 64 53.9 65.0 28.6 1.2 3.5 4.9 24.1Diabetes 215,733 44.8 64 50.3 64.7 27.8 1.9 3.7 2.7 23.2

Type I (juvenile) 20,518 4.3 47 53.8 74.4 21.5 1.0 1.8 13.2 16.1Type II (adult-onset or unspecified) 195,215 40.5 65 49.9 63.7 28.5 2.0 3.9 1.6 23.9

Glomerulonephritis (GN) 41,097 8.5 53 60.9 66.6 24.7 1.0 5.6 12.9 12.8Focal glomerulosclerosis, focal GN 11,037 2.3 49 60.8 58.2 37.0 0.6 2.8 14.7 10.0Membranous nephropathy 2,181 0.5 59 65.8 71.3 23.9 0.8 2.6 12.2 12.4Membranoproliferative GN, types I & II 1,665 0.3 50 60.5 73.2 19.2 1.5 4.3 16.3 12.7IgA nephropathy, Berger's disease 3,661 0.8 43 67.1 75.1 7.2 1.7 13.7 29.7 5.2IgM nephropathy 423 0.1 49 60.5 74.2 10.4 0.9 13.5 26.0 10.2Rapidly progressive GN 1,642 0.3 63 50.7 80.8 13.4 1.2 3.0 6.0 20.5Goodpasture's Syndrome 579 0.1 58 48.0 91.2 6.2 0.5 1.2 6.4 18.3Post-infectious GN, SBE 443 0.1 58 65.0 81.9 13.8 1.8 2.0 9.3 19.4Glomerulonephritis 18,170 3.8 58 60.8 65.7 23.8 1.1 6.6 8.9 15.0Other proliferative GN 1,296 0.3 55 53.5 73.1 20.3 0.9 3.4 11.8 14.0

Secondary GN/vasculitis 10,412 2.2 47 31.6 61.9 32.1 1.0 3.2 7.7 19.4

Lupus erythematosus (SLE nephritis) 5,301 1.1 38 18.1 43.7 48.1 0.9 4.8 9.3 12.9Polyarteritis 253 0.1 64 47.4 81.0 15.4 1.6 1.6 4.0 25.7Wegeners granulomatosis 1,261 0.3 64 57.3 92.0 5.4 0.6 1.0 6.6 20.9Henoch-Schonlein syndrome 164 . 32 51.8 84.8 10.4 1.8 2.4 26.8 11.0Vasculitis and its derivatives 1,097 0.2 68 43.8 86.3 8.8 1.8 1.9 4.1 30.3Scleroderma 840 0.2 56 24.5 78.8 17.5 0.8 1.7 2.3 40.1Hemolytic uremic syndrome 755 0.2 45 35.5 76.8 19.1 0.9 1.5 10.7 19.1Nephropathy from heroin/related abuse 213 . 45 75.1 38.0 59.6 . 1.4 1.9 16.0Secondary GN, other 528 0.1 55 54.2 68.0 28.4 0.6 2.3 4.9 26.5

Interstitial nephritis/pyelonephritis 17,582 3.6 65 57.5 81.4 13.9 0.6 2.7 7.6 24.5Chronic pyelonephritis, reflux nephritis 2,231 0.5 45 40.6 85.7 8.4 1.0 2.9 23.3 12.1Analgesic abuse 955 0.2 67 41.0 82.2 13.6 0.6 2.4 4.8 20.6Nephropathy caused by other agents 2,954 0.6 63 58.5 82.5 14.4 0.5 1.5 7.4 29.1Nephrolithiasis, obstruction, gouty 6,116 1.3 69 72.1 79.1 15.7 0.5 3.1 2.6 28.5Nephrocalcinosis 316 0.1 67 52.5 82.3 11.4 0.3 3.5 9.8 22.8Chronic interstitial nephritis 4,074 0.8 65 49.3 80.9 14.4 0.7 2.9 8.4 21.6Acute interstitial nephritis 936 0.2 68 53.0 84.4 12.2 0.3 2.0 2.2 30.1

Hypertensive/large vessel disease 130,704 27.1 70 56.2 59.0 36.2 0.4 3.2 1.9 26.8Hypertension (no primary renal disease) 117,439 24.4 70 56.1 55.2 39.7 0.4 3.5 2.1 25.7Renal artery stenosis or occlusion 9,213 1.9 75 53.5 91.7 6.3 0.3 1.2 0.7 36.7Cholesterol emboli, renal emboli 4,052 0.8 74 65.0 94.8 2.9 0.4 1.3 0.4 35.3

Cystic/hereditary/congenital diseases 15,206 3.2 50 56.7 82.3 12.9 0.6 2.4 26.9 6.7Polycystic kidneys, adult (dominant) 10,722 2.2 54 53.4 83.1 12.6 0.4 2.5 23.2 6.6Polycystic kidneys, infantile (recessive) 225 . 18 47.6 79.6 11.6 1.8 2.2 40.4 8.4Medullary cystic, including nephronophthisis 222 . 25 50.0 84.2 8.6 0.5 4.5 42.8 6.3Alport's, other hereditary/familial disease 1,048 0.2 36 64.7 87.0 8.0 0.7 3.0 34.4 3.2Tuberous sclerosis 167 . 56 44.3 77.8 17.4 0.6 0.6 12.0 25.7Cystinosis 81 . 16 48.1 81.5 9.9 2.5 2.5 53.1 9.9Primary oxalosis 38 . 48 44.7 84.2 5.3 2.6 2.6 36.8 10.5Fabrys disease 83 . 44 86.7 94.0 6.0 . . 20.5 8.4Congenital nephrotic syndrome 289 0.1 25 59.5 72.3 19.4 0.7 4.2 30.1 11.8Drash syndrome, mesangial sclerosis 42 . 44 52.4 71.4 19.0 . 2.4 11.9 16.7Congenital obstructive uropathy 1,245 0.3 21 75.6 78.0 16.1 1.2 1.5 35.6 8.0Renal hypoplasia, dysplasia 914 0.2 13 57.8 77.4 15.6 1.2 2.1 40.0 4.4Prune belly syndrome 130 . 12 96.9 72.3 25.4 0.8 1.5 46.2 4.6

Neoplasms/tumors 10,094 2.1 69 59.8 78.2 18.8 0.5 1.4 0.9 50.9Renal or urological neoplasms 2,846 0.6 70 72.6 80.2 17.4 0.4 0.8 1.4 40.3Multiple myeloma 5,390 1.1 70 53.8 75.6 21.3 0.5 1.7 . 59.4Light chain nephropathy 631 0.1 70 56.9 81.5 15.5 0.5 1.6 1.3 45.8Amyloidosis 1,227 0.3 67 57.6 83.2 13.0 0.8 1.5 3.1 41.2

Miscellaneous conditions 21,301 4.4 60 61.5 64.7 31.9 0.5 1.5 4.1 36.5Complication post-bone marrow/other tx 684 0.1 56 62.7 87.6 9.2 0.4 1.5 13.6 25.7Sickle cell disease/anemia or trait 521 0.1 43 50.1 6.0 93.1 0.4 0.4 3.3 28.2AIDS nephropathy 4,258 0.9 41 68.1 7.9 90.1 0.1 0.2 . 33.2Traumatic/surgical loss of kidney(s) 527 0.1 66 66.4 81.0 16.1 . 1.3 5.3 24.1Hepatorenal syndrome 1,205 0.3 54 67.3 81.9 12.3 2.1 2.0 15.1 57.8Tubular necrosis (no recovery) 8,124 1.7 69 58.5 81.3 15.3 0.5 1.4 0.8 39.6Post-partum failure, other renal disorders 5,982 1.2 66 59.9 80.0 15.7 0.4 2.4 8.1 33.5

Etiology uncertain 19,646 4.1 68 58.0 72.3 21.4 0.6 3.3 6.0 29.6Missing 3,223 0.7 52 56.7 63.5 21.8 0.2 2.2 48.9 25.9

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.

"." Zero values in this cell.


300

Reference section A

Table A.7 (continued)Incidence of reported ESRD, by primary diagnosis: all patients999-2003 combined, by detailed primary diagnosis

Table A.7 (continued)Incidence of reported ESRD, by primary diagnosis: all patients1999-2003 combined, by detailed primary diagnosis

Total Counts PercentCOLUMN PERCENT Patients White Black N Am Asian White Black N Am AsianAll ESRD (reference) 484,998 315,360 138,749 5,632 16,950 100.0 100.0 100.0 100.0Diabetes 215,733 139,620 59,957 4,142 8,057 44.6 43.4 73.6 47.7

Type I, juvenile type 20,518 15,269 4,403 214 369 4.9 3.2 3.8 2.2Type II, adult-onset or unspecified type 195,215 124,351 55,554 3,928 7,688 39.7 40.2 69.8 45.5

Glomerulonephritis 41,097 27,370 10,147 425 2,314 8.7 7.4 7.6 13.7Focal glomerulosclerosis, focal GN 11,037 6,422 4,088 68 313 2.0 3.0 1.2 1.9Membranous nephropathy 2,181 1,555 521 18 56 0.5 0.4 0.3 0.3Membranoproliferative GN, types I & II 1,665 1,218 320 25 72 0.4 0.2 0.4 0.4IgA nephropathy, Berger's disease 3,661 2,751 263 64 500 0.9 0.2 1.1 3.0IgM nephropathy 423 314 44 * 57 0.1 . 0.1 0.3Rapidly progressive GN 1,642 1,326 220 20 49 0.4 0.2 0.4 0.3Goodpasture's Syndrome 579 528 36 * * 0.2 . 0.1 .Post infectious GN, SBE 443 363 61 * * 0.1 . 0.1 0.1Glomerulonephritis (GN) 18,170 11,945 4,331 203 1,207 3.8 3.1 3.6 7.2Other proliferative GN 1,296 948 263 12 44 0.3 0.2 0.2 0.3

Secondary GN/vasculitis 10,412 6,449 3,339 102 337 2.1 2.4 1.8 2.0Lupus erythematosus (SLE nephritis) 5,301 2,316 2,551 50 256 0.7 1.8 0.9 1.5Polyarteritis 253 205 39 * * 0.1 . 0.1 .Wegeners granulomatosis 1,261 1,160 68 * 12 0.4 . 0.1 0.1Henoch-Schonlein syndrome 164 139 17 * * . . 0.1 .Vasculitis and its derivatives 1,097 947 96 20 21 0.3 0.1 0.4 0.1Scleroderma 840 662 147 * 14 0.2 0.1 0.1 0.1Hemolytic uremic syndrome 755 580 144 * 11 0.2 0.1 0.1 0.1Nephropathy from heroin /related abuse 213 81 127 . * . 0.1 . .Secondary GN, other 528 359 150 * 12 0.1 0.1 0.1 0.1

Interstitial nephritis/pyelonephritis 17,582 14,319 2,438 108 466 4.6 1.8 1.9 2.8Chronic pyelonephritis, reflux neph. 2,231 1,913 187 23 64 0.6 0.1 0.4 0.4Analgesic abuse 955 785 130 * 23 0.3 0.1 0.1 0.1Nephropathy caused by other agents 2,954 2,437 425 16 43 0.8 0.3 0.3 0.3Nephrolithiasis, obstruction, gouty 6,116 4,839 958 29 188 1.5 0.7 0.5 1.1Nephrocalcinosis 316 260 36 * 11 0.1 . . 0.1Chronic interstitial nephritis 4,074 3,295 588 30 118 1.1 0.4 0.5 0.7Acute interstitial nephritis 936 790 114 * 19 0.3 0.1 0.1 0.1

Hypertensive/large vessel disease 130,704 77,174 47,283 488 4,229 24.6 34.3 8.7 25.1Hypertension (no primary renal disease) 117,439 64,883 46,587 441 4,066 20.7 33.7 7.8 24.1Renal artery stenosis or occlusion 9,213 8,450 578 29 110 2.7 0.4 0.5 0.7Cholesterol emboli, renal emboli 4,052 3,841 118 18 53 1.2 0.1 0.3 0.3

Cystic/hereditary/congenital diseases 15,206 12,508 1,966 85 370 4.0 1.4 1.5 2.2Polycystic kidneys, adult (dominant) 10,722 8,913 1,352 40 267 2.8 1.0 0.7 1.6Polycystic kidneys, infantile (recessive) 225 179 26 * * 0.1 . 0.1 .Medullary cystic, including nephronophthisis 222 187 19 * 10 0.1 . . 0.1Alport's, other hereditary/familial disease 1,048 912 84 * 31 0.3 0.1 0.1 0.2Tuberous sclerosis 167 130 29 * * . . . .Cystinosis 81 66 * * * . . . .Primary oxalosis 38 32 * * * . . . .Fabrys disease 83 78 * . . . . . .Congenital nephrotic syndrome 289 209 56 * 12 0.1 . . 0.1Drash syndrome, mesangial sclerosis 42 30 * . * . . . .Congenital obstructive uropathy 1,245 971 201 15 19 0.3 0.1 0.3 0.1Renal hypoplasia, dysplasia 914 707 143 11 19 0.2 0.1 0.2 0.1Prune belly syndrome 130 94 33 * * . . . .

Neoplasms/tumors 10,094 7,894 1,901 50 143 2.5 1.4 0.9 0.8Renal or urological neoplasms 2,846 2,282 494 12 24 0.7 0.4 0.2 0.1Multiple myeloma 5,390 4,077 1,149 25 90 1.3 0.8 0.4 0.5Light chain nephropathy 631 514 98 * 10 0.2 0.1 0.1 0.1Amyloidosis 1,227 1,021 160 * 19 0.3 0.1 0.2 0.1

Miscellaneous conditions 21,301 13,772 6,803 100 310 4.4 4.9 1.8 1.8Complication post bone marrow/other txp 684 599 63 * * 0.2 . 0.1 0.1Sickle cell disease/anemia or trait 521 31 485 * * . 0.4 . .AIDS nephropathy 4,258 336 3,837 * * 0.1 2.8 0.1 .Traumatic/surgical loss of kidney(s) 527 427 85 . * 0.1 0.1 . .Hepatorenal syndrome 1,205 987 148 25 24 0.3 0.1 0.4 0.1Tubular necrosis (no recovery) 8,124 6,607 1,243 44 115 2.1 0.9 0.8 0.7Post-partum failure, other renal disorders 5,982 4,785 942 23 145 1.5 0.7 0.4 0.9

Etiology uncertain 19,646 14,206 4,213 127 654 4.5 3.1 2.3 3.9Missing 3,223 2,048 702 * 70 0.7 0.5 0.1 0.4

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

301


ON OUR WEBSITE & CDIncident counts of reported ESRD patients, by diabetic status & state: U.S. only, with unknowns dropped (A.8.1).

Table A.8Incident counts of reported ESRD patients, by diabetic status & state/territory: all patientsTable A.8Incident counts of reported ESRD patients, by diabetic status & state/territory: all patients

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992Alabama 332 372 401 526 505 546 573 674 793 1,022 939 1,053 1,186Alaska * * 13 17 13 14 34 24 32 46 34 48 50Arizona 268 300 342 416 425 472 557 656 655 768 789 881 1,100Arkansas 140 162 176 236 261 275 296 372 386 420 419 519 551California 1,866 2,267 2,440 2,905 3,009 3,324 3,794 4,041 4,521 5,061 5,670 6,186 6,463Colorado 186 200 209 208 246 266 329 340 358 429 434 490 535Connecticut 226 232 283 371 351 484 457 488 502 578 624 704 707Delaware 45 57 83 64 67 95 92 107 133 142 145 193 203District of Columbia 120 128 175 169 164 206 170 196 191 283 274 329 352Florida 1,141 1,226 1,309 1,481 1,676 1,818 2,116 2,414 2,579 2,949 3,111 3,512 3,881Georgia 484 641 633 773 797 815 954 1,084 1,319 1,413 1,497 1,776 1,961Hawaii 85 101 101 115 125 177 176 206 217 235 279 273 293Idaho 51 45 59 63 69 83 87 96 101 138 142 135 128Illinois 827 969 1,121 1,271 1,315 1,520 1,619 1,730 1,789 1,972 2,304 2,729 2,766Indiana 336 412 451 551 538 598 609 719 826 865 1,003 1,102 1,234Iowa 176 189 203 240 227 266 317 283 325 380 439 457 526Kansas 127 142 198 187 213 219 252 276 297 367 403 412 449Kentucky 235 249 272 281 323 371 406 460 483 542 668 762 836Louisiana 324 403 425 478 555 603 687 774 1,058 1,058 1,107 1,240 1,414Maine 40 83 63 76 110 94 109 120 120 108 146 146 158Maryland 314 391 439 465 541 588 576 751 771 959 1,063 1,247 1,329Massachusetts 398 343 483 589 579 586 641 688 788 870 933 1,053 1,206Michigan 765 803 884 946 1,096 1,127 1,231 1,321 1,510 1,743 1,804 1,991 2,225Minnesota 259 294 312 317 400 436 462 557 549 596 690 743 804Mississippi 212 198 244 342 329 356 384 423 486 610 652 671 785Missouri 334 361 441 469 551 614 664 764 832 893 1,017 1,098 1,207Montana 30 59 41 68 73 64 66 79 76 112 122 138 126Nebraska 88 115 102 110 118 141 146 176 198 221 220 260 300Nevada 89 82 83 102 106 126 175 166 184 185 211 248 251New Hampshire 52 72 62 70 70 86 84 101 113 130 125 139 151New Jersey 781 769 883 1,034 966 1,176 1,219 1,353 1,414 1,655 1,786 1,990 2,177New Mexico 124 104 132 155 162 177 191 214 269 267 288 351 355New York 1,466 1,623 1,789 2,058 2,245 2,395 2,697 2,826 3,174 3,418 3,869 4,028 4,546North Carolina 504 519 608 698 722 903 937 1,061 1,160 1,357 1,451 1,689 1,867North Dakota 26 42 40 40 51 57 74 65 79 103 99 99 128Ohio 708 809 952 1,060 1,117 1,258 1,350 1,468 1,711 1,851 2,246 2,324 2,546Oklahoma 203 222 242 263 301 303 371 404 485 506 596 580 675Oregon 127 153 179 221 214 250 305 312 359 400 415 509 482Pennsylvania 945 1,009 1,142 1,302 1,492 1,714 1,793 1,853 2,065 2,292 2,693 2,791 3,028Rhode Island 76 79 75 103 119 124 101 118 133 167 182 208 206South Carolina 270 336 365 425 460 548 564 625 763 829 934 1,008 1,089South Dakota 42 58 55 55 73 75 62 92 96 97 92 101 119Tennessee 335 350 415 534 469 561 582 744 748 1,118 1,077 1,169 1,269Texas 1,072 1,271 1,517 1,737 1,710 1,943 2,174 2,407 2,754 3,170 3,584 3,925 4,429Utah 92 116 99 96 148 120 140 146 193 184 194 192 211Vermont 36 27 36 37 36 45 36 47 53 61 66 83 64Virginia 503 518 593 730 736 764 818 935 1,042 1,110 1,221 1,488 1,642Washington 241 243 281 330 371 407 455 493 523 651 688 747 793West Virginia 118 122 154 190 217 196 236 241 298 278 302 365 392Wisconsin 311 337 418 381 460 474 532 647 726 773 782 892 984Wyoming 15 28 32 24 27 44 28 42 46 49 34 45 46

American Samoa * * * * * * * * * 13 * * 13Guam * * * * * * 12 * 19 19 28 36 43Puerto Rico 235 245 299 300 377 387 403 425 489 576 583 665 785Saipan . . . . * * . * * * * * 11Virgin Islands * * 11 * * 13 * 17 15 14 19 20 30

Foreign * 14 * 13 13 20 13 15 19 20 43 38 32Unknown 209 189 207 224 229 263 299 297 454 384 378 282 179

All 18,017 20,102 22,587 25,935 27,581 30,604 33,471 36,951 41,292 46,462 50,926 56,173 61,318

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. *Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.


302

Reference section A

Table A.8 (continued)Incident counts of reported ESRD patients, by diabetic status & state/territory: all patientsTable A.8 (continued)Incident counts of reported ESRD patients, by diabetic status & state/territory: all patients

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 1,197 1,297 1,374 1,501 1,659 1,596 1,700 1,754 1,791 1,816 1,859Alaska 45 136 219 69 81 66 72 87 91 80 98Arizona 1,144 1,125 1,226 1,302 1,391 1,535 1,634 1,697 1,760 1,795 1,886Arkansas 593 695 731 724 825 763 830 849 875 938 917California 6,985 7,938 8,037 8,540 9,109 9,854 10,418 10,773 11,125 11,897 12,089Colorado 558 576 556 672 689 781 762 783 783 848 828Connecticut 748 863 847 901 916 942 991 1,018 958 994 962Delaware 192 219 236 229 230 246 279 291 273 310 349District of Columbia 374 357 394 392 404 407 417 455 432 445 451Florida 3,934 4,256 4,343 4,881 5,101 5,177 5,549 5,748 5,970 6,250 6,344Georgia 1,981 2,178 2,293 2,504 2,511 2,682 2,977 3,151 3,209 3,302 3,359Hawaii 328 407 391 386 424 450 481 508 467 507 489Idaho 141 174 191 213 226 218 259 253 282 259 267Illinois 3,101 3,386 3,551 3,903 3,850 4,108 4,331 4,372 4,502 4,890 4,698Indiana 1,308 1,333 1,402 1,542 1,615 1,829 1,802 1,898 1,920 2,026 2,001Iowa 546 576 542 612 616 662 788 707 739 787 750Kansas 438 501 494 575 657 660 676 688 658 720 724Kentucky 831 881 903 971 1,044 1,143 1,231 1,229 1,274 1,270 1,330Louisiana 1,400 1,525 1,602 1,620 1,847 2,007 2,133 2,015 2,181 2,323 2,385Maine 177 194 226 215 265 268 258 297 296 312 326Maryland 1,422 1,544 1,720 1,828 1,903 2,090 2,117 2,206 2,252 2,340 2,380Massachusetts 1,345 1,396 1,372 1,509 1,572 1,629 1,599 1,696 1,621 1,698 1,777Michigan 2,395 2,452 2,543 2,923 2,917 3,131 3,208 3,330 3,489 3,655 3,616Minnesota 830 882 847 940 1,000 1,055 1,053 1,092 1,212 1,232 1,183Mississippi 854 941 915 1,025 1,091 1,135 1,196 1,144 1,230 1,336 1,323Missouri 1,296 1,383 1,439 1,522 1,634 1,797 1,820 1,877 1,918 1,839 1,981Montana 147 141 162 157 145 154 194 165 208 172 190Nebraska 296 315 330 357 409 428 466 490 529 483 490Nevada 303 374 356 377 413 455 565 548 616 621 728New Hampshire 156 183 182 167 206 222 253 271 246 273 282New Jersey 2,333 2,502 2,627 2,642 2,874 3,046 3,256 3,137 3,277 3,334 3,390New Mexico 377 373 428 476 488 474 555 571 561 547 600New York 4,936 5,001 5,113 5,507 5,844 6,081 6,272 6,535 6,623 6,798 6,913North Carolina 2,009 2,195 2,135 2,420 2,640 2,826 2,814 3,039 3,091 3,138 3,207North Dakota 127 148 118 140 136 137 136 161 187 182 164Ohio 2,603 2,911 3,003 3,440 3,441 3,749 3,985 4,264 4,184 4,361 4,482Oklahoma 729 755 781 827 948 1,037 1,035 1,073 1,124 1,137 1,259Oregon 552 568 571 604 641 672 718 740 786 855 902Pennsylvania 3,077 3,495 3,589 3,951 4,136 4,213 4,424 4,547 4,460 4,781 4,492Rhode Island 238 266 232 275 270 285 310 328 315 324 338South Carolina 1,130 1,324 1,235 1,385 1,459 1,596 1,656 1,600 1,678 1,641 1,826South Dakota 138 145 181 197 200 208 215 244 217 253 253Tennessee 1,263 1,453 1,504 1,569 1,709 1,784 1,973 1,897 1,850 2,000 2,055Texas 4,546 4,816 4,974 5,532 5,805 6,249 6,632 6,889 7,100 7,411 7,771Utah 261 254 270 263 270 347 345 335 403 373 365Vermont 83 80 101 111 111 117 128 122 101 132 139Virginia 1,684 1,796 1,902 2,071 2,343 2,341 2,440 2,272 2,472 2,685 2,675Washington 837 938 952 999 1,050 1,109 1,230 1,323 1,301 1,419 1,462West Virginia 420 461 492 532 616 659 649 701 725 703 709Wisconsin 965 1,053 1,068 1,168 1,229 1,359 1,320 1,390 1,468 1,591 1,633Wyoming 51 44 66 70 70 75 82 87 85 80 89

American Samoa * 14 * 12 * * 20 21 18 15 20Guam 40 44 50 63 69 67 73 67 83 96 93Puerto Rico 800 858 853 938 963 1,040 1,115 1,108 1,154 1,224 1,295Saipan * * 14 14 18 22 14 18 * 17 19Virgin Islands 22 23 32 30 43 41 37 31 39 46 43

Foreign 42 43 33 31 31 39 26 39 28 27 16Unknown 150 172 36 36 40 49 41 35 33 37 295

All 64,492 69,968 71,791 77,860 82,203 87,121 91,560 93,966 96,280 100,625 102,567


303


Table A.8 (continued)Incident counts of reported ESRD patients, by diabetic status & state/territory: diabetic patientsTable A.8 (continued)Incident counts of reported ESRD patients, by diabetic status & state/territory: diabetic patients

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991Alabama 26 42 62 89 104 120 143 183 190 288 298 350Alaska * * * * * * 11 * * 21 11 14Arizona 64 85 116 144 167 181 236 296 287 363 354 439Arkansas * 25 31 53 62 74 84 120 105 134 130 186California 211 463 597 723 814 1,040 1,216 1,259 1,433 1,880 2,080 2,388Colorado 38 42 51 69 81 96 137 135 156 183 189 213Connecticut 29 60 64 93 112 150 138 148 147 185 212 245Delaware * 12 16 * 17 25 29 29 51 59 52 70District of Columbia * 24 43 35 48 70 57 53 48 70 86 95Florida 126 203 267 298 368 427 585 657 682 810 929 1,047Georgia 53 127 154 150 191 222 268 340 359 440 503 558Hawaii 23 36 32 34 28 58 75 106 99 107 145 144Idaho * * 16 22 19 16 28 36 36 50 49 41Illinois 141 191 254 294 335 446 464 517 523 620 767 925Indiana 43 83 78 130 131 154 159 225 252 259 361 413Iowa 27 52 54 69 68 85 105 67 104 130 134 147Kansas 24 32 53 52 67 63 59 78 99 106 135 162Kentucky 38 46 49 80 105 95 112 146 143 176 237 281Louisiana 31 60 77 76 133 131 186 211 312 357 365 467Maine * 11 15 17 21 24 25 40 35 33 42 47Maryland 37 76 93 115 137 181 159 213 215 313 382 454Massachusetts 62 85 100 105 116 122 154 160 189 264 302 359Michigan 176 209 230 255 291 336 417 403 504 612 703 790Minnesota 71 84 99 121 158 144 168 202 192 241 264 286Mississippi 25 36 44 52 79 80 98 108 148 178 229 256Missouri 19 74 121 103 137 181 177 216 240 281 327 382Montana * 12 * 15 24 22 17 27 33 52 59 62Nebraska 16 33 28 35 32 38 46 58 66 83 80 103Nevada 19 17 22 17 23 26 44 60 54 70 81 91New Hampshire * * 11 15 16 20 20 28 35 42 41 45New Jersey 114 159 198 241 240 311 350 378 442 497 641 692New Mexico 27 33 43 69 67 61 88 108 135 135 130 202New York 202 315 392 485 595 627 795 851 996 1,038 1,252 1,367North Carolina 68 78 127 150 179 242 240 323 332 419 509 610North Dakota * * * 17 21 18 25 24 36 52 43 39Ohio 143 203 262 283 333 396 435 509 591 670 817 874Oklahoma 25 40 66 82 91 101 132 145 210 194 257 265Oregon 20 27 55 57 50 69 88 101 118 132 142 165Pennsylvania 174 191 258 304 432 448 518 569 647 740 917 1,026Rhode Island * 14 14 15 20 24 21 36 47 45 57 56South Carolina 41 51 78 89 127 167 156 198 224 267 308 372South Dakota * 23 12 19 29 32 26 37 47 36 32 52Tennessee 34 47 76 98 116 132 135 201 215 333 349 379Texas 158 267 398 422 545 633 697 812 1,006 1,333 1,541 1,683Utah 33 35 32 38 59 53 66 67 84 66 91 87Vermont * * 14 * * 16 * 15 * 25 21 32Virginia 59 73 124 169 184 172 223 248 310 342 374 477Washington 43 41 62 71 100 140 120 133 191 227 239 289West Virginia 19 22 32 54 56 53 82 77 92 94 112 131Wisconsin 77 84 126 118 159 147 185 226 237 281 305 359Wyoming * * 11 * * 21 * 16 15 23 12 14

American Samoa . * * . . * * * * * * *Guam * . * * * * * * * 11 13 20Puerto Rico 39 54 83 101 140 137 166 197 212 288 282 352Saipan . . . . * . . * * * * *Virgin Islands . * * * * * * * * * * *

Foreign . . * . * * * * . * * *Unknown 23 21 45 48 55 66 94 68 108 98 129 96

All 2,690 4,043 5,308 6,218 7,513 8,708 10,092 11,477 13,072 15,770 18,138 20,720



304

Reference section A

Table A.8 (continued)Incident counts of reported ESRD patients, by diabetic status & state/territory: diabetic patientsTable A.8 (continued)Incident counts of reported ESRD patients, by diabetic status & state/territory: diabetic patients

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 410 437 484 537 598 721 673 760 779 819 779 816Alaska 15 23 44 85 33 44 31 38 37 46 37 41Arizona 537 573 557 637 646 740 797 843 903 924 948 973Arkansas 178 205 230 281 302 318 303 336 356 370 405 402California 2,553 2,690 3,262 3,443 3,771 4,285 4,551 4,851 5,168 5,156 5,535 5,583Colorado 230 256 233 262 333 316 382 360 386 372 408 393Connecticut 246 267 331 334 349 417 381 425 451 384 415 449Delaware 58 73 76 78 82 89 98 123 128 109 128 150District of Columbia 123 116 116 142 164 148 148 153 162 163 164 171Florida 1,203 1,275 1,426 1,543 1,793 1,961 1,961 2,202 2,328 2,485 2,504 2,603Georgia 683 685 785 925 1,082 1,052 1,126 1,242 1,343 1,354 1,445 1,430Hawaii 151 194 231 231 239 248 266 270 311 291 306 292Idaho 61 57 76 75 85 102 104 118 112 108 113 102Illinois 906 1,016 1,201 1,359 1,533 1,496 1,594 1,803 1,777 1,830 1,938 1,863Indiana 465 466 531 607 673 673 825 779 797 813 862 871Iowa 192 216 224 230 262 252 272 318 293 302 317 294Kansas 153 172 204 187 235 268 314 308 331 301 327 295Kentucky 298 330 346 375 432 460 504 551 546 585 588 610Louisiana 540 490 571 620 720 806 906 939 870 970 1,008 1,026Maine 55 71 64 78 77 103 97 106 129 124 133 140Maryland 504 527 582 655 746 796 849 854 832 937 985 884Massachusetts 417 455 530 529 600 599 639 594 644 697 660 689Michigan 878 931 1,005 1,068 1,310 1,311 1,419 1,401 1,491 1,602 1,603 1,564Minnesota 296 336 347 338 361 391 402 382 414 444 469 427Mississippi 287 306 358 382 461 454 505 539 491 537 594 570Missouri 438 495 514 590 667 743 791 771 825 809 813 863Montana 66 58 64 86 69 70 78 93 81 112 86 98Nebraska 116 123 121 165 160 177 180 215 210 235 204 208Nevada 86 100 128 165 138 189 208 259 252 294 309 361New Hampshire 45 52 55 71 59 77 82 96 103 88 108 106New Jersey 703 821 909 1,054 1,090 1,170 1,319 1,358 1,311 1,335 1,386 1,352New Mexico 205 227 203 250 287 279 284 340 359 352 316 341New York 1,518 1,727 1,740 1,946 2,235 2,365 2,435 2,545 2,691 2,832 2,862 2,894North Carolina 668 774 879 877 1,043 1,150 1,282 1,217 1,354 1,344 1,329 1,422North Dakota 63 52 64 52 53 58 64 40 63 79 87 71Ohio 1,029 1,047 1,223 1,324 1,549 1,597 1,758 1,868 2,003 1,970 1,992 1,992Oklahoma 324 337 338 387 392 455 552 531 545 553 565 591Oregon 176 199 209 232 240 264 248 304 302 321 311 341Pennsylvania 1,135 1,123 1,337 1,478 1,593 1,672 1,760 1,827 1,949 1,970 2,013 1,908Rhode Island 70 75 85 86 108 107 114 119 105 117 121 112South Carolina 389 417 502 485 599 607 740 727 722 772 743 851South Dakota 61 67 64 94 91 91 96 119 109 98 115 120Tennessee 453 465 532 600 634 688 706 798 823 801 825 928Texas 1,885 2,085 2,189 2,440 2,780 3,031 3,208 3,377 3,651 3,719 3,995 4,139Utah 91 117 116 147 129 133 160 161 166 206 167 185Vermont 16 35 40 49 44 52 51 62 48 41 54 50Virginia 556 623 710 724 821 992 1,014 1,020 996 1,111 1,173 1,124Washington 322 329 361 380 407 456 473 528 566 550 561 617West Virginia 162 157 185 216 237 289 294 325 377 370 362 369Wisconsin 392 389 399 443 479 533 553 536 548 582 611 635Wyoming 12 25 22 39 31 37 31 39 44 34 37 45

American Samoa * * * * * * * * 18 14 12 16Guam 25 22 27 34 46 47 44 54 39 57 63 64Puerto Rico 441 417 471 452 539 551 628 698 691 736 766 834Saipan * * * * * 13 17 * 14 * 12 13Virgin Islands * * * 20 19 20 21 21 19 20 18 24

Foreign * * 13 * * * * * * * 11 *Unknown 61 42 48 * * * * . * * * 13

All 22,971 24,585 27,384 29,912 33,450 35,971 38,351 40,371 42,070 43,265 44,700 45,330


305


Table A.8 (continued)Incident counts of reported ESRD patients, by diabetic status & state/territory: non-diabetic patientsTable A.8 (continued)Incident counts of reported ESRD patients, by diabetic status & state/territory: non-diabetic patients

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991Alabama 306 330 339 437 401 426 430 491 603 734 641 703Alaska * * * 14 * 11 23 16 24 25 23 34Arizona 204 215 226 272 258 291 321 360 368 405 435 442Arkansas 131 137 145 183 199 201 212 252 281 286 289 333California 1,655 1,804 1,843 2,182 2,195 2,284 2,578 2,782 3,088 3,181 3,590 3,798Colorado 148 158 158 139 165 170 192 205 202 246 245 277Connecticut 197 172 219 278 239 334 319 340 355 393 412 459Delaware 38 45 67 54 50 70 63 78 82 83 93 123District of Columbia 110 104 132 134 116 136 113 143 143 213 188 234Florida 1,015 1,023 1,042 1,183 1,308 1,391 1,531 1,757 1,897 2,139 2,182 2,465Georgia 431 514 479 623 606 593 686 744 960 973 994 1,218Hawaii 62 65 69 81 97 119 101 100 118 128 134 129Idaho 41 36 43 41 50 67 59 60 65 88 93 94Illinois 686 778 867 977 980 1,074 1,155 1,213 1,266 1,352 1,537 1,804Indiana 293 329 373 421 407 444 450 494 574 606 642 689Iowa 149 137 149 171 159 181 212 216 221 250 305 310Kansas 103 110 145 135 146 156 193 198 198 261 268 250Kentucky 197 203 223 201 218 276 294 314 340 366 431 481Louisiana 293 343 348 402 422 472 501 563 746 701 742 773Maine 33 72 48 59 89 70 84 80 85 75 104 99Maryland 277 315 346 350 404 407 417 538 556 646 681 793Massachusetts 336 258 383 484 463 464 487 528 599 606 631 694Michigan 589 594 654 691 805 791 814 918 1,006 1,131 1,101 1,201Minnesota 188 210 213 196 242 292 294 355 357 355 426 457Mississippi 187 162 200 290 250 276 286 315 338 432 423 415Missouri 315 287 320 366 414 433 487 548 592 612 690 716Montana 25 47 35 53 49 42 49 52 43 60 63 76Nebraska 72 82 74 75 86 103 100 118 132 138 140 157Nevada 70 65 61 85 83 100 131 106 130 115 130 157New Hampshire 46 62 51 55 54 66 64 73 78 88 84 94New Jersey 667 610 685 793 726 865 869 975 972 1,158 1,145 1,298New Mexico 97 71 89 86 95 116 103 106 134 132 158 149New York 1,264 1,308 1,397 1,573 1,650 1,768 1,902 1,975 2,178 2,380 2,617 2,661North Carolina 436 441 481 548 543 661 697 738 828 938 942 1,079North Dakota 19 34 31 23 30 39 49 41 43 51 56 60Ohio 565 606 690 777 784 862 915 959 1,120 1,181 1,429 1,450Oklahoma 178 182 176 181 210 202 239 259 275 312 339 315Oregon 107 126 124 164 164 181 217 211 241 268 273 344Pennsylvania 771 818 884 998 1,060 1,266 1,275 1,284 1,418 1,552 1,776 1,765Rhode Island 67 65 61 88 99 100 80 82 86 122 125 152South Carolina 229 285 287 336 333 381 408 427 539 562 626 636South Dakota 32 35 43 36 44 43 36 55 49 61 60 49Tennessee 301 303 339 436 353 429 447 543 533 785 728 790Texas 914 1,004 1,119 1,315 1,165 1,310 1,477 1,595 1,748 1,837 2,043 2,242Utah 59 81 67 58 89 67 74 79 109 118 103 105Vermont 30 20 22 33 26 29 26 32 43 36 45 51Virginia 444 445 469 561 552 592 595 687 732 768 847 1,011Washington 198 202 219 259 271 267 335 360 332 424 449 458West Virginia 99 100 122 136 161 143 154 164 206 184 190 234Wisconsin 234 253 292 263 301 327 347 421 489 492 477 533Wyoming 12 21 21 19 19 23 18 26 31 26 22 31

American Samoa * * * * * * * * * * * *Guam * * * * * . * * * * 15 16Puerto Rico 196 191 216 199 237 250 237 228 277 288 301 313Saipan . . . . . * . * * * . *Virgin Islands * * * * * 12 * 15 11 11 17 14

Foreign * 14 * 13 11 18 * 13 19 14 36 30Unknown 186 168 162 176 174 197 205 229 346 286 249 186

All 15,327 16,059 17,279 19,717 20,068 21,896 23,379 25,474 28,220 30,692 32,788 35,453



306

Reference section A

Table A.8 (continued)Incident counts of reported ESRD patients, by diabetic status & state/territory: non-diabetic patientsTable A.8 (continued)Incident counts of reported ESRD patients, by diabetic status & state/territory: non-diabetic patien

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 776 760 813 837 903 938 923 940 975 972 1,037 1,043Alaska 35 22 92 134 36 37 35 34 50 45 43 57Arizona 563 571 568 589 656 651 738 791 794 836 847 913Arkansas 373 388 465 450 422 507 460 494 493 505 533 515California 3,910 4,295 4,676 4,594 4,769 4,824 5,303 5,567 5,605 5,969 6,362 6,506Colorado 305 302 343 294 339 373 399 402 397 411 440 435Connecticut 461 481 532 513 552 499 561 566 567 574 579 513Delaware 145 119 143 158 147 141 148 156 163 164 182 199District of Columbia 229 258 241 252 228 256 259 264 293 269 281 280Florida 2,678 2,659 2,830 2,800 3,088 3,140 3,216 3,347 3,420 3,485 3,746 3,741Georgia 1,278 1,296 1,393 1,368 1,422 1,459 1,556 1,735 1,808 1,855 1,857 1,929Hawaii 142 134 176 160 147 176 184 211 197 176 201 197Idaho 67 84 98 116 128 124 114 141 141 174 146 165Illinois 1,860 2,085 2,185 2,192 2,370 2,354 2,514 2,528 2,595 2,672 2,952 2,835Indiana 769 842 802 795 869 942 1,004 1,023 1,101 1,107 1,164 1,130Iowa 334 330 352 312 350 364 390 470 414 437 470 456Kansas 296 266 297 307 340 389 346 368 357 357 393 429Kentucky 538 501 535 528 539 584 639 680 683 689 682 720Louisiana 874 910 954 982 900 1,041 1,101 1,194 1,145 1,211 1,315 1,359Maine 103 106 130 148 138 162 171 152 168 172 179 186Maryland 825 895 962 1,065 1,082 1,107 1,241 1,263 1,374 1,315 1,355 1,496Massachusetts 789 890 866 843 909 973 990 1,005 1,052 924 1,038 1,088Michigan 1,347 1,464 1,447 1,475 1,613 1,606 1,712 1,807 1,839 1,887 2,052 2,052Minnesota 508 494 535 509 579 609 653 671 678 768 763 756Mississippi 498 548 583 533 564 637 630 657 653 693 742 753Missouri 769 801 869 849 855 891 1,006 1,049 1,052 1,109 1,026 1,118Montana 60 89 77 76 88 75 76 101 84 96 86 92Nebraska 184 173 194 165 197 232 248 251 280 294 279 282Nevada 165 203 246 191 239 224 247 306 296 322 312 367New Hampshire 106 104 128 111 108 129 140 157 168 158 165 176New Jersey 1,474 1,512 1,593 1,573 1,552 1,704 1,727 1,898 1,826 1,942 1,948 2,038New Mexico 150 150 170 178 189 209 190 215 212 209 231 259New York 3,028 3,209 3,261 3,167 3,272 3,479 3,646 3,727 3,844 3,791 3,936 4,019North Carolina 1,199 1,235 1,316 1,258 1,377 1,490 1,544 1,597 1,685 1,747 1,809 1,785North Dakota 65 75 84 66 87 78 73 96 98 108 95 93Ohio 1,517 1,556 1,688 1,679 1,891 1,844 1,991 2,117 2,261 2,214 2,369 2,490Oklahoma 351 392 417 394 435 493 485 504 528 571 572 668Oregon 306 353 359 339 364 377 424 414 438 465 544 561Pennsylvania 1,893 1,954 2,158 2,111 2,358 2,464 2,453 2,597 2,598 2,490 2,768 2,584Rhode Island 136 163 181 146 167 163 171 191 223 198 203 226South Carolina 700 713 822 750 786 852 856 929 878 906 898 975South Dakota 58 71 81 87 106 109 112 96 135 119 138 133Tennessee 816 798 921 904 935 1,021 1,078 1,175 1,074 1,049 1,175 1,127Texas 2,544 2,461 2,627 2,534 2,752 2,774 3,041 3,255 3,238 3,381 3,416 3,632Utah 120 144 138 123 134 137 187 184 169 197 206 180Vermont 48 48 40 52 67 59 66 66 74 60 78 89Virginia 1,086 1,061 1,086 1,178 1,250 1,351 1,327 1,420 1,276 1,361 1,512 1,551Washington 471 508 577 572 592 594 636 702 757 751 858 845West Virginia 230 263 276 276 295 327 365 324 324 355 341 340Wisconsin 592 576 654 625 689 696 806 784 842 886 980 998Wyoming 34 26 22 27 39 33 44 43 43 51 43 44

American Samoa * * * * * * * 12 * * * *Guam 18 18 17 16 17 22 23 19 28 26 33 29Puerto Rico 344 383 387 401 399 412 412 417 417 418 458 461Saipan * * * * * * * * * . * *Virgin Islands 24 15 16 12 11 23 20 16 12 19 28 19

Foreign 26 39 30 26 25 28 33 16 33 19 16 11Unknown 118 108 124 33 34 39 47 41 34 32 35 282

All 38,347 39,907 42,584 41,879 44,410 46,232 48,770 51,189 51,896 53,015 55,925 57,237


307


Table A.9Incident rates of reported ESRD, by diabetic status & state, adjusted: all patientsper million population

Table A.9Incident rates of reported ESRD, by diabetic status & state, adjusted: all patientsper million population

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991Alabama 74.8 82.3 82.4 110.8 107.9 112.1 118.5 136.9 166.7 212.6 184.6 206.8Alaska * * * 90.8 27.4 47.9 128.0 119.2 102.2 198.4 152.0 170.5Arizona 111.5 144.0 146.8 186.3 168.5 180.8 201.3 230.7 234.1 260.1 257.0 294.3Arkansas 61.9 74.7 81.3 101.9 110.8 116.4 121.5 155.0 165.2 175.2 167.2 212.6California 89.0 108.2 116.9 139.1 141.0 153.6 170.4 177.5 192.4 213.1 235.2 250.3Colorado 85.6 89.4 89.5 98.4 101.7 118.4 137.5 149.0 145.3 180.7 174.1 199.3Connecticut 82.2 83.4 103.5 135.1 119.6 171.2 164.2 172.2 172.3 203.1 204.1 235.0Delaware 73.9 101.2 138.9 109.8 110.7 146.7 149.4 159.5 193.5 206.5 225.2 271.1District of Columbia 118.8 88.1 121.8 105.0 117.7 131.4 97.8 114.5 194.0 177.0 196.7 199.4Florida 107.8 113.6 118.0 127.7 140.1 150.4 166.6 182.9 191.9 214.2 219.8 238.9Georgia 78.4 102.0 97.2 120.5 115.1 122.2 139.4 149.7 181.2 191.4 196.4 233.6Hawaii 130.7 112.9 66.4 89.8 127.0 120.0 163.2 145.6 107.5 154.3 247.9 211.2Idaho 131.5 105.8 62.0 58.7 137.2 88.0 348.0 92.5 101.1 199.0 151.0 204.8Illinois 76.2 88.4 103.2 114.4 119.8 139.6 146.3 156.1 161.2 174.8 204.6 239.6Indiana 73.1 87.5 100.8 121.2 115.5 128.3 123.1 162.4 173.5 182.6 208.3 225.2Iowa 91.6 117.3 96.3 122.1 93.5 110.3 167.2 137.3 165.7 203.1 229.4 244.8Kansas 63.4 77.5 97.8 102.0 114.4 104.9 126.3 139.9 148.4 185.0 202.7 203.7Kentucky 76.4 87.6 85.4 90.0 113.6 122.6 132.8 148.6 154.3 165.1 197.4 233.6Louisiana 71.2 86.1 89.2 104.0 114.9 123.3 141.8 159.3 218.6 207.5 224.7 259.7Maine 33.0 69.2 51.6 100.2 227.3 72.5 90.4 102.1 282.0 138.7 172.4 216.6Maryland 70.6 85.1 96.1 99.2 113.7 120.2 111.3 143.7 145.9 172.7 196.6 223.1Massachusetts 85.3 73.2 101.7 126.2 125.0 114.6 130.0 134.5 160.9 166.9 181.1 199.8Michigan 90.3 98.8 108.6 113.4 134.3 134.8 142.2 154.1 172.7 200.7 200.1 221.4Minnesota 98.7 93.7 124.6 112.8 139.7 144.7 170.0 202.4 217.2 204.1 242.3 261.9Mississippi 72.1 69.9 89.1 111.7 117.2 108.9 125.5 139.0 158.4 179.1 202.6 214.2Missouri 73.1 77.5 102.2 102.1 119.7 131.5 142.5 162.5 176.2 185.0 207.4 219.8Montana 39.4 71.9 50.5 485.7 428.6 76.9 82.2 95.2 177.9 129.8 477.9 295.6Nebraska 84.4 114.3 86.2 104.6 118.1 110.4 132.6 192.0 194.9 188.1 186.2 241.4Nevada 148.5 114.0 124.9 156.8 147.7 189.3 232.6 204.2 211.2 219.1 218.6 237.2New Hampshire 170.9 74.5 97.3 97.5 65.4 106.7 146.0 140.6 259.7 202.6 161.7 162.5New Jersey 111.6 106.9 121.6 144.0 129.7 158.4 160.6 175.0 180.6 212.8 225.8 249.0New Mexico 116.0 101.1 133.8 123.6 120.4 169.2 163.9 178.6 219.9 212.4 233.6 261.0New York 83.6 91.0 100.2 113.6 123.1 131.3 145.9 152.7 169.5 181.6 202.8 210.1North Carolina 76.4 80.2 94.5 105.1 109.1 131.2 132.9 146.6 155.0 179.9 188.2 219.7North Dakota 42.5 69.7 59.2 70.6 82.6 136.7 1,381.0 107.1 135.1 475.9 158.5 151.6Ohio 71.2 84.8 94.7 107.3 115.6 126.5 136.0 143.7 165.6 179.9 218.4 223.7Oklahoma 80.5 89.0 93.0 95.4 109.9 109.2 130.5 140.4 173.0 181.0 208.9 200.7Oregon 95.9 80.0 112.5 117.9 138.7 130.0 141.2 158.6 168.1 209.7 175.3 250.5Pennsylvania 83.2 89.2 100.2 115.2 129.8 147.7 151.9 158.2 173.0 191.9 226.2 229.4Rhode Island 96.0 109.0 110.1 121.4 142.4 158.5 110.7 139.2 151.3 220.8 230.2 218.6South Carolina 72.9 89.8 100.8 105.9 123.5 136.6 141.3 146.8 184.3 187.3 210.2 225.0South Dakota 63.2 83.9 77.3 382.6 113.6 111.5 91.4 131.3 138.4 134.1 511.7 449.5Tennessee 71.7 82.5 94.4 114.1 98.5 115.7 123.2 150.4 154.9 233.1 219.4 239.5Texas 87.1 101.4 115.2 131.7 129.4 140.7 159.4 174.8 197.9 221.5 248.3 272.2Utah 120.4 144.9 105.7 110.9 167.2 112.7 121.9 112.3 220.8 133.8 167.9 178.1Vermont 63.6 45.1 66.8 66.9 59.9 78.7 64.4 166.6 95.5 610.9 147.6 245.5Virginia 86.0 95.1 104.2 126.6 126.5 129.1 134.9 152.2 161.8 174.2 187.6 225.1Washington 84.5 72.0 82.3 90.4 106.9 133.9 138.8 143.8 148.0 178.2 192.0 201.6West Virginia 77.2 80.2 109.3 121.1 133.2 127.9 163.4 153.9 186.7 175.2 191.7 233.8Wisconsin 96.2 100.4 115.0 101.6 141.2 135.4 165.3 194.3 202.0 213.1 222.7 243.1Wyoming 105.9 63.3 62.9 91.3 68.3 240.4 165.7 149.6 231.7 182.0 121.8 362.8

All 84.0 93.6 105.1 119.5 125.2 137.3 148.1 161.7 177.8 197.9 214.0 232.5

Rates are adjusted by age, gender, & race.The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.*Values for cells with 10 or fewer patients are suppressed.


308

Reference section A

Table A.9 (continued)Incident rates of reported ESRD, by diabetic status & state, adjusted: all patientsper million population

Table A.9 (continued)Incident rates of reported ESRD, by diabetic status & state, adjusted: all patientsper million population

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 227.7 225.6 251.1 256.7 276.6 295.4 292.2 297.5 308.3 304.2 301.8 305.4Alaska 169.2 177.8 433.0 704.4 227.2 285.1 188.7 168.1 236.2 206.4 216.8 258.2Arizona 341.7 333.8 302.1 319.4 330.2 342.5 359.6 358.8 360.0 378.3 358.8 379.1Arkansas 226.2 225.8 262.8 285.4 274.6 304.1 268.2 296.2 287.5 297.6 314.8 308.2California 256.2 271.2 305.7 301.7 314.6 329.2 352.4 357.3 364.2 366.3 382.5 377.1Colorado 208.7 204.1 211.3 199.3 228.1 235.1 260.7 241.7 251.0 230.5 242.6 236.0Connecticut 237.7 250.7 283.0 268.1 285.7 281.0 289.2 295.0 305.5 276.0 282.0 268.2Delaware 287.2 250.7 280.5 297.0 284.1 270.0 283.8 308.4 320.1 296.4 332.4 352.7District of Columbia 252.8 226.5 232.4 246.1 233.5 232.5 223.5 275.6 309.3 236.7 246.9 290.1Florida 257.4 258.6 266.1 262.7 284.5 284.8 285.5 295.5 297.5 305.9 307.6 298.9Georgia 250.1 249.0 267.1 277.8 293.2 278.4 294.3 320.9 331.0 329.0 337.5 327.9Hawaii 206.8 196.8 204.7 219.1 236.5 271.1 214.6 318.3 258.9 225.6 218.9 170.1Idaho 337.8 377.4 503.3 346.5 244.3 633.3 272.8 410.5 217.5 425.5 265.8 242.5Illinois 237.4 263.2 285.5 294.2 321.4 315.1 330.6 347.6 345.5 352.5 376.6 357.0Indiana 246.9 263.4 262.8 268.8 297.3 302.0 341.5 333.6 343.5 341.2 356.4 341.5Iowa 264.0 265.7 289.3 263.3 360.9 269.3 323.4 348.8 305.6 292.0 342.1 304.7Kansas 219.8 221.0 236.1 237.9 278.4 299.7 304.1 308.2 303.6 297.5 319.7 308.4Kentucky 267.9 250.0 267.3 270.3 282.3 301.2 322.3 343.1 328.1 332.5 333.3 340.0Louisiana 280.4 277.5 292.0 297.3 296.1 334.2 351.0 388.5 357.9 381.9 403.1 410.3Maine 163.4 267.5 192.8 396.4 359.0 220.4 293.5 289.8 269.4 193.9 300.1 304.0Maryland 235.7 241.7 254.8 279.9 286.9 297.9 316.9 331.1 326.5 335.6 334.6 329.4Massachusetts 234.0 255.6 261.0 260.0 276.5 278.8 289.1 270.2 281.2 261.4 277.3 282.2Michigan 240.7 256.8 265.0 267.9 301.2 299.8 319.7 320.9 330.0 338.5 349.2 337.0Minnesota 250.0 278.7 284.6 282.8 279.2 288.1 306.2 291.4 290.1 316.7 312.0 302.7Mississippi 235.1 243.4 284.3 274.1 291.0 306.5 308.7 341.0 312.0 333.0 351.6 335.2Missouri 248.0 268.6 274.5 281.9 293.2 306.1 333.5 333.2 337.5 340.7 319.6 337.9Montana 216.9 259.0 417.2 806.1 165.7 149.4 225.4 387.0 161.3 319.8 320.4 211.4Nebraska 266.0 262.9 281.5 264.5 298.0 313.4 344.8 362.9 333.5 394.0 349.0 327.2Nevada 219.9 263.4 308.8 277.8 245.6 258.6 277.8 329.9 302.9 331.4 317.1 359.5New Hampshire 196.4 201.6 322.0 210.2 179.8 220.9 280.8 280.3 304.6 407.3 376.6 371.9New Jersey 269.9 283.5 297.5 309.2 305.8 327.4 340.8 359.8 340.1 349.5 352.7 351.9New Mexico 250.5 261.6 279.1 288.0 306.2 316.9 281.9 324.9 324.1 319.1 313.6 343.8New York 234.4 252.6 251.5 250.1 271.0 285.7 293.2 298.3 303.5 305.2 307.5 305.6North Carolina 235.4 244.9 260.6 249.4 273.9 293.8 303.6 293.3 316.8 315.3 314.1 311.4North Dakota 205.3 357.6 801.9 357.1 203.2 202.5 199.8 194.2 313.1 255.8 334.1 221.2Ohio 243.6 241.3 265.6 271.6 312.5 309.1 331.7 350.9 363.9 357.1 367.5 371.2Oklahoma 226.8 254.7 251.2 256.7 268.3 297.0 325.2 316.8 312.8 327.6 331.1 359.8Oregon 196.7 232.5 246.0 239.6 253.4 213.4 311.6 273.6 267.1 305.3 304.4 293.4Pennsylvania 249.6 250.6 283.5 286.8 307.3 318.9 322.2 338.1 342.5 329.7 349.9 324.5Rhode Island 221.4 257.3 307.4 269.4 313.5 293.4 291.0 327.5 325.6 310.6 313.4 321.2South Carolina 241.6 242.1 283.1 249.1 269.5 289.5 299.2 307.5 291.9 307.5 296.3 307.3South Dakota 534.8 202.6 208.2 255.5 301.7 550.6 401.4 250.9 309.4 432.5 279.1 411.4Tennessee 251.8 239.2 272.3 275.0 277.1 297.2 309.6 332.6 317.4 303.0 319.1 315.8Texas 295.6 297.0 308.5 303.2 328.5 338.8 360.3 373.8 373.3 379.4 388.7 391.0Utah 205.0 278.2 222.7 246.6 278.1 218.5 311.2 290.1 240.1 241.7 248.7 246.6Vermont 104.8 128.8 160.5 166.8 365.4 599.6 397.5 209.9 170.0 278.5 313.2 341.8Virginia 241.9 244.1 253.5 265.9 285.0 309.3 306.2 313.6 287.8 301.7 322.7 310.6Washington 219.8 223.7 235.4 231.2 242.5 244.7 251.2 261.9 290.1 262.5 292.1 290.1West Virginia 243.5 256.4 312.3 303.2 311.8 354.0 396.1 375.9 378.4 400.9 393.2 363.0Wisconsin 270.3 263.4 261.6 278.3 288.5 294.0 321.5 314.0 321.0 336.2 349.5 356.1Wyoming 183.0 226.5 148.0 205.8 237.7 213.8 193.4 255.9 228.2 285.6 143.8 166.0

All 249.4 258.3 275.5 276.9 294.3 304.9 317.5 327.7 328.9 331.5 339.9 337.6

Rates are adjusted by age, gender, & race.The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.

309


Table A.9 (continued)Incident rates of reported ESRD, by diabetic status & state, adjusted: diabetic patientsper million population


1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992Alabama * * 11.0 18.9 23.8 24.4 28.0 35.9 42.1 62.6 57.3 65.2 79.4Alaska * * * * * * 38.1 * * 117.4 41.3 40.5 46.3Arizona 24.5 44.3 55.9 62.8 64.3 73.1 89.3 102.1 103.5 124.3 110.5 148.8 170.6Arkansas * 11.9 17.3 23.8 28.8 32.7 34.3 52.7 45.4 54.9 51.3 76.0 74.1California * 21.6 28.3 34.7 38.5 47.5 54.4 54.8 61.3 79.1 87.3 96.9 101.5Colorado 14.6 18.3 24.6 34.3 32.2 37.1 57.6 60.1 63.6 83.7 75.6 87.5 89.6Connecticut * 20.7 23.5 32.7 38.8 54.6 48.8 50.4 49.3 65.0 71.8 82.4 84.6Delaware * 21.4 27.4 * 26.6 34.8 48.9 43.6 70.9 87.0 77.9 94.8 85.5District of Columbia * * 23.6 22.0 24.7 38.6 31.1 22.0 38.7 40.5 36.0 45.5 75.6Florida 13.1 18.8 24.9 27.4 32.5 37.7 49.8 52.7 52.7 62.8 70.5 74.7 84.0Georgia * 19.8 23.4 21.9 27.7 32.1 39.6 46.0 46.9 60.0 67.7 76.0 87.9Hawaii * 23.1 26.0 21.6 18.7 33.6 53.3 44.7 44.8 81.7 161.3 64.5 83.2Idaho * * 19.0 19.7 21.3 19.6 140.3 32.9 40.8 106.0 57.3 46.5 70.4Illinois 13.2 17.6 23.0 27.0 30.4 40.8 41.6 46.9 45.7 55.1 68.2 80.9 77.4Indiana * 18.4 17.4 28.8 28.3 32.1 32.1 48.6 52.0 52.7 72.9 81.5 96.1Iowa 23.8 26.1 23.4 41.8 28.7 31.8 65.9 37.9 60.9 67.4 65.9 79.3 86.5Kansas 14.3 17.3 28.9 26.5 34.8 36.6 33.1 46.7 52.5 55.8 67.5 86.4 78.6Kentucky 14.3 17.9 15.4 26.9 35.3 36.4 40.1 49.5 46.0 53.8 72.7 85.7 99.3Louisiana * 12.9 15.1 15.0 27.3 27.4 37.6 40.0 59.5 68.2 74.2 90.6 101.4Maine * * 11.1 13.4 26.0 16.3 19.3 30.5 96.5 24.1 64.5 131.0 41.6Maryland * 15.1 20.1 24.5 27.4 36.9 30.2 41.0 40.3 57.7 68.2 78.7 88.9Massachusetts 14.1 17.7 20.6 23.3 27.8 24.0 33.5 30.4 43.5 50.5 59.6 67.4 82.2Michigan 20.0 27.3 26.2 30.0 34.5 40.1 46.9 46.8 57.6 68.1 77.4 88.4 94.7Minnesota 27.8 30.4 36.4 48.9 62.8 47.2 66.5 87.0 86.7 92.2 105.4 98.7 95.6Mississippi * * 16.7 19.7 29.7 28.8 41.8 40.4 57.9 55.8 83.8 84.9 96.1Missouri * 17.1 27.7 22.7 30.6 39.5 38.5 45.8 50.5 58.5 67.8 77.2 95.1Montana * 15.6 * 172.7 31.1 28.8 22.8 36.3 128.5 63.7 333.7 210.7 78.8Nebraska 18.3 38.7 22.6 32.6 46.3 37.0 37.7 79.5 83.3 77.9 68.2 106.2 126.0Nevada 31.0 22.0 32.4 24.2 30.4 43.1 55.8 72.4 61.3 85.0 78.5 81.4 73.4New Hampshire * * 41.7 14.1 13.5 18.3 16.4 48.1 50.9 69.2 60.1 43.9 58.8New Jersey 15.8 21.6 27.3 33.3 30.9 41.6 44.9 48.1 55.9 63.4 81.0 86.1 87.0New Mexico 19.8 32.1 35.5 55.5 53.9 59.7 75.1 86.8 97.2 96.7 100.9 138.1 135.8New York 11.4 17.5 21.5 26.3 32.7 34.2 42.7 45.5 53.1 55.0 65.5 71.2 78.8North Carolina * 12.4 19.6 22.6 25.0 34.1 35.0 45.3 43.3 57.2 67.5 81.5 85.3North Dakota * * * 39.0 38.9 40.7 1,171.8 44.3 67.5 403.6 80.0 71.0 111.4Ohio 13.9 21.4 26.0 28.4 33.3 41.3 44.1 48.4 55.1 63.9 78.7 82.1 97.7Oklahoma * 15.5 25.3 29.8 35.1 36.2 45.7 51.8 73.7 66.0 85.1 91.7 104.7Oregon 14.2 19.8 40.2 36.3 36.0 44.7 41.2 63.1 53.5 85.8 61.4 83.3 70.5Pennsylvania 14.9 16.4 22.4 26.5 37.1 37.8 43.5 48.1 54.5 60.6 73.9 83.8 93.4Rhode Island * 13.4 16.8 16.7 23.6 37.3 19.0 54.8 46.2 68.0 81.6 56.3 84.7South Carolina * 12.8 21.6 20.8 32.9 41.5 38.0 44.5 52.5 56.2 70.0 83.4 81.5South Dakota * 36.7 17.4 29.3 46.9 49.7 42.4 59.2 74.2 55.4 49.3 388.5 460.3Tennessee * 12.7 16.2 21.0 23.8 27.6 28.1 40.2 47.5 72.6 70.5 79.5 89.4Texas 12.8 21.8 30.6 31.4 41.2 45.2 51.2 58.2 72.6 93.3 108.0 117.0 126.3Utah 27.8 32.3 27.9 67.5 47.9 46.1 45.8 47.0 128.4 49.4 67.9 79.0 106.5Vermont * * 27.7 * * 27.3 * 27.2 * 309.0 33.5 165.2 27.8Virginia * 13.2 22.5 27.0 31.3 27.5 35.8 38.2 47.3 50.2 54.6 69.1 80.3Washington 17.2 12.1 18.1 18.3 27.2 51.2 36.1 39.4 51.8 67.3 75.7 87.8 97.2West Virginia 12.7 20.3 16.8 44.4 35.7 30.1 61.6 51.7 63.5 73.1 72.4 91.6 97.7Wisconsin 23.0 30.6 36.8 33.7 49.4 42.5 63.6 73.7 69.4 81.3 90.7 99.0 103.3Wyoming * * 22.0 * * 189.7 * 87.7 97.8 68.2 77.2 27.8 50.2

All 12.5 18.8 24.8 28.9 34.1 39.3 44.7 50.3 56.4 67.2 76.6 85.9 93.5



310

Reference section A



1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 79.7 96.1 98.6 110.6 126.0 115.0 128.1 135.1 132.4 125.5 132.1Alaska 96.5 177.8 226.5 105.6 183.2 107.6 68.7 113.7 101.2 110.2 112.4Arizona 165.8 151.1 169.8 162.6 187.5 186.4 184.1 187.9 198.4 195.9 192.4Arkansas 80.7 88.7 110.4 118.1 118.1 109.6 119.8 123.9 125.2 135.7 136.1California 105.3 126.0 129.9 138.6 154.7 162.5 165.0 174.7 169.7 176.8 173.1Colorado 90.2 82.0 98.0 115.7 102.2 128.4 115.2 124.3 109.8 120.8 113.6Connecticut 91.9 112.8 107.2 113.3 132.7 118.9 128.6 135.8 110.2 121.8 126.8Delaware 94.1 98.0 97.2 104.2 101.2 112.9 134.8 136.0 118.6 134.2 147.8District of Columbia 49.7 65.9 74.1 101.1 78.2 67.9 76.4 94.4 90.5 91.4 113.9Florida 87.4 93.7 98.0 108.2 112.9 111.9 119.2 122.3 129.4 124.3 123.3Georgia 86.9 96.9 109.0 125.7 117.0 120.2 134.3 140.9 138.6 148.4 138.0Hawaii 116.8 97.7 115.6 127.6 128.4 122.7 149.7 135.2 136.1 118.6 87.5Idaho 233.9 78.6 74.9 103.7 349.4 136.0 108.6 95.5 194.8 90.1 80.2Illinois 85.6 101.0 112.0 125.3 121.9 128.3 144.8 141.7 143.8 149.8 142.1Indiana 97.1 104.7 114.8 127.7 126.8 154.1 147.3 142.5 144.0 154.0 148.9Iowa 108.3 129.6 131.3 170.1 132.5 167.5 153.9 131.5 129.9 142.6 132.2Kansas 94.0 97.9 95.9 114.6 128.4 147.4 147.3 152.2 143.7 152.2 132.9Kentucky 101.1 105.2 114.2 123.8 133.2 143.3 160.8 145.1 150.7 154.3 155.0Louisiana 97.8 104.7 116.5 129.0 141.2 155.5 173.6 146.2 166.0 167.4 171.3Maine 48.2 65.2 173.6 134.5 107.9 161.5 68.2 165.4 84.6 134.0 156.3Maryland 88.4 96.2 105.2 116.3 122.3 125.9 134.4 122.0 139.7 140.5 120.7Massachusetts 89.6 101.9 103.8 110.6 108.8 122.3 105.5 107.7 114.1 108.8 109.5Michigan 100.5 108.5 113.1 136.1 136.1 146.3 140.7 147.9 155.5 153.9 146.1Minnesota 136.9 116.8 114.4 112.0 125.2 129.9 114.5 120.9 126.5 131.2 118.2Mississippi 84.9 121.1 128.6 133.8 135.4 146.7 161.5 139.4 150.2 166.0 154.4Missouri 99.6 101.4 118.1 129.3 141.2 147.9 142.8 148.5 143.6 141.8 146.7Montana 125.8 236.0 521.5 74.7 74.7 81.5 290.4 80.2 107.0 242.1 89.0Nebraska 122.6 114.4 154.1 135.9 159.1 163.4 188.0 158.4 187.7 147.8 142.1Nevada 86.6 96.3 128.4 81.3 113.7 127.0 146.0 139.7 154.0 150.2 167.3New Hampshire 111.1 91.4 113.2 59.7 71.9 140.8 125.4 115.9 120.4 183.8 134.1New Jersey 100.4 108.2 124.4 125.2 132.7 146.3 147.7 141.6 140.7 145.6 139.3New Mexico 148.1 142.8 161.6 172.3 173.5 156.8 194.3 190.8 188.7 166.9 185.3New York 88.1 88.4 94.2 108.8 114.0 116.7 119.7 123.0 128.7 128.0 125.9North Carolina 94.9 105.8 103.3 116.7 124.9 135.8 125.7 137.9 135.7 130.3 136.1North Dakota 87.2 408.0 88.7 85.9 95.9 101.3 66.7 185.7 120.5 129.4 100.0Ohio 97.1 111.3 117.6 139.0 144.8 154.8 160.8 169.4 168.4 167.6 163.9Oklahoma 116.1 108.0 126.9 124.7 135.0 167.5 158.8 155.5 156.0 160.8 163.8Oregon 82.1 97.5 103.4 113.4 92.0 102.0 119.0 106.1 147.3 100.3 108.4Pennsylvania 90.0 107.4 118.6 123.6 128.0 134.0 137.7 144.4 145.6 146.6 137.4Rhode Island 85.4 103.1 107.2 133.9 117.8 121.2 134.0 115.5 125.4 127.7 115.2South Carolina 86.4 111.6 93.5 113.1 115.4 138.2 135.3 128.6 133.9 129.9 139.3South Dakota 96.7 89.4 126.7 118.7 189.9 251.1 143.9 127.9 288.2 131.3 172.1Tennessee 87.3 100.9 108.3 112.8 119.9 120.5 137.5 135.9 131.7 129.7 141.8Texas 137.3 140.2 148.5 165.4 177.3 185.1 190.2 198.5 199.2 209.4 208.2Utah 153.3 98.5 142.6 129.8 122.7 206.6 164.1 127.3 135.7 107.4 138.8Vermont 54.4 61.8 71.9 154.3 199.0 176.5 86.6 66.1 55.2 172.0 93.7Virginia 87.6 98.1 99.2 111.0 129.1 130.7 128.2 125.5 134.4 139.0 126.6Washington 98.7 91.8 98.4 102.2 111.2 109.4 115.4 128.4 118.6 119.3 130.4West Virginia 99.2 118.0 139.5 140.3 157.4 165.2 205.4 199.8 201.2 197.6 186.3Wisconsin 111.7 101.2 120.4 127.4 135.0 135.8 138.7 134.8 143.8 145.1 146.4Wyoming 56.8 97.3 86.1 78.4 137.7 99.4 86.9 98.3 154.4 67.5 86.2

All 98.8 108.1 115.6 126.5 133.4 139.7 144.1 146.8 148.3 150.1 148.3


311


Table A.9 (continued)Incident rates of reported ESRD, by diabetic status & state, adjusted: non-diabetic patientsper million population


1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992Alabama 69.5 73.9 71.4 91.9 84.0 87.7 90.5 101.0 124.6 150.0 127.4 141.6 148.3Alaska * * * 87.3 * 35.1 89.9 60.2 81.3 81.1 110.7 130.0 122.9Arizona 86.9 99.7 90.9 123.6 104.2 107.7 112.0 128.6 130.6 135.8 146.4 145.4 171.2Arkansas 57.5 62.9 64.0 78.1 82.0 83.8 87.2 102.3 119.8 120.3 116.0 136.6 152.2California 79.4 86.6 88.6 104.4 102.5 106.1 116.0 122.7 131.1 134.0 147.9 153.4 154.7Colorado 71.1 71.1 64.9 64.1 69.5 81.3 79.9 88.9 81.7 97.0 98.5 111.8 119.1Connecticut 72.6 62.6 80.0 102.4 80.8 116.6 115.4 121.8 123.0 138.1 132.3 152.6 153.2Delaware 63.0 79.8 111.5 93.8 84.1 111.9 100.5 115.9 122.6 119.5 147.4 176.3 201.7District of Columbia 111.8 82.5 98.2 83.1 93.0 92.9 66.7 92.6 155.2 136.5 160.7 154.0 177.2Florida 94.6 94.8 93.1 100.2 107.5 112.7 116.8 130.2 139.2 151.4 149.3 164.2 173.4Georgia 70.2 82.2 73.8 98.6 87.4 90.1 99.8 103.7 134.4 131.4 128.7 157.6 162.2Hawaii 104.1 89.8 40.4 68.2 108.4 86.3 109.9 100.9 62.7 72.6 86.5 146.7 123.6Idaho 121.3 96.2 43.0 39.1 116.0 68.4 207.7 59.6 60.3 93.0 93.6 158.3 267.4Illinois 63.0 70.8 80.2 87.3 89.4 98.8 104.6 109.3 115.5 119.8 136.4 158.7 160.0Indiana 63.3 69.1 83.5 92.4 87.3 96.2 90.9 113.8 121.5 129.9 135.3 143.7 150.8Iowa 67.7 91.2 72.9 80.3 64.8 78.5 101.3 99.4 104.8 135.7 163.5 165.6 177.6Kansas 49.1 60.2 68.9 75.5 79.6 68.4 93.3 93.2 95.9 129.2 135.2 117.2 141.2Kentucky 62.1 69.7 70.0 63.2 78.3 86.1 92.7 99.2 108.3 111.3 124.7 147.9 168.6Louisiana 64.9 73.2 74.1 89.0 87.6 96.0 104.2 119.4 159.1 139.3 150.5 169.1 179.0Maine 26.8 61.1 40.5 86.8 201.3 56.1 71.1 71.7 185.5 114.6 107.9 85.6 121.8Maryland 63.4 70.0 76.0 74.6 86.3 83.3 81.1 102.6 105.6 115.0 128.4 144.3 146.8Massachusetts 71.2 55.5 81.1 103.0 97.2 90.6 96.6 104.1 117.4 116.4 121.5 132.4 151.8Michigan 70.3 71.5 82.4 83.3 99.8 94.7 95.3 107.3 115.1 132.6 122.8 133.0 146.0Minnesota 70.9 63.3 88.2 63.8 76.9 97.4 103.5 115.3 130.5 111.9 137.0 163.3 154.3Mississippi 65.4 61.3 72.4 92.0 87.4 80.1 83.7 98.6 100.5 123.3 118.8 129.3 139.0Missouri 68.7 60.4 74.5 79.4 89.1 92.0 104.0 116.7 125.7 126.5 139.6 142.6 152.9Montana 31.4 56.3 42.4 313.0 397.5 48.1 59.5 58.9 49.4 66.2 144.2 84.9 138.2Nebraska 66.1 75.6 63.6 72.0 71.7 73.4 94.9 112.5 111.6 110.2 118.0 135.2 140.0Nevada 117.5 92.0 92.6 132.5 117.4 146.2 176.9 131.8 150.0 134.1 140.1 155.7 146.5New Hampshire 164.8 64.6 55.6 83.5 51.9 88.4 129.6 92.6 208.8 133.4 101.7 118.6 137.6New Jersey 95.8 85.3 94.3 110.6 98.8 116.8 115.7 126.9 124.6 149.4 144.8 162.8 182.9New Mexico 96.2 69.1 98.3 68.1 66.5 109.6 88.8 91.8 122.7 115.7 132.7 122.9 114.7New York 72.2 73.5 78.7 87.3 90.4 97.1 103.2 107.2 116.4 126.6 137.3 138.9 155.6North Carolina 66.7 67.7 74.9 82.4 84.1 97.1 97.9 101.4 111.8 122.6 120.7 138.2 150.2North Dakota 30.9 53.7 44.4 31.6 43.7 96.0 209.3 62.8 67.6 72.3 78.6 80.5 93.9Ohio 57.3 63.4 68.7 78.9 82.3 85.2 91.9 95.4 110.6 116.1 139.7 141.5 146.0Oklahoma 71.3 73.5 67.7 65.5 74.9 73.0 84.8 88.7 99.3 115.0 123.8 109.0 122.1Oregon 81.7 60.2 72.3 81.6 102.7 85.3 100.0 95.5 114.6 123.9 113.9 167.2 126.3Pennsylvania 68.3 72.7 77.8 88.7 92.7 109.9 108.3 110.1 118.6 131.2 152.3 145.5 156.2Rhode Island 88.2 95.6 93.3 104.8 118.8 121.2 91.7 84.4 105.1 152.8 148.5 162.3 136.6South Carolina 62.7 77.0 79.2 85.1 90.6 95.1 103.4 102.2 131.8 131.1 140.2 141.6 160.1South Dakota 47.3 47.2 59.9 353.2 66.7 61.8 49.0 72.1 64.3 78.7 462.3 61.0 74.5Tennessee 64.0 69.8 78.2 93.1 74.6 88.1 95.2 110.2 107.4 160.5 148.8 160.0 162.4Texas 74.3 79.6 84.7 100.3 88.2 95.5 108.2 116.7 125.4 128.2 140.3 155.2 169.3Utah 92.6 112.7 77.8 43.4 119.3 66.5 76.1 65.3 92.4 84.4 100.1 99.1 98.5Vermont 52.6 34.9 39.1 59.6 43.4 51.4 48.7 139.4 79.0 301.9 114.1 80.3 77.0Virginia 76.6 81.9 81.7 99.6 95.1 101.6 99.1 114.0 114.5 124.0 133.0 156.0 161.6Washington 67.3 60.0 64.2 72.1 79.7 82.8 102.8 104.4 96.2 110.9 116.3 113.9 122.6West Virginia 64.5 59.9 92.5 76.7 97.5 97.9 101.8 102.2 123.2 102.1 119.3 142.2 145.8Wisconsin 73.2 69.7 78.3 67.8 91.9 92.9 101.7 120.7 132.6 131.8 132.0 144.1 167.0Wyoming 90.1 49.6 40.9 83.0 47.0 50.7 104.6 61.9 133.9 113.8 44.6 335.0 132.8

All 71.5 74.8 80.3 90.7 91.1 97.9 103.4 111.3 121.4 130.8 137.4 146.6 155.9



312

Reference section A


1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 145.9 155.0 158.1 165.9 169.4 177.2 169.5 173.2 171.8 176.3 173.4Alaska 81.2 255.2 477.9 121.6 101.8 81.1 99.4 122.5 105.2 106.5 145.8Arizona 168.1 151.0 149.6 167.6 155.0 173.2 174.7 172.1 180.0 162.9 186.7Arkansas 145.0 174.0 175.0 156.6 186.0 158.6 176.5 163.5 172.4 179.1 172.1California 165.9 179.6 171.8 176.0 174.5 190.0 192.3 189.4 196.6 205.7 204.1Colorado 113.9 129.3 101.3 112.4 133.0 132.2 126.5 126.7 120.7 121.7 122.4Connecticut 158.8 170.2 160.9 172.4 148.3 170.4 166.4 169.6 165.8 160.2 141.4Delaware 156.5 182.5 199.8 179.9 168.8 171.0 173.6 184.1 177.8 198.3 204.8District of Columbia 176.8 166.5 171.9 132.3 154.3 155.7 199.1 214.9 146.2 155.5 176.1Florida 171.2 172.5 164.7 176.3 171.9 173.5 176.3 175.1 176.5 183.3 175.6Georgia 162.2 170.2 168.8 167.5 161.4 174.1 186.7 190.1 190.5 189.0 189.9Hawaii 80.0 107.0 103.5 109.0 142.7 91.9 168.6 123.8 89.5 100.3 82.6Idaho 143.5 424.6 271.6 140.6 283.9 136.8 301.9 122.0 230.8 175.8 162.3Illinois 177.6 184.5 182.2 196.1 193.2 202.4 202.8 203.8 208.7 226.9 215.0Indiana 166.3 158.1 154.0 169.5 175.2 187.4 186.3 201.0 197.3 202.4 192.6Iowa 157.4 159.7 131.9 190.7 136.8 155.9 194.9 174.1 162.2 199.4 172.5Kansas 127.0 138.3 142.0 163.8 171.3 156.7 160.9 151.4 153.8 167.5 175.4Kentucky 148.9 162.0 156.1 158.5 168.0 179.0 182.3 183.0 181.9 179.0 185.0Louisiana 179.7 187.2 180.8 167.1 193.0 195.5 215.0 211.7 215.9 235.7 239.0Maine 219.3 127.5 222.8 224.5 112.4 132.0 221.6 104.0 109.3 166.1 147.8Maryland 153.3 158.7 174.8 170.6 175.7 191.0 196.6 204.6 195.9 194.0 208.6Massachusetts 166.1 159.2 156.2 165.8 170.0 166.8 164.7 173.5 147.4 168.5 172.8Michigan 156.2 156.5 154.9 165.1 163.7 173.3 180.2 182.1 183.1 195.3 190.9Minnesota 141.9 167.8 168.4 167.2 162.9 176.3 176.9 169.1 190.3 180.8 184.6Mississippi 158.5 163.2 145.5 157.3 171.1 162.1 179.5 172.6 182.7 185.6 180.8Missouri 169.1 173.2 163.8 163.8 165.0 185.6 190.5 188.9 197.0 177.8 191.1Montana 133.3 181.2 284.6 91.0 74.7 143.9 96.6 81.1 212.8 78.3 122.4Nebraska 140.3 167.1 110.4 162.0 154.3 181.4 174.9 175.1 206.3 201.2 185.1Nevada 176.8 212.5 149.4 164.3 144.8 150.9 183.9 163.2 177.4 166.9 192.2New Hampshire 90.5 230.5 97.0 120.1 149.0 140.0 154.9 188.7 286.9 192.9 237.9New Jersey 183.1 189.3 184.8 180.6 194.7 194.5 212.1 198.4 208.8 207.1 212.6New Mexico 113.5 136.3 126.4 133.9 143.5 125.1 130.7 133.3 130.4 146.7 158.4New York 164.5 163.1 156.0 162.1 171.7 176.5 178.6 180.5 176.6 179.5 179.7North Carolina 150.0 154.8 146.1 157.2 169.0 167.8 167.7 179.0 179.6 183.8 175.3North Dakota 270.4 394.0 268.4 117.3 106.6 98.5 127.5 127.4 135.3 204.8 121.2Ohio 144.2 154.4 154.0 173.5 164.4 177.0 190.0 194.6 188.7 200.0 207.3Oklahoma 138.6 143.2 129.8 143.6 161.9 157.7 158.0 157.3 171.6 170.3 195.9Oregon 150.4 148.6 136.3 140.0 121.4 209.6 154.6 161.0 158.0 204.1 184.9Pennsylvania 160.6 176.1 168.2 183.7 190.9 188.2 200.4 198.1 184.1 203.3 187.1Rhode Island 171.9 204.3 162.2 179.6 175.6 169.8 193.4 210.1 185.1 185.7 206.0South Carolina 155.7 171.5 155.5 156.5 174.2 160.9 172.2 163.3 173.6 166.5 168.1South Dakota 105.9 118.8 128.8 183.0 360.6 150.3 107.0 181.5 144.4 147.9 239.4Tennessee 151.9 171.4 166.7 164.3 177.3 189.2 195.1 181.5 171.3 189.4 174.0Texas 159.6 168.3 154.7 163.1 161.5 175.3 183.6 174.8 180.1 179.3 182.8Utah 124.9 124.2 103.9 148.2 95.8 104.6 126.0 112.9 106.0 141.4 107.9Vermont 74.4 98.7 94.9 211.1 400.6 221.0 123.3 103.9 223.3 141.2 248.0Virginia 156.5 155.4 166.7 173.9 180.2 175.5 185.3 162.3 167.3 183.7 184.1Washington 125.0 143.6 132.8 140.3 133.6 141.8 146.5 161.7 143.9 172.8 159.7West Virginia 157.2 194.4 163.7 171.4 196.6 230.9 170.4 178.5 199.7 195.6 176.7Wisconsin 151.7 160.4 158.0 161.1 159.1 185.6 175.3 186.2 192.4 204.4 209.7Wyoming 169.7 50.6 119.7 159.3 76.1 94.0 168.9 129.9 131.2 76.2 79.8

All 159.6 167.4 161.3 167.8 171.5 177.8 183.6 182.1 183.2 189.8 189.2



313


ON OUR WEBSITE & CDIncident counts of reported ESRD patients: U.S. only, with unknowns dropped (A.10.1).

Table A.10Incident counts of reported ESRD patients, by diabetic status & ESRD networkTable A.10Incident counts of reported ESRD patients, by diabetic status & ESRD network

ALL 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19921 CT, MA, ME, NH, RI, VT 827 842 1,003 1,255 1,271 1,421 1,429 1,565 1,726 1,925 2,080 2,350 2,4942 NY 1,479 1,629 1,810 2,096 2,279 2,430 2,734 2,858 3,199 3,428 3,906 4,034 4,5583 NJ, PR, VI 1,123 1,126 1,293 1,437 1,455 1,701 1,753 1,868 2,040 2,341 2,468 2,721 2,9964 DE, PA 990 1,072 1,229 1,374 1,563 1,810 1,887 1,961 2,205 2,439 2,853 2,987 3,2415 MD, DC, VA, WV 1,054 1,160 1,369 1,558 1,662 1,759 1,802 2,130 2,323 2,644 2,868 3,432 3,7106 NC, SC, GA 1,259 1,497 1,606 1,898 1,974 2,262 2,453 2,765 3,248 3,595 3,878 4,470 4,9147 FL 1,172 1,246 1,319 1,480 1,671 1,814 2,116 2,414 2,587 2,949 3,101 3,509 3,8748 AL, MS, TN 883 924 1,059 1,402 1,306 1,459 1,542 1,842 2,030 2,761 2,674 2,909 3,2419 IN, KY, OH 1,282 1,468 1,674 1,896 1,977 2,237 2,371 2,657 3,040 3,270 3,922 4,185 4,61210 IL 830 974 1,119 1,275 1,313 1,521 1,617 1,734 1,788 1,982 2,302 2,722 2,76311 MI, MN, ND, SD, WI 1,414 1,540 1,715 1,748 2,093 2,181 2,370 2,692 2,963 3,316 3,480 3,823 4,26612 IA, KS, MO, NE 721 805 946 1,008 1,112 1,242 1,386 1,503 1,655 1,865 2,091 2,247 2,50613 AR, LA, OK 669 787 847 979 1,121 1,184 1,358 1,562 1,928 1,981 2,122 2,342 2,63114 TX 1,078 1,277 1,525 1,754 1,714 1,964 2,189 2,444 2,794 3,201 3,595 3,937 4,44415 AZ, CO, NV, NM, UT, WY 775 832 903 1,009 1,123 1,213 1,426 1,578 1,718 1,882 1,946 2,209 2,50616 AK, ID, MT, OR, WA 459 509 576 699 742 814 943 1,001 1,092 1,349 1,397 1,581 1,57317 N. CA, HI, Guam, AS 871 885 1,001 1,197 1,298 1,429 1,599 1,776 2,100 2,263 2,631 2,772 2,82218 S. CA 1,124 1,525 1,584 1,862 1,895 2,153 2,476 2,579 2,821 3,242 3,595 3,929 4,140Unknown * * * * 12 * 20 22 35 29 17 14 27

All 18,017 20,102 22,587 25,935 27,581 30,604 33,471 36,951 41,292 46,462 50,926 56,173 61,318

DIABETIC1 CT, MA, ME, NH, RI, VT 119 187 219 251 296 356 368 428 463 594 673 785 8492 NY 202 316 392 489 598 629 798 855 997 1,041 1,263 1,367 1,5193 NJ, PR, VI 170 223 309 373 421 492 565 603 709 826 960 1,069 1,1504 DE, PA 181 204 274 316 448 473 547 598 698 801 969 1,095 1,1955 MD, DC, VA, WV 126 195 294 374 426 478 521 592 665 816 956 1,158 1,3416 NC, SC, GA 161 258 359 391 495 631 667 860 915 1,126 1,317 1,538 1,7407 FL 129 205 268 298 369 427 585 656 684 811 929 1,049 1,2038 AL, MS, TN 85 126 183 239 301 329 377 492 552 802 879 986 1,1519 IN, KY, OH 225 332 389 494 569 646 707 883 984 1,105 1,416 1,566 1,79310 IL 139 192 255 294 335 447 463 517 522 622 763 923 90411 MI, MN, ND, SD, WI 345 411 478 533 659 677 822 895 1,016 1,225 1,353 1,527 1,69112 IA, KS, MO, NE 86 189 256 259 303 368 390 421 512 601 677 796 90613 AR, LA, OK 65 126 174 210 288 306 402 476 627 683 750 917 1,04214 TX 158 268 402 423 547 642 704 827 1,024 1,341 1,541 1,683 1,88515 AZ, CO, NV, NM, UT, WY 184 220 277 343 409 440 582 683 735 840 854 1,048 1,16416 AK, ID, MT, OR, WA 80 90 141 167 198 249 264 304 386 483 502 573 63917 N. CA, HI, Guam, AS 89 189 232 263 300 434 490 591 684 868 1,006 1,065 1,14418 S. CA 146 312 406 500 549 683 839 795 899 1,184 1,329 1,573 1,649Unknown . . . * * * * * . * * * *

All 2,690 4,043 5,308 6,218 7,513 8,708 10,092 11,477 13,072 15,770 18,138 20,720 22,971

NON-DIABETIC1 CT, MA, ME, NH, RI, VT 708 655 784 1,004 975 1,065 1,061 1,137 1,263 1,331 1,407 1,565 1,6452 NY 1,277 1,313 1,418 1,607 1,681 1,801 1,936 2,003 2,202 2,387 2,643 2,667 3,0393 NJ, PR, VI 953 903 984 1,064 1,034 1,209 1,188 1,265 1,331 1,515 1,508 1,652 1,8464 DE, PA 809 868 955 1,058 1,115 1,337 1,340 1,363 1,507 1,638 1,884 1,892 2,0465 MD, DC, VA, WV 928 965 1,075 1,184 1,236 1,281 1,281 1,538 1,658 1,828 1,912 2,274 2,3696 NC, SC, GA 1,098 1,239 1,247 1,507 1,479 1,631 1,786 1,905 2,333 2,469 2,561 2,932 3,1747 FL 1,043 1,041 1,051 1,182 1,302 1,387 1,531 1,758 1,903 2,138 2,172 2,460 2,6718 AL, MS, TN 798 798 876 1,163 1,005 1,130 1,165 1,350 1,478 1,959 1,795 1,923 2,0909 IN, KY, OH 1,057 1,136 1,285 1,402 1,408 1,591 1,664 1,774 2,056 2,165 2,506 2,619 2,81910 IL 691 782 864 981 978 1,074 1,154 1,217 1,266 1,360 1,539 1,799 1,85911 MI, MN, ND, SD, WI 1,069 1,129 1,237 1,215 1,434 1,504 1,548 1,797 1,947 2,091 2,127 2,296 2,57512 IA, KS, MO, NE 635 616 690 749 809 874 996 1,082 1,143 1,264 1,414 1,451 1,60013 AR, LA, OK 604 661 673 769 833 878 956 1,086 1,301 1,298 1,372 1,425 1,58914 TX 920 1,009 1,123 1,331 1,167 1,322 1,485 1,617 1,770 1,860 2,054 2,254 2,55915 AZ, CO, NV, NM, UT, WY 591 612 626 666 714 773 844 895 983 1,042 1,092 1,161 1,34216 AK, ID, MT, OR, WA 379 419 435 532 544 565 679 697 706 866 895 1,008 93417 N. CA, HI, Guam, AS 782 696 769 934 998 995 1,109 1,185 1,416 1,395 1,625 1,707 1,67818 S. CA 978 1,213 1,178 1,362 1,346 1,470 1,637 1,784 1,922 2,058 2,266 2,356 2,491Unknown * * * * * * 19 21 35 28 16 12 21

All 15,327 16,059 17,279 19,717 20,068 21,896 23,379 25,474 28,220 30,692 32,788 35,453 38,347



314

Reference section A

Table A.10 (continued)Incident counts of reported ESRD patients, by diabetic status & ESRD network

Unknown 17 109 31 14 * 20 27 18 30 19 149

All 64,492 69,968 71,791 77,860 82,203 87,121 91,560 93,966 96,280 100,625 102,567

18 S. CA 1,709 2,105 2,204 2,417 2,774 2,960 3,179 3,400 3,430 3,693 3,709

17 N. CA, HI, Guam, AS 1,795 1,910 1,843 1,888 1,959 2,150 2,325 2,310 2,357 2,423 2,504

Unknown 13 79 27 13 * 20 27 18 30 18 144

All 39,907 42,584 41,879 44,410 46,232 48,770 51,189 51,896 53,015 55,925 57,237

Table A.10 (continued)Incident counts of reported ESRD patients, by diabetic status & ESRD network

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20031 CT, MA, ME, NH, RI, VT 2,761 2,990 2,963 3,188 3,354 3,472 3,536 3,728 3,544 3,757 3,8392 NY 4,948 5,028 5,128 5,523 5,870 6,113 6,311 6,567 6,660 6,883 6,9633 NJ, PR, VI 3,150 3,374 3,506 3,605 3,880 4,126 4,417 4,299 4,490 4,619 4,7864 DE, PA 3,284 3,721 3,830 4,184 4,371 4,466 4,702 4,826 4,721 5,096 4,8585 MD, DC, VA, WV 3,898 4,151 4,517 4,835 5,269 5,512 5,641 5,651 5,868 6,164 6,2256 NC, SC, GA 5,109 5,691 5,656 6,310 6,606 7,081 7,418 7,762 7,980 8,017 8,3677 FL 3,935 4,261 4,334 4,881 5,089 5,176 5,543 5,721 5,934 6,224 6,2828 AL, MS, TN 3,312 3,688 3,794 4,095 4,463 4,517 4,866 4,784 4,870 5,154 5,2489 IN, KY, OH 4,728 5,122 5,310 5,955 6,105 6,732 7,024 7,403 7,373 7,654 7,84310 IL 3,103 3,382 3,553 3,899 3,860 4,123 4,339 4,398 4,509 4,911 4,73811 MI, MN, ND, SD, WI 4,466 4,696 4,758 5,380 5,495 5,909 5,941 6,216 6,573 6,920 6,89012 IA, KS, MO, NE 2,591 2,791 2,808 3,071 3,315 3,541 3,746 3,780 3,848 3,830 3,94613 AR, LA, OK 2,722 2,970 3,121 3,172 3,617 3,802 3,994 3,951 4,188 4,387 4,57914 TX 4,555 4,829 4,979 5,527 5,801 6,242 6,641 6,889 7,085 7,392 7,74615 AZ, CO, NV, NM, UT, WY 2,700 2,746 2,894 3,148 3,307 3,663 3,940 3,991 4,196 4,234 4,44316 AK, ID, MT, OR, WA 1,723 1,961 2,108 2,044 2,141 2,211 2,472 2,566 2,657 2,794 2,93517 N. CA, HI, Guam, AS 3,035 3,361 3,359 3,545 3,789 4,072 4,342 4,464 4,485 4,674 4,77218 S. CA 4,455 5,097 5,142 5,484 5,861 6,343 6,660 6,952 7,269 7,896 7,958

DIABETIC1 CT, MA, ME, NH, RI, VT 958 1,106 1,144 1,240 1,357 1,368 1,404 1,474 1,454 1,497 1,5462 NY 1,728 1,751 1,948 2,241 2,372 2,447 2,554 2,699 2,858 2,911 2,9073 NJ, PR, VI 1,241 1,384 1,523 1,648 1,743 1,966 2,078 2,035 2,097 2,171 2,2454 DE, PA 1,198 1,418 1,560 1,672 1,757 1,859 1,956 2,077 2,077 2,141 2,0605 MD, DC, VA, WV 1,424 1,592 1,738 1,969 2,226 2,305 2,360 2,364 2,572 2,680 2,5336 NC, SC, GA 1,873 2,161 2,286 2,722 2,805 3,140 3,168 3,408 3,459 3,486 3,6907 FL 1,274 1,427 1,544 1,788 1,949 1,957 2,196 2,310 2,459 2,504 2,5878 AL, MS, TN 1,210 1,369 1,521 1,694 1,865 1,886 2,095 2,096 2,163 2,200 2,3159 IN, KY, OH 1,845 2,100 2,308 2,657 2,735 3,091 3,195 3,350 3,367 3,441 3,47910 IL 1,015 1,199 1,357 1,533 1,498 1,601 1,812 1,783 1,833 1,942 1,87111 MI, MN, ND, SD, WI 1,774 1,885 1,996 2,303 2,391 2,540 2,475 2,621 2,806 2,883 2,82812 IA, KS, MO, NE 1,007 1,065 1,174 1,327 1,439 1,557 1,610 1,669 1,644 1,665 1,66013 AR, LA, OK 1,033 1,139 1,289 1,413 1,575 1,761 1,806 1,769 1,895 1,964 2,02314 TX 2,086 2,191 2,442 2,778 3,032 3,202 3,380 3,664 3,712 3,986 4,12415 AZ, CO, NV, NM, UT, WY 1,301 1,256 1,496 1,555 1,690 1,859 2,004 2,099 2,175 2,169 2,28016 AK, ID, MT, OR, WA 665 755 862 835 933 930 1,082 1,098 1,136 1,115 1,20017 N. CA, HI, Guam, AS 1,240 1,451 1,516 1,657 1,830 1,922 2,017 2,154 2,128 2,251 2,268

Unknown * 30 * * . . . . . * *

All 24,585 27,384 29,912 33,450 35,971 38,351 40,371 42,070 43,265 44,700 45,330

NON-DIABETIC1 CT, MA, ME, NH, RI, VT 1,803 1,884 1,819 1,948 1,997 2,104 2,132 2,254 2,090 2,260 2,2932 NY 3,220 3,277 3,180 3,282 3,498 3,666 3,757 3,868 3,802 3,972 4,0563 NJ, PR, VI 1,909 1,990 1,983 1,957 2,137 2,160 2,339 2,264 2,393 2,448 2,5414 DE, PA 2,086 2,303 2,270 2,512 2,614 2,607 2,746 2,749 2,644 2,955 2,7985 MD, DC, VA, WV 2,474 2,559 2,779 2,866 3,043 3,207 3,281 3,287 3,296 3,484 3,6926 NC, SC, GA 3,236 3,530 3,370 3,588 3,801 3,941 4,250 4,354 4,521 4,531 4,6777 FL 2,661 2,834 2,790 3,093 3,140 3,219 3,347 3,411 3,475 3,720 3,6958 AL, MS, TN 2,102 2,319 2,273 2,401 2,598 2,631 2,771 2,688 2,707 2,954 2,9339 IN, KY, OH 2,883 3,022 3,002 3,298 3,370 3,641 3,829 4,053 4,006 4,213 4,36410 IL 2,088 2,183 2,196 2,366 2,362 2,522 2,527 2,615 2,676 2,969 2,86711 MI, MN, ND, SD, WI 2,692 2,811 2,762 3,077 3,104 3,369 3,466 3,595 3,767 4,037 4,06212 IA, KS, MO, NE 1,584 1,726 1,634 1,744 1,876 1,984 2,136 2,111 2,204 2,165 2,28613 AR, LA, OK 1,689 1,831 1,832 1,759 2,042 2,041 2,188 2,182 2,293 2,423 2,55614 TX 2,469 2,638 2,537 2,749 2,769 3,040 3,261 3,225 3,373 3,406 3,62215 AZ, CO, NV, NM, UT, WY 1,399 1,490 1,398 1,593 1,617 1,804 1,936 1,892 2,021 2,065 2,16316 AK, ID, MT, OR, WA 1,058 1,206 1,246 1,209 1,208 1,281 1,390 1,468 1,521 1,679 1,735

18 S. CA 2,746 2,992 2,938 3,067 3,087 3,383 3,481 3,552 3,839 4,203 4,249


315


Table A.11Incident rates of reported ESRD, by diabetic status & ESRD network, adjustedper million population

Table A.11Incident rates of reported ESRD, by diabetic status & ESRD network, adjustedper million population

ALL 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19921 CT, MA, ME, NH, RI, VT 82.4 82.2 99.6 124.9 122.9 134.8 137.0 148.0 162.2 182.5 188.1 209.8 225.62 NY 83.6 91.0 100.5 114.0 123.2 131.5 146.6 153.1 169.6 181.2 203.4 210.0 234.53 NJ 112.3 107.2 121.6 143.4 129.9 158.5 160.2 174.8 181.3 212.7 225.4 249.6 270.74 DE, PA 82.5 90.1 102.5 115.3 129.4 147.8 152.4 158.1 174.6 192.8 226.7 232.3 253.15 MD, DC, VA, WV 79.4 88.1 102.9 115.5 121.4 125.6 126.3 146.8 156.6 174.8 189.9 223.4 239.76 NC, SC, GA 77.0 90.0 96.8 111.5 114.1 128.9 136.2 148.1 170.6 185.5 195.4 225.7 241.27 FL 108.3 113.6 117.7 127.2 139.4 149.6 166.2 182.9 191.5 213.9 218.7 237.3 256.68 AL, MS, TN 73.2 80.8 88.5 111.9 106.4 112.3 122.3 142.9 160.2 213.4 204.0 222.2 238.49 IN, KY, OH 72.4 85.3 94.5 107.8 115.2 126.3 132.1 148.6 164.9 178.2 213.2 225.7 247.810 IL 76.1 88.6 103.0 114.2 120.1 139.2 145.8 156.0 160.6 174.9 203.8 238.8 236.911 MI, MN, ND, SD, WI 93.8 100.9 109.9 115.7 139.6 141.3 154.7 170.7 187.7 209.3 214.4 231.0 254.912 IA, KS, MO, NE 74.8 83.7 100.7 105.4 115.3 124.6 143.0 156.9 169.1 187.4 206.5 222.4 250.213 AR, LA, OK 71.0 85.6 90.7 103.7 113.4 120.9 136.0 158.0 196.4 196.9 212.5 229.2 253.714 TX 86.9 101.3 115.1 131.5 129.0 140.9 159.3 174.7 197.9 221.6 248.3 272.3 295.815 AZ, CO, NV, NM, UT, WY 109.5 115.2 119.5 143.1 139.9 160.4 176.4 189.6 202.8 222.0 215.4 246.3 262.116 AK, ID, MT, OR, WA 83.6 73.1 84.7 96.4 112.6 126.5 137.5 143.9 151.5 187.2 185.8 213.7 208.417 N. CA, HI 96.1 94.8 108.8 125.1 135.2 144.2 155.0 170.4 190.8 204.2 228.7 238.3 237.318 S. CA 83.8 116.7 122.4 147.3 144.9 161.2 180.3 182.2 192.2 218.5 240.6 257.8 268.3

All 84.0 93.6 105.1 119.5 125.2 137.3 148.1 161.7 177.8 197.9 214.0 232.5 249.3

DIABETIC1 CT, MA, ME, NH, RI, VT 11.7 17.8 21.8 25.4 30.9 34.9 37.1 40.6 45.6 57.4 64.3 72.3 79.82 NY 11.4 17.5 21.4 26.4 32.8 34.2 42.8 45.7 53.1 54.9 65.5 71.1 78.83 NJ 15.8 21.6 27.3 33.2 31.2 42.1 44.9 48.0 55.9 63.2 81.1 86.7 87.04 DE, PA 14.7 16.9 22.7 25.9 36.5 37.5 44.4 48.2 55.6 62.3 74.2 85.0 93.35 MD, DC, VA, WV * 13.9 22.1 26.9 30.3 32.8 36.0 39.8 44.7 53.3 61.4 73.2 85.86 NC, SC, GA * 15.3 21.4 22.2 27.7 34.9 37.5 46.0 46.5 58.3 68.4 80.0 85.77 FL 13.1 18.8 24.9 27.4 32.5 37.6 49.7 52.6 52.9 62.9 70.5 74.8 84.08 AL, MS, TN * 10.9 14.7 19.7 25.8 26.0 31.4 38.2 47.8 65.0 69.0 75.8 87.19 IN, KY, OH 12.9 19.8 21.9 28.3 32.2 37.9 40.2 48.2 52.4 59.1 76.2 82.8 96.910 IL 12.9 17.7 23.0 26.9 30.4 40.9 41.6 46.6 45.6 55.1 67.8 80.7 77.111 MI, MN, ND, SD, WI 23.6 30.5 30.4 37.5 44.8 46.9 56.1 58.6 69.0 80.1 87.7 94.7 105.112 IA, KS, MO, NE * 22.1 28.4 27.2 33.5 40.0 42.0 48.9 54.0 61.9 67.5 81.7 98.213 AR, LA, OK * 15.1 20.9 24.4 31.1 33.4 42.0 51.3 66.8 69.7 78.3 91.5 103.014 TX 12.8 21.8 30.6 31.4 41.0 45.2 51.2 58.0 72.6 93.4 108.0 117.0 126.415 AZ, CO, NV, NM, UT, WY 23.4 31.6 39.2 48.5 51.1 58.3 73.2 81.6 87.6 102.2 93.4 116.3 123.816 AK, ID, MT, OR, WA 15.4 14.6 22.4 23.7 29.0 45.6 38.4 47.0 51.2 76.3 73.2 84.9 88.517 N. CA, HI * 19.2 24.5 28.1 32.2 43.9 44.5 53.9 60.9 77.8 86.2 86.3 92.318 S. CA * 23.4 31.1 39.1 42.2 50.6 61.3 56.2 62.1 80.8 90.0 104.3 107.7

All 12.5 18.8 24.8 28.9 34.1 39.3 44.7 50.3 56.4 67.2 76.6 85.9 93.5

NON-DIABETIC1 CT, MA, ME, NH, RI, VT 70.7 64.4 77.8 99.5 92.0 99.9 99.8 107.5 116.6 125.1 123.9 137.4 145.82 NY 72.3 73.5 79.1 87.6 90.4 97.4 103.9 107.5 116.6 126.4 137.9 138.9 155.73 NJ 96.6 85.6 94.3 110.3 98.7 116.5 115.3 126.8 125.3 149.5 144.3 162.9 183.74 DE, PA 67.8 73.3 79.8 89.5 92.9 110.3 107.9 109.9 119.0 130.5 152.5 147.3 159.85 MD, DC, VA, WV 70.5 74.1 80.8 88.6 91.1 92.8 90.3 107.0 111.8 121.5 128.6 150.2 153.96 NC, SC, GA 67.8 74.7 75.4 89.3 86.4 94.1 98.7 102.1 124.1 127.2 127.0 145.7 155.57 FL 95.2 94.8 92.9 99.7 106.9 112.0 116.6 130.3 138.6 150.9 148.2 162.5 172.68 AL, MS, TN 66.5 69.9 73.9 92.1 80.6 86.3 90.9 104.7 112.5 148.3 135.0 146.4 151.39 IN, KY, OH 59.6 65.5 72.5 79.5 83.0 88.4 91.9 100.4 112.5 119.1 137.0 142.9 150.910 IL 63.1 70.8 80.0 87.3 89.7 98.3 104.2 109.4 115.0 119.8 136.0 158.1 159.811 MI, MN, ND, SD, WI 70.3 70.4 79.5 78.2 94.8 94.4 98.6 112.1 118.8 129.2 126.7 136.3 149.912 IA, KS, MO, NE 64.8 61.6 72.3 78.3 81.8 84.5 101.1 108.0 115.1 125.5 138.9 140.7 152.013 AR, LA, OK 63.7 70.5 69.8 79.3 82.3 87.6 93.9 106.8 129.6 127.2 134.2 137.7 150.714 TX 74.1 79.5 84.5 100.1 88.0 95.7 108.0 116.7 125.4 128.2 140.4 155.3 169.515 AZ, CO, NV, NM, UT, WY 86.1 83.6 80.3 94.5 88.8 102.1 103.2 108.0 115.2 119.8 122.0 130.0 138.316 AK, ID, MT, OR, WA 68.3 58.5 62.3 72.8 83.6 80.8 99.1 97.0 100.3 111.0 112.6 128.8 119.917 N. CA, HI 87.4 75.6 84.3 97.0 103.0 100.3 110.5 116.5 129.8 126.4 142.4 152.0 145.018 S. CA 73.5 93.4 91.2 108.2 102.7 110.7 119.0 126.0 130.1 137.7 150.6 153.4 160.5

All 71.5 74.8 80.3 90.7 91.1 97.9 103.4 111.3 121.4 130.8 137.4 146.6 155.9

Rates are adjusted by age, race, & gender. The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.*Values for cells with 10 or fewer patients are suppressed.


316

Reference section AINCIDENCE OF REPORTED ESRDA Reference section A

Table A.11 (continued)Incident rates of reported ESRD: by diabetic status & ESRD network, adjustedper million population

Table A.11 (continued)Incident rates of reported ESRD: by diabetic status & ESRD network, adjustedper million population

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20031 CT, MA, ME, NH, RI, VT 247 267 260 274 277 285 281 289 268 282 2822 NY 253 252 251 272 287 294 300 305 307 311 3073 NJ 283 296 308 305 328 341 362 344 353 355 3604 DE, PA 251 285 288 306 316 321 336 340 327 349 3285 MD, DC, VA, WV 245 257 277 290 311 320 327 321 327 336 3306 NC, SC, GA 245 266 259 280 287 298 304 315 318 315 3147 FL 258 266 262 284 283 284 294 296 303 306 2958 AL, MS, TN 234 265 265 279 297 303 318 310 308 317 3159 IN, KY, OH 247 264 271 303 305 332 344 353 349 358 35810 IL 263 285 294 321 315 331 348 347 353 378 35711 MI, MN, ND, SD, WI 264 270 274 297 299 321 318 326 336 346 33912 IA, KS, MO, NE 254 268 266 291 297 324 332 325 329 322 32613 AR, LA, OK 258 276 284 286 320 328 344 335 351 361 37314 TX 297 309 303 328 338 360 374 373 378 387 38915 AZ, CO, NV, NM, UT, WY 274 269 270 275 283 303 310 305 315 303 31416 AK, ID, MT, OR, WA 226 251 269 244 240 260 261 275 271 285 28517 N. CA, HI 255 282 271 282 298 317 318 327 321 323 31518 S. CA 282 321 321 335 350 376 381 389 397 422 415

All 258 275 277 294 305 318 328 329 331 340 338

DIABETIC1 CT, MA, ME, NH, RI, VT 89 103 103 110 117 120 116 116 113 115 1162 NY 88 89 94 109 114 117 120 123 130 130 1263 NJ 100 108 124 125 133 146 148 144 142 146 1444 DE, PA 90 108 118 122 126 134 138 145 144 146 1395 MD, DC, VA, WV 88 98 105 117 131 132 136 135 143 146 1336 NC, SC, GA 90 103 104 119 120 130 129 136 136 135 1377 FL 87 94 98 108 112 111 118 121 128 124 1228 AL, MS, TN 85 101 107 116 125 124 139 137 136 135 1409 IN, KY, OH 98 108 116 134 138 152 156 158 159 162 15910 IL 85 101 112 125 122 129 146 142 144 150 14311 MI, MN, ND, SD, WI 109 112 119 131 134 143 138 142 147 150 14312 IA, KS, MO, NE 101 104 117 129 135 148 148 148 144 144 14013 AR, LA, OK 102 109 121 130 142 154 158 151 159 162 16414 TX 137 140 149 165 177 185 190 199 199 209 20715 AZ, CO, NV, NM, UT, WY 131 120 142 133 143 154 157 159 162 155 15816 AK, ID, MT, OR, WA 96 99 110 104 111 109 116 119 126 114 12217 N. CA, HI 101 117 116 123 138 145 138 149 144 147 14018 S. CA 110 133 140 150 167 176 183 192 188 198 194

All 99 108 116 127 133 140 144 147 148 150 148

NON-DIABETIC1 CT, MA, ME, NH, RI, VT 158 163 157 163 160 165 165 173 156 166 1672 NY 165 164 156 163 172 177 180 181 177 181 1813 NJ 183 188 184 180 195 195 213 200 211 208 2164 DE, PA 161 177 170 184 190 188 198 196 183 203 1895 MD, DC, VA, WV 157 159 172 174 181 188 191 186 184 190 1976 NC, SC, GA 155 163 156 161 167 168 175 179 182 180 1777 FL 171 173 164 176 171 173 176 175 175 182 1738 AL, MS, TN 150 163 158 163 172 179 180 173 171 183 1759 IN, KY, OH 150 156 155 170 167 180 189 195 190 197 19910 IL 177 184 182 196 193 202 202 205 209 228 21511 MI, MN, ND, SD, WI 155 158 155 166 165 178 180 184 189 196 19612 IA, KS, MO, NE 153 164 149 162 162 176 184 178 185 178 18613 AR, LA, OK 156 167 163 156 178 174 186 184 191 199 20914 TX 160 168 155 163 161 175 184 174 180 179 18215 AZ, CO, NV, NM, UT, WY 143 149 128 141 140 149 153 146 153 148 15616 AK, ID, MT, OR, WA 130 152 159 140 129 151 144 155 146 171 16417 N. CA, HI 154 165 155 159 160 172 180 178 177 176 17518 S. CA 172 188 181 186 183 200 199 197 209 225 221

All 160 167 161 168 171 178 184 182 183 190 189

Rates are adjusted by age, race, & gender. The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.

Prevalence of reported ESRD

BReferenceSec

tion

PREVALENCE OF REPORTED ESRDB

318

Reference section B

B.1 . 319 Point prevalent counts of reported ESRD: all patientspatients alive on December 3 of each year, by demographic characteristics & primary diagnosis

B.2 . 323 Point prevalent rates of reported ESRD patients alive on December 3 of each year, per million population, by demographic characteristics & primary diagnosis

B.3 . 327 Point prevalent rates of reported diabetic ESRDpatients alive on December 3 of each year, per million population, by demographic characteristics

B.4 . 329 Point prevalent counts of reported ESRD patients, 2001-2003patients alive on December 3 of each year, by age, gender, & race

B.5 . 330 Point prevalent rates of reported ESRD, 2001-2003patients alive on December 3 of each year, per million population, by age, gender, & race

B.6 . 331 Mean age at start of ESRD therapypatients alive on December 3 of each year, by demographic characteristics & primary diagnosis

B.7 . 333 Prevalence of reported ESRD, by primary diagnosis: all patients999-2003 combined, patients alive on December 3 of each year, by detailed primary diagnosis

B.8 . 335 Point prevalent counts of reported ESRD patients, by diabetic status & state/territory

B.9 . 341 Point prevalent rates of reported ESRD, by diabetic status & state, adjustedpatients alive on December 3 of each year, per million population

B.10 . 347 Point prevalent counts of reported ESRD patients, by diabetic status & ESRD networkpatients alive on December 3 of each year

B.11 . 349 Point prevalent rates of reported ESRD: by diabetic status & ESRD network, adjustedpatients alive on December 3 of each year, per million population

B.12 . 351 Period prevalent counts of reported ESRD: all patientsby demographic characteristics & primary diagnosis

319

2005 Annual Data ReportBPREVALENCE OF REPORTED ESRD

ON OUR WEBSITE & CDPoint prevalent counts of reported ESRD: diabetes, hypertension,glomerulonephritis, & cystic kidney disease (B.1.1-4).Point prevalent counts of reported ESRD patients (B.a).Percent decrease in point prevalent counts of ESRD patients (B.b).

Table B.1Point prevalent counts of reported ESRD: all patientspatients alive on December 31 of each year, by demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 73 112 168 208 233 290 315 347 348 357 343 3805-9 226 237 290 327 387 427 502 544 581 658 711 74310-14 574 632 715 797 845 864 889 960 1,027 1,073 1,166 1,22115-19 1,547 1,649 1,743 1,785 1,850 1,982 2,076 2,207 2,302 2,376 2,388 2,43020-29 6,714 7,514 8,388 9,245 9,969 10,634 11,291 11,796 12,426 13,051 13,726 14,20330-39 9,269 10,910 12,608 14,452 16,500 18,483 20,434 22,131 24,027 26,146 28,160 30,28240-49 9,854 11,054 12,453 14,636 16,339 18,082 20,090 22,566 25,504 28,910 32,287 36,42750-59 13,056 14,814 16,570 18,366 20,121 21,711 23,520 25,336 27,759 30,498 33,617 37,14860-64 6,271 7,511 8,616 10,180 11,473 12,661 13,572 15,079 16,462 18,085 19,987 21,80765-69 5,592 6,289 7,141 8,734 9,928 11,120 12,644 14,462 16,139 18,190 20,320 22,67070-79 5,977 7,043 8,356 10,681 12,474 14,209 16,322 18,477 20,785 23,937 27,398 32,09480+ 882 1,112 1,409 2,029 2,445 3,039 3,733 4,568 5,388 6,476 7,864 9,316Unknown * * 14 22 29 29 28 16 12 * 11 *

0-19 2,420 2,630 2,916 3,117 3,315 3,563 3,782 4,058 4,258 4,464 4,608 4,77420-44 20,727 23,721 27,042 30,876 34,467 38,001 41,867 45,256 49,288 53,816 58,582 63,05845-64 24,437 28,082 31,593 36,003 39,935 43,570 47,040 51,652 56,890 62,874 69,195 76,80965-74 9,534 10,846 12,533 15,452 17,629 19,772 22,491 25,453 28,407 32,214 36,553 41,77575+ 2,917 3,598 4,373 5,992 7,218 8,596 10,208 12,054 13,905 16,389 19,029 22,305Unknown * * 14 22 29 29 28 16 12 * 11 *

Male 33,219 37,886 43,195 50,173 56,377 62,187 68,451 75,307 82,715 91,801 101,588 112,738Female 26,822 30,997 35,274 41,285 46,211 51,336 56,956 63,172 70,034 77,955 86,379 95,980Unknown * * * * * * * * 11 11 11 12

White 41,752 47,543 53,845 62,190 69,244 76,265 83,948 92,162 100,702 111,124 122,228 134,853Black 16,581 19,330 22,338 26,545 30,188 33,597 37,239 41,453 46,337 52,101 58,170 65,063Native American 351 469 581 762 924 1,069 1,238 1,436 1,663 1,914 2,160 2,450Asian 413 577 864 1,162 1,483 1,880 2,272 2,716 3,291 3,940 4,695 5,583Other/unknown 945 966 843 803 754 720 719 722 767 688 725 781


Diabetes 5,756 8,039 10,850 13,850 17,360 20,943 24,956 29,330 34,231 40,808 48,017 56,244Hypertension 9,506 12,236 15,571 19,033 22,266 25,481 28,985 32,771 37,055 42,373 47,756 53,799Glomerulonephritis 13,537 15,798 18,351 21,320 24,105 26,709 29,275 31,926 34,544 37,413 40,288 43,403Cystic kidney 3,635 4,212 4,870 5,620 6,236 6,838 7,423 8,090 8,680 9,273 9,970 10,751Other urologic 1,626 2,065 2,587 3,149 3,679 4,242 4,667 5,177 5,641 6,048 6,356 6,858Other cause 6,614 7,970 9,676 11,559 13,217 14,829 16,338 17,602 18,913 20,609 22,120 23,735Unknown cause 6,254 6,748 6,810 7,295 7,675 7,777 8,136 8,627 9,038 9,175 9,603 10,273Missing disease 13,114 11,817 9,756 9,636 8,055 6,712 5,636 4,966 4,658 4,068 3,868 3,667

U.S. 58,913 67,618 77,048 89,808 100,651 111,322 122,985 135,841 149,706 166,325 184,271 204,828U.S territories 37 44 58 56 56 69 88 113 126 141 168 203Puerto Rico 615 710 821 974 1,181 1,336 1,467 1,608 1,753 1,981 2,191 2,407Foreign 41 51 51 66 69 82 89 92 98 108 143 164Unknown 436 462 493 558 636 722 787 835 1,077 1,212 1,205 1,128

All 60,042 68,885 78,471 91,462 102,593 113,531 125,416 138,489 152,760 169,767 187,978 208,730

Total lost-to-followup 3,433 4,093 4,964 3,708 3,702 4,136 4,344 4,799 5,292 5,634 5,995 6,210All with lost-to-followup 63,475 72,978 83,435 95,170 106,295 117,667 129,760 143,288 158,052 175,401 193,973 214,940

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed.

Table B.1Point prevalent counts of reported ESRD: all patientspatients alive on December 3 of each year, by demographic characteristics & primary diagnosis


320

Reference section B

Table B.1 (continued)Point prevalent counts of reported ESRD: all patientspatients alive on December 31 of each year, by demographic characteristics & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 394 424 418 420 446 414 430 450 492 495 497 5025-9 746 777 806 822 842 913 896 918 903 938 952 98210-14 1,294 1,353 1,457 1,537 1,591 1,586 1,683 1,711 1,799 1,826 1,924 1,90215-19 2,496 2,598 2,724 2,877 2,964 3,073 3,138 3,268 3,309 3,396 3,473 3,64720-29 14,716 15,074 15,380 15,624 16,015 16,296 16,620 16,726 16,817 16,847 16,831 16,94830-39 32,312 34,229 36,123 37,338 38,435 39,233 40,106 40,976 41,721 42,127 42,515 42,83240-49 40,238 44,246 48,351 52,673 56,557 59,624 63,207 66,264 69,316 71,737 73,998 76,32550-59 41,332 45,439 50,123 53,972 58,858 64,564 70,767 77,102 83,126 89,328 94,767 100,55960-64 23,604 25,384 27,419 29,463 31,578 33,786 36,384 38,585 40,793 43,165 46,277 49,56065-69 25,216 27,479 29,764 31,509 33,749 35,516 37,301 39,231 41,008 42,993 44,813 46,84370-79 36,476 40,227 45,209 49,131 53,891 58,793 62,866 66,530 69,942 72,239 75,423 77,57980+ 11,047 12,718 14,501 16,198 18,202 20,335 22,545 24,852 27,714 30,069 32,837 35,277Unknown * * * * * * * * * * * *

0-19 4,930 5,152 5,405 5,656 5,843 5,986 6,147 6,347 6,503 6,655 6,846 7,03320-44 67,241 71,167 74,787 77,984 80,952 83,477 86,143 88,380 90,122 91,459 92,428 93,60545-64 84,961 93,205 102,609 111,086 120,491 130,026 140,941 151,273 161,651 171,745 181,960 192,61965-74 46,966 51,586 56,680 60,310 64,780 68,950 72,554 75,997 79,423 82,620 85,969 89,10575+ 25,773 28,838 32,794 36,528 41,062 45,694 50,158 54,616 59,241 62,681 67,104 70,594Unknown * * * * * * * * * * * *

Male 123,871 134,852 146,834 157,167 169,140 181,135 193,447 205,449 217,217 227,955 239,615 250,523Female 105,993 115,088 125,436 134,386 143,976 152,985 162,485 171,152 179,710 187,192 194,677 202,400Unknown 13 12 * 13 14 14 12 13 14 14 16 34

White 147,243 158,626 171,580 181,966 194,293 206,486 218,833 231,476 244,098 255,176 266,451 277,048Black 72,426 79,577 87,176 93,977 101,167 108,207 115,703 121,844 127,561 132,792 138,624 144,245Native American 2,798 3,107 3,427 3,752 4,040 4,323 4,710 5,047 5,307 5,591 5,796 5,943Asian 6,538 7,689 8,851 9,935 10,961 11,992 13,144 14,347 15,551 16,733 17,993 19,129Other/unknown 872 953 1,246 1,936 2,669 3,126 3,554 3,900 4,424 4,869 5,444 6,592



U.S. 225,716 245,595 267,613 286,830 308,171 329,058 350,651 371,105 391,232 409,298 428,198 446,401U.S territories 252 275 310 351 404 449 490 548 582 614 674 708Puerto Rico 2,666 2,858 3,077 3,192 3,397 3,571 3,734 3,878 4,016 4,134 4,304 4,471Foreign 182 203 230 246 258 269 284 292 304 302 300 286Unknown 1,061 1,021 1,050 947 900 787 785 791 807 813 832 1,091

All 229,877 249,952 272,280 291,566 313,130 334,134 355,944 376,614 396,941 415,161 434,308 452,957

Total lost-to-followup 6,900 7,596 8,260 9,014 9,691 11,597 13,002 14,239 15,564 17,044 19,230 21,137All with lost-to-followup 236,777 257,548 280,540 300,580 322,821 345,731 368,946 390,853 412,505 432,205 453,538 474,094

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed.

Table B.1 (continued)Point prevalent counts of reported ESRD: all patientspatients alive on December 3 of each year, by demographic characteristics & primary diagnosis

321


Table B.1 (continued)Point prevalent counts of reported ESRD patients: U.S. only, with unknowns droppedpatients alive on December 31 of each year, by demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19920-4 66 104 162 205 227 280 304 332 333 339 329 361 3805-9 219 231 281 318 374 416 489 534 568 644 692 722 71710-14 562 615 701 781 823 839 866 934 1,000 1,039 1,137 1,187 1,26115-19 1,506 1,614 1,707 1,749 1,819 1,946 2,029 2,146 2,225 2,303 2,308 2,364 2,43820-29 6,534 7,341 8,211 9,040 9,736 10,393 11,036 11,532 12,113 12,728 13,397 13,855 14,36030-39 8,961 10,557 12,229 14,059 16,053 18,004 19,930 21,577 23,428 25,473 27,475 29,627 31,65440-49 9,514 10,692 12,085 14,216 15,887 17,575 19,529 21,935 24,757 28,120 31,419 35,474 39,23250-59 12,621 14,375 16,101 17,859 19,583 21,111 22,883 24,676 26,990 29,674 32,721 36,157 40,23960-64 6,068 7,282 8,389 9,937 11,212 12,392 13,282 14,768 16,124 17,671 19,533 21,339 23,10565-69 5,393 6,061 6,936 8,532 9,703 10,881 12,383 14,196 15,863 17,894 20,002 22,318 24,82470-79 5,753 6,786 8,111 10,420 12,174 13,897 15,998 18,155 20,425 23,579 27,015 31,688 35,97880+ 850 1,071 1,369 1,971 2,382 2,964 3,650 4,477 5,310 6,388 7,742 9,184 10,909

0-19 2,353 2,564 2,851 3,053 3,243 3,481 3,688 3,946 4,126 4,325 4,466 4,634 4,79620-44 20,081 23,028 26,311 30,069 33,561 37,009 40,808 44,112 48,000 52,428 57,141 61,591 65,74145-64 23,617 27,219 30,704 35,042 38,910 42,466 45,852 50,376 55,412 61,238 67,404 74,861 82,84965-74 9,200 10,450 12,169 15,090 17,217 19,346 22,027 24,983 27,913 31,712 36,011 41,180 46,25175+ 2,796 3,468 4,247 5,833 7,042 8,396 10,004 11,845 13,685 16,149 18,748 22,010 25,460

Male 32,098 36,679 41,950 48,825 54,863 60,598 66,739 73,448 80,661 89,536 99,141 110,146 121,105Female 25,949 30,050 34,332 40,262 45,110 50,100 55,640 61,814 68,475 76,316 84,629 94,130 103,992

White 40,925 46,615 52,824 61,005 67,846 74,705 82,255 90,354 98,637 108,785 119,676 132,108 144,316Black 16,375 19,092 22,053 26,215 29,800 33,148 36,741 40,903 45,746 51,463 57,543 64,467 71,803Native American 349 466 573 750 908 1,054 1,219 1,418 1,642 1,892 2,138 2,430 2,780Asian 398 556 832 1,117 1,419 1,791 2,164 2,587 3,111 3,712 4,413 5,271 6,198


Diabetes 5,534 7,773 10,565 13,527 16,960 20,471 24,359 28,656 33,437 39,874 46,942 55,045 63,278Hypertension 9,309 11,974 15,276 18,700 21,890 25,032 28,497 32,234 36,462 41,736 47,072 53,080 59,508Glomerulonephritis 13,203 15,406 17,921 20,810 23,498 26,055 28,593 31,202 33,761 36,550 39,389 42,464 45,403Cystic kidney 3,590 4,163 4,816 5,563 6,165 6,757 7,339 8,000 8,588 9,180 9,862 10,636 11,425Other urologic 1,567 1,995 2,505 3,056 3,572 4,115 4,541 5,052 5,488 5,885 6,178 6,686 7,101Other cause 6,496 7,839 9,527 11,398 13,045 14,640 16,127 17,387 18,675 20,355 21,856 23,445 25,156Unknown cause 5,922 6,409 6,504 6,960 7,309 7,395 7,745 8,232 8,641 8,808 9,246 9,911 10,520Missing disease 12,426 11,170 9,168 9,073 7,534 6,233 5,178 4,499 4,084 3,464 3,225 3,009 2,706

All 58,047 66,729 76,282 89,087 99,973 110,698 122,379 135,262 149,136 165,852 183,770 204,276 225,097

Patients dropped 1,995 2,156 2,189 2,375 2,620 2,833 3,037 3,227 3,624 3,915 4,208 4,454 4,780

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table B.1 (continued) Point prevalent counts of reported ESRD patients: U.S. only, with unknowns droppedpatients alive on December 3 of each year, by demographic characteristics & primary diagnosis


322

Reference section B

Table B.1 (continued)Point prevalent counts of reported ESRD patients: U.S. only, with unknowns droppedpatients alive on December 31 of each year, by demographic characteristics & primary diagnosis

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 409 402 402 422 392 410 431 476 474 465 4555-9 744 769 791 810 881 860 879 867 894 915 93810-14 1,320 1,417 1,491 1,545 1,533 1,633 1,663 1,742 1,768 1,855 1,80815-19 2,537 2,649 2,788 2,876 2,987 3,047 3,172 3,206 3,289 3,335 3,48320-29 14,731 15,029 15,256 15,623 15,871 16,162 16,262 16,290 16,308 16,219 16,24630-39 33,571 35,400 36,589 37,649 38,422 39,243 40,059 40,737 41,057 41,349 41,47940-49 43,228 47,268 51,511 55,287 58,286 61,799 64,803 67,761 70,135 72,317 74,42150-59 44,275 48,853 52,552 57,244 62,789 68,858 75,025 80,903 86,962 92,269 97,68860-64 24,811 26,746 28,705 30,739 32,882 35,402 37,546 39,631 41,921 44,951 48,07065-69 27,031 29,292 30,931 33,055 34,762 36,450 38,317 40,040 41,966 43,708 45,62770-79 39,708 44,639 48,479 53,097 57,864 61,846 65,450 68,728 70,932 74,006 76,01780+ 12,553 14,314 15,990 17,961 20,099 22,298 24,538 27,378 29,704 32,426 34,819

0-19 5,010 5,237 5,472 5,653 5,793 5,950 6,145 6,291 6,425 6,570 6,68420-44 69,672 73,198 76,324 79,207 81,686 84,235 86,384 87,939 89,147 89,886 90,69145-64 90,944 100,098 108,289 117,335 126,564 137,229 147,311 157,383 167,236 177,219 187,21365-74 50,800 55,844 59,316 63,601 67,630 71,079 74,420 77,711 80,823 83,991 86,96475+ 28,492 32,401 36,084 40,512 45,095 49,515 53,885 58,435 61,779 66,149 69,499

Male 131,949 143,610 153,598 165,158 176,813 188,776 200,418 211,726 222,097 233,252 243,340Female 112,969 123,168 131,887 141,150 149,955 159,232 167,727 176,033 183,313 190,563 197,711

White 155,560 168,342 178,829 191,179 203,304 215,560 228,072 240,527 251,506 262,669 273,057Black 78,951 86,555 93,384 100,570 107,614 115,079 121,209 126,945 132,171 137,981 143,584Native American 3,086 3,408 3,734 4,022 4,302 4,688 5,025 5,288 5,574 5,779 5,926Asian 7,321 8,473 9,538 10,537 11,548 12,681 13,839 14,999 16,159 17,386 18,484


Diabetes 71,141 80,193 89,221 99,211 109,277 118,995 127,702 137,002 145,158 153,311 160,453Hypertension 65,111 71,286 74,154 78,021 81,964 86,312 90,752 94,788 98,707 103,124 107,654Glomerulonephritis 48,413 51,637 54,400 57,347 59,991 62,720 65,176 67,178 69,063 70,953 72,498Cystic kidney 12,174 12,981 13,743 14,413 15,113 16,012 16,871 17,708 18,456 19,260 20,068Other urologic 7,288 7,632 8,455 9,265 10,010 10,673 11,490 12,054 12,523 13,093 13,531Other cause 26,820 28,534 30,631 32,538 34,334 36,473 38,332 40,219 41,781 43,456 45,205Unknown cause 11,290 12,019 12,362 12,976 13,519 14,154 14,950 15,725 16,490 17,189 17,949Missing disease 2,681 2,496 2,519 2,537 2,560 2,669 2,872 3,085 3,232 3,429 3,693

All 244,918 266,778 285,485 306,308 326,768 348,008 368,145 387,759 405,410 423,815 441,051

Patients dropped 5,034 5,502 6,081 6,822 7,366 7,936 8,469 9,182 9,751 10,493 11,906

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table B.1 (continued) Point prevalent counts of reported ESRD patients: U.S. only, with unknowns droppedpatients alive on December 3 of each year, by demographic characteristics & primary diagnosis

323


ON OUR WEBSITE & CDPoint prevalent rates of reported ESRD: diabetes, hypertension, glomerulo-nephritis, cystic kidney disease, adjusted (B.2.1-4).

Table B.2Point prevalent rates of reported ESRDpatients alive on December 3 of each year, per million population, by demographic characteristics & primary diagnosis

Table B.2Point prevalent rates of reported ESRDpatients alive on December 31 of each year, per million population, by demographic characteristics & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19920-4 4.0 6.1 9.3 11.6 12.8 15.6 16.9 18.3 18.2 18.2 17.3 18.6 19.45-9 13.1 14.4 17.6 19.6 22.7 24.6 28.3 30.4 31.8 35.8 38.1 39.3 38.710-14 30.9 33.8 38.9 44.2 47.7 50.1 52.7 56.8 60.1 61.1 65.0 65.9 68.215-19 71.9 79.7 86.8 91.3 96.6 103.7 108.2 115.4 121.5 128.4 131.7 137.0 140.420-29 159.1 174.3 192.8 210.8 226.6 242.9 260.6 276.4 294.7 313.6 332.5 347.0 364.730-39 277.1 313.4 352.1 393.0 433.9 469.4 506.5 539.5 574.8 613.7 647.9 684.6 719.540-49 409.9 460.0 505.4 575.4 626.0 676.4 720.9 769.1 831.8 907.2 974.2 1,057.6 1,130.650-59 542.9 624.7 707.9 795.2 882.3 959.6 1,047.6 1,134.9 1,242.0 1,361.6 1,487.7 1,614.5 1,740.360-64 596.4 696.0 790.6 926.2 1,032.9 1,138.7 1,227.5 1,369.1 1,500.0 1,657.3 1,840.4 2,024.6 2,224.965-69 607.4 677.1 765.1 930.4 1,045.7 1,152.2 1,284.6 1,451.8 1,603.7 1,786.0 1,988.5 2,228.0 2,477.570-79 487.7 561.0 655.0 823.4 943.3 1,058.2 1,197.8 1,335.6 1,477.8 1,678.3 1,881.9 2,153.5 2,396.480+ 160.0 196.2 243.3 340.2 399.5 483.1 577.4 688.4 793.7 927.6 1,088.0 1,249.1 1,436.2

0-19 32.5 35.8 40.1 43.2 46.1 49.5 52.4 55.8 58.0 60.4 61.8 63.5 64.820-44 235.1 261.6 292.0 326.7 357.7 388.0 422.0 451.9 487.6 527.1 565.9 604.0 642.345-64 529.4 612.0 690.6 787.4 873.1 951.6 1,024.6 1,115.6 1,213.3 1,329.0 1,446.8 1,569.2 1,683.365-74 583.0 652.4 747.4 913.4 1,028.3 1,138.1 1,274.5 1,425.4 1,573.0 1,763.6 1,978.7 2,239.3 2,488.075+ 274.0 330.7 393.5 525.5 617.5 716.7 831.2 959.2 1,081.2 1,244.8 1,406.4 1,607.3 1,813.4

Male 289.1 327.4 370.9 427.7 476.2 521.1 568.4 619.7 674.0 740.4 808.9 885.9 960.3Female 221.0 253.5 287.0 333.7 370.7 408.2 449.4 495.0 543.6 600.1 657.4 721.8 787.2

White 208.8 236.2 265.8 304.9 336.9 368.5 403.0 439.8 476.9 522.0 568.6 620.9 671.0Black 606.9 698.8 796.5 934.9 1,049.6 1,152.8 1,261.1 1,385.4 1,528.3 1,695.8 1,858.1 2,037.8 2,222.5Native American 238.6 308.5 365.7 461.2 538.2 601.9 670.6 751.2 836.6 929.0 1,021.6 1,122.6 1,239.9Asian 99.1 126.4 175.3 219.9 261.4 309.2 351.2 395.9 448.9 507.9 569.2 645.0 720.7



All 254.1 289.4 327.8 379.4 422.1 463.1 507.4 555.7 607.1 668.5 731.3 801.9 871.7

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed.


324

Reference section B

Table B.2 (continued)Point prevalent rates of reported ESRDpatients alive on December 3 of each year, per million population, by demographic characteristics & primary diagnosis


UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 20.7 20.4 20.6 21.8 20.4 21.4 22.5 24.7 24.4 23.6 22.95-9 39.5 40.0 40.3 40.4 43.2 41.8 42.6 42.6 44.5 46.1 47.710-14 70.0 74.2 77.2 79.2 77.8 81.6 81.5 84.0 84.2 87.7 85.115-19 143.5 146.2 149.5 150.1 152.3 152.6 157.0 158.4 162.0 163.4 169.520-29 380.4 393.6 403.0 413.6 418.9 424.6 425.0 422.3 418.3 410.0 403.930-39 754.1 790.3 816.8 845.3 871.0 898.4 925.4 945.7 959.4 976.0 990.940-49 1,206.3 1,272.1 1,334.2 1,392.8 1,440.1 1,493.0 1,531.8 1,569.9 1,598.1 1,626.4 1,654.450-59 1,846.4 1,977.5 2,072.7 2,157.5 2,238.3 2,345.5 2,447.1 2,528.4 2,621.5 2,691.1 2,760.560-64 2,427.4 2,636.7 2,835.5 3,028.0 3,190.0 3,353.3 3,467.2 3,606.4 3,692.2 3,793.1 3,888.965-69 2,696.2 2,931.5 3,102.3 3,336.5 3,560.4 3,793.2 4,044.6 4,199.6 4,388.4 4,522.0 4,643.270-79 2,603.0 2,882.6 3,091.6 3,350.3 3,610.4 3,824.6 4,022.9 4,229.4 4,383.7 4,598.7 4,752.780+ 1,602.0 1,773.2 1,925.3 2,108.9 2,305.0 2,497.4 2,683.5 2,904.8 3,053.2 3,241.0 3,395.6

0-19 66.7 68.8 70.9 72.4 73.4 74.7 76.4 78.0 79.5 81.0 82.220-44 678.5 711.1 739.9 766.3 788.6 811.8 831.1 843.0 851.9 857.0 863.245-64 1,797.2 1,922.9 2,020.5 2,120.5 2,210.4 2,314.2 2,398.7 2,478.9 2,551.3 2,619.6 2,683.865-74 2,710.6 2,966.0 3,147.5 3,391.3 3,630.7 3,843.2 4,057.1 4,234.7 4,413.8 4,585.9 4,736.975+ 1,982.0 2,200.8 2,388.0 2,610.6 2,839.2 3,053.9 3,257.1 3,466.2 3,599.9 3,791.2 3,922.9

Male 1,032.6 1,109.8 1,172.4 1,245.2 1,316.5 1,388.4 1,456.1 1,520.7 1,577.7 1,639.3 1,692.3Female 844.7 910.4 963.9 1,020.0 1,071.5 1,125.5 1,173.0 1,219.0 1,257.6 1,295.4 1,331.9

White 716.1 767.5 807.7 855.4 901.2 946.8 992.9 1,038.7 1,077.1 1,115.8 1,150.7Black 2,396.3 2,579.6 2,736.0 2,897.3 3,048.5 3,207.0 3,324.2 3,435.1 3,530.5 3,639.5 3,740.7Native American 1,329.3 1,419.2 1,500.6 1,558.5 1,607.5 1,686.7 1,741.1 1,754.1 1,826.1 1,869.7 1,892.6Asian 812.7 901.1 971.9 1,028.8 1,082.0 1,140.8 1,195.4 1,240.2 1,288.8 1,339.4 1,377.0

†Hispanic 935.3 986.7 1,035.9 1,086.3 1,138.4 1,187.8 1,236.5 1,282.6†Non-Hispanic 1,154.6 1,218.2 1,284.0 1,343.7 1,400.7 1,449.4 1,500.2 1,545.9


All 936.5 1,007.8 1,065.9 1,130.2 1,191.5 1,254.3 1,311.8 1,367.1 1,414.9 1,464.5 1,509.3

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed.

325




ADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19920-4 3.9 6.1 9.2 11.5 12.4 15.3 16.5 18.0 17.7 17.8 17.1 18.3 19.05-9 12.9 14.1 17.3 19.3 22.4 24.4 28.1 30.0 31.6 35.2 37.2 38.5 37.910-14 30.5 33.1 38.7 44.1 47.3 49.8 52.3 56.1 59.3 60.5 64.3 65.3 67.515-19 70.7 78.6 85.8 90.0 95.2 102.3 107.0 114.1 119.9 126.3 129.6 134.9 138.320-29 160.1 174.8 192.9 210.7 225.9 241.3 257.8 272.3 289.6 307.8 326.4 340.9 358.430-39 291.2 330.3 369.4 411.0 452.4 487.1 523.6 556.8 591.6 629.5 662.9 697.8 730.940-49 436.6 490.3 541.6 620.9 678.2 732.2 781.1 836.1 904.7 989.0 1,058.1 1,145.8 1,217.050-59 596.6 689.5 782.6 879.2 976.2 1,062.4 1,158.3 1,255.9 1,376.6 1,509.7 1,648.4 1,792.7 1,936.060-64 665.6 783.8 900.6 1,060.1 1,185.3 1,314.7 1,410.5 1,566.3 1,716.9 1,897.7 2,102.7 2,300.6 2,525.265-69 665.1 754.9 860.0 1,056.4 1,200.1 1,330.0 1,489.9 1,695.1 1,870.9 2,073.5 2,315.8 2,592.1 2,866.170-79 534.6 623.2 737.1 945.3 1,091.9 1,228.0 1,396.2 1,562.9 1,746.5 1,995.7 2,238.5 2,563.3 2,857.780+ 185.2 227.9 291.1 413.0 491.8 605.8 720.9 857.2 988.7 1,161.2 1,381.8 1,607.3 1,855.6

0-19 29.5 33.0 37.7 41.2 44.3 47.9 51.0 54.6 57.1 60.0 62.0 64.2 65.720-44 261.1 290.4 322.2 359.8 391.3 420.8 453.2 479.7 512.8 549.2 584.0 617.9 652.145-64 582.3 675.5 765.7 876.3 973.5 1,064.1 1,146.5 1,252.5 1,369.5 1,505.9 1,643.6 1,791.4 1,937.365-74 641.3 728.8 839.8 1,040.8 1,184.7 1,315.7 1,482.5 1,662.5 1,840.1 2,065.1 2,327.9 2,633.6 2,921.875+ 274.1 333.2 412.3 563.8 666.1 788.7 919.8 1,070.1 1,220.4 1,419.0 1,633.6 1,888.7 2,149.7

Male 336.6 382.0 432.1 500.1 556.3 607.9 660.9 718.3 780.1 856.1 934.0 1,020.4 1,102.3Female 234.6 268.6 303.2 350.2 387.5 425.0 465.4 509.6 557.9 613.8 669.8 731.8 794.0

White 219.4 247.4 276.9 316.4 348.3 379.6 413.3 448.9 485.2 529.2 575.0 625.4 673.0Black 823.7 948.8 1,078.0 1,266.9 1,418.7 1,556.7 1,698.3 1,861.4 2,051.3 2,274.1 2,493.5 2,738.8 2,989.4Native American 343.1 450.0 539.9 696.3 809.7 905.5 1,009.6 1,133.0 1,265.8 1,425.0 1,583.1 1,747.1 1,928.1Asian 111.2 148.9 214.8 279.0 339.4 405.9 464.5 526.4 603.6 691.2 778.9 885.3 985.7



All 282.6 322.0 363.8 420.5 466.5 510.4 556.6 606.8 661.1 726.1 791.6 864.4 935.2

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race/ethnicityare adjusted for gender & age, rates by primary diagnosis are adusted for age, gender, & race.The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.*Values for cells with 10 or fewer patients are suppressed.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


326

Reference section B



ADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 20.5 20.1 20.2 21.6 20.3 21.2 22.4 24.5 24.2 23.4 22.65-9 38.7 39.4 39.7 39.7 42.5 41.3 42.0 41.9 44.1 45.8 47.410-14 69.4 73.2 76.0 77.8 76.6 80.2 80.2 82.7 82.5 85.9 83.815-19 140.9 143.2 146.6 146.8 148.9 149.2 153.5 155.0 158.5 160.0 165.820-29 373.3 385.3 392.9 401.9 406.8 413.1 414.5 414.8 412.8 405.3 399.030-39 763.2 797.1 820.7 846.0 868.0 892.1 916.4 936.4 950.4 966.7 981.240-49 1,292.4 1,357.0 1,414.5 1,467.1 1,507.8 1,555.3 1,587.0 1,621.1 1,643.3 1,665.8 1,686.750-59 2,060.0 2,203.4 2,308.0 2,408.5 2,503.8 2,617.4 2,720.4 2,790.7 2,879.6 2,937.4 2,991.660-64 2,739.8 2,960.3 3,169.9 3,374.2 3,544.1 3,717.8 3,837.7 3,973.3 4,077.8 4,202.4 4,321.865-69 3,123.9 3,375.2 3,552.4 3,798.4 4,033.8 4,280.3 4,541.1 4,685.1 4,870.1 5,002.1 5,129.370-79 3,115.5 3,463.5 3,720.9 4,003.0 4,296.5 4,547.6 4,754.1 4,954.9 5,102.9 5,326.0 5,469.480+ 2,063.6 2,284.7 2,475.5 2,722.3 2,948.1 3,203.7 3,431.4 3,664.6 3,813.1 4,021.7 4,193.1

0-19 67.4 69.0 70.6 71.5 72.1 73.0 74.5 76.0 77.3 78.8 79.920-44 682.6 708.9 731.6 752.1 769.4 788.7 804.7 816.6 826.1 832.9 841.245-64 2,076.1 2,225.3 2,346.1 2,465.2 2,567.4 2,682.6 2,772.7 2,854.1 2,929.8 2,997.1 3,058.365-74 3,194.3 3,490.9 3,700.1 3,956.4 4,210.7 4,432.4 4,638.1 4,807.3 4,984.0 5,164.3 5,312.975+ 2,364.5 2,629.9 2,848.3 3,112.0 3,367.2 3,639.3 3,878.7 4,103.2 4,244.7 4,456.3 4,609.5

Male 1,180.0 1,262.6 1,326.6 1,400.2 1,469.5 1,540.3 1,604.8 1,662.1 1,711.2 1,763.9 1,805.6Female 848.8 909.3 957.4 1,006.0 1,048.0 1,093.2 1,131.8 1,165.7 1,193.4 1,218.4 1,242.1

White 715.8 764.4 801.7 844.9 885.6 926.5 967.1 1,006.7 1,038.3 1,068.9 1,095.6Black 3,216.1 3,454.6 3,645.6 3,838.1 4,017.1 4,200.4 4,323.6 4,430.1 4,518.1 4,622.9 4,712.3Native American 2,076.9 2,210.9 2,335.8 2,416.1 2,482.8 2,598.7 2,672.0 2,575.9 2,608.4 2,601.6 2,573.5Asian 1,104.1 1,224.5 1,317.8 1,386.3 1,439.6 1,504.4 1,559.5 1,587.1 1,616.6 1,654.0 1,671.4

†Hispanic 1,592.2 1,693.5 1,791.1 1,888.0 1,957.3 2,018.9 2,079.6 2,129.0†Non-Hispanic 1,144.6 1,198.6 1,254.8 1,304.5 1,350.3 1,387.6 1,425.3 1,457.6


All 1,000.3 1,070.8 1,126.1 1,185.5 1,240.1 1,296.1 1,345.7 1,390.0 1,427.2 1,464.5 1,496.2

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race/ethnicityare adjusted for gender & age, rates by primary diagnosis are adusted for age, gender, & race.The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.*Values for cells with 10 or fewer patients are suppressed.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

327


Table B.3Point prevalent rates of reported diabetic ESRDpatients alive on December 31 of each year, per million population, by demographic characteristics

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19920-4 * * * * * 1 1 1 1 1 1 * *5-9 * * * * * * * * * * * * *10-14 * * * * * * * * * * * * *15-19 1 1 1 1 1 1 1 1 1 1 1 2 220-29 11 14 18 21 24 28 30 33 34 38 40 42 4330-39 37 49 60 73 87 100 111 121 131 143 154 163 17340-49 43 57 73 90 107 128 148 170 194 223 247 276 30350-59 56 81 111 139 176 208 244 280 327 386 453 524 58660-64 66 93 131 175 219 263 306 375 440 523 626 731 83565-69 57 82 115 153 196 243 304 369 443 533 629 764 91670-79 31 49 71 98 132 161 203 247 299 380 472 581 68680+ 6 7 15 21 28 38 53 69 81 108 147 181 227

0-19 . . . . . 1 1 1 1 1 1 1 120-44 25 33 41 51 60 70 80 89 98 110 121 131 14045-64 55 79 108 137 171 204 238 277 322 378 441 505 56265-74 48 73 103 139 180 218 277 331 401 492 594 724 86075+ 15 19 30 43 59 80 100 131 153 198 251 308 372

Male 26 35 47 59 73 88 102 118 135 158 182 210 238Female 22 32 44 57 70 84 100 117 138 164 191 221 252

White 20 27 37 46 57 67 79 91 105 124 144 165 187Black 56 79 108 139 177 213 251 296 342 402 471 546 619Native American 65 109 136 184 223 271 315 373 434 499 560 635 718Asian 3 8 17 26 33 48 58 71 81 98 123 148 175


All 24 34 45 58 72 86 101 118 136 161 187 216 245

ADJUSTED0-4 * * * * * 1 1 1 1 1 1 * *5-9 * * * * * * * * * * * * *10-14 * * * * * * * * * * * * *15-19 1 1 1 1 1 1 1 1 1 1 1 2 220-29 11 14 18 21 23 27 29 31 33 36 39 41 4230-39 37 48 60 73 87 100 111 121 131 144 155 164 17340-49 45 60 76 95 113 135 157 180 206 238 262 294 32050-59 63 92 126 158 199 237 277 318 370 435 510 590 66160-64 78 110 159 213 265 316 365 444 521 617 734 851 97065-69 67 101 138 185 238 299 372 455 537 635 756 913 1,08270-79 35 57 84 116 157 198 251 305 366 465 572 704 82880+ 7 8 19 25 37 55 72 87 100 136 192 235 293

0-19 . . . . . . 1 1 1 1 1 1 120-44 27 36 45 55 65 75 84 93 101 113 123 132 14045-64 63 90 124 158 197 235 273 320 374 440 513 592 66565-74 55 87 122 166 217 265 336 405 483 591 716 871 1,02675+ 14 19 34 45 64 92 115 143 168 218 283 350 424

Male 31 41 55 69 85 102 119 136 155 182 211 242 273Female 24 34 47 60 74 88 104 122 142 168 195 225 255

White 22 29 39 48 59 69 81 93 107 126 145 166 187Black 76 107 147 190 241 292 346 407 471 556 654 762 864Native American 109 183 227 308 374 452 518 616 715 823 935 1,057 1,187Asian 4 11 26 39 51 77 94 111 126 154 192 229 270


All 27 38 51 64 80 95 112 129 149 175 204 235 265

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race/ethnicity are adjusted for gender & age.The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table B.3Point prevalent rates of reported diabetic ESRDpatients alive on December 3 of each year, per million population, by demographic characteristics


328

Reference section B

Table B.3 (continued)Point prevalent rates of reported diabetic ESRDpatients alive on December 31 of each year, per million population, by demographic characteristics

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 * * * * * . * * * * *5-9 * * * . * * * * * * *10-14 * * * * * * * * * * *15-19 2 2 1 1 1 1 1 1 1 1 120-29 41 40 40 38 37 35 33 33 32 30 2730-39 184 193 197 202 206 208 210 212 208 206 20540-49 331 356 382 403 417 435 444 458 468 479 48850-59 638 707 764 824 877 930 979 1,019 1,057 1,090 1,11660-64 947 1,070 1,201 1,332 1,450 1,573 1,650 1,722 1,793 1,849 1,87465-69 1,028 1,169 1,296 1,465 1,617 1,769 1,933 2,044 2,164 2,237 2,31270-79 791 915 1,056 1,211 1,371 1,504 1,619 1,763 1,867 1,987 2,08680+ 266 314 367 435 522 596 657 758 831 923 981

0-19 1 1 . . . . . . . . .20-44 149 157 164 169 173 177 178 180 180 178 17845-64 618 683 740 802 856 910 952 992 1,027 1,061 1,08465-74 976 1,113 1,250 1,419 1,574 1,711 1,852 1,977 2,090 2,190 2,28375+ 429 505 595 696 819 925 1,009 1,127 1,206 1,302 1,368

Male 265 295 325 358 395 428 458 490 518 548 573Female 279 311 341 373 402 430 453 477 495 512 526

White 206 229 250 274 299 321 342 366 385 403 419Black 692 767 846 934 1,010 1,088 1,140 1,189 1,233 1,286 1,326Native American 787 845 909 955 1,000 1,062 1,103 1,129 1,181 1,211 1,231Asian 209 242 275 300 325 351 377 402 430 451 467

†Hispanic 408 445 476 510 545 574 602 627†Non-Hispanic 361 392 423 447 474 496 518 536

All 272 303 333 366 398 429 455 483 507 530 549

ADJUSTED0-4 * * * * * . * * * * *5-9 * * * . * * * * * * *10-14 * * * * * * * * * * *15-19 2 2 1 1 1 1 1 1 1 1 120-29 40 39 38 36 35 34 32 33 33 30 2830-39 184 193 196 200 204 205 207 209 207 205 20540-49 349 375 399 419 432 449 456 470 479 488 49550-59 723 798 862 933 994 1,050 1,100 1,136 1,172 1,199 1,21560-64 1,090 1,220 1,360 1,500 1,624 1,758 1,842 1,909 1,994 2,059 2,09465-69 1,217 1,368 1,509 1,696 1,858 2,021 2,196 2,298 2,416 2,486 2,56770-79 959 1,113 1,287 1,463 1,649 1,810 1,935 2,086 2,194 2,325 2,42080+ 349 413 484 573 677 777 851 963 1,044 1,150 1,215

0-19 1 1 . . . . . . . . .20-44 147 154 159 162 165 168 169 171 172 171 17245-64 736 815 889 967 1,033 1,099 1,147 1,188 1,229 1,262 1,28165-74 1,170 1,330 1,490 1,678 1,850 1,998 2,141 2,265 2,377 2,482 2,57375+ 498 587 690 805 937 1,067 1,162 1,289 1,380 1,490 1,564

Male 303 336 369 404 442 476 505 536 563 589 610Female 281 311 339 369 393 417 436 454 467 477 485

White 205 228 248 271 294 314 332 354 370 384 396Black 966 1,070 1,178 1,296 1,397 1,497 1,560 1,612 1,660 1,715 1,749Native American 1,312 1,402 1,506 1,574 1,642 1,735 1,795 1,745 1,771 1,761 1,745Asian 318 367 415 450 479 507 538 562 587 602 609

†Hispanic 783 862 926 995 1,048 1,090 1,131 1,159†Non-Hispanic 357 385 411 432 454 471 487 499

All 293 324 354 387 417 446 469 493 512 530 543

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race/ethnicity are adjusted for gender & age.The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table B.3 (continued)Point prevalent rates of reported diabetic ESRDpatients alive on December 3 of each year, per million population, by demographic characteristics

329


ON OUR WEBSITE & CDPoint prevalent counts of reported ESRD patients, 1998-2000 (B.4.1).Point prevalent counts of reported ESRD: by primary diagnosis, 2000-2003 combined (B.4.2).

Table B.4Point prevalent counts of reported ESRD patients, 2001-2003patients alive on December 31 of each year, by age, gender, & race

Male Female AllWhite Black N Am Asian All White Black N Am Asian All White Black N Am Asian All

0-4 753 155 * 21 939 370 61 * 16 455 1,123 216 18 37 1,3945-9 1,315 309 16 45 1,685 878 155 * 25 1,062 2,193 464 20 70 2,74710-14 2,391 659 53 76 3,179 1,658 490 38 66 2,252 4,049 1,149 91 142 5,43115-19 4,177 1,346 76 191 5,790 2,994 1,073 59 191 4,317 7,171 2,419 135 382 10,10720-29 17,071 8,579 299 1,214 27,163 12,931 7,204 343 1,132 21,610 30,002 15,783 642 2,346 48,77330-39 41,879 25,759 674 2,671 70,983 30,508 19,224 811 2,359 52,902 72,387 44,983 1,485 5,030 123,88540-49 76,095 46,245 1,575 4,202 128,117 50,944 32,478 1,244 4,090 88,756 127,039 78,723 2,819 8,292 216,87350-59 94,475 56,425 2,451 5,910 159,261 66,966 43,243 2,299 5,150 117,658 161,441 99,668 4,750 11,060 276,91960-64 45,051 23,201 1,097 3,135 72,484 35,143 23,396 1,382 2,537 62,458 80,194 46,597 2,479 5,672 134,94265-69 43,780 19,671 856 2,763 67,070 36,614 23,755 1,254 2,608 64,231 80,394 43,426 2,110 5,371 131,30170-79 82,059 24,669 823 4,465 112,016 67,576 35,017 1,391 4,955 108,939 149,635 59,686 2,214 9,420 220,95580+ 39,936 7,811 199 2,056 50,002 31,668 12,811 317 2,151 46,947 71,604 20,622 516 4,207 96,949

0-19 8,636 2,469 155 333 11,593 5,900 1,779 109 298 8,086 14,536 4,248 264 631 19,67920-44 93,441 54,213 1,634 5,754 155,042 66,903 40,761 1,701 5,317 114,682 160,344 94,974 3,335 11,071 269,72445-64 181,130 105,996 4,462 11,378 302,966 129,589 84,784 4,378 9,951 228,702 310,719 190,780 8,840 21,329 531,66865-74 86,846 34,385 1,391 5,192 127,814 72,564 43,995 2,102 5,303 123,964 159,410 78,380 3,493 10,495 251,77875+ 78,929 17,766 487 4,092 101,274 63,294 27,588 860 4,411 96,153 142,223 45,354 1,347 8,503 197,427

Diabetes 154,948 64,443 4,935 9,021 233,347 129,463 81,356 6,269 8,487 225,575 284,411 145,799 11,204 17,508 458,922Hypertension 88,042 86,692 797 6,476 182,007 57,762 63,632 600 5,484 127,478 145,804 150,324 1,397 11,960 309,485Glomerulonephritis 87,139 32,516 1,326 7,030 128,011 53,571 23,304 1,289 6,339 84,503 140,710 55,820 2,615 13,369 212,514Other cause 118,853 31,178 1,071 4,222 155,324 97,454 30,615 992 4,970 134,031 216,307 61,793 2,063 9,192 289,355

All 448,982 214,829 8,129 26,749 698,689 338,250 198,907 9,150 25,280 571,587 787,232 413,736 17,279 52,029 1,270,276

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.Age is calculated as of December 31.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.*Values for cells with 10 or fewer patients are suppressed.

Table B.4Point prevalent counts of reported ESRD patients, 2001-2003patients alive on December 3 of each year, by age, gender, & race


330

Reference section B

ON OUR WEBSITE & CDPoint prevalent rates of reported ESRD, 1998-2000 (B.5.1).Point prevalent rates of reported ESRD: by primary diagnosis (B.5.2).

Table B.5Point prevalent rates of reported ESRD, 2001-2003patients alive on December 31 of each year, per million population, by age, gender, & race

Unadjusted rates Rates adjusted for:Male Female Gender Race Gender &

White Black N Am Asian White Black N Am Asian White Black N Am Asian Male Female race0-4 32 32 * 15 16 13 * 12 24 22 25 14 31 16 235-9 55 62 38 33 39 32 * 19 47 47 24 26 55 37 4610-14 95 123 114 55 69 94 84 51 82 108 99 53 97 72 8415-19 168 277 169 139 128 228 137 147 148 252 153 143 181 142 16120-29 353 1,020 381 371 286 819 472 344 322 943 439 352 449 365 40630-39 811 3,215 964 763 611 2,149 1,190 645 707 2,668 1,078 710 1,123 818 96640-49 1,388 6,006 2,421 1,487 930 3,696 1,828 1,311 1,159 4,885 2,147 1,410 2,024 1,326 1,66550-59 2,211 11,274 5,694 3,044 1,520 7,229 5,012 2,299 1,879 9,410 5,510 2,729 3,524 2,381 2,93660-64 3,075 15,119 8,496 5,109 2,219 11,912 9,867 3,665 2,637 13,482 9,203 4,370 4,797 3,634 4,20165-69 3,738 16,260 9,404 5,936 2,758 14,562 12,053 4,614 3,239 15,394 10,749 5,264 5,536 4,486 5,00170-79 4,429 15,785 7,610 7,512 2,808 14,299 10,118 6,061 3,616 14,945 8,751 6,841 6,099 4,526 5,29980+ 4,280 11,456 4,707 8,001 1,787 8,547 4,203 5,599 2,944 9,713 4,241 6,623 5,208 2,850 4,009

0-19 89 123 92 61 64 91 66 57 75 107 75 59 91 67 7920-44 729 2,644 892 696 543 1,822 963 620 617 2,238 949 662 970 704 83345-64 2,158 10,437 5,167 2,933 1,495 7,005 4,759 2,248 1,922 9,526 5,702 2,866 3,546 2,473 2,99565-74 3,962 16,238 8,923 6,408 2,814 14,760 11,488 5,134 3,388 15,491 10,128 5,825 5,747 4,582 5,15475+ 4,472 13,290 5,692 8,078 2,162 10,617 6,420 6,010 3,194 11,242 5,492 6,847 5,552 3,359 4,437

Diabetes 444 1,189 1,066 476 363 1,367 1,350 424 384 1,708 1,759 599 916 783 849Hypertension 252 1,599 172 342 162 1,069 129 274 194 1,712 220 412 848 486 662Glomerulonephritis 250 600 286 371 150 392 277 317 194 561 332 370 367 209 286Other cause 340 575 231 223 273 514 214 248 59 127 57 53 102 70 86

All 1,286 3,963 1,756 1,413 947 3,342 1,970 1,263 1,115 3,638 1,863 1,336 1,637 1,295 1,463All (age adjusted) 1,309 5,344 2,510 1,872 871 3,954 2,656 1,468 1,068 4,618 2,594 1,647 1,760 1,218 1,463

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded.The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.Age is calculated as of December 31.*Values for cells with 10 or fewer patients are suppressed.

Table B.5Point prevalent rates of reported ESRD, 2001-2003patients alive on December 3 of each year, per million population, by age, gender, & race

331


ON OUR WEBSITE & CDMedian age at start of ESRD therapy: Prevalent patients by demographic characteristics & primary diagnosis (B.c).

Table B.6Mean age at start of ESRD therapypatients alive on December 31 of each year, by demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19920-4 2.4 2.5 2.4 2.4 2.3 2.3 2.3 2.4 2.4 2.4 2.4 2.2 2.35-9 7.4 7.4 7.3 7.3 7.2 7.1 7.2 7.2 7.2 7.1 7.2 7.2 7.310-14 12.3 12.2 12.4 12.4 12.4 12.3 12.3 12.2 12.2 12.3 12.3 12.2 12.215-19 17.4 17.3 17.4 17.4 17.3 17.3 17.3 17.3 17.4 17.4 17.4 17.3 17.320-29 25.1 25.1 25.1 25.2 25.2 25.3 25.3 25.4 25.4 25.4 25.5 25.4 25.430-39 34.5 34.5 34.5 34.5 34.6 34.6 34.7 34.8 34.8 34.8 34.8 34.8 34.940-49 44.6 44.6 44.6 44.5 44.6 44.6 44.5 44.5 44.4 44.4 44.4 44.5 44.550-59 54.7 54.7 54.7 54.8 54.7 54.7 54.7 54.7 54.7 54.6 54.6 54.7 54.660-64 61.9 61.9 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.1 62.165-69 66.9 67.0 66.9 66.9 66.9 66.9 66.9 66.9 67.0 67.0 67.0 67.0 67.070-79 73.5 73.5 73.6 73.6 73.7 73.8 73.8 73.9 73.9 73.9 73.9 73.9 73.980+ 82.7 82.9 83.0 82.8 82.9 83.0 83.0 83.0 83.1 83.1 83.2 83.3 83.3

0-19 14.8 14.6 14.3 14.0 13.8 13.6 13.5 13.5 13.5 13.4 13.4 13.2 13.320-44 33.2 33.2 33.3 33.5 33.6 33.7 33.9 34.1 34.3 34.5 34.7 34.8 35.045-64 54.9 55.1 55.1 55.2 55.2 55.2 55.2 55.1 55.1 55.0 55.0 55.0 54.965-74 68.9 69.0 69.1 69.1 69.1 69.1 69.1 69.1 69.1 69.1 69.1 69.2 69.275+ 78.5 78.6 78.8 78.7 78.8 78.9 79.0 79.1 79.2 79.3 79.5 79.5 79.6

Male 48.6 48.7 48.9 49.5 49.7 50.0 50.3 50.6 50.9 51.3 51.8 52.4 52.8Female 49.9 50.3 50.6 51.4 51.8 52.1 52.5 53.0 53.3 53.7 54.1 54.6 55.1Unknown 29.0 31.5 32.5 39.8 38.8 34.6 36.7 37.5 43.3 44.3 45.3 48.5 50.5

White 48.9 49.1 49.3 50.0 50.3 50.6 51.0 51.4 51.8 52.4 52.9 53.5 54.0Black 50.0 50.4 50.6 51.3 51.6 51.9 52.2 52.5 52.7 52.8 53.1 53.5 53.8Native American 45.3 46.8 47.6 49.0 49.3 49.8 50.1 50.8 51.4 52.1 52.3 52.6 53.0Asian 41.1 43.1 44.5 46.2 47.3 47.9 48.6 49.4 49.9 50.5 51.3 52.2 52.7Other/unknown 51.4 52.3 51.5 51.0 50.2 49.3 48.7 48.1 47.0 45.3 45.4 45.6 46.9



U.S. 49.2 49.4 49.6 50.3 50.7 50.9 51.3 51.7 52.1 52.5 52.9 53.5 53.9U.S. territories 51.2 48.7 50.9 49.3 49.3 49.7 52.1 52.9 50.9 50.4 51.6 53.2 52.5Puerto Rico 49.2 49.5 49.3 50.2 50.9 51.4 51.5 51.5 52.0 52.8 53.2 53.4 54.0Foreign 48.5 48.2 47.9 49.3 51.1 50.7 51.6 52.4 50.6 50.8 50.7 48.9 48.6Unknown 48.5 49.2 49.3 48.9 47.9 47.4 47.7 45.9 45.2 45.1 45.5 45.5 45.6

All 49.2 49.4 49.6 50.3 50.6 50.9 51.3 51.7 52.0 52.4 52.9 53.4 53.9

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.Patients with unknown age are excluded. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table B.6Mean age at start of ESRD therapypatients alive on December 3 of each year, by demographic characteristics & primary diagnosis


332

Reference section B

Table B.6 (continued)Mean age at start of ESRD therapypatients alive on December 31 of each year, by demographic characteristics & primary diagnosis

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 2.3 2.4 2.4 2.5 2.4 2.3 2.3 2.3 2.4 2.4 2.35-9 7.3 7.3 7.2 7.2 7.2 7.2 7.3 7.3 7.3 7.2 7.210-14 12.2 12.2 12.2 12.2 12.3 12.2 12.3 12.2 12.3 12.3 12.315-19 17.3 17.3 17.3 17.3 17.2 17.3 17.3 17.3 17.2 17.2 17.220-29 25.4 25.4 25.4 25.4 25.5 25.5 25.5 25.4 25.4 25.3 25.330-39 34.9 34.9 34.9 35.0 35.1 35.1 35.1 35.1 35.1 35.1 35.140-49 44.5 44.6 44.7 44.7 44.7 44.7 44.8 44.8 44.8 44.8 44.950-59 54.6 54.6 54.6 54.5 54.5 54.5 54.5 54.5 54.5 54.5 54.560-64 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.065-69 67.0 67.0 67.0 67.0 67.0 67.0 67.0 67.0 67.0 67.0 67.070-79 73.9 73.9 73.9 74.0 74.0 74.1 74.2 74.2 74.2 74.2 74.280+ 83.3 83.3 83.4 83.5 83.6 83.6 83.7 83.7 83.7 83.7 83.8

0-19 13.2 13.3 13.3 13.3 13.4 13.4 13.4 13.4 13.4 13.4 13.420-44 35.1 35.2 35.3 35.4 35.5 35.6 35.7 35.7 35.8 35.8 35.845-64 54.8 54.7 54.7 54.6 54.6 54.6 54.6 54.6 54.7 54.7 54.865-74 69.3 69.3 69.4 69.4 69.4 69.4 69.4 69.4 69.4 69.4 69.375+ 79.7 79.7 79.7 79.8 79.8 79.9 80.0 80.1 80.1 80.2 80.3

Male 53.2 53.5 53.8 54.2 54.6 55.0 55.3 55.6 55.8 56.1 56.3Female 55.4 55.8 56.1 56.4 56.8 57.0 57.2 57.4 57.6 57.9 58.0Unknown 48.0 49.3 53.0 55.0 56.0 59.0 58.2 57.9 58.9 59.6 60.7

White 54.4 54.9 55.2 55.7 56.1 56.5 56.8 57.2 57.4 57.7 57.9Black 53.9 54.2 54.3 54.4 54.7 54.9 54.9 55.1 55.2 55.4 55.6Native American 53.5 53.7 53.9 54.0 54.4 54.6 54.9 55.1 55.2 55.5 55.8Asian 53.4 54.2 54.8 55.4 55.6 56.0 56.4 56.8 57.0 57.3 57.6Other/unknown 47.8 48.7 52.1 53.8 54.5 54.4 54.5 54.1 53.8 53.3 53.0



U.S. 54.2 54.6 54.9 55.3 55.6 55.9 56.2 56.4 56.7 56.9 57.1U.S. territories 53.0 53.0 53.2 53.7 53.8 54.6 55.0 55.8 56.2 56.0 55.7Puerto Rico 54.6 54.6 54.5 54.7 54.9 55.2 55.7 55.7 55.8 55.9 55.9Foreign 48.5 48.4 48.3 48.4 48.3 48.5 49.9 50.6 51.0 50.5 50.7Unknown 46.1 46.7 46.6 46.9 46.6 47.1 47.2 47.8 48.7 49.3 47.8

All 54.2 54.6 54.9 55.2 55.6 55.9 56.2 56.4 56.6 56.9 57.1

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.Patients with unknown age are excluded. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table B.6 (continued)Mean age at start of ESRD therapypatients alive on December 3 of each year, by demographic characteristics & primary diagnosis

333


ON OUR WEBSITE & CDPrevalence of reported ESRD, by primary diagnosis: Hispanics & non-Hispan-ics (B.7.1-2). Prevalence of reported ESRD: by detailed primary diagnosis, age <20, 20-64, & 65+ (B.7.3-5).

Table B.7Prevalence of reported ESRD, by primary diagnosis: all patients1999-2003 combined, patients alive on December 31 of each year, by detailed primary diagnosis

Total Percent Median Percent Percent % Tx % DiedROW PERCENT Patients Incident Age Male White Black N Am Asian 1st yr 1st yrAll ESRD (reference) 2,075,981 100.0 57 55.0 61.4 32.0 1.3 4.0 2.4 15.4Diabetes 742,927 36.2 61 50.6 61.2 31.3 2.4 3.8 2.0 19.9

Type I (juvenile) 145,994 7.1 48 54.6 72.9 23.3 1.3 1.8 3.2 14.0Type II (adult-onset or unspecified) 596,933 29.1 63 49.6 58.3 33.2 2.7 4.3 1.8 21.3

Glomerulonephritis (GN) 341,877 16.6 48 60.5 65.9 25.7 1.2 6.2 3.4 7.8Focal glomerulosclerosis, focal GN 73,479 3.6 45 60.8 55.4 40.1 0.7 3.0 4.4 6.9Membranous nephropathy 14,806 0.7 54 67.3 69.1 26.7 0.6 2.8 3.9 9.1Membranoproliferative GN, types I & II 14,503 0.7 45 57.6 74.7 17.9 1.8 4.9 3.4 6.4IgA nephropathy, Berger's disease 20,053 1.0 43 66.7 75.2 7.1 2.0 14.2 7.2 4.0IgM nephropathy 2,113 0.1 45 64.7 74.7 8.9 1.2 14.1 5.7 5.8Rapidly progressive GN 10,100 0.5 52 50.5 76.7 15.8 1.9 4.8 3.5 9.2Goodpasture's Syndrome 3,625 0.2 49 50.8 89.5 6.9 1.2 1.7 5.2 8.3Post-infectious GN, SBE 2,000 0.1 49 60.7 77.6 15.6 2.5 4.1 3.2 11.0Glomerulonephritis 190,950 9.3 50 60.4 66.5 24.1 1.2 7.1 2.5 8.5Other proliferative GN 10,248 0.5 47 56.4 72.8 20.1 1.0 5.1 3.4 8.1

Secondary GN/vasculitis 67,336 3.3 44 29.6 60.4 33.7 0.9 4.1 3.6 9.3

Lupus erythematosus (SLE nephritis) 39,573 1.9 41 17.5 48.8 44.2 0.8 5.2 3.9 7.7Polyarteritis 1,281 0.1 56 48.5 78.7 16.1 0.9 3.8 3.9 13.3Wegeners granulomatosis 6,163 0.3 58 57.5 90.5 6.7 0.7 1.5 3.9 11.0Henoch-Schonlein syndrome 1,871 0.1 32 51.3 85.5 7.3 2.0 5.1 4.2 3.8Vasculitis and its derivatives 5,247 0.3 58 42.6 83.9 11.2 2.1 2.3 2.7 14.0Scleroderma 3,045 0.1 53 21.8 73.7 23.1 0.6 1.4 2.7 18.4Hemolytic uremic syndrome 4,879 0.2 37 36.7 79.1 17.7 0.8 1.9 4.0 7.6Nephropathy from heroin/related abuse 3,197 0.2 47 63.5 44.9 49.6 1.3 4.1 1.0 10.3Secondary GN, other 2,080 0.1 50 56.5 61.1 33.6 0.7 4.0 3.7 12.5

Interstitial nephritis/pyelonephritis 96,214 4.7 55 54.1 80.0 14.9 0.8 3.4 2.3 12.6Chronic pyelonephritis, reflux nephritis 15,906 0.8 43 37.0 86.4 8.6 1.0 3.0 3.8 7.5Analgesic abuse 3,712 0.2 65 39.0 76.8 18.9 1.0 2.2 2.7 17.1Nephropathy caused by other agents 8,418 0.4 59 58.6 79.5 17.5 0.5 1.8 3.4 19.0Nephrolithiasis, obstruction, gouty 28,434 1.4 62 72.8 77.6 16.7 0.7 3.9 1.6 15.0Nephrocalcinosis 1,137 0.1 62 46.2 79.8 13.2 0.7 4.3 3.3 15.1Chronic interstitial nephritis 36,252 1.8 53 47.6 79.6 15.1 1.0 3.8 1.9 10.6Acute interstitial nephritis 2,355 0.1 65 53.6 79.9 16.3 0.3 2.4 2.6 18.2

Hypertensive/large vessel disease 503,315 24.5 63 58.8 46.8 48.2 0.5 3.8 1.9 17.5Hypertension (no primary renal disease) 469,180 22.8 61 58.7 43.5 51.2 0.4 3.9 2.0 16.9Renal artery stenosis or occlusion 23,658 1.2 74 56.3 89.8 7.1 0.6 2.2 0.8 27.7Cholesterol emboli, renal emboli 10,477 0.5 74 67.6 94.8 3.0 0.4 1.4 0.6 24.3

Cystic/hereditary/congenital diseases 138,647 6.7 51 58.1 84.2 12.3 0.6 2.2 3.7 5.9Polycystic kidneys, adult (dominant) 90,778 4.4 56 52.6 84.6 12.0 0.5 2.3 3.8 7.1Polycystic kidneys, infantile (recessive) 1,393 0.1 22 46.6 83.6 12.7 1.0 1.4 6.5 3.9Medullary cystic, including nephronophthisis 1,586 0.1 28 51.5 86.1 8.6 1.1 3.5 5.3 2.6Alport's, other hereditary/familial disease 11,517 0.6 39 73.2 87.0 9.5 1.0 2.0 4.2 3.3Tuberous sclerosis 768 . 48 43.4 78.8 18.4 0.1 0.8 2.1 13.5Cystinosis 943 . 23 55.5 90.9 7.1 0.5 0.4 1.7 4.0Primary oxalosis 588 . 38 50.3 88.8 3.9 2.6 1.0 2.6 7.1Fabrys disease 704 . 45 90.1 91.8 6.1 0.7 0.7 3.8 7.5Congenital nephrotic syndrome 1,713 0.1 25 59.5 74.5 18.4 1.1 4.9 4.6 4.6Drash syndrome, mesangial sclerosis 193 . 17 59.6 66.8 26.4 . 3.1 6.2 7.3Congenital obstructive uropathy 14,521 0.7 30 76.1 82.2 14.0 0.6 2.3 2.9 4.0Renal hypoplasia, dysplasia 12,951 0.6 22 61.1 82.4 14.1 0.9 1.7 3.1 2.7Prune belly syndrome 992 . 17 97.8 78.1 20.6 0.3 1.0 4.9 2.0

Neoplasms/tumors 18,824 0.9 67 61.8 76.3 20.8 0.6 1.4 1.4 31.6Renal or urological neoplasms 7,347 0.4 66 70.4 77.3 20.4 0.7 0.7 2.0 23.0Multiple myeloma 7,104 0.3 68 56.0 72.5 24.6 0.4 1.7 0.3 42.4Light chain nephropathy 1,231 0.1 69 61.3 80.6 16.6 0.2 2.0 2.1 31.8Amyloidosis 3,142 0.2 64 54.9 80.8 14.8 1.1 2.0 2.4 27.1

Miscellaneous conditions 63,034 3.1 52 60.0 62.8 33.4 0.5 2.1 1.6 18.2Complication post-bone marrow/other tx 5,159 0.3 48 59.4 76.9 19.2 0.3 3.0 2.5 11.0Sickle cell disease/anemia or trait 2,022 0.1 40 53.0 5.4 93.4 0.2 0.7 2.5 20.1AIDS nephropathy 11,704 0.6 43 72.0 7.0 91.0 0.2 0.2 0.4 21.3Traumatic/surgical loss of kidney(s) 1,794 0.1 60 68.5 79.4 17.5 0.1 1.7 3.1 16.6Hepatorenal syndrome 1,840 0.1 54 67.2 82.0 11.2 1.8 3.3 2.2 21.5Tubular necrosis (no recovery) 19,377 0.9 63 55.9 81.7 15.0 0.7 1.6 1.2 21.1Post-partum failure, other renal disorders 21,138 1.0 54 56.6 75.3 19.4 0.6 3.5 2.1 15.2

Etiology uncertain 81,966 4.0 55 57.9 67.4 24.9 1.0 4.9 2.4 13.9Missing 21,841 1.1 48 58.5 70.7 14.0 0.4 3.0 0.3 5.0

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.


Table B.7Prevalence of reported ESRD, by primary diagnosis: all patients999-2003 combined, patients alive on December 3 of each year, by detailed primary diagnosis


334

Reference section B

Table B.7 (continued)Prevalence of reported ESRD, by primary diagnosis: all patients1999-2003 combined, patients alive on December 31 of each year, by detailed primary diagnosis

Total counts PercentCOLUMN PERCENT Patients White Black N Am Asian White Black N Am AsianAll ESRD (reference) 2,075,981 274,249 665,066 27,684 83,753 100.0 100.0 100.0 100.0Diabetes 742,927 454,428 232,450 17,799 28,111 36.1 35.1 64.5 33.8

Type I, juvenile type 145,994 106,483 34,036 1,875 2,659 8.5 5.1 6.8 3.2Type II, adult-onset or unspecified type 596,933 347,945 198,414 15,924 25,452 27.6 30.0 57.7 30.6

Glomerulonephritis 341,877 225,384 87,801 4,026 21,272 17.9 13.3 14.6 25.6Focal glomerulosclerosis, focal GN 73,479 40,701 29,478 523 2,207 3.2 4.5 1.9 2.7Membranous nephropathy 14,806 10,229 3,953 91 417 0.8 0.6 0.3 0.5Membranoproliferative GN, types I & II 14,503 10,827 2,597 255 715 0.9 0.4 0.9 0.9IgA nephropathy, Berger's disease 20,053 15,084 1,423 398 2,848 1.2 0.2 1.4 3.4IgM nephropathy 2,113 1,579 189 25 298 0.1 . 0.1 0.4Rapidly progressive GN 10,100 7,747 1,600 194 481 0.6 0.2 0.7 0.6Goodpasture's Syndrome 3,625 3,244 250 43 60 0.3 . 0.2 0.1Post infectious GN, SBE 2,000 1,551 311 49 82 0.1 . 0.2 0.1Glomerulonephritis (GN) 190,950 126,963 45,941 2,350 13,645 10.1 6.9 8.5 16.4Other proliferative GN 10,248 7,459 2,059 98 519 0.6 0.3 0.4 0.6

Secondary GN/vasculitis 67,336 40,693 22,684 627 2,783 3.2 3.4 2.3 3.3Lupus erythematosus (SLE nephritis) 39,573 19,300 17,487 311 2,076 1.5 2.6 1.1 2.5Polyarteritis 1,281 1,008 206 12 49 0.1 . . 0.1Wegeners granulomatosis 6,163 5,577 411 44 94 0.4 0.1 0.2 0.1Henoch-Schonlein syndrome 1,871 1,599 137 37 95 0.1 . 0.1 0.1Vasculitis and its derivatives 5,247 4,401 588 109 119 0.3 0.1 0.4 0.1Scleroderma 3,045 2,243 704 17 42 0.2 0.1 0.1 0.1Hemolytic uremic syndrome 4,879 3,858 866 41 93 0.3 0.1 0.1 0.1Nephropathy from heroin /related abuse 3,197 1,436 1,586 41 132 0.1 0.2 0.1 0.2Secondary GN, other 2,080 1,271 699 15 83 0.1 0.1 0.1 0.1

Interstitial nephritis/pyelonephritis 96,214 77,015 14,292 806 3,311 6.1 2.2 2.9 4.0Chronic pyelonephritis, reflux neph. 15,906 13,747 1,373 161 479 1.1 0.2 0.6 0.6Analgesic abuse 3,712 2,852 700 36 82 0.2 0.1 0.1 0.1Nephropathy caused by other agents 8,418 6,694 1,469 38 155 0.5 0.2 0.1 0.2Nephrolithiasis, obstruction, gouty 28,434 22,061 4,744 194 1,108 1.8 0.7 0.7 1.3Nephrocalcinosis 1,137 907 150 * 49 0.1 . . 0.1Chronic interstitial nephritis 36,252 28,873 5,473 362 1,382 2.3 0.8 1.3 1.7Acute interstitial nephritis 2,355 1,881 383 * 56 0.1 0.1 . 0.1

Hypertensive/large vessel disease 503,315 235,322 242,358 2,289 18,934 18.7 36.6 8.3 22.8Hypertension (no primary renal disease) 469,180 204,156 240,378 2,111 18,261 16.2 36.3 7.6 22.0Renal artery stenosis or occlusion 23,658 21,238 1,669 134 524 1.7 0.3 0.5 0.6Cholesterol emboli, renal emboli 10,477 9,928 311 44 149 0.8 . 0.2 0.2

Cystic/hereditary/congenital diseases 138,647 116,780 17,014 811 3,075 9.3 2.6 2.9 3.7Polycystic kidneys, adult (dominant) 90,778 76,822 10,901 415 2,098 6.1 1.6 1.5 2.5Polycystic kidneys, infantile (recessive) 1,393 1,165 177 14 19 0.1 . 0.1 .Medullary cystic, including nephronophthisis 1,586 1,365 137 18 56 0.1 . 0.1 0.1Alport's, other hereditary/familial disease 11,517 10,017 1,089 112 229 0.8 0.2 0.4 0.3Tuberous sclerosis 768 605 141 * * . . . .Cystinosis 943 857 67 * * 0.1 . . .Primary oxalosis 588 522 23 15 * . . 0.1 .Fabrys disease 704 646 43 * * 0.1 . . .Congenital nephrotic syndrome 1,713 1,277 316 19 84 0.1 . 0.1 0.1Drash syndrome, mesangial sclerosis 193 129 51 . * . . . .Congenital obstructive uropathy 14,521 11,930 2,035 88 336 0.9 0.3 0.3 0.4Renal hypoplasia, dysplasia 12,951 10,670 1,830 116 216 0.8 0.3 0.4 0.3Prune belly syndrome 992 775 204 * 10 0.1 . . .

Neoplasms/tumors 18,824 14,359 3,911 118 266 1.1 0.6 0.4 0.3Renal or urological neoplasms 7,347 5,677 1,497 50 54 0.5 0.2 0.2 0.1Multiple myeloma 7,104 5,150 1,746 30 124 0.4 0.3 0.1 0.1Light chain nephropathy 1,231 992 204 * 25 0.1 . . .Amyloidosis 3,142 2,540 464 36 63 0.2 0.1 0.1 0.1

Miscellaneous conditions 63,034 39,581 21,068 331 1,334 3.1 3.2 1.2 1.6Complication post bone marrow/other txp 5,159 3,965 989 17 154 0.3 0.1 0.1 0.2Sickle cell disease/anemia or trait 2,022 109 1,888 * 14 . 0.3 . .AIDS nephropathy 11,704 824 10,656 19 20 0.1 1.6 0.1 .Traumatic/surgical loss of kidney(s) 1,794 1,425 314 * 30 0.1 . . .Hepatorenal syndrome 1,840 1,508 206 34 60 0.1 . 0.1 0.1Tubular necrosis (no recovery) 19,377 15,829 2,906 133 314 1.3 0.4 0.5 0.4Post-partum failure, other renal disorders 21,138 15,921 4,109 122 742 1.3 0.6 0.4 0.9

Etiology uncertain 81,966 55,244 20,437 789 4,015 4.4 3.1 2.9 4.8Missing 21,841 15,443 3,051 88 652 1.2 0.5 0.3 0.8

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table B.7 (continued)Prevalence of reported ESRD, by primary diagnosis: all patients999-2003 combined, patients alive on December 3 of each year, by detailed primary diagnosis

335


ON OUR WEBSITE & CDPoint prevalent counts of reported ESRD patients, by diabetic status & state: U.S. only, with unknowns dropped (B.8.1).

Table B.8Point prevalent counts of reported ESRD patients, by diabetic status & state/territory: all patientspatients alive on December 31 of each year

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991Alabama 1,149 1,295 1,496 1,806 1,996 2,178 2,060 2,348 2,626 3,355 3,821 4,156Alaska 40 38 58 67 69 70 97 103 119 139 152 175Arizona 812 975 1,124 1,323 1,488 1,678 1,897 2,160 2,326 2,624 2,923 3,251Arkansas 472 544 627 767 875 982 1,071 1,224 1,367 1,473 1,604 1,797California 6,198 7,592 8,560 9,819 10,928 12,031 13,323 14,743 16,165 18,059 20,167 22,599Colorado 608 684 779 859 960 1,076 1,206 1,337 1,456 1,649 1,819 2,000Connecticut 827 909 944 1,131 1,198 1,493 1,630 1,779 1,894 2,084 2,297 2,576Delaware 162 162 201 271 301 340 364 412 474 525 588 683District of Columbia 415 457 534 596 654 722 755 822 862 948 1,017 1,150Florida 3,320 3,927 4,474 5,092 5,791 6,413 7,245 8,002 8,779 9,724 10,721 11,972Georgia 1,621 1,974 2,226 2,630 3,003 3,299 3,642 4,070 4,663 5,249 5,826 6,609Hawaii 356 381 409 450 490 551 624 693 782 875 967 1,065Idaho 150 162 194 219 242 294 317 363 386 452 521 571Illinois 3,140 3,578 4,047 4,630 5,112 5,685 6,287 6,831 7,307 7,845 8,620 9,674Indiana 1,242 1,446 1,645 1,972 2,126 2,317 2,501 2,786 3,072 3,373 3,757 4,147Iowa 613 698 766 920 1,028 1,119 1,277 1,348 1,441 1,589 1,764 1,914Kansas 533 582 674 782 858 939 1,013 1,111 1,202 1,359 1,548 1,701Kentucky 703 860 1,003 1,105 1,239 1,395 1,545 1,714 1,886 2,052 2,310 2,630Louisiana 1,079 1,240 1,467 1,650 1,899 2,115 2,405 2,728 3,210 3,565 3,935 4,324Maine 129 228 260 298 361 387 399 453 532 560 623 671Maryland 1,125 1,320 1,503 1,761 2,013 2,225 2,385 2,699 3,017 3,385 3,845 4,427Massachusetts 1,556 1,423 1,564 2,162 2,358 2,501 2,689 2,951 3,239 3,533 3,842 4,226Michigan 2,519 2,821 3,183 3,510 3,935 4,305 4,639 5,036 5,487 6,157 6,740 7,399Minnesota 929 1,107 1,277 1,430 1,628 1,813 1,986 2,223 2,401 2,610 2,894 3,190Mississippi 678 760 874 1,079 1,230 1,410 1,547 1,733 1,965 2,210 2,462 2,688Missouri 1,094 1,221 1,255 1,706 1,968 2,186 2,452 2,796 3,115 3,479 3,863 4,232Montana 127 159 177 214 246 273 298 332 347 398 449 496Nebraska 320 388 422 465 510 573 623 698 767 873 952 1,042Nevada 243 282 318 370 407 450 542 610 663 709 763 861New Hampshire 166 212 248 276 307 343 380 418 464 532 563 603New Jersey 2,418 2,703 3,057 3,470 3,768 4,147 4,451 4,764 5,063 5,582 6,141 6,843New Mexico 372 412 456 537 596 667 747 828 947 1,039 1,177 1,324New York 4,920 5,605 6,177 7,213 8,257 9,129 10,047 10,838 11,688 12,592 13,766 15,040North Carolina 1,534 1,778 2,121 2,521 2,846 3,282 3,681 4,074 4,522 5,025 5,605 6,277North Dakota 123 155 176 196 219 243 282 292 317 353 387 427Ohio 2,272 2,602 3,073 3,529 4,012 4,485 4,994 5,548 6,216 6,926 7,865 8,744Oklahoma 619 720 792 925 1,028 1,130 1,243 1,384 1,552 1,745 1,955 2,135Oregon 472 549 640 751 870 986 1,131 1,227 1,365 1,525 1,675 1,906Pennsylvania 3,197 3,581 4,039 4,615 5,157 5,833 6,422 7,038 7,757 8,514 9,451 10,446Rhode Island 292 306 326 370 432 454 468 495 547 622 668 736South Carolina 848 1,049 1,240 1,507 1,714 1,582 2,155 2,397 2,738 3,043 3,405 3,771South Dakota 166 201 215 245 279 306 323 356 391 419 444 474Tennessee 1,189 1,335 1,530 1,861 2,028 2,251 2,474 2,806 3,074 3,638 4,010 4,419Texas 3,797 4,374 5,165 6,065 6,684 7,407 8,269 9,220 10,272 11,572 13,004 14,540Utah 270 326 361 412 496 544 607 657 754 804 850 927Vermont 109 124 138 152 161 183 182 199 224 243 259 293Virginia 1,639 1,848 2,090 2,485 2,790 3,014 3,252 3,553 3,989 4,334 4,742 5,350Washington 877 843 1,131 1,347 1,538 1,707 1,938 2,136 2,339 2,631 2,863 3,162West Virginia 312 362 442 526 635 700 782 854 958 1,045 1,125 1,255Wisconsin 1,098 1,246 1,479 1,620 1,812 1,976 2,194 2,495 2,798 3,086 3,316 3,705Wyoming 63 74 91 101 109 133 144 157 181 202 210 225

American Samoa . * * * * 14 18 21 18 23 23 28Guam 17 18 22 23 24 26 33 38 46 54 66 85Puerto Rico 615 710 821 974 1,181 1,336 1,467 1,608 1,753 1,981 2,191 2,407Saipan * * * * * * * * 13 16 21 22Virgin Islands 18 20 28 22 21 24 32 46 49 48 58 68

Foreign 41 51 51 66 69 82 89 92 98 108 143 164Unknown 436 462 493 558 636 722 787 835 1,077 1,212 1,205 1,128

All 60,042 68,885 78,471 91,462 102,593 113,531 125,416 138,489 152,760 169,767 187,978 208,730

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. *Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.

Table B.8Point prevalent counts of reported ESRD patients, by diabetic status & state/territory: all patientspatients alive on December 3 of each year


336

Reference section B

Table B.8 (continued)Point prevalent counts of reported ESRD patients, by diabetic status & state/territory: all patientspatients alive on December 31 of each year

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 4,548 4,940 5,362 5,748 6,309 6,805 7,120 7,424 7,879 8,194 8,452 8,750Alaska 203 219 327 496 467 467 452 456 474 511 515 541Arizona 3,681 4,077 4,383 4,742 5,102 5,513 5,931 6,351 6,759 7,128 7,429 7,857Arkansas 1,947 2,155 2,426 2,680 2,867 3,085 3,209 3,348 3,456 3,600 3,690 3,762California 24,944 27,287 30,243 32,327 34,643 36,906 39,489 42,152 45,057 47,943 51,059 53,967Colorado 2,228 2,443 2,672 2,810 3,022 3,244 3,513 3,710 3,912 4,086 4,295 4,495Connecticut 2,795 2,997 3,237 3,428 3,651 3,845 4,014 4,219 4,428 4,490 4,613 4,712Delaware 774 822 883 949 1,022 1,084 1,134 1,212 1,281 1,331 1,422 1,501District of Columbia 1,299 1,444 1,518 1,597 1,670 1,738 1,782 1,871 1,960 2,024 2,055 2,135Florida 13,293 14,431 15,611 16,545 17,914 19,027 20,000 21,098 22,225 23,311 24,373 25,272Georgia 7,390 8,060 8,913 9,645 10,425 11,092 11,837 12,603 13,332 14,033 14,744 15,272Hawaii 1,156 1,298 1,462 1,568 1,661 1,804 1,908 2,005 2,159 2,248 2,396 2,519Idaho 617 673 742 788 868 952 1,004 1,114 1,140 1,216 1,261 1,302Illinois 10,471 11,424 12,472 13,479 14,677 15,600 16,610 17,564 18,450 19,261 20,199 21,002Indiana 4,603 5,019 5,418 5,782 6,229 6,639 7,157 7,533 7,957 8,309 8,609 8,953Iowa 2,118 2,263 2,426 2,511 2,688 2,811 2,972 3,201 3,347 3,514 3,661 3,779Kansas 1,856 1,946 2,098 2,220 2,360 2,569 2,699 2,851 2,977 3,019 3,165 3,263Kentucky 2,955 3,168 3,365 3,642 3,865 4,121 4,418 4,613 4,864 5,123 5,289 5,533Louisiana 4,774 5,150 5,579 6,049 6,458 7,049 7,532 8,009 8,350 8,624 9,067 9,419Maine 724 808 885 974 1,032 1,104 1,191 1,241 1,310 1,381 1,447 1,512Maryland 4,952 5,484 6,046 6,574 7,121 7,655 8,179 8,653 9,057 9,506 9,985 10,413Massachusetts 4,664 5,075 5,463 5,742 6,068 6,448 6,836 7,013 7,277 7,431 7,672 7,904Michigan 8,203 9,002 9,769 10,457 11,453 12,091 12,851 13,363 14,080 14,768 15,403 16,100Minnesota 3,471 3,756 4,039 4,281 4,584 4,878 5,127 5,365 5,606 5,935 6,241 6,439Mississippi 2,940 3,268 3,640 3,913 4,252 4,572 4,869 5,141 5,344 5,582 5,838 6,057Missouri 4,615 5,033 5,422 5,817 6,219 6,586 7,072 7,485 7,840 8,153 8,408 8,670Montana 530 591 631 701 748 801 830 899 934 1,003 1,044 1,085Nebraska 1,183 1,266 1,371 1,476 1,545 1,666 1,771 1,888 1,998 2,094 2,176 2,248Nevada 966 1,096 1,231 1,352 1,492 1,622 1,752 1,924 2,038 2,212 2,357 2,540New Hampshire 637 678 738 796 818 872 926 1,000 1,087 1,131 1,206 1,261New Jersey 7,423 7,953 8,628 9,201 9,751 10,352 11,074 11,818 12,240 12,744 13,229 13,751New Mexico 1,473 1,600 1,702 1,874 2,018 2,177 2,321 2,478 2,684 2,802 2,874 3,005New York 16,352 17,708 18,879 20,065 21,304 22,789 24,393 25,807 27,149 28,153 29,346 30,504North Carolina 7,041 7,822 8,605 9,234 9,973 10,789 11,567 12,094 12,851 13,484 14,089 14,635North Dakota 478 519 556 557 577 607 639 662 689 753 807 822Ohio 9,601 10,323 11,281 12,073 12,969 13,718 14,646 15,524 16,505 17,166 17,903 18,621Oklahoma 2,372 2,610 2,849 3,074 3,268 3,541 3,807 4,021 4,235 4,393 4,593 4,832Oregon 2,033 2,214 2,412 2,558 2,709 2,859 3,032 3,184 3,338 3,556 3,763 3,987Pennsylvania 11,385 12,102 13,061 13,986 14,987 15,949 16,820 17,609 18,428 18,940 19,663 20,059Rhode Island 790 855 956 990 1,063 1,099 1,165 1,212 1,274 1,311 1,351 1,383South Carolina 4,164 4,531 4,998 5,395 5,790 6,217 6,622 7,039 7,293 7,634 7,815 8,221South Dakota 500 557 609 677 748 810 867 921 985 1,002 1,048 1,112Tennessee 4,854 5,179 5,742 6,195 6,616 6,998 7,440 7,887 8,256 8,481 8,740 8,988Texas 16,270 17,805 19,504 20,967 22,759 24,402 26,255 28,193 30,054 31,685 33,363 35,272Utah 998 1,134 1,226 1,337 1,400 1,464 1,604 1,713 1,839 1,960 2,050 2,138Vermont 308 335 365 407 450 493 532 563 597 615 627 663Virginia 6,038 6,652 7,194 7,755 8,381 9,149 9,802 10,388 10,779 11,233 11,789 12,225Washington 3,422 3,708 4,064 4,343 4,616 4,880 5,215 5,549 5,888 6,229 6,630 6,949West Virginia 1,369 1,475 1,587 1,711 1,836 2,019 2,180 2,309 2,465 2,586 2,661 2,760Wisconsin 4,074 4,392 4,757 5,052 5,410 5,758 6,122 6,436 6,674 6,975 7,337 7,744Wyoming 234 248 266 290 316 342 363 392 431 435 449 467

American Samoa 35 35 40 39 44 44 41 56 67 74 77 84Guam 109 127 146 172 195 218 233 263 280 298 330 349Puerto Rico 2,666 2,858 3,077 3,192 3,397 3,571 3,734 3,878 4,016 4,134 4,304 4,471Saipan 26 27 32 41 52 60 75 81 92 90 94 100Virgin Islands 82 86 92 99 113 127 141 148 143 152 173 175

Foreign 182 203 230 246 258 269 284 292 304 302 300 286Unknown 1,061 1,021 1,050 947 900 787 785 791 807 813 832 1,091

All 229,877 249,952 272,280 291,566 313,130 334,134 355,944 376,614 396,941 415,161 434,308 452,957


Table B.8 (continued)Point prevalent counts of reported ESRD patients, by diabetic status & state/territory: all patientspatients alive on December 3 of each year

337


Table B.8 (continued)Point prevalent counts of reported ESRD patients, by diabetic status & state/territory: diabetic patientspatients alive on December 31 of each year

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991Alabama 57 73 107 168 220 274 322 394 465 660 778 919Alaska * * * * 11 * 16 19 20 30 34 36Arizona 148 200 257 329 394 463 560 709 783 936 1,069 1,251Arkansas 23 42 58 90 118 152 162 228 254 305 350 421California 445 778 1,129 1,512 1,859 2,348 2,783 3,202 3,729 4,594 5,360 6,378Colorado 81 95 116 148 190 239 309 351 400 485 565 643Connecticut 91 127 141 190 226 303 349 392 425 500 559 678Delaware 14 22 28 32 44 54 70 89 120 139 162 196District of Columbia 39 47 70 91 123 151 166 189 187 213 252 278Florida 246 392 556 703 873 1,033 1,344 1,573 1,785 2,049 2,421 2,822Georgia 144 232 317 379 482 574 685 838 983 1,208 1,402 1,646Hawaii 59 75 77 81 82 107 147 201 241 285 341 394Idaho 15 19 25 36 42 50 63 86 94 122 150 159Illinois 320 419 561 678 803 1,014 1,180 1,355 1,513 1,746 2,016 2,398Indiana 129 179 216 288 336 377 437 533 627 728 881 1,061Iowa 51 88 114 163 201 227 282 284 320 370 417 464Kansas 56 71 105 132 169 191 188 229 262 311 385 455Kentucky 53 86 109 146 203 246 279 338 395 445 545 666Louisiana 66 103 154 180 273 322 410 519 664 811 953 1,139Maine * 22 32 36 52 56 64 85 105 111 136 150Maryland 82 130 169 236 307 389 433 519 607 753 941 1,166Massachusetts 167 192 227 291 330 363 413 463 536 658 800 950Michigan 328 409 494 572 685 812 955 1,046 1,224 1,467 1,743 2,035Minnesota 187 247 298 358 439 501 563 655 720 824 940 1,059Mississippi 45 68 99 129 174 206 244 303 383 477 576 677Missouri 55 107 193 247 319 402 457 556 649 757 889 1,045Montana 14 24 26 39 54 68 72 89 107 127 157 174Nebraska 51 70 84 99 102 119 135 159 190 237 280 315Nevada 37 48 57 56 59 68 92 118 139 157 191 230New Hampshire 14 22 29 38 42 54 66 77 98 116 131 141New Jersey 246 310 431 542 607 731 815 901 1,033 1,197 1,453 1,744New Mexico 49 75 91 136 158 177 219 264 334 383 434 529New York 382 577 765 1,001 1,313 1,556 1,879 2,152 2,470 2,781 3,223 3,646North Carolina 136 170 242 316 418 539 639 780 913 1,103 1,341 1,597North Dakota 24 29 36 48 59 65 78 80 94 123 135 150Ohio 295 390 525 624 779 926 1,105 1,318 1,530 1,803 2,176 2,490Oklahoma 52 73 109 158 191 231 282 339 436 497 600 698Oregon 30 49 94 119 146 178 229 268 312 370 431 490Pennsylvania 349 419 530 668 871 1,048 1,269 1,502 1,723 1,979 2,344 2,741Rhode Island 19 24 31 36 48 54 58 70 97 120 145 159South Carolina 78 108 151 200 279 319 415 499 589 702 827 988South Dakota 23 45 40 50 65 81 85 101 125 130 144 165Tennessee 62 90 146 207 257 329 375 472 568 759 882 1,036Texas 386 554 793 972 1,258 1,532 1,844 2,202 2,669 3,355 4,030 4,708Utah 43 59 70 98 133 158 182 207 252 262 301 325Vermont 15 20 28 26 30 44 44 49 48 62 70 79Virginia 134 174 237 330 420 464 553 637 776 915 1,058 1,284Washington 82 87 129 174 234 314 369 420 512 622 711 842West Virginia 32 39 61 85 112 118 161 187 218 245 281 329Wisconsin 177 208 281 333 405 451 533 633 737 838 933 1,111Wyoming * * 17 19 21 37 37 42 48 62 62 64

American Samoa . * * * * * * * * * * 13Guam * * * * * 11 14 13 14 20 25 35Puerto Rico 58 89 123 170 239 289 357 425 483 601 705 823Saipan . . . . * * * * * * 11 11Virgin Islands * * * * * * * * * * * *

Foreign . . * * * * * * * 11 17 20Unknown 40 45 56 71 91 110 151 149 201 226 239 212

All 5,756 8,039 10,850 13,850 17,360 20,943 24,956 29,330 34,231 40,808 48,017 56,244




338

Reference section B


1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 1,063 1,237 1,419 1,594 1,833 2,089 2,244 2,412 2,692 2,876 2,973 3,095Alaska 44 56 91 160 155 162 148 157 148 166 167 176Arizona 1,474 1,662 1,841 2,035 2,210 2,476 2,678 2,874 3,107 3,316 3,466 3,689Arkansas 472 537 634 753 858 948 992 1,045 1,114 1,203 1,241 1,293California 7,322 8,218 9,538 10,484 11,575 12,787 13,890 15,097 16,529 17,828 19,156 20,434Colorado 756 861 932 998 1,107 1,204 1,322 1,416 1,536 1,599 1,699 1,780Connecticut 752 829 924 1,024 1,110 1,241 1,292 1,365 1,490 1,492 1,559 1,623Delaware 216 231 260 277 300 337 363 399 446 459 498 532District of Columbia 341 390 406 441 498 515 516 547 570 598 613 647Florida 3,286 3,718 4,204 4,631 5,226 5,770 6,174 6,627 7,143 7,733 8,147 8,502Georgia 1,936 2,173 2,486 2,827 3,260 3,574 3,922 4,274 4,577 4,858 5,203 5,442Hawaii 432 529 617 683 733 805 862 919 1,034 1,110 1,196 1,241Idaho 181 206 235 250 288 331 368 413 418 445 465 461Illinois 2,633 2,933 3,334 3,831 4,356 4,755 5,162 5,632 6,014 6,266 6,653 6,948Indiana 1,264 1,403 1,569 1,818 2,019 2,151 2,395 2,560 2,719 2,845 2,979 3,142Iowa 558 626 703 764 851 894 961 1,053 1,113 1,181 1,226 1,257Kansas 505 550 626 673 739 823 931 1,007 1,074 1,100 1,159 1,182Kentucky 800 877 931 1,101 1,224 1,328 1,455 1,545 1,671 1,796 1,907 1,979Louisiana 1,347 1,472 1,621 1,814 2,076 2,365 2,611 2,803 2,971 3,081 3,248 3,391Maine 166 197 224 262 282 320 356 367 408 451 489 525Maryland 1,375 1,585 1,769 1,972 2,236 2,490 2,676 2,836 2,891 3,080 3,296 3,410Massachusetts 1,145 1,275 1,453 1,584 1,739 1,893 2,033 2,080 2,170 2,306 2,400 2,456Michigan 2,345 2,658 3,022 3,337 3,848 4,170 4,522 4,710 5,076 5,391 5,631 5,909Minnesota 1,136 1,272 1,353 1,440 1,529 1,632 1,728 1,802 1,897 2,002 2,117 2,160Mississippi 782 902 1,050 1,189 1,353 1,480 1,622 1,748 1,814 1,918 2,027 2,145Missouri 1,200 1,382 1,540 1,733 1,908 2,123 2,356 2,497 2,669 2,782 2,897 2,966Montana 193 214 232 276 296 320 332 361 395 438 460 479Nebraska 372 426 451 524 564 614 663 719 764 803 818 861Nevada 263 305 348 419 463 539 613 676 724 812 886 993New Hampshire 152 167 188 216 224 255 273 296 327 344 373 391New Jersey 1,915 2,113 2,423 2,742 3,045 3,322 3,692 4,006 4,172 4,345 4,540 4,657New Mexico 617 706 761 866 971 1,072 1,164 1,264 1,425 1,489 1,514 1,580New York 4,130 4,651 5,054 5,640 6,314 6,993 7,630 8,178 8,733 9,238 9,739 10,223North Carolina 1,881 2,166 2,523 2,815 3,228 3,622 3,998 4,227 4,596 4,833 5,094 5,331North Dakota 179 191 201 204 206 219 239 227 242 265 291 296Ohio 2,850 3,148 3,605 4,013 4,436 4,851 5,344 5,727 6,168 6,509 6,815 7,051Oklahoma 807 921 1,019 1,141 1,221 1,381 1,543 1,650 1,737 1,831 1,937 2,046Oregon 536 595 669 747 835 926 956 1,022 1,080 1,162 1,224 1,306Pennsylvania 3,168 3,440 3,820 4,257 4,619 5,043 5,450 5,739 6,106 6,356 6,688 6,845Rhode Island 188 205 231 252 296 324 362 384 392 408 417 417South Carolina 1,121 1,265 1,449 1,603 1,812 1,974 2,237 2,444 2,586 2,771 2,820 3,006South Dakota 194 223 243 277 310 338 356 398 417 425 453 497Tennessee 1,197 1,345 1,567 1,786 1,989 2,159 2,347 2,506 2,676 2,791 2,910 3,019Texas 5,410 6,122 6,913 7,718 8,704 9,666 10,649 11,580 12,661 13,488 14,513 15,521Utah 348 409 457 517 544 576 623 669 729 789 817 856Vermont 84 92 111 132 150 168 187 205 216 217 216 220Virginia 1,547 1,796 2,020 2,269 2,529 2,903 3,185 3,440 3,640 3,881 4,160 4,305Washington 975 1,097 1,232 1,323 1,442 1,603 1,743 1,866 1,999 2,140 2,269 2,379West Virginia 398 418 472 536 602 699 778 867 978 1,035 1,062 1,121Wisconsin 1,253 1,376 1,498 1,613 1,739 1,906 2,035 2,144 2,185 2,295 2,428 2,573Wyoming 61 75 88 109 120 136 140 152 171 171 173 184

American Samoa 16 16 19 19 20 18 19 26 37 44 47 54Guam 46 58 68 88 104 119 127 155 156 171 185 195Puerto Rico 982 1,058 1,161 1,197 1,313 1,417 1,516 1,642 1,739 1,814 1,929 2,093Saipan 11 11 15 21 27 31 44 48 58 61 63 64Virgin Islands 12 16 19 32 43 49 56 63 57 65 68 73

Foreign 21 17 24 22 23 22 21 27 29 29 36 31Unknown 187 173 169 129 103 61 54 49 46 47 49 61

All 64,645 72,594 81,832 91,178 101,605 111,989 121,955 130,942 140,532 148,949 157,406 165,113



339


Table B.8 (continued)Point prevalent counts of reported ESRD patients, by diabetic status & state/territory: non-diabetic patientspatients alive on December 31 of each year

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991Alabama 1,092 1,222 1,389 1,638 1,776 1,904 1,738 1,954 2,161 2,695 3,043 3,237Alaska 36 36 53 60 58 62 81 84 99 109 118 139Arizona 664 775 867 994 1,094 1,215 1,337 1,451 1,543 1,688 1,854 2,000Arkansas 449 502 569 677 757 830 909 996 1,113 1,168 1,254 1,376California 5,753 6,814 7,431 8,307 9,069 9,683 10,540 11,541 12,436 13,465 14,807 16,221Colorado 527 589 663 711 770 837 897 986 1,056 1,164 1,254 1,357Connecticut 736 782 803 941 972 1,190 1,281 1,387 1,469 1,584 1,738 1,898Delaware 148 140 173 239 257 286 294 323 354 386 426 487District of Columbia 376 410 464 505 531 571 589 633 675 735 765 872Florida 3,074 3,535 3,918 4,389 4,918 5,380 5,901 6,429 6,994 7,675 8,300 9,150Georgia 1,477 1,742 1,909 2,251 2,521 2,725 2,957 3,232 3,680 4,041 4,424 4,963Hawaii 297 306 332 369 408 444 477 492 541 590 626 671Idaho 135 143 169 183 200 244 254 277 292 330 371 412Illinois 2,820 3,159 3,486 3,952 4,309 4,671 5,107 5,476 5,794 6,099 6,604 7,276Indiana 1,113 1,267 1,429 1,684 1,790 1,940 2,064 2,253 2,445 2,645 2,876 3,086Iowa 562 610 652 757 827 892 995 1,064 1,121 1,219 1,347 1,450Kansas 477 511 569 650 689 748 825 882 940 1,048 1,163 1,246Kentucky 650 774 894 959 1,036 1,149 1,266 1,376 1,491 1,607 1,765 1,964Louisiana 1,013 1,137 1,313 1,470 1,626 1,793 1,995 2,209 2,546 2,754 2,982 3,185Maine 119 206 228 262 309 331 335 368 427 449 487 521Maryland 1,043 1,190 1,334 1,525 1,706 1,836 1,952 2,180 2,410 2,632 2,904 3,261Massachusetts 1,389 1,231 1,337 1,871 2,028 2,138 2,276 2,488 2,703 2,875 3,042 3,276Michigan 2,191 2,412 2,689 2,938 3,250 3,493 3,684 3,990 4,263 4,690 4,997 5,364Minnesota 742 860 979 1,072 1,189 1,312 1,423 1,568 1,681 1,786 1,954 2,131Mississippi 633 692 775 950 1,056 1,204 1,303 1,430 1,582 1,733 1,886 2,011Missouri 1,039 1,114 1,062 1,459 1,649 1,784 1,995 2,240 2,466 2,722 2,974 3,187Montana 113 135 151 175 192 205 226 243 240 271 292 322Nebraska 269 318 338 366 408 454 488 539 577 636 672 727Nevada 206 234 261 314 348 382 450 492 524 552 572 631New Hampshire 152 190 219 238 265 289 314 341 366 416 432 462New Jersey 2,172 2,393 2,626 2,928 3,161 3,416 3,636 3,863 4,030 4,385 4,688 5,099New Mexico 323 337 365 401 438 490 528 564 613 656 743 795New York 4,538 5,028 5,412 6,212 6,944 7,573 8,168 8,686 9,218 9,811 10,543 11,394North Carolina 1,398 1,608 1,879 2,205 2,428 2,743 3,042 3,294 3,609 3,922 4,264 4,680North Dakota 99 126 140 148 160 178 204 212 223 230 252 277Ohio 1,977 2,212 2,548 2,905 3,233 3,559 3,889 4,230 4,686 5,123 5,689 6,254Oklahoma 567 647 683 767 837 899 961 1,045 1,116 1,248 1,355 1,437Oregon 442 500 546 632 724 808 902 959 1,053 1,155 1,244 1,416Pennsylvania 2,848 3,162 3,509 3,947 4,286 4,785 5,153 5,536 6,034 6,535 7,107 7,705Rhode Island 273 282 295 334 384 400 410 425 450 502 523 577South Carolina 770 941 1,089 1,307 1,435 1,263 1,740 1,898 2,149 2,341 2,578 2,783South Dakota 143 156 175 195 214 225 238 255 266 289 300 309Tennessee 1,127 1,245 1,384 1,654 1,771 1,922 2,099 2,334 2,506 2,879 3,128 3,383Texas 3,411 3,820 4,372 5,093 5,426 5,875 6,425 7,018 7,603 8,217 8,974 9,832Utah 227 267 291 314 363 386 425 450 502 542 549 602Vermont 94 104 110 126 131 139 138 150 176 181 189 214Virginia 1,505 1,674 1,853 2,155 2,370 2,550 2,699 2,916 3,213 3,419 3,684 4,066Washington 795 756 1,002 1,173 1,304 1,393 1,569 1,716 1,827 2,009 2,152 2,320West Virginia 280 323 381 441 523 582 621 667 740 800 844 926Wisconsin 921 1,038 1,198 1,287 1,407 1,525 1,661 1,862 2,061 2,248 2,383 2,594Wyoming 56 64 74 82 88 96 107 115 133 140 148 161

American Samoa . * * * * 12 13 16 11 14 13 15Guam 13 16 19 17 17 15 19 25 32 34 41 50Puerto Rico 557 621 698 804 942 1,047 1,110 1,183 1,270 1,380 1,486 1,584Saipan * * * * * * * * * * * 11Virgin Islands 16 18 25 19 18 21 27 40 43 42 53 59

Foreign 41 51 49 64 67 78 83 84 92 97 126 144Unknown 396 417 437 487 545 612 636 686 876 986 966 916

All 54,286 60,846 67,621 77,612 85,233 92,588 100,460 109,159 118,529 128,959 139,961 152,486




340

Reference section B


1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 3,485 3,703 3,943 4,154 4,476 4,716 4,876 5,012 5,187 5,318 5,479 5,655Alaska 159 163 236 336 312 305 304 299 326 345 348 365Arizona 2,207 2,415 2,542 2,707 2,892 3,037 3,253 3,477 3,652 3,812 3,963 4,168Arkansas 1,475 1,618 1,792 1,927 2,009 2,137 2,217 2,303 2,342 2,397 2,449 2,469California 17,622 19,069 20,705 21,843 23,068 24,119 25,599 27,055 28,528 30,115 31,903 33,533Colorado 1,472 1,582 1,740 1,812 1,915 2,040 2,191 2,294 2,376 2,487 2,596 2,715Connecticut 2,043 2,168 2,313 2,404 2,541 2,604 2,722 2,854 2,938 2,998 3,054 3,089Delaware 558 591 623 672 722 747 771 813 835 872 924 969District of Columbia 958 1,054 1,112 1,156 1,172 1,223 1,266 1,324 1,390 1,426 1,442 1,488Florida 10,007 10,713 11,407 11,914 12,688 13,257 13,826 14,471 15,082 15,578 16,226 16,770Georgia 5,454 5,887 6,427 6,818 7,165 7,518 7,915 8,329 8,755 9,175 9,541 9,830Hawaii 724 769 845 885 928 999 1,046 1,086 1,125 1,138 1,200 1,278Idaho 436 467 507 538 580 621 636 701 722 771 796 841Illinois 7,838 8,491 9,138 9,648 10,321 10,845 11,448 11,932 12,436 12,995 13,546 14,054Indiana 3,339 3,616 3,849 3,964 4,210 4,488 4,762 4,973 5,238 5,464 5,630 5,811Iowa 1,560 1,637 1,723 1,747 1,837 1,917 2,011 2,148 2,234 2,333 2,435 2,522Kansas 1,351 1,396 1,472 1,547 1,621 1,746 1,768 1,844 1,903 1,919 2,006 2,081Kentucky 2,155 2,291 2,434 2,541 2,641 2,793 2,963 3,068 3,193 3,327 3,382 3,554Louisiana 3,427 3,678 3,958 4,235 4,382 4,684 4,921 5,206 5,379 5,543 5,819 6,028Maine 558 611 661 712 750 784 835 874 902 930 958 987Maryland 3,577 3,899 4,277 4,602 4,885 5,165 5,503 5,817 6,166 6,426 6,689 7,003Massachusetts 3,519 3,800 4,010 4,158 4,329 4,555 4,803 4,933 5,107 5,125 5,272 5,448Michigan 5,858 6,344 6,747 7,120 7,605 7,921 8,329 8,653 9,004 9,377 9,772 10,191Minnesota 2,335 2,484 2,686 2,841 3,055 3,246 3,399 3,563 3,709 3,933 4,124 4,279Mississippi 2,158 2,366 2,590 2,724 2,899 3,092 3,247 3,393 3,530 3,664 3,811 3,912Missouri 3,415 3,651 3,882 4,084 4,311 4,463 4,716 4,988 5,171 5,371 5,511 5,704Montana 337 377 399 425 452 481 498 538 539 565 584 606Nebraska 811 840 920 952 981 1,052 1,108 1,169 1,234 1,291 1,358 1,387Nevada 703 791 883 933 1,029 1,083 1,139 1,248 1,314 1,400 1,471 1,547New Hampshire 485 511 550 580 594 617 653 704 760 787 833 870New Jersey 5,508 5,840 6,205 6,459 6,706 7,030 7,382 7,812 8,068 8,399 8,689 9,094New Mexico 856 894 941 1,008 1,047 1,105 1,157 1,214 1,259 1,313 1,360 1,425New York 12,222 13,057 13,825 14,425 14,990 15,796 16,763 17,629 18,416 18,915 19,607 20,281North Carolina 5,160 5,656 6,082 6,419 6,745 7,167 7,569 7,867 8,255 8,651 8,995 9,304North Dakota 299 328 355 353 371 388 400 435 447 488 516 526Ohio 6,751 7,175 7,676 8,060 8,533 8,867 9,302 9,797 10,337 10,657 11,088 11,570Oklahoma 1,565 1,689 1,830 1,933 2,047 2,160 2,264 2,371 2,498 2,562 2,656 2,786Oregon 1,497 1,619 1,743 1,811 1,874 1,933 2,076 2,162 2,258 2,394 2,539 2,681Pennsylvania 8,217 8,662 9,241 9,729 10,368 10,906 11,370 11,870 12,322 12,584 12,975 13,214Rhode Island 602 650 725 738 767 775 803 828 882 903 934 966South Carolina 3,043 3,266 3,549 3,792 3,978 4,243 4,385 4,595 4,707 4,863 4,995 5,215South Dakota 306 334 366 400 438 472 511 523 568 577 595 615Tennessee 3,657 3,834 4,175 4,409 4,627 4,839 5,093 5,381 5,580 5,690 5,830 5,969Texas 10,860 11,683 12,591 13,249 14,055 14,736 15,606 16,613 17,393 18,197 18,850 19,751Utah 650 725 769 820 856 888 981 1,044 1,110 1,171 1,233 1,282Vermont 224 243 254 275 300 325 345 358 381 398 411 443Virginia 4,491 4,856 5,174 5,486 5,852 6,246 6,617 6,948 7,139 7,352 7,629 7,920Washington 2,447 2,611 2,832 3,020 3,174 3,277 3,472 3,683 3,889 4,089 4,361 4,570West Virginia 971 1,057 1,115 1,175 1,234 1,320 1,402 1,442 1,487 1,551 1,599 1,639Wisconsin 2,821 3,016 3,259 3,439 3,671 3,852 4,087 4,292 4,489 4,680 4,909 5,171Wyoming 173 173 178 181 196 206 223 240 260 264 276 283

American Samoa 19 19 21 20 24 26 22 30 30 30 30 30Guam 63 69 78 84 91 99 106 108 124 127 145 154Puerto Rico 1,684 1,800 1,916 1,995 2,084 2,154 2,218 2,236 2,277 2,320 2,375 2,378Saipan 15 16 17 20 25 29 31 33 34 29 31 36Virgin Islands 70 70 73 67 70 78 85 85 86 87 105 102

Foreign 161 186 206 224 235 247 263 265 275 273 264 255Unknown 874 848 881 818 797 726 731 742 761 766 783 1,030

All 165,232 177,358 190,448 200,388 211,525 222,145 233,989 245,672 256,409 266,212 276,902 287,844



341


Table B.9Point prevalent rates of reported ESRD, by diabetic status & state, adjusted: all patientspatients alive on December 31 of each year, per million population

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991Alabama 343 383 439 525 578 626 586 658 732 932 1,035 1,106Alaska 116 105 148 156 155 152 224 234 265 317 334 367Arizona 320 380 424 488 530 570 618 675 710 781 849 910Arkansas 230 264 302 363 410 462 502 563 627 671 723 798California 248 301 340 391 430 467 508 551 593 651 718 791Colorado 233 254 279 302 329 364 405 446 480 535 578 615Connecticut 297 324 336 400 414 515 561 609 639 701 765 852Delaware 332 328 410 548 602 658 693 758 843 915 1,005 1,138District of Columbia 661 732 859 965 1,034 1,131 1,173 1,265 1,348 1,484 1,635 1,861Florida 356 411 456 506 561 607 667 718 770 831 894 968Georgia 341 406 447 517 576 617 665 728 825 911 984 1,083Hawaii 217 251 345 419 484 575 670 731 825 911 985 1,059Idaho 176 185 218 241 269 327 350 392 409 477 539 568Illinois 299 339 383 435 480 533 585 633 674 717 780 864Indiana 249 287 327 395 423 458 487 541 591 644 705 765Iowa 232 267 293 354 392 430 495 522 559 612 674 722Kansas 242 260 304 353 385 421 447 488 525 587 661 711Kentucky 218 265 307 335 377 423 463 510 555 602 666 750Louisiana 304 347 407 452 516 570 646 736 874 969 1,054 1,141Maine 125 222 250 283 349 373 377 420 480 504 554 595Maryland 332 382 430 492 549 596 630 690 754 829 923 1,041Massachusetts 306 277 299 415 450 472 500 542 594 640 694 760Michigan 313 351 398 437 487 526 557 599 649 723 777 842Minnesota 267 313 361 400 447 491 531 586 627 674 738 797Mississippi 325 363 411 505 572 644 696 777 876 978 1,068 1,149Missouri 245 271 281 375 429 475 528 597 659 730 801 866Montana 183 227 252 289 346 376 415 462 479 538 615 662Nebraska 223 272 299 328 366 402 436 491 538 608 651 700Nevada 344 376 416 467 494 530 622 659 669 674 674 707New Hampshire 207 261 304 326 349 379 408 436 474 537 563 596New Jersey 364 402 449 509 545 597 633 667 700 771 837 924New Mexico 344 373 395 462 500 554 613 675 761 824 910 989New York 316 357 390 453 514 564 615 659 705 756 821 889North Carolina 293 336 393 458 509 577 635 688 749 820 891 977North Dakota 207 261 294 330 367 413 502 525 574 637 688 755Ohio 235 269 316 362 411 459 508 558 620 688 774 849Oklahoma 229 262 281 327 363 397 437 487 544 609 678 728Oregon 190 217 261 302 351 392 442 470 516 566 605 671Pennsylvania 293 327 368 423 473 534 581 634 695 761 837 915Rhode Island 349 367 392 440 505 527 537 551 597 677 717 780South Carolina 318 387 452 541 606 552 739 814 917 1,000 1,086 1,182South Dakota 278 332 349 402 466 507 534 582 638 675 707 771Tennessee 296 329 374 451 484 527 573 639 692 817 882 954Texas 282 314 357 410 445 484 536 593 654 725 799 874Utah 208 242 261 293 342 362 399 420 482 503 512 538Vermont 232 257 299 321 330 372 366 401 445 496 519 578Virginia 350 387 431 501 553 584 619 662 729 783 840 924Washington 224 216 288 342 387 427 476 512 544 598 634 675West Virginia 189 216 264 313 367 408 457 506 568 622 664 736Wisconsin 272 302 354 385 431 467 518 583 645 703 745 815Wyoming 161 173 203 225 245 307 327 369 434 496 503 529

All 283 322 364 420 467 510 557 607 661 726 792 864

Rates are adjusted by age, gender, & race.The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.

Table B.9Point prevalent rates of reported ESRD, by diabetic status & state, adjusted: all patientspatients alive on December 3 of each year, per million population


342

Reference section B

Table B.9 (continued)Point prevalent rates of reported ESRD, by diabetic status & state, adjusted: all patientspatients alive on December 31 of each year, per million population

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 1,184 1,264 1,353 1,427 1,539 1,627 1,672 1,716 1,796 1,846 1,879 1,918Alaska 410 420 611 900 836 828 782 766 774 812 794 809Arizona 984 1,035 1,055 1,091 1,121 1,166 1,213 1,257 1,296 1,325 1,335 1,364Arkansas 848 919 1,017 1,102 1,159 1,227 1,252 1,281 1,299 1,337 1,351 1,356California 861 931 1,021 1,075 1,128 1,170 1,221 1,272 1,326 1,376 1,429 1,471Colorado 659 696 735 749 783 816 859 880 903 918 945 968Connecticut 915 974 1,045 1,093 1,148 1,189 1,223 1,263 1,304 1,300 1,309 1,312Delaware 1,260 1,291 1,342 1,400 1,474 1,512 1,537 1,596 1,640 1,663 1,740 1,797District of Columbia 2,126 2,387 2,552 2,738 2,878 2,991 3,044 3,186 3,327 3,437 3,527 3,733Florida 1,046 1,107 1,163 1,194 1,250 1,286 1,315 1,350 1,385 1,413 1,433 1,442Georgia 1,168 1,232 1,317 1,378 1,438 1,476 1,524 1,569 1,613 1,655 1,694 1,711Hawaii 1,128 1,236 1,369 1,444 1,499 1,586 1,659 1,720 1,801 1,828 1,898 1,946Idaho 594 629 671 698 744 798 819 891 885 921 930 935Illinois 921 992 1,072 1,148 1,236 1,296 1,364 1,427 1,481 1,528 1,584 1,626Indiana 836 902 960 1,010 1,074 1,132 1,208 1,257 1,311 1,354 1,386 1,422Iowa 792 839 888 913 972 1,008 1,056 1,128 1,157 1,204 1,243 1,270Kansas 764 794 844 881 927 994 1,033 1,079 1,112 1,116 1,158 1,180Kentucky 830 879 918 982 1,028 1,081 1,139 1,173 1,216 1,264 1,287 1,326Louisiana 1,238 1,313 1,398 1,489 1,565 1,677 1,763 1,847 1,901 1,941 2,015 2,065Maine 639 707 769 839 876 924 985 1,008 1,041 1,080 1,111 1,138Maryland 1,141 1,232 1,326 1,403 1,483 1,556 1,622 1,671 1,710 1,756 1,806 1,845Massachusetts 835 898 954 988 1,026 1,072 1,117 1,126 1,146 1,153 1,175 1,194Michigan 922 998 1,072 1,132 1,224 1,277 1,342 1,379 1,431 1,481 1,524 1,571Minnesota 848 899 948 984 1,032 1,076 1,108 1,136 1,153 1,193 1,228 1,241Mississippi 1,235 1,346 1,468 1,545 1,644 1,726 1,805 1,874 1,910 1,968 2,030 2,075Missouri 932 1,003 1,065 1,128 1,188 1,240 1,314 1,372 1,412 1,449 1,476 1,501Montana 694 755 797 871 913 964 982 1,053 1,056 1,116 1,141 1,162Nebraska 780 826 880 934 959 1,017 1,071 1,127 1,175 1,219 1,252 1,274Nevada 749 800 842 867 897 912 933 981 990 1,034 1,060 1,101New Hampshire 621 651 699 733 737 766 792 832 883 899 938 960New Jersey 993 1,050 1,122 1,178 1,227 1,280 1,345 1,414 1,441 1,475 1,505 1,538New Mexico 1,061 1,120 1,155 1,230 1,285 1,338 1,383 1,431 1,498 1,526 1,523 1,551New York 957 1,029 1,084 1,135 1,189 1,253 1,320 1,375 1,419 1,445 1,481 1,511North Carolina 1,069 1,156 1,237 1,293 1,359 1,430 1,494 1,526 1,589 1,634 1,672 1,702North Dakota 838 909 967 954 969 1,014 1,063 1,131 1,105 1,197 1,273 1,282Ohio 921 980 1,059 1,124 1,196 1,254 1,327 1,395 1,466 1,511 1,560 1,607Oklahoma 792 857 923 981 1,026 1,095 1,156 1,195 1,237 1,264 1,300 1,340Oregon 699 741 793 825 857 887 923 953 980 1,025 1,061 1,101Pennsylvania 990 1,046 1,120 1,191 1,265 1,338 1,399 1,453 1,506 1,536 1,578 1,592Rhode Island 835 891 993 1,019 1,082 1,107 1,151 1,178 1,212 1,230 1,245 1,250South Carolina 1,280 1,363 1,470 1,550 1,623 1,694 1,756 1,821 1,845 1,889 1,890 1,945South Dakota 809 870 920 1,008 1,091 1,165 1,226 1,276 1,327 1,334 1,375 1,433Tennessee 1,025 1,068 1,162 1,224 1,275 1,317 1,375 1,431 1,471 1,485 1,500 1,511Texas 950 1,013 1,081 1,128 1,189 1,240 1,302 1,365 1,420 1,463 1,504 1,547Utah 563 615 642 676 690 703 753 790 824 855 873 888Vermont 599 629 674 748 816 887 937 973 1,000 1,012 1,012 1,050Virginia 1,017 1,097 1,161 1,224 1,294 1,382 1,445 1,494 1,517 1,549 1,589 1,609Washington 713 753 803 840 872 901 940 979 1,013 1,045 1,084 1,109West Virginia 796 856 919 989 1,057 1,155 1,241 1,309 1,385 1,444 1,470 1,510Wisconsin 878 931 989 1,031 1,087 1,142 1,198 1,242 1,259 1,295 1,339 1,391Wyoming 549 573 610 651 709 753 790 841 888 882 896 917

All 935 1,000 1,071 1,126 1,186 1,240 1,296 1,346 1,390 1,427 1,465 1,496


Table B.9 (continued)Point prevalent rates of reported ESRD, by diabetic status & state, adjusted: all patientspatients alive on December 3 of each year, per million population

343


Table B.9 (continued)Point prevalent rates of reported ESRD, by diabetic status & state, adjusted: diabetic patientspatients alive on December 31 of each year, per million population

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991Alabama 15 19 30 48 63 78 91 110 131 184 212 247Alaska * * * * 21 * 42 48 46 70 77 74Arizona 61 86 106 130 150 167 195 235 254 295 325 368Arkansas 12 21 30 45 57 75 78 108 118 138 154 183California 18 31 46 62 75 93 108 121 137 166 192 225Colorado 30 33 40 51 64 79 103 118 132 158 181 198Connecticut 32 46 50 67 78 104 121 134 142 168 187 225Delaware 30 51 67 71 92 102 132 167 215 244 276 328District of Columbia 57 69 108 142 195 238 256 290 291 332 403 451Florida 28 42 58 72 87 100 127 145 161 180 207 233Georgia 30 47 63 74 93 108 125 149 174 210 239 274Hawaii 22 32 60 73 83 126 181 231 268 311 360 398Idaho 16 22 29 37 48 55 70 91 100 128 156 160Illinois 31 41 54 65 76 96 111 127 140 160 183 216Indiana 27 37 44 60 68 75 85 103 119 137 162 194Iowa 20 35 45 66 79 88 111 112 125 144 159 174Kansas 27 32 48 61 77 88 84 103 116 136 164 190Kentucky 17 28 34 45 62 76 85 102 117 130 156 191Louisiana 19 30 44 49 75 88 110 140 181 221 256 303Maine * 21 30 33 51 53 59 79 94 100 122 135Maryland 24 36 49 66 84 105 117 136 154 186 234 281Massachusetts 33 37 42 55 62 68 77 84 98 120 144 171Michigan 41 52 62 70 84 99 112 122 143 170 200 230Minnesota 57 73 88 104 123 137 153 178 193 221 250 271Mississippi 19 30 44 59 80 93 111 136 173 214 255 296Missouri 13 25 45 56 70 88 99 119 138 160 186 216Montana 23 37 40 57 81 99 107 135 157 180 226 237Nebraska 37 53 64 71 77 85 95 117 139 171 199 221Nevada 60 71 86 81 80 89 114 139 147 155 174 195New Hampshire 22 31 41 47 47 60 69 80 102 117 133 143New Jersey 37 46 64 81 87 105 115 125 143 166 200 236New Mexico 51 72 83 127 143 160 195 230 282 321 353 416New York 24 37 48 62 83 98 116 132 150 168 194 217North Carolina 25 31 44 57 74 95 110 132 151 181 213 249North Dakota 39 46 57 85 101 117 160 164 185 237 252 281Ohio 31 41 54 65 80 96 113 133 152 178 214 242Oklahoma 18 27 42 62 74 87 105 127 162 180 214 245Oregon 14 21 43 50 60 72 90 103 117 135 156 171Pennsylvania 31 38 48 60 79 94 113 134 153 175 204 236Rhode Island 21 28 34 39 51 58 62 74 100 122 152 165South Carolina 27 38 53 69 97 112 143 170 199 232 266 315South Dakota 42 80 68 82 110 139 151 174 219 217 239 274Tennessee 16 22 35 49 60 76 86 106 127 171 196 226Texas 29 40 55 66 84 100 119 142 170 211 249 285Utah 34 46 51 71 93 104 117 129 163 166 184 191Vermont 31 39 63 56 63 90 88 104 96 132 150 168Virginia 28 37 49 65 82 89 104 118 141 165 186 220Washington 23 24 35 47 61 80 93 101 119 141 158 178West Virginia 19 24 37 54 65 67 94 112 129 146 165 193Wisconsin 45 52 69 80 97 107 129 151 175 194 213 248Wyoming * * 38 38 47 88 84 100 116 151 148 151

All 27 38 51 64 80 95 112 129 149 175 204 235

Rates are adjusted by age, gender, & race.The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.*Values for cells with 10 or fewer patients are suppressed.



344

Reference section B


1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 279 320 362 398 449 502 530 559 615 649 661 677Alaska 90 112 181 303 288 296 257 264 240 262 257 261Arizona 411 438 456 479 496 533 557 577 601 619 623 638Arkansas 204 229 267 310 348 378 388 400 419 447 454 465California 254 282 324 351 379 407 431 457 488 512 535 555Colorado 224 246 255 267 288 304 324 336 355 360 374 383Connecticut 247 272 300 327 349 385 393 409 438 430 440 449Delaware 352 364 393 408 435 471 493 526 573 576 611 635District of Columbia 563 654 694 766 868 901 896 944 984 1,032 1,071 1,147Florida 263 290 318 340 369 394 409 427 446 469 477 483Georgia 310 335 371 407 454 480 508 536 556 575 599 609Hawaii 433 521 597 647 676 718 758 796 868 905 946 953Idaho 177 196 216 224 250 281 303 334 326 338 343 331Illinois 232 255 287 327 367 395 424 459 484 498 523 538Indiana 229 252 278 318 348 367 405 428 448 463 479 498Iowa 206 229 255 277 309 321 342 372 385 405 416 422Kansas 207 225 252 266 289 315 355 379 400 406 424 426Kentucky 225 245 255 298 328 351 378 396 419 444 464 474Louisiana 353 379 411 452 510 569 617 652 680 695 722 742Maine 150 175 198 233 243 270 297 300 325 353 376 395Maryland 325 363 395 428 472 512 536 551 549 571 597 604Massachusetts 205 226 255 274 294 315 332 334 341 357 367 369Michigan 263 294 331 361 412 441 473 487 517 541 557 576Minnesota 283 311 324 335 347 362 376 384 391 402 416 415Mississippi 335 380 430 476 528 565 608 643 651 678 705 733Missouri 244 277 304 340 368 403 440 459 482 495 509 513Montana 259 278 302 355 372 394 397 429 448 488 502 510Nebraska 258 290 297 339 356 381 406 429 448 466 470 486Nevada 207 227 239 271 281 304 327 345 353 380 397 430New Hampshire 152 170 188 204 206 226 238 250 268 274 290 297New Jersey 256 280 316 353 383 410 447 476 489 501 513 517New Mexico 467 519 544 596 647 685 715 747 807 817 802 811New York 244 273 293 320 353 384 412 434 454 471 488 501North Carolina 288 323 365 398 444 483 519 537 571 588 606 620North Dakota 330 347 364 357 352 372 405 395 391 423 459 459Ohio 274 298 339 374 409 444 483 514 548 573 594 609Oklahoma 276 309 336 370 391 433 473 494 509 528 548 564Oregon 183 197 219 242 267 288 292 307 317 335 345 361Pennsylvania 272 295 326 361 388 420 451 472 498 515 537 543Rhode Island 195 206 235 256 299 326 358 370 371 380 381 373South Carolina 351 386 435 467 514 543 598 637 659 689 683 710South Dakota 322 362 385 431 470 504 520 566 567 569 594 637Tennessee 254 279 318 354 386 408 435 457 478 489 500 507Texas 318 350 385 416 454 490 527 560 598 622 653 677Utah 202 227 242 264 271 279 296 311 329 347 349 356Vermont 177 183 212 249 277 306 336 360 364 359 348 347Virginia 261 297 329 360 393 441 472 497 515 537 562 567Washington 202 222 243 255 273 297 315 331 345 360 371 379West Virginia 231 244 273 310 348 399 442 493 550 578 587 613Wisconsin 272 295 314 330 349 379 399 415 413 426 444 462Wyoming 150 180 209 250 271 302 309 329 353 345 344 360

All 265 293 324 354 387 417 446 469 493 512 530 543



345


Table B.9 (continued)Point prevalent rates of reported ESRD, by diabetic status & state, adjusted: non-diabetic patientspatients alive on December 31 of each year, per million population

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991Alabama 328 364 409 477 514 548 495 548 601 748 823 860Alaska 108 100 136 143 134 135 182 186 219 247 257 293Arizona 259 294 319 359 380 403 423 440 457 486 524 542Arkansas 218 243 272 318 353 387 424 455 510 533 568 615California 230 270 294 329 355 374 400 430 456 485 526 566Colorado 203 221 239 251 265 285 302 328 349 377 397 417Connecticut 265 279 285 333 336 410 440 474 497 533 578 627Delaware 301 276 343 477 509 556 561 591 627 671 729 810District of Columbia 604 663 751 822 839 893 917 976 1,057 1,153 1,232 1,410Florida 327 368 397 434 474 507 541 573 610 652 687 735Georgia 311 359 383 443 483 510 540 579 651 700 745 809Hawaii 196 219 284 346 401 449 489 500 557 600 625 660Idaho 159 163 189 204 221 272 280 302 309 349 383 408Illinois 267 298 329 370 404 437 474 506 534 557 597 649Indiana 222 250 283 335 355 383 402 439 472 508 543 572Iowa 212 232 248 288 313 342 385 410 434 468 514 548Kansas 215 228 256 293 308 333 362 384 409 450 497 521Kentucky 201 237 273 289 315 347 379 408 438 472 510 559Louisiana 285 317 364 403 441 482 536 596 692 749 798 838Maine 115 201 220 250 299 320 318 341 386 405 433 460Maryland 308 345 381 426 466 492 513 554 600 642 689 759Massachusetts 273 240 257 361 388 404 424 458 496 520 549 589Michigan 272 299 336 367 403 427 445 477 506 553 578 612Minnesota 210 240 273 296 324 354 378 408 434 452 488 527Mississippi 305 332 367 445 492 552 585 641 703 764 813 853Missouri 232 246 236 320 358 387 429 478 521 570 616 650Montana 159 190 211 232 265 277 308 327 322 358 389 425Nebraska 187 219 235 257 289 317 341 374 399 436 452 479Nevada 284 305 330 387 414 442 508 521 522 519 500 512New Hampshire 185 230 263 278 302 319 339 355 372 420 430 452New Jersey 327 355 385 429 458 492 519 541 558 605 638 688New Mexico 293 300 311 335 358 394 418 446 478 503 557 573New York 292 320 342 390 431 466 499 527 555 588 627 671North Carolina 269 304 348 401 435 482 525 556 598 640 678 727North Dakota 167 215 237 245 265 296 342 361 389 401 436 474Ohio 204 229 262 298 331 363 395 426 469 510 560 608Oklahoma 211 235 239 265 289 310 332 359 381 429 464 483Oregon 176 196 218 252 291 320 352 367 399 431 450 500Pennsylvania 262 290 320 363 394 439 468 501 542 586 632 679Rhode Island 328 339 358 400 453 469 475 477 497 555 565 615South Carolina 291 349 399 472 509 440 596 644 718 768 820 867South Dakota 236 252 280 320 356 368 383 408 419 458 468 498Tennessee 281 307 339 402 424 451 487 533 565 645 686 727Texas 254 274 302 344 361 384 416 451 483 514 549 589Utah 175 196 211 222 249 259 282 291 320 337 327 347Vermont 201 218 236 265 268 282 278 298 348 363 369 410Virginia 322 351 382 436 470 495 515 544 588 618 654 704Washington 202 192 253 295 326 346 383 411 425 457 477 497West Virginia 170 192 227 259 302 341 363 394 439 476 498 543Wisconsin 227 250 285 304 334 360 389 432 471 509 532 567Wyoming 140 148 164 187 198 219 243 269 317 345 355 378

All 255 284 313 356 387 415 445 477 512 551 588 630




346

Reference section B


1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 905 944 991 1,029 1,091 1,125 1,142 1,156 1,181 1,196 1,218 1,240Alaska 320 308 431 597 548 533 525 502 534 549 536 549Arizona 573 597 599 612 626 633 656 681 695 705 712 726Arkansas 644 690 750 792 810 849 864 881 880 890 897 891California 606 649 697 724 748 763 790 815 838 864 893 916Colorado 435 450 480 482 495 512 535 544 548 559 571 586Connecticut 668 703 745 766 800 804 829 855 866 870 869 863Delaware 908 927 949 992 1,039 1,041 1,044 1,071 1,067 1,087 1,128 1,162District of Columbia 1,563 1,733 1,858 1,972 2,011 2,089 2,147 2,242 2,343 2,405 2,456 2,586Florida 783 817 845 855 881 892 906 924 939 944 956 960Georgia 859 897 946 971 984 996 1,016 1,033 1,057 1,080 1,095 1,102Hawaii 695 715 772 797 823 868 901 924 934 922 952 993Idaho 418 433 454 474 494 517 516 557 559 584 588 604Illinois 689 737 785 821 869 901 939 968 997 1,029 1,061 1,087Indiana 607 650 682 692 726 765 803 829 863 892 908 924Iowa 586 611 633 636 663 687 714 756 772 799 826 848Kansas 557 570 592 615 638 679 678 700 711 710 735 754Kentucky 606 634 663 684 700 729 762 778 796 819 822 853Louisiana 885 934 987 1,037 1,054 1,108 1,146 1,195 1,221 1,246 1,293 1,323Maine 489 531 570 606 633 655 688 708 715 727 734 743Maryland 816 869 931 975 1,011 1,044 1,086 1,120 1,162 1,184 1,209 1,241Massachusetts 630 671 699 714 732 758 785 792 804 796 809 825Michigan 659 704 742 771 812 837 869 892 914 940 967 995Minnesota 565 588 625 649 684 714 732 752 762 791 812 826Mississippi 900 967 1,038 1,069 1,116 1,161 1,197 1,230 1,258 1,290 1,325 1,342Missouri 687 727 761 788 820 837 874 912 930 954 967 988Montana 435 477 495 516 541 570 585 623 608 628 639 651Nebraska 522 537 583 595 603 636 665 698 728 752 782 788Nevada 543 573 603 596 616 607 606 636 637 655 663 671New Hampshire 469 481 511 529 531 540 555 583 615 625 647 662New Jersey 737 770 805 826 843 870 898 938 952 975 992 1,021New Mexico 594 601 611 634 638 653 668 684 691 709 721 740New York 713 757 791 815 837 869 908 941 965 974 993 1,010North Carolina 781 833 872 896 916 947 975 989 1,018 1,046 1,066 1,082North Dakota 508 561 603 597 618 642 658 736 714 774 814 823Ohio 648 682 720 750 786 810 844 881 918 938 966 999Oklahoma 516 548 587 610 636 662 682 701 728 736 752 776Oregon 515 544 574 583 590 598 632 647 663 690 716 740Pennsylvania 717 751 795 830 878 917 948 981 1,008 1,021 1,042 1,049Rhode Island 641 684 758 763 782 781 793 808 841 849 864 877South Carolina 930 977 1,035 1,082 1,109 1,150 1,158 1,184 1,187 1,200 1,207 1,236South Dakota 487 508 535 577 622 661 706 710 760 765 780 796Tennessee 772 790 843 869 889 909 940 974 993 995 1,001 1,004Texas 632 663 696 713 735 750 775 804 822 840 852 869Utah 361 388 400 412 420 423 457 478 495 509 524 533Vermont 421 446 461 499 539 580 601 613 635 653 664 702Virginia 757 800 833 864 901 940 973 997 1,002 1,012 1,027 1,042Washington 511 531 560 585 600 604 625 648 668 685 713 730West Virginia 565 611 647 680 710 756 799 816 835 866 883 897Wisconsin 606 636 675 702 737 763 799 827 846 868 896 929Wyoming 400 392 401 402 438 451 481 513 535 537 552 558

All 671 708 747 772 799 823 850 877 897 915 935 953



347


ON OUR WEBSITE & CDPoint prevalent counts of reported ESRD patients: U.S. only, with unknowns dropped (B.10.1).

Table B.10Point prevalent counts of reported ESRD patients, by diabetic status & ESRD networkpatients alive on December 31 of each year

ALL 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19911 CT, MA, ME, NH, RI, VT 3,083 3,208 3,484 4,401 4,829 5,372 5,757 6,304 6,923 7,607 8,289 9,1562 NY 4,944 5,633 6,217 7,287 8,360 9,254 10,185 10,980 11,833 12,715 13,897 15,1583 NJ, PR, VI 3,243 3,653 4,133 4,698 5,217 5,756 6,178 6,582 7,057 7,764 8,469 9,3124 DE, PA 3,362 3,748 4,246 4,895 5,465 6,181 6,794 7,458 8,244 9,054 10,066 11,1595 MD, DC, VA, WV 3,494 3,991 4,579 5,378 6,106 6,678 7,192 7,951 8,865 9,761 10,785 12,2406 NC, SC, GA 4,000 4,799 5,583 6,656 7,553 8,151 9,462 10,522 11,907 13,298 14,813 16,6357 FL 3,363 3,968 4,508 5,108 5,792 6,406 7,231 7,982 8,762 9,704 10,693 11,9398 AL, MS, TN 3,022 3,401 3,908 4,751 5,259 5,838 6,080 6,887 7,667 9,215 10,309 11,2829 IN, KY, OH 4,220 4,907 5,718 6,608 7,377 8,205 9,053 10,070 11,214 12,401 13,980 15,56110 IL 3,143 3,588 4,055 4,644 5,121 5,698 6,299 6,848 7,316 7,861 8,637 9,68411 MI, MN, ND, SD, WI 4,866 5,555 6,360 7,038 7,918 8,695 9,479 10,462 11,455 12,687 13,853 15,26112 IA, KS, MO, NE 2,563 2,893 3,119 3,876 4,375 4,829 5,384 5,976 6,548 7,325 8,161 8,94313 AR, LA, OK 2,168 2,502 2,888 3,344 3,807 4,231 4,724 5,341 6,132 6,784 7,497 8,26214 TX 3,828 4,408 5,208 6,124 6,746 7,490 8,360 9,325 10,398 11,717 13,119 14,64715 AZ, CO, NV, NM, UT, WY 2,369 2,754 3,134 3,609 4,063 4,556 5,146 5,760 6,337 7,035 7,742 8,58316 AK, ID, MT, OR, WA 1,659 1,747 2,198 2,596 2,967 3,327 3,774 4,151 4,548 5,140 5,648 6,30317 N. CA, HI, Guam, AS 2,935 3,272 3,700 4,217 4,752 5,247 5,847 6,546 7,334 8,232 9,168 10,16318 S. CA 3,737 4,812 5,378 6,169 6,813 7,535 8,370 9,223 10,071 11,305 12,688 14,281Unknown 43 46 55 63 73 82 101 121 149 162 164 161

All 60,042 68,885 78,471 91,462 102,593 113,531 125,416 138,489 152,760 169,767 187,978 208,730

DIABETIC1 CT, MA, ME, NH, RI, VT 317 408 489 619 729 874 994 1,137 1,310 1,568 1,840 2,1582 NY 382 577 764 1,003 1,317 1,561 1,886 2,162 2,479 2,787 3,234 3,6573 NJ, PR, VI 333 431 595 759 906 1,088 1,248 1,382 1,586 1,848 2,196 2,5764 DE, PA 364 442 557 701 914 1,100 1,337 1,589 1,841 2,118 2,506 2,9365 MD, DC, VA, WV 287 390 538 743 964 1,125 1,316 1,536 1,792 2,126 2,536 3,0636 NC, SC, GA 357 511 710 896 1,176 1,430 1,738 2,113 2,481 3,011 3,564 4,2237 FL 250 397 560 706 877 1,037 1,343 1,570 1,783 2,048 2,422 2,8258 AL, MS, TN 164 232 353 504 652 806 939 1,166 1,412 1,895 2,237 2,6329 IN, KY, OH 478 655 850 1,058 1,318 1,550 1,824 2,196 2,555 2,979 3,605 4,21910 IL 317 418 560 678 802 1,014 1,179 1,354 1,511 1,746 2,013 2,39311 MI, MN, ND, SD, WI 746 946 1,158 1,372 1,663 1,920 2,222 2,526 2,911 3,394 3,911 4,53512 IA, KS, MO, NE 212 333 493 638 790 939 1,066 1,234 1,430 1,684 1,979 2,28913 AR, LA, OK 141 218 321 427 583 706 854 1,085 1,352 1,609 1,898 2,25414 TX 387 556 799 979 1,267 1,549 1,870 2,236 2,719 3,412 4,064 4,73415 AZ, CO, NV, NM, UT, WY 366 490 612 790 959 1,146 1,401 1,692 1,957 2,284 2,618 3,03816 AK, ID, MT, OR, WA 145 181 278 373 486 616 746 878 1,041 1,270 1,482 1,70217 N. CA, HI, Guam, AS 206 337 460 585 701 935 1,145 1,414 1,714 2,159 2,526 2,90018 S. CA 304 517 753 1,018 1,253 1,544 1,844 2,056 2,354 2,867 3,384 4,107Unknown . . . * * * * * * * * *

All 5,756 8,039 10,850 13,850 17,360 20,943 24,956 29,330 34,231 40,808 48,017 56,244

NON-DIABETIC1 CT, MA, ME, NH, RI, VT 2,766 2,800 2,995 3,782 4,100 4,498 4,763 5,167 5,613 6,039 6,449 6,9982 NY 4,562 5,056 5,453 6,284 7,043 7,693 8,299 8,818 9,354 9,928 10,663 11,5013 NJ, PR, VI 2,910 3,222 3,538 3,939 4,311 4,668 4,930 5,200 5,471 5,916 6,273 6,7364 DE, PA 2,998 3,306 3,689 4,194 4,551 5,081 5,457 5,869 6,403 6,936 7,560 8,2235 MD, DC, VA, WV 3,207 3,601 4,041 4,635 5,142 5,553 5,876 6,415 7,073 7,635 8,249 9,1776 NC, SC, GA 3,643 4,288 4,873 5,760 6,377 6,721 7,724 8,409 9,426 10,287 11,249 12,4127 FL 3,113 3,571 3,948 4,402 4,915 5,369 5,888 6,412 6,979 7,656 8,271 9,1148 AL, MS, TN 2,858 3,169 3,555 4,247 4,607 5,032 5,141 5,721 6,255 7,320 8,072 8,6509 IN, KY, OH 3,742 4,252 4,868 5,550 6,059 6,655 7,229 7,874 8,659 9,422 10,375 11,34210 IL 2,826 3,170 3,495 3,966 4,319 4,684 5,120 5,494 5,805 6,115 6,624 7,29111 MI, MN, ND, SD, WI 4,120 4,609 5,202 5,666 6,255 6,775 7,257 7,936 8,544 9,293 9,942 10,72612 IA, KS, MO, NE 2,351 2,560 2,626 3,238 3,585 3,890 4,318 4,742 5,118 5,641 6,182 6,65413 AR, LA, OK 2,027 2,284 2,567 2,917 3,224 3,525 3,870 4,256 4,780 5,175 5,599 6,00814 TX 3,441 3,852 4,409 5,145 5,479 5,941 6,490 7,089 7,679 8,305 9,055 9,91315 AZ, CO, NV, NM, UT, WY 2,003 2,264 2,522 2,819 3,104 3,410 3,745 4,068 4,380 4,751 5,124 5,54516 AK, ID, MT, OR, WA 1,514 1,566 1,920 2,223 2,481 2,711 3,028 3,273 3,507 3,870 4,166 4,60117 N. CA, HI, Guam, AS 2,729 2,935 3,240 3,632 4,051 4,312 4,702 5,132 5,620 6,073 6,642 7,26318 S. CA 3,433 4,295 4,625 5,151 5,560 5,991 6,526 7,167 7,717 8,438 9,304 10,174Unknown 43 46 55 62 70 79 97 117 146 159 162 158

All 54,286 60,846 67,621 77,612 85,233 92,588 100,460 109,159 118,529 128,959 139,961 152,486

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table B.10Point prevalent counts of reported ESRD patients, by diabetic status & ESRD networkpatients alive on December 3 of each year


348

Reference section B

ON OUR WEBSITE & CDPoint prevalent counts of reported ESRD patients: U.S. only, with unknowns dropped (B.10.1).

Table B.10 (continued)Point prevalent counts of reported ESRD patients, by diabetic status & ESRD networkpatients alive on December 31 of each year

ALL 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20031 CT, MA, ME, NH, RI, VT 9,970 10,815 11,712 12,407 13,159 13,949 14,756 15,329 16,050 16,440 17,018 17,5402 NY 16,475 17,835 19,022 20,208 21,454 22,955 24,584 26,039 27,400 28,437 29,704 30,9113 NJ, PR, VI 10,168 10,894 11,796 12,494 13,262 14,052 14,956 15,863 16,443 17,093 17,786 18,5244 DE, PA 12,198 12,969 13,992 14,980 16,058 17,078 18,002 18,868 19,742 20,288 21,104 21,6015 MD, DC, VA, WV 13,714 15,108 16,392 17,690 19,071 20,621 22,018 23,315 24,363 25,435 26,565 27,6086 NC, SC, GA 18,568 20,380 22,479 24,234 26,151 28,057 29,957 31,634 33,344 35,021 36,456 37,9177 FL 13,251 14,385 15,570 16,496 17,859 18,955 19,923 21,011 22,105 23,156 24,193 25,0298 AL, MS, TN 12,355 13,392 14,742 15,851 17,166 18,367 19,424 20,443 21,457 22,231 23,003 23,7699 IN, KY, OH 17,193 18,531 20,079 21,512 23,082 24,501 26,257 27,715 29,380 30,643 31,839 33,17810 IL 10,482 11,441 12,489 13,501 14,702 15,636 16,655 17,616 18,526 19,344 20,298 21,13411 MI, MN, ND, SD, WI 16,794 18,300 19,817 21,107 22,864 24,246 25,722 26,868 28,154 29,549 30,961 32,36212 IA, KS, MO, NE 9,843 10,584 11,399 12,103 12,892 13,711 14,588 15,492 16,245 16,866 17,497 18,05313 AR, LA, OK 9,091 9,913 10,844 11,801 12,590 13,669 14,539 15,367 16,045 16,619 17,340 18,01914 TX 16,367 17,885 19,585 21,039 22,820 24,455 26,298 28,241 30,098 31,711 33,368 35,25215 AZ, CO, NV, NM, UT, WY 9,581 10,603 11,486 12,403 13,339 14,336 15,450 16,531 17,593 18,539 19,337 20,34216 AK, ID, MT, OR, WA 6,790 7,394 8,169 8,892 9,415 9,963 10,523 11,191 11,760 12,488 13,193 13,85917 N. CA, HI, Guam, AS 11,009 11,982 13,075 13,870 14,722 15,747 16,809 17,983 19,232 20,431 21,581 22,71518 S. CA 15,854 17,362 19,360 20,705 22,250 23,649 25,296 26,903 28,785 30,629 32,809 34,747Unknown 174 179 272 273 274 187 187 205 219 241 256 397

All 229,877 249,952 272,280 291,566 313,130 334,134 355,944 376,614 396,941 415,161 434,308 452,957

DIABETIC1 CT, MA, ME, NH, RI, VT 2,488 2,769 3,133 3,468 3,802 4,204 4,509 4,702 5,003 5,221 5,463 5,6392 NY 4,139 4,660 5,071 5,655 6,333 7,015 7,660 8,218 8,780 9,311 9,862 10,3583 NJ, PR, VI 2,910 3,185 3,602 3,968 4,399 4,788 5,264 5,712 5,982 6,244 6,558 6,8774 DE, PA 3,385 3,670 4,083 4,540 4,923 5,379 5,811 6,143 6,555 6,816 7,185 7,3825 MD, DC, VA, WV 3,664 4,193 4,670 5,224 5,872 6,614 7,162 7,705 8,088 8,594 9,127 9,4606 NC, SC, GA 4,930 5,596 6,446 7,232 8,286 9,152 10,131 10,899 11,702 12,395 13,022 13,6707 FL 3,287 3,715 4,202 4,630 5,220 5,752 6,151 6,599 7,097 7,658 8,073 8,4108 AL, MS, TN 3,044 3,486 4,031 4,565 5,170 5,725 6,213 6,663 7,182 7,590 7,917 8,2669 IN, KY, OH 4,915 5,430 6,108 6,933 7,683 8,339 9,209 9,844 10,574 11,164 11,711 12,19210 IL 2,628 2,929 3,327 3,822 4,349 4,751 5,163 5,641 6,027 6,285 6,675 6,98011 MI, MN, ND, SD, WI 5,120 5,731 6,333 6,887 7,655 8,294 8,912 9,309 9,842 10,403 10,943 11,46312 IA, KS, MO, NE 2,652 3,001 3,340 3,716 4,085 4,476 4,933 5,297 5,649 5,892 6,129 6,29813 AR, LA, OK 2,622 2,927 3,271 3,706 4,150 4,684 5,137 5,490 5,812 6,104 6,401 6,71014 TX 5,426 6,132 6,919 7,723 8,704 9,666 10,643 11,577 12,671 13,490 14,506 15,50115 AZ, CO, NV, NM, UT, WY 3,517 4,020 4,425 4,939 5,404 5,987 6,519 7,033 7,665 8,139 8,503 9,00916 AK, ID, MT, OR, WA 1,926 2,165 2,456 2,757 3,018 3,341 3,542 3,815 4,036 4,344 4,586 4,80217 N. CA, HI, Guam, AS 3,220 3,645 4,133 4,531 4,955 5,516 6,001 6,574 7,191 7,749 8,272 8,79418 S. CA 4,763 5,327 6,242 6,844 7,561 8,300 8,993 9,720 10,675 11,549 12,471 13,295Unknown * 13 40 38 36 * * * * * * *

All 64,645 72,594 81,832 91,178 101,605 111,989 121,955 130,942 140,532 148,949 157,406 165,113

NON-DIABETIC1 CT, MA, ME, NH, RI, VT 7,482 8,046 8,579 8,939 9,357 9,745 10,247 10,627 11,047 11,219 11,555 11,9012 NY 12,336 13,175 13,951 14,553 15,121 15,940 16,924 17,821 18,620 19,126 19,842 20,5533 NJ, PR, VI 7,258 7,709 8,194 8,526 8,863 9,264 9,692 10,151 10,461 10,849 11,228 11,6474 DE, PA 8,813 9,299 9,909 10,440 11,135 11,699 12,191 12,725 13,187 13,472 13,919 14,2195 MD, DC, VA, WV 10,050 10,915 11,722 12,466 13,199 14,007 14,856 15,610 16,275 16,841 17,438 18,1486 NC, SC, GA 13,638 14,784 16,033 17,002 17,865 18,905 19,826 20,735 21,642 22,626 23,434 24,2477 FL 9,964 10,670 11,368 11,866 12,639 13,203 13,772 14,412 15,008 15,498 16,120 16,6198 AL, MS, TN 9,311 9,906 10,711 11,286 11,996 12,642 13,211 13,780 14,275 14,641 15,086 15,5039 IN, KY, OH 12,278 13,101 13,971 14,579 15,399 16,162 17,048 17,871 18,806 19,479 20,128 20,98610 IL 7,854 8,512 9,162 9,679 10,353 10,885 11,492 11,975 12,499 13,059 13,623 14,15411 MI, MN, ND, SD, WI 11,674 12,569 13,484 14,220 15,209 15,952 16,810 17,559 18,312 19,146 20,018 20,89912 IA, KS, MO, NE 7,191 7,583 8,059 8,387 8,807 9,235 9,655 10,195 10,596 10,974 11,368 11,75513 AR, LA, OK 6,469 6,986 7,573 8,095 8,440 8,985 9,402 9,877 10,233 10,515 10,939 11,30914 TX 10,941 11,753 12,666 13,316 14,116 14,789 15,655 16,664 17,427 18,221 18,862 19,75115 AZ, CO, NV, NM, UT, WY 6,064 6,583 7,061 7,464 7,935 8,349 8,931 9,498 9,928 10,400 10,834 11,33316 AK, ID, MT, OR, WA 4,864 5,229 5,713 6,135 6,397 6,622 6,981 7,376 7,724 8,144 8,607 9,05717 N. CA, HI, Guam, AS 7,789 8,337 8,942 9,339 9,767 10,231 10,808 11,409 12,041 12,682 13,309 13,92118 S. CA 11,091 12,035 13,118 13,861 14,689 15,349 16,303 17,183 18,110 19,080 20,338 21,452Unknown 165 166 232 235 238 181 185 204 218 240 254 390

All 165,232 177,358 190,448 200,388 211,525 222,145 233,989 245,672 256,409 266,212 276,902 287,844

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.*Values for cells with 10 or fewer patients are suppressed.

Table B.10 (continued)Point prevalent counts of reported ESRD patients, by diabetic status & ESRD networkpatients alive on December 3 of each year

349


Table B.11Point prevalent rates of reported ESRD, by diabetic status & ESRD network, adjustedpatients alive on December 31 of each year, per million population

ALL 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19921 CT, MA, ME, NH, RI, VT 281 289 311 390 423 467 494 534 579 631 682 749 8102 NY 317 357 391 453 515 565 617 661 707 758 823 891 9603 NJ 365 403 450 510 546 598 634 667 701 772 838 925 9954 DE, PA 296 328 371 429 479 541 588 641 703 769 846 928 1,0075 MD, DC, VA, WV 334 376 427 493 549 590 626 678 742 806 878 979 1,0796 NC, SC, GA 317 374 426 498 555 587 667 728 811 891 965 1,058 1,1497 FL 356 411 455 504 559 605 665 716 768 829 891 964 1,0418 AL, MS, TN 318 355 404 487 534 585 603 674 745 892 975 1,048 1,1259 IN, KY, OH 235 273 316 365 407 451 493 543 599 658 733 806 87910 IL 298 339 383 435 480 533 585 633 673 716 779 862 92011 MI, MN, ND, SD, WI 290 329 375 413 462 502 541 590 641 704 757 819 88812 IA, KS, MO, NE 239 269 292 360 404 446 493 545 593 659 725 783 85113 AR, LA, OK 260 297 339 388 438 486 542 612 704 776 848 919 99214 TX 282 314 357 409 445 484 535 592 653 725 799 874 95015 AZ, CO, NV, NM, UT, WY 280 318 348 394 432 472 521 568 612 664 708 756 80916 AK, ID, MT, OR, WA 200 208 262 304 348 387 433 467 501 556 596 643 67517 N. CA, HI 263 294 344 395 441 484 532 586 645 707 769 836 89218 S. CA 235 302 338 390 425 464 503 540 574 630 701 778 856

All 283 322 364 420 467 510 557 607 661 726 792 864 935

DIABETIC1 CT, MA, ME, NH, RI, VT 29 37 43 54 64 76 85 96 110 131 153 178 2042 NY 24 37 48 62 83 98 116 132 150 168 194 217 2443 NJ 37 47 64 81 87 106 116 126 143 166 200 237 2574 DE, PA 32 38 49 60 79 95 114 135 156 179 208 241 2775 MD, DC, VA, WV 27 36 50 68 87 100 115 132 151 177 209 248 2926 NC, SC, GA 27 39 53 66 86 103 122 146 169 203 234 272 3097 FL 28 42 58 72 87 100 126 144 161 180 207 233 2638 AL, MS, TN 16 23 35 51 65 80 93 113 138 185 214 248 2809 IN, KY, OH 27 37 48 60 74 86 100 118 136 157 189 219 25210 IL 31 40 54 65 76 96 111 127 140 160 183 215 23211 MI, MN, ND, SD, WI 46 58 70 82 98 113 129 145 166 192 218 247 27412 IA, KS, MO, NE 21 32 48 61 75 88 99 114 131 153 177 202 23113 AR, LA, OK 17 27 40 53 71 85 101 129 160 188 218 255 29114 TX 29 40 55 66 84 100 119 141 170 211 249 285 31815 AZ, CO, NV, NM, UT, WY 46 61 73 92 109 125 150 176 199 226 250 279 30916 AK, ID, MT, OR, WA 19 23 36 46 59 74 88 101 116 138 158 173 19217 N. CA, HI 16 28 44 56 67 90 107 130 152 186 213 239 26218 S. CA 19 33 48 66 80 98 114 122 136 162 189 227 261

All 27 38 51 64 80 95 112 129 149 175 204 235 265

NON-DIABETIC1 CT, MA, ME, NH, RI, VT 252 252 267 336 359 391 409 438 469 500 530 570 6052 NY 292 321 343 391 432 467 501 529 557 589 629 674 7163 NJ 328 357 386 430 459 492 518 541 558 606 639 688 7384 DE, PA 264 290 322 369 400 446 474 506 547 591 638 687 7295 MD, DC, VA, WV 307 339 377 425 462 490 511 546 591 629 669 731 7866 NC, SC, GA 289 335 372 432 469 484 545 581 642 688 731 786 8407 FL 328 368 397 433 472 505 539 571 607 649 683 730 7788 AL, MS, TN 302 332 369 436 469 506 510 560 607 707 761 801 8459 IN, KY, OH 208 235 269 305 334 365 393 425 463 501 545 587 62710 IL 267 299 329 370 405 437 474 506 533 557 596 648 68811 MI, MN, ND, SD, WI 244 271 305 331 364 389 412 445 475 512 539 573 61312 IA, KS, MO, NE 219 237 244 299 330 358 395 431 463 506 548 581 62013 AR, LA, OK 243 270 299 335 368 401 441 483 544 589 630 664 70114 TX 253 274 302 344 361 383 416 451 483 513 549 589 63215 AZ, CO, NV, NM, UT, WY 234 257 275 302 323 346 371 392 413 437 459 477 50016 AK, ID, MT, OR, WA 181 185 226 259 289 313 345 367 385 418 439 470 48417 N. CA, HI 247 266 301 338 374 394 426 457 493 521 556 597 63118 S. CA 216 269 290 324 345 366 389 417 438 468 512 552 596

All 255 284 313 356 387 415 445 477 512 551 588 630 671

Rates are adjusted by age, race, & gender. The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.

Table B.11Point prevalent rates of reported ESRD, by diabetic status & ESRD network, adjustedpatients alive on December 3 of each year, per million population


350

Reference section B

Table B.11 (continued)Point prevalent rates of reported ESRD, by diabetic status & ESRD network, adjustedpatients alive on December 31 of each year, per million population

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20031 CT, MA, ME, NH, RI, VT 868 930 971 1,013 1,056 1,097 1,120 1,150 1,158 1,179 1,1952 NY 1,032 1,087 1,139 1,194 1,258 1,326 1,383 1,428 1,456 1,495 1,5273 NJ 1,052 1,123 1,179 1,228 1,283 1,349 1,420 1,452 1,490 1,522 1,5624 DE, PA 1,062 1,135 1,205 1,279 1,350 1,409 1,463 1,514 1,542 1,587 1,6045 MD, DC, VA, WV 1,166 1,244 1,318 1,394 1,479 1,545 1,601 1,641 1,682 1,725 1,7606 NC, SC, GA 1,225 1,313 1,376 1,441 1,498 1,554 1,596 1,642 1,686 1,714 1,7437 FL 1,101 1,158 1,189 1,244 1,278 1,307 1,341 1,374 1,399 1,419 1,4248 AL, MS, TN 1,195 1,292 1,362 1,444 1,510 1,568 1,623 1,675 1,710 1,742 1,7689 IN, KY, OH 937 1,002 1,063 1,128 1,185 1,257 1,313 1,374 1,419 1,458 1,50110 IL 990 1,071 1,147 1,234 1,295 1,363 1,426 1,482 1,530 1,586 1,62811 MI, MN, ND, SD, WI 953 1,016 1,065 1,136 1,189 1,244 1,281 1,316 1,359 1,401 1,44112 IA, KS, MO, NE 904 959 1,007 1,059 1,111 1,169 1,227 1,266 1,299 1,333 1,35813 AR, LA, OK 1,063 1,145 1,224 1,285 1,372 1,434 1,490 1,531 1,566 1,611 1,64714 TX 1,013 1,081 1,128 1,188 1,239 1,300 1,364 1,418 1,461 1,501 1,54315 AZ, CO, NV, NM, UT, WY 856 887 919 950 982 1,024 1,060 1,090 1,116 1,130 1,15516 AK, ID, MT, OR, WA 717 774 825 854 885 916 955 979 1,016 1,048 1,07517 N. CA, HI 962 1,041 1,085 1,126 1,172 1,224 1,282 1,337 1,387 1,429 1,46318 S. CA 931 1,030 1,092 1,152 1,195 1,248 1,294 1,350 1,400 1,463 1,510

All 1,000 1,071 1,126 1,185 1,240 1,296 1,346 1,390 1,427 1,464 1,496

DIABETIC1 CT, MA, ME, NH, RI, VT 225 252 274 295 320 337 345 360 369 379 3832 NY 273 293 320 353 385 414 436 456 475 493 5073 NJ 280 317 352 383 410 448 478 492 505 518 5274 DE, PA 299 330 364 391 423 454 476 503 518 541 5495 MD, DC, VA, WV 328 359 394 435 479 508 534 549 573 596 6056 NC, SC, GA 340 381 415 461 493 529 554 579 599 614 6287 FL 289 318 339 369 392 407 424 443 464 472 4778 AL, MS, TN 315 357 395 438 474 505 532 562 585 600 6159 IN, KY, OH 275 306 344 377 405 442 468 496 518 537 55210 IL 255 286 326 366 395 424 459 485 500 525 54111 MI, MN, ND, SD, WI 302 328 350 383 409 434 447 462 480 496 51012 IA, KS, MO, NE 258 282 311 338 364 397 420 441 454 467 47313 AR, LA, OK 319 351 390 431 476 512 537 557 577 595 61114 TX 350 385 416 453 490 526 560 598 622 652 67615 AZ, CO, NV, NM, UT, WY 337 352 376 394 418 439 457 479 493 497 51016 AK, ID, MT, OR, WA 210 234 257 276 298 309 327 337 354 364 37217 N. CA, HI 294 332 357 381 410 434 465 496 520 540 55718 S. CA 289 337 366 397 425 449 472 506 532 559 579

All 293 324 354 387 417 446 469 493 512 530 543

NON-DIABETIC1 CT, MA, ME, NH, RI, VT 643 678 697 718 735 760 775 790 790 800 8122 NY 759 794 819 840 874 913 947 972 981 1,002 1,0203 NJ 771 806 827 845 872 901 943 959 984 1,003 1,0344 DE, PA 763 805 841 888 926 955 987 1,012 1,024 1,046 1,0555 MD, DC, VA, WV 838 884 924 959 999 1,037 1,067 1,092 1,110 1,129 1,1546 NC, SC, GA 885 932 961 980 1,005 1,025 1,042 1,063 1,087 1,100 1,1157 FL 812 840 849 875 886 899 917 931 936 946 9488 AL, MS, TN 880 935 966 1,006 1,037 1,064 1,091 1,112 1,125 1,142 1,1549 IN, KY, OH 662 696 719 751 780 815 846 879 901 921 94910 IL 736 784 820 868 901 939 967 997 1,030 1,062 1,08811 MI, MN, ND, SD, WI 650 688 715 753 779 810 834 854 879 905 93112 IA, KS, MO, NE 646 677 695 721 747 772 806 825 845 866 88513 AR, LA, OK 744 794 834 855 896 922 953 974 989 1,016 1,03614 TX 662 696 713 735 749 774 804 821 839 850 86715 AZ, CO, NV, NM, UT, WY 519 535 543 556 563 584 603 611 624 633 64516 AK, ID, MT, OR, WA 507 540 568 578 587 607 628 642 662 684 70317 N. CA, HI 668 709 729 745 762 790 817 841 866 889 90618 S. CA 642 693 725 755 770 799 822 845 869 904 931

All 708 747 772 799 823 850 877 897 915 935 953

Rates are adjusted by age, race, & gender. The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.

Table B.11 (continued)Point prevalent rates of reported ESRD, by diabetic status & ESRD network, adjustedpatients alive on December 3 of each year, per million population

351


Table B.12Period prevalent counts of reported ESRD: all patientsby demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 108 142 213 274 320 372 426 463 492 506 508 5255-9 285 323 342 378 437 490 549 617 650 712 812 84010-14 704 762 856 926 1,027 1,062 1,077 1,109 1,185 1,235 1,322 1,41415-19 1,861 2,023 2,105 2,187 2,216 2,292 2,439 2,560 2,729 2,828 2,924 2,87820-29 7,490 8,403 9,416 10,245 11,252 12,057 12,793 13,477 14,216 15,010 15,688 16,37730-39 10,165 11,753 13,678 15,459 17,529 19,813 22,156 24,268 26,428 28,679 31,039 33,30940-49 11,193 12,595 13,944 15,703 18,025 20,042 22,084 24,613 27,584 31,194 35,190 39,29050-59 15,319 17,431 19,504 21,423 23,495 25,631 27,524 29,810 32,542 35,492 38,860 42,63360-64 7,575 8,735 10,302 11,839 13,713 15,432 16,807 18,193 20,151 21,989 24,230 26,68965-69 7,114 7,865 8,891 10,476 12,256 13,862 15,580 17,761 20,132 22,683 25,444 28,35470-79 7,404 8,731 10,447 13,046 15,614 18,270 20,816 23,785 26,794 30,577 34,823 40,09580+ 1,103 1,373 1,758 2,426 3,128 3,828 4,708 5,677 6,857 8,295 9,835 11,733Unknown * * 16 24 31 46 43 34 21 22 18 14

0-19 2,958 3,250 3,516 3,765 4,000 4,216 4,491 4,749 5,056 5,281 5,566 5,65720-44 22,954 26,198 29,745 33,268 37,530 41,618 45,737 50,076 54,393 59,193 64,467 69,79745-64 28,788 32,719 37,099 41,401 46,484 51,357 55,627 60,285 66,528 73,171 80,540 88,50165-74 11,953 13,558 15,610 18,741 21,914 25,056 28,063 31,979 35,904 40,474 45,742 51,87575+ 3,668 4,411 5,486 7,207 9,084 10,904 13,041 15,244 17,879 21,081 24,360 28,307Unknown * * 16 24 31 46 43 34 21 22 18 14

Male 38,916 44,343 50,323 57,417 65,393 72,967 80,454 88,455 97,461 107,741 119,145 131,579Female 31,411 35,799 41,147 46,985 53,645 60,221 66,539 73,902 82,309 91,470 101,537 112,559Unknown * * * * * * * * 11 11 11 13

White 49,130 55,756 63,296 71,520 81,019 90,101 99,174 108,951 119,645 131,588 145,000 159,459Black 19,171 22,089 25,533 29,814 34,437 38,932 43,012 47,903 53,628 60,250 67,117 74,867Native American 382 495 655 856 1,048 1,224 1,441 1,662 1,943 2,208 2,510 2,801Asian 439 592 934 1,237 1,628 2,074 2,511 3,008 3,627 4,300 5,219 6,144Other/unknown 1,206 1,212 1,054 979 911 866 864 843 938 876 847 880



All 70,328 80,144 91,472 104,406 119,043 133,197 147,002 162,367 179,781 199,222 220,693 244,151

Patients alive on ESRD therapy and not lost to followup at any time during each year.The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed.

Table B.12Period prevalent counts of reported ESRD: all patientsby demographic characteristics & primary diagnosis


352

Reference section BPREVALENCE OF REPORTED ESRDB Reference section B

Table B.12 (continued)Period prevalent counts of reported ESRD: all patientsby demographic characteristics & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 533 581 570 586 606 622 589 612 647 697 679 7045-9 868 881 939 952 968 975 1,051 1,053 1,073 1,055 1,120 1,10510-14 1,469 1,537 1,613 1,738 1,807 1,872 1,856 1,983 2,022 2,111 2,171 2,26415-19 2,963 3,024 3,127 3,294 3,458 3,498 3,615 3,747 3,844 3,894 3,978 4,11020-29 16,998 17,543 17,900 18,085 18,339 18,675 19,037 19,276 19,427 19,529 19,451 19,37630-39 35,787 37,914 40,157 41,919 43,230 44,238 45,069 46,074 46,797 47,476 47,944 48,27540-49 43,970 48,258 52,723 57,387 62,400 66,285 70,147 73,953 77,255 80,334 83,097 85,63650-59 47,132 51,923 57,315 62,189 66,743 72,706 79,657 87,063 93,904 100,822 107,617 113,90060-64 28,840 31,002 33,228 35,540 38,003 40,570 43,301 46,118 48,640 51,221 53,834 57,54065-69 31,324 34,200 37,115 39,399 41,976 44,623 46,664 48,554 50,666 52,674 54,930 56,99370-79 46,292 51,489 56,862 62,351 68,475 74,686 80,688 86,112 90,251 93,956 97,385 100,29580+ 13,861 16,010 18,361 20,622 23,419 26,580 29,578 32,957 36,053 39,451 43,579 46,676Unknown 11 * * * * * * * * * * *

0-19 5,833 6,023 6,249 6,570 6,839 6,967 7,111 7,395 7,586 7,757 7,948 8,18320-44 74,977 79,391 83,713 87,401 90,963 93,686 96,689 99,384 101,647 103,285 104,634 105,60045-64 97,750 107,249 117,610 127,719 137,752 148,788 160,522 173,100 184,376 196,097 207,309 219,12765-74 58,595 64,591 70,749 76,017 81,615 87,011 91,804 95,880 99,730 103,545 107,385 110,56875+ 32,882 37,108 41,589 46,355 52,255 58,878 65,126 71,743 77,240 82,536 88,509 93,396Unknown 11 * * * * * * * * * * *

Male 145,185 158,230 171,908 184,686 198,728 212,932 227,532 242,401 255,717 269,022 282,583 295,199Female 124,850 136,122 147,999 159,368 170,684 182,387 193,709 205,089 214,849 224,185 233,187 241,632Unknown 13 17 13 17 14 14 14 14 14 14 16 44

White 175,193 189,247 203,889 217,266 231,902 247,444 262,478 278,401 292,863 306,765 320,627 332,738Black 83,440 91,991 100,827 109,083 117,230 125,360 134,075 142,083 148,484 155,121 161,604 167,981Native American 3,210 3,551 3,930 4,304 4,679 5,000 5,387 5,836 6,191 6,438 6,725 6,893Asian 7,216 8,474 9,866 11,170 12,449 13,613 14,930 16,339 17,527 18,937 20,314 21,601Other/unknown 989 1,106 1,408 2,248 3,166 3,916 4,385 4,845 5,515 5,960 6,516 7,662



All 270,048 294,369 319,920 344,071 369,426 395,333 421,255 447,504 470,580 493,221 515,786 536,875

Patients alive on ESRD therapy and not lost to followup at any time during each year.The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. Age is calculated as of December 31.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed.

Table B.12 (continued)Period prevalent counts of reported ESRD: all patientsby demographic characteristics & primary diagnosis

Patientcharacteristics

CReferenceSec

tion

PATIENT CHARACTERISTICSC

354

Reference section C

C.1 . 355 Counts of new ESRD patients with Medical Evidence formsby demographic characteristics & primary diagnosis

C.2 . 356 Mean lab valuesby demographic characteristics & diabetic status; incident patients with completed Medical Evidence forms, May 995-June 2004 combined

C.3 . 357 Mean serum albumin (g/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

C.4 . 358 Mean blood urea nitrogen (mg/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms, by demographic characteristics

C.5 . 359 Mean creatinine (mg/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

C.6 . 360 Mean hematocrit (%): by demographic characteristics & diabetic status incident patients with completed Medical Evidence forms

C.7 . 361 Mean hemoglobin (g/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

C.8 . 632 Mean height (cm): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

C.9 . 363 Mean weight (kg): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

C.10 . 364Mean body mass index (kg/m2): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

C.11 . 365 Mean eGFR (ml/min 1.73m2): by MDRD formula, demographic characteristics, & diabetic statusincident patients with completed Medical Evidence forms

C.12 . 366 Counts of new ESRD patients, with or without a Medical Evidence form: by raceincident patients with completed Medical Evidence forms

C.13 . 366 Percent distribution of patients, by race & Hispanic ethnicity: column percentincident patients with completed Medical Evidence forms

C.14 . 367 Percent distribution of diabetic patients, by race & Hispanic ethnicityincident patients with completed Medical Evidence forms

C.15 . 367 Percent distribution of patients, by employment statusincident patients with completed Medical Evidence forms

C.16 . 368 Insurance coverage in the incident populationincident patients with completed Medical Evidence forms; percent with coverage in each year

C.17 . 368Incident patient comorbidityincident patients with completed Medical Evidence forms; percent with comorbidity in each year

355

2005 Annual Data ReportCPATIENT CHARACTERISTICS

Table C.1Counts of new ESRD patients with Medical Evidence formsby demographic characteristics & primary diagnosis

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^ All0-4 95 173 175 170 180 192 199 174 200 90 1,6485-9 89 128 117 124 140 141 136 159 135 53 1,22210-14 154 244 257 253 265 281 286 325 310 131 2,50615-19 352 526 482 504 561 533 547 558 584 255 4,90220-29 1,619 2,560 2,516 2,607 2,512 2,583 2,615 2,507 2,465 1,074 23,05830-39 3,543 5,498 5,434 5,568 5,674 5,572 5,572 5,661 5,553 2,473 50,54840-49 5,643 9,115 9,235 10,082 10,259 10,576 10,709 11,106 11,352 5,009 93,08650-59 7,551 12,065 13,124 14,538 15,577 16,296 17,269 17,855 18,648 8,269 141,19260-64 5,085 8,079 8,521 9,240 9,394 9,757 10,207 10,435 11,017 4,816 86,55165-69 5,929 9,667 10,276 10,730 10,780 11,065 11,436 11,650 11,904 5,109 98,54670-79 10,537 17,958 19,576 21,116 22,258 23,064 23,585 24,589 24,326 10,346 197,35580+ 3,840 6,735 7,906 8,949 9,979 10,858 11,516 13,164 13,515 5,972 92,434Unknown * . * . * . * . . . *

0-19 690 1,071 1,031 1,051 1,146 1,147 1,168 1,216 1,229 529 10,27820-44 7,711 12,133 12,004 12,603 12,600 12,723 12,762 12,806 12,768 5,615 113,72545-64 15,730 25,184 26,826 29,432 30,816 32,061 33,610 34,758 36,267 16,026 280,71065-74 11,852 19,718 20,986 22,003 22,308 23,027 23,702 24,173 24,044 10,386 202,19975+ 8,454 14,642 16,772 18,792 20,709 21,960 22,835 25,230 25,701 11,041 186,136Unknown * . * . * . * . . . *

Male 23,321 38,785 41,329 44,615 46,805 48,602 50,583 53,309 54,123 24,092 425,564Female 21,118 33,963 36,291 39,266 40,775 42,313 43,495 44,874 45,886 19,505 367,486Unknown . . . . . * . . . . *

White 27,151 44,793 48,208 52,108 55,032 56,563 60,026 62,752 63,491 27,919 498,043Black 13,363 21,309 22,743 24,677 25,001 25,266 26,595 27,760 28,352 12,186 227,252Native American/Alaskan Native 680 1,219 896 1,110 1,373 2,058 1,091 1,071 1,059 453 11,010Asian 1,024 1,774 1,726 2,170 2,272 2,348 2,242 2,346 2,404 1,043 19,349Pacific Islander 380 681 683 788 725 784 860 924 968 430 7,223Middle-eastern/Arabian 176 172 228 274 291 372 338 388 359 161 2,759Indian Subcontinent 120 184 203 235 254 292 329 295 392 168 2,472Other/multiracial 1,245 2,215 2,592 2,239 2,309 2,751 2,342 2,366 2,769 1,135 21,963Unknown 300 401 341 280 323 484 255 281 215 102 2,982

Hispanic-Mexican 3,271 5,315 5,305 5,643 6,326 7,952 6,841 7,464 7,895 3,499 59,511Hispanic-other 1,939 3,153 3,487 3,765 4,024 4,200 4,629 4,926 5,228 2,252 37,603Non-Hispanic 38,599 63,585 68,179 73,724 76,687 78,447 82,450 85,581 86,658 37,733 691,643Unknown 630 695 649 749 543 319 158 212 228 113 4,296

Diabetes 18,855 31,547 34,137 37,186 38,968 41,102 42,601 43,942 44,810 19,797 352,945Hypertension 11,457 19,022 20,689 22,246 23,461 24,101 25,250 26,782 27,922 11,983 212,913Glomerulonephritis 5,062 7,901 7,915 8,202 8,199 8,018 7,942 8,166 7,877 3,461 72,743Cystic kidney 1,199 1,783 1,888 2,081 2,122 2,126 2,202 2,212 2,271 966 18,850Other urologic 863 1,483 1,411 1,523 1,612 1,597 1,589 1,674 1,594 659 14,005Other cause 5,257 8,081 8,501 9,238 9,775 10,215 10,621 11,486 11,606 5,118 89,898Unknown cause 1,661 2,836 2,977 3,333 3,370 3,721 3,868 3,921 3,928 1,613 31,228Missing 85 95 102 72 73 38 * . * . 471

All 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597 793,053

The age of the incident patient is determined as of the date of ESRD initiation. Data are based on first & new Medical Evidence forms filed between May 1995 & June 2004.^Incomplete data.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table C.1Counts of new ESRD patients with Medical Evidence formsby demographic characteristics & primary diagnosis


356

Reference section C

Table C.2Mean lab valuesby demographic characteristics & diabetic status; incident patients with completed Medical Evidence forms, May 1995-June 2004 combined

Serum Body mass eGFR (ml/min 1.73m2)albumin BUN Creat. Hct Hgb Height Weight index by MDRD

Patients (g/dl) (mg/dl) (mg/dl) % (g/dl) (cm) (kg) (kg/m2) formula0-4 1,648 3.1 72.7 4.9 29.3 9.9 98.7 20.4 19.2 10.95-9 1,222 3.3 88.0 7.0 28.1 9.5 117.5 25.2 18.0 10.810-14 2,506 3.4 89.0 9.0 28.0 9.5 146.0 43.9 20.6 11.315-19 4,902 3.3 91.6 10.8 27.4 9.3 164.5 63.9 23.9 9.720-29 23,058 3.2 90.8 11.0 27.2 9.2 168.0 71.4 25.9 7.330-39 50,548 3.1 88.1 10.1 28.1 9.4 169.2 75.0 26.8 7.640-49 93,086 3.1 88.5 9.1 28.6 9.6 169.5 78.4 27.8 7.950-59 141,192 3.1 88.4 8.0 29.1 9.7 168.5 79.3 28.5 8.560-64 86,551 3.1 88.4 7.4 29.2 9.7 167.4 76.6 27.9 8.965-69 98,546 3.2 88.3 7.0 29.5 9.8 166.9 73.8 27.1 9.170-79 197,355 3.2 88.4 6.6 29.8 9.9 166.3 69.8 25.8 9.680+ 92,434 3.2 88.3 6.1 30.1 10.0 164.9 64.4 24.1 10.1Unknown * 3.1 78.2 6.8 28.9 9.5 170.8 65.4 25.6 9.1

0-19 10,278 3.3 87.7 8.9 27.9 9.5 146.0 47.5 21.8 10.420-44 113,725 3.1 88.8 10.0 28.1 9.4 169.1 75.2 26.9 7.645-64 280,710 3.1 88.4 8.0 29.1 9.7 168.3 78.4 28.2 8.565-74 202,199 3.2 88.3 6.9 29.6 9.9 166.7 72.4 26.6 9.375+ 186,136 3.2 88.4 6.3 30.0 10.0 165.5 66.4 24.7 9.9Unknown * 3.1 78.2 6.8 28.9 9.5 170.8 65.4 25.6 9.1

Male 425,564 3.2 92.4 8.2 29.4 9.8 173.2 77.0 26.2 9.3Female 367,486 3.1 83.8 6.9 29.1 9.7 160.1 68.8 27.3 8.5Unknown * 2.5 59.7 4.5 29.3 9.6 180.2 79.2 24.6 15.4

White 498,043 3.2 89.1 7.0 29.8 10.0 167.4 73.0 26.6 9.2Black 227,252 3.1 86.7 8.8 28.3 9.4 167.9 75.7 27.4 8.6Native American/Alaskan Native 11,010 2.9 84.6 7.7 28.8 9.6 165.9 74.0 27.4 8.3Asian 19,349 3.2 90.3 8.1 29.1 9.8 160.0 58.8 23.4 7.9Pacific Islander 7,223 3.0 94.2 8.6 29.1 9.7 161.8 66.4 25.7 7.4Middle-eastern/Arabian 2,759 3.3 90.4 7.8 29.7 9.8 163.9 68.8 25.8 8.7Indian Subcontinent 2,472 3.2 85.1 7.7 29.3 9.8 163.3 63.3 24.1 8.7Other/multiracial 21,963 3.1 89.6 8.3 28.5 9.5 162.2 68.0 26.1 7.9Unknown 2,982 3.1 92.1 8.1 28.5 9.6 163.8 69.6 26.1 8.2

Hispanic-Mexican 59,511 3.1 86.6 7.6 28.8 9.6 162.3 67.6 26.5 8.7Hispanic-Other 37,603 3.1 88.7 8.0 28.9 9.6 163.0 69.0 26.2 8.2Non-Hispanic 691,643 3.2 88.5 7.6 29.3 9.8 167.8 73.9 26.8 9.0Unknown 4,296 3.1 99.1 8.7 28.8 9.6 164.3 67.7 25.6 7.5

Diabetic 352,945 3.1 86.9 6.8 29.4 9.8 166.7 76.7 28.1 9.6Non-diabetic 440,108 3.2 89.7 8.3 29.2 9.8 167.4 70.4 25.6 8.4

All 793,053 3.2 88.5 7.6 29.3 9.8 167.1 73.2 26.7 8.9

Completed forms 793,053 590,791 732,542 789,314 731,512 696,743 781,193 790,431 746,908 783,455

Data are based on first & new Medical Evidence forms filed between May 1995 & June 2004.The age of the incident patient is determined as of the date of ESRD initiation. *Values for cells with 10 or fewer patients are suppressed.

Table C.2Mean lab valuesby demographic characteristics & diabetic status; incident patients with completed Medical Evidence forms, May 995-June 2004 combined

357


Table C.3Mean serum albumin (g/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^0-4 3.2 3.1 3.2 3.1 3.1 3.0 3.2 3.2 3.2 3.25-9 3.6 3.3 3.3 3.2 3.4 3.1 3.2 3.2 3.3 3.310-14 3.6 3.5 3.4 3.5 3.4 3.4 3.3 3.2 3.3 3.215-19 3.4 3.4 3.3 3.3 3.2 3.3 3.3 3.3 3.3 3.220-29 3.3 3.3 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.130-39 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.140-49 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.150-59 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.160-64 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.165-69 3.3 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.170-79 3.3 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.2 3.180+ 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.2 3.1

0-19 3.4 3.4 3.3 3.3 3.3 3.2 3.2 3.2 3.3 3.220-44 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.145-64 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.165-74 3.3 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.2 3.175+ 3.3 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.2 3.1Unknown 3.6 . 1.8 . 3.5 . . . . .

Male 3.3 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.1Female 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.1Unknown . . . . . 2.5 . . . .

White 3.3 3.2 3.2 3.2 3.2 3.2 3.2 3.1 3.2 3.1Black 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.0Native American/Alaskan Native 3.1 3.1 3.0 3.0 2.9 3.0 2.8 2.9 2.9 2.8Asian 3.3 3.2 3.2 3.2 3.2 3.1 3.1 3.2 3.2 3.2Pacific Islander 3.0 3.1 3.1 3.1 3.0 3.0 3.0 3.1 3.1 3.1Middle-eastern/Arabian 3.3 3.4 3.5 3.3 3.2 3.3 3.3 3.3 3.2 3.2Indian Subcontinent 3.4 3.3 3.2 3.3 3.1 3.2 3.2 3.2 3.2 3.3Other/multiracial 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.0Unknown 3.2 3.1 3.1 3.1 3.1 3.0 3.2 3.1 3.1 3.0

Hispanic-Mexican 3.1 3.1 3.1 3.1 3.0 3.0 3.0 3.0 3.1 3.0Hispanic-Other 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1Non-Hispanic 3.3 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1Unknown 3.1 3.0 3.0 3.1 3.1 3.2 3.1 3.2 3.2 3.1

Diabetic 3.1 3.1 3.1 3.1 3.1 3.0 3.0 3.0 3.1 3.0Non-diabetic 3.3 3.3 3.3 3.3 3.2 3.2 3.2 3.2 3.2 3.2

All 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1

Completed forms 35,397 57,494 60,074 61,311 63,227 66,912 68,808 72,149 73,507 31,912

Data are based on first & new Medical Evidence forms filed between May 1995 & June 2004.The age of the incident patient is determined as of the date of ESRD initiation. ^Incomplete data."." Zero values in this cell.

Table C.3Mean serum albumin (g/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms


358

Reference section C

Table C.4Mean blood urea nitrogen (mg/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^0-4 . . . 31.0 10.6 10.5 12.5 . 23.0 .5-9 . . . . . 50.7 86.0 10.0 55.1 59.010-14 43.7 15.1 39.0 10.0 60.0 72.9 47.7 . . 12.015-19 48.3 22.8 54.3 46.4 83.0 . 46.6 37.8 33.2 52.620-29 31.3 39.7 35.6 46.1 44.9 45.1 40.8 51.4 37.0 21.230-39 36.0 38.0 37.6 39.4 35.4 31.0 44.4 41.5 39.9 44.940-49 39.3 37.7 40.1 34.7 39.0 43.1 37.2 37.4 37.8 40.550-59 35.8 36.0 42.9 39.1 36.4 40.5 39.2 35.7 41.9 45.060-64 37.6 35.6 37.5 39.5 46.3 42.6 36.0 43.9 36.8 34.565-69 34.1 41.8 36.6 39.3 32.5 36.7 37.0 40.5 38.4 37.070-79 33.8 36.0 38.3 41.0 40.6 40.6 36.4 39.3 40.0 38.280+ 39.2 40.4 36.7 46.7 42.3 42.5 38.5 42.2 43.2 36.7

0-19 45.5 19.0 51.2 36.0 51.2 44.7 47.5 30.8 38.0 44.020-44 35.4 42.2 37.5 41.2 39.3 38.7 40.2 41.7 36.4 42.145-64 36.9 34.8 40.9 37.7 40.3 41.6 37.9 38.5 40.0 40.065-74 34.8 38.1 36.2 37.9 37.3 38.9 35.8 40.5 39.8 35.475+ 35.3 39.1 39.0 46.6 40.3 41.2 38.4 40.0 40.9 39.9Unknown . . . . . . . . . .

Male 35.9 36.2 38.8 37.1 37.2 41.2 39.1 38.8 38.9 38.3Female 35.9 38.9 39.3 43.2 42.0 39.6 36.8 40.9 40.8 39.7Unknown . . . . . . . . . .

White 36.3 35.4 36.5 37.7 38.9 37.7 36.2 36.8 39.1 35.8Black 35.0 41.1 43.0 43.0 39.7 43.0 40.7 44.4 40.5 43.4Native American/Alaskan Native 66.3 35.4 44.5 40.8 32.1 40.9 55.8 34.8 37.9 .Asian 30.5 30.3 35.5 46.3 26.8 45.6 40.0 35.8 36.6 .Pacific Islander 25.0 . 32.2 75.6 52.6 65.2 45.7 68.9 42.0 58.5Middle-eastern/Arabian 42.5 11.0 . 75.9 40.0 38.5 31.0 42.0 38.2 67.5Indian Subcontinent . 13.5 49.5 . 10.4 10.0 44.3 11.0 53.8 .Other/multiracial 32.9 46.8 39.6 45.6 48.8 61.6 39.0 51.1 49.5 13.0Unknown 53.5 36.0 74.0 53.7 . 40.0 . 72.7 . .



All 35.9 37.5 39.0 40.0 39.4 40.4 37.9 39.8 39.8 38.9

Completed forms 369 415 453 580 668 676 651 627 742 331


Table C.4Mean blood urea nitrogen (mg/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

359


Table C.5Mean creatinine (mg/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^0-4 5.3 5.0 5.2 5.1 5.2 4.5 4.9 4.7 4.6 4.95-9 7.1 7.1 7.4 7.1 6.9 7.0 7.3 6.3 6.7 6.810-14 9.3 9.7 9.4 9.0 9.0 9.0 8.6 8.6 8.7 8.615-19 12.1 11.7 11.3 11.4 10.3 10.7 10.2 10.5 10.2 9.920-29 12.1 11.8 11.4 11.5 11.0 10.8 10.7 10.6 10.3 10.030-39 10.9 10.8 10.5 10.3 10.1 9.9 9.7 9.6 9.5 9.340-49 10.1 10.0 9.7 9.4 9.1 9.0 8.8 8.6 8.5 8.450-59 9.0 8.8 8.5 8.3 8.1 7.9 7.8 7.6 7.5 7.460-64 8.3 8.2 7.9 7.7 7.4 7.2 7.1 7.0 6.9 6.765-69 7.9 7.8 7.5 7.3 7.0 6.8 6.7 6.6 6.5 6.470-79 7.5 7.4 7.1 6.9 6.6 6.4 6.3 6.2 6.0 5.980+ 7.1 7.0 6.7 6.4 6.2 6.0 5.8 5.7 5.6 5.5

0-19 9.9 9.6 9.3 9.3 8.8 8.8 8.6 8.6 8.5 8.420-44 11.0 10.8 10.5 10.4 10.1 9.8 9.7 9.5 9.4 9.245-64 8.9 8.8 8.5 8.3 8.1 7.8 7.7 7.6 7.5 7.365-74 7.8 7.6 7.3 7.1 6.9 6.7 6.6 6.4 6.3 6.275+ 7.3 7.2 6.8 6.6 6.4 6.2 6.0 5.8 5.7 5.6Unknown 7.3 . 5.8 . 9.6 . 4.1 . . .





All 8.7 8.5 8.2 7.9 7.7 7.4 7.3 7.1 7.0 6.9

Completed forms 44,218 72,390 77,250 83,472 87,151 90,427 93,596 97,730 99,594 43,486


Table C.5Mean creatinine (mg/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms


360

Reference section C

Table C.6Mean hematocrit (%): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^0-4 28.6 28.3 28.5 28.2 28.9 29.3 29.7 30.1 30.8 30.05-9 26.7 26.9 27.4 27.6 28.5 28.5 28.3 28.5 29.3 28.410-14 26.6 26.8 27.2 27.0 28.1 28.7 28.5 28.9 28.7 28.815-19 26.5 25.6 26.6 26.9 27.4 27.6 28.1 28.0 28.3 29.420-29 25.9 26.1 26.7 26.8 27.2 27.5 27.8 27.9 28.0 28.030-39 26.9 27.0 27.3 27.6 27.9 28.4 28.7 28.7 29.1 29.240-49 27.4 27.5 27.8 28.1 28.5 28.8 29.1 29.3 29.6 29.750-59 27.6 27.7 28.2 28.5 28.9 29.2 29.5 29.8 30.0 30.060-64 27.8 28.1 28.4 28.6 29.2 29.4 29.5 29.9 30.2 30.565-69 28.2 28.3 28.8 28.9 29.4 29.7 30.0 30.2 30.5 30.770-79 28.4 28.7 29.0 29.3 29.8 30.0 30.2 30.5 30.8 30.980+ 28.6 28.7 29.1 29.4 29.9 30.2 30.5 30.7 31.0 31.2

0-19 26.9 26.5 27.2 27.2 27.9 28.2 28.5 28.6 28.9 29.320-44 26.8 26.9 27.3 27.6 28.0 28.3 28.6 28.7 29.0 29.145-64 27.6 27.8 28.2 28.5 29.0 29.2 29.5 29.7 30.0 30.165-74 28.2 28.4 28.9 29.1 29.6 29.8 30.0 30.3 30.6 30.875+ 28.6 28.8 29.1 29.4 29.9 30.1 30.4 30.7 30.9 31.1Unknown 30.6 . 21.1 . 29.4 . 33.0 . . .





All 27.8 28.0 28.4 28.7 29.2 29.5 29.7 30.0 30.2 30.4

Completed forms 40,002 65,779 70,115 75,843 80,814 84,723 87,496 91,870 93,763 41,107


Table C.6Mean hematocrit (%): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

361


Table C.7Mean hemoglobin (g/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^0-4 9.6 9.8 9.7 9.6 9.8 9.9 10.1 10.3 10.3 10.05-9 9.3 8.9 9.2 9.5 9.6 9.7 9.5 9.7 10.0 9.510-14 9.1 9.2 9.2 9.3 9.5 9.8 9.7 9.8 9.7 9.715-19 9.1 8.7 9.0 9.1 9.3 9.3 9.5 9.5 9.6 9.920-29 8.8 8.9 9.0 9.0 9.2 9.3 9.4 9.4 9.5 9.530-39 9.1 9.1 9.2 9.3 9.4 9.6 9.6 9.7 9.7 9.840-49 9.2 9.2 9.3 9.4 9.5 9.6 9.7 9.8 9.9 9.950-59 9.3 9.3 9.4 9.5 9.6 9.7 9.8 9.9 10.0 10.060-64 9.3 9.4 9.4 9.5 9.7 9.8 9.8 10.0 10.0 10.165-69 9.4 9.5 9.6 9.6 9.8 9.9 10.0 10.0 10.1 10.170-79 9.5 9.6 9.7 9.7 9.9 10.0 10.0 10.1 10.2 10.280+ 9.6 9.6 9.7 9.8 9.9 10.0 10.1 10.2 10.3 10.3

0-19 9.2 9.0 9.2 9.3 9.5 9.6 9.7 9.7 9.8 9.820-44 9.1 9.1 9.2 9.2 9.4 9.5 9.6 9.7 9.7 9.745-64 9.3 9.3 9.4 9.5 9.6 9.7 9.8 9.9 10.0 10.065-74 9.5 9.5 9.6 9.7 9.8 9.9 10.0 10.1 10.1 10.275+ 9.6 9.6 9.7 9.8 9.9 10.0 10.1 10.2 10.2 10.3Unknown 9.9 . 7.1 . 9.9 . 10.9 . . .





All 9.3 9.4 9.5 9.6 9.7 9.8 9.9 10.0 10.0 10.1

Completed forms 36,422 60,456 65,200 70,961 76,091 80,947 84,513 89,455 92,088 40,610


Table C.7Mean hemoglobin (g/dl): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms


362

Reference section C

Table C.8Mean height (cm): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^0-4 92.3 93.5 104.3 99.1 104.8 96.1 96.8 95.9 100.5 102.25-9 113.5 116.3 118.3 119.0 118.2 117.9 117.1 117.5 117.3 121.110-14 145.0 146.3 145.3 145.7 147.2 144.7 146.4 144.9 146.6 149.615-19 164.7 165.3 164.3 164.6 164.2 163.1 165.1 163.5 165.3 165.820-29 167.6 168.1 167.7 167.9 167.8 167.7 168.6 168.1 167.8 168.530-39 169.5 169.2 169.1 169.1 168.9 168.6 169.1 169.5 169.7 170.040-49 169.6 169.3 169.6 169.5 169.0 169.1 169.5 169.7 169.8 170.050-59 168.0 168.3 168.3 168.3 168.1 168.0 168.6 168.7 169.0 169.360-64 167.1 167.2 167.4 167.0 167.0 167.0 167.6 167.9 167.9 168.365-69 166.5 167.0 166.9 166.7 166.6 166.7 167.0 167.1 167.4 167.770-79 165.8 166.2 166.4 166.2 166.0 165.9 166.4 166.6 166.9 167.180+ 164.0 164.5 164.4 164.6 164.6 164.7 165.1 165.2 165.5 165.8

0-19 146.2 145.9 146.1 146.8 147.1 143.9 145.3 145.1 146.9 148.120-44 169.2 169.2 169.1 169.0 168.7 168.6 169.1 169.4 169.4 169.645-64 168.0 168.1 168.2 168.1 167.9 167.9 168.5 168.6 168.8 169.165-74 166.3 166.7 166.7 166.5 166.4 166.4 166.8 166.9 167.3 167.675+ 164.8 165.3 165.4 165.3 165.2 165.3 165.6 165.8 166.0 166.2Unknown 178.0 . 170.0 . 168.0 . 160.0 . . .





All 166.8 167.0 167.0 166.9 166.7 166.7 167.2 167.3 167.5 167.8

Completed forms 43,035 70,426 75,178 81,299 85,727 90,475 93,793 97,965 99,786 43,509


Table C.8Mean height (cm): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

363


Table C.9Mean weight (kg): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^0-4 19.3 19.0 17.2 20.6 23.8 20.7 20.0 19.1 22.1 22.05-9 23.9 25.5 24.4 25.3 26.0 27.0 24.2 24.9 25.1 25.710-14 41.6 40.3 40.3 42.8 44.1 44.2 46.7 44.6 46.2 48.515-19 58.5 60.6 61.6 62.9 62.6 65.3 66.9 65.4 67.5 66.320-29 65.5 66.6 67.2 68.5 70.9 74.5 74.9 75.0 75.1 76.530-39 67.0 68.9 69.4 70.5 74.6 77.9 79.5 80.1 80.9 81.440-49 71.6 72.5 73.1 74.4 76.9 81.4 82.0 82.6 83.2 83.550-59 71.3 72.8 73.5 74.8 77.8 82.0 82.8 83.7 83.8 84.660-64 68.8 70.1 71.0 72.3 75.5 79.1 80.5 81.0 81.4 82.265-69 66.4 67.7 68.5 69.8 72.5 76.8 77.4 78.1 79.2 79.170-79 63.2 64.1 64.7 66.0 68.6 71.9 72.9 73.5 74.3 74.780+ 57.8 59.0 59.9 60.7 63.0 65.9 66.4 67.2 67.9 68.3

0-19 44.8 45.1 44.5 46.8 47.8 47.9 49.0 47.9 50.1 50.320-44 68.0 69.4 69.9 71.3 74.3 78.1 79.3 79.8 80.6 80.745-64 70.7 72.0 72.7 74.0 77.1 81.1 82.0 82.8 83.0 83.965-74 65.3 66.5 67.1 68.5 71.2 75.1 75.8 76.6 77.5 77.775+ 59.9 60.9 61.8 62.7 65.1 68.0 68.9 69.4 70.1 70.4Unknown 57.4 . 87.0 . 71.0 . 54.0 . . .





All 66.3 67.4 68.0 69.3 72.0 75.6 76.5 77.0 77.7 78.2

Completed forms 44,352 72,610 77,464 83,690 87,247 90,190 93,784 97,926 99,710 43,458


Table C.9Mean weight (kg): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms


364

Reference section C

Table C.10Mean body mass index (kg/m2): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^0-4 17.7 18.7 18.9 18.2 19.8 19.2 18.8 19.7 20.1 19.75-9 17.6 17.7 17.4 19.2 18.5 18.8 17.8 17.9 17.6 17.610-14 20.0 19.3 19.9 20.2 20.5 20.6 21.4 21.0 21.1 21.315-19 22.5 23.0 24.1 23.9 23.9 24.1 24.3 24.3 24.5 23.820-29 24.7 25.0 25.2 25.5 25.8 26.3 26.3 26.4 26.5 26.830-39 24.9 25.5 25.6 26.0 26.9 27.3 27.6 27.8 28.0 28.240-49 26.2 26.6 26.8 27.1 27.5 28.3 28.4 28.7 28.9 28.950-59 26.8 27.0 27.2 27.6 28.2 28.9 29.0 29.4 29.4 29.660-64 26.0 26.4 26.7 27.1 27.8 28.2 28.6 28.8 28.9 29.165-69 25.4 25.6 25.8 26.3 26.8 27.6 27.7 27.9 28.3 28.270-79 24.4 24.5 24.7 25.1 25.5 26.0 26.2 26.5 26.7 26.880+ 22.9 23.1 23.4 23.6 23.9 24.2 24.3 24.7 24.8 24.9

0-19 20.8 21.0 21.6 21.9 21.9 21.9 22.1 22.1 22.3 22.020-44 25.2 25.6 25.9 26.2 26.8 27.4 27.5 27.7 28.0 28.045-64 26.5 26.8 27.0 27.3 28.0 28.6 28.8 29.1 29.2 29.365-74 25.1 25.2 25.4 25.9 26.4 27.1 27.2 27.5 27.7 27.775+ 23.5 23.6 23.9 24.2 24.5 24.8 25.1 25.3 25.5 25.5Unknown 25.9 . 30.1 . 25.2 . 21.1 . . .





All 25.2 25.4 25.6 26.0 26.5 27.1 27.2 27.5 27.6 27.7

Completed forms 38,445 63,555 68,052 74,492 81,171 88,718 92,770 97,254 99,187 43,264


Table C.10Mean body mass index (kg/m2): by demographic characteristics & diabetic statusincident patients with completed Medical Evidence forms

365


Table C.11Mean eGFR (ml/min/1.73 m2): by MDRD formula, demographic characteristics, & diabetic status incident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^0-4 9.9 9.9 10.2 10.2 10.5 11.2 11.2 10.7 12.3 11.75-9 10.6 10.9 10.2 10.5 10.5 10.9 10.2 11.7 11.4 11.310-14 10.7 10.4 10.7 10.9 11.2 11.3 11.6 11.9 12.0 12.115-19 8.7 9.1 9.1 9.0 9.9 9.7 10.4 10.0 10.6 10.720-29 6.5 6.6 6.9 6.9 7.3 7.5 7.6 7.8 8.0 8.230-39 6.7 6.8 7.1 7.3 7.5 7.7 7.9 8.1 8.2 8.440-49 6.9 7.0 7.3 7.6 7.8 8.0 8.3 8.6 8.6 8.850-59 7.2 7.4 7.8 8.1 8.3 8.7 8.8 9.2 9.3 9.560-64 7.5 7.7 8.1 8.4 8.8 9.0 9.3 9.5 9.7 9.965-69 7.7 7.9 8.4 8.7 9.0 9.4 9.6 9.9 10.0 10.370-79 8.0 8.2 8.6 9.0 9.4 9.8 10.1 10.4 10.6 10.880+ 8.2 8.5 8.9 9.4 9.8 10.2 10.6 10.9 11.1 11.3

0-19 9.5 9.7 9.8 9.8 10.4 10.5 10.8 10.9 11.2 11.320-44 6.7 6.8 7.1 7.3 7.5 7.7 7.9 8.1 8.3 8.445-64 7.3 7.5 7.8 8.1 8.4 8.7 8.9 9.2 9.3 9.565-74 7.8 8.0 8.5 8.8 9.2 9.6 9.8 10.1 10.2 10.475+ 8.1 8.4 8.8 9.3 9.7 10.1 10.4 10.7 10.9 11.2Unknown 8.1 . 13.2 . 5.1 . 11.0 . . .





All 7.5 7.7 8.1 8.5 8.8 9.1 9.4 9.7 9.8 10.0

Completed forms 44,034 72,123 76,887 82,997 86,590 89,727 92,767 96,806 98,520 43,004


ON OUR WEBSITE & CDMean eGFR by MDRD formula, demographic characteristics, & diabetic status (C.a). Counts of new ESRD patients, with or without a Medical Evidence form: by data source (C.b).

Table C.11Mean eGFR (ml/min/1.73 m2): by MDRD formula, demographic characteristics, & diabetic status incident patients with completed Medical Evidence forms


366

Reference section C

Table C.12Counts of new ESRD patients, with or without a Medical Evidence form: by raceincident patients with completed Medical Evidence forms

Nat. Am/ Pacific Mid-East/ Indian Sub- Other/ No CMS-White Black Alas. Native Asian Islander Arabian continent Multiracial Unknown 2728 All

1960-1972 828 211 18 14 * . . * 135 1,242 2,4551973 517 171 * * * . . * 2,739 437 3,8801974 653 206 13 14 * . * . 3,345 401 4,6351975 767 266 11 * * . * * 4,210 426 5,7031976 880 305 15 14 * . . * 4,823 516 6,5621977 1,666 590 30 28 * * . * 6,409 12,187 20,9301978 1,744 646 43 37 13 . . * 6,365 5,873 14,7221979 2,178 803 49 38 21 . . * 6,835 6,586 16,5201980 2,818 1,045 94 54 19 * * * 7,575 6,423 18,0371981 6,209 2,494 162 129 24 . . * 7,444 3,668 20,1361982 14,017 5,587 213 314 27 * . 13 609 1,829 22,6121983 15,111 6,467 280 329 159 * * * 443 3,166 25,9651984 16,840 7,176 294 385 317 . * 16 475 2,096 27,6001985 18,761 7,977 303 505 294 * * 13 596 2,185 30,6391986 20,200 8,364 385 523 383 * * 17 970 2,642 33,4871987 22,073 9,349 448 573 483 * * 15 1,245 2,776 36,9691988 23,940 10,244 520 698 329 * * 33 1,756 3,789 41,3141989 27,718 12,094 596 844 * * * 42 1,856 3,335 46,5001990 30,404 12,835 641 1,066 * * * 50 1,830 4,128 50,9721991 33,852 14,703 711 1,161 * * * 61 2,049 3,653 56,2071992 36,800 16,354 866 1,327 * * * 83 2,247 3,642 61,3421993 36,540 16,341 765 1,464 12 15 11 91 2,794 6,475 64,5081994 41,141 18,787 868 1,908 12 16 11 121 2,712 4,411 69,9871995 42,646 20,592 1,019 1,684 470 221 159 1,579 910 2,538 71,8181996 47,541 22,136 1,234 1,848 691 185 192 2,312 507 1,225 77,8711997 50,645 23,579 911 1,803 691 230 212 2,658 437 1,045 82,2111998 53,545 25,194 1,128 2,234 795 283 240 2,291 387 1,029 87,1261999 56,545 25,570 1,397 2,333 747 301 262 2,363 826 1,223 91,5672000 57,712 25,811 2,096 2,397 799 375 297 2,792 604 1,102 93,9852001 60,713 26,965 1,101 2,273 870 349 332 2,365 294 1,026 96,2882002 63,485 28,200 1,089 2,371 935 390 300 2,392 310 1,165 100,6372003 63,826 28,564 1,062 2,416 972 361 394 2,788 219 1,967 102,5692004^ 44,503 19,331 777 1,626 715 257 261 1,810 175 2,564 72,019

All 896,818 398,957 19,146 32,424 9,845 3,020 2,702 23,960 74,131 96,770 1,557,773

Table C.13Percent distribution of patients, by race & Hispanic ethnicity: column percentincident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^White 61.1 61.6 62.1 62.1 62.8 62.2 63.8 63.9 63.5 64.0Black 30.1 29.3 29.3 29.4 28.5 27.8 28.3 28.3 28.3 28.0Native American/Alaskan Native 1.5 1.7 1.2 1.3 1.6 2.3 1.2 1.1 1.1 1.0Asian 2.3 2.4 2.2 2.6 2.6 2.6 2.4 2.4 2.4 2.4Pacific Islander 0.9 0.9 0.9 0.9 0.8 0.9 0.9 0.9 1.0 1.0Mid-East/Arabian 0.4 0.2 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4Indian Subcontinent 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4Other/multiracial 2.8 3.0 3.3 2.7 2.6 3.0 2.5 2.4 2.8 2.6Unknown 0.7 0.6 0.4 0.3 0.4 0.5 0.3 0.3 0.2 0.2


Total N 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597

Data are based on first & new Medical Evidence forms filed between May 1995 & June 2004.^Incomplete data.*Values for cells with 10 or fewer are suppressed."." Zero values in this cell.


1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^White 61.1 61.6 62.1 62.1 62.8 62.2 63.8 63.9 63.5 64.0Black 30.1 29.3 29.3 29.4 28.5 27.8 28.3 28.3 28.3 28.0Native American/Alaskan Native 1.5 1.7 1.2 1.3 1.6 2.3 1.2 1.1 1.1 1.0Asian 2.3 2.4 2.2 2.6 2.6 2.6 2.4 2.4 2.4 2.4Pacific Islander 0.9 0.9 0.9 0.9 0.8 0.9 0.9 0.9 1.0 1.0Mid-East/Arabian 0.4 0.2 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4Indian Subcontinent 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4Other/multiracial 2.8 3.0 3.3 2.7 2.6 3.0 2.5 2.4 2.8 2.6Unknown 0.7 0.6 0.4 0.3 0.4 0.5 0.3 0.3 0.2 0.2


Total N 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597

Data are based on first & new Medical Evidence forms filed between May 1995 & June 2004.^Incomplete data.*Values for cells with 10 or fewer are suppressed."." Zero values in this cell.

ON OUR WEBSITE & CDPatient counts, by ESRD network (C.c).

Table C.12Counts of new ESRD patients, with or without a Medical Evidence form: by raceincident patients with completed Medical Evidence forms


367


Table C.14Percent distribution of diabetic patients, by race & Hispanic ethnicityincident patients with completed Medical Evidence forms

All diabetes 1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^White 48.8 49.4 50.1 50.5 51.6 52.9 53.4 53.7 54.1 54.9Black 48.8 50.3 50.5 51.4 51.7 52.9 54.2 54.3 54.6 55.1Native American/Alaskan Native 70.0 67.8 77.9 75.0 73.1 67.2 78.3 77.1 80.6 84.3Asian 45.0 47.8 49.4 49.4 51.1 51.3 51.8 51.6 52.6 56.9Pacific Islander 65.0 58.1 61.8 63.5 63.4 66.7 67.7 63.6 66.8 67.0Mid-East/Arabian 47.7 38.4 48.7 43.8 50.2 43.5 46.2 52.8 51.0 52.2Indian Subcontinent 45.8 47.8 53.7 55.3 53.5 52.7 59.6 60.3 55.1 66.1Other/multiracial 57.3 60.5 60.7 60.2 62.2 62.6 61.5 59.8 63.3 63.1Unknown 53.3 51.6 54.8 52.5 59.8 64.3 56.9 53.7 63.3 60.8


All 49.4 50.3 51.0 51.4 52.3 53.6 54.2 54.3 54.9 55.7

Diabetes as primary diagnosisWhite 41.8 42.4 43.2 43.5 43.8 44.7 44.7 44.2 44.3 44.8Black 41.2 42.6 42.7 43.5 42.9 43.3 44.1 43.7 43.2 43.7Native American/Alaskan Native 64.1 63.7 74.1 71.4 67.8 60.4 72.3 72.1 74.0 77.0Asian 38.7 43.2 43.5 44.2 45.5 44.8 44.4 43.9 44.3 46.3Pacific Islander 61.1 53.9 56.2 58.1 57.5 59.8 62.4 57.6 58.4 60.0Mid-East/Arabian 41.5 31.4 42.1 39.4 43.3 37.4 39.1 42.8 42.3 41.0Indian Subcontinent 38.3 43.5 45.3 47.7 45.3 46.2 51.7 54.2 47.2 54.8Other/multiracial 52.9 56.9 55.9 55.2 57.3 56.8 56.2 54.6 56.6 57.3Unknown 49.7 44.6 47.5 43.2 52.6 54.1 47.8 47.0 53.5 49.0


All 42.4 43.4 44.0 44.3 44.5 45.2 45.3 44.8 44.8 45.4

*All diabetes: diabetes listed on Medical Evidence form as either the cause of ESRD or a comorbidity.

Table C.15Percent distribution of patients, by employment statusincident patients with completed Medical Evidence forms

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^Current employment status

Employed full-time 8.2 8.2 8.6 8.6 8.8 8.6 8.7 8.4 8.2 8.4Employed part-time 1.9 1.8 1.8 1.9 1.8 1.7 1.7 1.7 1.7 1.7Homemaker 6.1 6.0 5.8 5.7 5.4 5.4 5.1 4.9 4.5 4.6Retired due to age/preference 31.6 33.9 36.7 38.0 38.7 38.5 38.8 39.7 39.5 38.8Retired due to disability 16.7 17.2 17.7 18.5 18.2 18.4 18.3 18.5 18.7 19.3Medical leave of absence 3.1 2.7 2.6 2.7 2.8 3.2 3.2 3.2 3.1 3.2Student 1.2 1.2 1.1 1.1 1.1 1.0 1.0 1.1 1.0 1.0Unemployed 21.8 20.7 19.9 19.2 19.1 19.0 19.1 18.2 19.1 19.2Missing 9.4 8.3 5.9 4.5 4.3 4.2 4.1 4.4 4.1 3.9

Previous employment statusEmployed full-time 15.1 14.2 14.3 14.5 14.6 14.5 14.6 13.3 12.6 13.0Employed part-time 2.7 2.5 2.3 2.5 2.3 2.2 2.2 2.1 2.1 2.2Homemaker 6.1 6.0 5.8 5.7 5.4 5.4 5.1 4.7 4.3 4.4Retired due to age/preference 29.1 31.6 34.4 36.0 36.4 36.5 36.8 36.7 35.3 35.1Retired due to disability 13.6 14.6 15.2 16.0 15.8 16.1 15.9 15.7 15.6 16.3Medical leave of absence 0.6 0.6 0.5 0.5 0.5 0.6 0.5 0.5 0.5 0.5Student 1.2 1.2 1.1 1.0 1.1 1.0 1.0 1.0 1.0 0.9Unemployed 16.8 16.3 15.8 15.1 15.5 15.2 15.3 14.0 14.4 14.7Missing 14.9 13.2 10.6 8.7 8.4 8.6 8.7 12.0 14.2 12.9

Total N 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597

All diabetes: diabetes listed on Medical Evidence form as either the cause of ESRD or a comorbidity.Data are based on first & new Medical Evidence forms filed between May 1995 & June 2004.^Incomplete data.

Table C.14Percent distribution of diabetic patients, by race & Hispanic ethnicityincident patients with completed Medical Evidence forms

Table C.15Percent distribution of patients, by employment statusincident patients with completed Medical Evidence forms

368

ON OUR WEBSITE & CDPatient employment status: current & previous (C.15.1-2).Patient comorbidity: ESRD, transplant, & dialysis patients (C.17.1-11).Denominators obtained from counts by network in Table C.c.

Table C.16Insurance coverage in the incident populationincident patients with completed Medical Evidence forms; percent with coverage in each year

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^Medicaid coverage 25.0 23.9 23.7 23.5 22.8 23.9 23.6 24.4 24.8 24.8Medicare coverage 48.0 49.4 50.5 49.9 50.2 54.5 55.1 56.0 55.8 55.8DVA coverage 1.8 1.3 1.1 1.1 1.6 1.2 1.3 1.3 1.4 1.3Employer group health insurance 25.3 24.1 23.9 23.3 23.0 22.9 23.5 23.4 22.5 22.4Other medical insurance 29.0 31.2 32.0 32.1 31.9 32.1 32.7 32.1 31.6 31.4No medical insurance 7.6 7.3 7.2 6.9 7.9 8.0 7.7 7.5 7.9 7.9Patient applying for Medicare 79.8 80.2 79.8 77.9 80.2 79.3 78.4 77.4 76.6 76.0

All 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597

Table C.17Incident patient comorbidityincident patients with completed Medical Evidence forms; percent with comorbidity in each year

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^Congestive heart failure 30.7 32.4 33.4 32.4 31.6 32.1 31.5 31.1 31.7 32.2Ischemic heart disease/CAD 21.2 22.6 23.8 23.7 23.8 24.6 24.9 24.9 25.1 25.2Myocardial infarction 8.4 8.8 9.0 8.8 8.8 9.0 8.9 8.7 8.3 8.1Cardiac arrest 1.0 1.1 0.9 0.8 0.8 0.8 0.7 0.7 0.8 0.7Cardiac dysrhythmia 5.3 5.6 5.9 5.7 5.8 6.0 6.0 6.2 6.3 6.4Pericarditis 1.5 1.2 1.1 0.9 0.8 0.7 0.6 0.5 0.5 0.4Cerebrovascular disease, CVA/TIA 8.0 8.8 9.2 9.1 9.1 9.1 9.4 9.4 9.2 9.0Peripheral vascular disease 13.8 14.3 14.9 14.6 14.2 14.4 14.2 13.9 14.1 13.7History of hypertension 67.5 71.4 73.7 74.0 75.3 76.7 78.3 79.3 80.3 81.0Diabetes: primary/contributing 36.0 38.5 40.0 40.4 41.5 43.3 44.7 45.3 46.5 46.9Diabetes: on insulin 22.2 23.4 23.9 23.4 23.2 23.2 22.6 22.3 22.7 22.9Chronic obstructive pulmonary disease 6.6 6.8 7.1 6.9 7.1 7.3 7.5 7.6 7.9 8.0Current smoker/tobacco use 5.9 5.8 5.6 5.2 5.0 5.0 5.0 5.0 5.0 5.0Malignant neoplasm/cancer 4.7 4.8 5.0 5.1 5.3 5.6 5.9 6.2 6.2 6.2Alcohol dependence 1.8 1.9 1.6 1.4 1.4 1.4 1.3 1.3 1.3 1.4Drug dependence 1.1 1.1 1.1 1.0 1.0 1.0 1.0 0.9 1.0 1.0AIDS 4.4 4.4 2.6 0.5 1.7 1.8 0.4 0.4 0.4 0.3HIV 4.7 4.8 2.9 0.9 2.1 2.2 0.7 0.8 0.8 0.8Inability to ambulate 4.9 4.6 4.3 3.9 3.9 4.1 3.9 4.2 4.2 4.2Inability to transfer 1.7 1.6 1.6 1.5 1.3 1.5 1.5 1.5 1.5 1.6

All 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597

Data are based on first & new Medical Evidence forms filed between May 1995 & June 2004.^Incomplete data.


1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^Congestive heart failure 30.7 32.4 33.4 32.4 31.6 32.1 31.5 31.1 31.7 32.2Ischemic heart disease/CAD 21.2 22.6 23.8 23.7 23.8 24.6 24.9 24.9 25.1 25.2Myocardial infarction 8.4 8.8 9.0 8.8 8.8 9.0 8.9 8.7 8.3 8.1Cardiac arrest 1.0 1.1 0.9 0.8 0.8 0.8 0.7 0.7 0.8 0.7Cardiac dysrhythmia 5.3 5.6 5.9 5.7 5.8 6.0 6.0 6.2 6.3 6.4Pericarditis 1.5 1.2 1.1 0.9 0.8 0.7 0.6 0.5 0.5 0.4Cerebrovascular disease, CVA/TIA 8.0 8.8 9.2 9.1 9.1 9.1 9.4 9.4 9.2 9.0Peripheral vascular disease 13.8 14.3 14.9 14.6 14.2 14.4 14.2 13.9 14.1 13.7History of hypertension 67.5 71.4 73.7 74.0 75.3 76.7 78.3 79.3 80.3 81.0Diabetes: primary/contributing 36.0 38.5 40.0 40.4 41.5 43.3 44.7 45.3 46.5 46.9Diabetes: on insulin 22.2 23.4 23.9 23.4 23.2 23.2 22.6 22.3 22.7 22.9Chronic obstructive pulmonary disease 6.6 6.8 7.1 6.9 7.1 7.3 7.5 7.6 7.9 8.0Current smoker/tobacco use 5.9 5.8 5.6 5.2 5.0 5.0 5.0 5.0 5.0 5.0Malignant neoplasm/cancer 4.7 4.8 5.0 5.1 5.3 5.6 5.9 6.2 6.2 6.2Alcohol dependence 1.8 1.9 1.6 1.4 1.4 1.4 1.3 1.3 1.3 1.4Drug dependence 1.1 1.1 1.1 1.0 1.0 1.0 1.0 0.9 1.0 1.0AIDS 4.4 4.4 2.6 0.5 1.7 1.8 0.4 0.4 0.4 0.3HIV 4.7 4.8 2.9 0.9 2.1 2.2 0.7 0.8 0.8 0.8Inability to ambulate 4.9 4.6 4.3 3.9 3.9 4.1 3.9 4.2 4.2 4.2Inability to transfer 1.7 1.6 1.6 1.5 1.3 1.5 1.5 1.5 1.5 1.6

All 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597

Data are based on first & new Medical Evidence forms filed between May 1995 & June 2004.^Incomplete data.

CReference section CPATIENT CHARACTERISTICS


Table C.16Insurance coverage in the incident populationincident patients with completed Medical Evidence forms; percent with coverage in each year

Treatmentmodalities

DReferenceSec

tion

TREATMENT MODALITIESD

370

Reference section D

D.1 . 371 Percentages & counts of reported ESRD patients: by treatment modalityincident & point prevalent patients

D.2 . 373 Counts of incident ESRD patients, by initial mode of therapy: all dialysis by demographic characteristics & primary diagnosis

D.3 . 375 Counts of incident ESRD patients, by initial mode of therapy: hemodialysisby demographic characteristics & primary diagnosis

D.4 . 377 Counts of incident ESRD patients, by initial mode of therapy: peritoneal dialysisby demographic characteristics & primary diagnosis

D.5 . 379 Counts of incident ESRD patients, by initial mode of therapy: transplant by demographic characteristics & primary diagnosis

D.6 . 381 Counts of prevalent ESRD patients, by mode of therapy: all dialysis point prevalent patients on December 3

D.7 . 383 Counts of prevalent ESRD patients, by mode of therapy: hemodialysispoint prevalent patients on December 3

D.8 . 385 Counts of prevalent ESRD patients, by mode of therapy: peritoneal dialysispoint prevalent patients on December 3

D.9. 387 Counts of prevalent ESRD patients, by mode of therapy: functioning transplantpoint prevalent patients on December 3

D.10 . 389 Incident ESRD patients, 2003: by age, gender, race/ethnicity, primary diagnosis, & modality

D.11 . 390 Prevalent ESRD patients, 2003: by age, gender, race/ethnicity, primary diagnosis, & modality

D.12 . 391 Treatment status two years after first ESRD service, 1999-2001incident patients with Medicare coverage, 999-200 combined

D.13 . 392 Prevalent ESRD patients, 2003: by patient vintage point prevalent patients on December 3, by year-end treatment modality & number of years patient has had ESRD (vintage)

D.14 . 393 Prevalent ESRD patients, 2003: by number of years on modality point prevalent patients on December 3, by year-end treatment modality

D.15 . 394 Incident ESRD patients, 2003: by modality & state/territoryincident ESRD patients

D.16 . 395 Prevalent ESRD patients, 2003: by modality & state/territorypoint prevalent ESRD patients on December 3

371

2005 Annual Data ReportDTREATMENT MODALITIES

Table D.1Percentages & counts of reported ESRD patients: by treatment modalityincident & point prevalent patients

Table D.1Percentages & counts of reported ESRD patients: by treatment modalityincident & point prevalent patients

INCIDENT COUNTS 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991Modality

Dialysis 17,678 19,777 22,168 25,528 27,109 30,060 32,745 36,040 40,244 45,413 49,820 55,079Started with a tx 339 325 419 407 472 544 726 911 1,048 1,049 1,106 1,094

Dialysis typeCenter hemodialysis 15,537 16,886 18,322 21,145 22,375 24,118 26,466 29,285 33,386 37,943 41,326 45,887Center self hemodialysis . . . . . . . . . . . 61Home hemodialysis 71 26 21 32 54 208 208 140 121 75 88 69CAPD 982 1,880 3,144 3,735 3,912 4,035 4,093 4,410 4,672 5,125 5,914 6,129CCPD * * * 16 37 136 223 336 310 460 610 834Other PD 681 439 267 286 273 587 733 663 719 773 663 771Uncertain dialysis 404 540 407 314 458 976 1,022 1,206 1,036 1,037 1,219 1,328

All 18,017 20,102 22,587 25,935 27,581 30,604 33,471 36,951 41,292 46,462 50,926 56,173

PERCENTAGESModality

Dialysis 98.1 98.4 98.1 98.4 98.3 98.2 97.8 97.5 97.5 97.7 97.8 98.1Started with a tx 1.9 1.6 1.9 1.6 1.7 1.8 2.2 2.5 2.5 2.3 2.2 1.9

Dialysis typeCenter hemodialysis 87.9 85.4 82.7 82.8 82.5 80.2 80.8 81.3 83.0 83.6 83.0 83.3Center self hemodialysis . . . . . . . . . . . 0.1Home hemodialysis 0.4 0.1 0.1 0.1 0.2 0.7 0.6 0.4 0.3 0.2 0.2 0.1CAPD 5.6 9.5 14.2 14.6 14.4 13.4 12.5 12.2 11.6 11.3 11.9 11.1CCPD 0.0 . . 0.1 0.1 0.5 0.7 0.9 0.8 1.0 1.2 1.5Other PD 3.9 2.2 1.2 1.1 1.0 2.0 2.2 1.8 1.8 1.7 1.3 1.4Uncertain dialysis 2.3 2.7 1.8 1.2 1.7 3.2 3.1 3.3 2.6 2.3 2.4 2.4

All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0

POINT PREVALENT COUNTSModality

Dialysis 49,949 56,237 63,047 72,963 80,414 87,003 93,716 101,937 111,619 124,159 137,437 152,927Functioning graft 10,093 12,648 15,424 18,499 22,179 26,528 31,700 36,552 41,141 45,608 50,541 55,803

Dialysis typeCenter hemodialysis 44,423 50,661 55,886 62,960 66,831 68,157 73,948 81,743 91,747 102,608 113,462 125,468Center self hemodialysis . * * * . . . * . . . 680Home hemodialysis 1,838 704 509 1,229 2,476 5,557 5,290 4,456 2,772 2,597 2,268 2,082CAPD 893 2,603 4,343 6,726 8,762 10,591 11,519 12,449 13,466 15,072 17,004 18,953CCPD * 17 46 72 202 540 789 1,007 1,118 1,347 1,992 2,903Other PD 1,428 1,096 1,022 874 785 876 787 700 657 612 495 445Uncertain dialysis 1,363 1,155 1,240 1,101 1,358 1,282 1,383 1,581 1,859 1,923 2,216 2,396

All 60,042 68,885 78,471 91,462 102,593 113,531 125,416 138,489 152,760 169,767 187,978 208,730

PERCENTAGESModality

Dialysis 83.2 81.6 80.3 79.8 78.4 76.6 74.7 73.6 73.1 73.1 73.1 73.3Functioning graft 16.8 18.4 19.7 20.2 21.6 23.4 25.3 26.4 26.9 26.9 26.9 26.7

Dialysis typeCenter hemodialysis 88.9 90.1 88.6 86.3 83.1 78.3 78.9 80.2 82.2 82.6 82.6 82.0Center self hemodialysis . . . . . . . . . . . 0.4Home hemodialysis 3.7 1.3 0.8 1.7 3.1 6.4 5.6 4.4 2.5 2.1 1.7 1.4CAPD 1.8 4.6 6.9 9.2 10.9 12.2 12.3 12.2 12.1 12.1 12.4 12.4CCPD . . 0.1 0.1 0.3 0.6 0.8 1.0 1.0 1.1 1.4 1.9Other PD 2.9 1.9 1.6 1.2 1.0 1.0 0.8 0.7 0.6 0.5 0.4 0.3Uncertain dialysis 2.7 2.1 2.0 1.5 1.7 1.5 1.5 1.6 1.7 1.5 1.6 1.6

All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0

The incident cohorts & associated modalities are determined at the time of ESRD initiation without applying the 60-day stable modality rule.The point prevalent cohorts & associated modalities are determined on Dec. 31 of each calendar year without applying the 60-day stable modality rule.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.


372

Reference section D

Table D.1 (continued)Percentages & counts of reported ESRD patients: by treatment modalityincident & point prevalent patients

Table D.1 (continued)Percentages & counts of reported ESRD patients: by treatment modalityincident & point prevalent patients

INCIDENT COUNTS 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Modality

Dialysis 60,214 63,405 68,864 70,569 76,550 80,876 85,715 89,957 92,228 94,429 98,666 100,499Started with a tx 1,104 1,087 1,104 1,222 1,310 1,327 1,406 1,603 1,738 1,851 1,959 2,068

Dialysis typeCenter hemodialysis 50,564 53,373 58,539 60,396 66,073 71,811 76,813 80,754 83,696 86,626 91,178 93,042Center self hemo. 56 40 24 53 57 48 46 42 30 37 44 39Home hemodialysis 63 92 47 231 488 201 485 646 249 234 170 195CAPD 6,298 6,710 6,735 6,573 6,149 5,638 5,153 4,971 4,644 4,681 4,425 4,561CCPD 1,084 1,029 1,278 1,957 2,258 2,141 2,239 2,261 2,259 2,306 2,184 2,129Other PD 732 662 630 472 447 417 389 256 302 277 415 289Uncertain dialysis 1,417 1,499 1,611 887 1,078 620 590 1,027 1,048 268 250 244

All 61,318 64,492 69,968 71,791 77,860 82,203 87,121 91,560 93,966 96,280 100,625 102,567

PERCENTAGESModality

Dialysis 98.2 98.3 98.4 98.3 98.3 98.4 98.4 98.2 98.2 98.1 98.1 98.0Started with a tx 1.8 1.7 1.6 1.7 1.7 1.6 1.6 1.8 1.8 1.9 1.9 2.0

Dialysis typeCenter hemodialysis 84.0 84.2 85.0 85.6 86.3 88.8 89.6 89.8 90.7 91.7 92.4 92.6Center self hemo. 0.1 0.1 . 0.1 0.1 0.1 0.1 . . . . .Home hemodialysis 0.1 0.1 0.1 0.3 0.6 0.2 0.6 0.7 0.3 0.2 0.2 0.2CAPD 10.5 10.6 9.8 9.3 8.0 7.0 6.0 5.5 5.0 5.0 4.5 4.5CCPD 1.8 1.6 1.9 2.8 2.9 2.6 2.6 2.5 2.4 2.4 2.2 2.1Other PD 1.2 1.0 0.9 0.7 0.6 0.5 0.5 0.3 0.3 0.3 0.4 0.3Uncertain dialysis 2.4 2.4 2.3 1.3 1.4 0.8 0.7 1.1 1.1 0.3 0.3 0.2

All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0

POINT PREVALENT COUNTSModality

Dialysis 168,845 183,424 200,367 213,987 229,776 244,915 260,404 274,993 288,967 300,708 313,023 324,826Functioning graft 61,032 66,528 71,913 77,579 83,354 89,219 95,540 101,621 107,974 114,453 121,285 128,131

Dialysis typeCenter hemodialysis 138,590 153,164 167,510 179,205 195,360 212,598 230,180 245,318 260,230 272,887 285,273 296,583Center self hemo. 764 133 196 513 527 463 359 339 268 320 272 193Home hemodialysis 2,114 559 829 1,844 1,944 1,649 1,641 1,550 1,450 1,192 1,149 1,325CAPD 20,846 22,624 23,778 22,454 20,203 18,081 16,076 14,573 13,325 12,464 11,555 11,281CCPD 3,701 4,319 5,418 7,840 9,586 10,431 10,606 11,312 11,948 12,763 13,724 14,544Other PD 378 296 287 235 179 138 116 86 73 66 84 67Uncertain dialysis 2,452 2,329 2,349 1,896 1,977 1,555 1,426 1,815 1,673 1,016 966 833

All 229,877 249,952 272,280 291,566 313,130 334,134 355,944 376,614 396,941 415,161 434,308 452,957

PERCENTAGESModality

Dialysis 73.5 73.4 73.6 73.4 73.4 73.3 73.2 73.0 72.8 72.4 72.1 71.7Functioning graft 26.5 26.6 26.4 26.6 26.6 26.7 26.8 27.0 27.2 27.6 27.9 28.3

Dialysis typeCenter hemodialysis 82.1 83.5 83.6 83.7 85.0 86.8 88.4 89.2 90.1 90.7 91.1 91.3Center self hemo. 0.5 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1Home hemodialysis 1.3 0.3 0.4 0.9 0.8 0.7 0.6 0.6 0.5 0.4 0.4 0.4CAPD 12.3 12.3 11.9 10.5 8.8 7.4 6.2 5.3 4.6 4.1 3.7 3.5CCPD 2.2 2.4 2.7 3.7 4.2 4.3 4.1 4.1 4.1 4.2 4.4 4.5Other PD 0.2 0.2 0.1 0.1 0.1 0.1 . . . . . .Uncertain dialysis 1.5 1.3 1.2 0.9 0.9 0.6 0.5 0.7 0.6 0.3 0.3 0.3

All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0

The incident cohorts & associated modalities are determined at the time of ESRD initiation without applying the 60-day stable modality rule.The point prevalent cohorts & associated modalities are determined on Dec. 31 of each calendar year without applying the 60-day stable modality rule."." Zero values in this cell.

373


Table D.2Counts of incident ESRD patients, by initial mode of therapy: all dialysis by demographic characteristics & primary diagnosis

Table D.2Counts of incident ESRD patients, by initial mode of therapy: all dialysis by demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 41 58 83 94 98 123 125 123 117 133 126 1615-9 86 80 87 79 95 80 103 92 83 94 122 8610-14 161 174 210 192 199 187 169 169 178 159 195 19915-19 409 451 425 415 395 405 403 420 456 463 480 43620-29 1,456 1,617 1,811 1,770 1,919 1,962 2,029 2,033 2,207 2,371 2,459 2,48830-39 2,133 2,386 2,661 2,735 2,944 3,178 3,453 3,590 4,019 4,383 4,602 4,84940-49 2,376 2,691 2,809 3,166 3,305 3,605 3,867 4,345 4,819 5,470 6,018 6,72350-59 3,730 4,344 4,635 4,813 5,074 5,456 5,735 6,162 7,059 7,608 8,220 8,88460-64 2,136 2,460 2,788 3,215 3,530 3,951 4,128 4,592 5,041 5,497 6,112 6,66665-69 2,185 2,272 2,602 3,333 3,517 3,925 4,452 5,107 5,661 6,532 7,240 8,02170-79 2,533 2,753 3,404 4,689 4,926 5,791 6,601 7,458 8,310 9,787 10,880 12,69480+ 432 490 645 1,017 1,098 1,381 1,666 1,943 2,289 2,906 3,358 3,869Unknown . * * * * 16 14 * * * * *

0-19 697 763 805 780 787 795 800 804 834 849 923 88220-44 4,672 5,274 5,781 5,980 6,385 6,828 7,313 7,715 8,531 9,301 10,021 10,58145-64 7,159 8,224 8,923 9,719 10,387 11,324 11,899 13,007 14,614 16,028 17,390 19,02965-74 3,793 4,022 4,764 6,205 6,452 7,416 8,278 9,476 10,436 12,051 13,509 15,30775+ 1,357 1,493 1,887 2,834 3,089 3,681 4,441 5,032 5,824 7,174 7,969 9,277Unknown . * * * * 16 14 * * * * *

Male 9,819 10,904 12,165 13,964 14,919 16,277 17,834 19,469 21,529 24,410 26,706 29,348Female 7,859 8,873 10,003 11,562 12,190 13,780 14,910 16,570 18,715 21,003 23,114 25,729Unknown . . . * . * * * . . . *

White 12,332 13,747 15,435 17,378 18,463 20,422 22,305 24,281 26,683 30,005 32,973 36,281Black 4,824 5,457 6,135 7,421 7,832 8,687 9,340 10,548 12,036 13,802 14,896 16,606Native American 122 142 185 267 282 291 367 419 496 543 586 631Asian 108 177 345 360 456 581 622 710 880 983 1,245 1,429Other/unknown 292 254 68 102 76 79 111 82 149 80 120 132


Diabetes 2,652 3,984 5,221 6,149 7,414 8,594 9,914 11,287 12,864 15,516 17,905 20,456Hypertension 3,116 4,503 5,800 6,316 7,129 8,211 8,880 10,269 11,858 13,823 15,233 16,914Glomerulonephritis 2,747 3,577 4,191 4,412 4,726 4,967 5,233 5,675 6,078 6,421 6,842 7,070Cystic kidney 763 931 1,072 1,086 1,130 1,204 1,266 1,291 1,333 1,344 1,478 1,525Other urologic 459 655 860 950 959 1,157 1,172 1,298 1,349 1,345 1,277 1,432Other cause 1,734 2,189 2,772 3,085 3,268 3,540 3,609 3,612 3,783 4,319 4,504 4,874Unknown cause 1,608 1,664 1,371 1,411 1,452 1,526 1,775 1,952 2,162 2,080 2,194 2,461Missing cause 4,599 2,274 881 2,119 1,031 861 896 656 817 565 387 347

All 17,678 19,777 22,168 25,528 27,109 30,060 32,745 36,040 40,244 45,413 49,820 55,079

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. * Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.


374

Reference section D

Table D.2 (continued)Counts of incident ESRD patients, by initial mode of therapy: all dialysis by demographic characteristics & primary diagnosis

Table D.2 (continued)Counts of incident ESRD patients, by initial mode of therapy: all dialysis by demographic characteristics & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 127 155 131 149 147 145 154 147 170 170 164 1685-9 88 107 127 111 111 96 105 121 121 120 130 10210-14 198 199 223 217 224 231 215 240 247 248 294 28915-19 492 469 458 495 504 466 489 527 505 500 505 54920-29 2,641 2,683 2,672 2,570 2,575 2,519 2,591 2,485 2,545 2,541 2,453 2,37930-39 5,214 5,330 5,648 5,485 5,613 5,532 5,522 5,684 5,502 5,455 5,487 5,47340-49 7,273 7,772 8,204 8,751 9,366 9,402 10,154 10,325 10,547 10,552 10,884 11,15850-59 9,816 10,415 11,715 11,868 12,544 13,583 14,803 15,962 16,402 17,250 17,795 18,58760-64 6,991 7,347 7,796 8,064 8,466 8,909 9,449 9,643 9,939 10,295 10,505 11,08965-69 8,636 8,963 9,616 9,605 10,441 10,827 11,103 11,196 11,366 11,583 11,841 12,04970-79 14,192 15,002 16,625 17,129 19,338 20,787 21,887 23,216 23,684 23,979 25,098 24,81980+ 4,544 4,963 5,643 6,121 7,221 8,378 9,241 10,411 11,200 11,736 13,510 13,837Unknown * . * * . * * . . . . .

0-19 905 930 939 972 986 938 963 1,035 1,043 1,038 1,093 1,10820-44 11,320 11,597 11,971 12,028 12,368 12,153 12,564 12,579 12,566 12,471 12,474 12,51545-64 20,615 21,950 24,064 24,710 26,196 27,792 29,955 31,520 32,369 33,622 34,650 36,17165-74 16,797 17,596 19,135 19,296 21,274 22,179 22,803 23,240 23,629 24,011 24,630 24,42475+ 10,575 11,332 12,749 13,559 15,726 17,813 19,428 21,583 22,621 23,287 25,819 26,281Unknown * . * * . * * . . . . .

Male 31,834 33,728 36,440 37,164 40,777 43,000 45,596 48,035 49,277 50,743 53,516 54,392Female 28,379 29,675 32,424 33,400 35,772 37,876 40,119 41,920 42,950 43,686 45,148 46,081Unknown * * . * * . . * * . * 26

White 39,401 41,048 44,381 44,741 48,916 52,012 54,746 58,163 59,891 61,063 63,771 64,575Black 18,262 19,475 21,078 21,688 23,028 24,065 25,768 26,246 26,497 27,417 28,631 29,170Native American 751 749 817 868 915 950 1,051 1,118 1,133 1,121 1,125 1,084Asian 1,604 1,914 2,147 2,290 2,474 2,622 2,906 3,165 3,129 3,333 3,517 3,550Other/unknown 196 219 441 982 1,217 1,227 1,244 1,265 1,578 1,495 1,622 2,120


Diabetes 22,739 24,330 27,137 29,636 33,137 35,677 38,069 40,061 41,785 42,900 44,308 44,963Hypertension 18,873 19,611 21,271 19,109 20,277 21,772 22,962 24,336 24,745 25,644 27,159 28,151Glomerulonephritis 7,235 7,519 8,120 8,121 8,536 8,481 8,639 8,632 8,312 8,179 8,348 8,025Cystic kidney 1,642 1,709 1,783 1,816 1,750 1,862 1,967 2,023 1,971 2,000 1,981 1,986Other urologic 1,497 1,298 1,348 1,999 2,281 2,328 2,371 2,773 2,600 2,632 2,834 2,703Other cause 5,259 5,588 6,132 6,964 7,362 7,552 8,193 8,460 8,832 8,977 9,767 9,909Unknown cause 2,684 2,883 2,867 2,734 3,027 3,069 3,328 3,472 3,749 3,913 3,925 4,107Missing cause 285 467 206 190 180 135 186 200 234 184 344 655

All 60,214 63,405 68,864 70,569 76,550 80,876 85,715 89,957 92,228 94,429 98,666 100,499


375


Table D.3Counts of incident ESRD patients, by initial mode of therapy: hemodialysisby demographic characteristics & primary diagnosis

Table D.3Counts of incident ESRD patients, by initial mode of therapy: hemodialysisby demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 22 18 22 26 19 30 38 20 24 36 35 355-9 58 47 49 32 35 29 29 33 27 30 50 3110-14 134 127 117 110 97 100 86 88 86 85 92 8115-19 375 394 342 325 299 299 296 293 337 344 336 32820-29 1,299 1,394 1,529 1,470 1,559 1,611 1,619 1,595 1,728 1,888 1,890 1,96730-39 1,848 2,015 2,155 2,161 2,369 2,472 2,685 2,779 3,145 3,398 3,529 3,68340-49 2,103 2,354 2,286 2,567 2,673 2,855 3,049 3,441 3,875 4,317 4,749 5,22950-59 3,280 3,731 3,877 3,966 4,167 4,433 4,697 5,032 5,900 6,259 6,707 7,29260-64 1,925 2,085 2,340 2,695 2,966 3,236 3,426 3,818 4,257 4,665 5,111 5,56965-69 1,970 1,949 2,205 2,902 2,996 3,228 3,722 4,285 4,870 5,671 6,225 6,96970-79 2,223 2,390 2,872 4,045 4,302 4,862 5,608 6,347 7,235 8,684 9,648 11,28580+ 371 407 542 869 940 1,157 1,407 1,689 2,018 2,633 3,034 3,546Unknown . * * * * 14 12 * * * * *

0-19 589 586 530 493 450 458 449 434 474 495 513 47520-44 4,110 4,513 4,738 4,817 5,157 5,418 5,730 5,996 6,714 7,283 7,736 8,11845-64 6,345 7,066 7,449 8,042 8,577 9,189 9,746 10,669 12,191 13,244 14,250 15,62265-74 3,380 3,454 4,027 5,373 5,531 6,166 6,965 7,976 9,000 10,558 11,734 13,40975+ 1,184 1,292 1,592 2,443 2,707 3,081 3,772 4,345 5,123 6,430 7,173 8,391Unknown . * * * * 14 12 * * * * *

Male 8,746 9,443 10,161 11,660 12,342 13,238 14,558 15,885 17,940 20,377 22,206 24,374Female 6,862 7,469 8,182 9,515 10,087 11,086 12,115 13,539 15,567 17,641 19,208 21,641Unknown . . . * . * * * . . . *

White 10,753 11,564 12,573 14,177 15,030 16,123 17,813 19,399 21,732 24,622 26,822 29,628Black 4,391 4,829 5,238 6,372 6,719 7,387 7,923 8,976 10,441 12,016 12,907 14,493Native American 108 130 161 223 227 247 304 357 422 469 500 541Asian 100 160 307 320 393 512 552 630 795 845 1,108 1,260Other/unknown 256 229 64 85 60 57 82 63 117 66 77 95


Diabetes 2,199 3,265 4,109 4,875 5,952 6,813 7,969 9,106 10,660 12,907 14,827 16,977Hypertension 2,746 3,927 4,886 5,366 6,132 6,888 7,509 8,770 10,228 12,010 13,163 14,755Glomerulonephritis 2,397 3,098 3,490 3,673 3,884 3,986 4,209 4,515 4,877 5,166 5,443 5,640Cystic kidney 691 789 914 918 926 987 1,020 1,029 1,066 1,057 1,133 1,142Other urologic 402 567 719 798 803 946 997 1,102 1,174 1,182 1,096 1,262Other cause 1,524 1,895 2,329 2,526 2,678 2,828 2,911 2,855 3,112 3,550 3,657 3,937Unknown cause 1,419 1,354 1,124 1,136 1,176 1,217 1,379 1,567 1,778 1,718 1,808 2,047Missing cause 4,230 2,017 772 1,885 878 661 680 481 612 428 287 257

All 15,608 16,912 18,343 21,177 22,429 24,326 26,674 29,425 33,507 38,018 41,414 46,017



376

Reference section D

Table D.3 (continued)Counts of incident ESRD patients, by initial mode of therapy: hemodialysisby demographic characteristics & primary diagnosis

Table D.3 (continued)Counts of incident ESRD patients, by initial mode of therapy: hemodialysisby demographic characteristics & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 21 38 27 40 24 37 30 33 42 46 39 445-9 36 35 50 50 39 33 44 45 51 55 59 4310-14 106 99 112 112 103 117 113 129 135 145 174 16115-19 335 334 336 358 373 343 379 421 390 393 413 44220-29 2,096 2,116 2,149 2,109 2,126 2,124 2,235 2,167 2,223 2,250 2,219 2,14030-39 4,035 4,137 4,433 4,401 4,624 4,680 4,716 4,912 4,833 4,815 4,849 4,88640-49 5,750 6,121 6,629 7,086 7,813 8,050 8,883 9,068 9,362 9,434 9,908 10,11850-59 8,016 8,627 9,704 9,974 10,704 11,781 13,057 14,274 14,776 15,542 16,217 17,00260-64 5,866 6,230 6,595 6,898 7,443 7,973 8,573 8,743 9,062 9,492 9,702 10,29065-69 7,600 7,803 8,481 8,438 9,276 9,856 10,162 10,256 10,401 10,807 11,034 11,23170-79 12,654 13,427 14,916 15,530 17,424 19,176 20,361 21,541 22,057 22,667 23,777 23,58280+ 4,167 4,538 5,174 5,681 6,669 7,889 8,789 9,853 10,643 11,251 13,001 13,337Unknown * . * * . * * . . . . .

0-19 498 506 525 560 539 530 566 628 618 639 685 69020-44 8,852 9,034 9,511 9,752 10,221 10,277 10,855 10,938 11,045 11,037 11,209 11,24945-64 16,911 18,197 19,999 20,716 22,489 24,331 26,609 28,226 29,211 30,496 31,686 33,18765-74 14,827 15,468 16,947 17,190 18,949 20,284 20,982 21,334 21,774 22,502 23,117 22,92075+ 9,594 10,300 11,624 12,459 14,420 16,637 18,330 20,316 21,327 22,223 24,695 25,230Unknown * . * * . * * . . . . .

Male 26,704 28,426 30,961 31,878 35,501 38,356 41,238 43,558 44,955 46,788 49,632 50,536Female 23,978 25,077 27,649 28,798 31,117 33,704 36,106 37,882 39,020 40,109 41,758 42,720Unknown * * . * . . . * . . * 20

White 32,469 33,980 37,046 37,745 41,659 45,556 48,668 51,842 53,828 55,601 58,557 59,457Black 16,023 17,053 18,650 19,377 20,933 22,228 24,015 24,533 24,863 25,859 27,101 27,617Native American 630 652 702 747 807 855 945 1,039 1,022 1,033 1,034 1,016Asian 1,404 1,647 1,829 1,947 2,141 2,313 2,589 2,877 2,819 3,030 3,197 3,224Other/unknown 157 173 383 864 1,078 1,108 1,127 1,151 1,443 1,374 1,503 1,962



All 50,683 53,505 58,610 60,680 66,618 72,060 77,344 81,442 83,975 86,897 91,392 93,276


377


Table D.4Counts of incident ESRD patients, by initial mode of therapy: peritoneal dialysisby demographic characteristics & primary diagnosis

Table D.4Counts of incident ESRD patients, by initial mode of therapy: peritoneal dialysisby demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 * 28 50 58 66 84 77 87 82 71 73 1005-9 15 22 33 42 54 44 60 49 45 54 53 4410-14 13 29 75 73 91 72 73 72 81 56 85 8715-19 15 30 63 73 76 84 82 100 81 103 110 8520-29 73 142 223 249 302 274 330 323 377 358 440 40830-39 139 240 414 501 485 558 590 627 685 788 852 96740-49 152 232 431 531 543 591 641 696 760 895 1,031 1,23050-59 240 438 628 748 791 793 810 884 889 1,059 1,191 1,26660-64 107 240 367 456 475 547 513 570 607 621 790 83065-69 84 212 327 372 424 431 458 526 512 608 762 76070-79 119 224 451 531 517 572 542 660 696 774 911 98780+ 19 49 88 116 123 121 139 151 167 196 226 199Unknown . . * * * . * * . * . .

0-19 52 109 221 246 287 284 292 308 289 284 321 31620-44 282 499 848 1,004 1,037 1,101 1,234 1,308 1,437 1,571 1,812 2,02145-64 429 793 1,215 1,481 1,559 1,662 1,650 1,792 1,881 2,150 2,492 2,68065-74 162 367 611 702 753 779 784 940 942 1,053 1,333 1,35975+ 60 118 255 317 311 345 355 397 433 525 566 587Unknown . . * * * . * * . * . .

Male 515 940 1,654 1,996 2,160 2,209 2,371 2,535 2,677 3,016 3,508 3,818Female 470 946 1,497 1,755 1,789 1,961 1,945 2,211 2,305 2,569 3,016 3,145Unknown . . . . . * . . . . . .

White 792 1,459 2,353 2,771 2,934 3,200 3,267 3,575 3,754 4,112 4,853 5,120Black 159 401 753 905 918 876 935 1,066 1,086 1,307 1,480 1,617Native American 11 * 17 41 46 40 55 51 68 61 74 75Asian * * 27 26 46 47 50 51 66 100 104 134Other/unknown 16 * * * * * * * * * 13 17


Diabetes 255 525 950 1,131 1,247 1,347 1,453 1,650 1,671 2,047 2,416 2,719Hypertension 215 402 792 842 844 916 917 993 1,178 1,310 1,613 1,618Glomerulonephritis 206 344 577 646 722 770 791 865 943 997 1,115 1,186Cystic kidney 46 101 132 147 178 170 194 206 211 231 281 318Other urologic 23 63 112 128 123 135 112 124 122 105 127 121Other cause 129 211 365 496 515 544 513 580 511 580 657 676Unknown cause 89 188 190 206 208 185 231 211 213 226 263 280Missing cause 22 52 33 155 112 104 105 117 133 89 52 45

All 985 1,886 3,151 3,751 3,949 4,171 4,316 4,746 4,982 5,585 6,524 6,963



378

Reference section D

Table D.4 (continued)Counts of incident ESRD patients, by initial mode of therapy: peritoneal dialysisby demographic characteristics & primary diagnosis

Table D.4 (continued)Counts of incident ESRD patients, by initial mode of therapy: peritoneal dialysisby demographic characteristics & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 88 100 84 98 115 104 121 111 122 120 118 1205-9 44 54 70 60 68 60 56 73 65 63 66 5410-14 80 83 97 98 112 108 98 105 106 98 119 12515-19 129 109 103 124 125 118 106 102 106 101 87 10420-29 429 459 428 420 420 367 339 298 295 270 221 23330-39 979 965 1,006 995 932 805 757 733 643 604 604 57140-49 1,242 1,351 1,307 1,537 1,475 1,262 1,193 1,171 1,110 1,061 938 99250-59 1,437 1,481 1,631 1,725 1,689 1,713 1,623 1,563 1,485 1,634 1,503 1,50760-64 872 861 928 1,015 938 871 805 811 794 765 755 76065-69 744 864 828 930 858 776 777 726 725 706 697 74670-79 1,083 1,130 1,211 1,208 1,334 1,246 1,180 1,178 1,119 1,148 1,098 1,06780+ 254 282 319 319 341 349 337 361 333 417 403 411Unknown * . * * . . . . . . . .

0-19 341 346 354 380 420 390 381 391 399 382 390 40320-44 2,023 2,065 2,039 2,086 2,027 1,764 1,603 1,545 1,441 1,355 1,201 1,21945-64 2,936 3,052 3,261 3,606 3,427 3,254 3,114 3,031 2,886 2,979 2,820 2,84465-74 1,401 1,560 1,591 1,654 1,695 1,499 1,475 1,412 1,353 1,358 1,298 1,35175+ 680 716 767 803 838 872 819 853 824 913 900 873Unknown * . * * . . . . . . . .

Male 3,958 4,094 4,236 4,532 4,449 4,088 3,848 3,782 3,665 3,650 3,522 3,562Female 3,424 3,645 3,777 3,998 3,957 3,691 3,544 3,450 3,238 3,337 3,087 3,126Unknown . . . . * . . . . . . *

White 5,398 5,563 5,696 6,041 6,054 5,705 5,375 5,367 5,051 5,063 4,729 4,704Black 1,706 1,857 1,901 1,979 1,821 1,602 1,547 1,464 1,388 1,440 1,395 1,466Native American 91 80 95 105 99 83 84 70 90 81 71 63Asian 167 222 288 313 311 282 286 240 266 295 310 316Other/unknown 20 17 33 92 122 107 100 91 108 108 104 141

†Hispanic 889 784 761 780 763 740 816 776†Non-Hispanic 7,518 6,995 6,631 6,452 6,140 6,247 5,793 5,914

Diabetes 2,972 3,039 3,247 3,670 3,767 3,443 3,253 3,214 3,042 2,990 2,869 2,808Hypertension 1,678 1,858 1,870 1,708 1,529 1,492 1,452 1,404 1,362 1,407 1,393 1,468Glomerulonephritis 1,231 1,219 1,330 1,424 1,397 1,274 1,198 1,084 1,076 1,041 928 961Cystic kidney 333 376 376 388 366 358 337 366 331 358 321 350Other urologic 142 144 132 213 204 209 181 194 196 200 198 178Other cause 712 730 745 831 822 727 734 723 662 731 662 664Unknown cause 288 336 289 277 306 265 228 237 225 252 210 219Missing cause 26 37 24 19 16 11 * * * * 28 42

All 7,382 7,739 8,013 8,530 8,407 7,779 7,392 7,232 6,903 6,987 6,609 6,690


379


Table D.5Counts of incident ESRD patients, by initial mode of therapy: transplantby demographic characteristics & primary diagnosis

Table D.5Counts of incident ESRD patients, by initial mode of therapy: transplantby demographic characteristics & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 * 11 18 12 14 16 11 25 28 25 25 215-9 11 17 18 * 15 23 19 23 23 37 32 4310-14 18 14 14 19 31 30 44 51 47 49 54 4915-19 24 25 31 29 36 37 54 64 66 63 68 5420-29 84 72 91 87 88 126 130 153 213 213 178 16330-39 89 98 107 116 133 135 220 244 278 269 291 30040-49 71 50 81 84 84 98 135 178 199 220 262 28050-59 29 31 55 40 55 54 78 128 147 125 142 13260-64 * * * * * * 18 29 31 30 33 3665-69 * * . * * * * * * 12 14 1370-79 . * . * * * * * * * * *80+ * * * . * * * * . * * .Unknown . . . . . * . . . . . .

0-19 59 67 81 69 96 106 128 163 164 174 179 16720-44 205 197 243 246 269 323 423 494 606 604 630 63445-64 71 58 94 89 94 98 158 238 262 253 276 27765-74 * * . * * 11 13 12 15 16 19 1575+ * * * . * * * * * * * *Unknown . . . . . * . . . . . .

Male 222 220 272 258 301 313 433 535 625 616 638 643Female 117 104 147 149 170 230 293 376 422 433 468 451Unknown . * . . * * . . * . . .

White 261 257 318 297 366 435 604 722 800 881 903 950Black 52 51 68 55 60 57 75 116 139 111 120 91Native American . * * * * * * * 11 * * *Asian * * 12 13 * * * 26 31 26 34 20Other/unknown 24 13 20 34 32 33 33 42 67 29 39 23


Diabetes 38 59 87 69 99 114 178 190 208 254 233 264Hypertension 25 25 38 33 23 30 44 73 79 55 68 68Glomerulonephritis 55 56 74 81 90 122 120 179 156 189 211 192Cystic kidney * 13 * 19 18 24 45 71 67 73 95 99Other urologic 24 24 14 18 26 27 42 43 40 60 54 62Other cause 47 38 55 49 75 68 99 117 107 136 142 135Unknown cause 17 15 43 46 43 62 57 69 80 69 93 93Missing cause 131 95 99 92 98 97 141 169 311 213 210 181

All 339 325 419 407 472 544 726 911 1,048 1,049 1,106 1,094



380

Reference section D

Table D.5 (continued)Counts of incident ESRD patients, by initial mode of therapy: transplantby demographic characteristics & primary diagnosis

Table D.5 (continued)Counts of incident ESRD patients, by initial mode of therapy: transplantby demographic characteristics & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 26 32 15 19 39 31 21 35 27 35 20 395-9 37 28 35 35 35 37 33 36 34 32 52 5110-14 50 44 37 64 46 50 55 60 64 64 51 5115-19 41 59 71 75 77 68 53 82 71 85 77 8820-29 154 144 154 135 140 141 150 171 156 171 151 16630-39 291 272 280 311 279 271 314 284 319 300 330 28740-49 270 248 273 285 361 326 369 421 444 466 476 48050-59 168 176 161 198 227 265 290 334 400 446 494 54660-64 42 51 48 57 74 83 66 91 116 133 164 17465-69 18 21 20 30 26 47 45 57 69 83 96 13170-79 * 11 * 13 * * * 30 37 35 48 5380+ * . . . . . * * * * . *Unknown . * . . . . . * . . . .

0-19 154 163 158 193 197 186 162 213 196 216 200 22920-44 599 553 575 586 611 581 648 662 701 692 701 65745-64 326 338 341 400 470 505 541 639 734 824 914 99665-74 23 29 28 41 31 52 51 86 104 111 135 17575+ * * * * * * * * * * * 11Unknown . * . . . . . * . . . .

Male 613 631 616 688 784 792 801 919 991 1,062 1,112 1,192Female 491 454 487 532 526 535 605 684 747 789 847 874Unknown . * * * . . . . . . . *

White 939 956 882 945 1,020 1,139 1,246 1,405 1,496 1,604 1,680 1,712Black 115 90 172 219 225 128 100 134 143 143 181 187Native American * * * * 12 * 13 * 11 * * 13Asian 29 22 30 29 40 30 32 30 51 53 64 58Other/unknown 12 15 14 20 13 20 15 26 37 41 25 98


Diabetes 232 255 247 276 313 294 282 310 285 365 392 367Hypertension 90 70 79 65 65 85 79 84 108 135 176 168Glomerulonephritis 215 193 191 249 259 240 266 291 324 340 376 359Cystic kidney 96 98 80 125 145 123 190 169 217 248 269 305Other urologic 39 53 58 114 83 109 78 74 116 105 144 124Other cause 155 142 145 183 195 209 197 207 226 289 290 283Unknown cause 100 144 119 67 77 110 70 139 100 115 137 102Missing cause 177 132 185 143 173 157 244 329 362 254 175 360

All 1,104 1,087 1,104 1,222 1,310 1,327 1,406 1,603 1,738 1,851 1,959 2,068


381


Table D.6Counts of prevalent ESRD patients, by mode of therapy: all dialysispoint prevalent patients on December 3

Table D.6Counts of prevalent ESRD patients, by mode of therapy: all dialysispoint prevalent patients on December 31

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 42 65 93 119 133 164 180 174 171 182 179 2055-9 112 106 131 154 165 137 161 167 174 193 208 18210-14 271 295 332 368 354 328 324 344 365 349 393 40815-19 843 858 901 848 845 887 855 889 957 1,028 1,024 1,04720-29 4,044 4,289 4,624 4,980 5,222 5,348 5,413 5,569 5,966 6,425 6,759 6,98630-39 6,421 7,155 7,968 8,771 9,584 10,230 10,773 11,376 12,243 13,415 14,365 15,50240-49 7,877 8,571 9,311 10,757 11,605 12,184 12,808 13,812 15,315 17,274 19,266 21,64850-59 11,862 13,272 14,596 15,911 16,989 17,854 18,591 19,370 20,803 22,553 24,554 27,02060-64 6,101 7,276 8,301 9,754 10,871 11,826 12,396 13,499 14,390 15,558 16,986 18,30565-69 5,533 6,217 7,047 8,613 9,760 10,863 12,266 13,873 15,313 17,105 18,927 20,91370-79 5,960 7,018 8,327 10,642 12,420 14,129 16,208 18,298 20,540 23,609 26,928 31,42080+ 879 1,110 1,405 2,027 2,440 3,027 3,716 4,552 5,371 6,459 7,839 9,284Unknown * * 11 19 26 26 25 14 11 * * *

0-19 1,268 1,324 1,457 1,489 1,497 1,516 1,520 1,574 1,667 1,752 1,804 1,84220-44 14,143 15,377 16,898 18,801 20,207 21,262 22,322 23,505 25,531 28,108 30,616 32,96945-64 22,162 25,186 27,902 31,372 34,064 36,180 37,659 40,121 43,186 47,117 51,314 56,49265-74 9,461 10,757 12,417 15,300 17,416 19,450 22,021 24,724 27,389 30,871 34,781 39,45975+ 2,911 3,588 4,362 5,982 7,204 8,569 10,169 11,999 13,835 16,302 18,913 22,158Unknown * * 11 19 26 26 25 14 11 * * *

Male 27,188 30,229 33,787 38,874 42,810 45,911 49,016 52,933 57,693 64,180 71,102 79,229Female 22,761 26,008 29,260 34,088 37,603 41,089 44,696 49,000 53,926 59,979 66,334 73,696Unknown . . . * * * * * . . * *

White 33,581 37,277 41,370 47,300 51,429 55,057 58,665 63,044 68,040 74,833 82,054 90,541Black 15,039 17,393 19,925 23,596 26,644 29,249 32,013 35,456 39,595 44,759 50,081 56,129Native American 280 376 465 626 748 850 979 1,139 1,305 1,487 1,688 1,910Asian 324 454 680 904 1,127 1,440 1,682 1,964 2,356 2,845 3,373 4,068Other/unknown 725 737 607 537 466 407 377 334 323 235 241 279


Diabetes 4,909 6,814 9,145 11,582 14,429 17,099 19,978 23,347 27,273 32,756 38,807 45,769Hypertension 8,502 10,928 13,892 16,880 19,643 22,209 25,003 28,095 31,692 36,393 40,995 46,328Glomerulonephritis 10,146 11,562 13,172 15,158 16,702 17,948 19,009 20,209 21,449 23,035 24,470 26,025Cystic kidney 3,207 3,636 4,129 4,688 5,026 5,326 5,478 5,667 5,793 5,959 6,173 6,474Other urologic 1,217 1,521 1,934 2,349 2,738 3,124 3,366 3,693 3,986 4,216 4,346 4,643Other cause 4,916 5,837 7,084 8,416 9,406 10,307 10,926 11,489 12,282 13,399 14,317 15,190Unknown cause 5,401 5,699 5,596 5,938 6,146 6,053 6,195 6,453 6,663 6,580 6,804 7,256Missing cause 11,651 10,240 8,095 7,952 6,324 4,937 3,761 2,984 2,481 1,821 1,525 1,242

All 49,949 56,237 63,047 72,963 80,414 87,003 93,716 101,937 111,619 124,159 137,437 152,927

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.The age of the point prevalent patient is determined as of December 31 of each calendar year. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. * Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.


382

Reference section D

Table D.6 (continued)Counts of prevalent ESRD patients, by mode of therapy: all dialysispoint prevalent patients on December 3

Table D.6 (continued)Counts of prevalent ESRD patients, by mode of therapy: all dialysispoint prevalent patients on December 31

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 202 223 220 235 231 204 217 214 248 233 232 2445-9 181 187 223 214 219 228 217 217 246 241 244 22310-14 415 422 450 445 432 430 457 433 495 521 567 52915-19 1,095 1,125 1,081 1,110 1,161 1,176 1,205 1,196 1,147 1,197 1,246 1,27520-29 7,409 7,679 8,016 8,196 8,435 8,621 8,893 8,972 9,075 9,083 8,989 8,98530-39 16,685 17,767 18,884 19,383 19,929 20,404 20,787 21,466 21,897 22,126 22,397 22,81440-49 23,779 25,994 28,375 30,884 33,247 34,999 37,087 38,777 40,321 41,513 42,668 43,89950-59 29,836 32,508 35,785 38,210 41,353 44,793 48,733 52,818 56,599 60,309 63,318 66,73460-64 19,634 20,968 22,514 23,969 25,377 26,910 28,697 30,099 31,517 32,947 34,873 36,91065-69 23,015 24,775 26,602 27,860 29,560 30,806 32,064 33,362 34,493 35,717 36,748 37,85470-79 35,575 39,094 43,762 47,341 51,715 56,106 59,631 62,766 65,446 67,043 69,276 70,54080+ 11,015 12,681 14,452 16,140 18,117 20,238 22,416 24,673 27,483 29,778 32,465 34,819Unknown * * * . . . . . . . . .

0-19 1,893 1,957 1,974 2,004 2,043 2,038 2,096 2,060 2,136 2,192 2,289 2,27120-44 35,467 37,669 39,894 41,528 43,266 44,770 46,226 47,556 48,531 49,211 49,593 50,39945-64 61,876 67,247 73,680 79,114 85,075 90,957 97,971 104,576 110,878 116,767 122,652 128,94365-74 44,000 47,927 52,307 55,206 58,843 62,110 64,788 67,234 69,461 71,396 73,303 74,93375+ 25,605 28,623 32,509 36,135 40,549 45,040 49,323 53,567 57,961 61,142 65,186 68,280Unknown * * * . . . . . . . . .

Male 87,317 95,100 103,917 110,853 119,491 127,980 136,679 145,108 153,131 160,065 167,682 174,554Female 81,525 88,322 96,448 103,131 110,281 116,931 123,723 129,881 135,832 140,639 145,335 150,250Unknown * * * * * * * * * * * 22

White 98,893 106,007 115,139 121,470 129,633 137,580 145,248 153,445 161,421 167,856 174,110 180,041Black 62,629 68,863 75,274 80,812 86,742 92,565 98,875 103,855 108,377 112,283 116,799 120,974Native American 2,208 2,467 2,705 2,967 3,204 3,430 3,753 3,997 4,193 4,429 4,577 4,674Asian 4,749 5,654 6,528 7,337 8,078 8,790 9,584 10,449 11,271 12,068 12,941 13,601Other/unknown 366 433 721 1,401 2,119 2,550 2,944 3,247 3,705 4,072 4,596 5,536



All 168,845 183,424 200,367 213,987 229,776 244,915 260,404 274,993 288,967 300,708 313,023 324,826


383


Table D.7Counts of prevalent ESRD patients, by mode of therapy: hemodialysispoint prevalent patients on December 3

Table D.7Counts of prevalent ESRD patients, by mode of therapy: hemodialysispoint prevalent patients on December 31

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 25 22 23 32 33 41 47 45 45 47 44 455-9 83 67 73 64 57 40 50 57 60 53 59 5810-14 224 233 228 223 179 163 138 152 160 150 169 15915-19 789 788 762 685 649 614 588 606 655 684 657 65320-29 3,780 3,948 4,158 4,301 4,376 4,412 4,401 4,467 4,722 5,104 5,301 5,42930-39 5,898 6,476 6,991 7,466 7,930 8,281 8,725 9,171 9,807 10,701 11,260 12,06240-49 7,267 7,824 8,285 9,280 9,811 10,074 10,530 11,342 12,551 14,115 15,584 17,27950-59 10,962 12,091 13,174 14,041 14,641 15,170 15,739 16,365 17,664 19,042 20,536 22,50160-64 5,742 6,674 7,510 8,667 9,507 10,151 10,607 11,525 12,303 13,343 14,452 15,63565-69 5,175 5,772 6,411 7,841 8,673 9,457 10,633 12,069 13,345 14,914 16,453 18,01870-79 5,519 6,472 7,520 9,721 11,222 12,553 14,389 16,241 18,291 21,129 24,007 27,87980+ 793 994 1,250 1,851 2,205 2,735 3,370 4,149 4,906 5,914 7,199 8,505Unknown * * 11 18 24 23 21 11 * * * *

0-19 1,121 1,110 1,086 1,004 918 858 823 860 920 934 929 91520-44 13,072 13,993 14,968 16,119 16,838 17,365 18,115 18,942 20,486 22,529 24,197 25,78545-64 20,577 23,020 25,150 27,636 29,427 30,723 31,887 33,928 36,561 39,776 42,936 47,12165-74 8,822 9,966 11,255 13,933 15,547 17,040 19,241 21,640 23,989 27,148 30,506 34,35275+ 2,665 3,272 3,926 5,480 6,553 7,705 9,151 10,819 12,553 14,809 17,153 20,050Unknown * * 11 18 24 23 21 11 * * * *

Male 25,258 27,692 30,278 34,113 36,832 38,796 41,370 44,600 48,704 54,174 59,713 66,153Female 21,003 23,674 26,118 30,076 32,474 34,915 37,866 41,598 45,815 51,031 56,017 62,075Unknown . . . * * * * * . . . *

White 30,745 33,523 36,330 40,606 43,060 45,035 47,905 51,435 55,527 61,159 66,506 72,958Black 14,278 16,379 18,457 21,743 24,214 26,342 28,711 31,816 35,523 40,112 44,658 49,900Native American 259 351 421 555 625 723 820 942 1,114 1,280 1,442 1,632Asian 315 427 622 816 998 1,271 1,486 1,728 2,093 2,478 2,946 3,526Other/unknown 664 686 566 470 410 343 316 279 262 176 178 214


Diabetes 4,299 5,918 7,762 9,787 12,025 14,146 16,651 19,540 22,983 27,726 32,751 38,479Hypertension 7,953 10,094 12,584 15,250 17,518 19,550 21,924 24,722 27,901 32,059 35,803 40,234Glomerulonephritis 9,318 10,444 11,648 13,067 14,003 14,759 15,589 16,491 17,411 18,675 19,717 20,829Cystic kidney 3,009 3,332 3,709 4,141 4,346 4,512 4,578 4,734 4,858 4,969 5,038 5,244Other urologic 1,132 1,390 1,722 2,084 2,392 2,710 2,926 3,232 3,483 3,687 3,756 4,015Other cause 4,544 5,309 6,284 7,286 7,958 8,523 9,052 9,466 10,149 10,994 11,691 12,283Unknown cause 4,946 5,135 4,966 5,189 5,292 5,141 5,228 5,477 5,665 5,579 5,732 6,150Missing cause 11,060 9,744 7,721 7,386 5,773 4,373 3,290 2,538 2,069 1,516 1,242 996

All 46,261 51,366 56,396 64,190 69,307 73,714 79,238 86,200 94,519 105,205 115,730 128,230



384

Reference section D

Table D.7 (continued)Counts of prevalent ESRD patients, by mode of therapy: hemodialysispoint prevalent patients on December 3

Table D.7 (continued)Counts of prevalent ESRD patients, by mode of therapy: hemodialysispoint prevalent patients on December 31

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 29 46 51 57 50 45 46 48 58 55 49 505-9 59 64 68 71 79 84 88 85 104 95 92 7610-14 176 177 205 203 190 184 214 211 242 262 286 26615-19 684 698 676 731 745 777 819 828 795 830 898 92220-29 5,732 5,895 6,185 6,392 6,699 6,932 7,288 7,464 7,594 7,635 7,638 7,65630-39 12,949 13,688 14,575 15,282 16,031 16,814 17,428 18,143 18,769 19,052 19,390 19,87040-49 18,953 20,743 22,667 24,911 27,478 29,459 31,915 33,775 35,430 36,806 38,044 39,24250-59 24,761 27,060 29,707 31,941 35,019 38,643 42,794 46,840 50,720 54,393 57,383 60,66060-64 16,629 17,898 19,211 20,530 22,111 23,822 25,861 27,365 28,847 30,348 32,188 34,02765-69 19,857 21,295 22,954 24,145 25,936 27,581 29,165 30,525 31,742 33,069 34,106 35,21670-79 31,487 34,595 38,894 42,341 46,631 51,341 55,217 58,434 61,305 63,186 65,336 66,54980+ 10,148 11,696 13,341 14,958 16,862 19,028 21,345 23,489 26,342 28,668 31,284 33,567Unknown * * * . . . . . . . . .

0-19 948 985 1,000 1,062 1,064 1,090 1,167 1,172 1,199 1,242 1,325 1,31420-44 27,686 29,252 31,032 32,807 34,955 36,886 38,913 40,408 41,705 42,533 43,213 44,05245-64 51,338 56,032 61,313 66,249 72,383 78,784 86,373 93,179 99,655 105,701 111,430 117,40365-74 38,282 41,555 45,556 48,382 52,110 56,039 59,223 61,805 64,292 66,523 68,402 69,93575+ 23,210 26,031 29,633 33,062 37,319 41,911 46,504 50,643 55,097 58,400 62,324 65,397Unknown * * * . . . . . . . . .


White 79,590 85,513 93,310 99,396 107,943 117,184 126,401 134,872 143,451 150,467 156,777 162,538Black 55,658 61,098 66,835 72,311 78,461 84,733 91,449 96,614 101,363 105,430 109,958 114,006Native American 1,864 2,113 2,323 2,573 2,830 3,055 3,402 3,682 3,852 4,080 4,226 4,326Asian 4,063 4,781 5,464 6,093 6,792 7,529 8,318 9,153 9,942 10,730 11,545 12,139Other/unknown 293 351 603 1,189 1,805 2,209 2,610 2,886 3,340 3,692 4,188 5,092



All 141,468 153,856 168,535 181,562 197,831 214,710 232,180 247,207 261,948 274,399 286,694 298,101


385


Table D.8Counts of prevalent ESRD patients, by mode of therapy: peritoneal dialysispoint prevalent patients on December 3

Table D.8Counts of prevalent ESRD patients, by mode of therapy: peritoneal dialysispoint prevalent patients on December 31

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 11 32 54 70 78 106 118 102 102 105 109 1405-9 * 20 44 70 86 72 90 89 87 114 118 10710-14 17 33 67 120 144 139 159 166 171 163 191 21415-19 11 39 91 126 158 231 216 239 242 291 300 32820-29 65 193 301 528 681 769 840 925 1,042 1,091 1,262 1,37630-39 146 378 620 1,010 1,328 1,647 1,722 1,880 2,084 2,332 2,731 3,07240-49 138 388 662 1,162 1,437 1,769 1,933 2,086 2,359 2,747 3,245 3,88950-59 227 651 956 1,488 1,945 2,268 2,469 2,625 2,726 3,096 3,562 4,00960-64 79 338 547 864 1,130 1,437 1,567 1,736 1,825 1,982 2,250 2,35765-69 89 253 434 608 889 1,198 1,441 1,569 1,714 1,928 2,196 2,61370-79 92 246 518 639 931 1,285 1,496 1,726 1,877 2,137 2,516 3,12480+ 13 49 95 112 155 208 255 310 355 433 516 627Unknown . . . * * * * * . . . .

0-19 48 124 256 386 466 548 583 596 602 673 718 78920-44 275 760 1,229 2,080 2,694 3,245 3,530 3,856 4,299 4,762 5,612 6,39645-64 380 1,188 1,857 2,972 3,827 4,645 5,001 5,396 5,737 6,486 7,438 8,30765-74 148 417 787 1,021 1,507 2,050 2,400 2,648 2,931 3,275 3,782 4,58275+ 46 131 260 338 468 641 792 957 1,015 1,223 1,446 1,782Unknown . . . * * * * * . . . .

Male 466 1,351 2,298 3,707 4,797 5,934 6,458 7,070 7,640 8,641 9,950 11,560Female 431 1,269 2,091 3,091 4,167 5,197 5,850 6,385 6,944 7,778 9,046 10,296Unknown . . . . . . . * . . . .

White 733 2,065 3,379 5,255 6,819 8,492 9,262 10,049 10,835 11,956 13,694 15,574Black 138 502 920 1,378 1,902 2,366 2,716 3,006 3,332 3,946 4,695 5,538Native American 13 19 36 63 111 113 149 182 176 191 229 265Asian * 20 43 67 106 133 156 200 221 309 359 455Other/unknown * 14 11 35 26 27 25 19 20 17 19 24


Diabetes 203 544 1,014 1,416 2,009 2,530 2,920 3,333 3,737 4,479 5,370 6,460Hypertension 169 496 929 1,295 1,720 2,224 2,626 2,892 3,240 3,765 4,601 5,429Glomerulonephritis 220 607 949 1,612 2,187 2,706 2,919 3,206 3,492 3,814 4,215 4,689Cystic kidney 64 177 302 454 583 718 803 828 822 877 1,007 1,129Other urologic 24 85 143 204 286 351 361 382 421 467 509 548Other cause 105 304 555 916 1,200 1,527 1,625 1,765 1,873 2,075 2,311 2,565Unknown cause 80 228 325 466 556 617 674 699 700 735 817 899Missing cause 32 179 172 435 423 458 380 351 299 207 166 137

All 897 2,620 4,389 6,798 8,964 11,131 12,308 13,456 14,584 16,419 18,996 21,856



386

Reference section D

Table D.8 (continued)Counts of prevalent ESRD patients, by mode of therapy: peritoneal dialysispoint prevalent patients on December 3

Table D.8 (continued)Counts of prevalent ESRD patients, by mode of therapy: peritoneal dialysispoint prevalent patients on December 31

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 149 148 153 161 169 151 167 162 181 167 176 1875-9 98 105 135 132 131 135 113 120 133 137 140 14010-14 208 208 217 210 219 228 225 205 231 237 269 24615-19 349 362 354 345 373 356 334 329 317 319 303 31920-29 1,489 1,619 1,670 1,658 1,616 1,579 1,477 1,366 1,345 1,335 1,251 1,25030-39 3,383 3,697 3,903 3,850 3,679 3,394 3,158 3,104 2,928 2,891 2,843 2,80140-49 4,343 4,797 5,224 5,585 5,500 5,273 4,909 4,735 4,613 4,470 4,409 4,47350-59 4,573 5,022 5,627 5,973 6,060 5,925 5,686 5,675 5,614 5,722 5,739 5,90060-64 2,705 2,807 3,033 3,238 3,129 2,989 2,742 2,614 2,570 2,521 2,596 2,79965-69 2,890 3,218 3,383 3,466 3,337 3,053 2,763 2,669 2,588 2,589 2,592 2,58870-79 3,633 4,115 4,510 4,631 4,539 4,380 4,139 3,919 3,775 3,772 3,836 3,91180+ 727 845 986 1,045 1,037 1,049 969 987 978 1,067 1,125 1,211Unknown . . * . . . . . . . . .

0-19 804 823 859 848 892 870 839 816 862 860 888 89220-44 7,007 7,633 8,039 8,130 7,846 7,446 6,850 6,645 6,361 6,254 6,018 6,04745-64 9,486 10,309 11,418 12,174 12,138 11,714 11,122 10,849 10,709 10,685 10,820 11,17665-74 5,181 5,871 6,280 6,358 6,142 5,685 5,284 5,039 4,811 4,770 4,799 4,89975+ 2,069 2,307 2,599 2,784 2,771 2,797 2,587 2,536 2,530 2,658 2,754 2,811Unknown . . * . . . . . . . . .

Male 12,879 14,121 15,209 15,716 15,295 14,553 13,567 13,135 12,913 12,792 12,938 13,189Female 11,668 12,822 13,987 14,578 14,494 13,959 13,115 12,750 12,360 12,435 12,341 12,635Unknown . . . . . . . . . . . *

White 17,371 18,720 20,019 20,610 20,103 19,169 17,756 17,201 16,708 16,678 16,630 16,896Black 6,217 7,052 7,738 7,950 7,820 7,454 7,066 6,842 6,646 6,561 6,582 6,749Native American 328 336 370 385 364 366 343 304 326 337 346 339Asian 602 798 1,003 1,187 1,234 1,217 1,212 1,216 1,269 1,303 1,347 1,429Other/unknown 29 37 66 162 268 306 305 322 324 348 374 412


Diabetes 7,640 8,336 9,330 9,995 10,117 9,788 9,167 8,899 8,751 8,788 8,836 9,006Hypertension 6,095 6,825 7,430 7,389 6,902 6,476 6,000 5,909 5,778 5,633 5,786 6,013Glomerulonephritis 5,097 5,541 5,955 6,214 6,207 5,945 5,548 5,219 5,084 4,959 4,864 4,882Cystic kidney 1,251 1,353 1,412 1,463 1,444 1,332 1,228 1,199 1,148 1,173 1,097 1,168Other urologic 611 661 688 747 748 758 733 739 744 766 794 794Other cause 2,794 3,044 3,158 3,268 3,185 3,056 2,919 2,903 2,775 2,898 2,914 2,942Unknown cause 966 1,105 1,173 1,173 1,152 1,128 1,061 988 968 993 956 958Missing cause 93 78 50 45 34 29 26 29 25 17 32 62

All 24,547 26,943 29,196 30,294 29,789 28,512 26,682 25,885 25,273 25,227 25,279 25,825


387


Table D.9Counts of prevalent ESRD patients, by mode of therapy: functioning transplantpoint prevalent patients on December 3

Table D.9Counts of prevalent ESRD patients, by mode of therapy: functioning transplantpoint prevalent patients on December 31

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 31 47 75 89 100 126 135 173 177 175 164 1755-9 114 131 159 173 222 290 341 377 407 465 503 56110-14 303 337 383 429 491 536 565 616 662 724 773 81315-19 704 791 842 937 1,005 1,095 1,221 1,318 1,345 1,348 1,364 1,38320-29 2,670 3,225 3,764 4,265 4,747 5,286 5,878 6,227 6,460 6,626 6,967 7,21730-39 2,848 3,755 4,640 5,681 6,916 8,253 9,661 10,755 11,784 12,731 13,795 14,78040-49 1,977 2,483 3,142 3,879 4,734 5,898 7,282 8,754 10,189 11,636 13,021 14,77950-59 1,194 1,542 1,974 2,455 3,132 3,857 4,929 5,966 6,956 7,945 9,063 10,12860-64 170 235 315 426 602 835 1,176 1,580 2,072 2,527 3,001 3,50265-69 59 72 94 121 168 257 378 589 826 1,085 1,393 1,75770-79 17 25 29 39 54 80 114 179 245 328 470 67480+ * * * * * 12 17 16 17 17 25 32Unknown * * * * * * * * * * * *

0-19 1,152 1,306 1,459 1,628 1,818 2,047 2,262 2,484 2,591 2,712 2,804 2,93220-44 6,584 8,344 10,144 12,075 14,260 16,739 19,545 21,751 23,757 25,708 27,966 30,08945-64 2,275 2,896 3,691 4,631 5,871 7,390 9,381 11,531 13,704 15,757 17,881 20,31765-74 73 89 116 152 213 322 470 729 1,018 1,343 1,772 2,31675+ * * 11 * 14 27 39 55 70 87 116 147Unknown * * * * * * * * * * * *

Male 6,031 7,657 9,408 11,299 13,567 16,276 19,435 22,374 25,022 27,621 30,486 33,509Female 4,061 4,989 6,014 7,197 8,608 10,247 12,260 14,172 16,108 17,976 20,045 22,284Unknown * * * * * * * * 11 11 * *

White 8,171 10,266 12,475 14,890 17,815 21,208 25,283 29,118 32,662 36,291 40,174 44,312Black 1,542 1,937 2,413 2,949 3,544 4,348 5,226 5,997 6,742 7,342 8,089 8,934Native American 71 93 116 136 176 219 259 297 358 427 472 540Asian 89 123 184 258 356 440 590 752 935 1,095 1,322 1,515Other/unknown 220 229 236 266 288 313 342 388 444 453 484 502


Diabetes 847 1,225 1,705 2,268 2,931 3,844 4,978 5,983 6,958 8,052 9,210 10,475Hypertension 1,004 1,308 1,679 2,153 2,623 3,272 3,982 4,676 5,363 5,980 6,761 7,471Glomerulonephritis 3,391 4,236 5,179 6,162 7,403 8,761 10,266 11,717 13,095 14,378 15,818 17,378Cystic kidney 428 576 741 932 1,210 1,512 1,945 2,423 2,887 3,314 3,797 4,277Other urologic 409 544 653 800 941 1,118 1,301 1,484 1,655 1,832 2,010 2,215Other cause 1,698 2,133 2,592 3,143 3,811 4,522 5,412 6,113 6,631 7,210 7,803 8,545Unknown cause 853 1,049 1,214 1,357 1,529 1,724 1,941 2,174 2,375 2,595 2,799 3,017Missing cause 1,463 1,577 1,661 1,684 1,731 1,775 1,875 1,982 2,177 2,247 2,343 2,425

All 10,093 12,648 15,424 18,499 22,179 26,528 31,700 36,552 41,141 45,608 50,541 55,803



388

Reference section D

Table D.9 (continued)Counts of prevalent ESRD patients, by mode of therapy: functioning transplantpoint prevalent patients on December 3

Table D.9 (continued)Counts of prevalent ESRD patients, by mode of therapy: functioning transplantpoint prevalent patients on December 31

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 192 201 198 185 215 210 213 236 244 262 265 2585-9 565 590 583 608 623 685 679 701 657 697 708 75910-14 879 931 1,007 1,092 1,159 1,156 1,226 1,278 1,304 1,305 1,357 1,37315-19 1,401 1,473 1,643 1,767 1,803 1,897 1,933 2,072 2,162 2,199 2,227 2,37220-29 7,307 7,395 7,364 7,428 7,580 7,675 7,727 7,754 7,742 7,764 7,842 7,96330-39 15,627 16,462 17,239 17,955 18,506 18,829 19,319 19,510 19,824 20,001 20,118 20,01840-49 16,459 18,252 19,976 21,789 23,310 24,625 26,120 27,487 28,995 30,224 31,330 32,42650-59 11,496 12,931 14,338 15,762 17,505 19,771 22,034 24,284 26,527 29,019 31,449 33,82560-64 3,970 4,416 4,905 5,494 6,201 6,876 7,687 8,486 9,276 10,218 11,404 12,65065-69 2,201 2,704 3,162 3,649 4,189 4,710 5,237 5,869 6,515 7,276 8,065 8,98970-79 901 1,133 1,447 1,790 2,176 2,687 3,235 3,764 4,496 5,196 6,147 7,03980+ 32 37 49 58 85 97 129 179 231 291 372 458Unknown * * * * * * * * * * * *

0-19 3,037 3,195 3,431 3,652 3,800 3,948 4,051 4,287 4,367 4,463 4,557 4,76220-44 31,774 33,498 34,893 36,456 37,686 38,707 39,917 40,824 41,591 42,248 42,835 43,20645-64 23,085 25,958 28,929 31,972 35,416 39,069 42,970 46,697 50,773 54,978 59,308 63,67665-74 2,966 3,659 4,373 5,104 5,937 6,840 7,766 8,763 9,962 11,224 12,666 14,17275+ 168 215 285 393 513 654 835 1,049 1,280 1,539 1,918 2,314Unknown * * * * * * * * * * * *


White 48,350 52,619 56,441 60,496 64,660 68,906 73,585 78,031 82,677 87,320 92,341 97,007Black 9,797 10,714 11,902 13,165 14,425 15,642 16,828 17,989 19,184 20,509 21,825 23,271Native American 590 640 722 785 836 893 957 1,050 1,114 1,162 1,219 1,269Asian 1,789 2,035 2,323 2,598 2,883 3,202 3,560 3,898 4,280 4,665 5,052 5,528Other/unknown 506 520 525 535 550 576 610 653 719 797 848 1,056


Diabetes 11,622 13,146 14,543 16,021 17,598 19,092 20,714 22,227 23,812 25,473 27,295 28,940Hypertension 8,323 9,167 10,143 11,102 12,037 12,896 13,772 14,549 15,389 16,388 17,431 18,391Glomerulonephritis 18,851 20,225 21,567 23,017 24,444 25,949 27,591 29,177 30,807 32,292 33,952 35,581Cystic kidney 4,831 5,316 5,773 6,341 6,882 7,522 8,178 8,774 9,418 10,104 10,826 11,663Other urologic 2,399 2,626 2,784 3,024 3,240 3,481 3,725 3,935 4,149 4,409 4,678 4,949Other cause 9,259 10,022 10,727 11,444 12,234 12,997 13,828 14,654 15,513 16,343 17,194 18,024Unknown cause 3,241 3,491 3,750 3,938 4,145 4,417 4,682 5,015 5,323 5,716 6,087 6,489Missing cause 2,506 2,535 2,626 2,692 2,774 2,865 3,050 3,290 3,563 3,728 3,822 4,094

All 61,032 66,528 71,913 77,579 83,354 89,219 95,540 101,621 107,974 114,453 121,285 128,131


389


ON OUR WEBSITE & CDIncident ESRD patients, 1995 & 1999: by age, gender, race/ethnicity, primary diagnosis, & modality (Table D.10.1).

Table D.10Incident ESRD patients, 2003: by age, gender, race/ethnicity, primary diagnosis, & modality Table D.10Incident ESRD patients, 2003: by age, gender, race/ethnicity, primary diagnosis, & modality

Center Center Home Uncertain hemo self hemo hemo CAPD CCPD Other PD dialysis Transplant All

0-4 44 . . * 110 . * 39 2075-9 43 . . 13 41 * * 51 15310-14 161 . . 14 111 * * 51 34015-19 441 * . 23 81 * * 88 63720-29 2,137 * * 160 73 * * 166 2,54530-39 4,877 . * 404 167 * * 287 5,76040-49 10,089 * 25 668 324 22 26 480 11,63850-59 16,964 * 33 1,055 452 31 47 546 19,13360-64 10,271 * 18 550 210 24 15 174 11,26365-69 11,204 * 22 551 195 41 31 131 12,18070-79 23,523 13 46 802 265 96 74 53 24,87280+ 13,288 * 40 311 100 62 27 * 13,839Unknown

0-19 689 * . 60 343 * * 229 1,33720-44 11,224 * 22 845 374 19 28 657 13,17245-64 33,114 * 65 1,992 852 65 75 996 37,16765-74 22,862 13 45 1,021 330 82 71 175 24,59975+ 25,153 14 63 643 230 117 61 11 26,292Unknown

Male 50,415 23 98 2,408 1,154 163 131 1,192 55,584Female 42,607 16 97 2,152 974 126 109 874 46,955Unknown 20 . . * * . * * 28

White 59,305 28 124 3,229 1,475 227 187 1,712 66,287Black 27,545 * 64 973 493 52 35 187 29,357Native American 1,016 . . 47 16 * * 13 1,097Asian 3,217 * * 245 71 * * 58 3,608Other/unknown 1,959 . * 67 74 * 14 98 2,218

Hispanic 12,255 * 24 464 312 36 22 142 13,258Non-Hispanic 80,787 36 171 4,097 1,817 253 222 1,926 89,309

Diabetes 41,844 17 79 2,016 792 114 101 367 45,330Hypertension 26,474 12 67 1,081 387 91 39 168 28,319Glomerulonephritis 7,010 * 11 596 365 24 17 359 8,384Cystic kidney 1,619 * * 226 124 * 11 305 2,291Other urologic 2,502 . * 117 61 12 * 124 2,827Other cause 9,160 * 20 374 290 32 27 283 10,192Unknown cause 3,859 . 15 125 94 * * 102 4,209Missing cause 574 . * 26 16 * 34 360 1,015

All 93,042 39 195 4,561 2,129 289 244 2,068 102,567

The incident cohorts and associated modalities are determined at the time of ESRD initiation without applying the 60-day stable modality rule.The age of the incident patient is determined as of the date of ESRD initiation.* Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.


390

Reference section D

ON OUR WEBSITE & CDPrevalent ESRD patients, 1995 & 1999 (Table D.11.1). Counts of incident ESRD patients

for selected years (Table D.a). Living ESRD patients on December 31 for selected

years (D.b). Incident ESRD patients for selected years (D.c). Living ESRD patients on

December 31 for selected years, by age & ESRD network of residence (D.d).

Table D.11Prevalent ESRD patients, 2003: by age, gender, race/ethnicity, primary diagnosis, & modality Table D.11Prevalent ESRD patients, 2003: by age, gender, race/ethnicity, primary diagnosis, & modality


0-4 49 . * 16 171 * * 258 5025-9 75 . * 24 116 * * 759 98210-14 259 . * 18 228 . 17 1,373 1,90215-19 915 . * 45 274 * 33 2,372 3,64720-29 7,623 * 32 470 780 * 76 7,963 16,94830-39 19,744 25 101 1,224 1,577 * 141 20,018 42,83240-49 38,982 52 208 2,027 2,446 * 178 32,426 76,32550-59 60,327 43 290 2,832 3,068 11 163 33,825 100,55960-64 33,864 22 141 1,383 1,416 13 71 12,650 49,56065-69 35,077 16 123 1,092 1,496 * 43 8,989 46,84370-79 66,253 25 271 1,650 2,261 12 68 7,039 77,57980+ 33,415 * 143 500 711 * 31 458 35,277Unknown . . . . . . . * *

0-19 1,298 . 16 103 789 * 62 4,762 7,03320-44 43,792 44 216 2,586 3,461 * 293 43,206 93,60545-64 116,748 99 556 5,350 5,826 28 336 63,676 192,61965-74 69,647 33 255 2,071 2,828 15 84 14,172 89,10575+ 65,098 17 282 1,171 1,640 14 58 2,314 70,594Unknown . . . . . . . * *

Male 159,959 119 787 5,504 7,685 36 464 75,969 250,523Female 136,605 74 538 5,777 6,858 31 367 52,150 202,400Unknown 19 . . . * . * 12 34

White 161,522 112 904 7,251 9,645 42 565 97,007 277,048Black 113,568 73 365 2,958 3,791 12 207 23,271 144,245Native American 4,316 * * 170 169 * * 1,269 5,943Asian 12,094 * 40 737 692 * 32 5,528 19,129Other/unknown 5,083 * * 165 247 11 21 1,056 6,592

Hispanic 41,753 11 95 1,345 1,991 18 86 14,309 59,608Non-Hispanic 254,830 182 1,230 9,936 12,553 49 747 113,822 393,349

Diabetes 126,489 50 422 4,161 4,845 16 190 28,940 165,113Hypertension 84,698 52 332 2,695 3,318 18 138 18,391 109,642Glomerulonephritis 33,450 51 268 2,031 2,851 * 206 35,581 74,444Cystic kidney 7,466 14 49 534 634 * 48 11,663 20,409Other urologic 8,028 * 46 319 475 * 38 4,949 13,861Other cause 24,764 21 142 1,092 1,850 17 112 18,024 46,022Unknown cause 11,100 * 62 416 542 * 39 6,489 18,656Missing cause 588 . * 33 29 . 62 4,094 4,810

All 296,583 193 1,325 11,281 14,544 67 833 128,131 452,957

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.The age of point prevalent patients determined as of December 31 of each cohort year.* Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.

391


ON OUR WEBSITE & CDTreatment status two years after first ESRD service, 1999-2001 (Tables D.12.1-18).

Table D.12Treatment status two years after first ESRD service, 1999-2001 incident patients with Medicare coverage, 999-200 combined

Table D.12Treatment status two years after first ESRD service, 1999-2001 incident patients with Medicare coverage, 1999-2001 combined

Treatment status two years after first ESRD service (percent of patients) Center Home CAPD & Oth/unk Lost to

ALL % on Day 90 Count hemo hemo CCPD dialysis Transplant Death FollowupAge at first service

0-19 1,397 29.5 0.1 16.6 0.8 45.8 5.6 1.620-44 19,478 58.9 0.1 9.2 0.1 14.7 15.2 1.845-64 49,796 61.1 0.2 5.8 . 5.3 26.2 1.365-74 48,482 52.4 0.2 4.3 . 1.9 39.4 1.775+ 44,950 42.6 0.1 1.9 . 0.1 53.9 1.2

Modality on day 90Center hemodialysis 145,971 56.9 0.1 1.5 . 2.9 36.9 1.6Home hemodialysis 494 29.8 14.6 2.4 . 3.0 49.0 1.2CAPD/CCPD 13,839 19.1 0.2 39.8 0.1 8.5 31.8 0.5Other/unknown dialysis 2,086 49.6 0.1 5.7 1.0 1.9 39.1 2.5Transplant 1,713 1.5 . 0.3 0.2 94.0 3.9 0.1

Interaction of age at first service & modality on day 900-19 Center hemodialysis 715 49.5 0.1 6.2 0.7 35.2 6.3 2.0

Home hemodialysis * 25.0 . 25.0 . 25.0 25.0 .CAPD/CCPD 480 10.8 0.2 38.5 0.6 42.1 6.0 1.7Other/unknown dialysis * 22.2 . 22.2 11.1 22.2 22.2 .Transplant 189 1.6 . . 1.1 96.8 0.5 .

20-44 Center hemodialysis 16,326 66.7 0.1 3.8 . 11.0 16.3 2.0Home hemodialysis 47 44.7 19.1 8.5 . 12.8 10.6 4.3CAPD/CCPD 2,443 21.9 0.2 47.3 0.2 19.1 10.8 0.5Other/unknown dialysis 54 38.9 . 9.3 11.1 18.5 22.2 .Transplant 608 1.5 . 0.7 0.2 94.7 2.8 0.2

45-64 Center hemodialysis 44,037 66.4 0.1 1.9 . 3.7 26.5 1.4Home hemodialysis 160 38.1 21.9 2.5 . 4.4 31.9 1.3CAPD/CCPD 4,637 21.3 0.3 43.8 . 8.3 26.0 0.3Other/unknown dialysis 329 50.8 0.3 6.4 1.8 3.3 31.6 5.8Transplant 633 1.4 . 0.2 . 93.4 5.1 .

65-74 Center hemodialysis 43,265 55.9 0.1 1.3 . 1.3 39.5 1.8Home hemodialysis 115 25.2 12.2 1.7 . 0.9 60.0 .CAPD/CCPD 3,950 18.3 0.3 37.3 . 3.0 40.6 0.5Other/unknown dialysis 882 53.2 0.2 6.7 0.6 1.7 34.5 3.2Transplant 270 1.9 . . . 92.6 5.6 .

75+ Center hemodialysis 41,628 44.2 0.1 0.4 . 0.1 53.9 1.3Home hemodialysis 168 20.8 8.3 0.6 . . 69.0 1.2CAPD/CCPD 2,329 14.9 0.1 28.4 . 0.3 55.8 0.4Other/unknown dialysis 812 46.3 . 3.8 0.4 0.2 48.5 0.7Transplant 13 . . . . 84.6 15.4 .

All 164,103 53.0 0.2 4.8 . 4.3 36.2 1.5

The incident cohorts and associated modalities are determined at the time of ESRD initiation without applying the 60-day stable modality rule.The age of the incident patient is determined as of the date of ESRD initiation.Includes only incident patients with known age & patients who have Medicare as their primary payor, are receiving their first ESRD service, & survive the first 90 days.* Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.


392

Reference section D

Table D.13Prevalent ESRD patients, 2003: by patient vintage point prevalent patients on December 3, by year-end treatment modality & number of years patient has had ESRD (vintage)

Table D.13Prevalent ESRD patients, 2003: by patient vintage point prevalent patients on December 31, by year-end treatment modality & number of years patient has had ESRD (vintage)

Functioning Center Center Home UncertainDialysis graft hemo self hemo hemo CAPD CCPD Other PD dialysis All

0 84,834 3,367 77,061 26 272 3,884 3,389 32 170 88,2011 62,008 5,962 56,135 14 147 2,428 3,178 17 89 67,9702 44,734 7,864 40,498 21 137 1,607 2,372 * 98 52,5983 32,865 9,164 30,133 20 138 860 1,666 * 44 42,0294 24,428 9,875 22,669 11 95 571 1,042 * 38 34,3035 17,536 9,926 16,308 17 60 425 677 * 45 27,4626 12,666 9,402 11,833 14 58 288 435 . 38 22,0687 9,358 8,793 8,717 * 54 211 312 * 54 18,1518 6,983 8,052 6,503 * 34 170 241 . 26 15,0359 5,475 7,313 5,050 * 29 144 211 * 33 12,78810 4,294 6,553 3,937 * 29 124 166 * 34 10,84711 3,460 5,891 3,169 * 25 96 136 . 28 9,35112 2,691 5,054 2,452 * 23 88 103 . 23 7,74513 2,279 4,466 2,075 * 19 62 101 . 18 6,74514 1,944 3,783 1,765 * 12 54 87 . 25 5,72715 1,629 3,331 1,477 * * 45 80 * 11 4,96016 1,245 2,881 1,114 * 21 41 59 . * 4,12617 1,063 2,499 941 * 13 39 59 . * 3,56218 879 2,143 779 * 14 22 53 * * 3,02219 789 1,929 701 * 20 18 40 * * 2,71820 666 1,717 609 * 14 17 21 . * 2,38321 580 1,580 526 * 16 13 20 . * 2,16022 447 1,288 391 * 14 18 17 . * 1,73523 388 1,122 354 * * * 15 . * 1,51024 377 918 334 . 17 * 19 . * 1,29525 286 862 255 * * * 12 . * 1,14826 312 832 272 * 15 12 11 . * 1,14427 146 402 136 . . * * . * 54828 146 314 123 * * * * . * 46029 128 269 105 . * * * . * 39730 86 243 71 . * * * . * 32931 42 110 35 . * * * . * 15232 23 86 21 . * . . . * 10933 * 38 * . . * * . . 4834 15 53 14 . . . * . . 6835 * 23 * . * . * . . 3236 * 26 * . . . . . . 31

All 324,826 128,131 296,583 193 1,325 11,281 14,544 67 833 452,957

The point prevalent cohorts & associated modalities are determined on December 31 of each calendar year without applying the 60-day stable modality rule.* Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.

393


Table D.14Prevalent ESRD patients, 2003: by number of years on modality point prevalent patients on December 3, by year-end treatment modality

Table D.14Prevalent ESRD patients, 2003: by number of years on modality point prevalent patients on December 31, by year-end treatment modality

Functioning Center Center Home UncertainDialysis graft hemo self hemo hemo CAPD CCPD Other PD dialysis All

0 205,057 15,068 186,796 139 970 6,980 9,449 36 687 220,1251 62,106 13,949 56,167 36 198 2,406 3,211 18 70 76,0552 28,272 12,783 25,877 11 77 1,111 1,152 * 40 41,0553 12,678 11,403 11,910 * 30 328 403 * * 24,0814 7,128 10,211 6,707 . 23 202 189 * * 17,3395 3,737 9,339 3,576 * * 75 71 . * 13,0766 2,275 7,924 2,176 * * 52 34 * * 10,1997 1,314 6,948 1,248 . * 42 20 * * 8,2628 1,144 6,160 1,094 . * 35 * * * 7,3049 359 5,091 347 . . * * . . 5,45010 186 4,536 169 . . 15 * . * 4,72211 128 3,667 125 . . * . . . 3,79512 108 3,441 98 . * * * . * 3,54913 73 2,858 71 . . * . . . 2,93114 58 2,447 51 . . * . . * 2,50515 36 2,063 31 . . * * * . 2,09916 34 1,805 32 . . * . . . 1,83917 22 1,665 22 . . . . . . 1,68718 17 1,249 15 . . * . . . 1,26619 * 1,092 * . * . . * . 1,10220 15 982 13 . . * . . . 99721 11 795 * . * . . . . 80622 * 657 * . * * . . . 66723 * 530 * . . . . . . 53524 * 455 * . . . . . . 46525 * 380 * . * . . . . 38626 * 267 * . . . . . . 27427 * 78 * . . . . . . 7928 * 85 * . . . . . * 9029 * 56 . . . . . . * 6130 * 55 * . . . . . * 6231 * 39 . . . . . . * 4032 * 24 . . . . . . * 2533 . 11 . . . . . . . 1134 . 18 . . . . . . . 18

All 324,826 128,131 296,583 193 1,325 11,281 14,544 67 833 452,957

The point prevalent cohorts and associated modalities are determined on December 31 of each calendar year without applying the 60-day stable modality rule.* Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.


394

Reference section D

ON OUR WEBSITE & CDIncident ESRD patients for selected years: by state (Table D.e).

Table D.15Incident ESRD patients, 2003: by modality & state/territoryincident ESRD patients

Table D.15Incident ESRD patients, 2003: by modality & state/territoryincident ESRD patients


Alabama 1,693 * . 107 21 * * 33 1,859Alaska 81 . . 11 * . . * 98Arizona 1,759 * . 78 15 * * 28 1,886Arkansas 799 * . 73 25 * * 11 917California 11,090 * * 637 161 11 42 143 12,089Colorado 760 . . 40 * . . 23 828Connecticut 779 . . 109 50 . * 22 962Delaware 331 . . 11 * . . * 349District of Columbia 425 . . 14 * * . * 451Florida 5,779 * 74 249 117 32 18 74 6,344Georgia 3,056 . * 186 73 * * 34 3,359Hawaii 449 . * 32 * . . * 489Idaho 227 . . 28 * * * * 267Illinois 4,184 . 47 248 95 14 * 103 4,698Indiana 1,787 * * 149 15 * * 36 2,001Iowa 666 . . 37 13 . * 30 750Kansas 634 * . 58 * * * 17 724Kentucky 1,188 . * 79 28 15 . 19 1,330Louisiana 2,265 . . 70 19 * * 25 2,385Maine 301 . . 14 * * . * 326Maryland 2,157 * . 90 60 * 19 52 2,380Massachusetts 1,594 . . 72 55 * * 50 1,777Michigan 3,225 . * 256 37 * * 86 3,616Minnesota 1,013 . . 47 21 * * 98 1,183Mississippi 1,184 . * 59 52 * . 19 1,323Missouri 1,781 . * 111 52 * * 23 1,981Montana 156 . . 23 * * . * 190Nebraska 430 . . 32 * . . 23 490Nevada 660 . . 43 * * * * 728New Hampshire 247 . . 19 * . * * 282New Jersey 3,145 . . 74 80 11 * 74 3,390New Mexico 534 . . 40 20 . . * 600New York 6,436 . * 188 93 55 * 125 6,913North Carolina 2,967 * * 96 98 * * 35 3,207North Dakota 132 . . 11 * * . 15 164Ohio 4,054 * 11 232 79 * 11 86 4,482Oklahoma 1,135 * . 53 29 23 . 18 1,259Oregon 790 . * 65 16 . * 29 902Pennsylvania 4,194 * * 95 128 * * 61 4,492Rhode Island 305 . * 13 . * * 11 338South Carolina 1,675 * . 65 63 . * 20 1,826South Dakota 227 . . 11 * . * * 253Tennessee 1,869 . . 59 94 * * 27 2,055Texas 7,158 . 17 237 219 38 14 88 7,771Utah 309 . * 22 * * * 19 365Vermont 127 . . * * . * * 139Virginia 2,450 . * 109 34 12 * 63 2,675Washington 1,311 19 * 75 11 * * 33 1,462West Virginia 627 . * 31 33 * * 15 709Wisconsin 1,423 . . 75 50 * * 73 1,633Wyoming 75 . . * * * . * 89

American Samoa 20 . . . . . . . 20Guam 89 . . * . . * . 93Puerto Rico 1,185 . . * 91 * . * 1,295Saipan 19 . . . . . . . 19Virgin Islands 39 . . * * . . . 43

Foreign 16 . . . . . . . 16Unknown 31 . . * * . 12 248 295

All 93,042 39 195 4,561 2,129 289 244 2,068 102,567

The incident cohorts and associated modalities are determined at the time of ESRD initiation without applying the 60-day stable modality rule.* Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.

395


ON OUR WEBSITE & CDLiving ESRD patients on December 31 for selected years: by state (Table D.f ).

Table D.16Prevalent ESRD patients, 2003: by modality & state/territorypoint prevalent ESRD patients on December 3

Table D.16Prevalent ESRD patients, 2003: by modality & state/territorypoint prevalent ESRD patients on December 31


Alabama 5,972 * * 236 312 * * 2,212 8,750Alaska 234 . * 41 34 . * 225 541Arizona 5,321 * * 163 237 . 11 2,114 7,857Arkansas 2,347 * * 230 142 . * 1,031 3,762California 36,135 21 42 1,659 1,730 * 121 14,253 53,967Colorado 2,648 * * 95 109 . * 1,626 4,495Connecticut 2,792 . * 185 346 . 15 1,369 4,712Delaware 958 . * 18 38 . * 485 1,501District of Columbia 1,725 . * 30 29 . * 344 2,135Florida 17,278 * 145 431 868 * 34 6,509 25,272Georgia 11,161 . 44 449 514 * 15 3,088 15,272Hawaii 1,874 . . 74 44 . * 525 2,519Idaho 617 * * 95 47 . * 533 1,302Illinois 12,947 * 232 572 673 * 38 6,530 21,002Indiana 5,565 * 19 349 264 * 20 2,733 8,953Iowa 2,008 . 19 94 68 . 16 1,574 3,779Kansas 1,997 . 16 141 105 * * 997 3,263Kentucky 3,501 * 11 145 191 * * 1,673 5,533Louisiana 7,211 * 12 158 217 . * 1,811 9,419Maine 872 * * 20 49 . * 560 1,512Maryland 6,630 * 11 250 349 . 27 3,143 10,413Massachusetts 4,590 . 20 151 233 * 19 2,890 7,904Michigan 10,079 . 22 628 387 . 38 4,946 16,100Minnesota 3,049 . * 92 116 . 13 3,163 6,439Mississippi 4,542 * 31 158 264 * * 1,054 6,057Missouri 5,539 * 47 271 345 * * 2,457 8,670Montana 548 . * 32 38 . * 459 1,085Nebraska 1,265 . * 97 64 . * 816 2,248Nevada 1,590 . * 105 88 * * 747 2,540New Hampshire 682 . . 32 48 . * 498 1,261New Jersey 9,377 11 20 223 400 * 24 3,694 13,751New Mexico 2,017 * * 96 131 . * 756 3,005New York 21,410 111 93 618 623 16 45 7,588 30,504North Carolina 10,562 * 28 287 598 * 18 3,136 14,635North Dakota 376 * . 31 * . . 404 822Ohio 12,044 * 69 547 571 * 32 5,356 18,621Oklahoma 3,131 . * 143 241 * * 1,305 4,832Oregon 2,107 . 11 130 154 . * 1,577 3,987Pennsylvania 12,596 * 27 311 476 * 52 6,593 20,059Rhode Island 813 . * 25 22 * * 511 1,383South Carolina 5,899 * 13 164 379 . 11 1,754 8,221South Dakota 636 . * 26 34 . * 409 1,112Tennessee 5,931 . 19 161 394 . 13 2,470 8,988Texas 24,810 * 100 644 1,238 . 53 8,425 35,272Utah 926 * * 73 33 . 11 1,089 2,138Vermont 379 . * * 14 . * 258 663Virginia 8,257 * 65 272 398 * 22 3,208 12,225Washington 3,890 * 83 162 162 * 23 2,619 6,949West Virginia 1,619 * * 79 146 * * 907 2,760Wisconsin 3,916 . 16 170 213 . 21 3,408 7,744Wyoming 236 . * 22 11 . . 195 467

American Samoa 82 . * . . . . * 84Guam 316 . . 17 * . . 15 349Puerto Rico 3,168 . * 65 337 * . 886 4,471Saipan 84 . . * . . . 13 100Virgin Islands 147 . . * * . . 21 175

Foreign 46 . . * * . . 237 286Unknown 131 . . * * . 24 931 1,091

All 296,583 193 1,325 11,281 14,544 67 833 128,131 452,957

The point prevalent cohorts & associated modalities are determined on December 31 of each calendar year without applying the 60-day stable modality rule.* Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.


396

Reference section DTREATMENT MODALITIESDReference section D

Transplantation:process

EReferenceSec

tion

TRANSPLANTATION: PROCESS

398

Reference section EE

E.1 . 399 Total patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

E.2 . 403 Total ESRD patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

E.3 . 405 Rate of wait-listing: ESRD patientsby age, gender, race/ethnicity, & primary diagnosis

E.4 . 407 Percent of patients either wait-listed or receiving a deceased-donor kidney within one year of their ESRD initiation dateby age, gender, race/ethnicity, & primary diagnosis

E.5 . 409 Renal transplants, by donor type

E.6 . 410 Renal transplants: recipients age <20by age, gender, race, ethnicity, donor type, & number of transplants

E.7 . 411 Counts of renal transplants, by donor typeby age, gender, race, ethnicity, & primary diagnosis

E.8 . 415 Counts of renal transplants, by donor type & number of transplants

E.9 . 415 Renal transplant rates, by donor typeby age, gender, race, ethnicity, & primary diagnosis

E.10 . 419 Treatment status two years after first transplant, 1999-2001

E.11 . 419 Percent panel reactive antibodies (PRA) for selected yearsby donor type

E.12 . 419 Cytomegalovirus (CMV) antibody status for selected yearsby recipient & donor CMV status

E.13 . 420 Hepatitus C (HCVAb) antibody status for selected yearsby recipient & donor HCVAb status, percent of transplant events within year

E.14 . 420 Cold ischemia time (hours): deceased donor transplants for selected years

399

2005 Annual Data Report

TRANSPLANTATION: PROCESSETable E.1Total patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosisTable E.1Total patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<1 * * * . * . * * 15 11 * *1-4 * * * * * * 13 30 22 30 23 335-9 * * * * 11 16 25 72 73 63 55 6610-14 * * * 11 18 34 60 126 141 145 164 16115-19 23 20 23 31 49 83 142 293 320 351 319 37620-29 63 89 106 148 228 373 656 1,359 1,522 1,703 1,866 1,95330-39 82 108 143 207 325 536 1,067 2,320 2,507 2,848 3,106 3,46040-49 33 54 89 137 256 497 940 2,119 2,442 2,879 3,271 3,72150-59 16 33 46 83 135 259 604 1,492 1,710 2,020 2,236 2,63560-64 * * * 11 23 52 151 387 445 562 676 79265-69 . * * * * 17 43 171 209 261 321 36370-79 . . . . * * * 27 46 61 95 12880+ . . . . . . . * * * * *Unknown . . . . . . * * 11 11 * *

0-19 31 28 38 51 83 140 241 525 571 600 569 64620-44 162 227 296 431 695 1,177 2,223 4,785 5,359 6,060 6,737 7,39045-64 37 60 94 155 272 540 1,195 2,892 3,267 3,952 4,418 5,17165-74 . * * * * 22 52 191 247 313 406 47075+ . . . . . . * * 12 * 14 26Unknown . . . . . . * * 11 11 * *

Male 124 163 214 318 536 982 1,964 4,632 5,305 6,157 6,923 7,783Female 106 154 216 323 521 897 1,749 3,770 4,162 4,789 5,231 5,921Unknown . . . . . . * * . . . .

White 146 196 261 380 614 1,113 2,261 5,353 6,056 6,884 7,579 8,378Black 78 113 158 240 409 703 1,304 2,592 2,873 3,418 3,809 4,478Native American * * * * 11 19 34 93 105 127 152 163Asian * * * 13 20 38 92 300 372 448 537 599Other/Unknown . . . * * * 23 68 61 69 77 86


Diabetes * 11 14 19 31 80 266 1,067 1,369 1,693 2,033 2,509Hypertension 22 37 53 71 118 215 461 1,178 1,515 1,868 2,219 2,666Glomerulonephritis 67 85 118 175 284 486 918 2,211 2,588 3,103 3,463 3,742Other cuase/unknown 131 184 245 376 624 1,098 2,069 3,950 3,995 4,282 4,439 4,787

All 230 317 430 641 1,057 1,879 3,714 8,406 9,467 10,946 12,154 13,704

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table E.1Total patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<1 * * * . * . * * 15 11 * *1-4 * * * * * * 13 30 22 30 23 335-9 * * * * 11 16 25 72 73 63 55 6610-14 * * * 11 18 34 60 126 141 145 164 16115-19 23 20 23 31 49 83 142 293 320 351 319 37620-29 63 89 106 148 228 373 656 1,359 1,522 1,703 1,866 1,95330-39 82 108 143 207 325 536 1,067 2,320 2,507 2,848 3,106 3,46040-49 33 54 89 137 256 497 940 2,119 2,442 2,879 3,271 3,72150-59 16 33 46 83 135 259 604 1,492 1,710 2,020 2,236 2,63560-64 * * * 11 23 52 151 387 445 562 676 79265-69 . * * * * 17 43 171 209 261 321 36370-79 . . . . * * * 27 46 61 95 12880+ . . . . . . . * * * * *Unknown . . . . . . * * 11 11 * *

0-19 31 28 38 51 83 140 241 525 571 600 569 64620-44 162 227 296 431 695 1,177 2,223 4,785 5,359 6,060 6,737 7,39045-64 37 60 94 155 272 540 1,195 2,892 3,267 3,952 4,418 5,17165-74 . * * * * 22 52 191 247 313 406 47075+ . . . . . . * * 12 * 14 26Unknown . . . . . . * * 11 11 * *

Male 124 163 214 318 536 982 1,964 4,632 5,305 6,157 6,923 7,783Female 106 154 216 323 521 897 1,749 3,770 4,162 4,789 5,231 5,921Unknown . . . . . . * * . . . .

White 146 196 261 380 614 1,113 2,261 5,353 6,056 6,884 7,579 8,378Black 78 113 158 240 409 703 1,304 2,592 2,873 3,418 3,809 4,478Native American * * * * 11 19 34 93 105 127 152 163Asian * * * 13 20 38 92 300 372 448 537 599Other/Unknown . . . * * * 23 68 61 69 77 86


Diabetes * 11 14 19 31 80 266 1,067 1,369 1,693 2,033 2,509Hypertension 22 37 53 71 118 215 461 1,178 1,515 1,868 2,219 2,666Glomerulonephritis 67 85 118 175 284 486 918 2,211 2,588 3,103 3,463 3,742Other cuase/unknown 131 184 245 376 624 1,098 2,069 3,950 3,995 4,282 4,439 4,787

All 230 317 430 641 1,057 1,879 3,714 8,406 9,467 10,946 12,154 13,704



400

Reference section EETable E.1 (continued)Total patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosisTable E.1 (continued)Total patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 * 12 * * * * 12 * 13 * 15 151-4 32 30 24 41 42 39 39 36 34 48 42 475-9 88 68 66 79 89 101 78 78 95 115 104 9210-14 178 173 145 156 189 174 196 167 196 219 238 25215-19 405 430 369 341 362 409 434 440 431 455 548 59720-29 2,202 2,351 2,522 2,651 2,816 3,007 3,086 3,273 3,233 3,352 3,493 3,67430-39 4,018 4,439 4,878 5,313 5,701 6,165 6,440 6,930 7,363 7,660 8,140 8,69940-49 4,530 5,108 5,755 6,738 7,498 8,195 8,982 9,773 10,689 11,418 12,413 13,35950-59 3,209 3,890 4,575 5,328 6,338 7,319 8,529 9,841 11,435 12,865 14,396 16,04360-64 937 1,129 1,454 1,768 2,086 2,499 2,992 3,493 4,199 4,896 5,699 6,45165-69 485 607 787 1,070 1,303 1,573 1,892 2,262 2,760 3,350 3,924 4,57770-79 181 221 236 304 433 566 765 1,029 1,392 1,730 2,145 2,70780+ . * * * 12 14 20 24 41 63 75 102Unknown * . . . . . * * * * * *

0-19 710 713 608 624 687 733 759 729 769 846 947 1,00320-44 8,552 9,429 10,263 11,248 12,080 13,083 13,874 14,860 15,533 16,304 17,270 18,40245-64 6,344 7,488 8,921 10,550 12,359 14,102 16,155 18,450 21,386 23,887 26,871 29,82465-74 643 802 991 1,328 1,660 2,041 2,537 3,108 3,891 4,731 5,624 6,73175+ 23 31 40 56 88 112 140 207 302 412 520 655Unknown * . . . . . * * * * * *

Male 9,302 10,590 11,977 13,574 15,352 17,102 19,242 21,507 24,074 26,506 29,437 32,441Female 6,970 7,872 8,846 10,232 11,522 12,969 14,225 15,848 17,808 19,675 21,797 24,168Unknown * * . . . . . . . . * *

White 9,874 10,830 12,115 13,615 15,192 16,865 18,536 20,606 22,947 24,966 27,538 30,448Black 5,385 6,439 7,308 8,485 9,643 10,790 12,188 13,644 15,282 16,962 18,663 20,427Native American 199 205 220 307 342 362 421 432 477 559 645 705Asian 710 880 1,069 1,270 1,535 1,834 2,018 2,279 2,654 3,026 3,462 3,795Other/Unknown 106 109 111 129 162 220 304 394 522 668 928 1,243

†Hispanic 21,308 23,935 26,415 29,374 32,519 36,174 39,628 43,806 48,224†Non-Hispanic 2,498 2,939 3,656 4,093 4,836 5,708 6,553 7,430 8,394

Diabetes 3,327 3,891 4,480 5,391 6,380 7,415 8,485 9,873 11,647 13,056 14,837 16,520Hypertension 3,294 3,999 4,552 5,111 5,711 6,265 6,962 7,900 9,040 10,042 10,938 12,009Glomerulonephritis 4,368 4,960 5,638 6,428 7,065 7,806 8,478 9,126 9,647 10,383 11,121 11,634Other cause/unknown 5,285 5,613 6,153 6,876 7,718 8,585 9,542 10,456 11,548 12,700 14,340 16,455

All 16,274 18,463 20,823 23,806 26,874 30,071 33,467 37,355 41,882 46,181 51,236 56,618


Table E.1 (continued)Total patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 * 12 * * * * 12 * 13 * 15 151-4 32 30 24 41 42 39 39 36 34 48 42 475-9 88 68 66 79 89 101 78 78 95 115 104 9210-14 178 173 145 156 189 174 196 167 196 219 238 25215-19 405 430 369 341 362 409 434 440 431 455 548 59720-29 2,202 2,351 2,522 2,651 2,816 3,007 3,086 3,273 3,233 3,352 3,493 3,67430-39 4,018 4,439 4,878 5,313 5,701 6,165 6,440 6,930 7,363 7,660 8,140 8,69940-49 4,530 5,108 5,755 6,738 7,498 8,195 8,982 9,773 10,689 11,418 12,413 13,35950-59 3,209 3,890 4,575 5,328 6,338 7,319 8,529 9,841 11,435 12,865 14,396 16,04360-64 937 1,129 1,454 1,768 2,086 2,499 2,992 3,493 4,199 4,896 5,699 6,45165-69 485 607 787 1,070 1,303 1,573 1,892 2,262 2,760 3,350 3,924 4,57770-79 181 221 236 304 433 566 765 1,029 1,392 1,730 2,145 2,70780+ . * * * 12 14 20 24 41 63 75 102Unknown * . . . . . * * * * * *

0-19 710 713 608 624 687 733 759 729 769 846 947 1,00320-44 8,552 9,429 10,263 11,248 12,080 13,083 13,874 14,860 15,533 16,304 17,270 18,40245-64 6,344 7,488 8,921 10,550 12,359 14,102 16,155 18,450 21,386 23,887 26,871 29,82465-74 643 802 991 1,328 1,660 2,041 2,537 3,108 3,891 4,731 5,624 6,73175+ 23 31 40 56 88 112 140 207 302 412 520 655Unknown * . . . . . * * * * * *

Male 9,302 10,590 11,977 13,574 15,352 17,102 19,242 21,507 24,074 26,506 29,437 32,441Female 6,970 7,872 8,846 10,232 11,522 12,969 14,225 15,848 17,808 19,675 21,797 24,168Unknown * * . . . . . . . . * *

White 9,874 10,830 12,115 13,615 15,192 16,865 18,536 20,606 22,947 24,966 27,538 30,448Black 5,385 6,439 7,308 8,485 9,643 10,790 12,188 13,644 15,282 16,962 18,663 20,427Native American 199 205 220 307 342 362 421 432 477 559 645 705Asian 710 880 1,069 1,270 1,535 1,834 2,018 2,279 2,654 3,026 3,462 3,795Other/Unknown 106 109 111 129 162 220 304 394 522 668 928 1,243


Diabetes 3,327 3,891 4,480 5,391 6,380 7,415 8,485 9,873 11,647 13,056 14,837 16,520Hypertension 3,294 3,999 4,552 5,111 5,711 6,265 6,962 7,900 9,040 10,042 10,938 12,009Glomerulonephritis 4,368 4,960 5,638 6,428 7,065 7,806 8,478 9,126 9,647 10,383 11,121 11,634Other cause/unknown 5,285 5,613 6,153 6,876 7,718 8,585 9,542 10,456 11,548 12,700 14,340 16,455

All 16,274 18,463 20,823 23,806 26,874 30,071 33,467 37,355 41,882 46,181 51,236 56,618


401


TRANSPLANTATION: PROCESSETable E.1 (continued)Total patients wait-listed for a kidney, with unknowns droppedby age, gender, race/ethnicity, & primary diagnosisTable E.1 (continued)Total patients wait-listed for a kidney, with unknowns droppedby age, gender, race/ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<1 * * . . . . * * * * * *1-4 * * * * * * * 23 21 24 17 275-9 * * * * * 13 22 59 64 55 46 5510-14 * * * * 11 21 41 97 116 123 145 13815-19 18 15 16 21 36 59 97 227 272 292 270 33020-29 51 65 78 105 159 255 455 1,046 1,282 1,475 1,629 1,73630-39 44 60 90 126 202 351 731 1,788 2,061 2,435 2,730 3,07940-49 16 24 44 69 138 284 581 1,557 1,957 2,431 2,883 3,34250-59 * 13 19 37 62 131 347 1,061 1,339 1,680 1,910 2,32260-64 * * * * * 17 68 260 343 454 576 68765-69 . . . . * * 16 110 155 197 254 29970-79 . . . . . . * 12 24 48 72 10180+ . . . . . . . . * . * *

0-19 24 21 25 32 58 97 170 409 482 500 485 55620-44 104 139 190 271 442 766 1,509 3,661 4,422 5,185 5,906 6,60745-64 15 24 42 69 125 272 673 2,051 2,560 3,290 3,822 4,55965-74 . . . . * * 17 119 176 238 320 38575+ . . . . . . . * * * * 18

Male 75 94 128 179 312 599 1,246 3,464 4,355 5,284 6,085 6,951Female 68 90 129 193 314 539 1,123 2,779 3,289 3,936 4,457 5,174

White 91 113 158 228 367 667 1,445 4,069 4,966 5,881 6,624 7,451Black 46 64 89 129 235 427 842 1,891 2,308 2,877 3,332 4,010Native American * * * * * 17 26 78 93 113 137 147Asian * * * * 15 27 56 205 277 349 449 517


Diabetes * 11 14 19 31 80 265 1,066 1,369 1,693 2,033 2,509Hypertension 22 37 53 71 118 215 461 1,177 1,515 1,867 2,218 2,664Glomerulonephritis 67 85 118 175 284 486 918 2,207 2,586 3,099 3,459 3,740Other cause 44 51 72 107 193 357 725 1,793 2,174 2,561 2,832 3,212

All 143 184 257 372 626 1,138 2,369 6,243 7,644 9,220 10,542 12,125


Table E.1 (continued)Total patients wait-listed for a kidney, with unknowns droppedby age, gender, race/ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<1 * * . . . . * * * * * *1-4 * * * * * * * 23 21 24 17 275-9 * * * * * 13 22 59 64 55 46 5510-14 * * * * 11 21 41 97 116 123 145 13815-19 18 15 16 21 36 59 97 227 272 292 270 33020-29 51 65 78 105 159 255 455 1,046 1,282 1,475 1,629 1,73630-39 44 60 90 126 202 351 731 1,788 2,061 2,435 2,730 3,07940-49 16 24 44 69 138 284 581 1,557 1,957 2,431 2,883 3,34250-59 * 13 19 37 62 131 347 1,061 1,339 1,680 1,910 2,32260-64 * * * * * 17 68 260 343 454 576 68765-69 . . . . * * 16 110 155 197 254 29970-79 . . . . . . * 12 24 48 72 10180+ . . . . . . . . * . * *

0-19 24 21 25 32 58 97 170 409 482 500 485 55620-44 104 139 190 271 442 766 1,509 3,661 4,422 5,185 5,906 6,60745-64 15 24 42 69 125 272 673 2,051 2,560 3,290 3,822 4,55965-74 . . . . * * 17 119 176 238 320 38575+ . . . . . . . * * * * 18

Male 75 94 128 179 312 599 1,246 3,464 4,355 5,284 6,085 6,951Female 68 90 129 193 314 539 1,123 2,779 3,289 3,936 4,457 5,174




All 143 184 257 372 626 1,138 2,369 6,243 7,644 9,220 10,542 12,125



402

Reference section EETable E.1 (continued)Total patients wait-listed for a kidney, with unknowns droppedby age, gender, race/ethnicity, & primary diagnosisTable E.1 (continued)Total patients wait-listed for a kidney, with unknowns droppedby age, gender, race/ethnicity, & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 * * * * * * 11 * 11 * 12 *1-4 29 24 20 38 38 28 33 28 27 35 28 305-9 72 54 56 64 75 89 69 66 83 88 81 5910-14 153 154 131 136 166 155 167 137 156 185 179 18015-19 350 384 323 300 319 359 379 381 367 382 427 44420-29 1,989 2,150 2,299 2,416 2,560 2,710 2,783 2,918 2,872 2,911 2,965 3,05230-39 3,667 4,104 4,518 4,913 5,268 5,676 5,888 6,302 6,661 6,912 7,229 7,52640-49 4,129 4,756 5,390 6,294 6,945 7,576 8,260 9,008 9,796 10,401 11,221 11,78150-59 2,908 3,617 4,262 4,962 5,910 6,779 7,845 9,068 10,531 11,843 13,100 14,25560-64 842 1,043 1,351 1,639 1,940 2,329 2,759 3,226 3,852 4,460 5,125 5,70665-69 419 552 720 981 1,182 1,442 1,737 2,099 2,542 3,059 3,519 4,03770-79 160 198 221 278 401 518 684 938 1,262 1,560 1,944 2,38880+ . * * * * 12 14 20 36 59 68 95

0-19 608 625 534 544 601 639 659 619 644 694 727 72120-44 7,788 8,710 9,482 10,378 11,105 11,985 12,662 13,509 14,052 14,666 15,285 15,85745-64 5,747 6,960 8,338 9,846 11,518 13,085 14,873 17,013 19,660 21,861 24,355 26,46365-74 559 724 910 1,216 1,512 1,870 2,311 2,870 3,566 4,302 5,055 5,93675+ 20 31 39 53 81 102 124 187 274 376 476 584

Male 8,479 9,829 11,149 12,620 14,217 15,745 17,623 19,697 21,958 24,064 26,426 28,488Female 6,243 7,221 8,154 9,417 10,600 11,936 13,006 14,501 16,238 17,835 19,472 21,073

White 8,967 10,056 11,275 12,643 14,062 15,522 17,031 18,947 21,038 22,790 24,802 26,706Black 4,950 6,015 6,853 7,963 9,065 10,156 11,375 12,791 14,310 15,872 17,430 18,909Native American 180 188 207 294 329 342 394 405 452 533 608 657Asian 625 791 968 1,137 1,361 1,661 1,829 2,055 2,396 2,704 3,058 3,289


Diabetes 3,326 3,886 4,472 5,375 6,341 7,352 8,389 9,735 11,453 12,826 14,536 16,161Hypertension 3,289 3,992 4,538 5,096 5,688 6,230 6,919 7,840 8,958 9,935 10,790 11,810Glomerulonephritis 4,363 4,954 5,631 6,415 7,046 7,773 8,421 9,058 9,559 10,263 10,952 11,388Other cause 3,744 4,218 4,662 5,151 5,742 6,326 6,900 7,565 8,226 8,875 9,620 10,202

All 14,722 17,050 19,303 22,037 24,817 27,681 30,629 34,198 38,196 41,899 45,898 49,561


Table E.1 (continued)Total patients wait-listed for a kidney, with unknowns droppedby age, gender, race/ethnicity, & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 * * * * * * 11 * 11 * 12 *1-4 29 24 20 38 38 28 33 28 27 35 28 305-9 72 54 56 64 75 89 69 66 83 88 81 5910-14 153 154 131 136 166 155 167 137 156 185 179 18015-19 350 384 323 300 319 359 379 381 367 382 427 44420-29 1,989 2,150 2,299 2,416 2,560 2,710 2,783 2,918 2,872 2,911 2,965 3,05230-39 3,667 4,104 4,518 4,913 5,268 5,676 5,888 6,302 6,661 6,912 7,229 7,52640-49 4,129 4,756 5,390 6,294 6,945 7,576 8,260 9,008 9,796 10,401 11,221 11,78150-59 2,908 3,617 4,262 4,962 5,910 6,779 7,845 9,068 10,531 11,843 13,100 14,25560-64 842 1,043 1,351 1,639 1,940 2,329 2,759 3,226 3,852 4,460 5,125 5,70665-69 419 552 720 981 1,182 1,442 1,737 2,099 2,542 3,059 3,519 4,03770-79 160 198 221 278 401 518 684 938 1,262 1,560 1,944 2,38880+ . * * * * 12 14 20 36 59 68 95

0-19 608 625 534 544 601 639 659 619 644 694 727 72120-44 7,788 8,710 9,482 10,378 11,105 11,985 12,662 13,509 14,052 14,666 15,285 15,85745-64 5,747 6,960 8,338 9,846 11,518 13,085 14,873 17,013 19,660 21,861 24,355 26,46365-74 559 724 910 1,216 1,512 1,870 2,311 2,870 3,566 4,302 5,055 5,93675+ 20 31 39 53 81 102 124 187 274 376 476 584

Male 8,479 9,829 11,149 12,620 14,217 15,745 17,623 19,697 21,958 24,064 26,426 28,488Female 6,243 7,221 8,154 9,417 10,600 11,936 13,006 14,501 16,238 17,835 19,472 21,073




All 14,722 17,050 19,303 22,037 24,817 27,681 30,629 34,198 38,196 41,899 45,898 49,561


403


TRANSPLANTATION: PROCESSETable E.2Total ESRD patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

Table E.2Total ESRD patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<1 * * . . . . * * 12 * * *1-4 * * * * * * 11 27 21 28 21 315-9 * * * * * 15 23 65 69 58 52 6410-14 * * * * 13 24 46 111 132 137 158 15715-19 19 16 19 25 39 64 108 252 294 320 297 35320-29 55 69 81 110 169 274 489 1,144 1,369 1,565 1,729 1,84330-39 52 68 98 137 221 380 789 1,916 2,200 2,605 2,903 3,26040-49 17 25 46 73 145 302 628 1,677 2,096 2,566 3,028 3,50550-59 * 13 19 38 65 140 387 1,154 1,443 1,786 2,021 2,44560-64 * * * * * 22 83 285 363 500 609 72365-69 . . . . * * 17 121 167 218 281 33170-79 . . . . . . * 18 29 50 79 11380+ . . . . . . . * * . * *

0-19 26 23 30 40 65 108 189 458 528 550 535 61520-44 117 152 203 289 474 823 1,628 3,955 4,717 5,518 6,264 6,97645-64 15 24 42 72 133 295 748 2,221 2,754 3,504 4,026 4,80065-74 . . . . * * 19 132 190 260 353 42675+ . . . . . . * * * * * 22

Male 84 103 138 197 339 647 1,366 3,765 4,661 5,615 6,458 7,356Female 74 96 137 204 334 582 1,218 3,005 3,537 4,227 4,732 5,484




All 158 199 275 401 673 1,229 2,585 6,774 8,198 9,842 11,190 12,840


Table E.2Total ESRD patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<1 * * . . . . * * 12 * * *1-4 * * * * * * 11 27 21 28 21 315-9 * * * * * 15 23 65 69 58 52 6410-14 * * * * 13 24 46 111 132 137 158 15715-19 19 16 19 25 39 64 108 252 294 320 297 35320-29 55 69 81 110 169 274 489 1,144 1,369 1,565 1,729 1,84330-39 52 68 98 137 221 380 789 1,916 2,200 2,605 2,903 3,26040-49 17 25 46 73 145 302 628 1,677 2,096 2,566 3,028 3,50550-59 * 13 19 38 65 140 387 1,154 1,443 1,786 2,021 2,44560-64 * * * * * 22 83 285 363 500 609 72365-69 . . . . * * 17 121 167 218 281 33170-79 . . . . . . * 18 29 50 79 11380+ . . . . . . . * * . * *

0-19 26 23 30 40 65 108 189 458 528 550 535 61520-44 117 152 203 289 474 823 1,628 3,955 4,717 5,518 6,264 6,97645-64 15 24 42 72 133 295 748 2,221 2,754 3,504 4,026 4,80065-74 . . . . * * 19 132 190 260 353 42675+ . . . . . . * * * * * 22

Male 84 103 138 197 339 647 1,366 3,765 4,661 5,615 6,458 7,356Female 74 96 137 204 334 582 1,218 3,005 3,537 4,227 4,732 5,484




All 158 199 275 401 673 1,229 2,585 6,774 8,198 9,842 11,190 12,840



404

Reference section EETable E.2 (continued)Total ESRD patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

Table E.2 (continued)Total ESRD patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 * 12 * * * * 12 * 13 * 14 111-4 32 27 23 41 42 35 37 34 31 45 37 405-9 85 66 65 75 85 100 78 76 93 106 93 7310-14 173 170 143 152 181 166 185 161 188 210 221 22015-19 390 420 358 334 354 400 421 425 412 435 510 53220-29 2,103 2,288 2,463 2,591 2,742 2,923 2,998 3,155 3,118 3,208 3,307 3,42230-39 3,855 4,319 4,755 5,166 5,537 5,985 6,223 6,682 7,085 7,352 7,737 8,14040-49 4,315 4,974 5,616 6,561 7,278 7,960 8,697 9,466 10,292 10,949 11,844 12,50550-59 3,043 3,777 4,442 5,172 6,151 7,088 8,210 9,495 11,042 12,393 13,756 15,00860-64 888 1,095 1,409 1,713 2,026 2,428 2,899 3,371 4,027 4,687 5,405 6,02965-69 453 585 761 1,027 1,247 1,519 1,815 2,185 2,658 3,218 3,733 4,25870-79 173 215 230 296 421 551 731 991 1,330 1,643 2,043 2,51780+ . * * * * 13 17 22 37 61 71 99

0-19 686 695 593 609 665 710 733 704 737 804 875 87620-44 8,183 9,179 10,006 10,951 11,735 12,702 13,441 14,347 14,951 15,656 16,433 17,19345-64 6,021 7,274 8,679 10,252 11,999 13,682 15,586 17,822 20,613 22,933 25,616 27,91165-74 606 774 960 1,278 1,594 1,976 2,431 2,999 3,733 4,526 5,344 6,25375+ 20 31 39 55 84 107 132 199 292 396 503 621

Male 8,923 10,340 11,707 13,250 14,956 16,640 18,631 20,806 23,216 25,473 28,101 30,430Female 6,593 7,612 8,570 9,895 11,121 12,537 13,694 15,266 17,111 18,843 20,672 22,418

White 9,466 10,590 11,838 13,271 14,740 16,334 17,863 19,836 21,991 23,794 25,957 27,912Black 5,156 6,282 7,148 8,277 9,417 10,537 11,846 13,281 14,852 16,477 18,058 19,590Native American 193 202 218 305 338 354 406 416 463 544 628 681Asian 667 844 1,028 1,218 1,467 1,768 1,943 2,177 2,530 2,862 3,244 3,482



All 15,518 17,953 20,277 23,145 26,077 29,177 32,325 36,072 40,327 44,316 48,775 52,857


Table E.2 (continued)Total ESRD patients wait-listed for a kidneyby age, gender, race/ethnicity, & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 * 12 * * * * 12 * 13 * 14 111-4 32 27 23 41 42 35 37 34 31 45 37 405-9 85 66 65 75 85 100 78 76 93 106 93 7310-14 173 170 143 152 181 166 185 161 188 210 221 22015-19 390 420 358 334 354 400 421 425 412 435 510 53220-29 2,103 2,288 2,463 2,591 2,742 2,923 2,998 3,155 3,118 3,208 3,307 3,42230-39 3,855 4,319 4,755 5,166 5,537 5,985 6,223 6,682 7,085 7,352 7,737 8,14040-49 4,315 4,974 5,616 6,561 7,278 7,960 8,697 9,466 10,292 10,949 11,844 12,50550-59 3,043 3,777 4,442 5,172 6,151 7,088 8,210 9,495 11,042 12,393 13,756 15,00860-64 888 1,095 1,409 1,713 2,026 2,428 2,899 3,371 4,027 4,687 5,405 6,02965-69 453 585 761 1,027 1,247 1,519 1,815 2,185 2,658 3,218 3,733 4,25870-79 173 215 230 296 421 551 731 991 1,330 1,643 2,043 2,51780+ . * * * * 13 17 22 37 61 71 99

0-19 686 695 593 609 665 710 733 704 737 804 875 87620-44 8,183 9,179 10,006 10,951 11,735 12,702 13,441 14,347 14,951 15,656 16,433 17,19345-64 6,021 7,274 8,679 10,252 11,999 13,682 15,586 17,822 20,613 22,933 25,616 27,91165-74 606 774 960 1,278 1,594 1,976 2,431 2,999 3,733 4,526 5,344 6,25375+ 20 31 39 55 84 107 132 199 292 396 503 621

Male 8,923 10,340 11,707 13,250 14,956 16,640 18,631 20,806 23,216 25,473 28,101 30,430Female 6,593 7,612 8,570 9,895 11,121 12,537 13,694 15,266 17,111 18,843 20,672 22,418

White 9,466 10,590 11,838 13,271 14,740 16,334 17,863 19,836 21,991 23,794 25,957 27,912Black 5,156 6,282 7,148 8,277 9,417 10,537 11,846 13,281 14,852 16,477 18,058 19,590Native American 193 202 218 305 338 354 406 416 463 544 628 681Asian 667 844 1,028 1,218 1,467 1,768 1,943 2,177 2,530 2,862 3,244 3,482



All 15,518 17,953 20,277 23,145 26,077 29,177 32,325 36,072 40,327 44,316 48,775 52,857


405


TRANSPLANTATION: PROCESSEON OUR WEBSITE & CDMedian time in days to first renal transplant from first ESRD service day, by age, gender, race, ethnicity, blood type, HLA mismatches, & peak PRA (E.a).

Table E.3Rate of wait-listing: ESRD patients, per 100 dialysis patient-yearsby age, gender, race/ethnicity, & primary diagnosis


1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<1 . . . . . 1.4 2.5 12.3 19.0 23.8 13.7 18.51-4 3.3 . . . 1.2 1.1 6.2 18.4 32.8 21.5 31.9 19.05-9 0.0 . 1.3 . 1.1 3.5 4.5 30.3 38.3 32.1 31.0 32.410-14 0.3 0.3 0.7 0.7 2.2 2.5 5.5 23.5 35.6 31.0 29.9 31.415-19 0.3 0.1 0.4 0.8 1.5 2.3 6.0 19.0 29.3 27.0 25.4 25.820-29 0.2 0.2 0.3 0.5 0.9 1.5 3.9 15.0 20.4 21.5 21.4 21.330-39 0.1 0.1 0.2 0.4 0.7 1.4 2.9 11.8 15.8 14.7 15.0 14.740-49 . 0.1 0.1 0.2 0.4 0.8 2.2 9.1 12.2 11.5 11.2 11.350-59 . . . 0.1 0.1 0.3 1.0 4.4 6.1 6.0 6.2 6.260-64 . . . . . 0.1 0.3 1.5 2.5 2.5 2.4 2.865-69 . . . . . . 0.1 0.6 1.0 0.9 1.1 1.170-79 . . . . . . . 0.1 0.2 0.1 0.2 0.280+ . . . . . . . . . . . .

0-19 0.3 0.1 0.5 0.6 1.6 2.3 5.6 20.8 31.3 27.8 26.7 27.020-44 0.1 0.1 0.2 0.4 0.7 1.3 3.1 12.1 16.2 15.5 15.7 15.445-64 . . . 0.1 0.1 0.3 0.9 4.1 5.7 5.7 5.6 5.865-74 . . . . . . . 0.4 0.7 0.6 0.7 0.775+ . . . . . . . . . . . .

Male 0.1 . 0.1 0.1 0.3 0.5 1.2 5.5 7.6 7.2 7.0 6.8Female 0.1 0.1 0.1 0.2 0.3 0.5 1.3 4.3 5.2 5.0 4.8 4.8

White . . 0.1 0.1 0.2 0.5 1.3 5.3 7.3 6.8 6.6 6.5Black 0.1 0.1 0.1 0.2 0.4 0.5 1.3 3.9 4.7 4.7 4.6 4.6Native American 0.4 . 0.2 0.3 0.6 1.0 1.0 5.9 6.4 6.7 5.0 5.2Asian 0.0 0.2 0.3 0.2 0.5 0.6 1.9 10.2 12.0 9.7 11.0 8.5


Diabetes . . . . 0.1 0.2 0.8 4.3 5.5 5.3 4.8 4.9Hypertension 0.1 0.1 0.1 0.1 0.2 0.4 0.9 3.2 4.5 4.0 4.2 4.1Glomerulonephritis 0.1 0.1 0.2 0.3 0.5 0.9 2.1 7.9 10.1 10.0 9.9 9.6Other cause . . 0.1 0.1 0.3 0.5 1.3 4.9 6.8 6.5 6.5 6.6

All 0.1 0.1 0.1 0.1 0.3 0.5 1.3 4.9 6.5 6.1 6.0 5.8

Dialysis patients who were already listed on January 1 of the given year are excluded.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.



1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<1 . . . . . 1.4 2.5 12.3 19.0 23.8 13.7 18.51-4 3.3 . . . 1.2 1.1 6.2 18.4 32.8 21.5 31.9 19.05-9 0.0 . 1.3 . 1.1 3.5 4.5 30.3 38.3 32.1 31.0 32.410-14 0.3 0.3 0.7 0.7 2.2 2.5 5.5 23.5 35.6 31.0 29.9 31.415-19 0.3 0.1 0.4 0.8 1.5 2.3 6.0 19.0 29.3 27.0 25.4 25.820-29 0.2 0.2 0.3 0.5 0.9 1.5 3.9 15.0 20.4 21.5 21.4 21.330-39 0.1 0.1 0.2 0.4 0.7 1.4 2.9 11.8 15.8 14.7 15.0 14.740-49 . 0.1 0.1 0.2 0.4 0.8 2.2 9.1 12.2 11.5 11.2 11.350-59 . . . 0.1 0.1 0.3 1.0 4.4 6.1 6.0 6.2 6.260-64 . . . . . 0.1 0.3 1.5 2.5 2.5 2.4 2.865-69 . . . . . . 0.1 0.6 1.0 0.9 1.1 1.170-79 . . . . . . . 0.1 0.2 0.1 0.2 0.280+ . . . . . . . . . . . .

0-19 0.3 0.1 0.5 0.6 1.6 2.3 5.6 20.8 31.3 27.8 26.7 27.020-44 0.1 0.1 0.2 0.4 0.7 1.3 3.1 12.1 16.2 15.5 15.7 15.445-64 . . . 0.1 0.1 0.3 0.9 4.1 5.7 5.7 5.6 5.865-74 . . . . . . . 0.4 0.7 0.6 0.7 0.775+ . . . . . . . . . . . .

Male 0.1 . 0.1 0.1 0.3 0.5 1.2 5.5 7.6 7.2 7.0 6.8Female 0.1 0.1 0.1 0.2 0.3 0.5 1.3 4.3 5.2 5.0 4.8 4.8

White . . 0.1 0.1 0.2 0.5 1.3 5.3 7.3 6.8 6.6 6.5Black 0.1 0.1 0.1 0.2 0.4 0.5 1.3 3.9 4.7 4.7 4.6 4.6Native American 0.4 . 0.2 0.3 0.6 1.0 1.0 5.9 6.4 6.7 5.0 5.2Asian 0.0 0.2 0.3 0.2 0.5 0.6 1.9 10.2 12.0 9.7 11.0 8.5


Diabetes . . . . 0.1 0.2 0.8 4.3 5.5 5.3 4.8 4.9Hypertension 0.1 0.1 0.1 0.1 0.2 0.4 0.9 3.2 4.5 4.0 4.2 4.1Glomerulonephritis 0.1 0.1 0.2 0.3 0.5 0.9 2.1 7.9 10.1 10.0 9.9 9.6Other cause . . 0.1 0.1 0.3 0.5 1.3 4.9 6.8 6.5 6.5 6.6

All 0.1 0.1 0.1 0.1 0.3 0.5 1.3 4.9 6.5 6.1 6.0 5.8




406

Reference section EETable E.3 (continued)Rate of wait-listing: ESRD patients, per 100 dialysis patient-yearsby age, gender, race/ethnicity, & primary diagnosis

Table E.3 (continued)Rate of wait-listing: ESRD patients, per 100 dialysis patient-yearsby age, gender, race/ethnicity, & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 18.5 28.2 18.9 18.4 19.6 17.2 19.7 14.3 20.2 20.1 21.0 27.11-4 19.0 30.0 30.1 16.9 29.9 36.6 21.5 33.4 20.7 22.8 36.6 27.15-9 32.4 33.5 24.5 20.3 27.1 27.3 31.9 18.4 21.4 23.4 31.1 26.210-14 31.4 32.6 28.9 27.3 27.1 31.4 32.3 28.2 32.0 28.2 33.5 31.715-19 25.8 26.8 29.7 24.5 27.7 25.6 24.9 26.3 28.9 25.8 26.9 28.520-29 21.3 22.3 21.6 20.7 20.3 19.8 21.1 19.1 20.6 18.7 19.8 20.630-39 14.7 15.7 14.8 15.0 14.6 14.1 14.4 14.6 14.5 14.6 14.3 14.940-49 11.3 11.8 11.8 11.2 11.6 10.7 10.6 10.3 10.3 10.7 10.3 10.850-59 6.2 6.4 6.9 6.9 7.2 7.2 7.2 7.5 7.8 8.2 7.9 8.260-64 2.8 3.0 3.1 3.5 3.7 3.9 4.1 4.3 4.6 5.2 5.3 5.265-69 1.1 1.4 1.4 1.5 1.8 2.0 2.0 2.2 2.4 2.8 2.9 3.270-79 0.2 0.3 0.2 0.2 0.3 0.3 0.4 0.4 0.5 0.6 0.6 0.780+ . . . . . . . . . 0.1 . .

0-19 27.0 29.0 28.3 23.7 27.2 27.4 26.7 25.5 27.8 25.6 29.2 28.820-44 15.4 16.1 15.6 15.0 15.0 14.2 14.4 14.2 14.2 14.0 14.1 14.545-64 5.8 6.1 6.4 6.5 6.7 6.8 6.9 7.0 7.2 7.7 7.5 7.765-74 0.7 1.0 0.9 0.9 1.1 1.3 1.3 1.4 1.6 1.9 1.9 2.175+ . . 0.1 . 0.1 . 0.1 0.1 0.1 0.2 0.2 0.2

Male 6.8 7.0 6.8 6.7 6.7 6.3 6.3 6.3 6.3 6.4 6.3 6.5Female 4.8 4.9 4.9 4.6 4.7 4.6 4.7 4.5 4.7 4.9 4.8 4.9


†Hispanic 5.5 5.6 5.4 5.3 5.3 5.3 5.5 5.4 5.5†Non-Hispanic 7.3 7.4 6.4 7.1 6.5 7.0 7.1 7.1 7.4

Diabetes 4.9 5.0 4.8 4.6 4.8 4.6 4.5 4.5 4.7 4.8 4.6 4.9Hypertension 4.1 4.3 4.3 4.2 4.0 3.9 3.9 3.9 4.1 4.4 4.4 4.2Glomerulonephritis 9.6 10.2 9.9 10.0 10.3 9.6 10.1 10.0 9.8 10.0 10.1 10.7Other cause 6.6 6.9 6.9 6.5 6.8 6.6 6.7 6.4 6.6 6.7 6.6 6.8

All 5.8 6.0 5.9 5.7 5.7 5.5 5.5 5.4 5.5 5.7 5.6 5.7



Table E.3 (continued)Rate of wait-listing: ESRD patients, per 100 dialysis patient-yearsby age, gender, race/ethnicity, & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 18.5 28.2 18.9 18.4 19.6 17.2 19.7 14.3 20.2 20.1 21.0 27.11-4 19.0 30.0 30.1 16.9 29.9 36.6 21.5 33.4 20.7 22.8 36.6 27.15-9 32.4 33.5 24.5 20.3 27.1 27.3 31.9 18.4 21.4 23.4 31.1 26.210-14 31.4 32.6 28.9 27.3 27.1 31.4 32.3 28.2 32.0 28.2 33.5 31.715-19 25.8 26.8 29.7 24.5 27.7 25.6 24.9 26.3 28.9 25.8 26.9 28.520-29 21.3 22.3 21.6 20.7 20.3 19.8 21.1 19.1 20.6 18.7 19.8 20.630-39 14.7 15.7 14.8 15.0 14.6 14.1 14.4 14.6 14.5 14.6 14.3 14.940-49 11.3 11.8 11.8 11.2 11.6 10.7 10.6 10.3 10.3 10.7 10.3 10.850-59 6.2 6.4 6.9 6.9 7.2 7.2 7.2 7.5 7.8 8.2 7.9 8.260-64 2.8 3.0 3.1 3.5 3.7 3.9 4.1 4.3 4.6 5.2 5.3 5.265-69 1.1 1.4 1.4 1.5 1.8 2.0 2.0 2.2 2.4 2.8 2.9 3.270-79 0.2 0.3 0.2 0.2 0.3 0.3 0.4 0.4 0.5 0.6 0.6 0.780+ . . . . . . . . . 0.1 . .

0-19 27.0 29.0 28.3 23.7 27.2 27.4 26.7 25.5 27.8 25.6 29.2 28.820-44 15.4 16.1 15.6 15.0 15.0 14.2 14.4 14.2 14.2 14.0 14.1 14.545-64 5.8 6.1 6.4 6.5 6.7 6.8 6.9 7.0 7.2 7.7 7.5 7.765-74 0.7 1.0 0.9 0.9 1.1 1.3 1.3 1.4 1.6 1.9 1.9 2.175+ . . 0.1 . 0.1 . 0.1 0.1 0.1 0.2 0.2 0.2

Male 6.8 7.0 6.8 6.7 6.7 6.3 6.3 6.3 6.3 6.4 6.3 6.5Female 4.8 4.9 4.9 4.6 4.7 4.6 4.7 4.5 4.7 4.9 4.8 4.9




All 5.8 6.0 5.9 5.7 5.7 5.5 5.5 5.4 5.5 5.7 5.6 5.7



407


TRANSPLANTATION: PROCESSETable E.4Percent of patients wait-listed or receiving a deceased-donor kidney within one year of their ESRD initiation dateby age, gender, race/ethnicity, & primary diagnosis

Dialysis patients who were already listed on January 1 of the given year are excluded†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank."." Zero values in this cell.

Table E.4% of patients wait-listed or receiving a deceased-donor kidney within one year of their ESRD initiation dateby age, gender, race/ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<1 51.1 29.3 43.0 37.9 26.1 29.0 39.3 33.4 31.2 34.2 27.5 33.51-4 31.3 19.8 49.1 51.2 49.0 58.3 48.6 61.6 76.2 56.2 66.5 30.05-9 54.8 52.6 50.4 52.2 50.5 57.3 69.0 68.7 70.1 62.8 60.8 74.710-14 41.9 40.3 38.6 40.7 45.1 54.9 58.8 67.5 66.3 55.4 49.5 55.415-19 31.7 30.8 33.8 35.2 36.7 37.9 46.7 52.3 56.8 50.6 51.6 44.820-29 27.4 27.2 27.9 28.2 28.0 31.2 35.7 41.5 40.6 40.7 36.4 39.130-39 18.8 21.3 22.4 22.9 22.3 25.6 30.8 34.9 34.4 33.0 32.6 31.340-49 11.1 12.8 12.1 13.5 13.2 15.9 20.5 26.2 26.6 25.3 24.4 24.350-59 4.1 3.9 4.0 4.3 4.9 5.5 8.5 12.2 12.7 12.0 12.5 12.760-64 0.4 0.8 0.6 1.1 1.2 1.8 2.9 4.4 4.8 4.5 5.1 5.665-69 0.3 . . 0.2 0.4 0.5 0.7 1.3 1.3 1.7 1.8 2.070-79 . . . 0.1 0.1 0.1 0.1 0.3 0.3 0.3 0.4 0.480+ . . . . 0.1 0.1 0.2 0.0 . 0.1 0.2 0.1

0-19 37.3 35.2 38.3 39.2 40.2 44.5 52.0 57.1 58.9 52.0 51.1 48.320-44 19.8 21.4 22.2 22.5 22.4 25.2 30.2 35.0 34.7 33.5 32.0 32.045-64 4.1 4.1 3.8 4.4 4.6 5.6 8.2 11.5 11.9 11.4 11.5 11.865-74 0.2 . 0.1 0.2 0.3 0.3 0.5 1.0 0.9 1.2 1.2 1.375+ . . . . 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1

Male 9.3 10.1 9.7 9.4 9.5 10.4 12.7 15.6 15.0 14.0 13.7 13.0Female 6.7 6.5 6.8 6.3 6.5 7.4 9.5 10.7 11.3 10.4 9.6 9.6




All 8.1 8.5 8.4 8.0 8.1 9.0 11.2 13.3 13.3 12.4 11.8 11.4

Dialysis patients who were already listed on January 1 of the given year are excluded†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank."." Zero values in this cell.


408

Reference section EETable E.4 (continued)Percent of patients wait-listed or receiving a deceased-donor kidney within one year of their ESRD initiation dateby age, gender, race/ethnicity, & primary diagnosis

Table E.4 (continued)% of patients wait-listed or receiving a deceased-donor kidney within one year of their ESRD initiation dateby age, gender, race/ethnicity, & primary diagnosis

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 24.6 22.9 17.0 17.5 23.3 24.2 36.1 22.5 17.9 11.6 17.6 22.21-4 64.1 41.5 53.5 56.3 53.8 50.9 47.1 46.7 37.3 53.3 34.3 58.85-9 58.3 60.9 50.4 64.6 60.6 60.3 43.0 55.9 44.8 48.6 39.0 50.010-14 51.8 62.0 46.8 60.7 59.8 56.5 54.7 54.6 46.0 47.9 43.2 55.415-19 46.2 41.3 50.9 42.0 34.6 43.5 43.0 43.5 36.9 35.0 39.0 48.620-29 37.0 35.6 36.2 33.3 35.0 33.0 30.9 31.3 28.9 29.5 29.9 32.930-39 32.1 31.0 29.6 30.1 29.0 27.9 28.9 27.4 26.7 25.4 27.4 29.540-49 24.7 23.8 23.3 24.0 22.8 21.4 21.3 21.3 20.3 20.2 19.2 21.550-59 13.2 13.6 13.9 13.3 13.5 14.4 14.1 13.9 13.7 13.6 14.4 15.960-64 5.4 6.1 6.1 7.4 7.4 8.0 7.9 8.4 8.9 8.5 9.4 11.265-69 2.2 2.8 2.9 3.7 3.3 3.5 4.2 4.5 4.7 5.1 5.9 6.870-79 0.5 0.4 0.4 0.6 0.5 0.7 0.8 1.0 1.1 1.2 1.3 1.680+ 0.1 . . 0.1 . . 0.1 0.1 0.1 0.1 0.1 0.2

0-19 47.6 46.0 47.3 47.3 43.1 47.2 45.1 46.2 38.0 38.7 38.1 48.520-44 31.4 30.3 29.6 29.1 28.7 27.5 26.9 26.4 25.3 24.7 25.2 27.845-64 12.4 12.7 12.9 13.3 13.0 13.3 13.4 13.4 13.3 13.1 13.7 15.365-74 1.5 1.7 1.8 2.3 2.1 2.3 2.7 2.9 3.2 3.4 3.9 4.775+ 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.3 0.3 0.3 0.4

Male 12.9 12.8 12.4 12.6 11.7 11.4 11.1 11.0 10.7 10.4 10.9 12.6Female 9.6 9.2 9.1 9.0 8.7 8.3 8.6 8.5 8.2 8.5 8.4 9.9




All 11.3 11.1 10.8 10.9 10.3 10.0 10.0 9.9 9.5 9.5 9.8 11.3

Dialysis patients who were already listed on January 1 of the given year are excluded†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank."." Zero values in this cell.Dialysis patients who were already listed on January 1 of the given year are excluded†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank."." Zero values in this cell.

409


TRANSPLANTATION: PROCESSETable E.5Renal transplants: by donor typeTable E.5Renal transplants: by donor type

Living Donor RelationLiving Distantly Spouse/ Paired Unrelated Nondirected Living-Deceased

Deceased (Total) Related Related Life Partner Exchange Directed Donation Exchange Unknown Unknown Total1980 2,578 914 . . . . . . . 914 290 3,7821981 2,867 1,134 . . . . . . . 1,134 224 4,2251982 3,402 1,550 . . . . . . . 1,550 158 5,1101983 3,968 1,710 . . . . . . . 1,710 199 5,8771984 4,614 1,927 * . . . . . . 1,926 195 6,7361985 4,947 2,326 . . . . * . . 2,325 228 7,5011986 5,773 2,859 . * . . . . . 2,858 244 8,8761987 6,055 2,692 361 * 12 . * . . 2,310 184 8,9311988 7,281 1,837 1,631 36 38 . 25 . . 107 112 9,2301989 7,113 1,921 1,706 31 53 . 30 . . 101 118 9,1521990 7,798 2,087 1,722 45 59 . 29 . . 232 127 10,0121991 7,735 2,392 2,167 47 59 . 47 . . 72 110 10,2371992 7,681 2,542 2,233 70 78 . 75 . . 86 162 10,3851993 8,181 2,874 2,397 96 114 . 67 . . 200 102 11,1571994 8,286 2,955 2,276 121 127 . 73 . . 358 157 11,3981995 8,460 3,375 2,773 178 254 . 157 . . 13 186 12,0211996 8,440 3,653 2,817 213 351 . 213 . * 58 168 12,2611997 8,598 3,929 2,992 236 380 . 270 . * 48 113 12,6401998 8,975 4,407 3,142 295 544 . 359 * * 64 160 13,5421999 8,951 4,709 3,270 346 573 . 470 * . 45 125 13,7852000 9,023 5,478 3,483 393 653 . 741 18 * 189 56 14,5572001 9,099 6,030 3,674 439 670 * 854 23 * 358 49 15,1782002 9,422 6,233 3,663 467 683 * 1,028 53 * 331 52 15,7072003 8,705 6,466 3,667 448 697 15 1,213 73 * 346 872 16,043

Age is calculated as of the day of transplantation.USRDS counts include non-Medicare patients.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table E.5Renal transplants: by donor type

Living Donor RelationLiving Distantly Spouse/ Paired Unrelated Nondirected Living-Deceased

Deceased (Total) Related Related Life Partner Exchange Directed Donation Exchange Unknown Unknown Total1980 2,578 914 . . . . . . . 914 290 3,7821981 2,867 1,134 . . . . . . . 1,134 224 4,2251982 3,402 1,550 . . . . . . . 1,550 158 5,1101983 3,968 1,710 . . . . . . . 1,710 199 5,8771984 4,614 1,927 * . . . . . . 1,926 195 6,7361985 4,947 2,326 . . . . * . . 2,325 228 7,5011986 5,773 2,859 . * . . . . . 2,858 244 8,8761987 6,055 2,692 361 * 12 . * . . 2,310 184 8,9311988 7,281 1,837 1,631 36 38 . 25 . . 107 112 9,2301989 7,113 1,921 1,706 31 53 . 30 . . 101 118 9,1521990 7,798 2,087 1,722 45 59 . 29 . . 232 127 10,0121991 7,735 2,392 2,167 47 59 . 47 . . 72 110 10,2371992 7,681 2,542 2,233 70 78 . 75 . . 86 162 10,3851993 8,181 2,874 2,397 96 114 . 67 . . 200 102 11,1571994 8,286 2,955 2,276 121 127 . 73 . . 358 157 11,3981995 8,460 3,375 2,773 178 254 . 157 . . 13 186 12,0211996 8,440 3,653 2,817 213 351 . 213 . * 58 168 12,2611997 8,598 3,929 2,992 236 380 . 270 . * 48 113 12,6401998 8,975 4,407 3,142 295 544 . 359 * * 64 160 13,5421999 8,951 4,709 3,270 346 573 . 470 * . 45 125 13,7852000 9,023 5,478 3,483 393 653 . 741 18 * 189 56 14,5572001 9,099 6,030 3,674 439 670 * 854 23 * 358 49 15,1782002 9,422 6,233 3,663 467 683 * 1,028 53 * 331 52 15,7072003 8,705 6,466 3,667 448 697 15 1,213 73 * 346 872 16,043

Age is calculated as of the day of transplantation.USRDS counts include non-Medicare patients.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.


410

Reference section EETable E.6Renal transplants: recipients age <20by age, gender, race, ethnicity, donor type, & number of transplants

Table E.6Renal transplants: recipients age <20by age, gender, race, ethnicity, donor type, & number of transplants

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 All<1 11 * * * * * * * 13 * * * * 871-4 97 102 119 78 85 110 120 91 114 94 127 116 122 1,3755-9 150 114 133 120 139 142 123 136 128 104 133 146 146 1,71410-14 196 194 198 219 237 218 210 229 253 206 225 237 281 2,90315-19 347 334 366 462 429 388 355 349 441 402 406 404 445 5,128

Male 475 436 467 534 537 552 474 463 537 459 532 552 582 6,600Female 326 312 356 348 362 316 339 350 412 351 364 356 414 4,606Unknown . . . . . . . . . . . . * *

White 625 583 631 628 643 639 611 601 719 600 670 679 707 8,336Black 135 128 148 211 199 179 154 169 191 165 160 180 204 2,223Native American 15 * * 16 16 * * 11 * * 15 * * 145Asian 24 26 27 23 33 28 31 27 22 28 33 30 39 371Other/unknown * * * * * 12 * * * 12 18 * 37 132

†Hispanic 126 131 124 127 159 145 167 178 185 1,342†Non-Hispanic 773 737 689 686 790 665 729 730 812 6,611

Deceased 382 362 375 483 421 387 346 358 443 356 362 373 452 5,100Living 409 373 435 388 457 463 452 436 493 447 527 529 541 5,950Unknown * 13 13 11 21 18 15 19 13 * * * * 157

1st transplant 667 634 719 739 771 751 720 696 835 714 813 800 886 9,7452nd transplant 114 93 90 120 109 96 76 99 90 84 71 100 101 1,2433rd transplant 16 19 12 21 13 17 15 17 22 11 11 * * 1884th transplant * * * * * * * * * * * * * 275th transplant . * * * . . * . . . . . . *

All 801 748 823 882 899 868 813 813 949 810 896 908 997 11,207

Age is calculated as of the day of transplantation.USRDS counts include non-Medicare patients.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table E.6Renal transplants: recipients age <20by age, gender, race, ethnicity, donor type, & number of transplants

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 All<1 11 * * * * * * * 13 * * * * 871-4 97 102 119 78 85 110 120 91 114 94 127 116 122 1,3755-9 150 114 133 120 139 142 123 136 128 104 133 146 146 1,71410-14 196 194 198 219 237 218 210 229 253 206 225 237 281 2,90315-19 347 334 366 462 429 388 355 349 441 402 406 404 445 5,128

Male 475 436 467 534 537 552 474 463 537 459 532 552 582 6,600Female 326 312 356 348 362 316 339 350 412 351 364 356 414 4,606Unknown . . . . . . . . . . . . * *

White 625 583 631 628 643 639 611 601 719 600 670 679 707 8,336Black 135 128 148 211 199 179 154 169 191 165 160 180 204 2,223Native American 15 * * 16 16 * * 11 * * 15 * * 145Asian 24 26 27 23 33 28 31 27 22 28 33 30 39 371Other/unknown * * * * * 12 * * * 12 18 * 37 132

†Hispanic 126 131 124 127 159 145 167 178 185 1,342†Non-Hispanic 773 737 689 686 790 665 729 730 812 6,611

Deceased 382 362 375 483 421 387 346 358 443 356 362 373 452 5,100Living 409 373 435 388 457 463 452 436 493 447 527 529 541 5,950Unknown * 13 13 11 21 18 15 19 13 * * * * 157

1st transplant 667 634 719 739 771 751 720 696 835 714 813 800 886 9,7452nd transplant 114 93 90 120 109 96 76 99 90 84 71 100 101 1,2433rd transplant 16 19 12 21 13 17 15 17 22 11 11 * * 1884th transplant * * * * * * * * * * * * * 275th transplant . * * * . . * . . . . . . *

All 801 748 823 882 899 868 813 813 949 810 896 908 997 11,207

Age is calculated as of the day of transplantation.USRDS counts include non-Medicare patients.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

411


TRANSPLANTATION: PROCESSEON OUR WEBSITE & CDRenal transplants, 1999-2003 (Table E.7.1-E.7.6)

Table E.7Counts of renal transplants, by donor type: allby age, gender, race, ethnicity, & primary diagnosis

Table E.7Counts of renal transplants, by donor type: allby age, gender, race, ethnicity, & primary diagnosis

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 All<1 35 35 46 29 35 35 37 41 46 28 48 45 40 5001-4 73 71 80 52 59 85 88 58 81 70 84 76 85 9625-9 150 114 133 120 139 142 123 136 128 104 133 146 146 1,71410-14 196 194 198 219 237 218 210 229 253 206 225 237 281 2,90315-19 347 334 366 462 429 388 355 349 441 402 406 404 445 5,12820-29 1,660 1,557 1,655 1,533 1,516 1,491 1,478 1,480 1,479 1,435 1,425 1,336 1,347 19,39230-39 2,563 2,606 2,682 2,712 2,841 2,647 2,634 2,885 2,690 2,781 2,825 2,833 2,683 35,38240-49 2,565 2,594 2,795 2,906 3,032 3,245 3,264 3,397 3,412 3,648 3,693 3,696 3,696 41,94350-59 1,722 1,841 2,047 2,179 2,306 2,444 2,768 3,067 3,144 3,453 3,695 3,965 4,068 36,69960-64 573 590 690 664 808 881 959 976 1,143 1,209 1,349 1,426 1,557 12,82565-69 276 329 343 379 451 507 532 671 684 820 853 987 1,093 7,92570-79 72 113 118 141 167 175 190 244 275 390 433 547 584 3,44980+ * * * * * * * * * 11 * * 18 86

0-19 801 748 823 882 899 868 813 813 949 810 896 908 997 11,20720-44 5,636 5,546 5,795 5,732 5,863 5,693 5,701 6,065 5,841 5,961 5,983 5,905 5,771 75,49245-64 3,447 3,642 4,074 4,262 4,640 5,015 5,402 5,740 6,027 6,565 7,004 7,351 7,580 70,74965-74 343 422 445 506 595 665 688 871 919 1,153 1,192 1,415 1,551 10,76575+ * 27 19 16 24 20 36 53 48 68 103 128 144 695

Male 6,138 6,123 6,673 6,854 7,301 7,296 7,538 7,997 8,196 8,605 8,989 9,315 9,593 100,618Female 4,099 4,262 4,482 4,543 4,718 4,965 5,102 5,545 5,589 5,951 6,189 6,392 6,447 68,284

White 7,709 7,709 8,333 8,081 8,645 8,770 9,099 9,834 9,902 10,463 10,792 11,208 11,154 121,699Black 2,088 2,177 2,320 2,733 2,817 2,884 2,875 2,977 3,089 3,242 3,490 3,598 3,772 38,062Native American 110 100 104 139 118 133 126 125 170 149 148 149 154 1,725Asian 303 383 371 425 408 440 500 556 563 617 651 684 728 6,629

†Hispanic 1,148 1,199 1,318 1,556 1,564 1,711 1,820 2,005 2,052 14,373†Non-Hispanic 10,873 11,062 11,322 11,986 12,221 12,846 13,358 13,702 13,991 111,361

Diabetes 2,406 2,379 2,829 2,874 3,041 3,201 3,266 3,623 3,601 3,792 4,062 4,328 4,290 43,692Hypertension 1,642 1,813 1,887 2,103 2,093 2,088 2,097 2,163 2,159 2,362 2,547 2,664 2,627 28,245Glomerulonephritis 2,939 2,883 2,956 2,983 3,247 3,239 3,359 3,562 3,592 3,748 3,719 3,899 3,904 44,030Other cause 3,250 3,310 3,485 3,438 3,640 3,733 3,918 4,194 4,433 4,655 4,850 4,816 5,222 52,944

All 10,237 10,385 11,157 11,398 12,021 12,261 12,640 13,542 13,785 14,557 15,178 15,707 16,043 168,911

Age is calculated as of the day of transplantation.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed.


412

Reference section EETable E.7 (continued)Counts of renal transplants, by donor type: deceased donorby age, gender, race, ethnicity, & primary diagnosis

Table E.7 (continued)Counts of renal transplants, by donor type: deceased donorby age, gender, race, ethnicity, & primary diagnosis

<1 * 14 * 12 * * * * * * * * * 1111-4 28 33 29 25 24 37 32 24 32 25 24 29 29 3715-9 64 45 67 58 54 69 62 65 57 44 56 67 65 77310-14 97 80 83 118 117 95 101 100 118 90 90 98 141 1,32815-19 184 190 188 270 222 178 143 161 226 191 182 174 208 2,51720-29 1,089 1,002 1,026 901 942 846 823 779 741 737 650 641 508 10,68530-39 1,917 1,905 1,942 1,920 1,948 1,785 1,740 1,837 1,729 1,693 1,666 1,670 1,194 22,94640-49 2,066 2,034 2,197 2,237 2,253 2,335 2,376 2,378 2,280 2,267 2,259 2,255 1,915 28,85250-59 1,454 1,498 1,652 1,737 1,751 1,843 2,024 2,180 2,189 2,268 2,378 2,517 2,436 25,92760-64 508 504 579 550 637 693 714 717 830 826 871 948 1,023 9,40065-69 253 274 302 329 369 401 416 522 520 584 596 641 739 5,94670-79 63 99 105 127 138 147 157 196 213 285 312 370 423 2,63580+ * * * * * * * * * * * * 15 62

0-19 382 362 375 483 421 387 346 358 443 356 362 373 452 5,10020-44 4,133 3,989 4,101 3,948 3,988 3,745 3,698 3,790 3,593 3,493 3,374 3,335 2,542 47,72945-64 2,901 2,954 3,295 3,397 3,543 3,757 3,979 4,101 4,176 4,298 4,450 4,696 4,534 50,08165-74 312 356 393 442 491 533 544 683 697 828 836 922 1,067 8,10475+ * 20 16 16 17 18 31 43 41 48 77 96 110 539

Male 4,697 4,598 4,923 5,064 5,247 5,092 5,183 5,389 5,370 5,413 5,451 5,628 5,316 67,371Female 3,038 3,083 3,256 3,221 3,211 3,348 3,415 3,586 3,581 3,610 3,648 3,794 3,388 44,179

White 5,647 5,495 5,915 5,678 5,879 5,767 5,859 6,155 6,088 6,050 6,005 6,178 5,390 76,106Black 1,742 1,790 1,874 2,181 2,202 2,232 2,269 2,305 2,322 2,440 2,566 2,670 2,650 29,243Native American 78 74 82 102 76 96 77 87 114 110 76 98 94 1,164Asian 249 313 288 314 292 328 378 407 401 395 410 445 476 4,696

†Hispanic 760 759 817 990 977 1,021 1,093 1,217 1,180 8,814†Non-Hispanic 7,700 7,681 7,781 7,985 7,974 8,002 8,006 8,205 7,525 70,859

Diabetes 1,850 1,843 2,223 2,223 2,335 2,393 2,468 2,638 2,613 2,623 2,709 2,888 2,152 30,958Hypertension 1,351 1,436 1,497 1,641 1,602 1,584 1,598 1,590 1,553 1,612 1,770 1,782 1,750 20,766Glomerulonephritis 2,173 2,081 2,074 2,047 2,142 2,075 2,087 2,211 2,192 2,217 2,072 2,193 2,113 27,677Other cause 2,361 2,321 2,387 2,375 2,381 2,388 2,445 2,536 2,593 2,571 2,548 2,559 2,690 32,155

All 7,735 7,681 8,181 8,286 8,460 8,440 8,598 8,975 8,951 9,023 9,099 9,422 8,705 111,556

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed.

413


TRANSPLANTATION: PROCESSETable E.7 (continued)Counts of renal transplants, by donor type: living related by age, gender, race, ethnicity, & primary diagnosis

Table E.7 (continued)Counts of renal transplants: by donor typeby age, gender, race, ethnicity, & primary diagnosis

LIVING RELATED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 All<1 24 18 31 * 27 23 25 29 30 18 31 34 25 3231-4 39 35 40 22 30 44 47 29 40 38 50 39 46 4995-9 79 62 54 48 75 61 52 53 55 49 55 67 64 77410-14 83 96 91 82 100 104 82 105 108 97 106 101 102 1,25715-19 147 123 153 152 177 176 180 143 168 157 177 171 169 2,09320-29 518 481 542 497 493 534 517 552 564 518 536 479 497 6,72830-39 571 589 618 572 708 658 675 725 684 678 689 669 646 8,48240-49 414 455 439 473 556 601 620 628 686 760 785 737 742 7,89650-59 216 260 300 308 402 395 517 570 577 664 697 766 765 6,43760-64 55 70 90 72 118 132 171 171 204 260 307 281 298 2,22965-69 18 41 31 35 64 67 81 106 109 161 155 216 203 1,28770-79 * * * * 22 19 22 31 41 77 76 104 106 51880+ . * * . . . . . * * * . * *

0-19 372 334 369 312 409 408 386 359 401 359 419 412 406 4,94620-44 1,324 1,318 1,402 1,322 1,502 1,482 1,518 1,599 1,593 1,566 1,588 1,527 1,532 19,27345-64 450 537 587 600 775 838 982 1,047 1,122 1,314 1,426 1,405 1,416 12,49965-74 21 43 39 42 83 84 102 130 148 227 218 302 289 1,72875+ . * * . * * * * * 12 15 18 23 86

Male 1,243 1,258 1,411 1,297 1,555 1,596 1,693 1,728 1,880 1,939 2,083 2,092 2,069 21,844Female 924 975 987 979 1,217 1,218 1,296 1,414 1,387 1,538 1,583 1,572 1,596 16,686

White 1,801 1,847 1,957 1,760 2,148 2,228 2,387 2,516 2,568 2,748 2,878 2,910 2,823 30,571Black 282 303 362 404 487 475 461 485 532 536 579 573 610 6,089Native American 26 23 18 30 31 28 35 23 35 27 51 30 30 387Asian 52 57 59 75 93 72 91 99 109 132 120 133 138 1,230

†Hispanic 305 354 400 416 429 477 495 531 512 3,919†Non-Hispanic 2,467 2,460 2,589 2,726 2,838 3,001 3,171 3,133 3,154 25,539

Diabetes 485 421 489 464 549 588 562 659 640 709 794 831 726 7,917Hypertension 235 296 319 341 367 345 360 414 420 482 497 549 537 5,162Glomerulonephritis 671 688 714 696 894 911 974 950 985 988 1,030 1,023 1,019 11,543Other cause 776 828 876 775 962 970 1,093 1,119 1,222 1,299 1,345 1,261 1,384 13,910

All 2,167 2,233 2,398 2,276 2,772 2,814 2,989 3,142 3,267 3,478 3,666 3,664 3,666 38,532

Age is calculated as of the day of transplantation.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.


414

Reference section EETable E.7 (continued)Counts of renal transplants, by donor type: living distant/unrelatedby age, gender, race, ethnicity, & primary diagnosis

Table E.7 (continued)Counts of renal transplants: by donor typeby age, gender, race, ethnicity, & primary diagnosis

LIVING DISTANT/UNRELATED<1 * * * * * * * * * * * * * 501-4 * * * * * * * * * * * * * 765-9 * * * * * * * 13 15 * 14 * 14 11610-14 * * * * 14 13 21 20 20 16 21 31 33 22015-19 * 12 11 18 18 20 22 32 40 46 37 55 55 37320-29 18 35 34 38 60 74 109 117 152 153 186 177 240 1,39330-39 38 52 56 86 127 159 194 270 246 358 398 423 444 2,85140-49 45 49 95 78 176 245 232 346 398 557 533 611 632 3,99750-59 21 42 45 56 124 171 201 274 349 459 524 581 646 3,49360-64 * * * 21 33 44 53 75 93 105 141 167 200 95165-69 * * * * 15 29 27 34 45 67 87 111 125 55870-79 * . . * * * 11 14 18 20 36 59 50 22180+ . . . . . . . . * * * * . *

0-19 23 30 36 37 48 49 61 71 89 80 88 108 115 83520-44 86 115 136 160 267 357 415 570 583 788 842 891 979 6,18945-64 42 72 98 119 253 336 374 512 655 844 940 1,068 1,183 6,49665-74 * * * * 17 35 34 46 61 84 115 160 165 73775+ . . . . * . * * * * * 12 * 51

Male 90 142 168 195 376 470 566 745 848 1,115 1,211 1,365 1,474 8,765Female 63 81 109 126 212 307 322 456 544 687 784 874 977 5,542

White 130 194 230 255 489 616 731 990 1,115 1,477 1,590 1,808 1,987 11,612Black 22 23 34 50 71 124 116 145 202 217 277 306 311 1,898Native American * * * * * * * 13 19 11 21 20 23 142Asian . * * 12 15 28 25 46 48 76 96 89 92 540

†Hispanic 62 65 83 121 134 180 190 206 242 1,283†Non-Hispanic 526 712 805 1,080 1,258 1,622 1,805 2,033 2,210 12,051

Diabetes 34 61 51 69 115 175 202 276 309 398 465 527 561 3,243Hypertension 18 32 29 33 90 112 116 132 156 230 235 287 262 1,732Glomerulonephritis 49 49 86 90 149 189 253 335 370 481 508 575 653 3,787Other cause 52 81 111 129 234 301 317 458 557 693 787 850 976 5,546

All 153 223 277 321 588 777 888 1,201 1,392 1,802 1,995 2,239 2,452 14,308

Age is calculated as of the day of transplantation.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1995 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

415


TRANSPLANTATION: PROCESSETable E.8Counts of renal transplants: by donor type & number of transplants

Table E.9Renal transplant rates, by donor type: allby age, gender, race, ethnicity, & primary diagnosis

Table E.8Counts of renal transplants: by donor type & number of transplants

ALL 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 All1st transplant 8,897 9,074 9,883 10,031 10,540 10,832 11,171 11,925 12,227 12,849 13,437 13,891 14,186 148,9432nd transplant 1,156 1,108 1,112 1,188 1,284 1,208 1,261 1,375 1,328 1,474 1,479 1,556 1,595 17,1243rd transplant 165 181 141 157 163 190 185 207 197 201 224 222 230 2,4634+ transplants* 19 22 21 22 34 31 23 35 33 33 38 38 32 381

DECEASED DONOR1st transplant 6,637 6,608 7,183 7,234 7,346 7,388 7,498 7,823 7,846 7,826 7,971 8,269 7,629 97,2582nd transplant 945 898 871 913 951 888 935 974 935 1,026 957 983 906 12,1823rd transplant 136 156 111 119 133 139 144 152 146 144 145 144 149 1,8184+ transplants* 17 19 16 20 30 25 21 26 24 27 26 26 21 298

LIVING RELATED1st transplant 2,008 2,074 2,220 2,094 2,536 2,585 2,758 2,887 3,002 3,189 3,348 3,327 3,301 35,3292nd transplant 141 141 156 156 215 198 206 220 231 257 277 290 327 2,8153rd transplant 17 15 17 25 19 31 26 29 30 34 41 44 33 3614+ transplants* * * * * * * * * * * * * * 49

LIVING DISTANT/UNRELATED1st transplant 135 204 244 285 530 700 813 1,075 1,271 1,630 1,762 1,974 2,140 12,7632nd transplant 17 19 27 33 56 69 71 110 109 154 202 230 272 1,3693rd transplant * . * * * * * 14 12 19 30 26 37 1644+ transplants* . . . * . . . * * * * * * 25

The maximum transplant number was 7.4,515 transplant events (2.7%) were dropped from the donor type-specific tables above due to unknown donor type.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table E.9Renal transplant rates: by donor typeby age, gender, race, ethnicity, & primary diagnosis

ALL 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 47.7 51.0 55.4 33.0 41.6 45.5 48.2 50.3 51.1 36.1 47.5 49.5 47.41-4 61.4 55.9 65.3 38.6 42.7 56.5 57.3 45.0 58.3 46.6 60.9 53.7 61.25-9 58.8 51.3 55.0 44.5 48.9 52.4 50.5 48.6 48.6 40.9 43.0 47.2 48.410-14 41.4 41.4 38.9 47.8 45.1 40.6 39.6 45.1 50.2 38.1 39.2 37.4 43.915-19 29.5 28.0 30.8 35.3 34.2 30.0 25.8 24.4 30.1 27.7 30.0 27.9 29.820-29 22.2 19.6 20.3 18.0 17.4 16.4 16.1 15.7 15.4 14.8 14.4 13.5 13.630-39 15.7 14.8 14.3 13.6 13.5 12.4 11.9 12.7 11.5 11.7 11.7 11.4 10.740-49 11.6 10.6 10.5 9.9 9.5 9.3 8.9 8.8 8.3 8.5 8.3 8.1 7.850-59 6.2 5.9 6.0 5.9 5.9 5.8 5.9 6.1 5.8 5.8 5.9 5.9 5.860-64 2.9 2.9 3.1 2.8 3.2 3.3 3.3 3.2 3.5 3.6 3.8 3.8 4.065-69 1.2 1.3 1.3 1.3 1.4 1.5 1.6 1.9 1.9 2.1 2.1 2.5 2.770-79 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.5 0.6 0.7 0.780+ . 0.1 . . . . . . . . . . .

0-19 37.9 35.9 38.2 39.2 39.4 37.3 34.2 33.9 38.9 32.9 36.2 34.8 37.620-44 16.4 14.9 14.6 13.7 13.4 12.4 11.9 12.2 11.4 11.4 11.1 10.9 10.545-64 5.8 5.7 5.9 5.6 5.6 5.7 5.7 5.7 5.5 5.6 5.7 5.7 5.665-74 0.8 0.9 0.9 0.9 1.0 1.0 1.0 1.2 1.2 1.5 1.5 1.7 1.875+ . 0.1 0.1 . 0.1 . 0.1 0.1 0.1 0.1 0.1 0.2 0.2

Male 7.8 7.0 7.0 6.6 6.5 6.0 5.8 5.7 5.5 5.4 5.4 5.3 5.2Female 5.6 5.2 5.1 4.7 4.5 4.4 4.3 4.4 4.2 4.2 4.2 4.2 4.1

White 8.4 7.7 7.7 6.9 6.9 6.6 6.4 6.6 6.2 6.2 6.1 6.1 5.8Black 3.8 3.6 3.4 3.7 3.5 3.3 3.1 3.0 2.9 2.9 3.1 3.0 3.0Native American 5.9 4.6 4.3 5.2 4.0 4.2 3.7 3.4 4.2 3.5 3.3 3.2 3.2Asian 7.8 8.3 6.8 6.6 5.6 5.4 5.6 5.7 5.3 5.3 5.2 5.1 5.1

Hispanic 9.2 8.3 7.4 6.2 5.9 5.1 4.9 5.2 4.7 4.7 4.6 4.7 4.4Non-Hispanic 6.5 6.0 6.0 5.6 5.5 5.3 5.1 5.1 4.9 4.9 4.9 4.8 4.8

Diabetes 5.5 4.7 4.9 4.4 4.2 3.9 3.6 3.6 3.3 3.3 3.3 3.3 3.1Hypertension 3.6 3.6 3.4 3.4 3.2 3.1 2.9 2.9 2.7 2.8 3.0 3.0 2.8Glomerulonephritis 10.9 10.2 9.9 9.4 9.7 9.1 9.1 9.3 9.1 9.2 9.0 9.3 9.2Other cause 8.8 8.5 8.6 8.1 8.1 7.8 7.8 7.9 7.9 7.9 7.9 7.5 7.8

All 6.7 6.2 6.1 5.7 5.5 5.3 5.1 5.1 4.9 4.9 4.9 4.8 4.7

The maximum transplant number was 7.4,515 transplant events (2.7%) were dropped from the donor type-specific tables above due to unknown donor type.*Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.


416

Reference section EETable E.9 (continued)Renal transplant rates, by donor type: deceased donorby age, gender, race, ethnicity, & primary diagnosis

Table E.9 (continued)Renal transplant rates: by donor typeby age, gender, race, ethnicity, & primary diagnosis

DECEASED DONOR<1 16.2 20.8 10.9 14.9 9.9 13.8 12.1 11.4 13.0 9.0 10.1 7.3 12.31-4 22.0 26.2 27.0 17.4 16.8 26.0 20.5 20.2 22.4 16.8 17.1 23.1 24.25-9 24.8 20.4 28.3 22.8 19.8 23.4 25.2 22.5 21.9 17.7 18.1 20.2 22.010-14 21.0 18.8 15.9 26.4 22.0 19.1 19.3 20.0 23.9 16.5 15.6 16.8 21.615-19 15.2 15.9 16.4 20.0 17.9 13.6 9.8 11.8 14.8 13.1 13.4 11.4 13.220-29 14.7 12.8 12.7 10.7 10.8 9.4 9.2 8.4 7.9 7.7 6.7 6.7 5.230-39 11.9 10.8 10.3 9.8 9.4 8.4 7.9 8.1 7.4 7.1 7.0 6.7 4.840-49 9.3 8.3 8.3 7.7 7.0 6.7 6.5 6.1 5.6 5.3 5.0 5.0 4.150-59 5.2 4.9 4.9 4.7 4.5 4.4 4.4 4.3 4.0 3.8 3.8 3.8 3.560-64 2.6 2.4 2.6 2.3 2.5 2.6 2.4 2.4 2.6 2.5 2.4 2.6 2.665-69 1.1 1.1 1.1 1.1 1.2 1.2 1.2 1.5 1.4 1.5 1.5 1.6 1.870-79 0.2 0.2 0.2 0.3 0.3 0.2 0.2 0.3 0.3 0.4 0.4 0.4 0.580+ . . . . . . . . . . . . .

0-19 18.0 17.8 17.9 21.3 18.7 16.8 14.3 15.2 17.9 14.4 14.5 14.2 16.720-44 12.1 10.8 10.3 9.5 9.1 8.1 7.8 7.7 7.1 6.7 6.3 6.2 4.745-64 4.9 4.6 4.8 4.5 4.3 4.3 4.2 4.1 3.8 3.7 3.6 3.6 3.365-74 0.7 0.7 0.8 0.8 0.8 0.8 0.8 0.9 0.9 1.1 1.0 1.1 1.375+ . 0.1 0.1 . . . 0.1 0.1 0.1 0.1 0.1 0.1 0.1

Male 5.9 5.3 5.2 4.9 4.7 4.2 4.0 3.9 3.6 3.4 3.3 3.2 2.9Female 4.1 3.8 3.7 3.3 3.1 3.0 2.9 2.8 2.7 2.6 2.5 2.5 2.2




All 5.1 4.6 4.4 4.1 3.9 3.6 3.5 3.4 3.2 3.0 2.9 2.9 2.6


417


TRANSPLANTATION: PROCESSETable E.9 (continued)Renal transplant rates, by donor type: living relatedby age, gender, race, ethnicity, & primary diagnosis


LIVING RELATED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<1 29.4 27.1 37.2 10.7 28.9 26.7 31.1 36.1 30.7 23.0 31.2 37.3 28.61-4 33.9 27.1 27.9 16.6 21.7 27.3 30.7 20.9 28.8 24.4 35.6 24.6 31.05-9 30.9 27.6 22.3 17.1 25.3 24.9 21.4 19.7 21.5 18.7 17.1 22.1 20.010-14 17.3 18.4 18.0 16.9 19.9 17.7 15.4 20.0 21.0 17.7 19.1 15.1 16.315-19 12.8 10.5 12.6 12.2 13.8 13.8 13.3 9.7 11.9 11.1 13.0 12.2 11.620-29 6.8 5.9 6.5 5.8 5.6 5.8 5.5 5.7 5.7 5.2 5.3 4.7 4.930-39 3.4 3.3 3.2 2.8 3.3 3.0 3.0 3.2 2.8 2.8 2.8 2.7 2.640-49 1.9 1.8 1.6 1.6 1.7 1.7 1.7 1.6 1.7 1.7 1.8 1.6 1.650-59 0.8 0.8 0.9 0.8 1.0 0.9 1.1 1.1 1.1 1.2 1.1 1.1 1.160-64 0.3 0.4 0.4 0.3 0.5 0.5 0.6 0.6 0.6 0.7 0.9 0.8 0.865-69 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.3 0.4 0.4 0.5 0.570-79 . . . . . . . . 0.1 0.1 0.1 0.1 0.180+ . . . . . . . . . . . . .

0-19 17.7 15.7 16.8 14.0 17.8 17.3 16.4 14.8 16.6 14.7 17.1 15.8 15.420-44 3.8 3.5 3.5 3.1 3.4 3.2 3.1 3.2 3.1 3.0 2.9 2.8 2.745-64 0.8 0.9 0.8 0.8 0.9 0.9 1.0 1.0 1.0 1.1 1.2 1.1 1.065-74 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.3 0.4 0.475+ . . . . . . . . . . . . .

Male 1.6 1.4 1.5 1.2 1.4 1.3 1.3 1.2 1.3 1.2 1.3 1.2 1.1Female 1.3 1.2 1.1 1.0 1.2 1.1 1.1 1.1 1.0 1.1 1.1 1.0 1.0




All 1.4 1.3 1.3 1.1 1.3 1.2 1.2 1.2 1.2 1.2 1.2 1.1 1.1



418

Reference section EETable E.9 (continued)Renal transplant rates, by donor type: living distant/unrelatedby age, gender, race, ethnicity, & primary diagnosis


LIVING DISTANT/UNRELATED<1 1.0 2.1 4.5 4.1 2.7 4.0 4.0 1.9 6.5 3.3 6.2 4.1 4.91-4 3.7 2.6 7.0 3.2 3.5 3.2 4.8 3.1 7.2 3.8 6.7 5.2 5.35-9 1.1 1.7 1.6 1.4 2.7 2.6 3.1 4.2 4.9 4.2 5.2 4.3 5.310-14 1.6 2.2 1.7 1.6 2.3 2.6 3.9 4.2 4.1 3.3 3.3 4.5 5.015-19 0.6 0.9 0.8 1.4 1.6 1.5 1.8 2.1 2.8 2.8 2.8 4.0 4.220-29 0.3 0.5 0.4 0.5 0.7 0.8 1.1 1.3 1.5 1.6 1.9 1.8 2.430-39 0.2 0.3 0.3 0.4 0.6 0.8 0.9 1.2 1.1 1.5 1.6 1.7 1.740-49 0.2 0.2 0.3 0.3 0.6 0.7 0.6 0.9 1.0 1.3 1.2 1.3 1.350-59 0.1 0.1 0.1 0.2 0.3 0.4 0.4 0.5 0.6 0.7 0.8 0.8 0.960-64 . . . 0.1 0.1 0.2 0.2 0.2 0.3 0.3 0.4 0.4 0.565-69 . . . . . 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.370-79 . . . . . . . . . . . 0.1 0.180+ . . . . . . . . . . . . .

0-19 1.0 1.4 1.6 1.7 2.1 2.1 2.7 2.8 3.7 3.2 3.6 4.2 4.620-44 0.3 0.3 0.3 0.4 0.6 0.8 0.9 1.2 1.1 1.5 1.6 1.6 1.845-64 0.1 0.1 0.1 0.2 0.3 0.4 0.4 0.5 0.6 0.7 0.8 0.8 0.965-74 . . . . . 0.1 . 0.1 0.1 0.1 0.1 0.2 0.275+ . . . . . . . . . . . . .

Male 0.1 0.2 0.2 0.2 0.3 0.4 0.4 0.5 0.6 0.7 0.7 0.8 0.8Female 0.1 0.1 0.1 0.1 0.2 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6

White 0.1 0.2 0.2 0.2 0.4 0.5 0.5 0.7 0.7 0.9 0.9 1.0 1.0Black . . 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.3Native American 0.1 . 0.1 0.1 0.3 0.2 0.3 0.4 0.5 0.3 0.5 0.4 0.5Asian 0.0 0.1 0.2 0.2 0.2 0.3 0.3 0.5 0.4 0.7 0.8 0.7 0.6



All 0.1 0.1 0.2 0.2 0.3 0.3 0.4 0.5 0.5 0.6 0.6 0.7 0.7


419


TRANSPLANTATION: PROCESSETable E.10Treatment status two years after first transplant, 1999-2001*

Table E.11Percent panel reactive antibodies (PRA) for selected years^by donor type, percent of transplant events within year

Table E.12Cytomegalovirus (CMV) antibody status for selected years^by recipient & donor CMV status, percent of transplant events within year

Table E.10Treatment status two years after first transplant, 1999-2001*

Treatment status two years after first transplant (percent of patients)Functioning CAPD & Oth/unk

ALL Count Graft Retransplanted Hemo CCPD dialysis DeathAge at first transplant

0-19 2,362 88.2 1.9 4.1 1.7 1.8 2.320-44 14,936 88.4 1.2 4.7 0.8 1.1 3.945-64 17,854 85.7 0.8 3.7 0.4 0.6 8.865-74 3,147 79.7 0.6 3.7 0.5 0.3 15.275+ 213 69.5 0.5 3.3 . 0.5 26.3

All 38,513 86.3 1.0 4.1 0.6 0.9 7.1

Table E.11Percent panel reactive antibodies (PRA) for selected years^by donor type, percent of transplant events within year

DECEASED DONOR 1996 1997 1998 1999 2000 2001 2002 2003 AllPeak PRA

<20% 77.1 77.4 78.9 76.7 77.8 79.3 78.8 75.8 77.720-39% 7.0 7.2 6.2 5.9 5.7 5.0 5.1 5.1 5.940-59% 3.9 3.8 3.4 3.5 3.5 3.2 3.6 3.4 3.660%+ 8.8 9.6 8.9 10.3 10.8 10.2 10.3 11.4 10.1Missing 3.1 2.0 2.5 3.6 2.2 2.3 2.2 4.3 2.8

Most recent PRA<20% 87.4 88.3 88.9 85.8 87.0 86.9 85.9 82.9 86.620-39% 3.7 3.7 3.4 3.5 3.4 3.2 3.2 3.7 3.540-59% 2.0 2.5 2.1 2.4 2.5 2.3 2.3 2.6 2.360%+ 4.2 4.0 3.9 4.4 4.8 5.0 5.6 6.3 4.8Missing 2.7 1.5 1.6 4.0 2.3 2.6 3.0 4.5 2.8

LIVING DONORPeak PRA

<20% 84.1 84.6 83.6 83.7 86.6 86.7 86.0 84.3 85.120-39% 4.8 4.9 4.7 4.1 3.5 4.2 4.7 3.6 4.240-59% 2.4 2.2 2.1 2.0 2.0 2.1 2.1 2.3 2.160%+ 3.6 3.8 3.2 3.4 4.0 4.1 4.3 5.4 4.1Missing 5.1 4.5 6.4 6.8 3.9 3.0 2.9 4.4 4.5

Most recent PRA<20% 89.7 90.6 89.0 87.8 90.2 90.5 89.9 88.6 89.520-39% 2.8 2.9 2.8 2.3 2.1 2.7 2.8 2.3 2.640-59% 1.3 1.1 1.5 1.2 1.5 1.3 1.3 1.8 1.460%+ 1.6 1.7 1.7 1.7 2.0 1.9 2.2 3.0 2.1Missing 4.5 3.7 5.0 7.0 4.3 3.5 3.8 4.3 4.4

Table E.12Cytomegalovirus (CMV) antibody status for selected years^by recipient & donor CMV status, percent of transplant events within year

DECEASED DONORRecipient CMV Donor CMV 1996 1997 1998 1999 2000 2001 2002 2003 AllPositive Positive 35.3 35.7 36.6 36.3 37.1 36.8 36.7 40.1 36.8

Negative 21.8 21.2 21.2 20.8 21.3 22.1 24.3 23.6 22.0Unknown 0.8 1.2 1.2 0.6 0.2 0.1 0.2 0.1 0.5

Negative Positive 19.6 18.1 18.6 19.0 17.8 18.6 18.4 17.5 18.5Negative 14.3 14.4 13.6 13.2 13.7 14.3 13.7 12.3 13.7Unknown 0.6 0.6 0.7 0.3 0.1 . 0.1 . 0.3

Unknown Positive 4.4 5.2 4.9 6.3 6.0 5.3 4.2 4.0 5.0Negative 3.1 3.3 2.9 3.4 3.7 2.8 2.5 2.4 3.0Unknown 0.2 0.3 0.3 . 0.1 . . . 0.1

LIVING DONORPositive Positive 28.9 31.6 29.2 29.5 29.3 33.4 33.3 34.0 31.5


Negative Positive 13.9 15.0 14.9 14.1 14.6 15.3 14.6 15.1 14.7Negative 25.1 22.8 22.7 21.8 21.5 21.2 22.2 22.2 22.3Unknown 3.2 2.2 3.3 3.9 3.2 3.1 3.0 2.2 3.0

Unknown Positive 3.3 2.9 2.8 3.2 3.0 1.9 1.6 1.7 2.4Negative 3.1 2.8 2.7 3.4 2.8 1.6 1.4 1.2 2.2Unknown 3.0 3.1 2.1 3.6 4.0 2.3 1.6 1.8 2.6

*One patient with unknown age is not included in the age-specific rows.^1,595 transplant events were excluded from the table due to unknown donor type."." Zero values in this cell.

420

ON OUR WEBSITEBayesian first renal transplant ratios: by state/territory (E.b).E TRANSPLANTATION: PROCESS

Reference section E

*One patient with unknown age is not included in the age-specific rows."." Zero values in this cell.^1,595 transplant events were excluded from the table due to unknown donor type.

Table E.14Cold ischemia time (hours): deceased donor transplants for selected years

Table E.13Hepatitus C (HCVAb) antibody status for selected years^by recipient & donor HCVAb status, percent of transplant events within year

Table E.13Hepatitus C (HCVAb) antibody status for selected years^by recipient & donor HCVAb status, percent of transplant events within year

DECEASED DONORRecipient HCVAb Donor HCVAb 1996 1997 1998 1999 2000 2001 2002 2003 AllPositive Positive 1.4 1.3 1.3 1.5 1.5 1.5 1.7 2.1 1.5

Negative 4.8 4.8 4.6 4.7 4.7 4.8 4.8 4.7 4.7Unknown . 0.1 0.1 0.1 . . . . 0.1


Unknown Positive 0.2 0.1 0.3 0.3 0.2 0.3 0.2 0.3 0.2Negative 8.4 10.2 9.4 12.0 10.9 8.1 8.6 8.1 9.5Unknown 0.2 0.2 0.1 0.1 0.1 . . . 0.1

LIVING DONORPositive Positive 0.1 0.1 0.2 0.1 0.1 0.1 0.1 . 0.1



Unknown Positive 0.1 0.1 . . 0.1 . . . .Negative 5.8 6.0 5.7 6.8 6.0 3.3 2.9 2.0 4.5Unknown 3.3 3.3 2.6 3.7 3.4 2.4 3.2 4.3 3.3

Table E.14Cold ischemia time (hours): deceased donor transplants for selected years

COUNTS 1996 1997 1998 1999 2000 2001 2002 2003 All0-12 1,480 1,637 1,736 1,748 1,817 1,950 2,230 2,084 14,68213-24 4,394 4,530 4,464 4,215 4,124 4,011 4,327 3,937 34,00225-36 1,979 1,815 1,860 1,615 1,467 1,372 1,288 1,254 12,65037+ 326 257 275 225 205 205 200 175 1,868Unknown 261 359 640 1,148 1,410 1,561 1,377 1,255 8,011

PERCENTAGES0-12 17.5 19.0 19.3 19.5 20.1 21.4 23.7 23.9 20.613-24 52.1 52.7 49.7 47.1 45.7 44.1 45.9 45.2 47.725-36 23.4 21.1 20.7 18.0 16.3 15.1 13.7 14.4 17.837+ 3.9 3.0 3.1 2.5 2.3 2.3 2.1 2.0 2.6Unknown 3.1 4.2 7.1 12.8 15.6 17.2 14.6 14.4 11.2

Transplantation:outcomes

ReferenceSectio

nF

TRANSPLANTATION: OUTCOMESF

422

Reference section F

For survival probabilities, first transplant, see Section I: Patient Survival

F.1 . 423 90-day graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.2 . 425 One-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.3 . 427 Two-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.4 . 429 Three-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.5 . 431 Five-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.6 . 433 Ten-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.7 . 434 90-day graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.8 . 436 One-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.9 . 438 Two-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.10 . 440 Three-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.11 . 442 Five-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.12 . 444 Ten-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.13 . 445 90-day survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.14 . 447 One-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.15 . 449 Two-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.16 . 451 Three-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.17 . 453 Five-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.18 . 455 Ten-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.19 . 456 90-day survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.20 . 458 One-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.21 . 460 Two-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.22 . 462 Three-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.23 . 464 Five-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.24 . 466 Ten-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

F.25 . 467 Risk factors for graft failure: deceased donor transplants, 1998-2003

F.26 . 471 Risk factors for graft failure: living donor transplants, 1998-2003

423



75+ . . . 100.0 100.0 75.9 . 100.0 73.5 72.3 89.4

Female 82.2 83.2 81.9 81.1 83.6 81.9 83.3 83.2 82.5 84.7 85.1

Other race 82.8 75.9 80.9 76.3 93.0 82.6 89.1 86.2 87.2 87.7 88.1

Other cause 80.8 82.7 81.2 81.8 83.6 82.7 84.1 83.3 82.6 84.2 85.2

Subsequent transplants 76.6 76.8 76.4 72.2 73.4 76.6 76.8 76.8 73.4 77.8 81.2

All 81.9 83.4 80.6 81.4 83.5 83.8 83.9 83.6 82.5 84.5 85.6

Table F.190-day graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 85.7 85.7 88.9 66.7 63.6 81.8 85.7 75.0 53.3 73.3 62.51-4 75.0 90.9 76.2 88.0 73.1 61.8 80.0 83.3 73.0 80.0 66.75-9 87.5 95.2 84.4 83.3 89.1 83.6 75.0 80.8 79.1 81.8 68.110-14 87.5 86.5 81.3 86.1 89.0 89.0 85.4 85.2 78.3 81.1 81.715-19 91.2 85.6 87.2 83.4 85.9 85.0 88.7 85.3 79.9 85.5 85.020-29 85.3 85.5 84.3 84.7 83.7 84.7 84.5 86.9 82.9 86.0 86.830-39 83.9 85.8 81.7 83.7 85.4 86.2 85.3 85.1 85.2 84.7 86.340-49 81.7 85.7 83.2 81.8 83.3 85.3 84.9 82.8 83.2 86.5 86.650-59 80.9 81.2 79.7 80.7 86.9 82.4 84.3 84.1 84.6 84.8 87.460-64 80.8 84.4 76.3 86.5 81.8 80.8 83.9 86.3 82.1 85.8 86.465-69 100.0 88.9 100.0 80.0 92.0 97.4 87.3 80.2 81.0 86.1 87.370-79 100.0 100.0 . 100.0 83.3 83.3 76.9 83.3 75.6 76.5 84.680+ . . . . 100.0 100.0 . . 100.0 . 100.0

Male 83.7 85.3 81.9 83.1 84.6 85.7 85.1 84.6 83.3 85.2 86.5Female 84.3 85.3 83.6 83.0 85.0 83.3 84.4 84.3 83.7 85.6 86.0

White 85.1 86.3 83.4 84.0 84.9 85.1 85.0 84.2 83.6 85.6 86.1Black 79.4 82.5 79.3 80.3 83.0 83.7 83.3 84.8 81.8 83.8 86.1Other race 86.1 80.2 84.7 81.5 94.2 85.2 91.1 88.5 89.1 89.0 89.4


Diabetes 82.7 86.7 85.9 85.0 87.8 86.7 84.1 84.9 83.5 87.1 86.2Hypertension 83.7 84.8 79.7 84.0 85.6 85.3 85.1 85.2 84.4 84.9 87.8Glomerulonephritis 87.1 86.6 81.8 81.4 82.6 84.7 85.3 84.2 82.5 84.5 85.6Other cause 82.3 84.2 82.6 83.2 84.8 83.6 84.8 84.2 83.6 85.0 86.0

First transplant 84.6 86.2 83.1 84.5 86.5 86.2 86.0 85.6 84.8 86.3 86.9Subsequent transplants 78.0 78.3 77.6 73.5 75.0 78.1 77.9 77.9 75.0 79.4 82.5

All 83.9 85.3 82.5 83.1 84.8 84.8 84.8 84.5 83.4 85.3 86.3

ADJUSTED0-19 88.7 86.8 84.1 83.6 85.4 83.5 85.6 83.8 78.1 83.7 79.720-44 83.5 85.0 82.2 83.0 84.6 85.6 85.1 84.7 84.0 85.5 86.345-64 79.0 82.2 80.2 81.2 83.7 82.9 83.9 84.2 83.2 84.8 87.065-74 100.0 90.2 100.0 80.5 89.2 97.6 84.4 79.5 79.3 83.6 85.9

Male 81.8 83.5 79.9 81.6 83.4 84.9 84.2 83.9 82.5 84.4 86.0

White 83.1 84.4 81.5 82.1 83.5 84.0 83.9 83.2 82.7 84.8 85.6Black 78.6 81.9 78.5 80.0 82.7 83.5 83.4 84.9 81.7 83.6 86.0

Diabetes 80.4 84.5 83.2 82.5 85.7 85.0 81.9 83.3 81.8 85.5 84.8Hypertension 85.1 85.6 81.3 85.3 87.1 86.5 86.7 86.6 86.1 86.4 89.0Glomerulonephritis 86.1 85.4 80.5 80.1 81.8 83.9 84.4 83.4 81.7 83.7 85.2

First transplant 82.6 84.2 81.2 82.8 85.2 85.0 85.0 84.7 83.9 85.5 86.3

Probabilities are adjusted for age, gender, race, primary diagnosis,first vs. subgsequent transplant, & standardized to 1996 patient characteristics.Adjusted survival probabilities for one of the five variables are adjusted for the remaining four.Patients of unknown age or gender are excluded.Age is calculated as of the day of transplant.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. "." Zero values in this cell.

Probabilities are adjusted for age, gender, race, primary diagnosis, & first vs. subsequent transplant, & standardized to 1996 patient characteristics. Adjusted survival probabilities for one of the five variables are adjusted for the remaining four.Patients of unknown age or gender are excluded.Age is calculated as of the day of transplant.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. "." Zero values in this cell.

ON OUR WEBSITE & CD90-day death-censored graft survival probabilities: all transplants, deceased donors (F.1.1).

Table F.190-day graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number


424

Reference section F


Table F.1 (continued)90-day graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.1 (continued)90-day graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<1 77.8 71.4 62.5 91.7 100.0 75.0 87.5 87.5 90.0 66.7 100.0 100.01-4 78.6 90.9 89.7 100.0 83.3 83.8 75.0 95.8 90.6 88.0 95.8 82.85-9 81.3 88.9 80.3 91.2 90.7 91.3 95.2 90.8 84.2 93.2 98.2 94.010-14 89.6 86.3 94.0 87.3 86.3 93.7 95.1 93.0 93.2 96.7 93.3 96.915-19 84.2 85.3 86.1 88.5 91.0 90.5 94.4 89.4 92.5 92.2 94.0 94.320-29 88.4 88.4 88.0 90.6 92.5 91.4 95.1 93.7 94.2 93.8 93.9 95.530-39 89.4 89.9 88.7 90.1 92.2 92.6 93.3 94.3 93.2 94.2 94.5 94.740-49 87.6 88.8 89.1 90.5 91.0 92.8 93.6 94.1 94.8 93.9 94.9 94.150-59 87.9 88.1 88.2 89.3 90.5 91.7 92.0 92.2 92.3 93.2 93.6 93.060-64 88.3 89.4 89.3 90.0 91.4 91.2 93.8 92.6 90.1 91.6 92.9 92.565-69 86.9 88.0 90.7 88.5 87.4 88.5 89.4 91.9 90.8 89.7 89.3 92.870-79 88.9 84.5 81.9 89.7 89.9 89.8 90.4 89.3 87.3 91.2 90.4 91.480+ 100.0 100.0 100.0 100.0 100.0 100.0 100.0 87.5 100.0 85.7 100.0 85.7

Male 88.3 88.8 88.9 90.5 91.1 91.6 93.8 93.2 93.3 93.6 93.5 93.7Female 87.8 88.5 88.0 89.1 91.1 92.2 91.9 93.1 92.0 92.6 94.0 93.5

White 88.3 88.9 88.6 89.7 90.8 92.2 93.0 93.1 93.0 93.4 93.7 94.1Black 87.2 87.6 87.8 90.4 91.6 90.6 92.6 92.9 92.3 92.1 93.2 92.4Other race 89.7 90.7 92.1 90.6 92.9 94.1 96.2 95.5 92.6 95.1 95.3 94.1

†Hispanic 93.6 94.0 94.5 93.9 94.7 94.8 95.2†Non-Hispanic 91.7 92.9 93.0 92.7 93.0 93.5 93.4


First transplant 88.8 89.4 89.3 90.6 91.7 92.2 93.4 93.5 93.1 93.6 94.0 93.7Subsequent transplants 83.5 84.4 82.9 85.7 87.4 89.7 90.5 90.9 90.9 90.3 91.4 93.0

All 88.1 88.7 88.5 90.0 91.1 91.9 93.0 93.2 92.8 93.2 93.7 93.6

ADJUSTED0-19 84.8 85.9 86.4 89.6 89.6 90.6 92.9 91.6 91.6 92.8 94.7 94.220-44 88.8 89.3 88.8 90.7 92.2 92.8 94.0 94.6 94.0 94.2 94.7 95.145-64 87.4 88.1 88.3 89.7 90.9 91.7 93.0 92.6 92.6 93.2 93.9 93.265-74 86.5 87.0 88.7 88.6 87.9 88.9 89.7 91.7 90.0 90.4 89.9 92.475+ 100.0 86.2 74.7 88.5 94.6 94.8 87.5 84.7 86.7 90.4 87.3 91.3

Male 87.9 88.6 88.7 90.6 91.2 91.7 94.0 93.5 93.5 93.9 93.9 94.2Female 87.2 87.9 87.5 88.9 91.0 92.2 91.9 93.1 92.0 92.7 94.1 93.7




All 87.6 88.3 88.2 89.9 91.1 91.9 93.1 93.3 92.9 93.4 94.0 94.0


425




ON OUR WEBSITE & CDOne-year death-censored graft survival probabilities: all transplants, de-ceased donors (F.2.1).

Table F.2One-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number


All 65.6 66.5 67.6 66.7 71.7 73.8 73.3 73.9 75.3 78.3 79.2

75+ . . . 100.0 55.6 75.9 . 100.0 73.5 72.3 57.3

Female 62.2 62.1 66.4 63.3 69.1 71.1 71.4 72.5 74.4 77.0 78.2

Other race 55.0 59.8 63.9 63.3 80.3 76.1 75.6 74.4 77.7 81.3 81.4

Other cause 61.9 63.6 66.1 64.1 70.2 70.5 71.5 72.7 73.7 75.8 78.2


All 61.5 62.7 64.5 63.7 69.4 72.1 71.6 72.4 73.9 77.1 78.3

Table F.2One-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 57.1 71.4 88.9 60.0 54.6 77.3 71.4 70.0 33.3 66.7 50.01-4 75.0 72.7 66.7 68.0 65.4 52.9 63.3 72.2 56.8 73.3 57.15-9 71.9 81.0 68.9 69.1 78.3 76.1 61.7 65.8 73.1 77.9 62.510-14 69.4 75.7 71.4 66.3 76.2 79.8 74.8 77.3 70.0 70.3 74.015-19 78.8 73.4 75.0 70.9 73.2 70.1 77.4 74.6 70.7 74.5 77.920-29 68.6 69.4 72.5 71.7 72.1 76.1 73.2 77.3 75.3 80.6 80.730-39 65.1 66.1 67.0 66.2 73.4 76.1 74.4 75.4 77.2 78.5 80.640-49 62.0 65.7 66.5 65.2 68.3 73.8 72.4 71.3 75.1 78.8 79.250-59 60.8 59.8 60.9 61.5 72.8 68.8 72.7 73.7 76.2 77.9 79.460-64 57.7 46.7 55.9 66.2 72.0 69.5 73.3 72.1 75.8 77.3 78.565-69 72.7 66.7 60.0 60.0 56.0 66.7 72.7 62.3 68.5 75.2 77.070-79 100.0 50.0 . 100.0 33.3 33.3 69.2 83.3 65.9 73.5 73.980+ . . . . 100.0 100.0 . . 100.0 . .

Male 65.2 66.7 66.6 66.9 71.7 74.2 73.4 73.7 74.9 78.3 79.0Female 66.2 66.3 69.2 66.4 71.6 73.1 73.1 74.2 76.0 78.2 79.5





ADJUSTED0-19 73.3 73.7 72.5 68.5 73.2 72.2 73.6 73.3 68.7 74.3 72.520-44 64.5 65.6 67.6 66.7 71.6 75.8 73.6 74.7 75.8 79.1 80.045-64 56.8 59.0 61.9 62.5 69.6 69.8 71.8 72.2 75.2 77.2 79.165-74 75.2 61.3 57.3 61.5 50.8 61.6 70.4 63.4 66.5 73.4 75.1

Male 61.3 63.0 63.5 64.1 69.6 72.7 71.8 72.4 73.7 77.2 78.3

White 63.5 65.4 65.7 65.4 70.1 72.7 72.3 72.4 74.8 78.1 78.7Black 57.1 55.2 61.4 58.7 66.6 70.1 69.2 72.3 71.2 73.9 77.3




426

Reference section F


Table F.2 (continued)One-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.2 (continued)One-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<1 66.7 71.4 62.5 83.3 75.0 75.0 87.5 87.5 80.0 66.7 90.0 100.01-4 67.9 78.8 79.3 96.0 79.2 81.1 75.0 95.8 84.4 80.0 95.8 75.95-9 78.1 88.9 75.8 86.0 88.9 85.5 93.6 89.2 79.0 90.9 96.4 91.010-14 80.2 82.5 89.2 85.6 82.9 91.6 93.1 90.0 89.8 92.2 87.8 93.915-19 77.7 79.0 79.7 80.4 82.4 85.4 90.2 82.0 86.7 87.4 91.2 92.020-29 83.2 82.1 82.9 85.5 88.0 87.8 90.1 90.8 90.2 89.7 90.3 90.230-39 84.4 83.5 83.0 84.4 87.7 88.8 89.9 90.8 89.0 91.0 91.0 90.740-49 82.2 84.1 83.9 84.7 85.7 87.2 89.1 90.7 90.4 89.2 90.4 89.950-59 82.0 81.1 81.8 83.0 85.1 86.2 86.7 87.3 86.4 86.7 88.2 88.460-64 82.5 81.6 81.6 83.8 83.5 84.2 87.4 84.3 84.1 83.7 86.1 87.065-69 79.7 82.9 79.0 79.3 80.0 82.0 82.0 83.5 83.5 82.2 82.4 85.070-79 79.4 83.5 68.6 77.8 80.4 83.7 80.1 79.1 79.3 83.2 80.8 82.480+ 100.0 66.7 100.0 50.0 100.0 100.0 100.0 87.5 80.0 71.4 100.0 71.4

Male 82.7 82.8 82.9 84.1 85.2 86.7 88.8 88.3 87.9 87.8 88.6 88.4Female 82.3 82.6 81.7 83.6 86.4 87.1 87.4 89.0 87.4 87.8 89.0 89.4





All 82.5 82.7 82.5 83.9 85.7 86.8 88.2 88.5 87.7 87.8 88.7 88.8

ADJUSTED0-19 77.8 80.6 80.5 83.8 83.5 86.5 90.0 86.9 86.4 88.4 91.4 91.220-44 83.4 83.4 83.4 85.3 87.6 88.5 89.9 91.3 89.8 90.5 91.0 91.245-64 81.8 81.7 82.0 83.4 85.0 86.2 87.8 87.5 87.2 86.9 88.7 88.565-74 78.4 82.6 76.9 78.7 80.2 82.4 81.5 82.7 82.7 82.7 82.4 84.475+ 100.0 76.9 50.4 71.2 72.9 79.4 78.1 75.9 75.7 78.8 77.1 80.7

Male 82.0 82.4 82.6 84.1 85.3 86.8 89.0 88.6 88.2 88.3 89.2 89.1Female 81.4 81.8 81.0 83.3 86.2 87.0 87.2 88.9 87.3 88.0 89.2 89.7




All 81.7 82.1 82.0 83.8 85.6 86.9 88.3 88.7 87.9 88.2 89.2 89.4

427


TRANSPLANTATION: OUTCOMESFON OUR WEBSITE & CDTwo-year death-censored graft survival probabilities: all transplants, de-ceased donors (F.3.1).


Table F.3Two-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number


All 55.6 57.9 58.0 57.7 63.2 65.7 65.2 66.0 68.6 72.0 73.7

75+ . . . 100.0 0.0 51.6 . 100.0 60.5 72.1 57.9

Female 50.9 53.3 55.2 55.0 61.0 63.0 63.5 65.5 67.9 70.7 72.6

Other race 41.5 46.1 56.0 55.5 71.9 66.6 68.9 66.2 71.4 74.4 74.9

Other cause 51.1 53.9 56.8 55.5 62.4 63.4 64.2 65.4 67.4 70.5 73.9


All 51.0 53.4 54.4 54.3 60.5 63.7 63.2 64.1 67.0 70.5 72.5

Table F.3Two-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 28.6 71.4 88.9 46.7 54.6 68.2 71.4 70.0 33.3 66.7 50.01-4 50.0 72.7 57.1 60.0 61.5 52.9 56.7 66.7 56.8 73.3 54.85-9 59.4 66.7 60.0 64.3 71.7 68.7 53.3 60.3 67.2 74.0 59.710-14 59.7 64.9 65.9 55.5 69.7 66.1 61.8 65.6 60.0 64.9 67.315-19 70.1 64.8 61.5 65.8 66.8 61.4 67.8 66.5 63.6 65.1 71.720-29 60.4 61.6 63.0 63.8 64.5 68.4 65.3 68.7 66.7 74.5 73.230-39 56.1 56.9 56.5 57.7 63.5 67.2 66.0 66.7 70.8 72.5 74.940-49 49.9 57.8 56.9 55.2 60.2 66.0 64.4 64.1 69.1 72.3 73.450-59 50.2 50.3 52.8 50.1 64.0 62.8 65.2 66.3 69.9 71.7 75.360-64 53.9 37.8 49.2 56.8 62.1 59.6 65.9 64.3 68.9 69.3 73.465-69 45.5 55.6 60.0 50.0 52.0 56.4 63.6 57.6 61.9 69.7 72.670-79 50.0 50.0 . 66.7 16.7 33.3 61.5 83.3 61.0 61.8 69.280+ . . . . . 50.0 . . 100.0 . .

Male 55.6 57.7 57.5 57.2 62.8 66.0 65.0 65.0 67.9 71.8 73.4Female 55.6 58.1 58.7 58.5 63.8 65.3 65.5 67.5 69.8 72.2 74.1





ADJUSTED0-19 62.8 64.0 62.6 61.6 67.3 63.1 63.9 65.5 62.1 68.0 67.520-44 54.9 57.0 57.5 58.0 62.5 67.4 65.5 66.2 68.9 72.8 73.745-64 45.9 49.7 52.8 51.5 61.2 62.7 64.1 64.8 68.6 70.6 74.465-74 44.1 51.7 57.4 47.7 44.1 51.9 61.3 59.2 60.4 66.4 70.3

Male 51.3 53.6 54.0 53.9 60.2 64.1 63.1 63.4 66.5 70.4 72.6

White 53.7 56.8 56.4 56.5 62.0 65.8 64.9 65.7 69.3 72.9 73.9Black 44.5 44.6 48.3 47.1 54.9 57.0 57.3 59.3 59.9 63.5 68.9




428

Reference section F


Table F.3 (continued)Two-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.3 (continued)Two-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<1 66.7 64.3 50.0 83.3 75.0 62.5 62.5 87.5 80.0 66.7 80.01-4 64.3 78.8 75.9 92.0 70.8 75.7 71.9 91.7 84.4 76.0 95.85-9 71.9 86.7 72.7 86.0 83.3 82.6 91.9 87.7 77.2 88.6 91.110-14 74.0 72.5 81.9 79.7 76.9 85.3 88.1 85.0 83.1 88.9 81.115-19 68.5 71.6 72.2 70.0 74.3 74.2 83.2 75.8 81.0 75.4 83.520-29 77.8 76.1 77.5 79.9 81.9 81.6 84.7 85.1 83.1 82.4 86.530-39 79.5 78.5 77.7 79.3 83.4 84.6 84.5 87.3 85.2 84.9 86.240-49 77.4 78.8 78.7 79.4 81.9 81.9 84.6 86.0 86.2 84.7 85.050-59 77.4 75.2 76.3 77.9 80.8 81.2 81.6 82.3 82.0 81.8 82.260-64 78.3 76.2 76.4 77.4 78.3 79.1 82.4 78.7 79.2 79.1 79.665-69 73.7 74.8 74.3 72.3 73.4 75.8 74.5 78.3 76.9 76.5 76.370-79 69.8 79.4 59.1 71.4 73.2 76.2 74.4 70.4 72.3 75.8 76.080+ 100.0 66.7 50.0 50.0 100.0 100.0 100.0 62.5 60.0 57.1 100.0

Male 77.4 77.0 77.2 78.4 80.4 81.4 83.0 83.6 83.4 82.4 83.1Female 77.6 77.3 76.8 78.3 81.7 81.7 83.1 84.0 82.3 82.1 83.4


†Hispanic 84.4 86.3 88.4 87.0 86.3 86.6†Non-Hispanic 81.2 82.7 83.2 82.5 81.8 82.7



All 77.5 77.1 77.1 78.4 80.9 81.5 83.1 83.8 83.0 82.3 83.2

ADJUSTED0-19 70.9 74.1 74.3 76.8 76.7 78.7 84.5 82.4 81.6 80.8 84.820-44 78.4 77.8 78.1 80.2 83.0 83.5 84.8 87.0 84.9 84.7 86.745-64 77.1 76.3 76.7 78.0 80.8 81.1 83.0 82.6 83.0 82.2 82.665-74 71.7 75.0 70.6 71.5 73.5 76.0 74.4 76.3 75.6 77.0 76.875+ 85.5 77.3 44.6 71.4 62.3 69.1 72.5 70.0 74.1 63.7 71.1

Male 76.6 76.5 76.8 78.5 80.6 81.6 83.4 84.0 83.8 83.2 84.0Female 76.5 76.3 76.0 77.9 81.4 81.7 82.9 84.0 82.3 82.3 83.8




All 76.6 76.3 76.4 78.2 80.9 81.6 83.2 84.0 83.2 82.8 83.9

429




ON OUR WEBSITE & CDThree-year death-censored graft survival probabilities: all transplants, de-ceased donors (F.4.1).

Table F.4Three-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number


All 49.4 50.4 51.2 51.3 56.1 58.3 58.1 59.4 63.0 66.2 68.2

75+ . . . 100.0 . 51.7 . 100.0 60.4 58.2 48.3

Female 43.7 45.1 49.1 48.5 54.5 55.7 57.2 58.9 62.6 64.9 66.7

Other race 35.0 42.4 49.1 53.6 67.8 61.0 66.1 60.6 66.0 69.5 71.5

Other cause 44.7 45.2 49.9 49.7 54.8 56.2 57.2 59.6 62.0 65.2 69.2


All 44.7 45.7 47.4 47.7 53.1 55.9 55.9 57.4 61.2 64.6 66.9

Table F.4Three-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 14.3 71.4 88.9 46.7 54.6 68.2 57.1 65.0 33.3 66.7 25.01-4 50.0 54.6 57.1 56.0 50.0 44.1 56.7 61.1 56.8 66.7 52.45-9 53.1 59.5 51.1 57.1 60.9 65.7 43.3 57.5 61.2 66.2 58.310-14 52.8 54.1 55.0 50.5 60.6 56.9 52.0 63.3 50.8 61.3 59.615-19 62.0 59.7 56.4 57.3 60.5 55.1 60.0 55.4 55.7 59.2 63.320-29 56.2 53.6 56.9 58.0 57.6 60.4 59.8 62.3 62.2 67.7 66.730-39 49.4 51.0 49.2 51.4 56.3 59.8 59.4 60.2 65.3 66.9 69.940-49 43.3 49.3 50.8 48.7 53.4 58.5 56.3 57.1 62.6 67.1 68.450-59 43.6 41.3 45.8 44.0 57.4 55.7 57.2 60.1 64.8 66.1 70.360-64 50.0 35.6 37.3 43.2 50.8 51.0 60.4 57.3 64.4 64.7 68.765-69 36.4 33.3 60.0 50.0 48.0 46.2 56.4 53.8 54.8 61.8 64.270-79 . 50.0 . 66.7 16.7 33.3 53.9 72.2 53.7 55.9 61.580+ . . . . . 50.0 . . 100.0 . .

Male 49.8 50.4 50.3 50.7 55.1 58.2 57.3 58.4 61.9 66.0 68.0Female 48.7 50.3 52.8 52.3 57.6 58.4 59.4 61.2 64.6 66.6 68.5





ADJUSTED0-19 55.2 56.6 55.8 54.9 59.6 56.8 55.5 58.7 55.1 62.7 60.920-44 48.9 50.0 51.0 51.7 55.2 59.6 58.8 59.5 63.3 66.8 68.245-64 39.8 40.9 45.3 44.5 54.4 55.5 56.3 58.4 63.0 65.3 69.365-74 29.2 32.9 57.3 47.5 40.6 42.3 53.7 54.1 52.7 58.8 62.0

Male 45.3 46.1 46.5 47.3 52.4 56.1 55.2 56.6 60.4 64.5 67.2

White 47.4 49.2 49.8 50.2 54.6 58.6 58.9 59.5 64.2 67.6 69.2Black 38.1 35.9 40.2 39.0 47.2 47.5 45.5 50.6 52.2 55.6 60.5




430

Reference section F


Table F.4 (continued)Three-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.4 (continued)Three-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<1 66.7 64.3 50.0 83.3 75.0 62.5 62.5 75.0 70.0 50.01-4 64.3 78.8 75.9 84.0 70.8 73.0 68.8 91.7 78.1 72.05-9 68.8 84.4 68.2 84.2 81.5 78.3 88.7 81.5 73.7 81.810-14 69.8 68.8 73.5 72.0 69.2 75.8 85.2 81.0 79.7 82.215-19 61.4 62.6 64.2 63.7 66.2 64.6 70.6 65.2 72.6 68.120-29 72.1 70.4 70.4 74.3 75.7 75.9 78.6 78.9 77.6 77.330-39 74.8 74.1 72.4 74.9 78.1 79.5 79.7 82.4 79.9 79.040-49 71.8 72.8 73.8 74.9 76.5 77.2 79.4 80.8 81.1 80.350-59 71.7 70.4 71.9 72.9 75.4 76.4 75.7 77.4 77.4 76.760-64 71.7 72.3 68.6 71.9 72.1 75.4 75.1 73.1 74.3 73.865-69 67.3 67.9 68.0 66.9 68.2 70.1 64.9 71.8 69.8 71.170-79 66.7 70.1 54.3 65.1 63.8 68.0 66.0 64.3 66.2 69.580+ 100.0 66.7 50.0 50.0 100.0 66.7 100.0 50.0 60.0 57.1

Male 71.6 71.7 71.3 73.4 74.8 76.4 77.1 78.3 78.3 77.4Female 72.8 72.2 71.8 73.4 76.1 76.4 77.3 78.4 76.9 76.5

White 74.3 73.9 73.4 75.3 76.8 78.7 79.2 80.1 79.9 79.7Black 63.6 64.1 64.1 67.9 70.0 69.9 71.1 72.4 71.2 69.6Other race 78.3 79.0 79.2 77.2 83.1 79.4 81.4 83.7 81.5 81.2

†Hispanic 80.2 81.8 83.2 82.1 81.9†Non-Hispanic 76.0 76.7 77.7 77.2 76.4

Diabetes 72.6 69.1 71.9 74.5 76.2 76.3 76.1 77.4 77.2 76.5Hypertension 68.4 68.9 68.1 71.7 71.5 73.7 73.4 75.0 74.9 70.7Glomerulonephritis 73.2 73.6 71.7 72.8 75.8 76.5 78.7 79.6 77.8 78.5Other cause 72.6 74.5 73.1 74.1 76.5 78.3 79.3 80.3 79.9 80.4

First transplant 73.1 72.3 72.1 73.8 76.1 76.8 77.6 78.8 78.2 77.8Subsequent transplants 65.4 69.3 67.2 70.4 69.6 73.5 73.7 74.8 74.1 72.0

All 72.0 71.9 71.5 73.4 75.3 76.4 77.1 78.3 77.7 77.1

ADJUSTED0-19 66.1 68.4 67.6 71.1 70.2 71.1 77.6 75.3 75.4 74.020-44 73.2 72.8 72.5 75.5 77.5 78.6 79.6 81.5 80.0 79.545-64 71.1 71.0 71.3 73.2 75.4 76.4 77.1 77.7 78.1 77.465-74 65.7 67.1 64.3 65.7 67.3 69.3 65.1 69.8 68.5 71.275+ 85.6 72.6 45.1 65.7 51.6 64.1 62.9 63.3 71.7 62.1

Male 70.6 71.1 70.9 73.5 75.0 76.6 77.5 78.8 78.9 78.3Female 71.5 70.9 70.8 72.9 75.8 76.4 77.1 78.3 76.8 76.8




All 70.9 71.0 70.8 73.3 75.2 76.5 77.3 78.6 78.1 77.7

431




ON OUR WEBSITE & CDFive-year death-censored graft survival probabilities: all transplants, de-ceased donors (F.5.1

Table F.5Five-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number


All 39.6 41.3 42.2 42.7 45.5 46.3 46.3 48.5 53.2 56.6 57.9

75+ . . . . . 34.8 . 100.0 48.8 29.1 38.4

Female 34.6 36.0 40.0 40.2 43.9 43.2 45.1 48.0 51.7 55.8 56.3

Other race 29.0 37.3 46.7 49.1 58.5 52.3 54.8 51.7 57.5 61.9 63.2

Other cause 34.9 36.8 40.9 40.6 44.6 43.9 45.2 50.9 53.9 56.7 60.1


All 34.7 36.5 38.2 38.9 42.3 43.6 43.8 46.2 51.1 54.7 56.4

Table F.5Five-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 14.3 71.4 88.9 46.7 54.6 59.1 50.0 60.0 26.7 60.0 25.01-4 50.0 54.6 42.9 48.0 50.0 44.1 46.7 61.1 56.8 60.0 52.45-9 43.8 42.9 37.8 50.0 54.4 59.7 38.3 54.8 58.2 54.6 51.410-14 43.1 41.9 38.5 43.6 50.5 44.0 41.5 55.5 42.5 48.7 48.115-19 51.8 51.1 46.2 50.3 51.7 40.6 42.6 44.2 43.5 48.9 48.320-29 47.6 44.6 49.0 50.5 48.1 48.0 48.8 52.6 52.3 57.5 57.930-39 38.6 42.8 42.7 42.4 45.2 48.8 50.1 48.7 55.2 57.3 59.540-49 35.0 40.1 41.1 39.2 43.3 45.2 44.1 46.2 53.8 59.2 58.550-59 32.3 31.8 33.7 35.3 45.2 44.7 43.5 48.3 54.0 55.1 59.160-64 19.2 26.7 30.5 35.1 36.4 36.4 43.8 45.4 53.4 54.3 59.365-69 36.4 11.1 20.0 35.0 36.0 30.8 38.2 35.9 45.2 52.1 50.570-79 . 50.0 . 33.3 . 33.3 30.8 66.7 46.3 44.1 44.680+ . . . . . . . . . . .

Male 39.6 41.2 41.2 41.8 44.4 46.4 45.5 47.2 52.5 55.9 57.5Female 39.8 41.5 44.0 44.3 47.4 46.2 47.7 50.6 54.1 57.7 58.4





ADJUSTED0-19 45.4 46.2 43.2 47.8 51.3 45.1 41.9 50.6 46.1 52.1 49.520-44 39.6 41.4 43.8 43.0 44.9 47.7 48.3 48.5 53.4 57.3 58.445-64 28.7 31.3 33.5 35.3 42.2 42.8 42.7 46.9 52.7 55.4 58.665-74 29.1 15.9 18.0 34.9 27.9 28.5 34.8 37.7 43.4 49.3 47.2

Male 35.0 36.9 37.4 38.2 41.4 44.0 43.2 45.2 50.9 54.1 56.5

White 37.9 40.2 40.8 41.6 44.6 47.0 47.7 49.5 54.5 58.7 59.4Black 26.0 25.3 29.7 29.0 33.5 32.7 31.3 35.6 40.6 42.7 47.3




432

Reference section F


Table F.5 (continued)Five-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.5 (continued)Five-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<1 66.7 64.3 50.0 75.0 75.0 50.0 62.5 50.01-4 53.6 69.7 65.5 72.0 70.8 70.3 68.8 87.55-9 54.7 77.8 60.6 75.4 68.5 73.9 80.7 72.310-14 65.6 61.3 61.5 60.2 60.7 62.1 70.3 69.015-19 50.0 50.5 51.9 48.9 54.1 53.9 57.3 54.020-29 62.0 59.0 60.7 61.4 64.4 64.3 66.9 67.630-39 64.1 64.2 63.7 65.1 67.5 68.9 69.4 72.740-49 61.3 61.2 65.2 64.4 66.2 66.8 69.6 71.550-59 59.6 59.1 59.0 61.9 64.7 64.1 65.7 66.360-64 57.0 62.7 57.2 57.5 57.6 62.9 62.9 59.565-69 54.2 51.8 51.0 51.4 56.4 57.4 52.2 60.570-79 46.0 54.6 41.0 49.2 42.0 49.0 51.3 51.580+ 50.0 66.7 50.0 50.0 100.0 66.7 50.0 50.0

Male 59.8 60.7 60.7 61.6 64.1 64.8 66.3 67.5Female 62.4 60.9 62.0 62.7 64.2 65.4 66.8 68.1

White 64.2 63.8 63.8 64.6 66.5 68.1 69.5 70.8Black 48.8 49.7 50.8 54.4 56.2 56.1 57.3 58.1Other race 66.3 69.4 71.5 67.5 74.3 70.3 73.3 75.3

†Hispanic 71.6 71.2 73.9†Non-Hispanic 64.4 66.0 67.0

Diabetes 59.9 56.6 59.7 60.9 64.2 63.4 64.8 65.4Hypertension 54.5 55.3 55.6 59.0 58.6 59.5 61.7 62.2Glomerulonephritis 61.7 62.7 62.4 61.4 65.1 66.4 68.2 70.4Other cause 64.4 65.8 65.1 65.8 67.0 69.2 69.9 71.4

First transplant 61.9 61.0 61.7 62.5 64.8 65.7 66.9 68.4Subsequent transplants 54.2 59.5 57.5 58.6 59.8 60.4 63.3 63.5

All 60.8 60.8 61.2 62.0 64.2 65.0 66.5 67.8

ADJUSTED0-19 56.4 58.5 56.5 58.4 59.8 61.4 66.1 64.520-44 62.7 62.2 63.5 65.0 67.4 68.3 69.3 71.745-64 58.9 59.5 60.0 61.8 63.7 64.4 66.8 66.865-74 50.6 51.0 48.3 50.2 52.9 55.1 51.5 57.975+ 70.7 58.7 27.2 50.1 34.3 43.7 51.3 54.8

Male 58.7 60.0 60.1 61.9 64.4 65.0 66.9 68.2Female 60.7 59.3 60.8 62.1 63.8 65.4 66.6 68.0




All 59.4 59.6 60.4 61.9 64.1 65.2 66.7 68.1

433




ON OUR WEBSITE & CD Ten-year graft survival probabilities: all transplants, deceased donors (F.6.1).

Table F.6Ten-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Subsequent transplants 15.2 20.0 23.5 16.5 17.5 16.3 21.4 26.1 26.8 29.6 33.2 33.1 34.0 33.7

All 25.8 27.5 28.4 28.2 27.3 27.5 28.4 30.8 33.3 35.8 36.0 37.4 36.3 38.5

75+ . . . . . 54.5 . . 27.7 . 14.0 17.6 26.8 18.0

Female 22.1 23.0 26.8 25.9 25.8 25.8 26.8 30.1 31.8 34.9 34.6 36.9 35.2 37.7

Other race 19.6 26.6 35.6 35.8 37.2 38.4 34.3 36.2 42.2 43.9 42.0 45.7 43.5 48.8

Other cause 22.8 25.4 27.9 26.6 28.6 27.5 30.2 35.0 36.4 39.2 39.3 41.1 41.9 43.6

Subsequent transplants 12.9 17.3 20.9 14.7 15.8 14.5 19.4 23.7 24.2 26.6 30.4 30.1 31.0 31.3

All 21.3 22.9 24.5 24.3 24.2 24.7 25.8 28.4 31.1 33.6 34.4 35.7 34.8 37.4

Table F.6Ten-year graft survival probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<1 . 71.4 77.8 46.7 54.6 54.6 42.9 35.0 13.3 53.3 . 66.7 50.0 37.51-4 50.0 45.5 42.9 48.0 34.6 17.7 36.7 44.4 35.1 43.3 47.6 42.9 54.6 55.25-9 34.4 31.0 37.8 33.3 37.0 32.8 26.7 34.3 46.3 29.9 33.3 39.1 48.9 47.010-14 26.4 25.7 25.3 31.7 31.2 28.4 30.1 30.5 23.3 33.3 32.7 40.6 37.5 43.415-19 38.7 42.5 32.7 38.2 39.0 23.7 29.1 35.3 31.4 33.6 33.3 32.6 33.2 36.920-29 33.5 33.4 36.1 36.2 32.0 34.0 32.2 36.4 36.9 39.2 39.1 41.7 36.4 40.730-39 25.1 27.2 29.9 28.6 28.1 30.8 31.7 31.7 36.2 38.1 39.0 40.6 41.6 41.940-49 20.3 24.0 24.0 23.8 24.8 26.3 26.8 30.4 33.6 38.1 37.2 39.2 39.0 42.750-59 19.1 19.4 18.6 18.8 22.4 18.8 22.9 26.8 31.5 32.2 33.9 34.2 32.3 34.660-64 15.4 8.9 17.0 13.5 10.6 15.9 19.8 23.1 26.6 26.5 29.5 27.9 27.1 31.265-69 9.1 * 20.0 10.0 12.0 7.7 16.4 15.1 16.7 24.2 20.1 23.5 20.8 21.370-79 . . . . . 16.7 . 38.9 24.4 14.7 21.5 9.5 20.6 10.580+ . . . . . . . . . . . 50.0 33.3 50.0

Male 25.0 27.0 26.9 27.1 26.1 26.7 27.7 29.6 32.6 35.0 35.3 36.3 35.7 37.9Female 27.3 28.3 30.9 30.0 29.4 28.9 29.4 32.8 34.5 37.1 37.2 39.0 37.3 39.4

White 29.5 31.3 31.4 31.5 30.2 31.1 32.3 34.5 36.4 39.4 39.0 40.0 39.6 41.3Black 12.4 12.4 16.3 14.5 15.4 14.1 14.4 17.1 20.7 22.0 24.8 26.4 24.0 27.1Other race 26.6 34.9 44.9 46.9 45.3 45.1 41.7 42.7 48.3 47.7 46.0 49.6 46.7 51.3


Diabetes 20.5 24.7 25.3 21.8 21.3 22.0 22.2 24.5 25.8 30.4 29.8 30.8 28.6 32.8Hypertension 18.7 19.6 20.6 21.0 18.6 17.8 20.0 21.9 25.4 26.8 30.7 30.4 28.1 32.2Glomerulonephritis 31.0 30.1 30.4 32.6 29.5 33.5 32.4 33.2 36.8 39.2 38.7 41.1 40.4 41.1Other cause 25.7 29.0 31.1 30.2 32.0 30.0 32.7 37.2 39.0 41.2 41.2 43.3 44.0 45.8

First transplant 27.2 28.5 29.0 29.9 29.1 29.7 29.6 31.6 34.4 36.8 36.5 38.0 36.7 39.2

ADJUSTED0-19 31.3 34.7 32.1 35.6 35.6 26.4 28.9 34.0 31.1 34.9 34.1 38.1 37.7 40.820-44 25.5 27.6 30.3 28.8 28.0 30.7 30.9 31.9 35.3 38.2 38.2 40.8 39.8 42.545-64 16.5 17.1 17.6 18.8 20.3 19.7 22.3 26.8 29.5 31.2 33.7 33.0 32.1 35.165-74 7.1 . 18.2 8.7 8.6 6.0 12.4 17.0 16.6 21.1 18.9 19.9 19.2 17.8

Male 21.0 22.9 23.3 23.4 23.3 24.1 25.4 27.5 30.7 32.8 34.3 34.9 34.6 37.3

White 24.4 26.4 26.9 27.0 26.7 28.0 29.5 32.0 34.2 37.5 37.7 38.8 38.8 40.7Black 11.5 11.8 15.7 14.1 15.0 13.7 14.4 17.0 20.7 21.8 24.6 26.3 23.8 27.2

Diabetes 15.2 19.5 20.0 17.4 16.8 17.9 18.3 21.1 22.8 26.5 26.8 27.8 25.7 30.3Hypertension 21.5 21.5 24.3 24.2 22.8 20.4 24.0 25.4 29.4 30.4 34.4 34.0 32.3 36.1Glomerulonephritis 27.3 26.2 26.8 29.0 27.2 31.0 29.5 30.9 34.6 37.0 37.3 39.5 39.0 39.5



434

Reference section F


ON OUR WEBSITE & CD90-day death-censored graft survival probabilities: all transplants, living do-nors (F.7.1).

Table F.790-day graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

75+ 100.0 . . . . 100.0 100.0 100.0 . . 100.0

Female 96.8 94.6 92.6 93.8 93.0 94.0 95.3 94.8 93.9 93.6 91.8

Other race 100.0 89.4 90.5 98.0 98.5 89.3 94.4 96.4 96.6 98.5 95.0

Other cause 95.1 92.8 93.6 93.8 94.7 94.4 95.1 95.0 94.2 93.0 91.5


All 94.8 94.0 92.4 93.3 93.5 94.4 95.3 94.3 92.2 92.9 91.7

Table F.790-day graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 100.0 100.0 85.7 100.0 86.7 90.0 100.0 81.3 73.9 92.6 93.81-4 80.0 100.0 81.3 94.7 91.7 100.0 96.3 88.4 81.5 96.6 77.45-9 95.7 94.7 84.9 89.7 95.6 88.0 81.3 88.0 87.8 82.1 86.210-14 95.8 97.4 80.7 95.7 93.9 93.1 92.6 94.1 94.9 95.0 83.315-19 93.9 94.6 95.9 94.5 93.2 95.2 97.0 97.0 94.2 97.8 89.020-29 96.6 96.3 94.4 93.4 92.7 94.8 95.6 95.1 92.5 92.6 95.030-39 94.8 94.0 92.5 93.6 94.4 94.7 96.1 95.1 92.1 93.7 92.640-49 95.9 92.6 92.1 94.6 94.7 95.6 95.9 93.8 95.7 93.4 92.550-59 92.9 92.0 96.6 92.9 94.2 93.4 95.9 94.5 91.9 95.2 92.360-64 . 100.0 92.9 92.3 94.1 96.6 91.4 95.3 89.7 85.1 94.965-69 100.0 100.0 . 80.0 100.0 100.0 94.3 94.1 100.0 85.7 90.970-79 . . . 100.0 100.0 100.0 77.8 100.0 . . 100.080+ 100.0 . . . . . 100.0 . . . .

Male 94.4 94.4 92.8 93.4 94.3 95.0 95.3 94.3 91.6 92.9 92.3Female 97.1 94.8 93.0 94.2 93.2 94.3 95.5 94.8 94.1 93.9 92.1





All 95.5 94.6 92.8 93.7 93.9 94.7 95.4 94.5 92.6 93.3 92.2

ADJUSTED0-19 93.5 95.0 88.5 93.5 92.4 92.7 93.0 92.8 90.4 93.1 84.720-44 95.7 94.1 93.0 93.5 93.6 95.0 96.0 95.2 92.6 93.1 93.845-64 93.1 93.6 95.4 93.9 95.0 94.2 95.2 93.5 93.8 93.2 91.465-74 100.0 100.0 . 81.4 100.0 100.0 89.8 94.4 100.0 86.4 90.9

Male 93.4 93.6 92.3 93.0 93.9 94.7 95.2 94.1 91.2 92.4 91.6

White 94.7 94.9 92.8 92.8 94.0 94.8 95.4 94.3 92.2 93.1 91.7Black 95.3 90.1 91.0 94.8 90.2 93.6 95.0 94.1 91.9 90.9 92.2



435




Table F.7 (continued)90-day graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.7 (continued)90-day graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<1 92.0 70.0 86.5 81.3 90.3 92.3 100.0 97.0 97.1 86.4 94.7 97.51-4 88.6 89.5 84.3 88.9 97.1 91.7 98.2 90.6 98.0 93.0 98.3 100.05-9 89.2 94.0 95.4 94.9 91.4 93.1 98.3 97.0 97.1 98.3 93.3 98.710-14 94.8 96.3 96.3 96.9 96.5 96.6 96.1 98.4 93.8 94.8 97.0 99.315-19 95.0 90.6 95.4 95.7 92.8 95.5 96.6 94.4 99.1 96.2 95.5 98.320-29 95.2 94.1 95.2 96.1 95.1 97.2 96.9 96.5 96.8 96.7 97.0 98.130-39 95.1 94.5 93.8 94.9 96.3 95.9 97.3 97.0 96.8 97.3 97.1 97.340-49 95.5 94.8 95.7 94.9 94.9 96.5 95.9 97.6 96.2 96.0 96.7 96.650-59 95.1 93.6 91.9 95.6 93.1 94.7 95.6 96.4 95.6 97.2 96.5 96.760-64 91.9 96.3 95.3 89.5 92.2 97.8 96.5 96.0 96.4 96.8 96.2 97.065-69 84.2 89.8 97.5 95.7 88.9 93.9 96.4 97.2 96.2 95.7 96.1 96.570-79 100.0 100.0 90.9 100.0 92.3 92.0 93.9 89.4 96.6 95.2 95.0 96.080+ . 100.0 . . . . . . 100.0 75.0 100.0 100.0

Male 94.6 94.2 94.7 95.1 94.5 96.6 96.9 96.8 97.2 96.8 97.0 97.3Female 94.7 93.6 93.6 95.0 94.7 95.1 96.0 96.6 95.4 96.2 96.1 96.9





All 94.7 93.9 94.2 95.1 94.6 96.0 96.5 96.7 96.4 96.6 96.6 97.1

ADJUSTED0-19 91.8 90.3 92.6 94.1 92.7 94.0 96.7 95.2 96.6 94.7 94.9 98.420-44 95.2 94.8 94.6 95.5 95.5 96.5 96.8 96.8 96.8 96.8 97.1 97.145-64 95.4 93.7 94.0 94.5 94.3 96.0 96.0 97.0 95.9 96.8 96.6 97.165-74 86.5 89.6 96.1 96.5 91.0 93.5 95.7 95.6 96.5 95.9 96.6 96.775+ . . 51.5 . 82.6 100.0 100.0 88.4 100.0 86.5 85.7 92.8

Male 94.3 93.8 94.5 95.0 94.5 96.6 96.8 96.8 97.3 97.0 97.2 97.4Female 94.8 93.6 93.6 95.0 94.8 95.0 95.9 96.5 95.3 96.2 96.1 97.0




All 94.5 93.7 94.1 95.0 94.6 96.0 96.4 96.7 96.5 96.7 96.7 97.3


436

Reference section F


ON OUR WEBSITE & CDOne-year death-censored graft survival probabilities: all transplants, living donors (F.8.1).

Table F.8One-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.8One-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 100.0 100.0 85.7 80.0 80.0 70.0 76.9 75.0 69.6 85.2 87.51-4 60.0 100.0 62.5 73.7 87.5 85.7 85.2 88.4 77.8 96.6 67.75-9 91.3 89.5 69.7 75.9 91.1 82.0 79.2 82.0 82.9 82.1 84.510-14 91.7 92.1 73.7 90.0 85.9 82.8 90.1 89.4 86.7 92.9 76.915-19 87.9 87.5 91.0 84.9 86.4 91.2 88.6 90.5 88.4 95.6 83.220-29 88.8 89.3 88.1 87.9 88.7 89.7 89.9 89.0 89.0 88.8 93.130-39 90.5 83.8 85.5 87.4 89.6 88.2 91.9 89.6 87.6 90.6 90.040-49 82.3 82.0 84.9 85.5 88.8 91.6 92.6 89.0 91.5 91.2 89.350-59 78.6 79.3 87.8 88.2 87.4 91.6 93.3 90.2 88.2 89.3 87.560-64 . 100.0 78.6 92.3 94.1 94.9 91.4 89.4 86.2 83.0 89.765-69 100.0 100.0 . 80.0 100.0 91.7 85.7 91.2 70.0 85.7 86.470-79 . . . 100.0 100.0 100.0 77.8 100.0 . . 100.080+ . . . . . . 100.0 . . . .

Male 86.8 85.0 85.3 86.0 89.7 89.9 91.2 88.8 86.8 89.8 89.1Female 88.8 87.0 86.5 88.1 86.9 89.1 90.8 90.1 90.0 90.7 88.6





All 87.6 85.8 85.7 86.8 88.6 89.6 91.0 89.3 88.1 90.1 88.9

ADJUSTED0-19 87.1 88.1 79.6 81.9 84.8 84.5 85.5 86.7 83.2 90.8 78.520-44 87.5 84.8 86.1 86.8 89.1 89.6 91.7 89.5 89.0 89.6 91.245-64 80.4 80.2 86.6 88.4 87.8 91.5 92.1 89.5 88.6 89.7 87.765-74 100.0 100.0 . 81.4 100.0 93.4 82.2 91.6 69.9 86.4 86.475+ . . . . . 100.0 100.0 100.0 . . 100.0

Male 84.7 82.9 84.1 84.9 88.9 89.5 90.9 88.4 86.0 89.0 88.2Female 87.5 85.8 85.5 87.4 86.3 88.7 90.4 89.8 89.6 90.3 88.2




All 85.8 84.0 84.5 85.9 87.8 89.1 90.7 88.9 87.4 89.5 88.2

437




Table F.8 (continued)One-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.8 (continued)One-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<1 92.0 70.0 86.5 75.0 90.3 88.5 100.0 97.0 97.1 86.4 92.1 97.51-4 88.6 89.5 82.4 88.9 97.1 87.5 92.6 90.6 98.0 93.0 98.3 93.55-9 88.0 92.5 89.2 91.5 88.9 90.3 98.3 97.0 94.3 98.3 93.3 97.410-14 91.7 91.7 92.7 95.9 91.2 95.8 93.2 96.9 93.0 93.9 96.2 98.515-19 92.6 84.8 90.7 92.0 91.8 94.0 92.8 91.5 96.7 93.8 94.1 95.620-29 93.6 92.1 92.6 93.8 92.7 94.8 95.3 93.6 93.8 93.6 94.6 95.830-39 93.2 92.0 91.4 93.3 94.2 93.7 95.4 94.8 94.7 95.3 95.1 95.540-49 92.9 92.7 93.0 91.5 93.0 94.8 93.5 95.7 94.8 94.2 94.5 94.550-59 91.5 89.1 86.9 91.9 89.1 92.6 92.7 94.3 93.6 93.3 93.6 94.160-64 82.3 92.5 88.7 81.9 87.6 92.8 92.1 92.4 93.4 95.3 92.4 94.165-69 84.2 77.6 87.5 95.7 82.7 88.9 92.0 93.0 93.0 93.2 91.8 93.670-79 100.0 100.0 81.8 100.0 88.5 92.0 93.9 78.7 91.5 88.5 92.6 92.680+ . 100.0 . . . . . . 100.0 75.0 75.0 100.0

Male 92.3 91.4 91.0 91.9 91.7 94.6 94.7 94.6 95.0 94.3 94.4 95.0Female 92.3 90.3 90.7 92.9 92.2 92.4 93.0 93.9 93.2 93.7 93.8 94.5





All 92.3 90.9 90.9 92.3 91.9 93.7 94.0 94.3 94.3 94.1 94.1 94.8

ADJUSTED0-19 89.5 85.9 88.2 90.9 90.2 91.8 93.1 93.3 94.7 92.9 93.8 95.920-44 93.3 92.4 92.3 93.3 93.4 94.4 95.0 94.6 94.4 94.4 94.9 95.145-64 91.4 90.2 89.3 90.7 90.7 93.8 92.8 94.6 94.1 94.1 93.8 94.665-74 86.5 77.3 86.1 96.5 85.6 89.4 92.1 90.1 92.9 92.0 92.8 94.075+ . . 51.5 . 82.6 100.0 100.0 76.2 100.0 86.5 81.2 85.8

Male 91.8 90.9 90.6 91.7 91.6 94.7 94.7 94.6 95.1 94.5 94.6 95.3Female 92.3 90.1 90.7 92.8 92.3 92.4 92.9 93.9 93.1 93.7 93.9 94.7




All 92.0 90.5 90.6 92.2 91.9 93.7 93.9 94.3 94.3 94.1 94.3 95.0


438

Reference section F


ON OUR WEBSITE & CDTwo-year death-censored graft survival probabilities: all transplants, living donors (F.9.1).

Table F.9Two-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

75+ . . . . . 100.0 100.0 100.0 . . 100.0

Female 82.4 81.0 79.0 82.1 82.4 84.8 86.4 85.1 86.0 86.0 84.6

Other race 73.2 78.5 72.4 86.5 89.5 82.6 87.1 90.1 84.9 95.6 88.8

Other cause 80.9 79.5 79.2 82.9 87.2 87.0 88.3 83.5 87.3 86.8 85.2


All 80.2 78.5 77.9 79.9 83.3 85.3 86.9 84.6 82.8 86.0 85.1

Table F.9Two-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 100.0 100.0 57.1 80.0 73.3 70.0 76.9 75.0 65.2 81.5 87.51-4 60.0 88.9 50.0 63.2 87.5 81.0 81.5 81.4 74.1 96.6 67.75-9 82.6 89.5 60.6 58.6 84.4 82.0 72.9 74.0 73.2 78.6 82.810-14 77.1 81.6 61.4 84.3 77.8 79.3 77.8 81.2 77.6 89.9 76.915-19 75.8 80.4 87.7 78.8 81.8 83.0 81.3 85.8 82.6 86.7 76.820-29 85.0 85.0 80.5 82.6 84.6 86.6 85.3 83.3 83.7 85.1 91.430-39 87.5 77.8 80.6 81.9 85.9 84.6 88.7 87.2 84.2 88.2 86.440-49 76.9 80.1 80.6 79.4 84.5 87.6 90.7 84.7 90.1 88.4 86.650-59 78.6 73.6 81.0 85.2 83.6 87.8 91.0 86.4 84.5 86.6 84.160-64 . 100.0 71.4 92.3 88.2 94.9 87.7 85.9 79.3 83.0 87.265-69 100.0 100.0 . 80.0 100.0 83.3 85.7 85.3 70.0 85.7 86.470-79 . . . 100.0 100.0 100.0 77.8 100.0 . . 80.080+ . . . . . . 100.0 . . . .

Male 81.5 79.6 78.9 80.1 85.0 86.1 87.8 84.8 81.9 87.1 86.7Female 84.2 82.5 80.3 83.1 83.2 85.3 86.9 85.5 86.5 86.6 85.2





All 82.6 80.7 79.4 81.3 84.3 85.8 87.4 85.0 83.7 86.9 86.0

ADJUSTED0-19 73.7 80.1 71.3 73.5 78.4 78.8 77.0 80.0 75.4 84.9 75.020-44 83.8 79.6 79.7 81.3 84.8 86.1 88.3 85.6 85.2 86.4 88.645-64 75.6 76.4 81.6 83.9 84.4 87.8 89.6 85.4 85.0 87.9 84.165-74 100.0 100.0 . 81.6 100.0 87.2 82.1 86.3 70.0 86.3 82.1

Male 78.8 76.9 77.3 78.7 83.9 85.6 87.3 84.2 80.8 86.1 85.6

White 80.6 79.4 79.2 80.9 84.7 86.4 87.4 84.7 83.7 86.9 85.9Black 81.1 74.4 72.5 73.6 74.6 79.9 85.1 82.6 78.6 79.6 80.8



439




Table F.9 (continued)Two-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.9 (continued)Two-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<1 92.0 65.0 86.5 75.0 90.3 80.8 92.9 90.9 91.4 86.4 89.51-4 88.6 84.2 82.4 88.9 97.1 79.2 88.9 90.6 98.0 93.0 96.65-9 86.8 89.6 83.1 89.8 85.2 87.5 96.7 95.5 92.9 93.2 90.710-14 88.5 85.3 87.2 94.9 88.6 90.7 89.3 95.3 90.7 89.6 91.715-19 88.2 76.8 87.2 89.3 85.6 87.9 88.4 87.6 89.1 87.5 91.920-29 89.4 88.5 89.1 90.3 88.6 90.9 91.2 88.8 88.8 89.0 90.730-39 89.3 89.4 87.1 90.8 91.2 90.0 92.9 91.9 92.0 92.3 92.040-49 88.1 90.4 91.3 88.0 90.4 92.0 90.7 93.3 92.5 91.3 92.550-59 89.9 84.7 83.2 88.6 86.0 89.7 90.0 91.0 91.4 90.0 90.560-64 75.8 90.0 85.9 80.0 81.7 90.0 89.4 90.4 90.4 92.1 88.265-69 79.0 77.6 85.0 93.5 76.5 83.8 86.6 88.7 89.9 87.6 89.470-79 100.0 66.7 81.8 75.0 88.5 88.0 93.9 74.5 84.8 84.6 83.580+ . 100.0 . . . . . . 100.0 50.0 75.0

Male 88.8 88.0 88.0 89.2 88.5 91.2 91.9 91.4 92.1 90.8 91.7Female 88.2 86.7 86.9 89.5 88.5 88.6 89.6 90.7 89.8 90.1 90.2





All 88.5 87.5 87.5 89.3 88.5 90.1 90.9 91.1 91.1 90.5 91.0

ADJUSTED0-19 86.4 78.8 84.0 88.8 85.7 85.3 88.5 90.2 89.4 87.4 90.320-44 89.1 89.6 88.8 90.5 90.3 90.8 92.1 91.2 91.0 91.2 91.845-64 88.1 86.6 86.6 87.3 87.3 91.1 89.9 91.8 91.7 90.7 91.065-74 82.0 75.4 84.3 89.5 81.0 84.6 87.9 85.9 89.5 87.4 89.275+ . . 58.5 . 82.4 100.0 100.0 76.4 82.3 72.2 68.3

Male 88.2 87.3 87.6 89.0 88.4 91.2 91.8 91.5 92.2 91.0 92.0Female 88.0 86.4 86.8 89.4 88.6 88.5 89.5 90.7 89.7 90.1 90.3




All 88.1 86.9 87.2 89.2 88.4 90.1 90.8 91.1 91.2 90.6 91.3


440

Reference section F


ON OUR WEBSITE & CDThree-year death-censored graft survival probabilities: all transplants, living donors (F.10.1).

Table F.10Three-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

75+ . . . . . 100.0 100.0 . . . 100.0

Female 77.6 74.4 74.0 76.8 76.7 80.5 83.6 82.0 81.9 80.6 81.3

Other race 68.2 73.2 68.2 84.6 88.0 77.4 83.2 88.3 83.1 94.1 86.5

Other cause 76.6 71.5 74.8 78.1 82.5 82.9 85.3 80.5 84.1 83.0 81.2


All 74.9 71.4 72.6 74.7 77.9 80.2 83.6 81.1 78.7 81.8 81.3

Table F.10Three-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 100.0 75.0 57.1 80.0 73.3 70.0 69.2 68.8 65.2 77.8 87.51-4 60.0 88.9 50.0 52.6 87.5 81.0 77.8 76.7 70.4 96.6 61.35-9 78.3 84.2 51.5 48.3 77.8 78.0 70.8 70.0 65.9 75.0 81.010-14 72.9 65.8 57.9 78.6 72.7 66.7 72.8 77.7 73.5 87.9 70.515-19 72.7 75.0 84.4 75.3 75.0 77.6 74.7 78.7 77.4 82.2 69.020-29 81.6 79.6 75.7 76.7 81.0 81.2 81.2 79.5 80.2 80.5 86.430-39 81.9 72.5 75.3 76.8 81.7 79.6 85.2 84.8 80.9 85.0 83.940-49 72.1 70.2 75.4 76.1 76.1 83.6 88.6 82.4 85.8 85.2 84.250-59 66.7 66.7 74.2 80.5 79.2 83.6 89.4 82.9 78.3 79.7 82.260-64 . 100.0 71.4 92.3 82.4 94.9 84.0 80.0 75.9 72.3 87.265-69 . 100.0 . 80.0 100.0 83.3 85.7 82.4 70.0 85.7 77.370-79 . . . 100.0 100.0 100.0 77.8 85.7 . . 80.080+ . . . . . . 100.0 . . . .

Male 76.5 72.8 73.7 75.2 80.2 80.8 84.2 81.1 77.9 83.8 82.6Female 79.9 76.3 75.7 78.1 77.8 81.1 84.3 82.4 82.5 81.4 82.0





All 77.8 74.2 74.5 76.3 79.3 80.9 84.2 81.6 79.7 82.8 82.4

ADJUSTED0-19 69.9 71.6 67.3 67.8 72.4 71.4 71.2 74.0 70.2 81.4 68.620-44 79.3 73.6 74.8 76.3 80.5 81.5 84.9 82.8 81.6 82.6 85.145-64 66.8 67.2 75.2 79.1 77.2 83.5 87.7 82.0 80.5 82.0 82.365-74 . 100.0 . 81.4 100.0 87.3 82.1 83.5 70.2 86.2 73.4

Male 73.1 69.4 71.9 73.5 78.8 80.2 83.6 80.5 76.6 82.6 81.3

White 75.6 72.5 73.8 75.1 79.8 81.9 84.4 81.1 80.3 82.8 82.1Black 74.1 65.3 67.8 70.6 65.6 72.3 79.9 79.3 69.1 73.5 76.9



441




Table F.10 (continued)Three-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.10 (continued)Three-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<1 88.0 60.0 86.5 75.0 90.3 80.8 92.9 90.9 88.6 81.81-4 88.6 81.6 80.4 85.2 94.1 77.1 88.9 90.6 98.0 93.05-9 85.5 86.6 81.5 89.8 85.2 84.7 96.7 94.0 92.9 91.510-14 81.3 80.7 81.7 92.9 84.2 86.4 87.4 92.1 83.7 87.815-19 82.6 72.5 78.5 82.4 81.5 84.4 83.1 81.4 80.5 83.720-29 85.3 84.9 84.2 87.1 83.9 85.9 87.8 84.2 84.7 84.930-39 85.4 87.1 84.2 86.9 89.3 86.6 89.8 87.8 89.8 89.640-49 85.3 86.5 87.9 85.1 87.3 88.2 87.3 90.6 89.5 87.650-59 85.0 82.8 78.7 84.4 80.8 86.1 86.3 88.2 88.9 86.360-64 72.6 88.8 78.3 70.5 77.8 86.1 85.5 87.3 81.7 88.265-69 79.0 71.4 77.5 87.0 69.1 79.8 84.8 82.4 84.2 83.870-79 100.0 66.7 81.8 66.7 88.5 88.0 78.8 72.3 84.8 76.080+ . 100.0 . . . . . . 100.0 50.0

Male 85.2 84.6 83.9 85.3 85.0 87.4 88.5 87.9 88.7 87.1Female 84.1 83.9 82.4 85.6 84.9 84.7 86.1 87.2 86.0 86.6





All 84.7 84.3 83.3 85.4 85.0 86.3 87.5 87.6 87.5 86.9

ADJUSTED0-19 81.4 74.3 78.1 84.2 82.3 81.7 85.3 86.0 82.8 84.320-44 85.5 86.4 85.0 87.3 87.2 86.7 88.8 87.2 88.1 87.945-64 84.1 84.4 82.2 82.6 83.3 87.7 86.3 89.2 88.0 87.065-74 82.0 69.2 78.4 82.4 75.6 81.4 83.6 80.5 85.6 82.075+ . . 55.2 . 83.4 100.0 58.6 73.0 80.7 69.7

Male 84.3 83.7 83.4 85.1 84.9 87.5 88.4 88.0 88.9 87.5Female 83.9 83.6 82.3 85.5 85.0 84.7 85.9 87.1 85.9 86.6




All 84.1 83.6 82.9 85.2 84.9 86.3 87.4 87.5 87.6 87.1


442

Reference section F


ON OUR WEBSITE & CDFive-year death-censored graft survival probabilities: all transplants, living donors (F.11.1).

Table F.11Five-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

75+ . . . . . 100.0 100.0 . . . 33.5

Female 68.4 65.8 65.4 68.0 69.3 73.1 76.2 74.3 72.5 73.6 72.0

Other race 63.2 62.7 62.1 78.9 82.2 69.9 79.3 83.0 68.5 88.2 84.1

Other cause 66.1 64.8 67.6 69.8 73.6 75.0 78.6 74.0 77.5 77.0 73.6


All 64.7 62.7 63.6 66.2 68.8 72.4 76.5 74.1 70.0 74.2 72.5

Table F.11Five-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 66.7 50.0 57.1 60.0 60.0 70.0 61.5 56.3 60.9 77.8 87.51-4 60.0 77.8 37.5 47.4 75.0 76.2 70.4 67.4 63.0 96.6 61.35-9 69.6 73.7 48.5 37.9 71.1 70.0 64.6 60.0 58.5 69.6 74.110-14 60.4 55.3 52.6 64.3 60.6 57.5 61.7 69.4 67.4 76.8 64.115-19 60.6 69.6 70.5 66.4 63.6 64.6 65.1 67.5 70.3 68.9 58.720-29 71.4 71.9 66.5 68.1 71.1 73.0 72.8 71.9 73.5 72.9 78.730-39 76.3 63.5 67.1 70.4 74.4 72.1 79.1 78.7 71.6 79.3 75.540-49 61.9 64.6 68.7 68.8 68.3 77.4 81.8 77.2 77.3 79.9 78.150-59 54.8 57.5 64.6 72.8 73.4 78.1 84.5 77.1 67.7 72.7 69.760-64 . 50.0 64.3 69.2 73.5 88.1 81.5 71.8 55.2 53.2 64.165-69 . 100.0 . 80.0 100.0 58.3 80.0 70.6 70.0 85.7 68.270-79 . . . 100.0 . 100.0 66.7 85.7 . . 60.080+ . . . . . . 100.0 . . . .

Male 66.5 64.8 64.9 67.3 70.7 72.9 77.5 74.7 70.2 76.2 74.7Female 71.6 68.3 67.5 69.8 70.9 74.0 77.1 74.9 73.5 74.7 73.1





All 68.6 66.1 65.8 68.3 70.7 73.4 77.4 74.8 71.5 75.6 74.0

ADJUSTED0-19 57.3 63.3 57.0 56.6 60.4 60.5 61.4 63.1 63.0 71.2 60.820-44 70.1 65.2 66.3 68.8 72.1 73.9 78.1 76.3 73.7 76.0 77.445-64 57.4 58.6 67.0 70.6 70.0 77.8 82.0 76.6 69.3 74.4 71.165-74 . 100.0 . 82.0 85.0 68.8 74.8 73.7 71.1 85.8 65.5

Male 62.3 60.7 62.7 65.2 68.8 72.1 76.8 74.0 68.6 74.6 73.0

White 65.7 64.1 64.8 66.5 71.2 74.3 77.4 74.5 72.7 76.2 73.7Black 61.2 56.1 58.3 61.9 54.1 63.1 71.7 69.8 56.2 59.9 64.1



443




Table F.11 (continued)Five-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.11 (continued)Five-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<1 88.0 60.0 86.5 68.8 80.7 76.9 89.3 90.91-4 84.1 76.3 78.4 85.2 88.2 77.1 85.2 87.55-9 79.5 77.6 80.0 88.1 79.0 83.3 90.0 92.510-14 74.0 68.8 71.6 86.7 78.1 78.0 76.7 89.815-19 76.4 65.2 61.1 70.6 72.3 73.9 68.1 68.920-29 76.7 76.2 76.6 76.9 74.4 76.5 78.8 75.430-39 77.6 79.9 77.5 77.8 82.5 79.8 83.4 81.840-49 74.9 78.0 78.9 76.6 79.5 79.4 79.8 84.450-59 72.9 74.4 70.1 77.5 73.2 76.3 77.3 78.560-64 64.5 78.8 68.9 55.2 68.0 75.0 73.1 75.365-69 79.0 63.3 60.0 76.1 59.3 74.8 73.2 67.670-79 75.0 33.3 72.7 58.3 76.9 68.0 66.7 61.780+ . 100.0 . . . . . .

Male 76.5 76.7 76.0 76.0 77.4 79.4 79.3 80.6Female 75.5 75.3 73.5 77.1 76.5 75.5 78.3 78.5





All 76.1 76.1 75.0 76.5 77.0 77.8 78.9 79.7

ADJUSTED0-19 74.7 65.1 67.2 75.5 73.8 73.7 73.0 79.020-44 76.8 78.2 77.7 77.7 79.5 78.5 80.8 79.945-64 73.9 76.3 73.6 75.6 75.5 78.7 78.0 80.965-74 77.8 60.0 64.0 72.8 66.3 75.0 72.7 68.075+ . . 61.7 . 58.6 20.9 38.9 69.3

Male 75.2 75.5 75.2 75.7 77.2 79.7 79.2 80.8Female 75.2 74.8 73.4 77.0 76.7 75.5 78.1 78.5




All 75.2 75.1 74.4 76.2 76.9 77.9 78.7 79.7


444

Reference section F


ON OUR WEBSITE & CDTen-year death-censored graft survival probabilities: all transplants, living donors (F.12.1).

Table F.12Ten-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.12Ten-year graft survival probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<1 66.7 25.0 57.1 40.0 46.7 50.0 53.9 37.5 56.5 66.7 75.0 72.0 50.0 83.81-4 20.0 55.6 12.5 36.8 50.0 71.4 55.6 53.5 51.9 86.2 48.4 59.1 65.8 68.65-9 47.8 47.4 24.2 27.6 51.1 50.0 47.9 34.0 39.0 51.8 53.5 65.1 55.2 55.410-14 37.5 31.6 36.8 41.4 41.4 36.8 40.7 48.2 41.8 51.5 51.3 51.0 52.3 51.415-19 45.5 50.9 48.4 44.5 50.8 39.5 49.4 50.3 49.0 53.3 36.8 57.1 44.9 50.020-29 60.5 56.9 50.1 53.5 56.1 55.9 53.5 54.0 60.1 56.5 58.7 59.8 54.6 58.730-39 59.1 50.6 51.4 54.8 55.7 51.9 57.9 56.3 52.1 60.8 61.0 59.6 59.2 59.740-49 44.9 46.0 51.2 52.9 47.5 55.0 57.8 52.3 54.6 56.3 57.0 56.9 59.5 55.550-59 31.0 40.2 42.9 55.0 53.6 50.2 54.3 53.5 47.2 48.7 43.8 46.2 48.9 45.760-64 . 50.0 50.0 46.2 50.0 64.4 55.6 38.8 37.9 25.5 28.2 38.7 38.8 39.665-69 . 100.0 . 60.0 60.0 33.3 48.6 41.2 30.0 42.9 50.0 63.2 44.9 25.070-79 . . . . . 33.3 22.2 42.9 . . 60.0 25.0 33.3 27.380+ . . . . . . 100.0 . . . . . 100.0 .

Male 52.0 49.2 47.6 50.7 52.8 51.0 54.5 51.7 51.6 56.5 55.4 59.0 55.7 56.9Female 54.3 51.7 49.5 53.6 52.4 53.8 55.6 53.8 54.8 55.3 53.8 54.2 53.8 52.0




First transplant 52.5 49.6 48.3 51.9 52.0 52.0 55.1 53.4 53.1 56.5 55.4 57.4 55.4 54.9Subsequent transplants 59.2 64.3 48.8 51.4 60.0 53.4 53.5 44.1 49.3 48.7 45.3 51.1 48.0 54.5

All 52.9 50.1 48.3 51.8 52.6 52.1 54.9 52.5 52.8 56.0 54.7 57.0 54.9 54.9

ADJUSTED0-19 37.9 42.4 36.6 36.6 43.6 39.0 44.5 43.9 42.3 52.8 42.5 53.9 46.7 52.220-44 56.0 50.7 50.7 53.8 54.3 54.9 57.3 56.0 56.5 58.3 60.4 59.4 57.7 59.145-64 34.9 39.9 45.5 52.4 49.8 52.4 54.2 50.4 47.8 48.3 43.9 51.2 51.9 49.265-74 . 100.0 . 50.2 58.8 41.1 44.1 42.2 28.8 41.4 50.2 56.6 45.9 32.775+ . . . . . . 2.0 . . . 50.1 . . 92.9

Male 47.0 44.6 45.3 48.4 50.5 50.2 53.4 51.0 49.6 54.4 53.4 57.2 54.1 55.8Female 49.6 48.5 46.6 50.9 49.9 52.5 54.2 53.0 52.8 53.6 52.0 53.9 53.2 51.9



First transplant 47.8 45.7 45.8 49.4 49.6 51.0 53.9 52.7 51.2 54.6 53.4 56.2 54.3 54.3Subsequent transplants 54.3 60.4 46.7 49.6 57.7 51.3 51.5 42.5 46.9 45.7 44.6 48.8 46.2 53.4

All 47.9 46.0 45.7 49.3 50.1 50.9 53.7 51.7 50.7 54.0 52.6 55.6 53.5 54.0

445




Table F.1390-day survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.1390-day survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 100.0 85.7 88.9 83.9 90.0 94.7 92.3 89.5 73.3 100.0 83.31-4 100.0 90.9 100.0 95.8 95.2 92.3 93.0 97.0 100.0 92.7 83.65-9 96.8 97.6 97.8 100.0 100.0 98.3 94.1 96.8 96.6 98.6 92.110-14 95.6 98.6 100.0 100.0 100.0 99.0 99.1 98.3 97.1 94.9 97.915-19 97.8 97.1 98.6 96.2 98.4 99.5 99.1 98.1 97.7 96.4 96.920-29 94.6 96.5 96.9 97.3 96.6 97.3 97.0 97.8 97.8 97.8 98.230-39 93.2 94.4 94.7 95.1 97.1 96.8 96.4 97.2 97.0 96.6 97.240-49 91.8 93.1 94.5 93.7 94.4 95.9 95.3 94.3 96.1 96.2 96.350-59 90.7 89.2 90.5 93.2 94.4 91.1 92.8 93.4 93.3 94.1 94.960-64 96.2 93.2 89.2 91.7 86.9 90.8 91.3 92.2 91.6 92.4 92.765-69 100.0 88.9 100.0 89.5 95.8 100.0 89.1 91.8 88.6 91.2 94.470-79 100.0 100.0 . 100.0 100.0 100.0 84.6 83.3 89.1 84.2 94.980+ . . . . 100.0 100.0 . . 100.0 . 100.0

Male 93.6 94.3 94.8 95.1 95.5 95.6 95.1 95.1 95.2 95.4 96.0Female 92.7 93.8 95.0 95.0 96.1 96.0 96.0 96.2 96.3 96.3 96.4




First transplant 93.3 94.2 95.0 95.4 96.0 95.8 95.4 95.5 95.8 95.7 96.1Subsequent txs 93.0 93.5 93.8 92.6 94.1 95.7 95.6 95.6 94.3 96.0 96.8

All 93.3 94.1 94.8 95.1 95.7 95.8 95.4 95.5 95.6 95.8 96.2

ADJUSTED0-19 97.0 96.9 98.7 97.2 98.7 98.5 97.9 97.6 97.0 96.6 95.220-44 93.5 94.4 95.2 95.3 96.4 96.9 96.7 96.4 96.9 96.9 97.345-64 88.7 89.9 91.2 92.7 92.7 91.9 92.5 93.6 93.7 94.2 94.665-74 100.0 89.9 100.0 89.8 96.1 100.0 87.5 89.9 88.8 89.8 94.575+ . . . . 100.0 100.0 . 100.0 71.6 69.9 88.4

Male 90.8 91.6 92.5 93.0 93.9 94.1 93.8 94.0 94.4 94.5 95.5Female 88.4 89.7 92.3 92.4 94.3 94.4 94.5 95.0 95.2 95.5 95.6




All 90.0 91.0 92.4 92.8 94.1 94.2 94.0 94.4 94.7 94.8 95.5


446

Reference section F


Table F.13 (continued)90-day survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.13 (continued)90-day survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<1 100.0 90.9 83.3 91.7 100.0 75.0 87.5 87.5 90.0 100.0 100.0 100.01-4 95.8 100.0 96.3 100.0 100.0 94.1 92.3 100.0 96.7 95.7 100.0 96.05-9 100.0 97.7 94.9 100.0 100.0 98.4 98.3 96.7 96.1 97.7 100.0 100.010-14 99.0 100.0 100.0 99.1 96.3 95.7 99.0 100.0 97.4 98.9 97.7 100.015-19 98.8 97.6 97.1 98.4 99.5 100.0 100.0 100.0 99.1 98.9 98.9 99.420-29 98.8 97.8 98.3 99.3 98.8 98.7 99.3 99.1 99.3 99.2 98.9 98.730-39 98.2 98.2 98.5 98.2 98.3 98.1 98.1 98.3 98.1 98.5 98.8 98.640-49 97.2 97.1 97.4 97.6 97.2 97.8 97.6 98.4 98.1 98.1 98.3 98.150-59 95.9 95.5 95.7 95.9 95.8 96.3 96.0 96.7 96.2 96.5 97.0 96.960-64 95.4 94.4 94.7 96.6 95.5 95.7 96.6 97.1 95.2 94.6 95.5 96.065-69 93.3 93.2 94.9 95.2 91.8 93.8 94.0 96.2 94.1 93.6 94.0 95.870-79 91.9 93.3 90.8 94.2 94.7 96.5 94.0 93.7 94.5 94.6 95.0 93.980+ 100.0 100.0 100.0 100.0 100.0 100.0 100.0 87.5 100.0 100.0 100.0 100.0

Male 97.1 96.9 96.9 97.2 96.8 97.2 97.4 97.8 97.3 97.0 97.3 97.4Female 97.4 96.7 97.3 97.7 97.3 97.3 96.9 97.6 97.0 97.4 97.7 97.4




First transplant 97.1 96.7 97.1 97.4 97.0 97.2 97.1 97.7 97.1 97.2 97.4 97.4Subsequent txs 98.3 97.4 96.5 97.4 96.7 97.7 97.8 97.9 97.8 97.1 97.6 98.0

All 97.2 96.8 97.0 97.4 97.0 97.2 97.2 97.7 97.2 97.2 97.4 97.4

ADJUSTED0-19 98.9 98.2 97.1 98.8 98.8 97.7 98.8 99.2 98.0 98.7 98.9 99.520-44 98.2 97.6 98.3 98.4 98.3 98.4 98.4 98.6 98.4 98.6 98.7 98.645-64 96.1 95.9 95.9 96.5 96.2 96.5 96.6 97.3 96.6 96.7 97.2 97.165-74 92.6 92.9 93.8 94.9 92.7 94.5 94.1 96.1 94.4 93.9 94.7 95.275+ 100.0 94.6 92.0 94.1 94.4 100.0 93.2 88.7 92.7 100.0 91.7 95.9

Male 96.8 96.6 96.7 97.1 96.8 97.2 97.6 98.0 97.5 97.4 97.6 97.9Female 96.9 96.2 97.0 97.5 97.1 97.3 96.9 97.7 97.1 97.6 97.9 97.7




All 96.8 96.4 96.8 97.3 97.0 97.3 97.3 97.9 97.3 97.5 97.8 97.8

447




Table F.14One-year survival with functioning graft probabilities: all tranplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.14One-year survival with functioning graft probabilities: all tranplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 66.7 71.4 88.9 83.9 77.1 89.5 92.3 83.5 45.8 90.9 83.31-4 100.0 90.9 100.0 90.8 90.0 87.9 93.0 93.7 100.0 92.7 74.45-9 89.7 97.6 97.8 97.0 100.0 94.7 87.7 96.8 96.6 97.0 90.210-14 92.2 96.9 98.6 98.7 99.0 95.8 98.0 96.4 94.9 92.8 97.915-19 96.2 93.6 97.8 93.1 97.2 98.8 97.5 97.0 97.1 94.9 96.420-29 92.1 93.0 94.1 95.6 94.0 95.6 94.1 95.7 96.6 96.5 96.830-39 86.4 88.6 90.3 90.0 92.5 94.1 92.8 94.2 94.3 94.8 95.440-49 82.8 84.3 88.1 87.1 87.3 91.1 90.4 89.3 93.2 93.0 92.950-59 82.3 78.8 78.6 84.7 86.8 82.6 85.8 86.9 88.2 89.7 90.760-64 90.5 64.4 82.4 79.3 81.1 84.5 85.5 84.7 87.3 86.9 87.865-69 81.8 77.8 60.0 72.3 69.5 80.3 79.5 82.4 79.9 85.9 87.870-79 100.0 100.0 . 100.0 40.0 40.0 84.6 83.3 80.1 81.0 89.580+ . . . . 100.0 100.0 . . 100.0 . .

Male 87.0 87.5 89.1 90.8 90.4 91.0 90.8 90.8 91.9 92.4 92.9Female 87.2 87.4 90.2 88.3 90.7 92.5 91.6 92.3 93.2 93.6 93.8





All 87.1 87.5 89.5 89.9 90.5 91.5 91.1 91.4 92.4 92.9 93.2

ADJUSTED0-19 93.3 94.1 97.9 94.5 97.1 96.2 96.1 96.1 95.4 94.7 93.920-44 87.7 88.7 90.4 90.7 91.5 94.2 93.3 93.2 94.3 94.9 95.245-64 77.3 77.3 81.5 83.8 85.2 84.3 85.5 86.9 89.2 89.7 90.465-74 83.2 78.8 57.3 73.6 64.5 74.3 79.0 81.7 79.2 84.4 87.775+ . . . . 53.7 100.0 . 100.0 71.6 69.9 62.6

Male 81.3 82.2 84.4 86.9 86.9 88.1 88.3 88.6 90.4 91.0 91.8Female 79.9 79.9 85.1 82.8 86.7 89.5 88.6 90.0 91.4 92.0 92.3




All 80.9 81.6 84.7 85.5 86.9 88.6 88.4 89.1 90.8 91.4 92.0


448

Reference section F


Table F.14 (continued)One-year survival with functioning graft probabilities: all tranplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.14 (continued)One-year survival with functioning graft probabilities: all tranplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<1 85.7 90.9 83.3 83.3 75.0 75.0 87.5 87.5 80.0 100.0 90.0 100.01-4 86.9 96.3 92.3 96.0 100.0 94.1 92.3 100.0 93.2 95.7 100.0 92.05-9 100.0 97.7 93.2 98.1 98.0 98.4 98.3 96.7 92.1 97.7 100.0 98.410-14 96.6 100.0 98.7 97.2 96.3 95.7 99.0 98.9 97.4 97.8 97.7 100.015-19 98.8 97.0 95.2 95.0 99.0 100.0 98.5 99.3 97.6 98.9 98.9 99.420-29 97.5 96.4 96.9 98.1 97.3 98.0 98.3 98.3 97.9 98.1 97.7 97.230-39 96.8 95.7 96.8 96.0 97.4 96.5 97.2 96.8 97.0 97.2 97.5 96.840-49 94.6 94.8 95.2 94.7 94.3 95.2 95.5 96.6 96.0 96.0 96.0 96.450-59 92.6 91.3 92.2 92.1 92.5 93.3 92.4 93.9 93.0 92.1 93.9 93.960-64 91.1 89.6 89.9 92.4 90.1 91.0 92.0 90.7 90.9 89.0 91.0 92.765-69 86.8 89.3 88.1 89.6 86.3 89.3 88.9 90.5 88.8 88.4 88.8 91.970-79 88.5 92.2 81.0 84.8 89.9 92.0 84.0 86.5 88.8 88.4 87.2 87.780+ 100.0 66.7 100.0 50.0 100.0 100.0 100.0 87.5 80.0 83.3 100.0 100.0

Male 94.5 94.0 94.2 93.9 94.1 94.6 94.7 95.1 94.6 93.8 94.4 94.7Female 95.1 94.2 94.6 95.0 94.9 94.9 94.6 95.3 94.5 94.6 95.1 95.3





All 94.7 94.1 94.3 94.3 94.4 94.8 94.6 95.1 94.5 94.1 94.7 94.9

ADJUSTED0-19 97.4 97.5 95.3 95.9 98.0 97.7 97.9 98.6 96.4 98.4 98.6 98.920-44 96.3 95.4 96.6 96.4 96.8 96.7 97.0 97.2 97.0 97.1 97.2 97.045-64 92.8 92.2 92.6 92.8 92.5 93.4 93.4 94.1 93.5 92.7 94.1 94.465-74 86.5 89.8 86.6 88.4 87.5 89.9 87.6 90.0 89.2 88.7 88.9 90.975+ 100.0 83.7 73.2 75.1 81.8 93.8 86.3 81.5 82.6 87.1 83.1 87.6

Male 93.8 93.4 93.9 93.7 94.1 94.8 95.0 95.4 95.0 94.6 95.2 95.5Female 94.3 93.3 94.0 94.5 94.5 94.9 94.6 95.4 94.6 94.9 95.5 95.8




All 94.0 93.4 93.9 94.0 94.2 94.8 94.8 95.4 94.9 94.7 95.3 95.7

449


TRANSPLANTATION: OUTCOMESFTRANSPLANTATION: OUTCOMES2005 Annual Data ReportF


Table F.15Two-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.15Two-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 66.7 71.4 88.9 83.9 77.1 83.9 92.3 83.5 45.8 90.9 83.31-4 100.0 90.9 100.0 85.1 84.7 87.9 88.1 93.7 100.0 92.7 74.45-9 85.8 91.7 97.8 97.0 97.1 94.7 87.7 96.8 94.5 97.0 90.210-14 92.2 96.9 97.0 97.2 99.0 93.4 95.6 93.1 94.9 92.8 97.915-19 95.2 93.6 97.0 91.7 97.2 97.4 96.9 96.5 97.1 93.2 96.420-29 89.6 91.6 90.4 93.7 91.6 94.1 92.2 93.8 94.8 95.8 95.730-39 82.2 85.8 85.4 85.9 88.0 90.4 90.0 91.1 92.7 93.6 94.240-49 75.8 80.3 83.2 81.1 83.4 87.4 86.7 85.9 90.8 90.1 90.450-59 76.8 73.6 74.2 76.6 81.7 78.5 81.3 82.2 84.5 85.9 88.760-64 90.5 61.0 77.4 71.0 75.8 78.7 81.1 79.4 81.6 81.0 84.565-69 68.2 77.8 60.0 65.7 64.5 71.1 71.5 76.2 76.3 83.1 83.970-79 50.0 100.0 . 100.0 20.0 40.0 75.2 83.3 74.2 74.2 83.980+ . . . . . 50.0 . . 100.0 . .

Male 82.4 84.5 85.5 85.7 86.0 87.4 87.2 86.9 89.1 89.8 90.9Female 83.4 84.9 84.9 84.9 87.8 89.7 89.2 90.1 91.1 91.6 92.0





All 82.8 84.6 85.3 85.4 86.7 88.2 87.9 88.1 89.9 90.5 91.3

ADJUSTED0-19 92.1 93.1 97.0 92.9 96.4 94.6 94.8 94.9 95.1 93.8 93.920-44 83.0 85.9 85.9 86.9 87.6 91.1 90.8 90.2 92.5 93.5 93.745-64 71.4 72.5 76.1 75.6 80.2 80.2 80.9 82.6 85.3 85.5 87.965-74 61.7 78.8 57.4 67.2 55.9 65.6 70.5 76.2 75.5 80.7 83.175+ . . . . . 68.8 . 100.0 59.0 69.5 64.0

Male 75.2 78.1 79.7 80.1 81.2 83.6 83.9 83.9 87.3 87.9 89.6Female 74.2 76.1 77.6 78.0 82.7 85.6 85.4 87.2 88.7 89.6 90.2




All 75.0 77.6 79.1 79.5 81.8 84.4 84.5 85.2 87.8 88.6 89.9


450

Reference section F


Table F.15 (continued)Two-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.15 (continued)Two-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<1 85.7 90.9 66.7 83.3 75.0 62.5 87.5 87.5 80.0 100.0 80.01-4 86.9 96.3 88.3 92.0 100.0 91.0 88.5 100.0 93.2 95.7 100.05-9 97.9 97.7 93.2 98.1 95.9 96.8 98.3 96.7 92.1 97.7 98.210-14 96.6 100.0 97.4 97.2 94.2 95.7 99.0 98.9 97.4 96.6 96.515-19 97.3 95.0 93.9 93.2 97.3 98.5 97.8 99.3 97.6 97.0 97.620-29 96.0 95.3 95.9 97.5 96.3 97.2 97.4 97.8 97.0 97.5 97.630-39 95.1 93.9 95.6 94.3 96.2 95.4 95.4 96.1 95.7 95.3 95.740-49 92.6 92.5 92.7 91.9 92.6 92.9 94.1 94.6 94.4 94.3 93.350-59 90.2 88.1 89.0 88.8 89.8 90.2 89.2 91.4 90.4 89.4 90.260-64 88.0 86.1 85.5 87.7 86.6 87.2 89.2 86.4 87.5 85.6 86.265-69 82.4 83.7 84.7 83.6 80.6 83.8 83.9 85.5 84.2 83.5 84.270-79 81.2 87.7 72.8 78.7 84.1 85.9 79.3 79.2 84.0 82.6 83.080+ 100.0 66.7 100.0 50.0 100.0 100.0 100.0 62.5 60.0 83.3 100.0

Male 92.1 91.8 91.6 91.0 91.9 92.4 92.2 92.8 92.4 91.3 91.3Female 93.5 91.5 92.4 92.8 93.0 92.3 92.9 93.4 92.5 92.3 92.4





All 92.6 91.7 92.0 91.7 92.3 92.4 92.5 93.0 92.5 91.7 91.7

ADJUSTED0-19 96.3 96.5 93.7 94.7 96.4 96.2 97.3 98.6 96.4 97.2 97.220-44 94.6 93.5 95.1 94.9 95.6 95.4 95.7 96.1 95.5 95.5 95.645-64 90.3 89.2 89.3 89.2 90.0 90.4 90.8 91.6 91.3 90.3 90.465-74 81.7 84.0 81.8 82.2 81.8 84.3 82.8 84.3 84.3 84.1 84.875+ 85.9 84.5 73.4 75.8 75.4 86.9 80.2 75.2 80.9 76.6 76.5

Male 91.2 91.1 91.3 90.8 91.9 92.6 92.5 93.3 93.1 92.4 92.5Female 92.3 90.3 91.7 92.2 92.5 92.3 92.9 93.5 92.7 92.9 93.1




All 91.6 90.8 91.4 91.3 92.1 92.4 92.7 93.4 93.0 92.6 92.8

451

TRANSPLANTATION: OUTCOMES2005 Annual Data ReportF


Table F.16Three-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.16Three-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 33.3 71.4 88.9 83.9 77.1 83.9 83.1 83.5 45.8 90.9 83.31-4 100.0 77.9 100.0 85.1 84.7 87.9 88.1 93.7 100.0 92.7 71.25-9 85.8 88.1 97.8 97.0 97.1 94.7 84.8 94.6 94.5 95.3 90.210-14 92.2 96.9 95.3 97.2 97.5 90.6 92.9 93.1 94.9 91.5 97.915-19 94.2 91.4 95.9 89.5 96.4 96.7 94.9 96.5 95.8 91.8 95.220-29 88.1 90.0 87.9 90.9 90.1 92.2 91.2 93.0 94.3 94.6 94.130-39 78.4 82.9 79.8 82.5 84.5 87.8 87.6 88.8 90.8 91.9 93.040-49 71.1 76.2 79.3 76.2 78.7 83.0 81.7 82.2 87.0 87.5 87.850-59 71.0 68.6 69.7 71.8 77.0 73.6 75.6 78.3 80.9 82.8 85.560-64 90.5 57.4 65.8 60.4 67.1 67.4 77.0 72.4 77.9 78.2 80.865-69 54.6 62.2 60.0 65.7 59.6 61.2 65.4 71.2 70.3 74.4 78.170-79 . 100.0 . 100.0 20.0 40.0 65.8 72.2 65.3 67.2 76.480+ . . . . . 50.0 . . 100.0 . .

Male 79.0 81.5 80.7 81.6 81.9 83.6 83.2 83.8 86.1 87.5 88.4Female 79.8 81.5 82.3 81.9 85.2 86.7 86.6 87.6 88.7 89.2 89.9





All 79.3 81.5 81.3 81.7 83.1 84.7 84.4 85.2 87.2 88.1 89.0

ADJUSTED0-19 91.2 91.1 96.1 91.9 95.8 93.8 92.7 94.8 94.6 92.9 93.220-44 79.5 82.9 81.5 83.2 83.9 88.0 88.3 88.0 90.5 91.7 92.145-64 66.1 68.1 71.0 70.0 75.5 75.0 75.4 78.0 81.4 82.6 84.565-74 40.8 63.7 57.0 66.9 51.4 56.3 63.4 69.6 68.3 72.2 76.975+ . . . . . 70.6 . 100.0 58.4 53.9 53.1

Male 70.8 74.2 73.5 74.7 76.1 78.8 79.3 80.4 83.9 85.3 86.9Female 69.0 71.3 74.0 73.9 79.2 81.7 82.1 84.1 85.9 86.7 87.6




All 70.3 73.4 73.8 74.6 77.3 79.9 80.3 81.8 84.7 85.9 87.2


452

Reference section F


Table F.16 (continued)Three-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.16 (continued)Three-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<1 85.7 90.9 66.7 83.3 75.0 62.5 87.5 75.0 80.0 100.01-4 86.9 96.3 88.3 92.0 100.0 91.0 84.6 100.0 93.2 95.75-9 97.9 97.7 93.2 98.1 95.9 96.8 98.3 96.7 89.9 95.010-14 95.2 100.0 95.9 97.2 94.2 95.7 99.0 98.9 97.4 95.315-19 95.7 92.8 92.4 93.2 97.3 97.7 97.8 98.4 97.0 97.020-29 94.8 94.9 94.4 96.8 95.8 96.4 96.2 97.5 96.6 96.930-39 93.8 92.7 94.2 93.4 94.9 94.0 93.9 94.8 94.0 93.840-49 90.5 90.0 90.3 89.9 90.4 91.0 92.0 92.4 92.3 92.950-59 86.3 84.5 86.0 86.0 86.3 87.4 86.0 88.5 87.7 86.560-64 82.5 82.9 79.7 83.7 82.9 84.8 84.1 81.9 83.4 82.065-69 76.6 78.3 78.6 78.0 76.0 78.0 76.7 80.4 78.3 80.170-79 77.5 80.7 70.5 73.4 75.6 80.4 71.0 75.2 78.5 76.980+ 100.0 66.7 100.0 50.0 100.0 100.0 100.0 50.0 60.0 83.3

Male 89.3 89.3 89.0 88.9 89.5 90.4 89.4 90.3 89.9 89.3Female 91.5 89.3 90.1 90.8 90.7 90.0 90.2 91.1 90.1 89.9




First transplant 90.2 89.0 89.3 89.2 89.9 89.9 89.5 90.3 89.8 89.4Subsequent txs 90.1 91.6 90.7 93.0 90.4 92.4 91.5 93.0 91.8 90.1

All 90.2 89.3 89.4 89.7 90.0 90.2 89.7 90.6 90.0 89.5

ADJUSTED0-19 95.5 95.6 93.0 94.9 96.5 96.1 97.1 98.0 96.0 96.620-44 93.2 92.3 93.5 93.5 94.1 94.2 94.3 94.9 94.3 94.245-64 86.4 85.7 85.9 86.7 87.0 87.8 87.5 88.5 88.2 87.765-74 75.9 78.1 76.3 76.6 76.5 78.4 75.4 79.6 78.4 79.975+ 85.8 78.9 73.2 69.7 61.3 86.6 69.8 68.5 78.5 75.1

Male 88.2 88.4 88.5 88.7 89.5 90.6 90.0 91.1 90.8 90.6Female 90.0 87.9 89.2 90.1 90.1 90.0 90.2 91.3 90.4 90.7




All 88.9 88.2 88.8 89.2 89.8 90.4 90.1 91.2 90.7 90.6

453




Table F.17Five-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.17Five-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 33.3 71.4 88.9 83.9 77.1 83.9 83.1 83.5 45.8 90.9 83.31-4 100.0 77.9 100.0 85.1 84.7 87.9 88.1 93.7 100.0 92.7 71.25-9 85.8 83.7 97.8 92.8 97.1 94.7 84.8 94.6 94.5 95.3 90.210-14 92.2 91.8 88.5 95.2 94.3 90.6 85.1 90.6 94.9 90.1 96.315-19 94.2 90.2 93.3 87.9 94.0 91.0 92.4 94.8 91.9 91.1 92.420-29 85.3 84.9 84.9 87.5 85.1 88.2 87.2 91.1 91.9 92.3 92.430-39 72.9 76.5 76.7 76.4 78.2 82.1 83.3 82.7 86.6 87.6 89.440-49 65.1 69.5 70.9 70.0 72.8 74.8 72.2 75.2 81.6 82.7 82.150-59 58.6 60.0 55.0 60.1 67.5 64.1 63.6 68.4 72.2 74.9 77.060-64 43.4 46.7 56.6 50.7 53.3 52.0 63.7 62.6 67.8 68.6 74.365-69 54.6 20.7 20.0 52.6 48.7 40.8 45.9 52.5 59.5 65.4 66.370-79 . 100.0 . 100.0 . 40.0 47.0 72.2 59.1 53.0 58.680+ . . . . . 50.0 . . . . .

Male 73.4 74.8 73.8 75.1 75.1 76.1 75.1 76.4 80.0 81.6 82.6Female 73.8 76.1 77.2 76.4 79.3 81.0 80.1 82.4 83.6 85.2 85.2





All 73.5 75.2 75.1 75.6 76.6 77.8 76.9 78.7 81.4 83.0 83.6

ADJUSTED0-19 91.5 88.9 93.2 90.3 93.8 91.7 89.6 93.5 93.0 92.4 91.820-44 74.7 76.8 77.5 77.6 78.0 82.3 83.0 83.0 86.1 87.9 88.545-64 54.3 58.9 57.9 60.1 66.0 64.5 63.7 68.4 73.3 75.0 76.965-74 40.8 30.1 18.1 55.2 38.4 38.1 44.2 54.0 58.1 63.0 63.375+ . . . . . 73.8 . 100.0 48.3 24.9 43.4

Male 63.9 65.8 65.1 66.6 68.0 69.8 70.1 72.1 77.3 78.7 80.6Female 60.9 64.0 67.2 66.9 71.7 74.4 74.2 77.9 79.8 82.2 82.2




All 63.1 65.5 66.0 66.9 69.4 71.6 71.6 74.3 78.3 80.0 81.3



454

Reference section F


Table F.17 (continued)Five-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.17 (continued)Five-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<1 85.7 90.9 66.7 83.3 75.0 62.5 87.5 62.51-4 86.9 92.3 84.1 92.0 100.0 91.0 84.6 100.05-9 95.7 97.7 91.0 98.1 95.9 94.9 96.5 94.810-14 95.2 98.2 92.7 97.2 93.0 92.9 99.0 97.515-19 93.9 91.9 90.7 91.4 95.9 95.7 96.6 96.420-29 92.8 92.7 92.3 94.9 93.7 94.5 94.1 95.930-39 90.0 88.8 90.5 89.7 92.1 90.7 91.2 92.640-49 84.1 83.9 86.0 84.6 85.2 85.9 87.2 88.950-59 77.6 75.1 76.8 78.8 79.4 79.8 79.1 81.860-64 70.1 74.4 69.4 71.6 71.7 76.6 74.7 70.465-69 65.3 62.4 63.3 63.2 67.2 67.7 67.2 70.770-79 58.7 65.0 56.7 57.8 54.0 59.9 58.1 64.780+ 50.0 66.7 100.0 50.0 100.0 100.0 50.0 50.0

Male 82.6 82.7 82.6 82.6 83.9 84.5 84.1 85.0Female 86.1 83.6 84.8 85.8 85.5 84.6 84.8 86.4




First transplant 83.8 82.5 83.1 83.3 84.4 84.3 84.1 85.2Subsequent txs 85.3 87.2 87.4 88.0 85.7 86.5 86.8 88.6

All 84.0 83.1 83.5 83.8 84.5 84.5 84.4 85.6

ADJUSTED0-19 94.5 94.5 91.0 94.2 95.6 94.4 96.4 96.220-44 89.3 88.5 90.1 90.0 91.3 91.2 91.3 92.745-64 77.3 76.7 77.9 79.3 79.6 80.5 80.7 81.865-74 62.8 62.1 61.3 61.8 65.0 66.0 65.2 69.875+ 72.3 64.2 59.4 57.7 39.1 63.5 58.3 62.0

Male 81.0 81.5 82.1 82.4 84.1 84.9 85.0 86.2Female 83.9 81.6 83.5 84.7 84.7 84.7 85.0 86.7




All 82.1 81.5 82.7 83.3 84.4 84.8 85.0 86.5


455




Table F.18Ten-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.18Ten-year survival with functioning graft probabilities: all transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<1 33.3 71.4 88.9 83.9 77.1 83.9 83.1 69.6 45.8 80.8 83.3 85.7 90.9 50.01-4 100.0 77.9 100.0 85.1 84.7 82.0 88.1 93.7 100.0 92.7 68.0 86.9 88.1 84.15-9 85.8 83.7 97.8 77.3 97.1 91.8 84.8 91.2 89.3 88.5 90.2 92.1 94.5 85.810-14 88.0 87.6 82.0 92.5 90.3 88.3 85.1 82.2 94.9 82.4 91.1 91.9 95.4 90.915-19 86.7 90.2 92.0 86.0 91.9 84.1 89.2 88.5 89.8 87.1 91.6 92.6 87.5 85.020-29 77.4 78.2 76.4 82.0 78.3 81.2 79.8 84.9 86.3 84.8 84.3 85.4 85.3 85.830-39 59.5 61.2 64.4 62.7 64.8 68.3 68.6 69.7 72.8 76.6 77.3 78.0 76.8 80.840-49 43.6 51.0 52.5 55.1 55.0 56.8 56.0 59.9 64.1 65.4 66.0 66.5 67.9 69.950-59 40.4 40.1 36.1 39.0 41.6 34.7 39.9 44.5 49.5 52.5 53.1 53.9 50.6 55.360-64 34.7 17.5 40.1 22.6 20.3 26.5 35.5 34.8 38.6 40.1 44.0 40.9 39.1 43.665-69 13.6 . 20.0 15.0 16.2 13.1 21.9 24.9 26.8 32.5 31.2 33.7 29.4 31.770-79 . . . . . 20.0 . 46.3 36.0 17.7 28.3 14.3 28.7 17.080+ . . . . . 50.0 . . . . . 50.0 33.3 100.0

Male 57.6 60.2 59.3 60.5 58.8 58.4 58.2 59.9 62.4 64.4 64.2 64.2 63.0 65.8Female 62.8 63.9 66.5 66.1 65.4 66.8 66.5 68.2 68.0 70.0 70.1 70.3 67.9 69.6




First transplant 60.3 61.9 61.6 63.5 62.1 62.0 60.7 62.3 64.2 66.2 65.4 66.0 63.9 66.6Subsequent txs 49.5 57.9 65.7 55.7 55.3 57.4 64.8 68.5 66.8 70.2 74.0 70.7 72.3 73.8

All 59.4 61.5 61.9 62.6 61.3 61.4 61.2 63.0 64.5 66.6 66.5 66.5 64.9 67.3

ADJUSTED0-19 85.7 87.9 90.9 86.8 91.7 87.4 88.0 87.3 91.1 87.6 90.0 92.6 91.1 86.820-44 60.5 63.2 65.4 65.4 65.7 69.3 70.1 71.2 73.9 76.2 76.2 77.2 76.4 79.845-64 35.9 38.7 37.4 40.3 40.4 38.1 41.3 45.5 48.9 51.8 53.4 53.1 51.6 56.365-74 9.8 . 17.9 15.0 12.6 11.2 17.8 27.8 27.9 29.3 29.4 29.9 28.5 27.775+ . . . . . 87.3 . . 27.5 . 14.9 26.2 29.9 39.3

Male 46.3 49.1 48.6 49.6 50.0 49.9 51.8 54.3 58.6 60.3 61.6 61.7 61.2 65.0Female 47.6 49.5 54.1 54.7 55.4 57.6 58.7 61.9 62.4 65.4 65.6 66.8 64.6 67.6



First transplant 48.2 50.3 50.6 52.8 53.3 53.7 54.5 57.3 60.7 62.8 63.1 64.2 62.6 66.1Subsequent txs 35.5 44.0 53.6 43.1 43.3 45.5 54.5 57.5 56.2 59.4 65.0 61.2 63.3 67.3

All 47.0 49.6 50.7 51.7 52.1 52.7 54.4 57.2 60.1 62.3 63.2 63.8 62.6 66.1



456

Reference section F


Table F.1990-day survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.1990-day survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 100.0 100.0 100.0 100.0 93.3 100.0 100.0 100.0 85.4 100.0 100.01-4 100.0 100.0 93.8 100.0 95.8 100.0 100.0 100.0 100.0 100.0 89.65-9 100.0 100.0 96.6 96.4 100.0 100.0 100.0 100.0 97.3 98.2 91.110-14 100.0 100.0 100.0 98.5 98.9 98.8 97.4 100.0 100.0 99.0 90.415-19 96.9 99.1 100.0 99.3 99.2 99.3 99.4 100.0 100.0 100.0 94.020-29 99.3 98.3 99.1 97.7 98.2 98.2 99.3 99.4 99.4 98.3 99.230-39 97.4 97.0 98.2 97.5 99.0 98.6 99.5 98.3 98.5 99.4 98.540-49 98.6 96.9 95.5 97.8 97.5 97.8 98.2 98.5 98.9 99.4 97.250-59 95.2 93.1 98.6 95.8 95.6 95.4 97.9 98.2 96.8 98.4 97.060-64 . 100.0 92.9 92.3 97.1 100.0 93.7 98.8 89.7 91.1 97.465-69 100.0 100.0 . 100.0 100.0 100.0 97.1 97.1 100.0 85.7 90.970-79 . . . 100.0 100.0 100.0 87.5 100.0 . . 100.080+ 100.0 . . . . . 100.0 . . . .

Male 98.2 98.0 98.2 97.4 98.8 98.4 98.5 98.9 98.7 98.6 97.4Female 98.6 96.7 97.9 97.9 96.8 97.6 99.0 98.6 98.4 98.9 97.0





All 98.4 97.4 98.1 97.6 98.1 98.1 98.7 98.8 98.6 98.8 97.2

ADJUSTED0-19 97.9 99.2 98.8 98.3 98.2 99.0 98.7 100.0 98.2 99.2 89.820-44 98.3 97.2 98.1 97.7 98.7 98.6 99.3 98.8 98.9 98.9 98.845-64 97.0 95.4 97.3 96.1 96.2 96.5 97.4 98.3 97.3 98.1 96.565-74 100.0 100.0 . 100.0 100.0 100.0 94.6 97.3 100.0 85.8 91.375+ 100.0 . . . . 100.0 100.0 100.0 . . 100.0

Male 97.2 96.8 97.4 96.4 98.6 98.1 98.3 98.7 98.2 98.1 96.7Female 97.6 95.4 96.9 97.1 95.9 97.0 98.8 98.4 97.8 98.6 96.3




All 97.3 96.2 97.3 96.7 97.5 97.7 98.5 98.6 98.0 98.3 96.5

457




Table F.19 (continued)90-day survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.19 (continued)90-day survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<1 95.8 82.6 100.0 87.5 93.3 100.0 100.0 100.0 100.0 95.0 100.0 97.51-4 95.1 97.1 97.9 100.0 97.1 100.0 100.0 100.0 100.0 100.0 98.3 100.05-9 98.7 100.0 100.0 100.0 96.2 98.6 100.0 98.5 100.0 100.0 98.6 100.010-14 97.9 98.1 100.0 100.0 100.0 99.1 100.0 99.2 97.6 100.0 100.0 100.015-19 98.7 98.4 100.0 100.0 99.5 99.5 100.0 98.8 100.0 99.5 100.0 100.020-29 99.8 99.4 98.8 99.8 99.3 100.0 99.7 100.0 99.9 99.9 99.5 99.730-39 99.0 99.4 98.3 98.9 99.5 99.3 99.2 99.0 99.5 99.7 99.4 99.340-49 99.1 99.4 99.6 99.7 99.0 98.8 98.9 99.4 99.1 99.0 99.5 99.650-59 98.4 98.0 98.1 98.5 97.4 97.0 98.0 98.9 98.3 98.5 98.5 98.860-64 95.1 97.5 100.0 95.0 96.7 99.4 98.2 97.6 97.3 98.7 97.9 98.165-69 88.9 93.6 97.5 100.0 93.6 95.9 96.4 98.6 98.1 96.1 98.4 97.970-79 100.0 100.0 100.0 100.0 100.0 95.8 97.0 89.4 96.6 96.1 95.8 97.780+ . 100.0 100.0 . . . . . 100.0 100.0 100.0 100.0

Male 98.7 98.8 99.0 99.0 98.4 98.6 99.1 98.9 98.9 98.9 99.0 98.9Female 98.9 98.8 98.9 99.4 98.9 99.1 98.7 99.1 99.0 99.1 99.1 99.4





All 98.8 98.8 98.9 99.2 98.6 98.8 98.9 99.0 99.0 99.0 99.0 99.1

ADJUSTED0-19 97.1 96.7 99.7 99.3 97.8 99.1 100.0 98.7 99.1 99.3 99.4 99.720-44 99.3 99.4 98.8 99.4 99.3 99.4 99.5 99.3 99.5 99.5 99.4 99.445-64 98.5 98.4 98.8 98.6 98.1 98.1 98.2 99.1 98.5 98.9 98.8 99.065-74 90.6 93.5 98.1 100.0 95.3 96.0 96.5 96.7 97.8 96.5 98.2 98.175+ . . . . 100.0 100.0 100.0 87.9 100.0 91.0 90.3 95.3

Male 98.4 98.6 98.8 98.9 98.3 98.6 99.1 99.0 99.1 99.1 99.2 99.1Female 98.7 98.6 98.7 99.4 98.9 99.1 98.7 99.2 99.1 99.2 99.2 99.6




All 98.5 98.6 98.8 99.1 98.6 98.8 99.0 99.1 99.1 99.2 99.2 99.3


458

Reference section F


Table F.20One-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.20One-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 100.0 100.0 100.0 80.0 93.3 100.0 83.9 92.3 80.4 92.0 93.31-4 100.0 100.0 93.8 94.1 91.5 100.0 92.2 100.0 100.0 100.0 78.45-9 95.5 100.0 93.0 88.6 97.7 97.6 100.0 100.0 97.3 98.2 91.110-14 97.8 97.3 100.0 98.5 97.8 96.2 97.4 100.0 96.7 97.9 89.015-19 95.4 97.1 99.1 95.6 99.2 99.3 98.8 98.1 98.6 99.2 93.320-29 97.9 96.9 95.9 96.8 97.0 96.8 98.2 97.6 98.7 97.2 98.830-39 95.1 94.4 94.7 95.9 98.0 97.0 97.6 96.4 97.2 98.3 97.540-49 92.7 91.6 92.6 93.9 94.8 95.5 96.6 96.1 96.3 97.7 96.450-59 90.0 89.3 94.3 92.7 93.1 94.3 96.1 95.8 93.5 95.6 95.060-64 . 100.0 78.6 92.3 97.1 100.0 93.7 96.4 89.7 88.8 92.165-69 100.0 100.0 . 100.0 100.0 100.0 91.1 97.1 77.8 85.7 86.470-79 . . . 100.0 100.0 100.0 87.5 100.0 . . 100.080+ . . . . . . 100.0 . . . .

Male 94.9 95.3 95.0 95.0 97.5 97.0 96.7 96.8 97.1 97.0 96.2Female 96.4 94.2 94.9 95.9 95.1 95.9 97.6 96.8 96.5 97.8 95.8





All 95.5 94.9 95.0 95.4 96.6 96.6 97.1 96.8 96.8 97.3 96.0

ADJUSTED0-19 94.7 96.7 97.4 93.2 96.7 97.5 96.5 98.3 95.6 97.4 87.320-44 95.8 94.7 94.7 96.0 97.4 96.9 98.0 96.8 98.0 97.7 98.045-64 90.6 89.9 92.9 92.8 93.1 95.2 95.6 96.2 93.5 96.1 94.965-74 100.0 100.0 0.0 100.0 100.0 100.0 89.2 97.3 78.7 85.8 87.075+ . . . . . 100.0 100.0 100.0 . . 100.0

Male 92.1 92.8 93.2 93.0 96.6 96.5 96.2 96.3 96.1 96.0 95.2Female 94.2 91.5 92.5 94.4 93.5 95.0 97.2 96.3 95.3 97.2 94.8




All 92.9 92.2 93.0 93.6 95.4 95.9 96.6 96.3 95.7 96.5 95.0

Probabilities are adjusted for age, gender, race, primary diagnosis,first vs. subgsequent transplant, & standardized to 1996 patient characteristics.Adjusted survival probabilities for one of the five variables are adjusted for the remaining four.Patients with unknown age or gender are excluded.Age is calculated as of the day of transplant.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. "." Zero values in this cell.

459




Table F.20 (continued)One-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.20 (continued)One-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<1 95.8 82.6 100.0 80.8 93.3 95.8 100.0 100.0 100.0 95.0 97.2 97.51-4 95.1 97.1 97.9 100.0 97.1 100.0 98.1 100.0 100.0 100.0 98.3 97.85-9 98.7 100.0 98.4 98.2 94.9 98.6 100.0 98.5 100.0 100.0 98.6 100.010-14 96.8 96.2 98.1 99.0 98.2 98.3 99.0 99.2 97.6 100.0 100.0 100.015-19 98.7 96.8 99.4 98.3 98.9 99.5 99.5 98.8 100.0 99.5 99.1 99.620-29 99.4 99.0 98.3 99.5 99.1 99.7 98.7 99.7 99.1 99.4 99.1 99.430-39 98.5 98.6 97.1 98.1 98.8 98.4 98.3 98.7 98.6 98.5 98.4 98.740-49 97.5 98.2 98.0 98.0 98.2 98.3 97.4 98.1 98.0 98.0 98.0 98.650-59 96.2 96.0 95.2 96.2 94.6 96.1 95.6 97.6 96.9 96.1 96.7 96.860-64 86.7 93.7 96.0 90.9 93.9 94.4 95.5 94.3 94.6 97.6 95.3 96.665-69 88.9 82.7 90.0 100.0 88.3 93.8 92.0 95.7 96.1 94.4 95.2 95.670-79 100.0 100.0 90.0 100.0 95.8 95.8 97.0 80.7 91.5 94.1 93.3 94.880+ . 100.0 100.0 . . . . . 100.0 100.0 75.0 100.0

Male 97.5 97.5 97.4 97.2 96.9 98.0 97.9 97.8 97.6 97.5 97.3 97.8Female 98.2 97.5 97.3 98.7 98.0 97.8 96.8 98.2 98.3 98.0 97.9 98.1





All 97.8 97.5 97.4 97.8 97.4 97.9 97.4 98.0 97.9 97.7 97.6 97.9

ADJUSTED0-19 96.7 95.1 98.2 97.0 96.5 98.4 99.0 98.7 99.1 99.3 98.6 99.220-44 98.7 98.7 98.0 98.5 98.7 98.9 98.3 98.8 98.5 98.5 98.3 98.845-64 96.0 96.4 96.1 96.5 95.9 96.8 96.1 97.5 97.2 97.2 97.2 97.565-74 90.6 82.5 90.2 100.0 90.6 94.3 92.9 92.3 95.2 94.7 95.3 95.875+ . . . . 100.0 100.0 100.0 87.9 100.0 91.0 85.9 90.9

Male 96.9 97.0 97.0 96.9 96.8 98.0 97.9 98.0 97.9 97.9 97.8 98.3Female 97.8 97.2 97.0 98.6 98.0 97.9 96.8 98.3 98.3 98.3 98.2 98.5




All 97.3 97.0 97.0 97.6 97.3 97.9 97.4 98.1 98.1 98.1 98.0 98.4



460

Reference section F


Table F.21Two-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Other race 85.2 92.3 85.1 94.6 97.3 91.4 93.1 96.6 92.1 100.0 97.7

†Non-Hispanic

Other cause 93.6 92.1 92.9 92.9 96.0 96.6 97.2 96.0 95.8 96.4 94.3

Subsequent txs 95.8 92.3 95.9 95.0 94.1 95.4 97.3 93.2 96.2 94.5 94.9

All 94.2 93.5 93.1 93.5 95.4 95.2 96.1 95.3 95.6 96.3 95.0

75+ . . . . . 100.0 100.0 100.0 . . 100.0

Female 91.1 89.6 91.1 92.3 91.6 93.8 95.9 94.5 93.9 95.8 93.6

Other race 82.0 89.6 78.5 92.2 95.8 89.1 90.9 95.7 88.9 100.0 97.2

Other cause 90.6 88.5 91.0 90.4 94.8 96.1 96.8 95.6 93.8 94.7 92.6

Subsequent txs 93.5 87.3 93.8 92.8 91.7 93.6 96.3 90.8 94.3 91.9 93.1

All 90.9 90.2 90.5 91.1 93.8 94.4 95.4 94.7 94.1 95.1 93.7

Table F.21Two-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 100.0 100.0 83.3 80.0 93.3 100.0 83.9 92.3 75.4 92.0 93.31-4 100.0 100.0 93.8 86.9 91.5 100.0 92.2 100.0 95.2 100.0 78.45-9 95.5 100.0 93.0 83.6 97.7 97.6 97.4 100.0 94.4 98.2 91.110-14 92.8 97.3 97.6 96.9 96.6 96.2 96.1 98.7 95.5 97.9 89.015-19 93.5 97.1 99.1 94.8 99.2 98.5 98.1 97.5 97.9 98.4 92.620-29 97.1 95.8 94.7 96.3 96.2 96.6 97.1 96.3 97.8 96.0 98.430-39 94.7 91.7 92.7 93.2 96.9 95.4 96.8 95.5 96.5 97.0 96.340-49 89.6 91.6 90.4 91.1 92.8 93.8 95.9 93.4 95.6 96.3 94.950-59 90.0 86.6 90.6 90.8 90.5 91.4 94.7 94.2 90.8 93.8 93.460-64 . 100.0 71.4 92.3 97.1 100.0 92.4 95.1 82.5 88.8 89.565-69 100.0 100.0 . 100.0 100.0 90.9 91.1 93.9 77.8 85.7 86.470-79 . . . 100.0 100.0 100.0 87.5 100.0 . . 80.080+ . . . . . . 100.0 . . . .

Male 94.0 93.9 92.6 92.9 96.4 95.4 95.8 95.4 95.7 95.9 95.2Female 94.5 92.9 93.8 94.4 93.7 95.0 96.5 95.2 95.4 96.7 94.8

White 94.3 93.6 93.4 93.8 95.8 95.3 96.0 95.2 95.8 96.2 94.8Black 96.3 92.9 92.7 91.1 92.1 95.5 97.5 95.8 95.5 95.0 95.7

†Hispanic



ADJUSTED0-19 91.1 96.7 96.0 90.8 96.2 96.9 95.1 97.4 93.2 97.0 86.820-44 95.1 92.8 92.7 94.2 96.3 95.8 97.1 95.7 97.4 96.5 97.345-64 86.1 88.5 90.4 90.5 91.0 93.2 94.5 93.8 90.8 94.7 92.665-74 100.0 100.0 . 100.0 100.0 93.4 89.1 94.5 78.6 85.7 82.7

Male 90.8 90.6 90.1 90.3 95.2 94.8 95.1 94.7 94.3 94.6 93.9

White 90.9 90.2 91.1 91.4 94.4 94.4 95.4 94.4 94.4 95.0 93.6Black 94.3 90.6 89.6 89.1 89.9 95.7 97.0 95.4 93.9 93.6 93.9




461




Table F.21 (continued)Two-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.21 (continued)Two-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<1 95.8 82.6 100.0 80.8 93.3 91.7 96.3 93.8 94.1 95.0 94.41-4 95.1 97.1 97.9 100.0 97.1 92.9 96.1 100.0 100.0 100.0 98.35-9 98.7 100.0 94.9 98.2 94.9 98.6 98.3 98.5 98.5 98.3 98.610-14 96.8 96.2 98.1 99.0 98.2 98.3 99.0 99.2 97.6 100.0 98.415-19 98.7 94.2 98.7 98.3 97.8 98.9 98.4 98.2 99.0 99.0 99.120-29 98.6 98.6 97.9 99.1 98.3 99.3 98.5 98.9 98.8 98.3 98.130-39 96.1 98.1 95.8 97.5 97.8 97.1 97.5 97.7 97.7 97.3 98.040-49 95.2 97.0 97.8 95.9 96.8 96.5 96.4 96.9 96.9 96.4 96.950-59 95.0 94.9 93.5 93.9 91.8 94.2 94.0 95.6 95.8 93.8 94.560-64 81.5 92.4 92.9 88.7 89.0 92.7 93.7 93.1 92.9 95.2 92.265-69 83.3 82.7 87.4 97.7 81.7 90.6 89.3 92.8 93.5 88.8 93.570-79 100.0 66.7 90.0 75.0 95.8 91.7 97.0 80.7 86.3 92.1 84.980+ . 100.0 100.0 . . . . . 100.0 66.7 75.0

Male 96.0 96.7 96.4 96.0 95.3 96.6 96.8 96.6 96.3 95.5 96.0Female 96.4 96.7 96.5 97.5 96.5 96.5 95.8 97.0 97.4 96.5 96.2





All 96.2 96.7 96.4 96.6 95.8 96.5 96.4 96.8 96.8 95.9 96.1

ADJUSTED0-19 96.7 93.8 97.1 97.0 95.8 96.8 97.4 97.7 97.6 98.7 97.720-44 97.1 98.1 97.3 97.9 97.9 97.7 97.8 97.8 97.6 97.3 97.745-64 93.8 95.2 94.7 94.1 93.0 95.2 94.7 96.0 96.1 95.1 95.265-74 85.9 80.4 88.2 92.7 85.8 90.9 90.8 90.1 92.2 90.5 92.375+ . . . . 100.0 100.0 100.0 88.4 100.0 71.4 72.9

Male 95.1 96.0 95.9 95.7 95.1 96.6 96.9 96.9 96.8 96.3 96.8Female 95.7 96.3 96.0 97.2 96.4 96.5 95.9 97.1 97.6 96.9 96.8




All 95.3 96.1 95.9 96.3 95.6 96.5 96.5 97.0 97.1 96.5 96.8



462

Reference section F


Table F.22Three-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Other race 80.2 92.3 85.1 94.6 95.9 90.0 93.1 95.8 92.1 98.5 97.7

†Non-Hispanic

Other cause 91.8 88.7 90.9 91.0 95.0 95.9 96.4 95.1 94.9 95.2 93.4

Subsequent txs 93.5 92.3 95.9 92.9 91.8 95.4 96.9 92.2 93.8 92.6 92.2

All 92.1 90.6 90.9 91.4 93.6 93.7 95.2 94.3 94.4 94.8 93.8

75+ . . . . . 100.0 100.0 . . . 100.0

Female 88.6 87.0 88.3 89.1 88.8 92.7 95.0 93.5 92.9 93.7 92.5

Other race 76.6 89.5 78.7 92.2 93.8 87.7 90.5 94.6 88.8 98.3 97.3

Other cause 88.1 83.9 88.6 88.1 93.5 95.3 96.0 94.6 92.6 93.1 91.4

Subsequent txs 90.0 87.0 93.8 89.9 88.5 93.5 95.7 89.5 90.8 89.1 89.5

All 87.6 86.1 87.7 88.4 91.5 92.7 94.4 93.5 92.6 93.2 92.2

Table F.22Three-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 100.0 100.0 83.3 80.0 93.3 100.0 75.5 92.3 75.4 87.8 93.31-4 100.0 100.0 93.8 79.6 91.5 100.0 92.2 100.0 95.2 100.0 78.45-9 95.5 94.1 93.0 83.6 97.7 97.6 97.4 100.0 91.1 98.2 91.110-14 92.8 97.3 94.8 96.9 95.3 96.2 96.1 98.7 95.5 97.9 89.015-19 93.5 96.0 99.1 94.0 98.2 97.7 98.1 96.8 96.3 98.4 91.820-29 96.3 93.9 93.4 93.9 95.7 95.7 96.5 95.8 97.0 95.6 97.130-39 91.8 89.2 90.1 90.9 95.2 94.0 95.7 94.9 95.6 96.2 94.940-49 87.2 85.8 88.1 89.4 89.3 91.0 95.2 92.6 94.8 93.9 93.550-59 79.1 81.1 85.2 87.6 87.9 89.2 93.7 92.3 86.8 89.1 91.860-64 . 100.0 71.4 92.3 93.8 100.0 88.5 89.8 82.5 81.9 89.565-69 . 100.0 . 100.0 100.0 90.9 91.1 90.7 77.8 85.7 81.870-79 . . . 100.0 100.0 100.0 87.5 85.7 . . 80.080+ . . . . . . 100.0 . . . .

Male 91.5 90.4 90.4 91.0 94.9 93.4 94.8 94.3 94.3 94.5 93.7Female 92.9 91.0 91.9 92.0 91.6 94.1 95.8 94.3 94.6 95.1 94.0

White 91.9 90.7 91.3 91.4 94.3 93.9 95.2 94.1 94.8 94.8 93.4Black 96.3 89.7 89.7 90.6 88.4 93.5 96.3 94.9 92.7 92.8 95.2

†Hispanic



ADJUSTED0-19 91.1 94.7 95.3 89.6 95.1 96.4 94.6 96.9 91.7 96.5 86.420-44 93.4 90.2 90.8 92.0 95.1 94.8 96.2 95.0 96.5 95.6 95.945-64 78.2 81.0 86.1 87.7 86.8 90.3 93.2 92.0 88.7 90.6 91.565-74 . 100.0 . 100.0 100.0 93.5 89.1 91.6 78.7 85.7 78.5

Male 87.0 85.5 87.2 87.9 93.2 92.6 94.0 93.4 92.4 92.8 92.0

White 87.3 85.9 88.3 88.1 92.4 92.7 94.4 93.2 93.1 93.2 91.9Black 94.2 86.6 85.6 88.4 85.2 93.5 95.6 94.4 90.3 90.9 93.1




463




Table F.22 (continued)Three-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.22 (continued)Three-year survival with functioning graft probabilities: all transplants, livby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<1 95.8 82.6 100.0 80.8 93.3 91.7 96.3 93.8 94.1 90.01-4 95.1 94.1 95.6 100.0 97.1 92.9 96.1 100.0 100.0 100.05-9 98.7 100.0 94.9 98.2 94.9 97.0 98.3 98.5 98.5 96.510-14 95.6 96.2 98.1 99.0 98.2 98.3 99.0 99.2 97.6 100.015-19 98.0 94.2 98.7 97.1 97.8 98.4 96.8 98.2 98.5 99.020-29 97.2 98.0 97.2 98.4 97.3 98.8 98.0 98.6 97.8 98.330-39 94.7 97.2 94.9 96.2 97.4 96.5 96.8 96.2 97.1 96.440-49 93.8 95.3 95.8 94.7 95.5 95.1 94.9 95.8 95.5 94.850-59 91.9 93.1 89.9 90.7 89.5 92.0 91.7 94.0 94.3 91.660-64 79.8 91.1 85.7 81.3 85.4 88.6 90.9 90.6 85.1 92.765-69 83.3 78.3 79.7 90.9 75.1 86.2 87.4 87.6 88.9 86.270-79 100.0 66.7 90.0 66.7 95.8 91.7 84.3 78.4 86.3 83.780+ . 100.0 100.0 . . . . . 100.0 66.7

Male 94.4 95.4 94.4 94.6 94.0 95.3 95.3 95.0 94.7 93.8Female 95.2 95.8 95.2 95.4 95.3 95.2 94.5 96.0 95.8 95.1





All 94.7 95.6 94.7 95.0 94.6 95.2 95.0 95.5 95.2 94.4

ADJUSTED0-19 96.0 93.3 96.8 96.2 95.8 96.2 96.3 97.7 97.3 98.020-44 95.8 97.4 96.3 97.0 97.3 96.9 97.0 96.8 96.8 96.445-64 91.4 93.2 91.4 91.1 90.8 93.2 92.5 94.4 93.5 93.165-74 85.9 75.9 82.2 85.4 81.0 87.4 87.1 85.7 89.1 86.375+ . . . . 100.0 100.0 31.3 82.4 100.0 65.5

Male 93.1 94.5 93.7 94.1 93.8 95.3 95.4 95.4 95.4 94.9Female 94.3 95.2 94.6 95.0 95.1 95.3 94.6 96.2 96.0 95.7




All 93.6 94.8 94.1 94.5 94.3 95.3 95.1 95.8 95.6 95.2

Probabilities are adjusted for age, gender, race, primary diagnosis,first vs. subgsequent transplant, & standardized to 1996 patient characteristics.Adjusted survival probabilities for one of the five variables are adjusted for the remaining four.Patients with unknown age or gender are excluded.Age is calculated as of the day of transplant.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore bee"." Zero values in this cell.


464

Reference section F


Table F.23Five-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Other race 80.2 89.4 82.8 91.0 94.4 85.9 91.2 92.2 83.7 96.9 96.5

†Non-Hispanic

Other cause 89.2 84.9 86.5 88.5 93.3 93.0 93.3 92.1 92.3 93.4 91.2

Subsequent txs 88.8 89.3 91.0 90.6 91.0 94.8 94.0 90.2 87.7 89.6 88.4

All 89.6 86.4 86.7 87.7 90.3 90.0 91.8 91.3 90.7 92.1 90.6

75+ . . . . . 100.0 100.0 . . . .

Female 84.8 83.1 82.6 85.2 84.8 89.0 91.4 90.8 87.2 90.7 88.1

Other race 76.6 85.5 75.9 86.9 91.7 83.1 88.1 90.2 78.1 96.5 95.8

Other cause 84.5 78.7 83.5 84.9 91.3 92.0 92.6 91.4 88.8 90.5 88.6

Subsequent txs 83.5 82.0 86.9 87.0 87.5 92.7 91.9 87.0 82.4 84.9 84.9

All 83.9 80.3 82.3 83.6 87.2 88.5 90.5 90.1 87.7 89.9 88.3

Table F.23Five-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<1 66.7 66.7 83.3 80.0 93.3 100.0 67.1 83.1 75.4 87.8 93.31-4 100.0 100.0 80.4 79.6 91.5 100.0 92.2 90.9 90.2 100.0 78.45-9 95.5 94.1 93.0 83.6 97.7 97.6 94.4 100.0 87.6 98.2 87.210-14 92.8 92.9 94.8 95.1 95.3 96.2 94.3 98.7 95.5 95.6 87.315-19 93.5 94.8 99.1 93.1 94.1 93.1 96.4 96.8 96.3 97.4 91.820-29 93.7 91.8 89.9 91.1 94.0 93.4 93.6 93.7 96.0 94.8 96.030-39 90.3 82.7 86.0 87.9 91.2 91.0 92.7 91.7 90.1 93.9 91.940-49 81.9 81.2 82.5 83.8 85.2 86.3 90.8 90.3 89.6 90.0 90.450-59 76.2 75.5 76.5 80.5 83.0 83.7 89.3 87.5 79.8 84.3 83.360-64 . 66.7 64.3 69.2 83.8 94.6 85.9 83.1 63.3 64.4 70.765-69 . 100.0 . 100.0 100.0 72.7 85.0 81.0 77.8 85.7 77.070-79 . . . 100.0 . 100.0 75.0 85.7 . . 60.080+ . . . . . . 100.0 . . . .

Male 89.1 85.2 86.2 86.8 91.4 89.4 91.2 90.8 91.0 91.7 90.7Female 90.4 88.0 87.5 89.0 88.5 91.0 92.6 91.9 90.1 92.8 90.4

White 89.1 86.3 87.0 87.6 91.1 90.3 91.5 91.2 91.5 92.7 90.0Black 96.3 86.2 85.2 87.1 83.1 89.5 93.7 91.3 86.4 86.2 92.7

†Hispanic



ADJUSTED0-19 89.7 91.5 94.4 88.2 92.7 93.2 91.8 94.9 90.6 95.1 85.020-44 90.5 85.5 86.9 88.8 92.2 91.9 93.3 92.4 93.2 93.7 93.745-64 74.6 74.9 78.0 79.3 80.9 85.0 88.6 88.1 80.9 84.7 84.465-74 . 100.0 . 100.0 84.8 80.8 80.8 83.2 79.2 85.5 74.2

Male 83.3 78.4 82.1 82.5 88.6 88.3 89.9 89.7 88.2 89.2 88.5

White 83.1 79.8 82.9 83.2 88.3 88.6 90.2 90.0 88.9 90.5 87.8Black 94.1 82.3 79.9 84.3 78.5 89.3 92.6 90.6 82.0 82.7 89.6



Probabilities are adjusted for age, gender, race, primary diagnosis,

465




Table F.23 (continued)Five-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.23 (continued)Five-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<1 95.8 82.6 100.0 80.8 89.9 91.7 96.3 93.81-4 95.1 94.1 93.3 100.0 97.1 92.9 92.1 100.05-9 98.7 100.0 94.9 98.2 93.4 97.0 98.3 96.910-14 95.6 95.1 97.0 97.8 98.2 97.3 96.7 99.215-19 98.0 93.3 97.1 97.1 97.8 97.2 93.7 97.520-29 95.9 97.0 96.0 97.3 94.9 97.4 96.5 96.930-39 91.7 94.9 92.3 93.1 95.2 94.1 94.2 94.440-49 88.4 90.3 91.4 91.2 92.1 91.7 91.3 92.950-59 84.3 88.0 82.9 85.8 84.5 85.7 86.0 86.860-64 74.5 82.0 77.4 68.5 78.9 81.6 81.7 81.065-69 83.3 69.3 68.7 79.6 65.6 82.9 78.0 74.670-79 75.0 33.3 80.0 58.3 87.1 75.0 74.6 68.980+ . 100.0 100.0 . . . . .

Male 91.4 92.4 90.7 91.1 90.9 92.5 91.0 91.0Female 91.8 92.4 92.1 92.7 92.2 91.1 91.2 92.2





All 91.6 92.4 91.3 91.8 91.4 91.9 91.1 91.5

ADJUSTED0-19 96.0 92.4 95.1 95.8 95.1 95.2 93.0 97.020-44 93.3 95.1 93.9 94.3 95.0 94.4 94.3 94.645-64 85.0 87.6 85.4 86.5 86.0 88.5 87.2 88.765-74 81.4 65.2 72.3 75.1 72.7 82.7 78.4 74.275+ . . . . 100.0 13.9 0.0 82.7

Male 89.5 91.0 89.6 90.4 90.6 92.6 91.3 91.9Female 90.4 91.5 91.2 92.1 92.0 91.4 91.3 92.6




All 89.8 91.2 90.2 91.1 91.1 92.1 91.3 92.1

Probabilities are adjusted for age, gender, race, primary diagnosis,


466

Reference section F


Table F.24Ten-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Other race 74.9 78.7 77.7 82.6 86.6 75.4 83.0 83.6 76.0 89.8 86.9 87.1 88.1 82.4

†Non-Hispanic

Other cause 79.4 77.5 77.4 81.0 86.0 83.5 82.2 82.7 86.3 85.9 85.8 90.6 86.4 85.9

Subsequent txs 83.7 89.3 83.9 77.5 82.6 82.6 80.8 73.3 77.2 76.8 82.6 80.8 81.3 81.0

All 79.5 78.5 74.9 77.4 80.2 78.0 78.2 78.3 80.8 82.4 82.0 82.4 80.8 80.6

81.8 91.8 88.6 91.588.3 85.5 86.4 87.062.0 69.5 66.5 66.161.2 62.2 54.2 36.2

75+ . . . . . . 2.0 . . . 59.7 . . .

78.1 79.2 78.7 77.5Female 69.3 74.5 69.9 73.6 74.7 78.3 78.9 79.0 76.7 81.3 78.8 79.9 79.0 80.6

78.5 80.0 78.5 79.375.9 74.3 77.6 74.9

Other race 71.4 73.4 70.9 75.5 81.7 71.8 78.3 80.2 69.6 87.8 84.1 84.8 85.3 78.4

65.9 62.2 64.3 64.779.3 80.5 79.8 79.882.8 85.0 83.6 84.3

Other cause 71.8 69.4 73.5 76.1 82.7 81.8 81.0 81.6 80.8 80.4 82.0 86.8 83.4 82.6

78.4 79.8 78.9 78.8Subsequent txs 76.9 82.1 77.7 73.0 77.3 77.5 75.8 68.0 69.2 68.0 78.8 74.7 76.5 78.7

All 70.4 70.6 69.1 71.8 75.4 76.0 76.3 76.7 75.9 78.3 78.3 79.4 78.7 78.7

Table F.24Ten-year survival with functioning graft probabilities: all transplants, living donorsby age, gender, race/ethnicity, primary diagnosis, & transplant number

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<1 66.7 33.3 83.3 80.0 81.7 100.0 67.1 83.1 75.4 87.8 86.2 95.8 82.6 100.01-4 100.0 100.0 80.4 69.7 91.5 100.0 92.2 87.3 90.2 96.4 78.4 88.9 87.6 90.75-9 88.1 94.1 75.5 83.6 97.7 97.6 90.5 93.3 83.0 98.2 84.7 98.7 93.6 90.810-14 82.6 88.0 91.7 88.1 90.0 96.2 85.6 94.8 95.5 89.8 85.4 91.1 95.1 93.015-19 88.7 88.1 96.4 88.2 93.0 91.0 91.6 91.0 94.2 93.7 90.4 95.3 91.8 96.220-29 91.4 88.0 83.1 84.7 88.1 87.0 88.1 87.4 93.1 90.8 91.7 92.6 89.9 92.030-39 77.2 76.3 73.6 78.2 82.2 80.4 81.8 81.8 77.3 86.7 87.1 81.6 87.0 84.740-49 65.7 66.4 67.6 68.8 67.8 71.6 74.8 73.0 71.3 73.3 77.8 77.2 77.2 77.150-59 43.1 57.8 52.9 65.5 67.9 62.0 65.0 67.7 65.1 65.0 59.3 63.6 63.8 62.060-64 . 66.7 50.0 46.2 62.4 70.7 61.8 56.6 46.9 32.9 37.9 56.1 45.9 53.665-69 . 100.0 . 75.0 80.0 49.9 53.8 55.5 33.3 42.9 61.6 71.4 54.9 28.670-79 . . . . . 33.3 25.0 53.6 . . 60.0 25.0 33.3 35.080+ . . . . . . 100.0 . . . . . 100.0 100.0

Male 79.8 76.8 73.9 76.2 80.3 75.9 76.5 76.7 80.5 80.7 81.7 82.3 81.0 79.3Female 79.0 81.0 76.6 79.3 80.1 81.4 80.7 80.9 81.3 85.0 82.4 82.5 80.5 82.4

White 79.3 78.6 74.9 78.2 81.1 78.3 78.2 78.5 81.5 83.1 81.7 82.9 81.0 81.2Black 81.5 77.2 74.2 70.6 71.1 76.4 75.7 74.6 77.8 74.1 81.6 76.5 77.2 75.4

†Hispanic

Diabetes 61.8 56.9 52.1 55.5 59.8 57.5 61.2 63.0 64.0 70.5 69.4 63.3 64.2 64.8Hypertension 77.0 84.9 72.1 77.9 82.0 76.9 75.3 78.4 71.2 76.1 78.9 79.9 78.0 77.4Glomerulonephritis 87.3 86.7 84.9 84.6 83.9 86.5 86.3 83.1 88.6 87.9 87.2 87.9 85.9 86.4


ADJUSTED0-19 79.7 82.7 87.9 80.5 88.7 91.5 84.8 87.4 88.1 90.120-44 81.6 78.7 76.7 79.7 82.9 82.8 83.6 83.1 83.8 86.745-64 49.0 58.1 56.9 62.5 64.4 65.0 66.3 67.0 65.1 64.065-74 . 100.0 . 60.0 73.0 54.6 49.0 55.4 31.3 41.5

Male 71.2 67.9 68.4 70.6 75.7 74.7 74.6 75.1 75.4 76.2

White 70.1 70.2 69.1 72.2 76.7 76.1 76.4 76.9 76.7 79.0Black 73.8 72.8 67.7 67.8 65.1 76.1 74.5 73.6 72.2 68.8

Diabetes 55.8 53.0 47.7 49.8 54.8 56.1 58.3 61.5 59.2 67.6Hypertension 73.3 83.4 69.8 80.5 82.6 79.4 77.8 79.8 71.3 76.2Glomerulonephritis 81.0 81.2 80.0 80.3 80.4 84.2 85.3 81.4 85.4 84.6

First transplant 70.2 70.3 68.8 71.9 75.3 76.0 76.3 77.4 76.5 78.9

467


TRANSPLANTATION: OUTCOMESFTable F.25Risk factors for graft failure: deceased donor transplants, 1998-2003 (n=42,979)

All-cause graft failurePercent of patients Haz. ratio 95% CI P-value

Transplant era (reference: 1998-2000, 48.5% of patients)2001-2003 51.5 0.97 (0.92-1.02) 0.2269

Recipient age (years) (reference: 18-34, 13.7% of patients)0-17 3.7 1.27 (1.11-1.46) 0.000635-49 30.8 0.87 (0.81-0.94) 0.000150-64 39.7 1.05 (0.98-1.13) 0.134165+ 12.1 1.42 (1.31-1.55) <.0001

Recipient gender (reference: female, 39.7% of patients)Male 60.3 0.99 (0.95-1.03) 0.5380

Recipient race (reference: white, 62.9% of patients)Black 30.4 1.15 (1.09-1.21) <.0001Asian 5.3 0.72 (0.64-0.81) <.0001Other/Unknown 1.8 0.88 (0.74-1.04) 0.1385

Recipient ethnicity (reference: non-Hispanic, 87.1% of patients)Hispanic 12.9 0.75 (0.70-0.80) <.0001

Primary cause of ESRD (reference: glomerulonephritis, 24.4% of patients)Diabetes 24.6 1.25 (1.17-1.32) <.0001Hypertension 20.9 1.15 (1.08-1.23) <.0001

Cystic kidney disease 9.3 0.73 (0.66-0.80) <.0001

Other 20.8 1.07 (1.00-1.14) 0.0391

Pre-transplant hepatitis B & C serology (reference: negative/unknown)

Hep. B Core Ab+ 8.5 0.96 (0.89-1.03) 0.2661

Hep. B Surface Ag+ 1.8 1.01 (0.87-1.17) 0.8937

Hep. C Ab+ 6.1 1.37 (1.26-1.48) <.0001

Education level (reference: <college, 63.8% of patients)

College+ 13.5 0.95 (0.89-1.02) 0.1627

Unknown 22.7 1.06 (1.01-1.11) 0.0284

Employment status (reference: unable to work, 34.9% of patients)Able to work 49.3 0.84 (0.80-0.88) <.0001

Unknown 15.7 0.98 (0.92-1.04) 0.5264Primary payor (reference: non-Medicare, 43.7% of patients)

Medicare 56.3 1.10 (1.05-1.15) <.0001Prior dialysis time (years) (reference: <1, 11.6% of patients)

None (preemptive) 5.4 0.92 (0.81-1.04) 0.19101-<2 19.6 1.14 (1.06-1.24) 0.00102-<3 18.4 1.22 (1.12-1.32) <.00013+ 43.9 1.24 (1.15-1.34) <.0001Unknown 1.3 1.28 (1.05-1.56) 0.0128

Donor age (years) (reference: 18-34, 25.7% of patients)0-17 14.7 1.03 (0.95-1.12) 0.450735-49 26.0 1.18 (1.11-1.26) <.000150-64 20.5 1.43 (1.32-1.55) <.000165+ 3.8 1.78 (1.57-2.01) <.0001Unknown 9.4 1.44 (1.14-1.82) 0.0020

Donor gender (reference: female, 46.9% of patients)Male 53.1 0.92 (0.88-0.97) 0.0007

Donor race (reference: white, 76.6% of patients)Black 9.8 1.13 (1.05-1.20) 0.0005Asian 1.5 0.94 (0.79-1.12) 0.4935Other/Unknown 12.1 1.05 (0.94-1.19) 0.3946

Donor cause of death (reference: non-trauma, 53.9% of patients)Trauma 46.2 0.95 (0.90-1.00) 0.0316

Table F.25Risk factors for graft failure: deceased donor transplants, 1998-2003 (n=42,979)


468

Reference section F

Table F.25 (continued)Risk factors for graft failure: deceased donor transplants, 1998-2003 (n=42,979)

All-cause graft failurePercent of patients Haz. ratio 95% CI P-value

HLA mismatches (reference: 3, 18.1% of patients)0 12.4 0.85 (0.78-0.92) <.00011 3.4 0.99 (0.88-1.12) 0.89832 8.3 0.98 (0.90-1.07) 0.61484 22.4 1.03 (0.97-1.10) 0.31285 20.7 1.18 (1.10-1.25) <.00016 11.1 1.24 (1.15-1.34) <.0001Unknown 3.6 1.02 (0.91-1.14) 0.7437

Cold ischemia time (hours) (reference: 0-12, 19.8% of patients)13-24 46.7 1.05 (0.99-1.11) 0.125625-36 17.5 1.13 (1.06-1.21) 0.000337+ 2.7 1.19 (1.06-1.34) 0.0045Unknown 13.4 1.04 (0.97-1.12) 0.2827

Donor documented history of:Diabetes 3.7 1.11 (1.01-1.23) 0.0342Hypertension 18.2 1.18 (1.11-1.25) <.0001

Expanded Criteria Donor (reference: non-ECD, 85.1% of patients)ECD 14.9 1.11 (1.02-1.22) 0.0190

Body surface area matching (reference: R D, 76.0% of patients)

R 1.6-2.2 m2, D<1.6m2 9.9 1.10 (1.02-1.19) 0.0135

R>2.2m2, D<1.6m2 1.4 1.23 (1.05-1.44) 0.0121

Unknown 12.7 0.90 (0.75-1.08) 0.2419

Recipient body mass index (BMI) (reference: 18.5-24.9 kg/m2, 36.3% of patients)

<18.5 kg/m2 4.5 1.04 (0.93-1.16) 0.4975

25.0-29.9 kg/m2 32.3 1.03 (0.98-1.09) 0.2121

30.0-34.9 kg/m2 17.1 1.12 (1.05-1.19) 0.0002

�35.0 kg/m2 7.5 1.25 (1.15-1.35) <.0001

Unknown 2.4 1.11 (0.90-1.38) 0.3169PRA (reference: 50%, 96.2% of patients)

>50% 3.8 1.26 (1.13-1.39) <.0001CMV serology (reference: donor-/recipient-, 18.4% of patients)

Donor-/Recipient+ 25.9 0.99 (0.93-1.06) 0.7562Donor+/Recipient+ 34.9 1.07 (1.00-1.14) 0.0538Donor+/Recipient- 20.9 1.12 (1.05-1.20) 0.0011

Baseline Immunosuppressive Regimen (reference: Tacrolimus & MMF, 34.9% of patients)Cyclosporine Microemulsion & MMF 29.4 1.11 (1.05-1.18) 0.0004MMF 5.1 1.47 (1.32-1.62) <.0001None listed 4.7 4.30 (4.00-4.63) <.0001Tacrolimus & Rapamycin 3.7 1.38 (1.22-1.56) <.0001Other 22.2 1.44 (1.36-1.53) <.0001


469


TRANSPLANTATION: OUTCOMESFTable F.25 (continued)Risk factors for graft failure: deceased donor transplants, 1998-2003 (n=42,979)

Return to dialysis / preemptive retransplant Death with functionHaz. ratio 95% CI P-value Haz. ratio 95% CI P-value

Transplant era (reference: 1998-2000, 48.5% of patients)2001-2003 0.97 (0.90-1.03) 0.3258 0.98 (0.91-1.05) 0.5480

Recipient age (years) (reference: 18-34, 13.7% of patients)0-17 1.37 (1.18-1.60) <.0001 1.06 (0.75-1.51) 0.727235-49 0.70 (0.65-0.76) <.0001 1.90 (1.62-2.24) <.000150-64 0.57 (0.53-0.63) <.0001 3.72 (3.18-4.35) <.000165+ 0.58 (0.52-0.65) <.0001 6.21 (5.26-7.33) <.0001

Recipient gender (reference: female, 39.7% of patients)Male 0.93 (0.88-0.98) 0.0127 1.06 (0.99-1.13) 0.0947

Recipient race (reference: white, 62.9% of patients)Black 1.41 (1.32-1.51) <.0001 0.86 (0.79-0.93) 0.0001Asian 0.77 (0.67-0.90) 0.0009 0.66 (0.56-0.78) <.0001Other/Unknown 0.95 (0.75-1.21) 0.6853 0.81 (0.63-1.03) 0.0813

Recipient ethnicity (reference: non-Hispanic, 87.1% of patients)Hispanic 0.83 (0.76-0.92) 0.0002 0.65 (0.58-0.72) <.0001

Primary cause of ESRD (reference: glomerulonephritis, 24.4% of patients)Diabetes 0.85 (0.78-0.93) 0.0002 2.01 (1.83-2.21) <.0001Hypertension 1.00 (0.93-1.09) 0.9291 1.49 (1.34-1.65) <.0001

Cystic kidney disease 0.69 (0.61-0.78) <.0001 0.86 (0.74-0.99) 0.0399

Other 0.92 (0.85-1.00) 0.0520 1.44 (1.29-1.60) <.0001

Pre-transplant hepatitis B & C serology (reference: negative/unknown)

Hep. B Core Ab+ 0.92 (0.83-1.02) 0.1104 1.01 (0.90-1.13) 0.8537

Hep. B Surface Ag+ 1.07 (0.88-1.30) 0.5133 0.95 (0.75-1.20) 0.6608

Hep. C Ab+ 1.34 (1.21-1.49) <.0001 1.41 (1.25-1.59) <.0001

Education level (reference: <college, 63.8% of patients)

College+ 0.96 (0.88-1.05) 0.4016 0.94 (0.85-1.03) 0.1745

Unknown 1.11 (1.04-1.19) 0.0025 0.99 (0.92-1.07) 0.8580

Employment status (reference: unable to work, 34.9% of patients)Able to work 0.90 (0.85-0.96) 0.0015 0.76 (0.71-0.82) <.0001

Unknown 0.93 (0.85-1.01) 0.0765 1.05 (0.96-1.15) 0.2963Primary payor (reference: non-Medicare, 43.7% of patients)

Medicare 1.21 (1.14-1.29) <.0001 0.97 (0.90-1.04) 0.3402Prior dialysis time (years) (reference: <1, 11.6% of patients)

None (preemptive) 0.83 (0.70-0.99) 0.0428 1.05 (0.87-1.25) 0.62921-<2 1.13 (1.02-1.26) 0.0234 1.16 (1.03-1.32) 0.01492-<3 1.12 (1.01-1.25) 0.0394 1.35 (1.20-1.53) <.00013+ 1.08 (0.97-1.20) 0.1509 1.49 (1.33-1.68) <.0001Unknown 0.76 (0.55-1.05) 0.0961 1.98 (1.54-2.54) <.0001

Donor age (years) (reference: 18-34, 25.7% of patients)0-17 1.11 (1.00-1.23) 0.0508 0.93 (0.83-1.05) 0.268535-49 1.21 (1.10-1.32) <.0001 1.16 (1.05-1.27) 0.002950-64 1.48 (1.32-1.65) <.0001 1.37 (1.22-1.54) <.000165+ 1.98 (1.68-2.35) <.0001 1.62 (1.34-1.95) <.0001Unknown 1.38 (1.02-1.86) 0.0379 1.56 (1.09-2.24) 0.0160

Donor gender (reference: female, 46.9% of patients)Male 0.90 (0.85-0.96) 0.0009 0.95 (0.89-1.02) 0.1489

Donor race (reference: white, 76.6% of patients)Black 1.23 (1.13-1.34) <.0001 0.99 (0.88-1.10) 0.8002Asian 0.88 (0.69-1.13) 0.3156 1.03 (0.80-1.33) 0.8229Other/Unknown 1.06 (0.90-1.24) 0.5099 1.07 (0.89-1.28) 0.4855

Donor cause of death (reference: non-trauma, 53.9% of patients)Trauma 0.92 (0.86-0.99) 0.0239 0.97 (0.90-1.05) 0.4641



470

Reference section F



HLA mismatches (reference: 3, 18.1% of patients)0 0.80 (0.71-0.90) 0.0002 0.89 (0.79-1.00) 0.04891 0.89 (0.75-1.06) 0.1845 1.10 (0.93-1.29) 0.26862 1.06 (0.95-1.19) 0.3173 0.89 (0.78-1.01) 0.06584 1.05 (0.97-1.15) 0.2330 1.02 (0.92-1.12) 0.76165 1.23 (1.13-1.34) <.0001 1.11 (1.01-1.23) 0.03196 1.32 (1.19-1.46) <.0001 1.15 (1.03-1.29) 0.0176Unknown 0.98 (0.85-1.14) 0.8307 1.05 (0.90-1.24) 0.5265

Cold ischemia time (hours) (reference: 0-12, 19.8% of patients)13-24 1.07 (0.99-1.16) 0.0869 1.02 (0.94-1.11) 0.667925-36 1.18 (1.07-1.29) 0.0005 1.08 (0.98-1.20) 0.120737+ 1.37 (1.18-1.60) <.0001 0.98 (0.81-1.19) 0.8336Unknown 1.03 (0.93-1.14) 0.5811 1.06 (0.95-1.18) 0.3257

Donor documented history of:Diabetes 1.18 (1.04-1.35) 0.0110 1.04 (0.90-1.22) 0.5917Hypertension 1.26 (1.17-1.37) <.0001 1.08 (0.98-1.18) 0.1136

Expanded Criteria Donor (reference: non-ECD, 85.1% of patients)ECD 1.27 (1.12-1.43) 0.0001 0.96 (0.84-1.10) 0.5544


R 1.6-2.2 m2, D<1.6m2 1.14 (1.03-1.26) 0.0108 1.05 (0.94-1.18) 0.4064

R>2.2m2, D<1.6m2 1.22 (0.98-1.51) 0.0721 1.21 (0.95-1.53) 0.1257

Unknown 0.98 (0.78-1.23) 0.8492 0.77 (0.58-1.03) 0.0810


<18.5 kg/m2 0.98 (0.86-1.13) 0.7910 1.16 (0.97-1.40) 0.1001

25.0-29.9 kg/m2 1.06 (0.99-1.14) 0.0979 0.99 (0.92-1.07) 0.8270

30.0-34.9 kg/m2 1.20 (1.11-1.30) <.0001 1.02 (0.93-1.12) 0.6666

�35.0 kg/m2 1.25 (1.12-1.39) <.0001 1.23 (1.09-1.39) 0.0007

Unknown 1.00 (0.76-1.31) 0.9764 1.33 (0.96-1.84) 0.0911PRA (reference: 50%, 96.2% of patients)

>50% 1.29 (1.12-1.48) 0.0004 1.22 (1.04-1.43) 0.0158CMV serology (reference: donor-/recipient-, 18.4% of patients)

Donor-/Recipient+ 0.99 (0.91-1.09) 0.8832 0.98 (0.89-1.08) 0.7037Donor+/Recipient+ 1.08 (0.99-1.18) 0.0899 1.05 (0.95-1.16) 0.3473Donor+/Recipient- 1.09 (0.99-1.19) 0.0768 1.16 (1.05-1.29) 0.0048

Baseline Immunosuppressive Regimen (reference: Tacrolimus & MMF, 34.9% of patients)Cyclosporine Microemulsion & MMF 1.09 (1.01-1.18) 0.0274 1.13 (1.04-1.23) 0.0047MMF 1.67 (1.46-1.91) <.0001 1.23 (1.05-1.45) 0.0095None listed 5.09 (4.64-5.59) <.0001 3.38 (3.01-3.80) <.0001Tacrolimus & Rapamycin 1.43 (1.21-1.68) <.0001 1.33 (1.11-1.61) 0.0027Other 1.49 (1.38-1.62) <.0001 1.38 (1.27-1.51) <.0001


471


TRANSPLANTATION: OUTCOMESFTable F.26Risk factors for graft failure: living donor transplants, 1998-2003 (n=30,068)

All-cause graft failurePercent of patiHaz. ratio 95% CI P-value

Transplant era (reference: 1998-2000, 44.3% of patients)2001-2002 55.8 0.93 (0.86-1.02) 0.1350

Donor relationship (reference: related, 63.3% of patients)Distant/unrelated 32.8 1.05 (0.95-1.15) 0.3493Unknown 3.9 1.12 (0.72-1.76) 0.6108

Recipient age (years) (reference: 18-34, 23.1% of patients)0-17 7.6 1.02 (0.87-1.20) 0.823835-49 32.3 0.76 (0.69-0.84) <.0001

50-64 30.0 0.92 (0.84-1.02) 0.1155

65+ 7.0 1.27 (1.10-1.46) 0.0012

Recipient gender (reference: female, 41.5% of patients)

Male 58.5 0.89 (0.83-0.95) 0.0011

Recipient race (reference: white, 78.9% of patients)

Black 15.3 1.18 (0.98-1.42) 0.0833

Asian 3.8 0.80 (0.61-1.06) 0.1183

Other/Unknown 2.0 0.87 (0.65-1.16) 0.3405

Recipient ethnicity (reference: non-Hispanic, 87.3% of patients)

Hispanic 12.7 0.81 (0.72-0.91) 0.0002

Primary cause of ESRD (reference: glomerulonephritis, 27.1% of patients)Diabetes 22.0 1.22 (1.11-1.34) <.0001Hypertension 13.6 1.00 (0.89-1.11) 0.9361Cystic kidney disease 9.3 0.69 (0.58-0.80) <.0001Other 28.1 0.91 (0.82-1.00) 0.0464

Pre-transplant hepatitis B & C serology (reference: negative/unknown)Hep. B Core Ab+ 6.1 0.89 (0.77-1.03) 0.1200Hep. B Surface Ag+ 1.5 1.14 (0.87-1.50) 0.3552Hep. C Ab+ 2.8 1.52 (1.28-1.80) <.0001

Education level (reference: <college, 60.9% of patients)College+ 18.6 0.78 (0.70-0.86) <.0001Unknown 20.6 1.00 (0.91-1.09) 0.9281

Employment status (reference: unable to work, 24.9% of patients)Able to work 59.4 0.81 (0.75-0.88) <.0001Unknown 15.7 0.87 (0.78-0.98) 0.0154

Primary payor (reference: non-Medicare, 71.0% of patients)Medicare 29.0 1.13 (1.05-1.23) 0.0019

Prior dialysis time (years) (reference: <1, 35.6% of patients)None (preemptive) 22.5 0.78 (0.70-0.87) <.00011-<2 21.1 1.14 (1.04-1.25) 0.00382-<3 8.9 1.28 (1.14-1.44) <.00013+ 9.8 1.31 (1.16-1.47) <.0001Unknown 2.2 0.82 (0.62-1.07) 0.1380

Donor age (years) (reference: <35, 32.0% of patients)35-49 45.6 1.17 (1.08-1.27) 0.000250-64 17.8 1.25 (1.13-1.39) <.000165+ 1.0 1.84 (1.40-2.42) <.0001Unknown 3.7 0.86 (0.52-1.43) 0.5707

Donor gender (reference: female, 59.9% of patients)Male 40.1 0.96 (0.89-1.03) 0.2035

Donor race (reference: white, 76.9% of patients)Black 13.2 1.05 (0.87-1.28) 0.6102Asian 2.3 0.66 (0.44-0.98) 0.0379Other/Unknown 7.6 1.17 (0.97-1.40) 0.1036

Table F.26Risk factors for graft failure: living donor transplants, 1998-2003 (n=30,068)


472

Reference section F

Table F.26 (continued)Risk factors for graft failure: living donor transplants, 1998-2003 (n=30,068)

All-cause graft failurePercent of paHaz. ratio 95% CI P-value

HLA mismatches (reference: 3, 29.7% of patients)0 10.6 0.58 (0.50-0.67) <.00011 6.7 0.85 (0.73-0.98) 0.03002 19.6 0.93 (0.85-1.03) 0.14524 11.7 0.98 (0.87-1.11) 0.77225 13.0 1.04 (0.92-1.17) 0.54186 6.7 1.02 (0.87-1.18) 0.8334Unknown 2.1 0.97 (0.78-1.20) 0.7687


R 1.6-2.2 m2, D<1.6m24.0 1.07 (0.88-1.30) 0.4827

R>2.2m2, D<1.6m20.4 1.26 (0.77-2.07) 0.3646

Unknown 36.5 1.07 (0.99-1.16) 0.0873


<18.5 kg/m2 6.5 0.99 (0.85-1.16) 0.9202

25.0-29.9 kg/m2 29.0 0.98 (0.90-1.07) 0.6992

30.0-34.9 kg/m2 15.1 1.17 (1.05-1.30) 0.0030

�35.0 kg/m2 6.7 1.50 (1.32-1.70) <.0001

Unknown 4.6 1.02 (0.86-1.21) 0.8078

PRA (reference: 50, 98.1% of patients)>50% 1.9 1.18 (0.93-1.49) 0.1736

CMV serology (reference: donor-/recipient-, 30.4% of patients)Donor-/Recipient+ 22.2 1.05 (0.96-1.16) 0.3014Donor+/Recipient- 30.4 1.03 (0.94-1.13) 0.5407Donor+/Recipient+ 16.9 1.12 (1.01-1.24) 0.0363

Baseline Immunosuppressive Regimen (reference: Tacrolimus & MMF, 36.2% of patients)Cyclosporine Microemulsion & MMF 29.0 0.98 (0.89-1.07) 0.5927MMF 4.6 1.69 (1.43-2.00) <.0001None listed 3.8 5.03 (4.46-5.66) <.0001Tacrolimus & Rapamycin 4.8 1.19 (0.98-1.45) 0.0788Other 21.6 1.33 (1.21-1.47) <.0001


473


TRANSPLANTATION: OUTCOMESFTable F.26 (continued)Risk factors for graft failure: living donor transplants, 1998-2003 (n=30,068)


Transplant era (reference: 1998-2000, 44.3% of patients)2001-2002 0.96 (0.85-1.07) 0.4432 0.90 (0.79-1.04) 0.1567

Donor relationship (reference: related, 63.3% of patients)Distant/unrelated 1.01 (0.90-1.14) 0.8456 1.09 (0.95-1.26) 0.2343Unknown 0.79 (0.41-1.53) 0.4901 1.63 (0.89-3.01) 0.1150

Recipient age (years) (reference: 18-34, 23.1% of patients)0-17 1.15 (0.96-1.38) 0.1252 0.67 (0.45-1.00) 0.048735-49 0.60 (0.53-0.67) <.0001 1.58 (1.29-1.93) <.0001

50-64 0.46 (0.41-0.53) <.0001 3.14 (2.59-3.80) <.0001

65+ 0.43 (0.34-0.54) <.0001 5.29 (4.21-6.64) <.0001

Recipient gender (reference: female, 41.5% of patients)

Male 0.74 (0.67-0.81) <.0001 1.17 (1.04-1.31) 0.0066

Recipient race (reference: white, 78.9% of patients)

Black 1.32 (1.05-1.67) 0.0188 0.96 (0.70-1.32) 0.7983

Asian 0.80 (0.56-1.14) 0.2184 0.81 (0.52-1.27) 0.3633

Other/Unknown 0.98 (0.68-1.40) 0.8953 0.71 (0.44-1.16) 0.1707

Recipient ethnicity (reference: non-Hispanic, 87.3% of patients)

Hispanic 0.88 (0.76-1.02) 0.0793 0.70 (0.58-0.84) 0.0001

Primary cause of ESRD (reference: glomerulonephritis, 27.1% of patients)Diabetes 0.76 (0.67-0.87) <.0001 2.34 (1.99-2.74) <.0001Hypertension 0.93 (0.81-1.07) 0.2933 1.28 (1.05-1.56) 0.0143Cystic kidney disease 0.66 (0.54-0.81) <.0001 0.84 (0.64-1.09) 0.1935Other 0.72 (0.64-0.81) <.0001 1.52 (1.28-1.81) <.0001

Pre-transplant hepatitis B & C serology (reference: negative/unknown)Hep. B Core Ab+ 0.95 (0.78-1.14) 0.5563 0.82 (0.64-1.04) 0.0981Hep. B Surface Ag+ 1.08 (0.76-1.55) 0.6649 1.26 (0.82-1.93) 0.2877Hep. C Ab+ 1.39 (1.10-1.76) 0.0060 1.72 (1.34-2.20) <.0001

Education level (reference: <college, 60.9% of patients)College+ 0.82 (0.72-0.94) 0.0051 0.70 (0.60-0.83) <.0001Unknown 1.03 (0.91-1.15) 0.6623 0.94 (0.82-1.07) 0.3565

Employment status (reference: unable to work, 24.9% of patients)Able to work 0.81 (0.73-0.90) <.0001 0.81 (0.72-0.93) 0.0016Unknown 0.83 (0.72-0.96) 0.0106 0.93 (0.79-1.10) 0.4164

Primary payor (reference: non-Medicare, 71.0% of patients)Medicare 1.19 (1.07-1.32) 0.0012 1.08 (0.95-1.22) 0.2430

Prior dialysis time (years) (reference: <1, 35.6% of patients)None (preemptive) 0.86 (0.75-0.98) 0.0216 0.69 (0.58-0.82) <.00011-<2 1.11 (0.98-1.24) 0.0939 1.17 (1.01-1.34) 0.03142-<3 1.09 (0.93-1.28) 0.3077 1.52 (1.27-1.80) <.00013+ 1.11 (0.94-1.30) 0.2118 1.62 (1.35-1.95) <.0001Unknown 0.84 (0.59-1.20) 0.3378 0.81 (0.53-1.24) 0.3343

Donor age (years) (reference: <35, 32.0% of patients)35-49 1.19 (1.08-1.33) 0.0009 1.11 (0.97-1.27) 0.115450-64 1.30 (1.14-1.49) <.0001 1.16 (0.99-1.36) 0.074365+ 2.12 (1.44-3.12) 0.0001 1.52 (1.03-2.23) 0.0344Unknown 1.11 (0.55-2.24) 0.7762 0.69 (0.33-1.43) 0.3181

Donor gender (reference: female, 59.9% of patients)Male 0.96 (0.87-1.05) 0.3605 0.96 (0.86-1.08) 0.4955

Donor race (reference: white, 76.9% of patients)Black 1.13 (0.89-1.44) 0.3226 0.93 (0.67-1.30) 0.6796Asian 0.55 (0.32-0.95) 0.0309 0.78 (0.43-1.40) 0.3988Other/Unknown 1.22 (0.97-1.54) 0.0923 1.07 (0.79-1.46) 0.6521



474

Reference section F


All-cause graft failure Death with functionHaz. ratio 95% CI P-value Haz. ratio 95% CI P-value

HLA mismatches (reference: 3, 29.7% of patients)0 0.48 (0.40-0.58) <.0001 0.76 (0.61-0.94) 0.01041 0.80 (0.66-0.98) 0.0277 0.92 (0.73-1.15) 0.44442 0.98 (0.87-1.11) 0.7786 0.86 (0.74-1.00) 0.05144 1.01 (0.86-1.19) 0.8936 0.94 (0.77-1.14) 0.50985 1.07 (0.91-1.25) 0.4032 0.99 (0.82-1.19) 0.87886 1.14 (0.94-1.39) 0.1850 0.87 (0.68-1.11) 0.2669Unknown 1.01 (0.77-1.34) 0.9328 0.88 (0.63-1.25) 0.4846


R 1.6-2.2 m2, D<1.6m2 1.13 (0.88-1.45) 0.3360 0.99 (0.74-1.34) 0.9681

R>2.2m2, D<1.6m2 1.33 (0.71-2.50) 0.3717 1.11 (0.49-2.48) 0.8084

Unknown 1.11 (1.00-1.23) 0.0553 1.03 (0.91-1.17) 0.6282


<18.5 kg/m2 0.91 (0.76-1.10) 0.3391 1.22 (0.91-1.62) 0.1806

25.0-29.9 kg/m2 1.03 (0.92-1.16) 0.5815 0.90 (0.79-1.03) 0.1311

30.0-34.9 kg/m2 1.19 (1.04-1.37) 0.0128 1.09 (0.94-1.28) 0.2582

�35.0 kg/m2 1.70 (1.45-1.99) <.0001 1.18 (0.96-1.46) 0.1197

Unknown 0.82 (0.65-1.03) 0.0870 1.30 (1.02-1.65) 0.0347

PRA (reference: 50, 98.1% of patients)>50% 1.28 (0.96-1.71) 0.0918 1.03 (0.68-1.57) 0.8851

CMV serology (reference: donor-/recipient-, 30.4% of patients)Donor-/Recipient+ 0.98 (0.86-1.12) 0.8119 1.13 (0.97-1.30) 0.1152Donor+/Recipient- 1.06 (0.94-1.20) 0.3237 0.98 (0.85-1.14) 0.8154Donor+/Recipient+ 1.08 (0.95-1.23) 0.2294 1.18 (1.00-1.39) 0.0562

Baseline Immunosuppressive Regimen (reference: Tacrolimus & MMF, 36.2% of patients)Cyclosporine Microemulsion & MMF 0.94 (0.83-1.06) 0.3189 1.01 (0.88-1.17) 0.8984MMF 1.92 (1.56-2.37) <.0001 1.39 (1.06-1.83) 0.0179None listed 6.59 (5.71-7.61) <.0001 2.89 (2.31-3.61) <.0001Tacrolimus & Rapamycin 1.10 (0.84-1.43) 0.4939 1.33 (0.99-1.79) 0.0570Other 1.29 (1.14-1.46) <.0001 1.39 (1.20-1.62) <.0001


Morbidity &hospitalization

GReferenceSec

tion

MORBIDITY & HOSPITALIZATION

476

Reference section GG

G.1 . 477 Total admission rates per 1,000 patient years: ESRD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

G.2 . 478Total admission rates per 1,000 patient years: dialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

G.3 . 479Total admission rates per 1,000 patient years: hemodialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

G.4 . 480Total admission rates per 1,000 patient years: CAPD/CCPD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

G.5. 481Total admission rates per 1,000 patient years: transplant patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

G.6 . 482Hospital days per patient year: ESRD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

G.7. 483Hospital days per patient year: dialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

G.8 . 484Hospital days per patient year: hemodialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

G.9 . 485Hospital days per patient year: CAPD/CCPD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

G.10 . 486Hospital days per patient year: transplant patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

G.11 . 487Inpatient utilization by principal diagnosis of hospitalization: ESRD patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 00 patient years

G.12 . 488Inpatient utilization by principal diagnosis of hospitalization: dialysis patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 00 patient years

G.13 . 489Inpatient utilization by principal diagnosis of hospitalization: hemodialysis patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 00 patient years

G.14 . 490Inpatient utilization by principal diagnosis of hospitalization: CAPD/CCPD patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 00 patient years

G.15 . 491Inpatient utilization by principal diagnosis of hospitalization: transplant patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 00 patient years

G.16 . 492Total hospital discharges, by general Diagnostic Related Group period prevalent patients

477


MORBIDITY & HOSPITALIZATIONGON OUR WEBSITEjkfjON OUR WEBSITE & CDTotal admission rates per 1,000 patient years: ESRD patients, by primary diagnosis, adjusted (G.1.1). Total admission rates per 1,000 patients: ESRD patients, adjusted (G.1.2). ESRD patients: counts of total admissions (G.1.3). Total admission rates per 1,000 patient years: ESRD pa-tients, adjusted (G.1.4). ESRD patients: counts of total admissions, years at risk, & patients used to compute total admissions per 1,000 patient years in G.1.4 (G.1.5).

Table G.1Total admission rates per 1,000 patient years: ESRD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Table G.1Total admission rates per 1,000 patient years: ESRD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 2,219 2,146 2,545 2,273 2,374 2,199 2,142 2,161 2,131 2,219 1,9695-9 1,557 1,831 1,575 1,734 1,794 1,750 1,946 1,531 2,179 1,428 1,60110-14 1,537 1,604 1,800 1,408 1,414 1,725 1,414 1,338 1,445 1,652 1,56815-19 1,641 1,652 1,651 1,560 1,343 1,557 1,602 1,671 1,674 1,760 1,66020-29 1,723 1,654 1,667 1,631 1,597 1,578 1,605 1,581 1,609 1,652 1,63830-39 1,732 1,780 1,764 1,761 1,705 1,715 1,749 1,738 1,752 1,783 1,72740-49 1,706 1,702 1,718 1,747 1,692 1,696 1,753 1,777 1,838 1,847 1,78950-59 1,836 1,881 1,848 1,881 1,848 1,836 1,889 1,863 1,908 1,899 1,86260-64 1,909 1,940 1,977 2,000 1,943 1,977 2,007 1,986 1,998 2,030 1,94665-69 2,052 2,049 2,040 2,052 2,033 2,054 2,083 2,042 2,063 2,063 2,01370-79 2,096 2,094 2,105 2,138 2,112 2,109 2,148 2,140 2,147 2,117 2,06180+ 2,237 2,240 2,209 2,239 2,253 2,200 2,285 2,231 2,261 2,201 2,151

Male 1,793 1,812 1,792 1,806 1,776 1,789 1,831 1,809 1,840 1,838 1,805Female 2,033 2,044 2,071 2,105 2,069 2,070 2,125 2,118 2,151 2,149 2,079


†Hispanic 1,859 1,906 1,856 1,896 1,925 1,880†Non-Hispanic 1,931 1,980 1,969 1,999 1,993 1,940

Diabetes 2,357 2,352 2,320 2,361 2,297 2,302 2,351 2,323 2,331 2,299 2,229Hypertension 1,872 1,893 1,870 1,872 1,837 1,827 1,874 1,855 1,900 1,902 1,856Glomerulonephritis 1,535 1,538 1,574 1,549 1,518 1,514 1,526 1,526 1,545 1,546 1,516Other cause 1,659 1,661 1,683 1,705 1,682 1,693 1,738 1,717 1,751 1,774 1,718

All 1,910 1,925 1,927 1,950 1,916 1,923 1,972 1,956 1,987 1,984 1,933

ADJUSTED0-19 1,850 2,068 1,841 1,687 1,569 2,083 2,162 2,512 1,957 1,410 1,51120-44 1,926 1,930 1,928 1,930 1,866 1,864 1,911 1,900 1,947 1,989 1,93145-64 1,873 1,885 1,869 1,888 1,839 1,837 1,880 1,871 1,898 1,898 1,84365-74 2,046 2,043 2,028 2,051 2,029 2,031 2,065 2,026 2,038 2,022 1,98675+ 2,205 2,206 2,196 2,226 2,199 2,172 2,221 2,209 2,222 2,183 2,114

Male 1,902 1,912 1,869 1,883 1,845 1,846 1,883 1,856 1,876 1,864 1,825Female 2,081 2,080 2,094 2,120 2,077 2,068 2,112 2,104 2,131 2,129 2,058




All 1,982 1,987 1,972 1,992 1,952 1,949 1,989 1,970 1,995 1,987 1,933

Overall rates are adjusted for age, gender, race, & primary diagnosis; rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2003 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Age is determined as of January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method uses data from the current & previous two years, cells for years prior to 1998 have been left blank.


478

Reference section GGON OUR WEBSITE & CDTotal admission rates per 1,000 patient years: dialysis patients, by primary diagnosis, adjust-ed (G.2.1). Total admission rates per 1,000 patients: dialysis patients, adjusted (G.2.2). Dialysis patients: counts of total admissions (G.2.3). Total admission rates per 1,000 patient years: di-alysis patients, adjusted (G.2.4). Dialysis patients: counts of total admissions, years at risk, & patients used to compute total admissions per 1,000 patient years in G.2.4 (G.2.5).

Table G.2Total admission rates per 1,000 patient years: dialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Table G.2Total admission rates per 1,000 patient years: dialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 3,061 3,128 3,765 2,883 2,940 3,040 3,071 2,566 2,774 2,945 2,6715-9 2,233 2,904 2,579 2,520 2,542 2,413 3,167 2,517 3,745 1,625 2,16910-14 1,959 1,942 2,570 1,707 1,755 2,120 1,891 1,683 1,871 2,109 1,84015-19 1,897 1,910 1,865 1,898 1,567 1,734 1,632 1,865 1,871 2,155 1,80320-29 1,945 1,817 1,793 1,799 1,729 1,684 1,699 1,654 1,714 1,779 1,79330-39 1,912 1,914 1,918 1,923 1,863 1,860 1,881 1,868 1,890 1,917 1,88140-49 1,814 1,801 1,837 1,872 1,788 1,794 1,860 1,882 1,944 1,956 1,92150-59 1,917 1,973 1,930 1,974 1,927 1,919 1,982 1,952 1,997 1,983 1,96260-64 1,966 1,998 2,033 2,057 2,000 2,042 2,073 2,045 2,065 2,102 2,01265-69 2,078 2,075 2,063 2,080 2,060 2,085 2,120 2,082 2,103 2,098 2,05970-79 2,102 2,101 2,112 2,148 2,120 2,117 2,157 2,149 2,158 2,129 2,07580+ 2,237 2,240 2,210 2,239 2,254 2,201 2,285 2,231 2,261 2,201 2,153

Male 1,886 1,895 1,872 1,898 1,856 1,867 1,908 1,881 1,911 1,910 1,884Female 2,113 2,120 2,148 2,182 2,141 2,139 2,197 2,190 2,225 2,218 2,156




All 1,999 2,007 2,009 2,038 1,996 2,000 2,049 2,030 2,062 2,057 2,014

ADJUSTED0-19 2,313 2,589 2,184 2,091 1,896 2,598 2,477 3,160 2,382 1,677 1,52320-44 2,113 2,088 2,104 2,124 2,032 2,020 2,064 2,048 2,103 2,137 2,09945-64 1,941 1,956 1,946 1,970 1,911 1,912 1,963 1,947 1,974 1,977 1,93465-74 2,060 2,055 2,041 2,068 2,044 2,048 2,085 2,047 2,061 2,046 2,01875+ 2,205 2,206 2,196 2,227 2,198 2,171 2,222 2,210 2,221 2,183 2,115

Male 1,955 1,959 1,920 1,944 1,895 1,898 1,937 1,906 1,927 1,918 1,887Female 2,136 2,134 2,155 2,181 2,130 2,120 2,168 2,161 2,194 2,188 2,127




All 2,036 2,037 2,027 2,052 2,004 2,001 2,045 2,023 2,051 2,043 1,998


479


MORBIDITY & HOSPITALIZATIONGON OUR WEBSITE & CDTotal admission rates per 1,000 patient years: hemodialysis patients, by primary diagnosis, adjusted (G.3.1). Total admission rates per 1,000 patients: hemodialysis patients, adjusted (G.3.2). Hemodialysis patients: counts of total admissions (G.3.3). Total admission rates per 1,000 patient years: hemodi-alysis patients, adjusted (G.3.4). Hemodialysis patients: counts of total admissions, years at risk, & patients used to compute total admissions per 1,000 patient years in G.3.4 (G.3.5).

Table G.3Total admission rates per 1,000 patient years: hemodialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Table G.3Total admission rates per 1,000 patient years: hemodialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 1,885 3,015 4,537 3,444 3,809 * 4,340 2,908 * 4,636 3,0655-9 3,163 2,676 3,833 2,660 3,238 2,877 3,055 2,280 6,916 2,238 2,27110-14 2,156 1,976 2,754 2,173 1,992 2,436 1,991 2,034 1,999 2,461 2,15115-19 1,990 1,800 1,938 2,007 1,608 1,616 1,542 1,958 1,876 2,157 1,80220-29 1,949 1,801 1,745 1,778 1,725 1,659 1,678 1,635 1,722 1,779 1,81930-39 1,885 1,914 1,885 1,896 1,845 1,831 1,889 1,844 1,896 1,909 1,88940-49 1,776 1,773 1,808 1,853 1,788 1,804 1,864 1,891 1,947 1,963 1,92150-59 1,890 1,958 1,890 1,938 1,910 1,895 1,974 1,947 1,994 1,982 1,96660-64 1,956 1,993 2,011 2,032 1,982 2,019 2,061 2,028 2,069 2,105 2,02365-69 2,078 2,077 2,046 2,070 2,044 2,079 2,122 2,092 2,101 2,099 2,06270-79 2,111 2,105 2,112 2,141 2,113 2,109 2,158 2,148 2,161 2,140 2,08980+ 2,238 2,246 2,206 2,247 2,262 2,208 2,293 2,230 2,266 2,207 2,160

Male 1,876 1,887 1,846 1,880 1,845 1,853 1,902 1,878 1,912 1,911 1,888Female 2,111 2,124 2,143 2,179 2,147 2,144 2,212 2,199 2,239 2,233 2,175




All 1,994 2,006 1,994 2,028 1,993 1,995 2,053 2,032 2,069 2,064 2,024

ADJUSTED0-19 2,672 2,490 2,252 2,299 1,980 2,810 2,017 4,580 2,540 1,663 1,52820-44 2,107 2,103 2,105 2,126 2,034 2,017 2,072 2,044 2,116 2,144 2,11745-64 1,921 1,940 1,913 1,941 1,900 1,900 1,960 1,942 1,975 1,980 1,94065-74 2,064 2,055 2,029 2,057 2,030 2,038 2,084 2,051 2,061 2,051 2,02675+ 2,200 2,209 2,189 2,220 2,196 2,165 2,223 2,204 2,221 2,185 2,122

Male 1,944 1,951 1,896 1,924 1,882 1,882 1,929 1,902 1,926 1,919 1,889Female 2,130 2,131 2,146 2,172 2,127 2,115 2,174 2,163 2,202 2,199 2,141




All 2,027 2,031 2,009 2,036 1,994 1,990 2,042 2,021 2,053 2,048 2,005

Overall rates are adjusted for age, gender, race, & primary diagnosis;rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2003 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Age is determined as of January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method uses data from the current & previous two years, cells for years prior to 1998 have been left blank. * Values for cells with 10 or fewer patients are suppressed.


480

Reference section GGON OUR WEBSITE & CDTotal admission rates per 1,000 patient years: CAPD/CCPD patients, by primary diagnosis, adjust-ed (G.4.1). Total admission rates per 1,000 patients: CAPD/CCPD patients, adjusted (G.4.2). CAPD/CCPD patients: counts of total admissions (G.4.3). Total admission rates per 1,000 patient years: CAPD/CCPD patients, adjusted (G.4.4). CAPD/CCPD patients: counts of total admissions, years at risk, & patients used to compute total admissions per 1,000 patient years in G.4.4 (G.4.5).

Table G.4Total admission rates per 1,000 patient years: CAPD/CCPD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Table G.4Total admission rates per 1,000 patient years: CAPD/CCPD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 3,224 2,971 3,497 2,699 2,684 2,744 2,688 2,334 2,762 2,641 2,6045-9 1,515 3,095 2,068 2,266 2,174 2,015 3,275 2,639 1,687 1,287 2,13810-14 1,879 1,739 2,398 1,342 1,541 1,895 1,794 1,236 1,772 1,722 1,61415-19 1,721 2,091 1,714 1,726 1,491 1,959 1,895 1,628 1,792 1,995 1,81420-29 1,918 1,820 1,957 1,839 1,729 1,767 1,797 1,712 1,669 1,770 1,64030-39 1,999 1,896 2,010 2,018 1,923 1,996 1,837 1,983 1,848 1,948 1,80840-49 1,941 1,908 1,949 1,952 1,771 1,726 1,829 1,798 1,907 1,886 1,89750-59 2,047 2,044 2,133 2,163 2,024 2,087 2,040 1,992 2,011 1,972 1,91360-64 1,996 2,023 2,167 2,209 2,120 2,240 2,193 2,232 1,995 2,063 1,85865-69 2,049 2,035 2,168 2,141 2,166 2,132 2,095 1,947 2,116 2,100 2,00470-79 2,012 2,043 2,095 2,204 2,176 2,205 2,136 2,129 2,099 1,940 1,85480+ 2,210 2,126 2,242 2,127 2,111 2,050 2,114 2,238 2,148 2,068 1,999

Male 1,918 1,919 2,010 1,997 1,923 1,971 1,958 1,886 1,892 1,881 1,823Female 2,098 2,068 2,155 2,191 2,086 2,095 2,055 2,086 2,078 2,048 1,942




All 2,006 1,992 2,081 2,092 2,003 2,032 2,007 1,987 1,985 1,964 1,883

ADJUSTED0-19 1,402 3,381 2,079 1,640 1,254 2,050 3,017 2,260 2,129 2,008 1,93120-44 2,162 2,051 2,149 2,154 2,054 2,060 2,042 2,066 2,061 2,141 2,01745-64 2,050 2,054 2,128 2,155 2,002 2,047 2,043 2,032 2,012 2,015 1,91965-74 2,079 2,091 2,192 2,248 2,240 2,212 2,146 2,046 2,119 2,060 1,95775+ 2,357 2,200 2,327 2,397 2,258 2,381 2,292 2,398 2,322 2,342 2,070

Male 2,040 2,014 2,079 2,091 1,997 2,059 2,037 1,962 1,966 1,983 1,893Female 2,213 2,176 2,267 2,339 2,226 2,232 2,180 2,234 2,237 2,187 2,036




All 2,120 2,088 2,172 2,213 2,109 2,143 2,108 2,095 2,099 2,083 1,961


481


MORBIDITY & HOSPITALIZATIONGON OUR WEBSITE & CDTotal admission rates per 1,000 patient years: transplant patients, by primary diagnosis, adjusted (G.5.1). Total admission rates per 1,000 patients: transplant patients, adjusted (G.5.2). Transplant patients: counts of total admissions (G.5.3). Total admission rates per 1,000 patient years: transplant patients, adjusted (G.5.4). Transplant patients: counts of total admissions, years at risk, & patients used to compute total admissions per 1,000 patient years in G.5.4 (G.5.5). Bayesian standardized hospitalization ratios (G.a).

Table G.5Total admission rates per 1,000 patient years: transplant patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Table G.5Total admission rates per 1,000 patient years: transplant patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 1,154 1,054 1,348 1,283 1,510 1,467 1,181 1,510 1,482 1,479 1,1395-9 802 950 869 955 910 1,143 1,264 981 948 1,112 95810-14 947 854 860 820 878 1,008 743 817 906 995 95715-19 849 770 1,034 854 851 942 1,049 1,163 1,079 942 1,03920-29 828 817 883 799 805 867 860 887 848 871 81130-39 851 948 858 887 843 844 896 877 864 920 84340-49 860 891 818 817 843 837 819 803 869 866 77850-59 897 850 895 865 892 837 827 845 881 877 81160-64 863 894 860 910 968 906 913 1,008 929 915 94765-69 870 951 1,033 942 884 933 999 917 991 1,007 93470-79 1,008 1,000 1,003 874 1,045 954 1,053 980 1,082 1,027 1,02980+ * * * * * 608 837 1,504 1,469 1,965 525

Male 825 845 827 808 807 802 814 824 836 844 797Female 925 956 954 938 966 964 971 963 994 1,007 928

White 825 850 837 822 820 821 843 855 871 886 824Black 1,047 1,072 1,051 1,032 1,067 1,040 1,007 1,006 1,026 1,040 973Native American 980 1,038 1,188 1,051 940 1,055 1,072 1,042 1,104 812 920Asian 554 522 473 404 563 542 584 507 580 542 522

†Hispanic 848 835 878 875 874 832†Non-Hispanic 869 883 881 905 916 854

Diabetes 1,321 1,386 1,297 1,304 1,262 1,240 1,238 1,232 1,233 1,252 1,188Hypertension 878 852 798 766 854 826 795 785 827 893 810Glomerulonephritis 667 711 719 685 691 653 667 712 731 724 695Other cause 711 689 724 693 699 758 799 777 795 773 692

All 865 890 878 859 870 867 878 881 901 910 851

ADJUSTED0-19 652 618 1,250 1,004 941 757 698 510 831 611 94920-44 1,050 1,065 1,006 996 1,014 997 1,014 987 984 1,055 95745-64 1,018 1,021 961 958 973 945 923 943 970 957 89965+ 1,022 1,071 1,166 1,045 1,023 1,012 1,116 1,027 1,115 1,124 1,067

Male 1,019 1,055 1,020 975 969 958 952 939 975 982 936Female 1,044 1,053 1,094 1,021 1,017 1,014 1,088 1,029 1,093 1,101 1,022

White 994 1,001 970 912 902 910 939 926 974 977 911Black 1,062 1,133 1,215 1,148 1,140 1,093 1,162 1,099 1,149 1,178 1,115Other race 891 847 833 762 743 855 907 747 830 714 709

†Hispanic 944 865 875 915 903 862†Non-Hispanic 951 1,005 968 1,020 1,028 961

Diabetes 1,358 1,353 1,311 1,281 1,185 1,179 1,236 1,230 1,276 1,271 1,218Hypertension 884 914 922 818 929 906 902 815 878 927 870Glomerulonephritis 781 825 859 832 854 765 819 818 873 809 816Other cause 732 780 867 820 780 836 904 819 871 867 740

All 1,029 1,049 1,052 990 983 977 1,016 978 1,029 1,034 972



482

Reference section GGON OUR WEBSITE & CDHospital days per patient year: ESRD patients, adjusted (G.6.1). Hospital days per pa-tient: ESRD patients, adjusted (G.6.2). ESRD patients: counts of total hospital days (G.6.3). Hospital days per patient year: ESRD patients, adjusted (G.6.4). ESRD patients: counts of hospital days, years at risk, & patients used to compute hospital days per patient year in G.6.4 (G.6.5).

Table G.6Hospital days per patient year: ESRD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Table G.6Hospital days per patient year: ESRD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 19.0 15.7 17.6 16.2 15.8 14.0 15.3 14.6 17.0 15.3 15.05-9 11.6 13.9 10.3 11.9 11.6 11.7 10.2 8.9 10.1 8.2 10.410-14 11.5 11.2 11.0 8.3 10.0 10.4 8.9 8.1 8.6 10.5 10.215-19 11.4 11.8 10.6 9.3 7.9 9.4 9.0 10.1 10.1 10.2 10.620-29 12.1 11.0 10.5 9.8 9.2 9.3 9.1 8.8 9.3 9.5 9.430-39 13.1 12.8 11.8 11.2 10.8 10.5 10.8 10.6 10.8 10.9 10.440-49 13.6 12.9 12.2 11.9 11.3 11.3 11.8 11.6 12.2 12.2 11.650-59 15.3 15.0 14.1 13.7 13.3 13.2 13.6 13.5 14.0 13.8 13.460-64 16.3 15.9 15.2 15.0 14.4 14.6 15.0 14.9 15.1 15.4 14.765-69 17.7 16.9 16.3 15.5 15.4 15.5 15.8 15.5 15.6 15.7 15.470-79 18.1 17.1 16.3 15.9 15.8 15.6 16.1 16.2 16.3 16.1 15.580+ 18.7 17.7 16.8 16.3 16.4 16.0 16.8 16.2 16.3 15.9 15.4

Male 14.5 14.0 13.2 12.8 12.4 12.4 12.8 12.7 13.0 12.9 12.6Female 17.1 16.4 15.8 15.3 15.1 15.0 15.6 15.4 15.8 15.8 15.2

White 16.0 15.2 14.6 14.2 13.9 13.9 14.3 14.2 14.3 14.3 13.8Black 15.9 15.5 14.5 14.1 13.7 13.6 14.3 14.1 14.7 14.7 14.3Native American 13.8 14.1 13.7 13.4 13.0 12.7 14.0 13.4 13.2 13.8 13.0Asian 9.8 9.7 9.3 9.8 10.1 10.0 10.4 10.8 10.9 10.6 10.0



All 15.8 15.2 14.4 14.0 13.7 13.7 14.2 14.0 14.3 14.3 13.8

ADJUSTED0-19 15.8 19.1 13.4 12.6 10.5 16.3 15.9 13.2 13.4 8.0 8.420-44 14.8 14.2 13.3 12.7 12.0 11.9 12.2 11.8 12.3 12.6 11.945-64 15.7 15.1 14.1 13.7 13.2 13.1 13.5 13.4 13.8 13.7 13.265-74 17.8 16.9 16.1 15.4 15.2 15.2 15.6 15.4 15.4 15.3 15.075+ 18.9 18.0 17.2 16.8 16.5 16.1 16.8 16.6 16.6 16.4 15.7

Male 15.8 15.2 14.0 13.6 13.1 13.1 13.4 13.3 13.4 13.3 12.9Female 17.6 16.7 16.0 15.4 15.1 15.0 15.4 15.2 15.5 15.5 14.9




All 16.6 15.8 14.9 14.4 14.0 13.9 14.3 14.2 14.4 14.3 13.8


483


MORBIDITY & HOSPITALIZATIONGON OUR WEBSITE & CDHospital days per patient year: dialysis patients, adjusted (G.7.1). Hospital days per patient: di-alysis patients, adjusted (G.7.2). Dialysis patients: counts of total hospital days (G.7.3). Hospital days per patient year: dialysis patients, adjusted (G.7.4). Dialysis patients: counts of hospital days, years at risk, & patients used to compute hospital days per patient year in G.7.4 (G.7.5).

Table G.7Hospital days per patient year: dialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Table G.7Hospital days per patient year: dialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 25.1 19.7 26.6 21.3 20.0 19.4 20.2 20.3 27.2 19.1 23.05-9 14.9 18.4 15.5 16.3 17.4 15.8 14.8 16.5 13.4 10.0 12.510-14 15.1 13.7 14.4 9.4 12.6 13.0 11.3 9.7 10.5 12.1 11.315-19 11.5 12.6 11.4 10.0 8.8 10.2 8.7 10.9 10.5 11.6 11.420-29 12.7 11.3 10.4 10.5 9.5 9.6 9.4 9.0 9.6 10.1 10.230-39 13.5 13.0 12.4 11.9 11.5 11.2 11.4 11.1 11.3 11.6 11.240-49 13.9 13.1 12.7 12.4 11.7 11.8 12.4 12.1 12.7 12.8 12.350-59 15.6 15.4 14.4 14.2 13.7 13.6 14.2 14.0 14.5 14.4 14.160-64 16.6 16.2 15.5 15.2 14.7 15.0 15.5 15.3 15.5 15.9 15.265-69 17.9 17.0 16.4 15.6 15.5 15.7 16.1 15.8 15.9 16.0 15.770-79 18.1 17.2 16.4 16.0 15.8 15.7 16.2 16.3 16.4 16.1 15.580+ 18.7 17.7 16.8 16.3 16.4 16.0 16.8 16.2 16.3 15.9 15.4

Male 14.9 14.4 13.5 13.3 12.9 12.9 13.3 13.2 13.4 13.4 13.1Female 17.7 16.9 16.3 15.9 15.6 15.5 16.2 15.9 16.3 16.3 15.8




All 16.3 15.6 14.9 14.6 14.2 14.2 14.7 14.5 14.8 14.8 14.4

ADJUSTED0-19 18.1 23.7 18.1 15.3 12.5 18.2 13.5 14.8 15.0 8.8 7.620-44 15.4 14.7 14.0 13.7 12.8 12.7 13.0 12.5 13.0 13.4 12.845-64 15.9 15.3 14.4 14.1 13.5 13.5 14.0 13.8 14.2 14.2 13.865-74 17.9 16.9 16.1 15.5 15.3 15.3 15.6 15.6 15.6 15.5 15.275+ 19.0 18.0 17.2 16.8 16.5 16.0 16.8 16.6 16.6 16.4 15.7

Male 15.9 15.2 14.2 13.9 13.3 13.3 13.7 13.5 13.6 13.6 13.2Female 17.8 16.9 16.3 15.8 15.4 15.3 15.8 15.5 15.9 15.9 15.3




All 16.7 16.0 15.1 14.7 14.3 14.2 14.7 14.4 14.7 14.6 14.2



484

Reference section GGON OUR WEBSITE & CDHospital days per patient year: hemodialysis patients, adjusted (G.8.1). Hospital days per pa-tient: hemodialysis patients, adjusted (G.8.2). Hemodialysis patients: counts of total hospital days (G.8.3). Hospital days per patient year: hemodialysis patients, adjusted (G.8.4). Hemo-dialysis patients: counts of hospital days, years at risk, & patients used to compute hospital days per patient year in G.8.4 (G.8.5).

Table G.8Hospital days per patient year: hemodialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Table G.8Hospital days per patient year: hemodialysis patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 22.9 19.3 31.4 24.8 15.2 * 24.6 25.1 * 24.5 18.15-9 20.1 22.1 24.5 10.1 22.1 17.0 16.0 12.6 16.3 14.9 12.510-14 16.9 11.9 11.8 11.2 12.9 16.1 11.1 11.0 11.7 13.3 13.015-19 11.6 10.8 11.7 9.9 8.2 8.5 7.7 10.9 9.7 11.4 11.120-29 12.5 11.0 9.9 10.0 9.2 9.0 9.1 8.7 9.4 10.0 10.330-39 12.9 12.6 11.9 11.5 11.0 10.7 11.2 10.7 11.2 11.4 11.140-49 13.1 12.6 12.0 11.8 11.3 11.6 12.3 11.9 12.4 12.7 12.250-59 15.0 14.9 13.8 13.5 13.2 13.1 14.0 13.7 14.3 14.2 14.060-64 16.2 15.8 15.0 14.7 14.3 14.6 15.3 15.0 15.4 15.7 15.165-69 17.4 16.7 15.8 15.2 15.1 15.4 15.9 15.7 15.7 15.9 15.670-79 17.8 16.8 16.1 15.6 15.6 15.5 16.0 16.2 16.3 16.2 15.680+ 18.4 17.5 16.6 16.2 16.3 15.9 16.8 16.2 16.3 15.9 15.4

Male 14.5 14.1 13.1 12.9 12.6 12.7 13.2 13.0 13.3 13.4 13.1Female 17.3 16.5 16.0 15.5 15.3 15.4 16.1 15.9 16.3 16.3 15.8




All 15.9 15.3 14.5 14.2 13.9 14.0 14.6 14.4 14.7 14.8 14.4

ADJUSTED0-19 20.6 23.2 19.0 16.4 12.7 22.2 15.3 22.3 15.5 8.6 7.120-44 15.0 14.5 13.6 13.4 12.5 12.4 12.9 12.3 12.9 13.4 12.845-64 15.3 14.8 13.8 13.5 13.1 13.2 13.8 13.6 14.0 14.1 13.765-74 17.5 16.5 15.7 15.0 14.9 15.0 15.5 15.4 15.4 15.4 15.175+ 18.5 17.7 16.9 16.5 16.3 15.9 16.7 16.5 16.5 16.3 15.6

Male 15.4 14.9 13.7 13.4 13.0 13.0 13.5 13.3 13.5 13.5 13.1Female 17.3 16.4 15.8 15.3 15.0 14.9 15.6 15.3 15.7 15.8 15.3




All 16.3 15.6 14.7 14.3 13.9 13.9 14.5 14.2 14.5 14.5 14.1


485


MORBIDITY & HOSPITALIZATIONGON OUR WEBSITE & CDHospital days per patient year: CAPD/CCPD patients, adjusted (G.9.1). Hospital days per pa-tient: CAPD/CCPD patients, adjusted (G.9.2). CAPD/CCPD patients: counts of total hospital days (G.9.3). Hospital days per patient year: CAPD/CCPD patients, adjusted (G.9.4). CAPD/CCPD patients: counts of hospital days, years at risk, & patients used to compute hospital days per patient year in G.9.4 (G.9.5).

Table G.9Hospital days per patient year: CAPD/CCPD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Table G.9Hospital days per patient year: CAPD/CCPD patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 23.5 19.2 25.2 20.2 21.1 20.8 18.8 12.5 23.9 18.4 23.85-9 9.6 16.2 11.3 18.0 14.9 14.7 13.3 18.4 11.6 7.5 12.610-14 14.8 13.8 17.3 8.0 12.3 10.8 11.5 7.3 9.5 10.8 10.115-19 10.9 15.0 10.6 10.4 9.9 13.0 11.4 10.7 12.2 11.6 12.720-29 13.2 11.8 12.3 12.0 10.4 11.8 10.7 10.8 10.4 10.5 9.830-39 15.4 14.1 13.9 13.7 13.6 13.2 12.7 12.9 12.1 12.6 11.640-49 16.5 15.3 15.4 15.2 13.6 12.8 13.1 13.3 14.4 13.6 13.850-59 18.5 18.0 17.5 17.6 16.2 17.1 16.3 16.0 16.3 15.9 15.560-64 18.7 18.8 18.9 18.2 17.4 18.5 17.7 18.2 17.0 17.6 16.065-69 20.3 18.8 19.7 18.5 18.1 17.9 17.6 16.6 17.7 17.4 16.270-79 19.7 19.2 18.3 19.1 18.5 18.1 18.0 17.8 18.1 15.9 15.380+ 22.8 20.1 19.4 17.5 17.4 16.1 18.2 17.6 17.3 16.6 16.2

Male 16.7 15.9 15.8 15.6 14.7 14.9 14.6 14.4 14.6 14.0 13.6Female 19.2 18.3 18.2 17.8 17.0 16.8 16.5 16.4 16.8 16.2 15.6




All 17.9 17.1 16.9 16.7 15.8 15.9 15.6 15.5 15.7 15.1 14.6

ADJUSTED0-19 9.4 27.0 14.7 10.9 8.0 9.0 12.3 10.4 15.1 11.4 12.720-44 16.8 15.0 15.3 15.1 14.5 14.3 13.9 13.9 13.9 13.9 13.245-64 18.5 18.2 17.6 17.5 16.0 16.5 15.9 16.2 16.3 16.0 15.565-74 20.6 19.7 19.9 19.8 19.1 18.8 18.3 17.6 18.3 17.1 16.375+ 25.5 21.8 20.8 21.2 19.6 19.7 20.1 20.6 19.7 19.8 17.5

Male 18.6 17.4 16.9 16.9 15.7 16.2 15.9 15.6 15.4 15.1 14.4Female 21.3 20.2 19.8 19.6 18.7 18.4 18.0 18.2 18.7 17.9 16.9




All 19.9 18.8 18.3 18.3 17.2 17.3 16.9 16.9 17.0 16.4 15.6



486

Reference section GGON OUR WEBSITE & CDHospital days per patient year: transplant patients, adjusted (G.10.1). Hospital days per pa-tient: transplant patients, adjusted (G.10.2). Transplant patients: counts of total hospital days (G.10.3). Hospital days per patient year: transplant patients, adjusted (G.10.4). Transplant pa-tients: counts of hospital days, years at risk, & patients used to compute hospital days per patient year in G.10.4 (G.10.5).

Table G.10Hospital days per patient year: transplant patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Table G.10Hospital days per patient year: transplant patientsperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 7.8 5.5 6.0 7.2 7.2 7.4 5.9 8.4 6.7 6.8 5.65-9 4.2 6.3 5.3 5.9 3.7 6.2 5.7 4.3 5.1 5.2 5.010-14 5.7 4.6 4.6 4.2 4.7 5.3 4.1 4.2 5.0 6.2 5.715-19 5.8 5.3 6.2 5.2 4.7 4.9 5.3 6.5 6.1 5.8 6.020-29 5.8 5.4 5.3 4.4 4.6 5.0 4.7 4.5 4.8 4.9 4.130-39 6.6 6.9 5.4 5.4 5.1 5.0 5.4 5.4 5.4 5.6 4.740-49 7.4 7.2 5.9 5.7 5.6 5.5 5.5 5.6 6.0 5.8 5.150-59 7.7 7.4 7.2 6.4 6.7 6.0 5.6 6.3 6.4 6.2 5.760-64 7.2 7.6 6.5 7.5 7.4 6.8 6.8 7.1 7.5 7.2 7.265-69 7.6 8.8 8.6 7.0 7.0 6.8 7.4 6.7 7.7 7.7 7.170-79 9.3 9.0 8.2 6.5 8.5 7.6 9.7 6.8 8.2 7.7 7.980+ * * * * * 4.1 4.2 5.8 12.1 14.9 4.1

Male 6.7 6.7 5.8 5.6 5.4 5.3 5.6 5.7 5.8 5.8 5.3Female 7.3 7.3 6.6 6.1 6.5 6.3 6.1 6.2 6.8 6.8 6.2




All 7.0 7.0 6.1 5.8 5.9 5.7 5.8 5.9 6.2 6.2 5.6

ADJUSTED0-19 4.4 3.6 5.2 6.4 5.3 4.4 3.5 2.4 5.3 3.6 7.120-44 8.4 7.9 6.7 6.5 6.5 6.1 6.2 6.0 6.5 6.9 5.645-64 9.0 8.8 7.6 7.2 7.3 6.8 6.5 6.8 7.3 7.0 6.665+ 9.2 9.8 10.0 7.9 8.4 7.7 8.8 7.5 9.1 8.8 8.5

Male 9.3 9.6 8.5 7.4 7.4 6.9 7.3 6.8 7.4 7.4 6.8Female 8.9 8.6 8.2 7.3 7.8 7.2 7.4 7.1 8.4 8.2 7.6




All 9.0 9.0 8.3 7.3 7.5 7.0 7.4 6.9 7.8 7.7 7.2

Overall rates are adjusted for age, gender, race, & primary diagnosis; rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2003 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Age is determined as of January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method uses data from the current & previous two years, cells for years prior to 1998 have been left blank. * Values for cells with 10 or fewer patients are suppressed.

487


MORBIDITY & HOSPITALIZATIONG

Three years of data are included & age is reclassified on January 1 of each calendar year; therefore, each patient may contribute to a maximum of two consecutive age groups.

Table G.11Inpatient utilization by principal diagnosis of hospitalization: ESRD patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 00 patient years

Table G.11Inpatient utilization by principal diagnosis of hospitalization: ESRD patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 100 patient years

Number of All Vascular Circulatory Digestive Genitourinary Endocrine Respiratory Infectious Allpatients causes access diseases diseases diseases metabolic diseases diseases others

0-4 339 212.3 30.2 11.7 27.3 34.1 16.3 19.4 13.9 59.55-9 503 175.8 24.1 20.1 12.0 29.7 8.6 9.4 10.4 61.410-14 961 155.2 30.8 18.8 13.5 20.4 8.7 6.2 6.3 50.515-19 2,082 170.5 29.3 28.4 13.3 18.3 10.1 8.7 7.0 55.320-29 12,714 163.3 30.1 30.3 13.6 10.8 19.5 9.1 6.6 43.430-39 29,883 175.5 30.5 34.9 15.0 8.7 24.8 10.0 7.9 43.740-49 52,675 182.4 31.6 42.4 16.1 6.9 21.8 11.4 8.2 44.050-59 74,315 189.0 30.9 49.7 16.2 6.1 20.2 12.7 8.3 44.860-64 46,709 198.9 30.5 57.6 16.4 5.7 18.7 15.2 9.0 45.765-69 61,348 204.6 30.8 61.3 17.0 5.9 17.0 16.6 9.6 46.470-79 109,355 210.9 31.3 64.9 16.9 5.9 13.9 19.4 10.6 47.980+ 51,594 220.2 33.0 66.3 17.7 6.4 10.7 22.8 12.3 51.0

Male 208,243 182.8 27.5 51.1 15.1 5.9 17.0 15.0 8.6 42.7Female 186,908 212.6 35.4 57.0 17.9 7.5 18.8 15.8 10.1 50.2

White 239,529 197.8 28.0 54.7 16.1 7.4 17.9 16.7 9.3 47.7Black 133,585 201.0 36.4 54.5 17.4 5.8 18.0 13.5 9.6 45.9Native American 5,552 198.4 36.0 37.6 15.5 6.9 26.6 19.1 8.4 48.3Asian 13,197 132.8 21.7 39.2 10.8 4.7 10.6 11.9 6.6 27.4

Hispanic 47,233 191.6 33.6 51.2 15.8 6.7 20.7 14.0 8.6 41.1Non-Hispanic 347,918 197.6 30.8 54.2 16.5 6.6 17.4 15.6 9.4 47.0

Diabetes 165,430 228.5 34.7 61.2 16.9 6.2 30.9 15.8 11.1 51.7Hypertension 111,216 188.5 30.6 59.2 16.9 5.3 10.0 16.4 8.0 42.0Glomerulonephritis 47,608 153.6 25.2 40.2 14.8 7.4 8.4 12.8 6.3 38.6Other cause 70,897 174.8 29.2 40.2 15.9 9.3 9.0 14.7 9.8 46.8

All 395,151 196.8 31.2 53.9 16.4 6.7 17.8 15.4 9.3 46.2


488



Table G.12Inpatient utilization by principal diagnosis of hospitalization: dialysis patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 00 patient years

Table G.12Inpatient utilization by principal diagnosis of hospitalization: dialysis patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 100 patient years


0-4 166 280.7 77.3 16.7 58.6 34.8 16.1 17.4 11.6 48.35-9 210 253.6 64.1 38.3 22.6 26.3 6.9 5.1 5.1 85.310-14 478 192.7 66.9 27.1 24.5 15.5 8.4 7.3 5.2 37.815-19 1,277 195.0 51.0 38.6 18.4 14.1 12.2 11.4 7.7 41.520-29 9,911 176.1 40.7 33.0 15.9 8.1 22.1 10.6 6.7 39.130-39 23,870 189.6 39.7 38.9 17.0 7.0 26.1 11.5 8.4 41.240-49 44,534 193.9 38.1 45.8 17.9 5.9 22.4 12.6 8.6 42.750-59 65,842 198.1 35.6 52.9 17.4 5.3 20.2 13.6 8.6 44.560-64 42,885 205.8 33.8 60.3 17.5 4.9 18.6 16.0 9.2 45.565-69 58,415 208.6 32.9 62.9 17.6 5.3 16.9 17.2 9.7 46.370-79 107,755 212.1 32.0 65.3 17.1 5.7 13.9 19.6 10.6 47.880+ 51,535 220.3 33.0 66.4 17.7 6.4 10.7 22.8 12.3 51.0

Male 190,078 190.2 31.1 54.2 16.0 5.1 16.8 16.2 9.0 41.9Female 174,426 220.0 38.8 60.1 18.9 6.5 18.8 16.7 10.4 49.9




All 364,504 204.4 34.7 57.0 17.4 5.8 17.7 16.4 9.7 45.7

489




Table G.13Inpatient utilization by principal diagnosis of hospitalization: hemodialysis patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 00 patient years

Table G.13Inpatient utilization by principal diagnosis of hospitalization: hemodialysis patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 100 patient years


0-4 29 384.2 146.2 25.1 37.6 45.9 12.5 25.1 16.7 75.25-9 81 401.4 103.1 46.7 5.5 26.1 13.8 5.5 6.9 193.810-14 248 219.2 91.0 28.4 6.9 18.4 6.5 10.8 8.5 48.815-19 965 196.2 55.4 39.2 11.3 13.9 11.6 12.5 8.0 44.320-29 8,496 177.2 41.8 34.3 12.7 8.2 22.3 11.1 7.1 39.730-39 21,028 189.9 40.3 40.0 14.7 7.0 26.0 11.9 8.9 41.240-49 40,232 194.3 38.6 46.9 16.2 5.8 22.0 13.1 8.9 42.850-59 60,412 198.2 35.9 53.6 16.2 5.2 19.8 14.1 8.8 44.660-64 39,805 206.4 34.3 60.9 16.5 4.9 18.2 16.5 9.5 45.765-69 54,142 208.7 33.2 63.2 16.7 5.3 16.4 17.6 9.9 46.370-79 101,516 213.0 32.4 65.8 16.5 5.7 13.6 20.1 10.8 48.280+ 49,523 220.9 33.3 66.6 17.2 6.4 10.5 23.2 12.5 51.2

Male 176,407 190.5 31.3 54.7 15.0 5.1 16.3 16.7 9.3 42.2Female 161,513 221.5 39.2 61.5 17.7 6.4 18.3 17.3 10.7 50.4




All 337,920 205.2 35.1 57.9 16.3 5.7 17.3 17.0 9.9 46.1


490



Table G.14Inpatient utilization by principal diagnosis of hospitalization: CAPD/CCPD patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 00 patient years

Table G.14Inpatient utilization by principal diagnosis of hospitalization: CAPD/CCPD patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 100 patient years

Number of All Vascular Circulatory Digestive Genitourinary Endocrine Respiratory Infectious Allpatients causes access diseases diseases diseases Metabolic diseases diseases others

0-4 140 263.4 65.3 15.4 63.0 32.3 16.9 16.1 10.8 43.85-9 134 178.3 45.1 33.1 31.7 25.4 3.5 4.9 4.2 30.310-14 248 168.5 44.3 25.5 41.8 12.6 10.3 4.1 2.2 27.715-19 355 184.6 38.1 36.6 36.6 14.3 14.0 7.0 7.3 30.620-29 1,813 170.1 34.8 26.3 32.3 7.6 21.2 7.9 4.5 35.530-39 3,668 186.8 35.4 31.1 31.7 7.5 26.7 8.8 5.4 40.340-49 5,434 189.2 33.5 36.5 32.4 6.7 25.1 8.1 6.2 40.850-59 6,791 196.6 32.4 45.7 29.5 6.1 24.6 8.8 6.8 42.760-64 3,575 196.8 28.1 53.2 29.5 5.2 23.8 9.2 6.2 41.865-69 4,924 207.3 28.6 58.3 28.6 6.2 22.8 11.2 6.4 45.370-79 7,249 196.8 25.3 56.9 26.5 6.7 19.5 11.8 7.5 42.680+ 2,161 206.2 26.4 60.3 30.7 7.5 17.0 12.4 7.8 44.1

Male 17,216 186.5 28.3 47.6 28.4 6.0 21.8 9.6 5.8 39.0Female 16,476 202.3 33.6 44.3 31.7 7.6 23.9 9.6 7.1 44.5

White 23,180 192.3 27.9 47.5 28.3 7.1 23.6 10.2 6.3 41.3Black 8,362 211.0 39.1 45.9 36.2 6.4 22.2 8.6 7.2 45.4Native American 459 205.7 34.9 33.8 28.5 9.6 34.4 10.0 6.2 48.3Asian 1,343 119.9 21.6 28.8 19.6 4.0 11.8 6.1 4.0 24.0



All 33,692 194.4 30.9 45.9 30.1 6.8 22.9 9.6 6.5 41.7

491




Table G.15Inpatient utilization by principal diagnosis of hospitalization: transplant patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 00 patient years

Table G.15Inpatient utilization by principal diagnosis of hospitalization: transplant patients, 2001-2003period prevalent patients, by age, gender, race/ethnicity, & primary diagnosis; hospitalizations per 100 patient years


0-4 213 136.6 4.2 3.4 10.3 17.1 15.6 20.6 13.7 51.75-9 339 100.6 1.1 1.9 5.5 17.8 9.6 11.8 12.6 40.510-14 570 95.2 4.0 3.4 5.2 11.0 9.3 5.5 6.7 50.015-19 989 102.1 4.0 4.7 6.9 11.0 5.9 4.9 4.9 59.820-29 3,949 84.3 2.9 4.5 6.5 9.0 8.7 4.7 5.6 42.430-39 8,307 87.6 2.4 5.6 8.1 8.3 13.3 5.3 5.7 39.040-49 10,752 83.5 2.0 8.9 6.6 6.7 11.8 5.8 5.5 36.250-59 11,195 85.3 1.7 12.1 7.7 6.7 10.6 7.0 5.5 34.060-64 4,716 92.9 1.1 16.0 6.9 8.2 10.3 8.2 5.9 36.365+ 5,551 100.1 1.4 20.1 8.2 8.1 8.0 9.4 7.0 37.9

Male 25,758 82.4 1.6 10.7 6.9 5.5 10.3 6.4 5.2 35.7Female 17,825 97.4 2.5 10.3 8.0 11.1 11.4 6.9 6.8 40.5

White 30,512 85.9 1.7 10.2 7.2 7.7 10.8 6.4 5.8 36.0Black 10,738 101.1 2.8 12.2 8.3 8.1 11.4 7.5 6.1 44.8Native American 497 94.4 1.6 9.9 5.4 10.0 17.6 8.1 6.1 35.6Asian 1,772 54.6 1.5 5.3 4.5 6.2 4.4 5.4 4.4 23.0



All 43,583 88.5 2.0 10.5 7.3 7.8 10.8 6.6 5.9 37.7


492

Reference section GGON OUR WEBSITE & CDTotal hospital discharges, by detailed Diagnostic Related Group (G.16.1).

One DRG per discharge.* Values for cells with 10 or fewer discharges are suppressed.

Table G.16Total hospital discharges, by general Diagnostic Related Group period prevalent patients

Table G.16Total hospital discharges, by general Diagnostic Related Groupperiod prevalent patients

1998 1999 2000ALL Medical Procedure All Medical Procedure All Medical Procedure AllNervous 22,563 2,906 25,469 23,399 2,921 26,320 24,336 3,061 27,397Eye 291 463 754 294 380 674 391 334 725Ear, nose, & throat 1,735 345 2,080 2,086 283 2,369 2,057 289 2,346Respiratory 35,361 1,697 37,058 38,933 1,842 40,775 39,093 2,266 41,359Circulatory 101,506 80,612 182,118 109,048 82,614 191,662 116,249 83,598 199,847Gastrointestinal 31,774 7,944 39,718 32,360 7,792 40,152 34,150 7,781 41,931Hepatic 6,801 2,955 9,756 7,060 3,013 10,073 7,295 3,181 10,476Muscular/skeletal 9,476 10,619 20,095 10,555 11,261 21,816 11,190 12,015 23,205Skin/breast 6,435 3,117 9,552 7,227 3,271 10,498 8,073 3,361 11,434Endocrine 18,473 4,068 22,541 19,778 4,372 24,150 21,325 4,462 25,787Renal 50,884 28,653 79,537 53,390 27,951 81,341 57,564 28,549 86,113Male reproductive 361 695 1,056 353 714 1,067 425 761 1,186Female reproductive 392 855 1,247 418 775 1,193 499 890 1,389Pregnancy 156 81 237 200 82 282 163 91 254Hematologic 4,031 252 4,283 4,126 228 4,354 4,542 235 4,777Myeloproliferative 1,396 326 1,722 1,399 335 1,734 1,445 371 1,816Infection 22,288 5,728 28,016 22,290 5,248 27,538 22,192 5,290 27,482Psychological 5,336 282 5,618 5,644 276 5,920 5,605 229 5,834Injury/poisoning 6,746 4,640 11,386 7,145 4,555 11,700 7,469 4,500 11,969Burns 98 82 180 155 50 205 133 41 174Other factors 12,161 1,034 13,195 14,560 1,165 15,725 15,745 1,270 17,015Unclassifed * 3,468 3,468 * 3,589 3,589 * 3,804 3,804HIV 1,700 176 1,876 1,910 199 2,109 2,113 210 2,323

All 339,964 160,998 500,962 362,330 162,916 525,246 382,054 166,589 548,643

DIALYSISNervous 18,446 2,235 20,681 18,971 2,323 21,294 19,732 2,399 22,131Eye 216 364 580 217 296 513 282 275 557Ear, nose, & throat 1,105 237 1,342 1,307 177 1,484 1,415 191 1,606Respiratory 29,087 1,254 30,341 31,558 1,374 32,932 31,820 1,756 33,576Circulatory 86,446 70,636 157,082 93,637 72,475 166,112 99,247 72,968 172,215Gastrointestinal 25,702 6,240 31,942 25,788 6,121 31,909 26,871 5,997 32,868Hepatic 5,071 2,143 7,214 5,163 2,169 7,332 5,246 2,188 7,434Muscular/skeletal 7,534 7,782 15,316 8,396 8,439 16,835 9,011 9,009 18,020Skin/breast 4,687 2,396 7,083 5,382 2,551 7,933 6,057 2,612 8,669Endocrine 13,471 3,183 16,654 14,466 3,449 17,915 15,575 3,415 18,990Renal 36,867 16,144 53,011 38,971 15,834 54,805 41,695 15,907 57,602Male reproductive 252 500 752 232 501 733 283 505 788Female reproductive 274 552 826 294 475 769 359 545 904Pregnancy 63 24 87 82 33 115 79 38 117Hematologic 3,067 114 3,181 3,092 123 3,215 3,321 113 3,434Myeloproliferative 1,036 227 1,263 1,061 215 1,276 1,081 235 1,316Infection 17,347 4,649 21,996 17,325 4,272 21,597 17,224 4,209 21,433Psychological 4,336 258 4,594 4,574 240 4,814 4,457 209 4,666Injury/poisoning 5,536 3,738 9,274 5,817 3,698 9,515 5,987 3,589 9,576Burns 71 62 133 125 35 160 109 28 137Other factors 10,153 909 11,062 12,134 1,006 13,140 13,173 1,073 14,246Unclassifed * 2,764 2,764 * 2,796 2,796 * 2,976 2,976HIV 1,596 164 1,760 1,774 188 1,962 1,988 190 2,178

All 272,363 126,575 398,938 290,366 128,790 419,156 305,012 130,427 435,439

* Values for cells with 10 or fewer patients are suppressed.

493




Table G.16 (continued)Total hospital discharges, by general Diagnostic Related Group period prevalent patients

Table G.16 (continued)Total hospital discharges, by general Diagnostic Related Groupperiod prevalent patients

1998 1999 2000HEMODIALYSIS Medical Procedure All Medical Procedure All Medical Procedure AllNervous 15,866 1,935 17,801 16,699 2,095 18,794 17,562 2,145 19,707Eye 189 330 519 189 265 454 253 255 508Ear, nose, & throat 995 208 1,203 1,184 160 1,344 1,308 183 1,491Respiratory 26,530 1,127 27,657 29,073 1,263 30,336 29,410 1,614 31,024Circulatory 77,966 65,416 143,382 85,842 67,873 153,715 91,394 68,408 159,802Gastrointestinal 20,114 4,848 24,962 21,208 4,974 26,182 22,286 4,913 27,199Hepatic 4,317 1,849 6,166 4,612 1,912 6,524 4,671 1,929 6,600Muscular/skeletal 6,883 7,061 13,944 7,740 7,780 15,520 8,333 8,359 16,692Skin/breast 4,225 2,169 6,394 4,904 2,312 7,216 5,525 2,353 7,878Endocrine 11,176 2,853 14,029 12,429 3,087 15,516 13,493 3,108 16,601Renal 31,827 13,366 45,193 34,355 13,359 47,714 36,838 13,574 50,412Male reproductive 211 444 655 201 446 647 252 455 707Female reproductive 230 453 683 259 416 675 312 474 786Pregnancy 55 22 77 76 30 106 73 36 109Hematologic 2,645 105 2,750 2,699 114 2,813 2,868 98 2,966Myeloproliferative 902 203 1,105 903 195 1,098 933 207 1,140Infection 15,391 4,189 19,580 15,738 3,876 19,614 15,695 3,838 19,533Psychological 3,919 229 4,148 4,251 214 4,465 4,122 197 4,319Injury/poisoning 2,913 1,770 4,683 3,201 1,801 5,002 3,447 1,859 5,306Burns 65 58 123 114 32 146 101 28 129Other factors 8,919 810 9,729 10,840 902 11,742 11,780 956 12,736Unclassifed * 2,365 2,365 * 2,426 2,426 * 2,632 2,632HIV 1,429 141 1,570 1,620 161 1,781 1,841 169 2,010

All 236,767 111,951 348,718 258,137 115,693 373,830 272,497 117,790 390,287

PERITONEAL DIALYSISNervous 2,070 223 2,293 1,759 181 1,940 1,632 203 1,835Eye 22 28 50 21 28 49 19 17 36Ear, nose, & throat 94 23 117 109 15 124 88 * 93Respiratory 1,805 79 1,884 1,722 73 1,795 1,574 94 1,668Circulatory 5,859 3,610 9,469 5,048 3,212 8,260 4,859 3,024 7,883Gastrointestinal 4,918 1,162 6,080 3,942 947 4,889 3,893 894 4,787Hepatic 620 245 865 453 208 661 444 210 654Muscular/skeletal 517 600 1,117 505 546 1,051 461 495 956Skin/breast 372 192 564 349 199 548 378 207 585Endocrine 1,930 270 2,200 1,674 307 1,981 1,653 241 1,894Renal 2,777 1,125 3,902 2,351 990 3,341 2,281 921 3,202Male reproductive 33 39 72 25 36 61 22 27 49Female reproductive 36 83 119 32 53 85 33 60 93Pregnancy * * * * * * * * *Hematologic 326 * 335 303 * 309 321 * 329Myeloproliferative 42 * 52 52 * 57 66 12 78Infection 1,459 352 1,811 1,115 268 1,383 1,012 265 1,277Psychological 332 20 352 241 21 262 244 * 250Injury/poisoning 2,408 1,793 4,201 2,390 1,710 4,100 2,283 1,518 3,801Burns * * * * * 13 * * *Other factors 908 66 974 843 67 910 885 68 953Unclassifed * 298 298 * 266 266 * 245 245HIV 135 16 151 130 13 143 123 12 135

All 26,673 10,248 36,921 23,080 9,157 32,237 22,283 8,534 30,817



494





1998 1999 2000TRANSPLANT Medical Procedure All Medical Procedure All Medical Procedure AllNervous 1,684 271 1,955 1,691 239 1,930 1,905 288 2,193Eye 39 46 85 48 42 90 49 37 86Ear, nose, & throat 356 67 423 467 70 537 367 64 431Respiratory 2,742 216 2,958 3,300 234 3,534 3,231 245 3,476Circulatory 4,525 2,524 7,049 4,705 2,520 7,225 5,076 2,652 7,728Gastrointestinal 2,413 711 3,124 2,610 673 3,283 2,936 729 3,665Hepatic 908 428 1,336 958 426 1,384 999 491 1,490Muscular/skeletal 946 1,544 2,490 1,089 1,451 2,540 1,043 1,588 2,631Skin/breast 988 361 1,349 1,019 382 1,401 1,145 381 1,526Endocrine 2,536 415 2,951 2,624 423 3,047 2,745 502 3,247Renal 6,449 2,051 8,500 6,699 2,046 8,745 7,434 2,194 9,628Male reproductive 51 88 139 57 103 160 59 129 188Female reproductive 84 187 271 60 188 248 74 219 293Pregnancy 70 41 111 84 36 120 59 30 89Hematologic 424 31 455 432 29 461 537 51 588Myeloproliferative 178 62 240 141 78 219 180 70 250Infection 2,186 408 2,594 2,181 355 2,536 2,224 371 2,595Psychological 429 * 432 448 * 452 509 * 513Injury/poisoning 339 217 556 392 187 579 451 229 680Burns 17 11 28 13 * 19 * * 18Other factors 881 38 919 983 51 1,034 1,058 65 1,123Unclassifed * 292 292 * 329 329 * 372 372HIV * * * * * * * * *

All 28,253 10,012 38,265 30,005 9,872 39,877 32,091 10,719 42,810

2001 2002 2003ALL Medical Procedure All Medical Procedure All Medical Procedure AllNervous 26,101 3,378 29,479 27,847 3,687 31,534 28,168 3,738 31,906Eye 344 282 626 383 288 671 379 269 648Ear, nose, & throat 1,997 314 2,311 2,378 321 2,699 2,598 375 2,973Respiratory 41,952 2,545 44,497 46,211 2,889 49,100 48,545 3,164 51,709Circulatory 128,520 85,462 213,982 137,779 85,952 223,731 142,716 85,942 228,658Gastrointestinal 37,251 8,244 45,495 39,987 8,424 48,411 41,012 8,963 49,975Hepatic 7,991 3,446 11,437 8,960 3,815 12,775 9,210 4,037 13,247Muscular/skeletal 12,414 13,436 25,850 12,977 14,521 27,498 13,189 15,681 28,870Skin/breast 8,743 3,634 12,377 9,457 3,766 13,223 9,345 4,202 13,547Endocrine 23,955 5,343 29,298 27,773 5,711 33,484 27,798 5,758 33,556Renal 62,009 30,006 92,015 65,050 30,384 95,434 66,713 32,103 98,816Male reproductive 425 722 1,147 468 774 1,242 545 794 1,339Female reproductive 501 967 1,468 565 1,064 1,629 595 972 1,567Pregnancy 148 74 222 154 75 229 165 89 254Hematologic 5,431 270 5,701 6,100 278 6,378 6,198 266 6,464Myeloproliferative 1,579 378 1,957 1,743 439 2,182 1,542 371 1,913Infection 23,953 5,630 29,583 27,243 5,994 33,237 28,632 6,388 35,020Psychological 5,568 257 5,825 5,695 237 5,932 5,443 227 5,670Injury/poisoning 7,900 4,836 12,736 7,853 4,777 12,630 7,894 4,666 12,560Burns 128 28 156 117 36 153 156 35 191Other factors 15,930 1,325 17,255 15,889 1,261 17,150 15,333 1,261 16,594Unclassifed * 4,300 4,300 * 5,175 5,175 * 5,311 5,311HIV 2,163 232 2,395 2,168 229 2,397 2,350 252 2,602

All 415,003 175,109 590,112 446,797 180,097 626,894 458,526 184,864 643,390


495






2001 2002 2003DIALYSIS Medical Procedure All Medical Procedure All Medical Procedure AllNervous 20,792 2,634 23,426 22,390 2,909 25,299 23,052 3,025 26,077Eye 264 225 489 296 210 506 295 200 495Ear, nose, & throat 1,330 193 1,523 1,603 202 1,805 1,763 233 1,996Respiratory 33,827 1,958 35,785 37,460 2,240 39,700 39,804 2,475 42,279Circulatory 109,185 73,769 182,954 117,985 74,513 192,498 123,159 74,836 197,995Gastrointestinal 29,146 6,273 35,419 31,323 6,352 37,675 32,450 6,858 39,308Hepatic 5,837 2,342 8,179 6,589 2,566 9,155 6,946 2,801 9,747Muscular/skeletal 9,823 9,926 19,749 10,312 10,886 21,198 10,677 11,967 22,644Skin/breast 6,523 2,756 9,279 7,146 2,913 10,059 7,200 3,349 10,549Endocrine 17,415 4,138 21,553 20,568 4,470 25,038 21,164 4,575 25,739Renal 44,718 16,095 60,813 47,211 16,365 63,576 47,847 17,754 65,601Male reproductive 303 498 801 333 515 848 399 551 950Female reproductive 370 601 971 401 664 1,065 445 607 1,052Pregnancy 65 34 99 77 32 109 99 51 150Hematologic 4,030 157 4,187 4,516 160 4,676 4,699 163 4,862Myeloproliferative 1,165 230 1,395 1,319 287 1,606 1,135 238 1,373Infection 18,323 4,426 22,749 21,068 4,695 25,763 22,439 5,172 27,611Psychological 4,397 223 4,620 4,442 216 4,658 4,344 200 4,544Injury/poisoning 6,278 3,728 10,006 6,298 3,764 10,062 6,304 3,715 10,019Burns 105 20 125 91 26 117 122 28 150Other factors 12,950 1,127 14,077 12,999 1,039 14,038 12,467 1,050 13,517Unclassifed * 3,224 3,224 * 3,717 3,717 * 3,794 3,794HIV 2,022 208 2,230 1,995 202 2,197 2,194 225 2,419

All 328,868 134,785 463,653 356,422 138,943 495,365 369,004 143,867 512,871

HEMODIALYSISNervous 18,573 2,377 20,950 20,188 2,638 22,826 20,998 2,770 23,768Eye 239 207 446 268 196 464 277 190 467Ear, nose, & throat 1,211 172 1,383 1,493 186 1,679 1,647 216 1,863Respiratory 31,617 1,842 33,459 35,204 2,112 37,316 37,401 2,344 39,745Circulatory 101,407 69,550 170,957 110,400 70,397 180,797 115,971 70,875 186,846Gastrointestinal 24,660 5,205 29,865 26,785 5,368 32,153 28,028 5,874 33,902Hepatic 5,217 2,093 7,310 5,877 2,315 8,192 6,261 2,563 8,824Muscular/skeletal 9,157 9,199 18,356 9,643 10,188 19,831 10,049 11,250 21,299Skin/breast 5,994 2,564 8,558 6,651 2,724 9,375 6,653 3,107 9,760Endocrine 15,280 3,785 19,065 18,380 4,134 22,514 19,008 4,252 23,260Renal 39,902 13,979 53,881 42,661 14,294 56,955 43,461 15,686 59,147Male reproductive 270 459 729 298 469 767 363 492 855Female reproductive 329 529 858 353 590 943 393 554 947Pregnancy 58 29 87 75 28 103 90 46 136Hematologic 3,520 149 3,669 3,996 150 4,146 4,237 154 4,391Myeloproliferative 1,023 208 1,231 1,176 258 1,434 1,009 219 1,228Infection 16,730 4,061 20,791 19,052 4,318 23,370 20,324 4,735 25,059Psychological 4,119 205 4,324 4,147 203 4,350 4,108 187 4,295Injury/poisoning 3,797 2,065 5,862 4,078 2,124 6,202 4,094 2,076 6,170Burns 97 19 116 85 20 105 116 27 143Other factors 11,596 1,013 12,609 11,901 945 12,846 11,413 966 12,379Unclassifed * 2,863 2,863 * 3,303 3,303 * 3,387 3,387HIV 1,892 187 2,079 1,829 187 2,016 2,076 197 2,273

All 296,688 122,760 419,448 324,540 127,147 451,687 337,977 132,167 470,144



496

Reference section GG MORBIDITY & HOSPITALIZATIONReference section GG




2001 2002 2003PERITONEAL DIALYSIS Medical Procedure All Medical Procedure All Medical Procedure AllNervous 1,662 207 1,869 1,694 206 1,900 1,547 207 1,754Eye 20 14 34 26 12 38 16 * 25Ear, nose, & throat 99 17 116 95 15 110 94 14 108Respiratory 1,430 81 1,511 1,544 80 1,624 1,595 86 1,681Circulatory 4,904 2,886 7,790 4,833 2,796 7,629 4,823 2,801 7,624Gastrointestinal 3,824 871 4,695 3,912 826 4,738 3,823 811 4,634Hepatic 477 190 667 560 198 758 513 175 688Muscular/skeletal 482 565 1,047 503 582 1,085 473 572 1,045Skin/breast 411 151 562 387 153 540 432 189 621Endocrine 1,732 292 2,024 1,828 277 2,105 1,823 270 2,093Renal 2,364 844 3,208 2,277 833 3,110 2,184 863 3,047Male reproductive 23 27 50 30 29 59 30 43 73Female reproductive 34 56 90 32 65 97 45 47 92Pregnancy * * 11 * * * * * 14Hematologic 400 * 406 407 * 415 378 * 386Myeloproliferative 36 * 44 44 11 55 36 * 42Infection 1,062 258 1,320 1,461 282 1,743 1,510 347 1,857Psychological 216 13 229 234 * 242 185 * 193Injury/poisoning 2,233 1,490 3,723 1,999 1,481 3,480 2,009 1,473 3,482Burns * * * * * * * * *Other factors 905 57 962 734 69 803 752 51 803Unclassifed * 261 261 * 293 293 * 285 285HIV 88 14 102 122 * 129 87 21 108

All 22,416 8,313 30,729 22,728 8,239 30,967 22,367 8,291 30,658

TRANSPLANTNervous 2,039 291 2,330 2,119 264 2,383 2,016 307 2,323Eye 40 32 72 44 38 82 40 29 69Ear, nose, & throat 373 80 453 451 79 530 452 73 525Respiratory 3,498 279 3,777 3,765 323 4,088 3,960 327 4,287Circulatory 5,575 2,758 8,333 5,857 2,876 8,733 6,117 3,043 9,160Gastrointestinal 3,303 813 4,116 3,578 875 4,453 3,744 1,018 4,762Hepatic 1,032 525 1,557 1,117 604 1,721 1,113 637 1,750Muscular/skeletal 1,238 1,766 3,004 1,219 1,827 3,046 1,206 1,939 3,145Skin/breast 1,150 429 1,579 1,194 414 1,608 1,230 341 1,571Endocrine 3,044 548 3,592 3,413 564 3,977 3,033 549 3,582Renal 8,132 2,315 10,447 8,556 2,244 10,800 9,643 2,418 12,061Male reproductive 53 87 140 57 120 177 77 126 203Female reproductive 65 211 276 92 237 329 98 224 322Pregnancy 48 23 71 48 27 75 38 29 67Hematologic 599 37 636 686 44 730 705 43 748Myeloproliferative 166 89 255 180 88 268 184 75 259Infection 2,319 414 2,733 2,589 444 3,033 2,796 444 3,240Psychological 463 * 473 492 * 497 578 * 586Injury/poisoning 452 289 741 449 283 732 506 279 785Burns * * 16 13 * 16 13 * 19Other factors 1,147 57 1,204 1,124 66 1,190 1,260 70 1,330Unclassifed * 397 397 * 422 422 * 449 449HIV * * 11 * * * * * *

All 34,752 11,461 46,213 37,048 11,847 48,895 38,815 12,434 51,249


Mortality &causes of death

HReferenceSec

tion

MORTALITY & CAUSES OF DEATHH

498

Reference section H

H.1 . 500 Total patient deaths: ESRD patientsby demographic characteristics, primary diagnosis, & patient vintage

H.2 . 504 Annual mortality rates per 1,000 patient years at risk: ESRD patientsperiod prevalent patients; 200 ESRD patients used as reference

H.3 . 506 Total patient deaths: dialysis patientsby demographic characteristics, primary diagnosis, & patient vintage

H.4 . 508 Annual mortality rates per 1,000 patient years at risk: dialysis patientsperiod prevalent patients; 200 ESRD patients used as reference

H.5 . 510 Total patient deaths: ESRD patients, never on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage

H.6 . 512 Annual mortality rates per 1,000 patient years at risk: dialysis patients, never on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference

H.7 . 514 Total patient deaths: dialysis patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage

H.8 . 516 Annual mortality rates per 1,000 patient years at risk: dialysis patients, on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference

H.9 . 518 Total patient deaths: dialysis patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage

H.10 . 520 Annual mortality rates per 1,000 patient years at risk: dialysis patients, returned to dialysis from transplantperiod prevalent patients; 200 ESRD patients used as reference

H.11 . 522 Total patient deaths: hemodialysis patientsby demographic characteristics, primary diagnosis, & patient vintage

H.12 . 524 Annual mortality rates per 1,000 patient years at risk: hemodialysis patientsperiod prevalent patients; 200 ESRD patients used as reference

H.13 . 526Total patient deaths: hemodialysis patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage

H.14 . 528 Annual mortality rates per 1,000 patient years at risk: hemodialysis patients, never on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference

H.15 . 530Total patient deaths: hemodialysis patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage

H.16 . 531 Annual mortality rates per 1,000 patient years at risk: hemodialysis patients, on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference

H.17 . 532 Total patient deaths: hemodialysis patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage

H.18 . 534 Annual mortality rates per 1,000 patient years at risk: hemodialysis patientsperiod prevalent patients; 200 ESRD patients used as reference

H.19 . 536 Total patient deaths: CAPD/CCPD patientsby demographic characteristics, primary diagnosis, & patient vintage

H.20 . 538 Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patientsperiod prevalent patients; 200 ESRD patients used as reference

H.21 . 540 Total patient deaths: CAPD/CCPD patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage

H.22 . 542 Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, never on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference

H.23 . 544 Total patient deaths: CAPD/CCPD patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage

H.24 . 545 Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference

H.25 . 546 Total patient deaths: CAPD/CCPD patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage

H.26 . 548 Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, returned to dialysis from transplantperiod prevalent patients; 200 ESRD patients used as reference

H.27 . 550 Total patient deaths: transplant patientsby demographic characteristics, primary diagnosis, & patient vintage

499

2005 Annual Data Report HMORTALITY & CAUSES OF DEATH

H.28 . 552 Annual mortality rates per 1,000 patient years at risk: transplant patientsperiod prevalent patients; 200 ESRD patients used as reference

H.29 . 554 Mortality rates by primary cause of mortality, unadjustedrates per ,000 patient years at risk, period prevalent patients, 200-2003 combined

H.30 . 557 Mortality rates by cause of withdrawal, unadjustedrates per ,000 patient years at risk, period prevalent dialysis patients, 200-2003 combined

H.31 . 558 Expected remaining lifetimes (years) of the general U.S. population, & of prevalent dialysis & transplant patientsgeneral U.S. population, 2002

H.32 . 559 First-year mortality rates, ESRD per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.33 . 560 First-year mortality rates, dialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.34 . 561 First-year mortality rates, hemodialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.35 . 562 First-year mortality rates, CAPD/CCPD per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.36 . 563 First-year mortality rates, transplant per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.37 . 564 Second-year mortality rates, ESRD per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.38 . 565 Second-year mortality rates, dialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.39 . 566 Second-year mortality rates, hemodialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.40 . 567 Second-year mortality rates, CAPD/CCPD per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.41 . 568 Second-year mortality rates, transplant per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.42 . 569 Third-year mortality rates, ESRD per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.43 . 570 Third-year mortality rates, dialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.44 . 571 Third-year mortality rates, hemodialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.45 . 572 Third-year mortality rates, CAPD/CCPD per ,000 patient years at risk, incident patients, by modality & demographic characteristics

H.46 . 573 Third-year mortality rates, transplant per ,000 patient years at risk, incident patients, by modality & demographic characteristics


500

Reference section H

Table H.1Total patient deaths: ESRD patientsby demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 10 12 12 15 24 23 33 31 43 39 59 455-9 14 19 12 * * 15 13 12 14 14 30 1710-14 28 13 12 10 18 23 24 19 26 27 41 2515-19 46 63 34 61 48 48 42 50 56 49 83 5920-29 356 384 359 383 392 411 453 447 525 558 568 52130-39 797 822 955 941 1,097 1,209 1,393 1,515 1,615 1,632 1,839 1,82940-49 1,132 1,276 1,258 1,387 1,545 1,702 1,932 2,083 2,295 2,459 2,853 3,04050-59 2,207 2,359 2,590 2,964 2,938 3,440 3,550 3,781 4,169 4,394 4,673 4,93560-64 1,494 1,648 1,898 2,076 2,431 2,810 3,053 3,212 3,586 3,741 4,057 4,34865-69 1,832 1,992 2,134 2,529 2,764 3,216 3,681 4,007 4,557 4,883 5,398 5,83070-79 2,421 2,860 3,280 3,822 4,535 5,347 5,964 6,978 7,825 8,518 9,635 10,61580+ 653 776 907 1,093 1,372 1,675 1,969 2,456 2,933 3,345 3,733 4,417Unknown

0-19 98 107 70 94 99 109 112 112 139 129 213 14620-44 1,621 1,770 1,872 1,907 2,200 2,343 2,676 2,914 3,147 3,332 3,718 3,78245-64 4,365 4,719 5,188 5,844 6,203 7,229 7,705 8,124 9,043 9,452 10,272 10,89165-74 3,268 3,721 4,094 4,769 5,384 6,280 7,011 7,912 8,856 9,493 10,604 11,64175+ 1,638 1,907 2,227 2,675 3,287 3,958 4,603 5,529 6,459 7,253 8,162 9,221Unknown

Male 6,231 7,008 7,570 8,549 9,482 11,054 12,330 13,603 15,172 16,105 17,688 18,940Female 4,759 5,216 5,881 6,740 7,691 8,865 9,777 10,988 12,472 13,554 15,281 16,741Unknown . . . . . . . . . . . .

White 7,927 8,882 9,839 11,085 12,385 14,242 15,617 17,420 19,497 20,553 22,982 24,850Black 2,774 3,027 3,229 3,831 4,378 5,183 5,911 6,537 7,339 8,292 9,075 9,902Native American 25 29 80 91 122 155 195 225 273 293 350 351Asian 14 11 57 78 127 184 233 261 318 338 479 497Other/unknown 250 275 246 204 161 155 151 148 217 183 83 81


Diabetes 1,226 1,700 2,405 3,249 3,934 5,029 6,035 6,985 8,021 9,045 10,830 12,451Hypertension 1,208 1,693 2,370 3,008 3,826 4,777 5,331 6,388 7,480 8,506 9,863 10,957Glomerulonephritis 983 1,208 1,522 1,763 2,045 2,379 2,757 3,071 3,545 3,667 4,114 4,126Cystic kidney 262 336 363 454 539 619 720 686 810 814 895 861Other urologic 147 214 321 418 453 593 738 820 892 981 995 975Other cause 634 791 1,018 1,372 1,658 1,925 2,131 2,386 2,490 2,695 3,072 3,249Missing disease 5,550 5,234 4,281 3,927 3,581 3,123 2,952 2,769 2,604 2,041 1,380 1,218Unknown cause 980 1,048 1,171 1,098 1,137 1,474 1,443 1,486 1,802 1,910 1,820 1,844

<2 years 7,049 7,505 7,983 8,889 9,729 11,017 11,971 13,546 15,138 15,900 18,104 19,2502-<5 years 3,230 3,748 3,683 4,155 4,674 5,606 6,265 6,632 7,490 8,185 8,795 9,9525+ years 711 971 1,785 2,245 2,770 3,296 3,871 4,413 5,016 5,574 6,070 6,479

All 10,990 12,224 13,451 15,289 17,173 19,919 22,107 24,591 27,644 29,659 32,969 35,681

The age of patient is determined as of the date of death.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table H.1Total patient deaths: ESRD patientsby demographic characteristics, primary diagnosis, & patient vintage

Patient age is determined as of the date of death.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

501


Table H.1 (continued)Total patient deaths: ESRD patientsby demographic characteristics, primary diagnosis, & patient vintage

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 47 35 41 42 29 40 32 43 38 53 38 335-9 16 19 11 16 18 13 13 20 13 20 10 2110-14 21 22 21 26 22 26 15 34 20 17 29 3315-19 49 54 56 61 54 55 54 57 58 55 52 7820-29 610 587 572 600 590 544 526 547 537 589 614 57230-39 2,039 2,143 2,243 2,358 2,339 2,245 2,186 2,308 2,208 2,258 2,231 2,14640-49 3,468 3,703 4,058 4,552 4,724 4,870 5,031 5,355 5,489 5,844 5,972 5,94050-59 5,388 6,073 6,646 7,194 7,629 8,174 8,843 9,937 10,373 11,148 11,613 12,12660-64 4,769 4,990 5,296 5,665 5,929 6,214 6,657 7,232 7,417 7,778 7,892 8,53765-69 6,415 6,902 7,226 7,801 8,162 8,609 8,967 9,325 9,649 10,018 10,031 10,39170-79 12,481 13,917 14,816 16,515 18,077 19,145 20,966 22,687 23,343 24,255 24,845 25,13580+ 5,201 6,002 6,926 7,745 8,741 10,034 11,364 12,819 13,920 15,192 16,581 17,576Unknown

0-19 133 130 129 145 123 134 114 154 129 145 129 16520-44 4,252 4,408 4,629 4,987 4,963 4,826 4,870 5,053 5,012 5,135 5,229 5,04845-64 12,022 13,088 14,186 15,382 16,248 17,221 18,373 20,326 21,012 22,482 23,093 24,27365-74 13,361 14,470 15,384 16,728 17,701 18,552 19,712 20,691 21,247 21,932 22,312 22,55875+ 10,736 12,351 13,584 15,333 17,279 19,236 21,585 24,140 25,665 27,533 29,145 30,544Unknown

Male 21,402 23,318 25,165 27,472 29,560 31,106 33,646 36,542 38,103 40,482 41,997 43,901Female 19,102 21,123 22,744 25,100 26,754 28,863 31,008 33,821 34,960 36,742 37,911 38,679Unknown . * * * . . . * * * . *

White 28,218 30,675 32,555 35,450 37,739 40,211 43,326 46,648 48,577 51,248 53,231 54,865Black 11,122 12,433 13,707 15,099 16,032 16,877 18,159 20,112 20,720 22,087 22,575 23,446Native American 406 439 501 551 635 671 677 782 872 850 917 941Asian 614 716 961 1,177 1,404 1,540 1,705 1,922 1,916 2,121 2,225 2,396Other/unknown 144 184 188 298 504 670 787 900 980 921 960 940


Diabetes 14,418 16,455 18,025 20,480 22,980 25,061 28,047 31,200 32,345 34,815 35,879 37,242Hypertension 12,293 13,836 15,012 16,085 16,267 17,365 18,289 19,615 20,389 21,413 22,240 23,028Glomerulonephritis 4,423 4,626 4,923 5,370 5,617 5,760 5,897 6,237 6,322 6,340 6,492 6,522Cystic kidney 923 1,024 1,018 1,170 1,174 1,236 1,226 1,311 1,311 1,467 1,415 1,417Other urologic 1,082 1,115 1,035 1,261 1,497 1,595 1,704 1,917 2,069 2,145 2,260 2,287Other cause 3,509 3,846 4,307 4,800 5,379 5,548 5,852 6,416 6,668 7,099 7,641 7,928Missing disease 1,708 1,324 1,391 1,060 1,005 925 1,015 1,000 1,052 885 874 971Unknown cause 2,148 2,221 2,201 2,349 2,395 2,479 2,624 2,668 2,909 3,063 3,107 3,193

<2 years 22,035 23,232 24,770 26,260 27,771 29,327 31,887 34,492 35,228 36,792 37,588 38,5832-<5 years 11,424 13,096 14,149 15,950 17,097 17,940 19,125 20,657 21,382 22,597 23,538 23,9735+ years 7,045 8,119 8,993 10,365 11,446 12,702 13,642 15,215 16,455 17,838 18,782 20,032

All 40,504 44,447 47,912 52,575 56,314 59,969 64,654 70,364 73,065 77,227 79,908 82,588


Table H.1 (continued)Total patient deaths: ESRD patientsby demographic characteristics, primary diagnosis, & patient vintage



502

Reference section H

Table H.1 (continued)Total patient deaths: ESRD patients, with unknowns droppedby demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 * 11 * 11 22 22 28 30 42 39 53 425-9 13 16 10 * * 12 13 12 14 12 30 1510-14 21 * * * 17 18 22 18 25 24 40 2215-19 38 53 27 54 39 42 40 49 51 43 79 5320-29 300 335 325 355 358 374 419 420 478 513 523 48330-39 725 756 876 857 1,035 1,126 1,321 1,417 1,510 1,514 1,710 1,69440-49 1,004 1,171 1,153 1,303 1,449 1,559 1,831 1,982 2,153 2,303 2,718 2,89150-59 2,010 2,147 2,349 2,757 2,761 3,209 3,319 3,564 3,921 4,159 4,436 4,72160-64 1,335 1,492 1,724 1,925 2,256 2,607 2,864 3,030 3,363 3,522 3,877 4,16365-69 1,640 1,789 1,892 2,305 2,558 2,946 3,405 3,754 4,262 4,567 5,116 5,59570-79 2,104 2,463 2,888 3,430 4,145 4,889 5,502 6,471 7,167 7,871 9,057 10,00480+ 576 679 795 988 1,234 1,497 1,764 2,226 2,656 3,031 3,437 4,079

0-19 81 89 52 81 86 94 103 109 132 118 202 13220-44 1,442 1,607 1,715 1,757 2,061 2,169 2,520 2,743 2,936 3,094 3,474 3,52745-64 3,932 4,294 4,712 5,440 5,798 6,706 7,234 7,670 8,489 8,917 9,790 10,42565-74 2,882 3,280 3,635 4,314 4,963 5,767 6,501 7,394 8,223 8,874 10,022 11,09575+ 1,438 1,651 1,940 2,409 2,974 3,565 4,170 5,057 5,862 6,595 7,588 8,583

Male 5,554 6,213 6,791 7,812 8,738 10,136 11,420 12,680 14,047 14,916 16,645 17,852Female 4,221 4,708 5,263 6,189 7,144 8,165 9,108 10,293 11,595 12,682 14,431 15,910

White 7,179 8,076 8,936 10,228 11,530 13,173 14,560 16,365 18,212 19,266 21,731 23,558Black 2,558 2,808 2,991 3,616 4,115 4,812 5,565 6,148 6,881 7,736 8,564 9,396Native American 24 27 72 87 118 146 184 217 254 282 334 339Asian 14 10 55 70 119 170 219 243 295 314 447 469


Diabetes 1,190 1,641 2,362 3,216 3,913 5,009 6,017 6,970 7,993 9,022 10,816 12,428Hypertension 1,201 1,675 2,350 2,988 3,814 4,764 5,323 6,385 7,466 8,485 9,846 10,943Glomerulonephritis 960 1,181 1,494 1,745 2,032 2,367 2,743 3,061 3,527 3,650 4,107 4,117Cystic kidney 259 331 361 449 538 615 718 686 806 810 895 861Other urologic 147 211 318 416 451 590 737 820 888 976 993 974Other cause 619 783 1,010 1,364 1,650 1,917 2,127 2,378 2,482 2,689 3,069 3,246Missing disease 5,399 5,099 4,159 3,823 3,484 3,039 2,863 2,673 2,480 1,966 1,350 1,193

<2 years 6,421 6,834 7,301 8,332 9,182 10,341 11,287 12,770 14,125 14,874 17,152 18,2032-<5 years 2,798 3,319 3,267 3,716 4,267 5,153 5,874 6,284 7,046 7,670 8,322 9,4875+ years 556 768 1,486 1,953 2,433 2,807 3,367 3,919 4,471 5,054 5,602 6,072

All 9,775 10,921 12,054 14,001 15,882 18,301 20,528 22,973 25,642 27,598 31,076 33,762

The age of patient is determined as of the date of death.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed.


Patient age is determined as of the date of death.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed.

503



1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 41 32 36 36 25 32 27 36 33 42 31 305-9 15 17 10 16 17 13 13 17 12 18 10 1810-14 19 20 20 21 17 24 13 31 17 13 27 2715-19 46 47 51 57 49 53 44 53 51 48 48 7220-29 555 540 532 550 544 504 496 501 495 544 580 53530-39 1,867 1,964 2,049 2,187 2,162 2,111 2,061 2,171 2,068 2,100 2,102 2,02640-49 3,255 3,486 3,846 4,318 4,443 4,630 4,756 5,078 5,188 5,567 5,684 5,66350-59 5,140 5,795 6,381 6,916 7,298 7,791 8,415 9,525 9,883 10,644 11,093 11,58960-64 4,556 4,787 5,086 5,428 5,698 5,953 6,372 6,890 7,056 7,455 7,546 8,17765-69 6,093 6,600 6,918 7,474 7,826 8,213 8,566 8,932 9,238 9,621 9,616 9,96270-79 11,811 13,211 14,124 15,710 17,180 18,171 19,932 21,626 22,221 23,088 23,674 23,96980+ 4,830 5,560 6,482 7,231 8,187 9,350 10,575 11,969 12,949 14,134 15,464 16,421

0-19 121 116 117 130 108 122 97 137 113 121 116 14720-44 3,912 4,069 4,294 4,645 4,594 4,551 4,589 4,747 4,697 4,823 4,959 4,78445-64 11,461 12,503 13,600 14,754 15,551 16,438 17,511 19,418 19,993 21,487 22,046 23,20665-74 12,706 13,819 14,736 16,002 16,906 17,687 18,807 19,816 20,298 21,003 21,353 21,62375+ 10,028 11,552 12,788 14,413 16,287 18,047 20,266 22,711 24,110 25,840 27,401 28,729

Male 20,094 21,918 23,746 25,975 27,958 29,354 31,797 34,590 35,904 38,217 39,693 41,570Female 18,134 20,136 21,786 23,968 25,488 27,491 29,473 32,238 33,307 35,057 36,182 36,912



Diabetes 14,392 16,422 17,986 20,385 22,771 24,693 27,612 30,701 31,774 34,264 35,317 36,704Hypertension 12,284 13,810 14,991 16,030 16,203 17,278 18,179 19,485 20,250 21,265 22,099 22,876Glomerulonephritis 4,415 4,617 4,913 5,354 5,592 5,730 5,862 6,184 6,265 6,283 6,428 6,452Cystic kidney 923 1,023 1,017 1,169 1,170 1,229 1,220 1,307 1,301 1,453 1,405 1,411Other urologic 1,079 1,112 1,034 1,243 1,475 1,575 1,690 1,897 2,046 2,128 2,243 2,265Other cause 3,502 3,839 4,287 4,769 5,332 5,504 5,798 6,353 6,587 7,038 7,567 7,853Missing disease 1,633 1,236 1,307 994 903 836 909 902 988 843 816 928


All 38,228 42,059 45,535 49,944 53,446 56,845 61,270 66,829 69,211 73,274 75,875 78,489





504

Reference section H

ON OUR WEBSITE & CDAnnual mortality rates per 1,000 patient years at risk: ESRD patients, by primary diagnosis, adjusted (H.2.1). Annual deaths per 1,000 patients: ESRD patients, by primary diagnosis (H.2.2). ESRD patients: counts of total deaths, by primary diag-nosis (H.2.3). Annual mortality rates: ESRD patients, unadjusted (H.2.4).

Table H.2Annual mortality rates per 1,000 patient years at risk: ESRD patientsperiod prevalent patients; 200 ESRD patients used as reference

Table H.2Annual mortality rates per 1,000 patient years at risk: ESRD patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 116.7 105.6 69.4 53.8 71.0 71.0 78.0 73.0 62.7 63.3 66.7 97.25-9 61.6 51.6 41.5 21.8 25.5 33.5 26.4 20.7 11.3 21.3 15.5 20.410-14 40.6 20.9 20.3 12.7 15.5 34.3 22.7 20.7 22.3 19.1 13.2 14.615-19 27.3 35.5 20.3 34.2 26.4 26.1 23.9 24.0 23.9 19.5 16.9 20.520-29 49.0 48.9 42.8 42.9 38.5 39.8 40.1 38.2 44.0 42.2 39.8 38.430-39 79.5 72.8 75.5 66.0 71.7 68.2 69.2 70.5 67.2 65.1 65.8 60.440-49 111.6 109.6 99.0 98.8 95.3 97.1 102.5 96.3 96.0 90.9 92.1 89.050-59 153.0 150.6 150.7 160.0 151.6 161.3 155.0 154.1 156.9 152.2 146.8 140.560-64 228.3 212.9 215.4 212.8 220.5 227.0 229.9 223.2 225.5 219.9 208.5 206.365-69 288.6 280.7 275.1 287.8 274.6 286.6 293.0 276.7 282.0 276.9 274.4 261.970-79 351.4 356.1 351.3 351.1 358.1 368.2 361.2 364.4 364.9 364.3 356.1 342.880+ 521.1 541.5 526.2 482.9 511.0 514.1 512.5 483.8 518.7 515.1 472.1 476.8

Male 161.8 163.5 159.2 161.2 163.8 172.2 175.6 173.2 177.1 175.0 171.0 167.3Female 159.0 151.9 154.1 159.8 164.0 169.8 170.7 170.5 176.0 175.2 175.6 175.0




<2 years 193.3 191.0 190.0 196.1 208.0 221.5 221.7 223.6 229.2 224.4 222.4 219.62-5 yrears 141.0 142.3 142.8 145.4 144.2 153.0 160.9 156.5 166.1 168.0 165.0 165.35+ years 79.0 88.1 90.5 105.8 105.1 106.4 110.1 109.4 109.2 109.8 108.2 103.5

All 160.6 158.3 156.9 160.6 163.9 171.1 173.3 172.0 176.6 175.1 173.1 170.8

ADJUSTED0-19 51.8 54.9 44.8 47.9 45.6 52.9 56.1 49.3 45.3 40.5 37.2 40.720-44 92.9 91.4 88.4 84.4 84.2 82.3 83.1 79.4 80.7 76.8 75.6 72.045-64 172.0 170.3 169.5 179.4 175.9 183.3 183.1 178.4 177.7 169.6 161.8 154.565-74 278.0 293.2 294.6 308.0 301.9 311.8 312.5 305.9 305.1 296.9 289.0 277.375+ 386.5 381.4 395.3 407.0 425.6 428.0 423.4 414.9 425.3 422.5 409.5 395.8

Male 218.6 220.3 219.9 226.3 224.7 231.6 231.1 226.6 228.4 221.4 211.5 201.0Female 200.0 200.1 201.2 209.3 208.5 213.4 210.3 206.1 206.9 201.1 195.7 190.3




All 209.6 210.7 210.9 218.1 216.9 223.2 221.7 217.1 218.4 211.8 204.1 196.2

Reference cohort is 2001 prevalent ESRD patients. Overall mortality rates are adjusted for age, gender, race, primary diagnosis, & vintage.Mortality rates for primary diagnosis are adjusted for age, gender, race, & vintage.Mortality rates for age are adjusted for gender, race, primary diagnosis, & vintage.Mortality rates for gender are adjusted for age, race, primary diagnosis, & vintage.Mortality rates for race are adjusted for gender, age, primary diagnosis, & vintage.Mortality rates for vintage are adjusted for gender, age, race, & primary diagnosis.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year. Patient age is determined on January 1 of each calendar year. Patients of unknown age, gender are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Reference cohort is 2001 prevalent ESRD patients. Overall mortality rates are adjusted for age, gender, race, primary diagnosis, & vintage.Adjusted rates for one of the five variables are adjusted for the other four.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year. Patient age is determined on January 1 of each calendar year. Patients of unknown age or gender are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

505


Table H.2 (continued)Annual mortality rates per 1,000 patient years at risk: ESRD patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 87.7 70.2 67.1 64.4 48.7 78.1 47.9 68.2 65.4 79.0 60.2 59.95-9 17.7 16.4 10.4 16.6 17.6 13.6 12.6 19.5 15.5 18.0 9.7 17.310-14 18.2 15.6 12.8 13.2 13.9 14.6 9.0 20.1 8.2 7.3 15.6 18.215-19 22.4 19.2 21.3 23.0 18.6 18.6 20.4 16.4 18.6 17.8 16.1 21.620-29 40.2 38.3 36.6 37.1 37.2 32.8 31.4 33.8 31.1 34.7 35.9 34.030-39 61.7 63.0 61.2 62.3 60.9 57.2 54.9 57.0 53.4 55.1 53.1 50.140-49 90.4 86.7 86.1 89.6 85.3 83.7 81.8 82.7 80.3 83.1 82.0 79.450-59 137.3 140.6 138.6 138.7 136.3 133.5 131.3 134.0 128.8 129.4 126.2 124.160-64 207.2 205.4 196.8 196.9 194.1 190.5 188.2 192.9 185.6 182.7 175.0 179.565-69 258.2 256.8 250.0 250.2 247.8 243.3 244.7 242.3 238.4 236.7 229.5 225.370-79 347.3 348.3 334.8 335.2 337.3 328.1 332.9 339.4 331.6 329.8 325.7 317.780+ 476.9 475.7 469.0 474.4 470.6 478.9 485.0 502.0 488.1 490.6 489.3 480.5

Male 170.2 171.4 168.6 171.3 171.6 167.8 169.5 173.3 169.9 172.1 169.9 170.0Female 178.3 182.3 179.5 183.5 183.0 184.8 186.8 192.9 188.7 190.4 188.8 185.4





All 174.0 176.4 173.6 176.9 176.8 175.6 177.4 182.3 178.5 180.4 178.4 176.9

ADJUSTED0-19 43.2 40.3 37.5 36.6 32.2 33.6 31.5 34.5 31.8 31.9 30.8 35.020-44 72.7 72.1 70.2 71.4 70.2 67.6 66.7 67.4 64.6 64.9 65.5 64.145-64 152.3 150.5 144.9 144.5 141.3 137.2 134.8 136.9 131.7 132.0 128.4 127.065-74 275.7 272.4 263.6 265.4 263.9 258.2 258.8 261.2 254.3 252.5 247.3 242.175+ 390.6 395.4 386.7 394.2 396.9 391.6 396.3 410.2 400.6 404.4 399.1 393.3

Male 198.8 197.7 191.2 191.5 189.9 183.8 182.5 184.9 178.8 179.0 175.3 173.2Female 190.3 190.8 185.8 187.2 184.8 182.4 182.7 187.1 181.8 182.3 179.6 176.1




All 194.8 194.3 188.5 189.4 187.3 182.9 182.5 185.8 180.0 180.4 177.1 174.3


Table H.2 (continued)Annual mortality rates per 1,000 patient years at risk: ESRD patientsperiod prevalent patients; 200 ESRD patients used as reference



506

Reference section H

Table H.3Total patient deaths: dialysis patientsby demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 * * * * * 10 15 14 12 17 18 265-9 * * * * * 10 * * * * * *10-14 * * * * * 10 10 * 14 13 13 1115-19 21 31 21 37 27 36 23 27 29 21 24 3120-29 230 251 244 238 247 281 306 296 372 402 391 38430-39 519 557 640 634 768 871 941 1,112 1,160 1,206 1,341 1,36640-49 817 895 904 1,036 1,146 1,301 1,473 1,566 1,719 1,844 2,110 2,29450-59 1,649 1,794 2,012 2,365 2,461 2,802 2,921 3,061 3,386 3,589 3,741 3,98760-64 1,174 1,267 1,547 1,711 2,088 2,390 2,599 2,748 3,043 3,192 3,371 3,61265-69 1,357 1,508 1,625 1,996 2,241 2,684 3,119 3,323 3,824 4,214 4,585 4,95670-79 1,701 2,041 2,401 2,882 3,706 4,376 4,866 5,619 6,395 7,181 8,054 9,00180+ 359 440 578 706 1,017 1,225 1,511 1,780 2,255 2,679 2,965 3,644

0-19 41 49 38 51 49 66 52 52 62 58 61 7720-44 1,095 1,200 1,273 1,290 1,534 1,689 1,874 2,116 2,261 2,450 2,687 2,80045-64 3,294 3,564 4,074 4,694 5,176 5,956 6,366 6,667 7,419 7,783 8,267 8,84365-74 2,382 2,764 3,075 3,712 4,397 5,210 5,870 6,486 7,376 8,127 8,939 9,88775+ 1,035 1,225 1,529 1,872 2,567 3,075 3,626 4,236 5,098 5,947 6,665 7,714

Male 4,320 4,956 5,518 6,336 7,427 8,712 9,731 10,582 11,911 12,985 13,972 15,260Female 3,527 3,846 4,471 5,283 6,296 7,284 8,057 8,975 10,305 11,380 12,647 14,061Unknown

White 5,582 6,337 7,152 8,225 9,743 11,198 12,303 13,534 15,312 16,500 18,130 20,050Black 2,077 2,252 2,558 3,113 3,643 4,400 5,013 5,504 6,285 7,198 7,728 8,503Native American 19 22 69 71 110 132 166 190 229 257 308 306Asian * * 36 57 102 154 205 234 270 284 408 417Other/unknown 161 183 174 153 125 112 101 95 120 126 45 45


Diabetes 1,065 1,403 1,964 2,712 3,297 4,257 5,106 5,954 6,857 7,748 9,199 10,602Hypertension 1,038 1,391 1,900 2,497 3,193 4,014 4,483 5,372 6,356 7,181 8,123 9,168Glomerulonephritis 834 984 1,232 1,432 1,698 1,967 2,256 2,516 2,949 3,016 3,295 3,392Cystic kidney 225 294 312 383 449 517 614 571 663 701 722 705Other urologic 114 172 252 342 382 492 629 695 752 833 834 803Other cause 555 658 835 1,091 1,355 1,561 1,769 1,986 2,062 2,200 2,441 2,687Unknown cause 832 872 984 901 956 1,224 1,213 1,225 1,458 1,639 1,437 1,476Missing disease 3,184 3,028 2,510 2,261 2,393 1,964 1,718 1,238 1,119 1,047 568 488

<2 years 4,956 5,322 5,918 6,907 8,191 9,410 10,193 11,310 12,867 14,022 15,536 17,1952-<5 years 2,421 2,772 3,182 3,104 3,512 4,180 4,730 5,009 5,695 6,278 6,770 7,5725+ years 470 708 889 1,608 2,020 2,406 2,865 3,238 3,654 4,065 4,313 4,554

All 7,847 8,802 9,989 11,619 13,723 15,996 17,788 19,557 22,216 24,365 26,619 29,321All with unknowns dropped 6,854 7,747 8,831 10,565 12,642 14,660 16,474 18,237 20,638 22,600 25,137 27,800


Table H.3Total patient deaths: dialysis patientsby demographic characteristics, primary diagnosis, & patient vintage


507


Table H.3 (continued)Total patient deaths: dialysis patientsby demographic characteristics, primary diagnosis, & patient vintage

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 27 18 22 24 18 22 16 21 27 31 21 225-9 * 11 * * 10 * * 12 * 15 * 1410-14 17 14 11 13 14 15 12 21 * * 17 2515-19 31 30 29 38 31 35 31 37 32 35 31 4420-29 438 430 429 438 461 420 419 432 430 467 475 47930-39 1,526 1,625 1,696 1,838 1,873 1,748 1,713 1,845 1,756 1,798 1,791 1,72840-49 2,692 2,909 3,076 3,507 3,650 3,818 3,956 4,277 4,383 4,693 4,833 4,83450-59 4,475 4,911 5,356 5,841 6,190 6,644 7,186 8,045 8,424 9,148 9,579 9,96160-64 3,973 4,175 4,390 4,740 4,963 5,177 5,559 6,034 6,200 6,432 6,582 7,13665-69 5,396 5,921 6,158 6,609 6,992 7,319 7,618 7,971 8,150 8,499 8,522 8,77970-79 10,530 11,856 12,591 14,048 15,360 16,387 17,890 19,451 19,952 20,620 21,180 21,43080+ 4,262 4,993 5,721 6,464 7,275 8,213 9,258 10,477 11,451 12,600 13,735 14,623

0-19 84 73 69 80 73 81 66 91 73 89 73 10520-44 3,209 3,371 3,507 3,855 3,879 3,734 3,822 4,028 3,983 4,072 4,221 4,07945-64 9,895 10,679 11,440 12,509 13,258 14,073 15,011 16,605 17,210 18,466 19,039 20,05965-74 11,303 12,400 13,191 14,279 15,152 15,874 16,806 17,732 18,069 18,625 18,981 19,20175+ 8,885 10,370 11,279 12,842 14,475 16,045 17,960 20,167 21,484 23,094 24,456 25,631


White 22,866 24,986 26,298 28,749 30,686 32,597 35,123 37,923 39,436 41,578 43,438 44,737Black 9,571 10,822 11,857 13,188 14,083 14,820 15,907 17,673 18,159 19,431 19,796 20,622Native American 355 393 449 472 559 577 603 690 769 744 823 822Asian 525 609 797 1,015 1,205 1,350 1,464 1,641 1,671 1,836 1,940 2,107Other/unknown 59 83 85 141 304 463 568 696 784 757 773 787


Diabetes 12,473 14,234 15,531 17,624 19,870 21,663 24,187 27,051 27,985 30,121 31,159 32,448Hypertension 10,383 11,760 12,710 13,842 14,016 14,804 15,590 16,668 17,314 18,178 18,884 19,560Glomerulonephritis 3,717 3,852 4,022 4,406 4,560 4,664 4,781 5,085 5,114 5,107 5,283 5,285Cystic kidney 759 825 806 915 906 968 924 970 963 1,081 1,038 1,047Other urologic 939 947 866 1,006 1,209 1,276 1,358 1,550 1,669 1,764 1,841 1,870Other cause 2,875 3,134 3,431 3,769 4,230 4,375 4,629 5,101 5,313 5,574 6,012 6,165Unknown cause 1,682 1,758 1,749 1,876 1,912 1,963 2,094 2,100 2,337 2,436 2,488 2,563Missing disease 548 383 371 127 134 94 102 98 124 85 65 137




Table H.3 (continued)Total patient deaths: dialysis patientsby demographic characteristics, primary diagnosis, & patient vintage



508

Reference section H

ON OUR WEBSITE & CDAnnual mortality rates per 1,000 patient years at risk: dialysis patients, by primary diagnosis, adjusted (H.4.1). Annual deaths per 1,000 patients: dialysis patients, by primary diagnosis (H.4.2). Dialysis patients: counts of total deaths, by primary di-agnosis (H.4.3). Annual mortality rates: dialysis patients, unadjusted (H.4.4).

Table H.4Annual mortality rates per 1,000 patient years at risk: dialysis patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 111.7 135.2 90.5 79.3 94.3 91.1 113.9 100.3 98.0 115.6 120.4 169.15-9 75.7 61.5 47.6 26.1 36.5 68.8 23.0 21.2 33.9 39.6 33.4 49.110-14 40.3 30.4 24.1 19.3 21.4 46.8 34.0 24.3 44.4 40.6 42.0 31.415-19 35.2 42.1 28.1 50.9 39.0 47.6 38.3 40.0 36.6 28.2 26.1 35.520-29 67.6 68.8 64.2 60.0 57.9 62.5 66.0 64.1 77.7 75.1 69.2 66.530-39 94.6 91.3 95.6 85.8 94.9 98.8 102.1 113.8 108.3 106.9 109.2 101.040-49 119.9 120.6 109.9 116.9 112.3 121.2 132.9 131.4 134.0 127.6 129.6 126.350-59 160.2 157.6 159.6 171.5 165.2 177.9 176.4 179.3 188.3 185.3 179.4 173.760-64 230.5 217.2 219.3 217.9 224.5 234.5 239.8 237.6 243.9 243.4 230.8 230.165-69 290.1 282.6 277.0 289.3 276.9 289.9 297.0 283.6 290.2 287.8 285.3 275.870-79 352.0 357.0 351.8 352.2 359.4 369.6 362.8 366.4 367.8 367.4 359.8 347.680+ 521.2 541.1 526.8 481.9 511.3 514.2 513.9 485.1 519.8 516.3 472.9 477.5

Male 184.4 190.4 190.0 195.7 200.7 217.0 226.9 230.6 238.7 237.7 230.1 225.2Female 179.0 173.6 176.8 186.3 192.2 202.8 206.9 211.1 220.7 220.8 221.4 220.9





All 181.9 182.6 183.8 191.3 196.7 210.3 217.4 221.2 230.0 229.5 225.9 223.1

ADJUSTED0-19 66.6 68.7 56.0 67.5 62.4 79.4 81.3 71.7 67.6 61.2 59.8 69.120-44 113.0 114.5 112.0 109.8 109.0 112.1 116.9 118.8 122.8 118.7 116.7 111.845-64 184.1 181.7 181.4 193.6 190.9 201.6 205.1 205.0 209.3 204.2 196.2 189.565-74 291.0 305.0 304.7 317.3 310.9 322.1 323.8 319.7 320.9 314.1 306.2 297.075+ 404.0 397.4 410.6 418.8 436.4 441.4 437.6 431.6 443.7 442.0 428.8 417.1

Male 231.9 234.1 234.0 241.3 240.1 250.3 253.0 253.2 258.7 253.1 242.7 232.5Female 211.8 211.4 212.3 221.3 220.4 227.8 226.1 224.8 227.9 223.3 217.8 213.3




All 222.2 223.2 223.6 231.7 230.7 239.9 240.9 240.2 244.5 239.3 231.2 223.8


Table H.4Annual mortality rates per 1,000 patient years at risk: dialysis patientsperiod prevalent patients; 200 ESRD patients used as reference


509


Table H.4 (continued)Annual mortality rates per 1,000 patient years at risk: dialysis patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 158.1 132.3 116.9 117.3 89.3 128.2 88.4 121.5 139.9 151.7 108.5 119.05-9 53.8 54.1 32.5 38.4 51.1 36.0 40.0 55.1 33.7 62.7 17.5 56.410-14 46.1 34.8 30.5 30.9 40.2 38.6 27.4 57.0 19.1 21.1 33.6 52.215-19 42.3 30.7 34.7 40.2 33.1 34.7 34.5 33.3 37.8 40.1 33.3 44.020-29 71.8 64.9 63.8 63.8 63.3 54.8 53.2 55.5 52.2 56.1 58.5 59.330-39 104.9 106.0 103.3 105.0 104.8 95.3 92.7 95.9 89.3 91.1 88.8 83.440-49 131.9 128.7 124.8 130.7 124.2 123.4 119.8 123.4 120.1 124.6 124.3 122.350-59 174.5 175.9 174.7 175.5 172.1 170.2 169.9 174.4 168.6 171.1 169.4 167.360-64 233.6 233.6 224.1 224.5 223.4 220.3 221.4 227.7 220.7 218.4 212.3 219.365-69 272.5 273.0 268.6 269.0 269.2 266.9 269.0 270.0 266.0 267.2 261.3 259.070-79 352.9 355.2 341.4 342.5 345.8 337.9 343.3 351.4 344.8 344.9 342.8 335.880+ 478.0 475.9 469.7 475.5 472.0 480.3 486.4 504.2 490.2 493.4 492.8 484.5

Male 230.9 230.4 226.0 228.3 229.5 224.5 226.5 231.9 227.5 230.4 228.6 229.4Female 225.5 230.7 226.3 231.4 230.8 233.0 236.7 245.5 240.3 243.4 242.9 239.3





All 228.3 230.5 226.2 229.8 230.1 228.6 231.4 238.3 233.5 236.5 235.3 234.0

ADJUSTED0-19 78.4 71.1 63.8 63.2 59.3 62.7 57.9 65.8 61.4 66.6 59.3 68.820-44 114.3 113.1 110.1 112.8 111.9 108.4 106.8 107.8 102.9 102.1 103.4 101.745-64 190.1 189.6 183.3 183.7 181.3 178.4 177.2 181.3 175.7 176.9 174.7 173.965-74 298.0 295.7 287.5 290.8 291.7 289.0 291.3 296.4 290.5 291.1 289.1 286.475+ 413.4 417.1 407.4 415.5 420.4 417.2 423.6 439.6 429.8 435.1 432.0 426.8

Male 232.6 231.1 223.7 224.3 223.8 218.2 217.4 220.8 214.2 215.0 212.4 210.9Female 215.3 216.8 211.7 214.9 213.1 212.1 213.2 219.6 213.8 215.1 214.0 211.1




All 224.6 224.3 218.1 219.8 218.6 215.1 215.4 220.1 213.8 214.9 212.9 210.7


Table H.4 (continued)Annual mortality rates per 1,000 patient years at risk: dialysis patientsperiod prevalent patients; 200 ESRD patients used as reference



510

Reference section H

Table H.5Total patient deaths: dialysis patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 * * * * * 10 15 14 11 17 15 235-9 * * * * * 10 * * * * * *10-14 * * * * * 10 10 * 11 12 10 *15-19 21 31 21 37 27 36 23 27 27 18 19 2520-29 230 251 244 238 247 281 305 294 356 366 352 32930-39 519 557 640 633 768 871 941 1,097 1,117 1,118 1,220 1,20240-49 817 895 904 1,036 1,146 1,300 1,473 1,552 1,644 1,718 1,972 2,11150-59 1,649 1,794 2,012 2,365 2,461 2,802 2,921 3,053 3,326 3,486 3,599 3,79160-64 1,174 1,267 1,547 1,711 2,088 2,390 2,599 2,745 3,021 3,161 3,302 3,54565-69 1,357 1,508 1,625 1,996 2,241 2,684 3,119 3,322 3,808 4,194 4,556 4,92570-79 1,701 2,041 2,401 2,882 3,706 4,376 4,866 5,619 6,391 7,176 8,045 8,98380+ 359 440 578 706 1,017 1,225 1,511 1,780 2,255 2,679 2,965 3,643

0-19 41 49 38 51 49 66 52 52 56 51 49 6320-44 1,095 1,200 1,273 1,289 1,534 1,688 1,873 2,094 2,161 2,259 2,457 2,49045-64 3,294 3,564 4,074 4,694 5,176 5,956 6,366 6,647 7,303 7,590 7,988 8,48865-74 2,382 2,764 3,075 3,712 4,397 5,210 5,870 6,485 7,358 8,102 8,901 9,84375+ 1,035 1,225 1,529 1,872 2,567 3,075 3,626 4,236 5,096 5,947 6,665 7,708




Diabetes 1,065 1,403 1,964 2,712 3,297 4,257 5,106 5,937 6,761 7,597 9,004 10,340Hypertension 1,038 1,391 1,900 2,496 3,193 4,014 4,483 5,368 6,319 7,117 8,019 9,032Glomerulonephritis 834 984 1,232 1,432 1,698 1,967 2,256 2,505 2,909 2,934 3,174 3,246Cystic kidney 225 294 312 383 449 517 614 570 652 677 698 669Other urologic 114 172 252 342 382 492 629 694 748 824 827 792Other cause 555 658 835 1,091 1,355 1,561 1,769 1,982 2,032 2,151 2,371 2,601Unknown cause 832 872 984 901 956 1,223 1,213 1,224 1,452 1,620 1,417 1,445Missing disease 3,184 3,028 2,510 2,261 2,393 1,964 1,717 1,234 1,101 1,029 550 467



The age of patient is determined as of the date of Death.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed.

Table H.5Total patient deaths: dialysis patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage


511


Table H.5 (continued)Total patient deaths: dialysis patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 24 17 19 23 15 21 13 19 24 29 20 185-9 * * * * * * * 11 * * * 1310-14 12 12 * 10 10 12 * 14 * * 10 1515-19 29 20 17 27 25 24 19 28 23 24 18 3320-29 376 365 348 350 362 318 298 317 317 341 351 34130-39 1,346 1,430 1,468 1,566 1,541 1,403 1,392 1,462 1,371 1,406 1,406 1,34440-49 2,437 2,578 2,711 3,024 3,094 3,197 3,328 3,536 3,576 3,862 4,014 3,91350-59 4,244 4,627 4,914 5,369 5,641 5,962 6,375 7,111 7,341 7,918 8,271 8,48160-64 3,859 4,057 4,244 4,556 4,717 4,849 5,176 5,601 5,703 5,836 5,965 6,42965-69 5,343 5,835 6,054 6,455 6,769 7,067 7,356 7,624 7,748 8,051 8,018 8,19870-79 10,507 11,820 12,540 13,976 15,259 16,257 17,703 19,215 19,633 20,299 20,752 20,92880+ 4,262 4,993 5,719 6,461 7,272 8,209 9,253 10,469 11,437 12,580 13,701 14,589

0-19 72 57 51 64 58 64 47 72 59 69 50 7920-44 2,834 2,957 3,015 3,268 3,202 3,009 3,078 3,224 3,134 3,205 3,335 3,19445-64 9,428 10,100 10,670 11,597 12,153 12,720 13,491 14,803 15,174 16,158 16,672 17,31465-74 11,231 12,286 13,046 14,061 14,848 15,522 16,406 17,212 17,435 17,936 18,152 18,25275+ 8,881 10,362 11,267 12,831 14,452 16,011 17,906 20,096 21,383 22,994 24,319 25,463


White 22,222 24,236 25,384 27,621 29,316 31,097 33,460 35,975 37,317 39,250 41,003 41,972Black 9,317 10,487 11,389 12,638 13,422 13,971 14,999 16,578 16,875 18,040 18,274 18,954Native American 340 375 428 445 528 542 569 648 724 698 760 757Asian 508 583 763 977 1,149 1,272 1,352 1,538 1,528 1,644 1,776 1,897Other/unknown 59 81 85 140 298 444 548 668 741 730 715 722


Diabetes 12,133 13,805 14,995 17,005 19,061 20,715 23,100 25,720 26,497 28,424 29,379 30,468Hypertension 10,196 11,540 12,385 13,466 13,569 14,244 15,008 15,966 16,557 17,287 17,972 18,529Glomerulonephritis 3,550 3,628 3,751 4,064 4,136 4,208 4,285 4,542 4,453 4,468 4,582 4,441Cystic kidney 711 767 753 809 802 846 786 836 807 916 865 854Other urologic 921 932 837 974 1,171 1,235 1,304 1,490 1,583 1,664 1,721 1,754Other cause 2,772 2,999 3,270 3,578 4,007 4,088 4,325 4,743 4,937 5,188 5,552 5,684Unknown cause 1,631 1,713 1,698 1,802 1,836 1,899 2,021 2,013 2,234 2,332 2,393 2,438Missing disease 532 378 360 123 131 91 99 97 117 83 64 134




Table H.5 (continued)Total patient deaths: dialysis patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage



512

Reference section H

Table H.6Annual mortality rates per 1,000 patient years at risk: dialysis patients, never on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference

Table H.6Annual mortality rates per 1,000 patient years at risk: dialysis patients, never on transplant waitlistfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 175.7 222.1 155.7 161.5 184.1 151.1 212.4 218.2 209.7 254.4 238.7 350.45-9 124.1 106.6 96.1 51.6 76.1 164.5 59.4 64.3 125.8 91.6 75.8 131.910-14 63.0 50.1 41.9 36.1 41.9 95.0 81.6 72.2 112.2 139.5 155.2 100.315-19 52.1 65.4 44.1 84.9 65.8 88.1 76.7 97.7 91.1 70.7 65.0 85.820-29 86.3 90.9 88.1 85.5 85.3 96.5 109.6 120.8 156.7 151.8 142.7 135.430-39 109.2 108.1 115.4 106.5 122.6 131.7 144.6 174.8 170.7 166.0 173.5 158.040-49 127.5 130.4 120.3 130.4 128.1 143.3 165.6 177.0 181.5 172.7 179.4 175.750-59 161.9 160.1 163.5 177.1 172.5 188.7 192.7 204.7 217.5 214.8 209.5 203.160-64 230.7 217.7 220.3 219.5 226.9 238.6 246.7 248.9 256.8 257.7 243.9 246.565-69 290.1 282.7 277.1 289.6 277.3 290.9 299.6 288.3 295.9 294.6 292.5 283.770-79 352.0 357.1 351.9 352.3 359.6 369.8 363.2 367.2 368.7 368.5 361.2 349.280+ 521.2 541.1 526.8 481.9 511.3 514.2 514.0 485.5 520.1 516.6 473.2 477.5

Male 196.3 204.1 205.1 213.4 220.9 242.1 259.4 274.3 287.5 287.9 279.7 274.1Female 189.2 185.2 189.8 201.5 209.3 223.5 232.4 243.1 255.5 255.8 257.9 257.0




<2 years 220.9 219.7 221.1 231.4 246.7 267.3 277.2 293.4 303.6 295.6 291.4 285.82-<5 years 171.9 181.6 187.2 200.3 199.6 221.2 239.4 248.0 265.7 273.3 267.1 265.55+ years 114.0 127.1 132.9 152.3 156.5 166.3 182.9 193.1 203.1 211.3 210.7 208.1

All 193.1 195.4 198.0 207.8 215.4 233.2 246.4 259.0 271.7 271.9 268.9 265.6

ADJUSTED0-19 . . 81.3 101.2 95.7 126.7 136.5 139.4 138.1 132.3 128.0 145.520-44 . . 126.4 126.4 128.4 136.6 150.0 166.1 179.3 176.9 177.1 168.945-64 . . 184.9 198.1 196.8 210.3 218.7 225.9 234.2 230.6 223.6 217.365-74 . . 305.3 317.6 311.7 323.4 326.3 324.1 323.4 315.4 307.6 298.775+ . . 413.8 421.4 436.1 443.0 439.8 433.4 441.3 437.3 423.6 411.4

. .Male . . 239.5 247.7 247.8 261.0 268.6 276.7 285.8 281.3 271.7 260.9Female . . 218.0 227.7 227.8 237.5 239.3 243.4 248.2 243.7 238.9 234.1

. .White . . 252.6 263.3 265.2 278.6 282.5 290.3 297.5 291.5 284.5 277.7Black . . 184.6 196.0 194.1 205.1 214.1 218.8 225.8 227.2 219.2 213.0Other race . . 228.1 223.5 221.6 228.4 229.1 230.2 233.4 219.6 213.6 189.5

. .Diabetes . . 301.4 317.7 314.2 326.9 334.6 342.2 346.4 332.4 322.3 311.9Hypertension . . 184.4 192.5 197.3 212.6 213.5 221.8 230.7 231.3 229.1 225.4Glomerulonephritis . . 156.0 159.9 161.9 170.0 176.7 183.4 198.8 196.9 199.4 192.1Other cause . . 215.3 219.1 221.7 233.0 242.9 243.3 248.8 252.4 238.3 229.8

. .<2 years . . 249.3 253.0 255.6 268.9 272.5 277.8 283.9 275.5 265.2 254.62-<5 years . . 227.9 236.9 232.4 245.3 253.1 259.3 269.1 267.0 259.8 253.45+ years . . 195.7 214.1 215.1 223.5 229.7 237.7 244.3 243.2 241.0 236.1

. .All . . 229.1 238.2 238.3 250.2 255.5 261.6 268.7 264.0 256.8 249.0

Reference cohort is 2001 prevalent ESRD patients. Overall mortality rates are adjusted for age, gender, race, primary diagnosis, & vintage.Mortality rates for primary diagnosis are adjusted for age, gender, race, & vintage.Mortality rates for age are adjusted for gender, race, primary diagnosis, & vintage.Mortality rates for gender are adjusted for age, race, primary diagnosis, & vintage.Mortality rates for race are adjusted for gender, age, primary diagnosis, & vintage.Mortality rates for vintage are adjusted for gender, age, race, & primary diagnosis.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year. Patient age is determined on January 1 of each calendar year. Patients of unknown age, gender are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

513


Table H.6 (continued)Annual mortality rates per 1,000 patient years at risk: dialysis patients, never on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference


Table H.6 (continued)Annual mortality rates per 1,000 patient years at risk: dialysis patients, never on transplant waitlistfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 340.7 275.4 226.1 248.7 157.7 217.9 141.9 238.3 287.3 274.8 192.4 184.35-9 172.0 159.5 121.1 100.9 137.4 115.2 99.5 143.2 70.3 113.8 32.0 120.610-14 127.6 97.4 78.2 72.7 95.4 102.0 62.6 133.1 56.5 53.9 60.8 81.515-19 134.6 77.9 78.3 96.2 81.5 77.1 66.1 78.4 84.4 76.2 57.9 80.620-29 147.6 137.1 132.5 133.7 131.4 113.2 102.1 107.3 98.2 101.7 105.4 96.230-39 166.8 173.8 170.0 171.9 169.1 151.8 151.2 153.0 142.3 146.1 140.7 127.440-49 184.0 180.2 175.4 182.3 173.3 171.5 168.9 172.5 165.7 172.3 172.1 161.750-59 207.0 212.3 209.2 215.7 212.7 210.7 211.1 220.4 212.8 216.4 213.1 205.260-64 250.0 252.3 245.6 247.1 247.7 245.3 249.9 259.7 254.6 253.4 247.3 254.265-69 280.4 281.3 278.2 280.0 281.1 279.9 285.4 289.4 286.9 291.1 287.2 284.570-79 355.0 357.5 344.0 345.3 349.0 341.6 347.4 356.3 350.4 352.7 350.7 344.180+ 478.1 476.1 469.9 475.6 472.2 480.6 486.8 504.8 490.7 494.2 493.4 485.8

Male 281.4 282.9 278.2 282.1 283.3 277.8 281.5 288.8 284.0 287.2 284.0 280.4Female 263.1 270.2 265.2 271.7 272.4 274.4 280.1 291.9 285.6 290.7 289.9 282.8





All 272.3 276.6 271.7 276.9 277.9 276.1 280.8 290.4 284.8 288.9 286.9 281.6

ADJUSTED0-19 175.7 160.5 137.0 132.1 119.8 125.5 108.5 126.2 122.4 126.7 105.5 114.520-44 175.1 175.6 171.1 175.2 172.2 166.1 164.8 166.3 158.4 156.3 157.5 151.045-64 219.8 222.6 217.3 220.5 219.7 218.1 218.6 226.0 220.4 223.5 222.4 218.165-74 300.3 299.1 291.3 295.7 297.7 295.9 300.5 307.6 302.9 306.9 307.6 305.775+ 407.8 412.6 403.1 411.5 416.5 413.1 420.2 436.2 426.1 433.1 431.0 425.7

Male 262.9 263.5 255.9 258.5 258.1 252.2 252.3 257.5 250.8 252.6 250.1 245.9Female 238.4 242.0 237.2 242.0 241.2 240.8 243.5 252.6 245.6 248.8 248.6 243.5




All 251.9 253.5 247.3 250.9 250.2 246.8 248.2 255.1 248.2 250.6 249.2 244.5


514

Reference section H

Table H.7Total patient deaths: dialysis patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage

1987 1988 1989 1990 1991 1992 1993 19940-4 . . . * * . . *5-9 . . * . . . * .10-14 . * * . * * * *15-19 . * . * * * * *20-29 . * 16 20 19 23 25 3530-39 * 19 43 63 72 79 94 9940-49 * 34 51 57 75 92 142 15750-59 * 25 56 63 87 87 120 19860-64 . 10 18 32 31 47 43 5565-69 . * * 16 17 16 23 4470-79 . * * * * * 17 2280+ . . . . * . . *

0-19 . * * * * * * *20-44 10 43 84 114 129 147 185 21645-64 * 52 100 121 155 181 239 32865-74 . * 10 22 20 21 37 6275+ . * . . * * * *

Male 11 59 114 165 184 220 273 351Female * 49 82 95 130 133 197 264Unknown

White 12 66 138 180 223 248 309 390Black * 37 49 73 83 94 138 201Native American . * * * * * * 10Asian . * * * * * 16 14Other/unknown * * * . . . * .


Diabetes * 40 74 94 112 136 190 240Hypertension * 18 23 50 58 69 87 137Glomerulonephritis * 20 40 56 63 61 90 100Cystic kidney . * 12 10 16 13 21 15Other urologic . * * * * * * 12Other cause * 11 26 26 37 48 60 78Unknown cause . * 12 10 * 15 17 29Missing disease * 12 * * 10 * * *

<2 years * 37 75 75 98 113 157 2072-<5 years * 40 64 95 110 123 177 2085+ years * 31 57 90 106 117 136 200

All 19 108 196 260 314 353 470 615All with unknowns dropped 17 102 183 250 305 338 451 586

The age of the patient is determined as of the date of death.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table H.7Total patient deaths: dialysis patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage


515


Table H.7 (continued)Total patient deaths: dialysis patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage

1995 1996 1997 1998 1999 2000 2001 2002 20030-4 . . * * * * * * .5-9 . . * . . * . . .10-14 . * * * * . . * *15-19 * * * * * * * * *20-29 39 42 48 52 58 51 58 59 6230-39 126 158 157 169 209 183 204 191 19840-49 230 259 286 307 360 399 401 404 44050-59 218 263 355 414 469 600 676 692 77260-64 78 109 162 189 210 279 305 329 37965-69 60 108 125 110 161 182 231 250 28870-79 21 42 48 67 94 113 125 167 22180+ * * * . * * * * 11

0-19 * * 10 * * * * 11 1020-44 273 306 332 369 409 411 425 431 42745-64 418 525 676 762 897 1,101 1,219 1,244 1,42465-74 79 146 162 162 231 275 329 382 46175+ * * 14 15 25 21 35 44 59

Male 425 558 676 748 920 1,012 1,162 1,208 1,433Female 353 431 518 569 648 801 851 904 948Unknown

White 495 619 691 779 944 1,025 1,151 1,189 1,367Black 253 325 422 438 535 658 711 760 821Native American 10 14 25 16 15 18 24 25 40Asian 20 27 43 67 55 79 105 92 113Other/unknown . * 13 17 19 33 22 46 40

†Hispanic 84 105 158 174 196 258 315 332†Non-Hispanic 905 1,089 1,159 1,394 1,617 1,755 1,797 2,049

Diabetes 288 401 494 593 713 805 969 1,000 1,089Hypertension 162 205 267 245 302 382 423 445 474Glomerulonephritis 138 192 197 214 254 286 284 286 389Cystic kidney 46 35 48 51 48 70 57 75 91Other urologic 15 14 17 27 25 41 38 56 55Other cause 94 103 144 152 181 167 195 212 225Unknown cause 32 37 25 35 45 58 46 38 56Missing disease * * * . . * * . *

<2 years 236 290 339 364 402 451 472 423 4292-<5 years 295 386 461 514 632 729 886 956 9955+ years 247 313 394 439 534 633 655 733 957

All 778 989 1,194 1,317 1,568 1,813 2,013 2,112 2,381All with unknowns dropped 746 949 1,156 1,266 1,504 1,722 1,947 2,029 2,286


Table H.7 (continued)Total patient deaths: dialysis patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage



516

Reference section H

Table H.8Annual mortality rates per 1,000 patient years at risk: dialysis patients, on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference

Reference cohort is 2001 prevalent ESRD patients. Overall mortality rates are adjusted for age, gender, race, primary diagnosis, & vintage.Adjusted rates for one of the five variables are adjusted for the other four.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year. Patient age is determined on January 1 of each calendar year. Patients of unknown age or gender are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table H.8Annual mortality rates per 1,000 patient years at risk: dialysis patients on transplant waitlistfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1987 1988 1989 1990 1991 1992 1993 1994 19950-4 . . 75.7 72.1 54.8 . . 47.7 .5-9 . . . . . . 22.2 . .10-14 . 49.9 12.7 . 30.9 20.3 18.9 9.6 12.815-19 . 6.7 . 11.2 11.0 4.5 20.9 8.1 14.220-29 . 9.3 18.5 21.9 21.3 22.3 18.9 25.3 29.530-39 11.6 16.5 34.4 41.2 39.4 38.2 40.8 37.0 41.040-49 16.0 37.6 42.0 32.9 38.7 43.4 52.7 48.4 61.250-59 11.8 35.9 66.7 62.6 66.1 53.4 58.7 79.4 71.160-64 . 67.0 84.9 105.4 92.4 109.6 83.5 68.9 82.465-69 . 99.8 83.8 103.1 109.4 85.7 65.6 108.6 101.470-79 . 378.8 62.9 200.6 118.5 56.1 164.7 151.1 120.180+ . . . . 609.8 . . 313.0 383.7

Male 10.3 27.5 43.6 49.0 46.2 49.5 48.5 53.1 54.8Female 8.1 27.7 37.4 36.4 44.0 36.5 47.6 51.3 60.9

White 9.2 26.4 46.3 49.4 54.2 53.0 55.2 58.5 66.4Black 7.7 29.4 30.8 36.3 34.2 31.9 37.7 45.9 48.7Other race 26.0 31.7 35.4 19.3 19.1 23.3 40.7 32.9 31.1


Diabetes 40.1 73.0 105.6 100.3 97.2 92.3 96.9 101.5 102.4Hypertension 7.5 24.6 23.9 40.2 39.3 38.6 39.0 48.1 49.4Glomerulonephritis 3.6 15.6 25.0 28.0 28.6 26.2 32.6 30.5 35.3Other cause 7.4 23.2 38.2 33.6 38.8 35.4 36.1 41.1 51.6

<2 years 9.6 26.1 39.8 30.3 34.6 35.7 39.3 44.3 45.42-<5 years 6.8 34.9 45.2 53.5 53.7 49.4 57.7 57.0 67.15+ years 10.9 23.1 37.8 50.7 50.6 49.1 50.0 58.6 63.1

All 9.2 27.6 40.8 43.4 45.3 43.8 48.1 52.3 57.4

ADJUSTED0-19 . . 30.1 40.8 45.1 26.5 33.5 22.8 25.220-44 . . 44.5 49.0 49.4 45.2 46.6 47.8 53.145-64 . . 84.1 77.5 79.7 73.5 77.1 81.2 82.165-74 . . 115.0 130.1 108.5 92.1 99.2 120.9 123.575+ . . 213.2 66.3 381.1 222.2 261.1 200.6 170.5

. .Male . . 100.2 82.0 127.6 106.5 119.0 106.5 99.1Female . . 97.9 69.6 98.3 65.5 73.9 88.0 86.6

. .White . . 123.1 90.6 139.8 105.4 120.7 120.9 106.7Black . . 46.7 55.4 69.3 52.7 58.1 59.4 70.7Other race . . 118.5 68.0 55.1 81.0 64.4 65.3 80.7

. .Diabetes . . 156.6 119.2 161.8 133.3 158.6 153.2 136.4Hypertension . . 65.6 60.3 96.4 75.1 78.4 84.5 77.5Glomerulonephritis . . 53.9 46.7 80.2 58.7 51.0 57.3 65.2Other cause . . 91.1 69.3 98.5 65.3 67.8 62.9 71.1

. .<2 years . . 79.3 48.2 74.9 58.1 68.5 71.9 66.32-<5 years . . 108.3 86.7 133.6 97.7 114.2 104.8 102.35+ years . . 126.6 112.2 175.1 133.0 141.4 142.8 129.4

. .All . . 98.5 76.5 113.9 87.3 97.9 97.8 92.7

Reference cohort is 2001 prevalent ESRD patients. Overall mortality rates are adjusted for age, gender, race, primary diagnosis, & vintage.Mortality rates for primary diagnosis are adjusted for age, gender, race, & vintage.Mortality rates for age are adjusted for gender, race, primary diagnosis, & vintage.Mortality rates for gender are adjusted for age, race, primary diagnosis, & vintage.Mortality rates for race are adjusted for gender, age, primary diagnosis, & vintage.Mortality rates for vintage are adjusted for gender, age, race, & primary diagnosis.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year. Patients of unknown age, gender are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

517


Table H.8 (continued)Annual mortality rates per 1,000 patient years at risk: dialysis patient, on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference


Table H.8 (continued)Annual mortality rates per 1,000 patient years at risk: dialysis patients on transplant waitlistfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1996 1997 1998 1999 2000 2001 2002 20030-4 . 109.6 118.2 58.3 50.6 53.6 63.3 .5-9 . . . . 30.7 . . .10-14 24.7 10.5 21.3 22.8 11.5 11.1 40.9 36.415-19 23.6 32.2 22.6 12.4 17.6 29.6 31.0 49.620-29 28.6 27.8 30.3 33.9 28.7 38.7 47.7 70.430-39 51.0 49.1 47.4 58.5 51.4 57.2 65.0 92.840-49 58.6 65.1 62.6 69.9 76.1 80.8 92.1 138.750-59 73.2 85.2 87.9 90.1 108.5 115.8 135.1 196.860-64 94.9 111.1 111.0 113.2 133.0 131.3 145.2 221.665-69 140.6 140.8 103.0 128.1 137.3 146.4 167.9 241.770-79 165.3 143.9 163.4 177.1 155.1 147.4 190.5 305.780+ 292.8 301.1 . 91.6 69.1 387.6 257.7 238.7

Male 63.1 68.3 68.7 79.2 82.9 93.9 108.6 170.9Female 64.9 73.5 71.6 77.5 92.6 96.2 115.7 161.2




<2 years 50.6 54.5 53.1 57.2 61.8 67.2 75.1 109.42-<5 years 71.8 75.8 73.9 83.1 91.0 104.4 121.1 165.95+ years 71.9 85.2 86.7 99.1 112.9 114.0 135.5 220.4

All 63.8 70.6 70.0 78.5 86.9 94.8 111.5 166.9

ADJUSTED0-19 32.2 48.9 60.7 49.3 42.0 45.2 57.7 73.520-44 56.9 62.2 61.8 67.8 68.3 69.2 78.2 105.945-64 86.3 93.5 92.3 101.2 110.9 115.6 127.9 186.565-74 153.9 165.2 140.2 149.0 156.1 155.5 174.7 255.975+ 150.3 201.8 196.5 234.7 185.9 182.5 206.5 296.9

Male 101.6 111.0 103.1 120.6 114.8 119.0 130.0 193.4Female 96.7 113.0 107.8 111.5 117.2 118.3 135.6 188.5



<2 years 69.6 77.0 71.4 77.7 76.2 78.7 88.4 127.22-<5 years 106.9 117.2 105.8 116.4 113.0 120.9 138.0 193.15+ years 142.6 170.5 165.7 188.2 184.8 183.9 199.5 293.5

All 99.1 112.1 105.5 116.6 115.6 118.6 132.3 190.8

Reference cohort is 2001 prevalent ESRD patients. Overall mortality rates are adjusted for age, gender, race, primary diagnosis, & vintage.Mortality rates for primary diagnosis are adjusted for age, gender, race, & vintage.Mortality rates for age are adjusted for gender, race, primary diagnosis, & vintage.Mortality rates for gender are adjusted for age, race, primary diagnosis, & vintage.Mortality rates for race are adjusted for gender, age, primary diagnosis, & vintage.Mortality rates for vintage are adjusted for gender, age, race, & primary diagnosis.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year. Patient age is determined on January 1 of each calendar year.Patients of unknown age, gender are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.


518

Reference section H

Table H.9Total patient deaths: dialysis patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19920-4 . . . . . . . * * . * * .5-9 * * . * . * * * . * * * *10-14 * * * * . * * * * * * * *15-19 * * * * * * * * 10 * 10 * *20-29 20 29 21 25 38 31 37 47 52 65 73 76 8130-39 31 30 45 49 76 103 115 139 154 178 165 209 20340-49 25 34 40 54 70 102 104 143 181 204 256 255 28450-59 25 29 35 55 71 65 117 112 154 144 185 216 22560-64 * * * * 10 32 27 30 43 54 65 65 8765-69 . * * * * 11 14 10 32 25 36 39 3570-79 * . . . . * * * * 12 16 20 2580+ * . . . . * . . . . . * *

0-19 * * * * * 12 * 11 19 14 16 14 1220-44 66 76 83 98 153 182 194 260 300 355 374 418 42145-64 43 50 64 91 112 151 206 211 284 290 370 403 45965-74 * * * * * 14 20 13 37 35 48 56 5375+ * . . . . * . * . * * * *

Male 75 91 98 120 177 249 290 320 399 430 507 538 604Female 41 43 57 76 103 112 137 177 241 266 305 357 350Unknown

White 91 97 115 132 214 261 288 326 441 486 547 588 655Black 21 33 34 53 60 92 125 153 186 199 245 289 280Native American . . . * * * * * * * * * 12Asian . . . . * * * * * * 12 * *Other/unknown * * * 10 * * * * * * * * *


Diabetes 20 14 27 39 50 66 76 105 136 155 190 201 231Hypertension * 10 20 30 36 59 62 64 103 121 137 175 187Glomerulonephritis 26 24 35 48 70 84 123 127 169 182 232 258 231Cystic kidney * * * * 13 20 25 22 37 32 41 46 57Other urologic * * * * * * * 13 11 * * 10 20Other cause * 15 12 13 27 39 60 66 98 93 126 147 147Unknown cause * 15 15 10 30 29 21 34 34 48 48 34 55Missing disease 40 48 39 45 52 56 58 66 52 56 33 24 26

<2 years 27 22 19 16 24 21 16 23 46 54 39 47 392-<5 years 67 84 100 84 98 133 133 158 162 188 200 210 2115+ years 22 28 36 96 158 207 278 316 432 454 573 638 704

All 116 134 155 196 280 361 427 497 640 696 812 895 954All with unknowns dropped 104 117 136 176 247 331 399 456 602 646 762 857 897

The age of of the patient is determined as of the date of death.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table H.9Total patient deaths: dialysis patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage


519


Table H.9 (continued)Total patient deaths: dialysis patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 * . . . . . . . . . *5-9 * . . * * * . * * * *10-14 * * * * * * * . . * *15-19 * 12 10 11 * * * * * * *20-29 56 64 64 78 72 84 81 86 94 86 7930-39 210 204 217 236 246 239 236 242 255 230 20940-49 299 301 338 389 464 411 480 508 532 519 54050-59 250 323 354 342 369 439 491 490 561 605 63660-64 104 105 113 125 160 176 181 189 225 221 25465-69 82 63 111 97 105 124 131 172 170 164 19870-79 30 46 44 62 74 98 104 123 146 177 15580+ * * * * * * * * * 13 *

0-19 16 14 14 16 12 11 14 * 13 12 1220-44 418 404 443 497 547 521 511 563 580 575 50845-64 501 593 643 673 764 828 958 952 1,087 1,086 1,21065-74 101 96 146 140 157 195 204 258 276 295 31175+ 16 20 15 20 23 30 35 42 47 59 49

Male 623 656 719 809 855 915 1,016 1,051 1,188 1,173 1,174Female 429 471 542 537 648 670 706 773 815 854 916Unknown

White 719 725 827 916 975 1,027 1,073 1,155 1,272 1,272 1,289Black 311 371 403 396 480 510 596 605 663 679 721Native American * 12 17 13 13 17 16 19 17 26 20Asian 12 18 14 21 34 31 37 43 50 47 57Other/unknown * * . . * . . * * * *


Diabetes 259 265 277 320 341 393 450 459 505 487 510Hypertension 224 270 300 284 331 338 398 378 434 454 448Glomerulonephritis 289 295 349 377 425 421 434 518 537 539 612Cystic kidney 54 56 75 95 114 96 105 99 120 101 114Other urologic 25 29 30 29 39 47 48 65 74 86 62Other cause 152 157 169 185 211 236 244 257 276 308 280Unknown cause 34 46 59 54 42 51 42 47 56 51 64Missing disease 15 * * * . * * * * * .

<2 years 39 39 25 24 17 13 12 11 16 11 172-<5 years 184 205 165 181 159 166 163 148 143 122 1345+ years 829 883 1,071 1,141 1,327 1,406 1,547 1,665 1,844 1,894 1,939

All 1,052 1,127 1,261 1,346 1,503 1,585 1,722 1,824 2,003 2,027 2,090All with unknowns dropped 1,016 1,080 1,202 1,292 1,460 1,534 1,680 1,775 1,946 1,973 2,023

The age of of the patient is determined as of the date of death.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table H.9 (continued)Total patient deaths: dialysis patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage



520

Reference section H

Table H.10Annual mortality rates per 1,000 patient YAR: dialysis patients, returned to dialysis from transplantfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 . . . . . . . 126.6 50.1 . 131.6 152.35-9 371.3 103.3 . 38.9 . 22.6 47.5 20.6 . 29.9 27.0 24.810-14 34.3 71.2 37.1 13.2 . 64.3 34.1 16.1 67.3 39.8 30.7 30.415-19 29.8 26.5 15.4 30.1 53.1 42.5 26.1 48.4 48.3 24.5 35.4 28.520-29 57.2 73.7 49.8 40.5 48.1 36.1 37.1 41.3 44.8 50.0 47.0 52.230-39 80.6 62.4 73.6 66.0 65.7 79.5 78.3 80.5 86.6 80.2 75.0 81.140-49 93.0 84.4 92.6 88.1 77.1 98.3 90.7 106.6 118.2 107.6 111.8 97.650-59 154.6 105.9 103.0 122.7 123.4 97.8 164.8 132.5 150.8 126.4 148.9 150.260-64 262.1 104.8 105.3 107.1 130.2 218.9 163.4 176.4 195.2 180.8 179.8 163.365-69 . 372.5 439.5 65.5 265.6 321.9 319.9 105.1 323.4 195.2 265.0 218.370-79 . . . . . 364.0 586.3 354.9 171.5 290.0 315.3 321.180+ . . . . . . . . . . . .

Male 87.4 80.2 74.8 68.0 70.6 89.9 96.2 91.4 103.5 92.1 98.4 96.6Female 90.3 69.3 71.4 74.8 75.6 64.6 69.4 78.4 91.1 86.9 89.7 90.9





All 88.4 76.4 73.6 70.5 72.4 80.5 85.9 86.3 98.7 90.1 94.9 94.3

ADJUSTED0-19 . . . . . . . . . 57.7 58.1 83.020-44 . . . . . . . . . 94.3 95.5 97.345-64 . . . . . . . . . 154.0 158.5 149.165-74 . . . . . . . . . 238.3 290.5 223.275+ . . . . . . . . . 318.1 452.0 288.2

. . . . . . . . .Male . . . . . . . . . 197.1 223.2 185.5Female . . . . . . . . . 157.3 204.3 154.1

. . . . . . . . .White . . . . . . . . . 210.7 250.7 203.3Black . . . . . . . . . 116.6 142.6 120.8Other race . . . . . . . . . 194.8 226.1 99.9

. . . . . . . . .Diabetes . . . . . . . . . 263.9 328.5 227.7Hypertension . . . . . . . . . 130.3 172.5 163.7Glomerulonephritis . . . . . . . . . 108.6 122.6 145.7Other cause . . . . . . . . . 168.8 145.7 122.5

. . . . . . . . .<2 years . . . . . . . . . 153.5 171.8 140.82-<5 years . . . . . . . . . 188.4 229.0 176.65+ years . . . . . . . . . 205.8 277.1 211.7

. . . . . . . . .All . . . . . . . . . 176.7 212.5 169.3


Table H.10Annual mortality rates per 1,000 patient YAR: dialysis patients, returned to dialysis from transplantperiod prevalent patients; 200 ESRD patients used as reference


521


Table H.10 (continued)Annual mortality rates per 1,000 patient YAR: dialysis patients, returned to dialysis from transplantfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 . 193.7 . . . 152.7 . . . 137.9 98.6 132.85-9 37.7 13.6 . 33.6 33.9 . 49.4 . 73.1 176.5 . 32.610-14 37.7 18.7 12.3 33.8 44.0 21.4 34.6 107.3 8.9 . 63.9 49.915-19 40.9 41.8 43.4 36.5 33.1 27.2 36.4 22.9 26.7 38.7 23.0 34.320-29 51.3 39.5 44.4 41.7 42.9 43.9 50.2 43.1 47.2 60.2 45.8 54.230-39 75.7 74.6 60.2 63.4 73.3 74.8 70.2 70.0 73.4 70.7 64.3 53.040-49 99.8 99.4 91.5 102.1 102.7 118.2 100.8 114.3 115.3 119.7 116.1 115.350-59 141.0 140.4 150.3 156.6 143.1 150.0 162.8 167.2 159.8 161.1 166.8 161.260-64 192.8 202.1 171.0 196.0 178.3 222.5 209.3 224.5 195.5 228.3 224.3 232.365-69 154.5 309.8 180.6 299.1 241.1 250.6 297.7 239.3 323.1 285.8 230.6 258.970-79 334.3 245.0 320.4 274.7 244.3 331.2 346.7 348.3 351.3 345.1 402.2 312.380+ 414.6 404.6 602.9 . 172.1 172.4 376.0 515.0 399.1 505.4 771.8 304.3

Male 101.6 96.6 91.0 96.6 101.2 106.9 108.4 116.2 116.9 126.8 119.0 115.3Female 82.7 96.0 90.7 105.1 96.8 115.2 112.0 113.1 118.5 119.6 123.6 125.4





All 94.0 96.4 90.9 100.1 99.4 110.3 109.9 114.9 117.6 123.8 120.9 119.5

ADJUSTED0-19 81.2 74.9 56.2 64.3 69.7 57.0 54.0 62.9 55.2 66.1 48.3 58.220-44 90.5 87.8 77.8 77.9 79.9 82.9 80.8 76.7 75.7 80.1 74.3 74.645-64 146.1 148.8 146.2 141.6 133.4 133.4 132.2 136.6 132.0 139.3 126.4 138.365-74 181.5 245.4 235.0 251.1 206.3 216.7 239.8 225.2 237.7 238.9 220.2 219.475+ 398.7 354.7 422.8 348.1 351.8 312.9 342.1 308.8 292.3 314.3 307.3 264.2

Male 196.8 176.5 188.3 174.1 169.8 161.8 167.8 162.3 159.6 172.1 159.0 155.3Female 137.7 172.5 177.4 169.8 150.1 148.9 161.4 151.1 148.3 147.0 139.4 147.4




All 169.2 176.2 183.6 171.3 159.9 154.8 164.9 157.6 154.4 160.0 149.1 151.3


Table H.10 (continued)Annual mortality rates per 1,000 patient YAR: dialysis patients, returned to dialysis from transplantperiod prevalent patients; 200 ESRD patients used as reference



522

Reference section H

Table H.11Total patient deaths: hemodialysis patientsby demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 * * * * * * * * * * * 105-9 * * * * * * . * * * * *10-14 * * * * * * * * * * * *15-19 21 26 16 27 20 28 13 18 18 15 15 2220-29 204 231 218 198 203 234 242 244 295 328 322 30330-39 446 477 544 532 640 701 722 887 917 954 1,088 1,08840-49 738 785 790 882 939 1,065 1,140 1,257 1,369 1,488 1,703 1,83450-59 1,468 1,611 1,780 2,060 2,113 2,323 2,393 2,517 2,770 2,969 3,094 3,24160-64 1,074 1,159 1,375 1,491 1,801 2,039 2,162 2,290 2,543 2,676 2,805 2,99365-69 1,248 1,366 1,482 1,765 1,991 2,311 2,645 2,794 3,208 3,617 3,909 4,13770-79 1,530 1,869 2,171 2,548 3,344 3,862 4,249 4,875 5,535 6,305 7,086 7,83480+ 315 393 515 603 916 1,086 1,335 1,591 2,019 2,408 2,691 3,293

0-19 35 37 25 33 27 37 28 32 35 34 29 3820-44 965 1,052 1,100 1,090 1,265 1,364 1,450 1,697 1,778 1,952 2,173 2,21145-64 2,965 3,211 3,607 4,073 4,431 4,998 5,209 5,498 6,116 6,463 6,839 7,24865-74 2,178 2,520 2,791 3,285 3,925 4,534 5,031 5,528 6,267 7,026 7,709 8,37975+ 915 1,108 1,377 1,631 2,326 2,725 3,198 3,732 4,495 5,304 5,977 6,885




Diabetes 864 1,156 1,634 2,199 2,733 3,493 4,092 4,860 5,654 6,506 7,694 8,801Hypertension 930 1,245 1,675 2,157 2,837 3,451 3,886 4,661 5,521 6,289 7,140 7,955Glomerulonephritis 742 890 1,091 1,250 1,480 1,653 1,854 2,095 2,432 2,476 2,734 2,806Cystic kidney 208 268 283 330 376 440 514 468 543 571 607 584Other urologic 105 151 225 298 326 431 551 612 656 742 745 700Other cause 499 598 758 955 1,189 1,353 1,483 1,677 1,732 1,899 2,086 2,271Unknown cause 739 791 878 789 846 1,052 1,025 1,042 1,223 1,420 1,247 1,241Missing disease 2,971 2,829 2,356 2,134 2,187 1,785 1,511 1,072 930 876 474 403




Table H.11Total patient deaths: hemodialysis patientsby demographic characteristics, primary diagnosis, & patient vintage


523


Table H.11 (continued)Total patient deaths: hemodialysis patientsby demographic characteristics, primary diagnosis, & patient vintage

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 11 * * 13 * * * * * 12 * 105-9 * * * * * * * * * * * *10-14 * * * * * * * 13 * * 11 1615-19 26 23 12 19 22 23 17 23 20 24 19 3520-29 354 349 321 350 370 354 343 353 376 411 417 40530-39 1,193 1,244 1,306 1,441 1,500 1,416 1,449 1,593 1,518 1,595 1,566 1,55040-49 2,108 2,246 2,403 2,768 2,894 3,158 3,327 3,711 3,852 4,168 4,340 4,38250-59 3,637 3,946 4,327 4,683 5,038 5,507 6,083 6,983 7,430 8,182 8,644 9,04860-64 3,301 3,363 3,607 3,951 4,107 4,353 4,802 5,322 5,531 5,816 6,011 6,56565-69 4,518 4,923 5,174 5,497 5,914 6,281 6,670 7,150 7,337 7,708 7,819 8,10970-79 9,141 10,288 10,791 12,211 13,411 14,538 16,118 17,772 18,334 19,152 19,820 20,11280+ 3,852 4,525 5,176 5,844 6,648 7,548 8,646 9,920 10,860 11,986 13,168 14,006

0-19 46 41 30 40 36 35 35 45 37 50 39 6920-44 2,522 2,615 2,701 3,036 3,091 3,064 3,204 3,471 3,461 3,591 3,754 3,65345-64 8,071 8,533 9,263 10,157 10,818 11,724 12,800 14,491 15,246 16,581 17,224 18,29765-74 9,600 10,522 11,147 12,060 12,960 13,771 14,873 15,981 16,361 17,033 17,556 17,82475+ 7,911 9,214 9,994 11,492 13,013 14,596 16,561 18,861 20,170 21,813 23,251 24,403








Table H.11 (continued)Total patient deaths: hemodialysis patientsby demographic characteristics, primary diagnosis, & patient vintage



524

Reference section H

ON OUR WEBSITE & CDAnnual mortality rates per 1,000 patient years at risk: hemodialysis patients, by primary di-

agnosis, adjusted (H.12.1). Annual deaths per 1,000 patients: hemodialysis patients, by pri-

mary diagnosis (H.12.2). Hemodialysis patients: counts of total deaths, by primary diagnosis

(H.12.3). Annual mortality rates: hemodialysis patients, unadjusted (H.12.4).

Table H.12Annual mortality rates per 1,000 patient years at risk: hemodialysis patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 82.7 167.0 101.8 48.6 67.5 114.2 300.1 206.7 216.6 187.5 190.6 272.95-9 60.0 42.4 45.7 32.3 17.2 44.5 0.0 43.6 20.3 61.3 41.3 60.510-14 42.6 27.4 22.4 18.7 20.7 42.6 39.7 31.5 55.2 65.0 42.4 31.715-19 36.2 38.4 24.1 45.0 34.5 49.1 32.3 38.4 32.6 30.0 25.1 34.220-29 62.9 68.3 62.3 55.5 56.6 63.1 63.3 66.3 78.8 77.3 71.4 68.530-39 87.7 83.9 90.4 83.0 92.2 96.8 96.9 112.7 105.2 105.6 112.6 101.640-49 115.1 115.6 106.8 112.5 107.4 118.6 125.3 128.6 130.7 126.2 128.5 126.950-59 151.1 153.5 155.3 166.0 162.1 172.1 170.5 173.6 183.0 181.2 176.2 168.660-64 221.9 210.7 212.5 209.7 217.3 228.0 233.7 233.6 237.6 238.9 226.0 225.665-69 281.4 275.1 273.0 281.9 272.5 283.0 289.9 275.5 281.8 285.3 278.7 265.170-79 338.0 351.7 348.1 343.8 355.8 363.0 355.9 358.7 359.4 361.7 356.0 340.980+ 504.9 539.1 522.0 454.1 501.6 500.8 505.1 480.2 507.7 507.8 466.7 469.2

Male 178.6 186.3 187.3 194.0 200.8 218.0 224.1 231.3 237.6 240.1 232.3 225.0Female 168.4 167.6 172.3 177.9 190.0 199.3 205.9 209.8 220.1 222.4 224.5 223.7





All 174.0 177.8 180.3 186.5 195.7 209.2 215.4 221.0 229.1 231.5 228.5 224.4

ADJUSTED0-19 62.3 62.6 51.0 59.2 52.5 71.4 75.9 74.3 70.8 67.8 60.1 64.820-44 108.2 110.1 111.0 108.4 109.9 113.3 116.2 120.9 124.7 122.7 120.9 115.945-64 175.0 175.5 177.9 188.0 187.9 198.1 199.5 200.9 204.6 201.5 194.2 186.865-74 277.7 296.5 303.8 310.9 307.7 318.2 318.4 314.1 314.0 310.7 301.6 288.975+ 385.2 394.1 410.0 409.8 436.5 434.0 427.1 425.3 433.0 434.4 423.3 408.8

Male 222.8 228.8 233.6 238.7 240.3 249.9 249.1 251.6 254.8 252.1 241.8 229.2Female 198.1 203.1 206.3 210.2 214.2 220.4 219.3 219.0 221.9 219.2 214.4 209.7




All 210.8 216.5 220.4 225.1 227.9 236.2 235.5 236.6 239.6 236.9 229.1 220.4


Table H.12Annual mortality rates per 1,000 patient years at risk: hemodialysis patientsperiod prevalent patients; 200 ESRD patients used as reference


525


Table H.12 (continued)Annual mortality rates per 1,000 patient years at risk: hemodialysis patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 350.8 379.8 213.1 281.1 110.9 99.5 164.0 132.9 253.5 329.4 171.8 253.25-9 58.2 70.7 66.2 61.1 66.2 29.9 39.8 50.0 36.9 93.8 32.8 90.110-14 45.3 35.8 38.0 25.8 42.9 32.9 52.3 77.4 24.8 26.1 42.5 67.315-19 53.0 38.6 27.4 37.3 38.9 38.8 32.2 30.3 37.5 39.9 31.4 49.920-29 74.9 68.0 62.9 65.7 64.7 57.0 54.3 55.0 54.6 59.4 60.8 59.130-39 104.9 105.3 103.6 106.7 106.7 96.1 94.2 98.6 91.0 93.9 89.9 86.440-49 130.6 125.2 122.3 128.5 121.5 123.4 119.9 124.5 121.3 125.9 126.0 124.250-59 170.8 170.2 170.3 170.7 168.2 165.9 165.9 172.3 167.6 170.7 169.4 167.460-64 228.7 223.2 217.5 219.1 216.1 212.9 216.1 223.0 216.2 215.7 211.0 219.265-69 265.8 264.7 262.7 260.2 261.4 261.6 263.5 266.6 261.9 263.5 258.8 257.970-79 346.7 348.9 330.8 335.8 339.1 333.4 338.4 347.5 341.7 342.6 340.9 334.780+ 469.6 467.0 461.7 466.2 466.2 474.6 483.1 502.1 489.3 490.3 491.5 482.4

Male 230.8 229.7 225.7 228.0 229.1 224.5 227.0 233.4 228.7 232.1 231.1 231.5Female 229.9 232.6 228.1 234.3 233.7 236.4 240.2 249.6 244.8 248.2 247.8 245.1





All 230.4 231.1 226.8 231.1 231.3 230.2 233.3 241.1 236.3 239.6 238.9 237.8

ADJUSTED0-19 81.6 77.0 64.6 62.3 57.8 57.0 55.9 59.2 57.2 64.3 57.4 74.220-44 118.4 116.0 111.8 115.3 113.6 110.8 108.8 110.5 105.5 104.7 106.2 104.945-64 188.2 185.2 179.0 180.1 177.8 175.4 174.4 179.6 174.6 176.6 175.0 174.865-74 290.8 289.0 280.8 284.7 284.9 284.1 286.3 292.9 287.1 288.4 286.8 285.375+ 407.3 408.0 397.5 407.9 412.9 411.9 418.8 435.5 426.4 431.6 428.8 424.2

Male 229.8 226.3 219.2 220.4 220.0 215.3 214.8 219.2 213.1 214.3 212.2 211.1Female 213.6 213.3 207.6 211.5 209.8 210.0 211.1 218.3 213.0 214.8 214.3 212.4




All 222.2 220.1 213.6 216.2 215.0 212.4 212.9 218.6 212.8 214.3 212.9 211.3


Table H.12 (continued)Annual mortality rates per 1,000 patient years at risk: hemodialysis patientsperiod prevalent patients; 200 ESRD patients used as reference



526

Reference section H

Table H.13Total patient deaths: hemodialysis patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 * * * * * * * * * * * *5-9 * * * * * * . * * * * *10-14 * * * * * * * * * * * *15-19 21 26 16 27 20 28 13 18 17 13 11 1920-29 204 231 218 198 203 234 241 243 283 297 289 26130-39 446 477 544 532 640 701 722 873 886 887 996 96340-49 738 785 790 882 939 1,064 1,140 1,244 1,313 1,389 1,589 1,69350-59 1,468 1,611 1,780 2,060 2,113 2,323 2,393 2,509 2,725 2,885 2,974 3,07860-64 1,074 1,159 1,375 1,491 1,801 2,039 2,162 2,287 2,525 2,650 2,745 2,94565-69 1,248 1,366 1,482 1,765 1,991 2,311 2,645 2,793 3,197 3,602 3,885 4,11370-79 1,530 1,869 2,171 2,548 3,344 3,862 4,249 4,875 5,531 6,300 7,078 7,82180+ 315 393 515 603 916 1,086 1,335 1,591 2,019 2,408 2,691 3,292

0-19 35 37 25 33 27 37 28 32 31 31 22 3220-44 965 1,052 1,100 1,090 1,265 1,363 1,449 1,677 1,707 1,801 1,991 1,97445-64 2,965 3,211 3,607 4,073 4,431 4,998 5,209 5,479 6,025 6,307 6,602 6,96665-74 2,178 2,520 2,791 3,285 3,925 4,534 5,031 5,527 6,254 7,006 7,677 8,34775+ 915 1,108 1,377 1,631 2,326 2,725 3,198 3,732 4,493 5,304 5,977 6,879




Diabetes 864 1,156 1,634 2,199 2,733 3,493 4,092 4,846 5,588 6,392 7,548 8,608Hypertension 930 1,245 1,675 2,157 2,837 3,451 3,886 4,657 5,491 6,236 7,043 7,845Glomerulonephritis 742 890 1,091 1,250 1,480 1,653 1,854 2,084 2,400 2,410 2,634 2,687Cystic kidney 208 268 283 330 376 440 514 467 533 554 587 554Other urologic 105 151 225 298 326 431 551 611 652 733 738 692Other cause 499 598 758 955 1,189 1,353 1,483 1,673 1,710 1,858 2,028 2,205Unknown cause 739 791 878 789 846 1,051 1,025 1,041 1,219 1,405 1,232 1,217Missing disease 2,971 2,829 2,356 2,134 2,187 1,785 1,510 1,068 917 861 459 390



The age of patient is determined as of the date of Death.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table H.13Total patient deaths: hemodialysis patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage


527


Table H.13 (continued)Total patient deaths: hemodialysis patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 * * * 12 * * * * * 12 * *5-9 * * * * * * * * * * * *10-14 * * * * * * * * * * * 1015-19 24 16 * 13 17 17 11 17 15 17 10 2720-29 305 303 261 286 299 278 254 268 280 305 313 28930-39 1,048 1,104 1,149 1,248 1,251 1,153 1,205 1,286 1,212 1,271 1,260 1,22640-49 1,927 1,981 2,146 2,414 2,469 2,678 2,850 3,125 3,182 3,494 3,646 3,60950-59 3,454 3,722 3,965 4,329 4,622 4,972 5,428 6,232 6,515 7,135 7,508 7,76360-64 3,217 3,272 3,492 3,803 3,928 4,096 4,494 4,964 5,111 5,292 5,474 5,94365-69 4,471 4,856 5,089 5,364 5,740 6,082 6,458 6,854 6,990 7,327 7,367 7,59770-79 9,119 10,254 10,750 12,146 13,320 14,428 15,960 17,572 18,055 18,867 19,441 19,67380+ 3,852 4,525 5,175 5,841 6,645 7,545 8,641 9,914 10,847 11,966 13,136 13,974

0-19 40 33 22 31 27 26 25 33 30 38 24 5320-44 2,232 2,310 2,376 2,615 2,581 2,516 2,643 2,838 2,774 2,886 3,022 2,91445-64 7,719 8,072 8,637 9,465 9,988 10,661 11,588 13,037 13,526 14,611 15,179 15,91665-74 9,535 10,428 11,030 11,870 12,711 13,489 14,543 15,542 15,815 16,440 16,820 16,98875+ 7,907 9,207 9,984 11,481 12,994 14,566 16,516 18,798 20,077 21,720 23,124 24,256








Table H.13 (continued)Total patient deaths: hemodialysis patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage



528

Reference section H

Table H.14Annual mortality rates per 1,000 patient YAR: hemodialysis patients, never on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference

Table H.14Annual mortality rates per 1,000 patient YAR: hemodialysis patients, never on transplant waitlistfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 144.9 284.0 173.4 75.5 130.7 156.0 422.9 291.2 329.0 339.5 276.9 428.45-9 99.0 77.2 84.7 61.8 31.6 105.1 0.0 124.4 66.2 205.5 85.8 195.010-14 68.4 46.4 42.8 36.9 38.6 87.9 88.6 88.7 100.8 182.2 124.8 78.815-19 54.4 60.2 38.0 75.9 59.1 90.7 66.2 98.9 79.2 72.9 60.5 86.920-29 81.0 90.8 86.5 79.5 83.8 98.2 105.5 124.0 156.7 152.6 145.0 136.530-39 102.1 100.1 109.9 103.6 119.7 130.0 137.9 172.5 166.0 162.4 175.9 155.540-49 122.6 125.2 117.2 126.1 122.7 140.4 156.5 172.8 175.4 168.9 175.8 174.450-59 152.7 156.0 159.2 171.4 169.2 182.5 186.5 198.3 211.3 209.7 204.3 195.460-64 222.1 211.2 213.5 211.2 219.8 232.1 240.4 244.8 250.0 252.2 238.2 241.365-69 281.4 275.1 273.1 282.1 273.0 283.9 292.4 279.9 287.6 292.3 285.8 272.770-79 338.1 351.7 348.2 343.9 355.9 363.2 356.2 359.4 360.2 362.6 357.3 342.780+ 504.9 539.1 522.0 454.1 501.6 500.8 505.1 480.3 507.9 507.9 466.9 469.3

Male 190.5 200.2 202.6 211.4 220.7 242.6 255.3 273.5 284.0 287.8 279.0 270.4Female 178.3 178.9 185.0 192.0 205.8 218.4 229.4 238.9 251.0 253.5 256.6 254.9





All 184.9 190.4 194.4 202.3 213.6 231.0 242.8 256.5 267.6 270.6 267.8 262.6

ADJUSTED0-19 . . 74.1 88.9 80.0 111.7 124.0 141.6 135.3 138.6 121.5 134.120-44 . . 125.5 124.9 129.2 137.8 149.1 168.4 181.4 181.4 181.9 172.645-64 . . 181.5 192.6 193.9 206.7 213.1 221.8 229.4 227.6 220.7 213.465-74 . . 304.7 311.3 308.6 319.4 320.9 318.5 316.8 312.5 303.5 291.375+ . . 413.5 411.4 435.7 435.3 429.3 427.0 431.2 430.5 418.6 404.0

Male . . 239.3 245.1 248.0 260.7 264.8 275.3 282.3 280.5 270.7 257.3Female . . 212.1 216.6 221.4 229.7 232.2 237.2 241.7 239.2 235.0 229.8

White . . 249.5 255.5 261.6 274.8 276.4 285.8 291.7 288.3 282.0 273.5Black . . 180.5 189.8 191.3 200.0 208.3 214.0 221.3 225.0 216.6 208.4Other race . . 228.0 221.5 224.6 226.9 227.1 234.7 230.5 220.2 211.4 187.2

Diabetes . . 296.4 307.3 309.9 321.5 325.4 335.6 339.2 329.7 319.4 306.1Hypertension . . 181.8 186.6 195.4 207.1 209.0 219.6 227.5 230.7 228.5 223.6Glomerulonephritis . . 154.4 157.8 161.6 169.3 174.1 182.5 197.3 196.1 197.9 189.8Other cause . . 217.3 218.1 221.3 232.7 240.6 242.5 244.8 250.8 236.8 226.6

<2 years . . 239.9 242.5 250.9 264.2 267.0 274.4 279.6 274.9 265.2 252.92-<5 years . . 223.9 228.5 227.8 240.4 245.9 254.7 263.0 262.5 255.4 247.55+ years . . 205.1 215.9 217.2 222.4 225.9 234.5 239.8 240.0 237.0 230.5

All . . 226.2 231.5 235.5 246.3 249.9 257.9 263.8 261.6 254.4 245.0

Reference cohort is 2001 prevalent ESRD patients. Overall mortality rates are adjusted for age, gender, race, primary diagnosis, & vintage.Mortality rates for primary diagnosis are adjusted for age, gender, race, & vintage.Mortality rates for age are adjusted for gender, race, primary diagnosis, & vintage.Mortality rates for gender are adjusted for age, race, primary diagnosis, & vintage.Mortality rates for race are adjusted for gender, age, primary diagnosis, & vintage.Mortality rates for vintage are adjusted for gender, age, race, & primary diagnosis.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year. Patients of unknown age, gender are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

529


Table H.14 (continued)Annual mortality rates per 1,000 patient YAR: hemodialysis patients, never on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference

Table H.14 (continued)Annual mortality rates per 1,000 patient YAR: hemodialysis patients, never on transplant waitlistfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 520.6 706.6 386.8 535.7 173.2 94.6 283.4 208.8 484.5 595.9 269.1 374.05-9 148.5 185.5 253.6 175.3 197.5 112.9 153.0 158.2 62.5 115.9 70.2 179.710-14 142.5 105.0 91.9 54.0 94.3 96.9 110.5 208.1 94.6 73.1 72.8 97.715-19 159.2 93.3 63.0 84.0 91.1 88.9 62.2 72.8 79.5 72.5 49.2 87.120-29 151.7 143.6 126.7 135.8 133.1 116.6 104.4 104.8 99.7 105.3 107.7 92.930-39 161.2 168.6 166.6 169.8 166.8 149.5 151.3 153.7 141.4 147.4 140.8 129.740-49 180.5 170.9 169.0 175.6 165.0 168.1 166.4 171.5 164.7 172.3 171.6 162.150-59 201.3 203.5 201.0 207.4 205.5 202.3 203.6 215.8 209.0 213.3 210.3 203.260-64 244.8 240.7 237.4 240.0 239.1 236.3 242.7 253.3 247.9 248.3 244.5 252.465-69 272.9 272.5 271.5 269.5 272.1 274.0 279.2 284.8 281.5 286.6 283.3 282.270-79 348.9 351.1 333.3 338.3 342.0 336.8 342.3 352.3 347.1 350.0 348.5 342.780+ 469.6 467.2 462.0 466.3 466.4 474.8 483.5 502.7 489.9 491.0 492.0 483.6

Male 278.0 278.2 273.4 277.1 278.4 273.8 278.4 287.2 281.8 286.1 283.8 279.9Female 262.2 266.3 260.9 268.5 269.4 272.5 278.6 291.1 285.4 290.7 290.3 284.7





All 270.0 272.2 267.1 272.8 273.9 273.2 278.5 289.1 283.5 288.3 286.9 282.2

ADJUSTED0-19 176.9 170.8 142.5 133.0 116.3 114.0 108.0 117.5 115.9 121.0 96.5 118.520-44 178.0 176.1 170.8 176.2 171.5 166.6 165.1 167.7 159.4 158.3 159.0 153.245-64 217.1 216.6 210.8 214.6 214.1 212.9 213.8 222.8 217.4 221.3 220.6 217.165-74 293.9 292.9 285.1 289.7 291.1 291.3 295.9 304.4 299.3 304.1 305.0 304.175+ 402.8 404.4 394.1 404.8 410.1 408.8 416.5 433.1 423.3 430.3 428.3 423.8

Male 259.7 257.9 250.2 253.4 253.0 247.8 248.6 255.1 248.4 250.8 248.7 245.1Female 236.3 237.6 232.0 237.7 236.7 237.7 240.6 250.4 243.9 247.3 247.3 243.6




All 249.0 248.5 241.7 246.1 245.3 242.9 244.8 252.8 246.1 249.0 247.9 244.0

Reference cohort is 2001 prevalent ESRD patients. Overall mortality rates are adjusted for age, gender, race, primary diagnosis, & vintage.Mortality rates for primary diagnosis are adjusted for age, gender, race, & vintage.Mortality rates for age are adjusted for gender, race, primary diagnosis, & vintage.Mortality rates for gender are adjusted for age, race, primary diagnosis, & vintage.Mortality rates for race are adjusted for gender, age, primary diagnosis, & vintage.Mortality rates for vintage are adjusted for gender, age, race, & primary diagnosis.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year. Patients of unknown age, gender are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


530

Reference section H

Table H.15Total patient deaths: hemodialysis patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage

1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 . . . * . . . . . . . * * * . . .5-9 . . . . . . * . . . * . . * . . .10-14 . * * . * . . * . . . * * . . * *15-19 . * . * * * * * * * * * * * * * *20-29 . * 14 19 16 18 16 30 25 27 34 37 43 41 47 49 4830-39 * 13 32 54 60 63 64 64 85 117 122 131 162 142 164 153 16840-49 * 25 42 51 59 63 115 110 162 196 210 224 292 339 324 342 36050-59 * 21 46 52 74 69 94 160 158 190 279 327 360 495 567 584 65360-64 . * 16 28 25 32 32 41 64 77 119 145 166 233 265 287 32665-69 . * * 13 12 12 18 38 54 79 101 82 128 149 194 221 25270-79 . * * * * * 15 17 20 36 38 57 82 90 112 151 19380+ . . . . * . . . * * * . * . * * *

0-19 . * * * * * * * * * * * * * * * *20-44 10 29 66 102 105 114 130 142 186 225 252 273 322 331 339 358 34645-64 * 42 84 102 129 131 191 263 308 382 512 591 701 919 1,028 1,057 1,20965-74 . * * 18 12 16 31 52 72 113 130 130 188 223 281 337 40575+ . * . . * * * * * * 11 * 23 16 33 44 49

Male 10 49 94 143 149 163 212 270 322 419 526 583 737 852 986 1,051 1,232Female * 34 65 82 104 100 145 193 252 308 383 426 503 640 696 752 783Unknown

White 11 49 107 153 174 180 226 284 346 437 509 594 715 822 935 1,012 1,136Black * 31 45 67 72 74 110 162 203 256 336 337 455 557 622 659 719Native American . . * * * * * * * 10 20 13 11 18 18 21 30Asian . * * * * * 14 10 18 22 32 52 41 69 89 75 96Other/unknown * * * . . . * . . * 12 13 18 26 18 36 34

†Hispanic 62 85 131 148 159 216 261 277†Non-Hispanic 665 824 878 1,092 1,333 1,466 1,542 1,738

Diabetes * 27 54 73 89 94 147 165 192 275 370 471 556 670 807 860 928Hypertension * 14 21 46 47 51 64 109 129 167 208 194 254 325 362 388 418Glomerulonephritis * 18 32 50 50 45 68 82 114 142 146 146 194 228 229 237 308Cystic kidney . * 10 * 14 10 15 11 29 27 37 34 33 54 48 64 78Other urologic . * * * * * * 10 11 * 14 22 21 37 34 51 51Other cause * * 25 25 31 40 45 59 70 76 112 114 149 125 165 169 183Unknown cause . * * * * 14 15 24 26 30 20 28 33 49 36 34 47Missing disease * 10 * * * * * * * * * . . * * . *

<2 years * 24 57 60 72 84 113 141 160 202 241 286 305 362 378 347 3372-<5 years * 32 50 82 87 85 135 160 204 270 343 371 490 577 742 820 8445+ years * 27 52 83 94 94 109 162 210 255 325 352 445 553 562 636 834

All 18 83 159 225 253 263 357 463 574 727 909 1,009 1,240 1,492 1,682 1,803 2,015All with unknowns dropped 16 79 149 217 245 249 340 439 548 695 877 968 1,189 1,417 1,630 1,734 1,935


Table H.15Total patient deaths: hemodialysis patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage


531


Table H.16Annual mortality rates per 1,000 patient YAR: hemodialysis patients on transplant waitlistfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 . . . 364.9 . . . . . . 157.1 137.4 126.2 149.3 . . .5-9 . . . . . . 52.6 . . . . . . 66.4 . . .10-14 . 105.2 29.7 . 50.1 . . 22.9 22.8 . . 49.8 49.6 0.0 24.4 53.7 52.215-19 . 9.3 . 16.1 8.0 7.6 20.5 14.6 22.6 30.3 22.4 24.6 19.6 19.1 15.0 31.7 48.420-29 . 9.8 20.5 25.7 21.3 20.0 16.1 27.9 25.0 25.0 26.4 27.0 31.9 29.3 38.1 49.7 68.930-39 13.9 14.0 30.1 44.5 42.4 43.2 35.4 33.2 37.7 50.6 51.2 46.3 56.8 51.1 57.4 64.5 96.440-49 16.5 34.2 43.5 35.2 38.3 38.4 55.1 43.6 56.4 58.6 60.7 59.6 71.2 78.6 79.9 95.3 137.850-59 13.0 34.0 64.2 63.4 69.1 51.1 57.0 83.2 68.3 66.6 87.8 85.7 84.4 108.4 117.5 136.3 196.960-64 . 50.7 87.8 111.3 88.9 84.8 74.5 62.9 83.9 83.8 100.6 103.5 104.2 131.6 129.9 147.9 220.965-69 . 98.9 80.4 94.3 90.3 79.2 67.5 114.3 111.4 135.0 136.2 94.6 118.6 128.5 139.5 166.2 238.370-79 . 378.8 79.1 184.2 84.7 44.6 163.9 133.7 131.5 175.0 136.3 164.4 177.4 138.6 150.2 197.5 311.080+ . . . . 721.8 . . . 383.7 343.1 301.1 . 103.4 . 435.8 292.9 193.3

Male 11.0 27.1 43.4 51.9 46.6 46.0 47.8 52.4 53.5 60.6 67.1 66.1 76.6 83.1 93.7 111.3 172.5Female 9.8 25.1 37.9 39.9 45.9 37.1 46.1 51.6 59.5 63.5 74.0 70.8 77.1 94.2 99.0 120.1 165.6

White 10.3 25.1 46.5 54.1 56.5 51.9 54.5 59.4 64.4 71.6 76.5 77.0 85.9 91.4 99.5 118.5 174.8Black 8.7 29.0 32.4 39.0 34.6 30.4 36.7 45.4 48.2 52.9 61.7 56.3 69.6 82.7 92.6 112.8 168.0Other race 29.9 21.1 33.6 17.0 19.1 25.0 46.0 31.3 35.9 39.3 68.1 67.5 52.6 85.6 86.3 99.9 145.3


Diabetes 44.8 63.8 103.8 100.7 103.3 86.0 100.0 95.1 90.6 104.7 117.3 122.3 128.3 135.7 150.5 173.5 239.9Hypertension 8.5 22.1 24.5 43.5 37.0 35.3 35.0 47.2 49.2 56.3 64.4 56.4 64.7 81.1 87.8 106.3 158.1Glomerulonephritis 4.3 17.3 24.6 31.8 29.6 25.0 32.3 33.8 39.6 43.3 42.9 37.0 47.2 54.5 56.9 68.6 117.0Other cause 8.8 23.5 42.1 38.4 41.3 38.8 36.0 43.7 51.9 48.4 57.0 54.2 62.0 69.2 70.5 88.4 133.5

<2 years 10.1 22.8 40.2 32.3 35.0 36.8 38.7 43.0 43.6 50.9 54.2 55.8 56.7 63.6 68.4 79.5 109.92-<5 years 8.1 33.4 44.5 57.4 53.3 44.7 56.1 56.7 61.2 64.0 72.4 68.0 79.5 86.7 103.9 122.8 168.35+ years 12.4 23.4 38.8 53.2 52.1 46.1 47.7 58.4 65.0 71.6 85.0 82.4 96.2 116.3 114.5 136.7 220.3

All 10.4 26.2 41.0 46.7 46.3 42.2 47.1 52.1 56.0 61.8 69.9 68.0 76.8 87.5 95.8 114.8 169.7

ADJUSTED0-19 40.3 60.8 45 28.7 33.4 25.4 31.8 36.2 39 64.5 66.3 54.7 43.7 58.5 77.320-44 43 50.9 51 46.2 45.8 43.7 47.1 53.5 60.3 60 66.1 69.6 68.6 80.7 106.345-64 82.5 79.8 79.7 65.6 74.9 80.6 78.2 79.9 89.1 88.3 95.7 109.4 114.3 128.1 18465-74 124.2 123.1 88.8 71.4 93.8 118.6 128.1 153.8 160.7 133.6 140.4 146 148 170.1 250.775+ 188.3 74 436.2 192.4 225.6 127 157.8 127.5 189.7 149.6 218.9 164 176.8 222.4 291.7

Male 106.6 82.4 127.4 87.8 107.8 93.2 98 95.5 108.7 96.3 114.6 110.4 116.1 132.1 190Female 86.9 71.2 104.3 61.9 70.7 75.9 78.8 88.8 104.5 96.3 104.4 110.3 114.1 135.9 187.3

White 123.3 91.7 142 92 111.2 104.8 100.7 104.8 116.5 107.4 123.6 118.7 121.7 138.6 198Black 44.8 55.4 77.1 47.5 53.6 53.2 68.6 74.2 93.5 77.8 90.6 95.2 104.2 126.6 177Other race 77.1 84.6 39.3 49.2 63.3 56.1 82.8 66.9 89 90.8 88 102.5 103.2 117.1 160.8

Diabetes 150.3 115.4 163.6 105.5 143.7 133.6 126.1 130.6 152.1 138.8 161.8 163.5 165.8 188.2 258.2Hypertension 66.1 65.7 96.8 66.3 68.1 66.7 74.8 82.4 98.7 92.8 100.3 94.9 102 119.4 169.4Glomerulonephritis 49.5 47.3 92 58 55.7 55.2 71.1 75.6 81.6 68.1 74.3 76.6 79.3 95 142.5Other cause 93.6 74.8 100 67.7 66 60 68 65.1 73.3 70.1 89.4 87 92.2 107.5 153.6

<2 years 77 49.1 78 53.6 65.4 63.2 63.3 67 75.4 68.9 76.4 74.9 78.2 91.9 126.92-<5 years 103.7 88 135 81.3 102.6 89.5 93.7 92.3 105.8 90.9 106.3 102.4 114.6 137.5 191.25+ years 126.2 111.4 177.7 110.7 127.6 120.5 125.6 134.2 164.1 150.3 175.5 175.5 176.9 198 285.4

All 96.1 77.4 116.4 75.9 90.5 85 88.1 92 106.8 96.5 110.1 110.1 115.2 133.5 188.3

Reference cohort is 2001 prevalent ESRD patients.Overall mortality rates are adjusted for age, gender, race, primary diagnosis, & vintage.Mortality rates for primary diagnosis are adjusted for age, gender, race, & vintage.Mortality rates for age are adjusted for gender, race, primary diagnosis, & vintage.Mortality rates for gender are adjusted for age, race, primary diagnosis, & vintage.Mortality rates for race are adjusted for gender, age, primary diagnosis, & vintage.Mortality rates for vintage are adjusted for gender, age, race, & primary diagnosis.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year. Patient age is determined on January 1 of each calendar year.Patients of unknown age, gender are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table H.16Annual mortality rates per 1,000 patient YAR: hemodialysis patients, on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference



532

Reference section H

Table H.17Total patient deaths: hemodialysis patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 . . . . . . . * . . * *5-9 * * . * . . . . . . . .10-14 * * * * . * * . * * * *15-19 * * * * * * * * * * * *20-29 17 28 20 23 34 25 30 38 45 54 57 5930-39 31 29 43 47 68 84 94 117 120 144 135 16040-49 24 32 39 49 61 81 82 122 144 154 200 20650-59 25 26 33 54 62 57 98 100 124 117 166 18460-64 * * * * * 31 25 23 35 43 57 5065-69 . * * * * 10 11 10 25 21 26 3470-79 * . . . . * * * * 11 11 1680+ * . . . . * . . . . . *

0-19 * * * * * * * * 11 * * *20-44 62 73 80 94 134 147 157 216 238 280 289 32645-64 43 46 60 84 99 131 172 184 230 232 326 33365-74 * * * * * 13 16 11 28 30 35 4775+ * . . . . * . * . * * *

Male 73 88 93 114 156 212 240 284 316 347 428 442Female 39 39 55 69 89 86 110 135 191 203 233 276Unknown

White 87 94 109 121 181 210 225 259 330 364 431 450Black 21 30 33 52 59 82 112 144 167 176 213 252Native American . . . * * . * * * * * *Asian . . . . * * * * * * 10 *Other/unknown * * * * * * * * * * * *


Diabetes 19 14 26 38 42 52 55 81 98 112 139 141Hypertension * 10 20 28 33 49 54 56 90 100 124 153Glomerulonephritis 24 23 34 42 60 67 101 112 133 142 189 215Cystic kidney * * * * 11 16 17 19 29 24 34 38Other urologic * * * * * * * 11 * * * *Other cause * 13 12 12 24 33 50 54 77 73 99 120Unknown cause * 15 14 * 26 23 21 28 30 45 43 23Missing disease 39 44 36 45 47 50 50 58 42 49 28 21

<2 years 25 21 18 15 20 18 11 14 29 30 26 292-<5 years 66 79 95 78 84 105 106 138 122 136 156 1555+ years 21 27 35 90 141 175 233 267 356 384 479 534

All 112 127 148 183 245 298 350 419 507 550 661 718All with unknowns dropped 100 111 130 166 217 274 323 385 473 503 616 691


Table H.17Total patient deaths: hemodialysis patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage


533


Table H.17 (continued)Total patient deaths: hemodialysis patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 . . . . . . . . . . . *5-9 * * . . . * * . * * * *10-14 * * * * * * * * . . * *15-19 * * * * * * * * * * * *20-29 65 43 50 52 54 52 57 57 73 82 74 6530-39 150 156 159 172 183 185 184 188 190 215 192 17840-49 213 233 220 261 299 368 334 378 422 446 441 46350-59 189 202 257 277 269 305 371 420 423 499 534 56960-64 69 84 93 91 105 131 155 163 170 208 200 23565-69 30 68 56 91 78 87 112 120 158 156 150 17770-79 23 28 33 36 55 64 86 86 115 133 157 14480+ * * * * * * * * * * 12 *

0-19 * * * * 10 * * 11 * * 10 *20-44 316 318 299 338 379 414 398 401 450 487 486 43245-64 370 400 480 515 531 627 703 805 828 963 955 1,07865-74 46 86 77 120 115 130 173 180 237 250 263 28275+ * 15 19 13 19 22 28 29 41 45 56 46

Male 483 491 526 569 648 702 773 859 922 1,050 1,039 1,054Female 263 337 357 424 406 498 535 567 638 703 731 793Unknown

White 490 540 533 621 693 753 831 862 963 1,093 1,085 1,126Black 239 270 329 348 334 412 444 520 543 601 620 651Native American 11 * * 13 10 10 13 14 19 13 23 19Asian * * 11 11 17 24 20 30 34 45 41 49Other/unknown * * * . . * . . * * * *

†Hispanic 78 85 107 122 122 144 157 150†Non-Hispanic 976 1,115 1,201 1,304 1,438 1,609 1,613 1,697

Diabetes 166 192 189 202 244 261 327 363 388 425 427 458Hypertension 154 191 233 243 238 286 285 354 338 386 406 407Glomerulonephritis 183 226 221 276 285 333 330 358 440 472 453 520Cystic kidney 42 35 44 57 72 90 84 90 91 108 93 101Other urologic 15 24 23 25 20 30 41 37 59 67 79 58Other cause 120 121 130 141 147 166 194 188 203 248 266 252Unknown cause 44 27 36 47 46 34 45 35 40 47 45 51Missing disease 22 12 * * * . * * * . * .

<2 years 29 22 24 15 15 11 * * 10 11 * 122-<5 years 155 133 152 113 133 109 125 129 114 122 104 1205+ years 562 673 707 865 906 1,080 1,174 1,289 1,436 1,620 1,658 1,715

All 746 828 883 993 1,054 1,200 1,308 1,426 1,560 1,753 1,770 1,847All with unknowns dropped 700 799 846 946 1,008 1,165 1,263 1,391 1,519 1,705 1,724 1,794


Table H.17 (continued)Total patient deaths: hemodialysis patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage



534

Reference section H

Table H.18Annual mortality rates per 1,000 patient YAR: hemodialysis patients, returned to dialysis from transplantperiod prevalent patients; 200 ESRD patients used as reference

Table H.18Annual mortality rates per 1,000 patient YAR: hemodialysis patients, returned to dialysis from transplantfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 . . . . . . . 365.3 . . 181.5 373.35-9 423.9 103.3 . 65.3 . . . . . . . .10-14 34.8 78.9 40.8 15.5 . 18.4 59.0 . 80.3 32.6 54.0 53.515-19 31.1 27.4 15.9 28.4 47.1 37.3 34.4 59.7 28.7 24.9 28.1 28.220-29 50.6 75.0 48.8 39.7 51.1 34.7 36.5 43.3 44.5 54.4 47.6 53.430-39 82.8 62.9 72.9 70.6 67.6 78.3 76.1 80.6 82.8 80.9 78.4 76.140-49 91.1 80.0 96.1 86.3 77.0 89.7 85.3 108.2 120.2 101.2 104.7 100.450-59 158.8 99.1 102.2 126.1 118.6 94.6 161.4 134.0 139.8 118.0 158.3 145.760-64 262.1 120.6 95.1 74.3 123.6 248.3 176.2 170.3 180.5 174.3 191.2 154.365-69 . 372.5 439.5 70.1 269.5 399.7 321.8 121.6 329.1 176.2 227.8 209.070-79 . . . . . 364.0 479.5 261.8 145.4 408.4 238.0 291.280+ . . . . . . . . . . . .

Male 87.3 80.8 74.1 70.5 71.5 89.0 95.0 98.2 100.9 91.8 102.1 97.7Female 88.9 65.2 73.1 74.3 78.6 60.8 71.4 75.7 91.5 87.4 90.5 92.2





All 87.9 75.4 73.8 71.9 74.0 78.8 86.2 89.7 97.3 90.1 97.6 95.5

ADJUSTED0-19 . . . . . . 57.4 63.3 72.9 58.1 59.2 78.620-44 . . . . . . 91.0 91.5 104.6 99.1 101.8 100.745-64 . . . . . . 147.8 156.6 158.0 146.4 169.8 152.465-74 . . . . . . 353.0 215.2 285.7 212.3 260.9 211.575+ . . . . . . 558.0 649.6 177.8 312.5 309.0 246.6

Male . . . . . . 302.4 268.0 200.3 177.0 198.9 180.0Female . . . . . . 144.0 171.1 146.0 158.8 188.0 149.5

White . . . . . . 277.9 263.0 202.2 193.2 223.1 193.3Black . . . . . . 122.4 144.1 123.9 122.2 144.7 128.6Other race . . . . . . 138.7 176.1 153.3 179.3 174.4 100.6

Diabetes . . . . . . 362.9 338.9 247.3 232.6 285.4 213.1Hypertension . . . . . . 134.0 167.2 139.0 123.4 156.6 166.4Glomerulonephritis . . . . . . 119.9 131.2 109.4 119.6 119.6 133.4Other cause . . . . . . 221.1 184.8 160.8 181.1 146.2 126.0

<2 years . . . . . . 189.5 161.0 136.2 147.8 168.4 148.42-<5 years . . . . . . 245.1 289.4 203.3 178.6 201.8 168.55+ years . . . . . . 283.5 267.3 201.4 186.5 227.2 189.7

All . . . . . . 226.3 220.7 172.5 166.7 192.8 165.2


535


Table H.18 (continued)Annual mortality rates per 1,000 patient YAR: hemodialysis patients, returned to dialysis from trafrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 . . . . . 586.3 . . . 822.6 200.1 386.95-9 66.8 43.9 . . . . 55.2 . 97.5 237.3 . 95.210-14 30.5 13.6 29.5 45.6 67.0 12.7 67.0 178.2 . . 105.7 65.415-19 44.4 54.4 46.9 40.5 39.7 22.4 35.0 18.3 23.4 44.0 32.9 44.420-29 52.5 38.0 47.3 43.1 39.0 41.8 44.9 38.8 50.0 67.0 45.9 57.730-39 71.0 73.2 61.3 63.8 70.6 71.1 65.6 67.2 72.3 71.8 65.2 53.240-49 92.7 94.4 85.8 98.5 98.2 111.8 100.0 107.0 111.9 117.4 115.1 115.350-59 139.5 137.0 144.6 148.3 137.6 146.8 160.3 167.1 158.1 164.7 166.1 161.460-64 181.5 192.1 182.6 176.9 173.8 204.9 213.3 230.9 202.2 235.8 223.9 238.565-69 156.1 315.2 193.6 297.8 228.6 234.5 296.5 242.4 318.7 281.9 230.0 257.970-79 344.5 265.6 270.5 267.8 252.4 321.5 332.0 325.4 365.2 353.9 389.0 321.880+ 414.6 404.6 602.9 . 172.1 208.2 429.9 475.4 443.4 518.8 829.9 333.2

Male 100.3 94.5 91.7 93.1 99.5 103.5 108.0 114.3 117.9 128.9 119.0 117.0Female 81.6 100.3 93.8 110.4 95.9 115.0 114.1 114.9 122.4 127.3 130.5 132.4





All 93.0 96.8 92.5 99.9 98.1 107.9 110.4 114.6 119.7 128.3 123.6 123.2

ADJUSTED0-19 95.9 88.8 69.0 64.7 94.2 66.8 65.5 77.4 71.5 91.6 75.3 96.620-44 99.8 95.1 85.6 87.9 92.0 91.3 88.9 87.0 92.2 100.1 89.3 93.345-64 161.0 153.0 156.9 148.3 142.6 139.5 146.4 155.1 162.8 173.0 147.2 165.865-74 189.8 272.2 271.1 289.9 220.0 218.1 254.4 255.2 284.7 287.5 245.5 255.375+ 399.5 397.3 536.7 480.0 435.0 355.6 397.4 373.0 371.5 410.2 375.8 322.4

Male 213.9 192.5 224.2 209.9 191.2 173.6 188.2 186.5 198.0 218.0 187.4 187.6Female 151.1 188.7 212.1 203.3 174.8 160.1 181.1 180.3 189.4 188.5 167.8 181.4




All 184.7 192.6 219.4 205.6 182.2 165.9 185.0 184.5 194.0 203.7 177.2 184.3


Table H.18 (continued)Annual mortality rates per 1,000 patient YAR: hemodialysis patients, returned to dialysis from transplantperiod prevalent patients; 200 ESRD patients used as reference



536

Reference section H

Table H.19Total patient deaths: CAPD/CCPD patientsby demographic characteristics, primary diagnosis, & patient vintage

Table H.19Total patient deaths: CAPD/CCPD patientsby demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 . * * * * * * * * * * 145-9 * * * * * * * * * * * *10-14 . . . * * * * * * * * *15-19 . * * * * * * * 11 * * *20-29 * * 15 25 39 38 55 42 69 66 63 7530-39 10 24 52 60 101 147 186 197 221 225 229 24940-49 13 26 55 110 169 198 293 273 311 305 373 41850-59 23 46 124 203 270 403 453 492 553 559 592 68060-64 10 29 85 152 224 294 378 420 458 468 527 57565-69 10 38 89 167 194 303 390 475 552 531 597 73070-79 19 40 128 220 261 406 528 644 741 766 878 1,00980+ * * 33 59 66 101 130 156 193 220 235 288

0-19 * * * 12 19 25 16 18 23 22 25 3220-44 17 43 93 130 227 277 365 365 431 442 464 53145-64 41 86 238 420 576 803 1,000 1,059 1,181 1,181 1,320 1,46665-74 22 61 166 302 354 550 713 849 977 976 1,104 1,31675+ 16 24 84 144 167 260 335 426 509 541 606 711

Male 51 114 324 492 748 1,010 1,373 1,464 1,699 1,723 1,921 2,235Female 46 104 264 516 595 905 1,056 1,253 1,422 1,439 1,598 1,821Unknown

White 79 185 473 804 1,083 1,523 1,960 2,159 2,500 2,540 2,773 3,178Black 15 31 106 186 231 345 421 513 539 559 657 802Native American * . * * 15 24 20 29 47 41 47 44Asian . * * 10 * 17 19 * 25 16 37 28Other/unknown * * * * * * * * 10 * * *


Diabetes 42 81 202 367 426 628 847 979 1,072 1,118 1,395 1,615Hypertension 19 39 136 233 269 465 497 613 738 774 885 1,070Glomerulonephritis 10 24 79 112 163 259 348 373 462 482 506 526Cystic kidney * * 12 38 61 65 91 95 110 117 104 114Other urologic * * 19 29 40 48 69 74 81 74 77 89Other cause 11 20 45 99 140 181 251 281 299 268 316 375Unknown cause * 26 55 82 82 128 153 155 198 177 156 199Missing disease * 13 40 48 162 141 173 147 161 152 80 68

<2 years 92 199 507 844 950 1,329 1,547 1,751 1,941 1,948 2,215 2,5392-<5 years * 17 67 120 279 431 621 664 803 829 875 1,0355+ years * * 14 44 114 155 261 302 377 385 429 482

All 97 218 588 1,008 1,343 1,915 2,429 2,717 3,121 3,162 3,519 4,056All with unknowns dropped 87 191 529 924 1,252 1,781 2,269 2,555 2,913 2,980 3,359 3,853


537


Table H.19 (continued)Total patient deaths: CAPD/CCPD patientsby demographic characteristics, primary diagnosis, & patient vintage

Table H.19 (continued)Total patient deaths: CAPD/CCPD patientsby demographic characteristics, primary diagnosis, & patient vintage

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 12 * 14 11 13 20 10 16 18 19 14 125-9 * * * * * * * * * * * *10-14 10 * * * * * * * * * * *15-19 * * 13 18 * 12 12 14 11 10 12 *20-29 67 73 99 80 86 65 71 75 51 56 57 6930-39 308 337 359 366 349 310 253 239 230 194 219 16940-49 535 582 604 686 706 636 604 546 510 498 474 43350-59 770 871 953 1,080 1,099 1,096 1,070 1,018 958 934 899 88660-64 621 733 706 732 817 793 740 686 645 598 554 55065-69 790 916 915 1,041 1,028 986 909 790 775 755 682 64770-79 1,234 1,405 1,640 1,719 1,860 1,706 1,679 1,587 1,480 1,365 1,308 1,25980+ 338 390 469 562 583 600 548 512 514 535 543 581

0-19 33 24 34 38 36 45 29 46 35 37 33 3520-44 620 668 737 754 737 640 588 533 500 462 457 40645-64 1,681 1,928 1,984 2,190 2,320 2,260 2,150 2,031 1,894 1,818 1,746 1,70165-74 1,527 1,708 1,890 2,084 2,102 1,975 1,839 1,672 1,608 1,502 1,378 1,32675+ 835 1,003 1,134 1,238 1,369 1,317 1,297 1,217 1,161 1,153 1,155 1,161


White 3,708 4,171 4,467 4,791 4,920 4,760 4,483 4,121 3,895 3,712 3,600 3,433Black 891 1,033 1,163 1,326 1,372 1,204 1,160 1,076 1,020 1,000 916 917Native American 48 57 70 64 76 64 60 67 48 50 49 62Asian 42 63 74 109 158 154 133 169 158 150 150 161Other/unknown * * * 14 38 55 67 66 77 60 54 56


Diabetes 1,914 2,284 2,516 2,772 3,030 2,988 2,891 2,669 2,503 2,402 2,307 2,163Hypertension 1,257 1,456 1,544 1,723 1,650 1,530 1,366 1,266 1,211 1,221 1,080 1,147Glomerulonephritis 616 610 715 720 795 729 699 668 576 518 518 524Cystic kidney 125 154 147 183 153 164 157 137 126 119 120 100Other urologic 99 92 108 104 132 127 114 121 137 124 124 103Other cause 411 479 481 550 565 486 470 449 469 421 436 427Unknown cause 217 214 229 238 224 207 200 184 168 162 176 159Missing disease 57 42 39 14 15 * * * * * * *

<2 years 2,895 3,214 3,403 3,516 3,577 3,321 3,014 2,763 2,584 2,470 2,336 2,3032-<5 years 1,238 1,508 1,680 2,040 2,090 2,069 1,996 1,831 1,730 1,621 1,546 1,5095+ years 563 609 696 748 897 847 893 905 884 881 887 817




538

Reference section H

ON OUR WEBSITE & CDAnnual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, by primary diagnosis, adjusted (H.20.1). Annual deaths per 1,000 patients: CAPD/CCPD Patients, by primary diagnosis (H.20.2). CAPD/CCPD Patients: counts of total deaths, by primary diagnosis (H.20.3). Annual mortality rates: CAPD/CCPD patients, unadjusted (H.20.4).

Table H.20Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 19920-4 . 74 85 118 116 104 61 62 47 106 88 149 1015-9 116 257 44 25 47 93 29 13 26 26 28 49 6210-14 . . . 15 27 47 16 22 41 27 50 27 4915-19 . 68 67 56 66 46 42 50 55 29 22 39 3020-29 60 50 80 89 74 60 82 53 76 71 67 64 5730-39 174 153 129 97 112 115 123 121 128 115 101 99 10840-49 210 157 124 166 145 137 174 151 158 134 141 128 14050-59 263 179 181 204 175 215 208 217 222 214 204 203 19760-64 187 294 245 298 282 281 276 273 291 278 268 265 27365-69 364 333 341 372 308 336 332 344 353 307 330 344 31270-79 548 414 420 434 403 428 428 439 445 429 409 401 40380+ 1,093 300 572 660 606 706 607 583 709 647 571 579 584

Male 261 206 215 210 202 215 243 237 253 233 228 230 235Female 237 206 191 249 193 220 209 222 231 214 211 207 203

White 256 218 211 240 209 228 243 245 262 246 241 240 246Black 207 167 180 193 163 181 179 192 182 165 165 171 160Other race 342 83 173 186 176 208 178 139 220 155 182 125 130


Diabetes 417 353 326 361 297 318 348 351 337 306 318 306 299Hypertension 308 192 237 249 204 271 225 238 262 241 235 236 237Glomerulonephritis 97 95 120 116 101 119 134 132 149 144 138 128 135Other cause 209 198 166 198 202 190 212 207 224 203 175 184 179

<2 years 280 223 226 242 210 238 240 249 254 228 224 220 2182-<5 years 107 166 149 192 190 199 221 214 244 243 230 237 2425+ years 42 32 72 143 145 145 181 180 196 180 185 183 190

All 249 206 204 228 198 217 227 230 242 224 220 219 220

ADJUSTED0-19 . . 84 103 87 105 86 71 65 55 60 73 7720-44 . . 109 115 115 119 130 122 129 116 114 109 11145-64 . . 186 234 216 235 246 242 252 229 223 218 21665-74 . . 318 413 377 389 388 401 407 366 367 371 36875+ . . 494 551 513 556 576 568 596 568 545 551 513

Male . . 241 275 261 270 284 285 301 278 268 266 265Female . . 241 308 276 303 297 293 299 278 272 268 255

White . . 255 311 291 307 316 316 331 308 298 294 290Black . . 235 273 236 261 263 275 263 241 229 247 234Other race . . 211 269 242 288 276 215 285 245 286 202 205

Diabetes . . 334 402 369 380 399 397 405 371 364 365 350Hypertension . . 194 245 218 266 245 240 253 234 229 227 227Glomerulonephritis . . 205 197 155 177 190 190 200 180 192 185 188Other cause . . 181 224 242 243 263 258 277 251 233 233 231

<2 years . . 290 296 267 288 284 281 286 258 245 238 2272-<5 years . . 251 300 271 287 291 285 303 295 288 292 2865+ years . . 139 268 269 283 309 315 329 300 303 302 301

All . . 241 291 268 287 292 291 302 279 272 269 263


Table H.20Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patientsperiod prevalent patients; 200 ESRD patients used as reference


539


Table H.20 (continued)Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 62 103 79 92 147 73 123 120 117 93 855-9 58 19 24 40 42 43 67 35 39 8 4110-14 35 25 40 45 43 9 43 15 18 26 4015-19 15 46 49 24 31 38 44 40 42 44 2820-29 55 68 58 60 49 49 61 42 43 48 6130-39 107 105 100 97 91 87 83 83 75 85 6540-49 140 132 142 136 125 121 119 113 116 112 10750-59 202 199 199 193 196 197 192 181 178 170 16760-64 289 258 259 271 275 269 273 270 253 228 22065-69 329 309 332 336 319 326 315 323 317 294 27270-79 407 418 402 427 403 419 418 407 393 374 35380+ 580 567 614 606 640 585 583 575 582 539 543

Male 233 229 235 239 230 228 225 221 216 205 208Female 219 217 218 219 216 216 216 207 203 197 180

White 254 251 254 257 256 255 251 245 239 232 222Black 167 167 177 177 160 162 159 155 156 145 143Other race 133 127 130 160 151 142 172 158 140 131 140


Diabetes 315 315 314 323 318 321 313 301 295 280 260Hypertension 247 234 243 238 236 224 224 217 224 201 207Glomerulonephritis 123 133 126 134 124 125 128 117 108 111 114Other cause 180 168 177 172 160 161 162 167 156 158 147

<2 years 223 219 214 216 211 208 206 196 190 179 1762-<5 years 259 252 277 268 263 260 254 255 247 233 2265+ years 185 188 187 212 196 203 210 206 210 217 199

All 227 223 227 230 223 222 221 214 209 201 194

ADJUSTED0-19 63 68 73 76 90 76 93 89 91 83 7920-44 114 113 115 116 108 105 100 98 96 95 8845-64 221 213 212 213 207 206 205 199 194 185 17965-74 362 356 363 384 366 369 360 361 355 348 33075+ 543 542 538 559 534 546 566 547 538 548 519

Male 272 262 264 270 258 256 253 247 242 233 227Female 264 264 265 271 260 262 262 256 253 247 229

White 300 293 292 296 286 287 283 277 273 265 252Black 243 240 243 251 230 230 231 220 215 212 203Other race 189 182 173 193 186 182 196 201 190 172 171

Diabetes 366 362 367 378 365 370 366 356 348 338 314Hypertension 236 230 231 230 222 218 220 212 214 203 200Glomerulonephritis 169 169 164 176 163 165 167 162 152 151 152Other cause 236 225 222 230 212 209 206 209 204 205 197

<2 years 230 222 218 218 207 204 202 193 186 173 1652-<5 years 302 295 310 308 296 292 287 281 275 263 2485+ years 306 306 303 331 319 331 332 329 335 343 329

All 269 264 265 271 260 260 258 251 248 240 229


Table H.20 (continued)Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patientsperiod prevalent patients; 200 ESRD patients used as reference



540

Reference section H

Table H.21Total patient deaths: CAPD/CCPD patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 . * * * * * * * * * * 135-9 * * * * * * * * * * * *10-14 . . . * * * * * * * * *15-19 . * * * * * * * 10 * * *20-29 * * 15 25 39 38 55 41 65 64 60 6630-39 10 24 52 60 101 147 186 196 210 207 204 21840-49 13 26 55 110 169 198 293 272 294 288 353 38450-59 23 46 124 203 270 403 453 492 544 540 574 65060-64 10 29 85 152 224 294 378 420 454 464 519 55865-69 10 38 89 167 194 303 390 475 548 527 593 72370-79 19 40 128 220 261 406 528 644 741 766 877 1,00680+ * * 33 59 66 101 130 156 193 220 235 288

0-19 * * * 12 19 25 16 18 22 19 21 2720-44 17 43 93 130 227 277 365 363 405 412 425 47345-64 41 86 238 420 576 803 1,000 1,058 1,162 1,151 1,285 1,40365-74 22 61 166 302 354 550 713 849 973 972 1,099 1,30675+ 16 24 84 144 167 260 335 426 509 541 606 711

Male 51 114 324 492 748 1,010 1,373 1,462 1,670 1,689 1,875 2,158Female 46 104 264 516 595 905 1,056 1,252 1,401 1,406 1,561 1,762Unknown

White 79 185 473 804 1,083 1,523 1,960 2,156 2,462 2,486 2,709 3,068Black 15 31 106 186 231 345 421 513 529 549 641 778Native American * . * * 15 24 20 29 46 39 46 43Asian . * * 10 * 17 19 * 25 15 35 27Other/unknown * * * * * * * * * * * *


Diabetes 42 81 202 367 426 628 847 976 1,045 1,085 1,353 1,557Hypertension 19 39 136 233 269 465 497 613 732 769 878 1,050Glomerulonephritis 10 24 79 112 163 259 348 373 456 469 489 502Cystic kidney * * 12 38 61 65 91 95 110 111 101 110Other urologic * * 19 29 40 48 69 74 81 74 77 88Other cause 11 20 45 99 140 181 251 281 293 262 309 359Unknown cause * 26 55 82 82 128 153 155 196 175 151 193Missing disease * 13 40 48 162 141 173 147 158 150 78 61

<2 years 92 199 507 844 950 1,329 1,547 1,749 1,915 1,919 2,179 2,4912-<5 years * 17 67 120 279 431 621 663 791 801 842 9775+ years * * 14 44 114 155 261 302 365 375 415 452

All 97 218 588 1,008 1,343 1,915 2,429 2,714 3,071 3,095 3,436 3,920All with unknowns dropped 87 191 529 924 1,252 1,781 2,269 2,552 2,866 2,915 3,281 3,723


Table H.21Total patient deaths: CAPD/CCPD patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage


541


Table H.21 (continued)Total patient deaths: CAPD/CCPD patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 12 * 12 11 11 19 * 16 16 17 13 *5-9 * * * * * * * * * * . *10-14 * * * * * * * * * * * *15-19 * * * 14 * * * 11 * * * *20-29 59 57 80 59 61 39 43 49 35 36 38 4930-39 274 288 292 296 271 237 180 170 152 130 145 11340-49 467 526 511 570 584 501 462 400 383 358 355 29550-59 732 818 884 971 975 956 924 849 803 763 736 70060-64 595 708 677 701 751 729 666 617 570 526 480 46965-69 784 898 897 1,024 981 938 864 741 723 692 631 58370-79 1,234 1,403 1,631 1,713 1,851 1,688 1,650 1,555 1,442 1,334 1,264 1,19780+ 338 390 468 562 583 599 548 511 513 535 541 579

0-19 28 17 25 32 30 37 22 39 28 30 25 2520-44 543 573 586 607 581 473 419 378 346 311 312 26945-64 1,584 1,824 1,858 1,990 2,061 1,989 1,856 1,707 1,597 1,502 1,442 1,35765-74 1,521 1,689 1,864 2,061 2,049 1,912 1,774 1,595 1,525 1,414 1,289 1,21975+ 835 1,002 1,132 1,238 1,366 1,313 1,288 1,212 1,153 1,147 1,147 1,140


White 3,561 4,001 4,237 4,514 4,582 4,413 4,129 3,728 3,548 3,345 3,252 3,038Black 859 982 1,093 1,240 1,259 1,062 1,006 937 855 847 756 742Native American 45 56 63 57 68 58 54 58 48 41 40 50Asian 39 59 67 103 142 138 109 146 132 115 123 131Other/unknown * * * 14 36 53 61 62 66 56 44 49


Diabetes 1,827 2,196 2,372 2,607 2,815 2,776 2,678 2,420 2,287 2,132 2,070 1,919Hypertension 1,225 1,415 1,492 1,662 1,587 1,437 1,268 1,181 1,113 1,106 985 1,039Glomerulonephritis 583 568 660 660 695 627 575 554 473 437 408 373Cystic kidney 117 138 133 154 131 137 126 109 104 98 102 78Other urologic 97 90 102 99 122 119 106 109 130 113 114 96Other cause 395 448 447 510 515 427 413 388 383 368 365 360Unknown cause 211 209 222 222 207 195 187 165 152 145 163 139Missing disease 56 41 37 14 15 * * * * * * *

<2 years 2,844 3,146 3,295 3,404 3,437 3,171 2,892 2,623 2,453 2,325 2,211 2,1612-<5 years 1,157 1,426 1,573 1,895 1,911 1,893 1,786 1,634 1,529 1,422 1,359 1,2945+ years 510 533 597 629 739 660 681 674 667 657 645 555



Table H.21 (continued)Total patient deaths: CAPD/CCPD patients, never on transplant waitlist by demographic characteristics, primary diagnosis, & patient vintage



542

Reference section H

Table H.22Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, never on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference


Table H.22Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, never on transplant waitlistfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 . 113.1 144.4 260.9 235.4 180.8 134.8 184.5 138.5 219.2 198.3 328.45-9 151.5 314.7 78.7 53.1 101.2 193.1 67.8 43.0 102.9 41.7 55.2 93.410-14 . . . 24.9 56.2 97.7 41.6 67.0 150.2 110.7 207.3 85.415-19 . 100.8 101.6 89.2 103.3 87.0 81.2 105.8 135.5 75.8 52.5 102.720-29 72.2 68.0 106.2 126.3 108.2 88.7 134.2 103.9 165.6 161.3 148.3 147.730-39 191.4 178.8 154.7 121.7 143.1 151.2 172.0 192.9 204.9 184.5 167.5 170.440-49 218.4 173.0 134.5 182.6 166.5 162.3 217.0 208.4 224.2 195.6 205.5 188.650-59 277.1 183.0 185.4 212.0 182.8 228.8 226.9 247.8 259.9 248.7 247.0 249.060-64 187.3 297.6 248.3 301.6 285.4 287.0 284.1 286.6 309.7 298.7 286.6 285.765-69 363.5 333.4 340.5 371.6 309.1 337.9 336.3 351.1 359.6 312.3 338.9 353.070-79 548.4 414.0 419.9 433.6 402.8 429.0 429.3 440.6 447.5 431.4 410.3 401.880+ . 299.6 572.4 659.7 605.5 706.1 609.6 586.0 711.8 646.6 572.3 579.0

Male 275.3 221.4 233.3 232.1 227.2 244.3 284.3 292.4 317.7 295.5 292.5 297.4Female 258.0 227.9 208.7 277.3 220.9 254.3 246.9 275.4 294.7 275.0 273.7 272.7





All 266.8 224.5 221.6 253.2 224.4 248.9 266.7 284.3 306.8 285.8 283.7 285.8

ADJUSTED0-19 . . 115.7 150.8 135.5 169.5 149.4 139.9 145.1 124.0 130.7 152.420-44 . . 125.3 135.8 139.3 148.4 168.2 174.8 192.0 179.2 176.9 173.645-64 . . 192.5 242.0 222.0 246.1 260.9 265.9 279.5 257.4 255.3 253.065-74 . . 321.9 418.0 379.7 392.4 391.3 405.1 404.7 361.0 362.4 367.475+ . . 504.8 568.4 529.7 571.1 588.6 577.7 583.2 551.6 532.0 529.4

Male . . 249.4 286.3 272.8 284.5 304.1 313.9 330.2 306.5 297.5 298.0Female . . 249.0 319.0 287.2 317.2 312.5 314.4 321.8 299.3 295.9 291.6

White . . 263.0 322.2 303.3 322.2 334.4 342.7 359.6 335.7 327.0 324.8Black . . 243.5 282.2 246.0 273.2 279.8 297.6 284.4 262.2 252.4 270.4Other race . . 227.5 284.2 254.6 305.5 292.8 233.7 305.8 259.9 307.1 236.1

Diabetes . . 344.7 417.3 384.2 397.1 420.5 427.4 426.9 389.7 385.7 385.9Hypertension . . 201.3 255.0 227.4 280.3 261.9 260.6 275.8 256.0 253.7 253.7Glomerulonephritis . . 212.5 205.5 163.0 186.4 204.0 212.7 227.6 208.8 223.9 216.8Other cause . . 188.8 234.9 254.6 258.4 283.1 288.0 312.9 285.5 268.4 273.9

<2 years . . 297.3 305.2 277.6 302.3 303.6 311.3 322.6 293.9 281.8 275.82-<5 years . . 260.4 313.1 283.9 301.7 308.8 306.5 324.4 316.2 311.5 317.65+ years . . 149.7 282.6 280.2 298.4 324.7 333.1 341.1 309.0 313.1 312.6

All . . 249.4 301.8 280.0 301.1 310.6 315.7 328.1 304.2 298.7 297.6


543


Table H.22 (continued)Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, never on trafrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 263.7 133.1 187.6 166.8 161.8 262.0 109.7 254.8 252.6 211.4 171.5 128.65-9 197.3 161.1 59.9 49.6 93.5 123.7 82.8 153.4 81.5 97.7 . 92.910-14 115.3 87.8 59.7 91.8 106.2 93.7 28.3 85.7 30.9 40.5 50.4 65.915-19 112.5 25.9 100.8 131.7 63.5 56.1 79.6 100.4 95.3 92.1 93.9 53.320-29 126.7 116.9 158.6 129.2 130.9 98.8 92.7 129.7 89.8 83.1 95.1 121.730-39 194.1 190.3 186.5 183.7 177.4 162.9 151.3 149.7 148.3 134.1 144.6 105.740-49 202.8 217.5 202.1 217.1 215.2 193.0 188.0 182.5 177.6 172.3 175.6 156.850-59 243.2 256.2 256.6 260.9 256.2 267.6 270.3 261.9 254.6 251.8 242.9 228.860-64 293.0 314.1 289.1 293.4 307.2 318.0 319.0 328.5 335.8 320.1 286.5 276.965-69 324.8 341.7 325.0 356.7 360.1 342.0 354.1 348.8 364.2 355.8 341.5 317.070-79 404.6 410.0 421.0 406.5 433.4 411.1 426.3 425.5 415.5 409.7 389.6 367.680+ 583.8 580.7 565.8 613.9 606.8 641.3 585.7 584.5 575.2 586.1 542.6 547.0

Male 304.1 307.4 305.7 317.5 323.6 316.8 316.0 312.5 315.5 302.0 288.3 286.8Female 271.2 293.7 290.8 295.2 302.0 296.5 300.5 305.6 295.7 295.5 285.7 254.5





All 288.7 300.9 298.6 306.8 313.3 307.0 308.4 309.1 305.9 298.9 287.0 271.2

ADJUSTED0-19 177.9 136.8 132.0 138.7 143.5 164.7 134.6 164.2 171.8 164.4 148.7 129.520-44 179.7 186.5 183.1 188.2 191.4 177.4 171.3 165.1 162.1 153.3 153.8 140.645-64 251.6 261.4 257.4 260.7 265.4 260.2 262.2 260.9 259.6 256.8 248.9 237.065-74 363.8 360.3 354.1 366.6 390.0 371.4 375.2 368.5 373.7 371.0 370.0 353.275+ 494.5 523.8 524.0 520.2 544.5 517.5 531.4 546.7 534.0 525.6 539.3 508.9

Male 297.8 308.0 299.2 306.7 315.3 302.1 301.5 297.3 294.7 288.3 280.0 270.0Female 280.3 292.7 292.9 297.0 305.6 293.4 296.0 298.3 294.2 294.4 290.5 268.8




All 291.9 301.9 297.6 303.0 312.2 299.4 300.4 298.4 295.0 291.7 285.9 270.4


Table H.22 (continued)Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, never on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference



544

Reference section H

Table H.23Total patient deaths: CAPD/CCPD patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 . . . . . . * . . * * . . * * .5-9 . * . . . . . . . . . . . . . .10-14 . . . * * * . . * * . . . . * *15-19 . . . * . * . . * * * . * * * *20-29 * * * * * * * 14 12 14 13 13 10 11 10 1330-39 * 10 * 11 16 28 33 39 41 34 37 44 41 39 37 3040-49 * * * 16 28 25 45 65 58 76 82 68 59 76 61 7950-59 * 10 * 12 17 25 34 59 72 75 86 107 103 109 105 11860-64 * * * * 15 11 13 14 32 41 44 44 46 40 41 5265-69 * * * * * * * * 29 23 27 32 33 35 29 3670-79 . . * * . * * * * 10 10 11 23 13 16 2880+ . . . . . . * . . * . . * . . *

0-19 . * . * * * * . * * * . * * * *20-44 13 16 12 23 32 51 71 82 76 79 92 82 79 85 72 8045-64 * 16 16 25 48 47 59 109 139 161 170 194 180 190 182 21265-74 * * * * * * 10 * 33 31 31 41 52 46 45 5675+ . . . . . * * . * * * * * * . 10

Male * 19 20 32 54 58 76 100 134 148 159 177 158 173 152 201Female 15 16 12 25 32 50 67 97 119 132 143 142 160 154 151 161Unknown

White 16 29 25 45 65 80 102 143 175 178 179 223 201 212 172 227Black * * * 11 19 26 35 49 67 85 101 77 100 89 101 102Native American * * * . * . * * * * * * . * * 10Asian . * * * . * * * * 11 15 14 10 16 17 17Other/unknown * . . . . . . . * * * * * * * *


Diabetes 12 20 18 23 41 41 73 92 121 124 119 151 134 160 137 159Hypertension * * * 10 17 22 24 32 37 57 51 48 57 60 56 56Glomerulonephritis * * * 12 14 21 16 23 49 49 65 59 56 55 48 81Cystic kidney . * * * * * * 17 * 11 17 15 16 * 11 12Other urologic . . . * * * * * * * * * * * * *Other cause * * * * * 14 18 23 27 31 38 31 42 30 42 41Unknown cause * * * * * * * * * * * 11 * 10 * *Missing disease * * . * * * * . . . . . . . . .

<2 years 12 17 14 24 27 40 62 71 84 96 76 94 88 93 74 912-<5 years * 13 11 21 38 41 46 90 114 117 141 139 152 144 136 1505+ years * * * 12 21 27 35 36 55 67 85 86 78 90 93 121

All 23 35 32 57 86 108 143 197 253 280 302 319 318 327 303 362All with unknowns dropped 21 33 30 56 85 106 138 191 245 274 292 307 302 313 290 347


Table H.23Total patient deaths: CAPD/CCPD patients, on transplant waitlistby demographic characteristics, primary diagnosis, & patient vintage


545


Table H.24Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, on transplant waitlistfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 . 113.6 . . . . 100.0 . . 108.4 115.7 . . 67.5 101.6 .5-9 . . . . . . . . . . . . . . . .10-14 . . . 19.8 37.7 35.8 . . 63.4 20.3 . . 22.7 . 24.7 23.715-19 . . . 19.2 0.0 24.5 . . 14.1 55.1 23.2 . 14.7 61.7 33.0 61.620-29 7.8 5.9 5.9 23.3 28.6 31.2 18.7 46.1 34.9 34.6 39.0 38.7 29.1 44.5 42.3 74.230-39 29.9 54.1 30.8 29.4 25.0 58.3 48.8 50.6 55.3 44.0 53.0 64.1 54.9 58.0 69.9 81.140-49 52.4 38.3 17.9 43.6 63.1 45.1 64.1 77.9 53.9 81.8 74.6 67.6 66.8 87.5 78.4 147.150-59 40.7 88.8 58.9 53.8 63.8 68.7 64.1 84.7 99.5 77.4 98.2 117.6 111.7 110.6 130.2 201.460-64 152.5 74.5 80.6 124.1 276.3 134.4 93.2 79.4 146.4 156.7 152.7 165.9 144.1 147.0 127.6 227.165-69 105.4 119.2 167.0 215.3 124.0 58.0 86.3 52.2 164.9 159.5 140.9 179.4 197.2 188.8 180.2 267.270-79 . . 448.7 430.7 . 188.4 261.8 51.9 120.2 187.9 161.0 163.4 297.0 125.7 137.1 268.980+ . . . . . . . . . . . . 566.3 . . 578.8

Male 26.7 47.7 36.1 44.7 65.2 53.3 56.4 62.3 72.5 76.3 80.7 92.8 84.3 98.0 94.3 168.2Female 40.6 35.9 24.0 39.9 35.8 54.0 51.5 66.4 69.1 73.6 76.7 80.9 89.9 88.3 100.8 144.3

White 31.5 46.8 34.1 47.5 58.1 60.1 58.8 74.4 78.7 78.2 77.9 99.7 90.8 97.5 86.6 152.8Black 29.4 23.8 18.5 34.5 39.4 43.7 47.0 53.6 64.1 74.9 87.7 71.9 95.4 92.8 126.8 178.2Other race 107.1 49.2 32.5 21.0 18.5 22.5 34.7 19.7 36.3 54.2 57.6 54.2 43.6 69.0 93.2 131.8


Diabetes 103.7 119.0 91.1 85.8 115.6 92.7 122.6 139.9 142.9 144.0 131.8 172.4 150.5 183.8 167.8 258.9Hypertension 43.3 22.4 23.9 50.6 54.8 59.5 47.9 51.9 55.5 84.7 70.4 73.3 87.6 96.9 107.9 140.8Glomerulonephritis 8.4 26.3 15.4 25.7 28.8 34.4 19.7 24.1 46.6 39.4 53.2 50.2 48.7 51.3 51.1 123.7Other cause 20.0 21.9 14.6 28.5 26.2 39.1 36.5 54.3 46.5 48.6 68.1 62.2 75.5 55.9 76.5 99.6

<2 years 36.0 40.8 26.0 34.4 33.6 40.7 47.8 49.9 48.4 55.8 45.1 57.8 56.5 63.6 59.2 108.92-<5 years 47.1 49.1 33.0 54.7 69.6 66.2 58.0 87.9 99.6 90.0 97.0 99.8 113.3 110.0 114.2 155.05+ years 16.5 32.8 35.9 44.5 66.6 68.3 63.7 60.6 78.5 94.6 117.0 126.5 102.6 120.9 136.1 238.2

All 34.0 41.8 30.1 42.4 50.7 53.6 54.0 64.3 70.8 75.0 78.7 87.0 87.1 93.2 97.5 156.7

ADJUSTED0-19 . . . . . . . . 23.2 88.5 62.9 31.6 24.7 51.3 49.8 70.620-44 . . . . . . . . 70.2 75.1 78.1 84.3 74.1 82.0 76.6 116.445-64 . . . . . . . . 117.5 121.8 122.1 144.4 136.6 137.3 140.8 220.165-74 . . . . . . . . 182.9 206.4 195.1 226.7 254.8 256.5 246.6 335.875+ . . . . . . . . 256.2 285.7 501.5 403.0 524.5 279.0 91.6 413.8

Male . . . . . . . . 147.2 133.8 144.9 176.3 184.6 164.7 133.5 249.3Female . . . . . . . . 132.2 161.9 187.2 178.3 207.0 172.5 150.2 225.4

White . . . . . . . . 157.2 165.0 174.4 200.1 216.8 184.4 145.7 238.7Black . . . . . . . . 93.4 129.1 156.2 147.8 169.1 151.6 143.5 252.3Other race . . . . . . . . 160.7 80.5 102.8 100.6 92.3 123.1 110.0 232.2

Diabetes . . . . . . . . 234.2 230.1 243.2 278.6 284.2 279.3 231.2 372.9Hypertension . . . . . . . . 100.3 131.8 130.8 152.4 172.8 144.2 119.1 201.0Glomerulonephritis . . . . . . . . 87.3 110.5 138.6 105.2 108.8 83.6 71.5 166.0Other cause . . . . . . . . 75.0 77.1 119.5 112.0 145.2 94.4 92.6 159.0

<2 years . . . . . . . . 81.4 84.3 86.5 92.3 103.9 92.1 75.7 141.32-<5 years . . . . . . . . 181.4 176.0 190.6 189.3 224.9 185.3 151.5 227.25+ years . . . . . . . . 207.1 236.7 294.7 335.4 347.6 299.7 245.2 430.6

. . . . . . . .All . . . . . . . . 139.1 147.0 165.7 176.7 193.3 167.8 141.5 238.4


Table H.24Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, on transplant waitlistperiod prevalent patients; 200 ESRD patients used as reference



546

Reference section H

Table H.25Total patient deaths: CAPD/CCPD patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage

1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 19950-4 . . . . * . . . . . . . .5-9 . . . . * . * * * * * . .10-14 . . * . * * * * * * * . *15-19 . * * * * * * * * * * * *20-29 . * * * * * * 12 14 10 * 12 1030-39 . * 19 18 18 27 29 26 39 49 48 42 3740-49 . * 20 21 19 32 37 49 37 60 55 64 6550-59 . * * 18 10 23 25 14 28 26 40 53 6760-64 . * * . * * * * 11 15 17 * 1565-69 . * * * . * * * * * 13 * 1670-79 . . . * * * * * * * * 12 *80+ . . . . . . . . . . . . .

0-19 . * * * * * * * * * * * *20-44 . 17 33 33 37 51 60 71 73 91 85 90 8945-64 . 12 18 30 24 46 47 36 56 69 83 90 10565-74 . * * * * * * 11 * * 14 18 2175+ . . . . . . . * . . * * *

Male . 19 32 46 32 73 70 67 73 99 113 111 122Female . 13 24 22 35 39 48 57 64 75 75 93 101Unknown . . . . . . . . . . . . .

White . 30 47 58 58 93 101 95 108 139 152 159 172Black . * * * * 17 16 26 28 34 32 36 45Native American . . * . * . * * . * * * *Asian . . * . . * . * * . * * *Other/unknown . * . * * . . . . . . . .


Diabetes . * 12 19 22 30 37 43 44 57 54 56 64Hypertension . * * * * 12 13 13 16 27 27 33 44Glomerulonephritis . 10 16 20 11 34 34 35 36 41 55 66 61Cystic kidney . * * * * * * * * 15 14 * 16Other urologic . . . . * * * . * * . * *Other cause . * * * 10 17 16 18 21 23 28 23 24Unknown cause . * * . * * * * 10 * * * 11Missing disease . * * * * * * * * * * * .

<2 years . * * * * * 13 * * * * * *2-<5 years . 13 25 23 18 31 45 36 38 44 39 39 395+ years . 16 29 40 45 72 60 81 92 124 141 158 177

All . 32 56 68 67 112 118 124 137 174 188 204 223All with unknowns dropped . 28 51 67 60 108 116 119 127 167 181 195 212


Table H.25Total patient deaths: CAPD/CCPD patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage


547


Table H.25 (continued)Total patient deaths: CAPD/CCPD patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage

1996 1997 1998 1999 2000 2001 2002 20030-4 . . . . . . . .5-9 * . * . * * . .10-14 * * . * . . * *15-19 * * * * * * * *20-29 22 20 23 21 11 12 11 1130-39 47 52 50 43 49 34 33 2640-49 81 88 65 92 74 69 70 6550-59 63 57 56 54 51 47 60 5660-64 19 23 20 12 16 15 14 1465-69 16 16 * 10 11 * 12 1570-79 * * 12 15 * 10 18 1080+ . . . . . * * .

0-19 * * * * * * * *20-44 107 122 107 97 101 80 80 6445-64 125 118 107 125 100 97 108 10865-74 22 24 16 22 17 18 28 2275+ . * * * * * * *

Male 141 135 117 129 108 109 111 98Female 118 135 118 121 116 91 110 102Unknown

White 195 200 165 187 161 146 164 130Black 57 58 56 56 54 46 49 62Native American * * * * . * * *Asian * 10 11 * * * * *Other/unknown . . . . * . . *


Diabetes 66 68 54 70 54 60 50 33Hypertension 39 36 42 29 35 35 41 33Glomerulonephritis 85 87 79 71 67 56 75 86Cystic kidney 19 24 11 13 * 10 * 10Other urologic * * * 11 * * * *Other cause 36 40 38 49 49 25 36 23Unknown cause * * * * * * * 11Missing disease . . . . . . . .

<2 years * * * . * * * *2-<5 years 35 40 26 21 26 16 14 *5+ years 218 228 208 229 197 183 206 192

All 259 270 235 250 224 200 221 200All with unknowns dropped 252 263 229 243 217 193 215 188


Table H.25 (continued)Total patient deaths: CAPD/CCPD patients, returned to dialysis from transplantby demographic characteristics, primary diagnosis, & patient vintage



548

Reference section H

Table H.26Annual mortality rates per 1,000 patient YAR: CAPD/CCPD patients, returned to dialysis from transplantfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 19930-4 . . . . 133.8 . . . . . 117.55-9 . . . . 45.1 . 34.4 51.0 53.8 29.0 .10-14 . . 60.9 . 32.4 74.0 63.3 16.0 14.9 58.8 29.715-19 150.2 130.0 79.6 14.2 35.2 120.7 30.0 19.4 24.1 46.3 34.020-29 88.7 43.6 30.7 46.6 34.7 50.2 29.4 48.0 51.1 42.9 37.130-39 52.5 64.6 115.4 98.5 77.8 109.7 87.4 75.2 99.9 105.5 91.340-49 158.0 80.6 191.3 137.7 108.6 126.3 138.3 164.3 89.2 148.4 132.450-59 86.6 234.4 113.9 215.4 143.8 259.2 267.2 109.9 229.5 155.4 167.660-64 . 266.2 54.8 . 231.0 295.7 250.9 124.5 150.7 292.4 348.565-69 . 318.2 129.0 313.9 . 316.3 375.2 546.9 285.8 175.9 299.870-79 . . . . 389.4 309.8 . 889.6 415.1 252.2 180.880+ . . . . . . . . . . .

Male 51.6 85.5 105.7 117.9 71.6 135.4 112.6 101.5 97.6 121.5 121.3Female 160.2 76.4 98.7 63.4 86.9 92.1 85.9 89.7 88.4 93.1 84.3

White 104.6 96.9 107.8 99.1 86.2 127.6 106.7 97.4 99.9 119.4 114.1Black . 13.1 81.4 80.5 44.1 78.1 85.3 95.1 80.5 83.1 76.7Other race 226.9 107.0 91.9 39.4 85.6 57.7 24.8 65.8 20.1 16.8 65.2


Diabetes . 131.7 257.1 279.5 246.5 237.2 250.6 288.6 256.4 311.0 264.1Hypertension 83.1 65.1 152.7 101.6 70.1 135.0 109.0 77.7 94.6 126.2 101.0Glomerulonephritis 94.3 62.9 68.4 73.3 35.9 82.1 75.6 67.8 58.3 69.3 83.2Other cause 108.1 93.9 87.6 68.6 81.3 110.8 75.5 74.8 83.8 80.7 75.2

<2 years . 58.2 32.3 84.3 74.1 103.5 129.7 77.5 78.7 61.6 104.72-<5 years 68.7 94.2 113.6 85.1 55.8 94.2 121.2 86.9 81.6 100.9 88.35+ years 122.2 78.9 107.6 101.2 91.7 128.4 87.2 101.8 99.0 113.2 107.6

All 90.7 81.8 102.8 94.2 78.6 116.5 100.4 96.0 93.3 107.7 103.2

ADJUSTED0-19 . . . . . . . . . . .20-44 . . . . . . . . . . .45-64 . . . . . . . . . . .65-74 . . . . . . . . . . .75+ . . . . . . . . . . .

Male . . . . . . . . . . .Female . . . . . . . . . . .

White . . . . . . . . . . .Black . . . . . . . . . . .Other race . . . . . . . . . . .

Diabetes . . . . . . . . . . .Hypertension . . . . . . . . . . .Glomerulonephritis . . . . . . . . . . .Other cause . . . . . . . . . . .

<2 years . . . . . . . . . . .2-<5 years . . . . . . . . . . .5+ years . . . . . . . . . . .

All . . . . . . . . . . .


Table H.26Annual mortality rates per 1,000 patient YAR: CAPD/CCPD patients, returned to dialysis from transplantperiod prevalent patients; 200 ESRD patients used as reference


549


Table H.26 (continued)Annual mortality rates per 1,000 patient YAR: CAPD/CCPD patients, returned to dialysis from transplantfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 . . . . . . . . . .5-9 . 74.1 33.0 . 65.0 . 89.5 94.5 . .10-14 . 30.9 37.3 49.4 . 30.0 32.7 . 27.9 46.515-19 43.2 32.9 28.2 55.2 35.1 41.8 49.4 31.2 10.2 12.820-29 39.4 38.0 65.0 62.9 76.0 71.0 41.9 45.0 53.8 36.130-39 67.9 61.3 88.1 93.1 102.6 93.4 102.4 74.7 72.4 57.540-49 114.9 128.5 138.5 163.6 109.1 177.7 154.1 147.4 151.3 136.050-59 188.0 220.6 176.1 200.0 192.5 193.5 204.2 159.7 204.5 193.160-64 104.8 313.3 260.2 370.0 234.6 161.8 189.6 217.5 229.2 219.265-69 147.2 302.9 335.9 392.3 196.6 275.7 464.5 372.3 312.5 267.470-79 651.3 366.1 165.6 504.8 524.1 520.9 221.3 282.4 619.7 226.080+ . . . . . . . 525.5 . .

Male 98.0 121.0 123.8 144.9 118.6 153.1 140.9 135.8 145.4 120.1Female 85.6 93.0 108.8 126.1 115.1 118.4 115.7 92.4 109.1 100.3




<2 years 76.9 86.8 95.1 40.1 33.6 . 36.8 53.0 62.2 54.82-<5 years 80.9 85.7 79.7 106.7 84.5 82.3 113.8 94.8 74.3 37.25+ years 95.4 112.8 124.9 142.4 123.2 142.9 129.9 113.9 131.0 116.3

All 91.9 106.8 116.2 135.0 116.8 134.5 127.1 111.7 125.0 108.9

ADJUSTED0-19 . . . 50.3 40.5 45.5 61.9 61.7 28.8 17.620-44 . . . 91.6 81.0 75.3 83.6 86.3 99.8 63.745-64 . . . 188.1 142.7 138.6 140.3 144.8 166.2 146.965-74 . . . 417.5 296.8 252.8 233.6 243.6 432.8 273.475+ . . . 148.2 44.3 153.5 67.4 123.2 197.4 210.8

Male . . . 204.1 156.7 154.2 151.4 163.1 245.4 191.2Female . . . 201.5 128.7 130.4 116.5 130.2 179.0 129.5

White . . . 234.5 148.2 156.7 161.7 179.4 275.3 189.2Black . . . 154.2 139.3 124.5 107.9 110.2 144.2 117.2Other race . . . 211.9 128.5 117.3 54.5 60.5 48.2 113.4

Diabetes . . . 316.5 202.6 208.3 181.1 214.5 339.9 246.1Hypertension . . . 141.2 128.4 119.9 149.3 148.0 219.2 137.8Glomerulonephritis . . . 99.8 97.4 89.9 87.5 76.4 106.1 120.2Other cause . . . 178.3 112.4 130.5 110.1 116.5 113.7 92.4

<2 years . . . 140.6 91.0 42.1 52.4 72.6 137.3 124.92-<5 years . . . 197.1 137.5 162.2 156.4 173.5 224.1 127.15+ years . . . 325.6 225.2 290.6 243.9 251.9 359.6 267.8

All . . . 204.4 142.7 143.0 135.9 148.3 214.2 160.8


Table H.26 (continued)Annual mortality rates per 1,000 patient YAR: CAPD/CCPD patients, returned to dialysis from transplantperiod prevalent patients; 200 ESRD patients used as reference



550

Reference section H

Table H.27Total patient deaths: transplant patientsby demographic characteristics, primary diagnosis, & patient vintage

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 * * * * * * * * * * * *5-9 * * * * * * * * * * * *10-14 12 * * * * 12 10 * * * . *15-19 * 21 11 13 14 * 15 17 17 16 * 1320-29 36 51 49 83 73 75 77 89 91 78 80 7630-39 89 90 140 151 204 188 247 233 273 257 263 25540-49 101 124 149 141 186 187 249 265 317 362 422 43150-59 64 95 116 146 150 210 219 293 327 367 414 43660-64 20 13 22 27 54 62 75 85 111 120 179 21565-69 * * * 14 17 16 29 25 56 62 109 10570-79 * * * * * * * 11 17 29 39 3980+ . * . * . * * * * * * *

0-19 27 31 21 21 25 28 37 38 31 30 15 2620-44 161 198 261 304 381 365 448 445 515 515 554 55345-64 149 175 215 244 286 357 419 520 604 669 804 86065-74 * * 10 16 17 22 35 36 67 85 143 14075+ * * * * * * * * * * * 10

Male 230 278 317 385 464 506 619 691 837 871 1,030 1,061Female 111 134 191 203 246 268 323 350 388 435 494 528Unknown

White 249 307 407 472 531 601 717 780 932 978 1,165 1,212Black 72 85 81 95 161 151 200 232 255 290 316 335Native American * * . * * * 12 12 10 10 19 10Asian . . * * * * * 10 16 16 17 30Other/unknown 19 19 18 13 13 13 * * 12 12 * *


Diabetes 47 65 102 115 177 185 259 283 347 387 431 505Hypertension 27 36 48 47 83 89 140 141 164 187 238 274Glomerulonephritis 59 78 103 124 127 159 202 230 252 294 349 336Cystic kidney 16 20 21 31 38 42 52 63 81 67 111 100Other urologic * * 13 * 10 14 22 24 27 30 34 53Other cause 20 23 29 52 66 99 95 121 130 136 172 144Unknown cause 35 31 55 53 57 58 51 42 80 66 90 73Missing disease 134 155 137 157 152 128 121 137 144 139 99 104

<2 years 162 161 162 168 190 169 173 208 218 189 178 1722-<5 years 153 199 256 227 286 300 393 350 423 418 450 4395+ years 26 52 90 193 234 305 376 483 584 699 896 978

All 341 412 508 588 710 774 942 1,041 1,225 1,306 1,524 1,589All with unknowns dropped 288 362 437 523 643 703 884 992 1,133 1,228 1,427 1,514

The age of patient is determined as of the date of Death.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. *Values for cells with 10 or fewer patients are suppressed."." Zero values in this cell.

Table H.27Total patient deaths: transplant patientsby demographic characteristics, primary diagnosis, & patient vintage


551


Table H.27 (continued)Total patient deaths: transplant patientsby demographic characteristics, primary diagnosis, & patient vintage

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 * * * * * * * * * * * *5-9 * * * * * * * * * * * *10-14 * * * * * * * * * * 10 *15-19 * 15 13 19 15 16 18 11 16 11 15 1920-29 68 78 63 60 61 63 56 67 50 72 75 4230-39 251 279 261 276 251 299 269 292 275 299 266 24840-49 432 428 558 616 649 606 659 632 650 738 710 65450-59 389 540 593 647 760 814 853 954 1,017 1,056 1,062 1,16160-64 225 258 295 333 363 408 392 485 496 556 565 65165-69 159 190 215 291 294 329 398 386 480 499 539 60970-79 76 87 129 181 226 223 327 396 442 526 568 70280+ * 10 * * * 17 18 16 38 42 49 63

0-19 19 25 23 32 23 32 26 29 29 20 35 3420-44 522 550 556 584 609 646 615 608 612 685 625 55845-64 843 1,033 1,214 1,348 1,475 1,544 1,614 1,822 1,876 2,036 2,053 2,19865-74 222 257 322 433 472 500 656 674 794 866 938 1,07475+ 16 30 28 46 55 69 87 124 166 201 218 300

Male 1,038 1,264 1,367 1,592 1,696 1,724 1,892 2,050 2,145 2,382 2,401 2,565Female 584 631 776 851 938 1,067 1,106 1,207 1,332 1,426 1,468 1,599Unknown

White 1,259 1,454 1,665 1,881 2,024 2,162 2,305 2,470 2,648 2,918 2,895 3,173Black 315 390 418 474 510 531 590 673 695 740 814 839Native American 17 18 18 22 34 29 26 36 44 46 50 53Asian 24 30 39 53 55 64 69 73 84 95 104 91Other/unknown * * * 13 11 * * * * * * *


Diabetes 544 594 711 793 835 939 1,096 1,130 1,220 1,360 1,386 1,512Hypertension 260 319 386 405 451 492 505 553 586 637 690 698Glomerulonephritis 336 390 439 527 601 616 615 659 751 800 760 821Cystic kidney 101 141 134 186 196 193 245 269 285 324 299 328Other urologic 36 51 54 62 61 76 76 90 96 95 110 113Other cause 153 184 211 251 282 272 262 346 317 386 387 462Unknown cause 91 128 118 138 126 140 129 123 137 118 151 152Missing disease 101 88 90 81 82 63 70 87 85 88 86 78

<2 years 167 143 189 164 173 160 135 156 137 178 186 1762-<5 years 420 474 496 532 562 566 569 570 589 609 613 5985+ years 1,035 1,278 1,458 1,747 1,899 2,065 2,294 2,531 2,751 3,021 3,070 3,390



Table H.27 (continued)Total patient deaths: transplant patientsby demographic characteristics, primary diagnosis, & patient vintage



552

Reference section H

ON OUR WEBSITE & CDAnnual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, by primary diagnosis, adjusted (H.28.1). Annual deaths per 1,000 patients: CAPD/CCPD patients, by primary diagnosis (H.28.2). CAPD/CCPD patients: counts of total deaths, by primary diagnosis (H.28.3). Annual mortality rates: CAPD/CCPD patients, unadjusted (H.28.4).

Table H.28Annual mortality rates per 1,000 patient years at risk: transplant patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 124.2 63.7 40.8 25.3 43.9 47.8 38.8 43.4 34.1 17.0 17.4 25.15-9 48.9 43.3 36.7 18.6 17.0 13.2 28.0 20.5 2.6 14.5 8.6 10.010-14 40.9 12.8 17.2 7.6 11.2 26.2 16.6 18.9 11.1 8.9 . 6.415-19 17.4 28.1 12.3 17.6 15.8 9.8 13.4 13.7 15.8 13.5 10.4 9.620-29 16.2 20.1 15.7 23.3 17.1 16.4 15.9 15.8 15.4 13.1 12.3 12.030-39 41.4 32.7 38.4 33.4 37.3 28.0 31.0 25.1 25.7 22.8 21.7 19.440-49 72.3 65.4 61.5 45.8 48.8 39.9 42.0 36.9 37.7 36.5 37.3 34.350-59 66.3 79.3 73.5 73.8 62.8 70.7 57.2 60.1 55.3 52.9 54.1 50.260-64 131.2 59.7 92.8 78.0 126.0 91.9 89.8 70.7 69.5 57.8 70.7 70.265-69 62.1 91.0 103.3 165.1 112.7 99.0 119.9 59.2 92.2 77.9 101.9 71.770-79 158.6 62.2 186.4 35.2 26.0 58.3 79.5 91.7 81.2 108.1 96.2 75.780+ . 824.5 . 1168.8 . 483.1 180.0 156.2 163.3 76.0 148.0 251.1

Male 49.1 46.5 41.7 41.4 41.5 37.8 38.5 36.0 37.9 35.5 38.1 35.6Female 34.9 33.2 38.5 34.0 34.5 31.3 31.8 28.8 27.6 27.4 27.9 26.8





All 43.4 41.1 40.5 38.5 38.8 35.3 35.9 33.2 33.9 32.3 34.1 32.1

ADJUSTED0-19 . . . . 42.4 32.4 36.9 37.4 35.8 28.6 23.6 20.520-44 . . . . 47.4 35.8 34.6 30.1 31.1 28.0 28.1 24.645-64 . . . . 74.0 66.6 64.0 59.8 58.2 54.5 55.4 52.465-74 . . . . 93.1 86.7 98.2 76.1 80.7 81.3 89.0 77.875+ . . . . 136.0 137.8 111.0 69.7 86.2 77.1 78.9 72.4

. . . .Male . . . . 86.1 79.2 80.9 64.4 66.9 64.9 64.0 58.2Female . . . . 70.6 63.6 59.8 48.1 50.6 45.5 49.5 45.7

. . . .White . . . . 85.7 76.2 76.4 57.9 60.8 55.7 57.2 51.2Black . . . . 69.7 70.4 66.7 59.9 60.4 58.6 59.1 57.5Other race . . . . 44.9 40.3 37.6 35.4 40.9 40.7 51.3 43.9

. . . .Diabetes . . . . 99.0 84.1 82.6 68.5 72.7 72.7 71.1 69.2Hypertension . . . . 56.4 59.3 68.8 52.2 51.9 46.3 52.0 47.8Glomerulonephritis . . . . 55.0 67.3 48.8 40.3 42.2 42.7 49.3 41.5Other cause . . . . 99.2 82.2 73.3 60.1 66.2 53.9 54.5 43.9

. . . .<2 years . . . . 88.0 75.7 68.2 55.0 57.1 52.8 51.9 45.82-<5 years . . . . 78.0 71.1 76.4 56.3 59.1 53.2 54.5 49.15+ years . . . . 67.0 66.7 69.2 59.8 62.8 62.7 68.5 66.6

. . . .All . . . . 79.4 71.9 70.8 56.8 59.3 55.6 57.2 52.4


Table H.28Annual mortality rates per 1,000 patient years at risk: transplant patientsperiod prevalent patients; 200 ESRD patients used as reference


553


Table H.28 (continued)Annual mortality rates per 1,000 patient years at risk: transplant patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, primary diagnosis, & vintage

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 17.5 15.3 15.2 10.0 5.1 32.6 13.9 23.3 4.3 16.3 22.9 15.15-9 7.1 5.3 3.4 8.7 6.7 6.5 4.5 8.9 10.0 3.0 7.1 5.610-14 4.9 6.8 5.4 5.9 3.7 6.0 2.6 7.4 4.7 2.3 8.5 5.215-19 7.9 10.7 11.6 12.2 9.6 8.3 11.7 6.2 7.8 6.5 6.9 9.520-29 10.3 12.0 8.9 8.8 9.1 8.9 7.3 9.4 7.2 10.0 9.9 5.530-39 17.6 18.3 16.9 16.9 14.9 17.0 15.1 15.8 14.7 16.4 14.4 13.540-49 30.6 27.0 31.7 32.0 30.9 28.0 28.2 25.5 24.8 26.3 24.7 22.050-59 38.3 49.1 47.7 47.2 49.7 47.1 44.4 44.8 42.8 41.3 37.6 38.260-64 68.8 65.6 66.4 70.3 66.8 68.5 59.0 64.3 62.2 62.3 56.4 59.565-69 87.0 86.5 79.2 92.2 84.8 77.4 87.0 74.7 83.1 77.7 75.9 74.570-79 94.5 85.9 109.4 118.1 115.5 99.3 117.1 121.6 115.3 115.7 109.6 117.280+ 113.6 397.0 208.4 122.7 81.6 177.8 181.1 129.8 199.5 168.8 150.9 141.6

Male 31.5 35.4 35.1 37.9 37.3 35.5 36.4 36.9 36.2 38.0 36.1 36.4Female 26.5 26.2 29.5 29.9 30.5 32.3 31.2 31.7 32.8 33.1 32.1 33.0





All 29.5 31.7 32.9 34.7 34.6 34.2 34.3 34.8 34.8 36.0 34.5 35.0

ADJUSTED0-19 17.4 17.2 19.5 17.6 14.9 14.5 15.0 13.5 12.6 10.3 12.4 12.720-44 21.5 20.7 21.2 19.4 18.6 17.4 16.8 16.1 15.2 16.2 15.6 14.745-64 46.2 47.1 47.9 46.4 44.9 41.8 38.7 37.9 35.8 36.3 34.0 33.265-74 80.3 81.0 83.9 90.2 84.7 77.1 78.4 75.8 75.1 74.6 72.2 71.075+ 77.5 128.6 102.9 130.6 110.1 92.4 94.5 106.7 108.7 114.5 108.9 114.0

Male 52.8 63.6 60.1 66.6 57.4 50.7 49.4 50.7 49.3 50.8 48.7 48.0Female 46.3 49.7 48.8 48.2 48.5 45.8 44.1 44.6 43.0 44.0 42.0 42.7




All 49.9 57.1 54.9 57.5 53.2 48.6 47.1 47.9 46.3 47.6 45.5 45.5


Table H.28 (continued)Annual mortality rates per 1,000 patient years at risk: transplant patientsperiod prevalent patients; 200 ESRD patients used as reference


554

Reference section H

ON OUR WEBSITE & CDMortality rates by primary cause of mortality, diabetic patients, unadjusted (H.29.1). Mortality rates by primary cause of mortality, non-diabetic patients, un-adjusted (H.29.2). Mortality rates by specific cause of mortality: ESRD patients, unadjusted (H.a.1).

Table H.29Mortality rates by primary cause of mortality, unadjustedrates per 1,000 patient years at risk, period prevalent patients, 2001-2003 combined

ESRDMale Female White Black N. Am. Asian All

Acute M.I. 14.2 13.7 15.3 11.8 13.1 11.4 14.0Hyperkalemia 2.2 2.7 3.1 1.3 2.3 1.7 2.4Pericarditis 0.2 0.2 0.2 0.3 0.3 0.1 0.2Atherosclerotic H.D. 4.9 5.2 6.0 3.4 3.6 4.1 5.0Cardiomyopathy 6.7 5.5 7.5 3.9 4.2 4.0 6.2Cardiac arrhythmia 7.4 7.3 8.1 6.3 5.6 5.9 7.4Cardiac arrest 37.5 41.0 39.8 38.9 35.8 32.6 39.1Valvular heart disease 0.9 1.0 1.1 0.8 0.6 0.6 1.0Pulmonary edema 1.4 1.7 1.8 1.2 1.9 0.7 1.5AIDS 0.8 0.5 0.1 1.9 0.1 . 0.7Cachexia 1.4 2.0 2.0 1.2 0.9 1.1 1.7Cerebrovascular disease 7.0 10.5 8.5 8.4 9.4 8.7 8.6G.I. hemorrhage 1.2 1.3 1.2 1.3 0.5 1.3 1.3Other hemorrhage 1.5 1.8 1.5 1.7 1.5 1.9 1.6Septicemia 16.7 22.9 18.7 21.3 20.2 13.7 19.5Pulmonary infection 4.1 3.5 4.4 2.7 3.6 4.0 3.8Viral infection 0.3 0.3 0.3 0.3 0.1 0.4 0.3Other infection 0.8 1.2 1.0 0.9 1.4 0.8 1.0Malignant disease 7.1 5.9 7.5 5.5 4.5 3.6 6.6Other cause 45.7 50.1 53.6 39.9 40.1 25.7 47.6Unknown cause 6.8 8.0 7.1 8.2 7.9 3.6 7.4

All 168.9 186.3 188.9 161.1 157.5 125.8 176.7

Years at risk 664,419 541,674 738,258 388,295 16,194 49,379 1,206,092Patients 793,476 654,611 894,997 459,156 19,038 57,409 1,448,087

DIALYSISMale Female White Black N. Am. Asian All


All 225.5 238.4 271.6 183.4 187.6 165.5 231.5

Years at risk 464,855 404,402 480,284 328,078 12,802 35,774 869,257Patients 587,994 513,489 629,205 397,398 15,555 43,539 1,101,483

"All" category includes patients of other & unknown races.U.S. only; patients of unknown age or gender are excluded."." Zero values in this cell.

Table H.29Mortality rates by primary cause of mortality, unadjustedrates per ,000 patient years at risk, period prevalent patients, 200-2003 combined

555


ON OUR WEBSITE & CDMortality rates by specific cause of mortality: dialysis patients, unadjusted (H.a.2). Mortality rates by specific cause of mortality: hemodialysis patients, unadjusted (H.a.3). Mortality rates by specific cause of mortality: CAPD/CCPD patients, unad-justed (H.a.4). Bayesian standardized mortality ratios: by state & territory (H.b).

Table H.29 (continued)Mortality rates by primary cause of mortality, unadjustedrates per 1,000 patient years at risk, period prevalent patients, 2001-2003 combined

TRANSPLANTMale Female White Black N. Am. Asian All

Acute M.I. 1.8 1.2 1.5 1.8 2.9 1.0 1.6Hyperkalemia 0.1 0.1 0.1 0.1 . 0.2 0.1Pericarditis <0.05 <0.05 <0.05 0.1 . 0.1 <0.05Atherosclerotic H.D. 0.3 0.2 0.3 0.2 0.3 0.2 0.2Cardiomyopathy 0.4 0.2 0.3 0.5 . 0.1 0.3Cardiac arrhythmia 0.5 0.5 0.5 0.5 0.6 0.2 0.5Cardiac arrest 2.4 2.1 2.1 3.2 2.1 1.7 2.3Valvular heart disease 0.1 0.1 0.1 <0.05 0.6 . 0.1Pulmonary edema 0.1 0.1 0.1 0.1 0.3 . 0.1AIDS <0.05 <0.05 <0.05 <0.05 . . <0.05Cachexia 0.1 0.1 0.1 0.1 . . 0.1Cerebrovascular disease 0.8 1.1 0.9 1.1 2.1 0.6 0.9G.I. hemorrhage 0.1 0.1 0.1 0.2 . 0.2 0.1Other hemorrhage 0.3 0.2 0.2 0.3 0.3 0.1 0.2Septicemia 1.8 2.0 1.7 2.3 4.7 1.2 1.8Pulmonary infection 0.6 0.6 0.6 0.7 1.5 0.6 0.6Viral infection 0.2 0.1 0.1 0.1 0.3 0.1 0.1Other infection 0.1 0.1 0.1 0.2 . . 0.1Malignant disease 1.9 1.5 1.9 1.4 2.9 0.8 1.8Other cause 24.5 21.8 23.3 26.1 24.5 13.9 23.4Unknown cause 0.8 0.7 0.7 0.9 0.9 0.2 0.7

All 36.8 32.7 34.8 39.7 43.9 21.3 35.2

Years at risk 199,563 137,272 257,973 60,217 3,392 13,604 336,835Patients 205,482 141,122 265,792 61,758 3,483 13,870 346,604

HEMODIALYSISMale Female White Black N. Am. Asian All


All 228.0 244.0 277.9 186.1 190.2 171.8 235.4

Years at risk 424,298 365,893 428,242 307,349 11,757 31,678 790,191Patients 536,949 465,808 562,738 372,728 14,282 38,671 1,002,757

"All" category includes patients of other & unknown races.U.S. only; patients of unknown age or gender are excluded so that rates can be calculated appropriately."." Zero values in this cell.

Table H.29 (continued)Mortality rates by primary cause of mortality, unadjustedrates per ,000 patient years at risk, period prevalent patients, 200-2003 combined


556

Reference section H

Table H.29 (continued)Mortality rates by primary cause of mortality, unadjustedrates per 1,000 patient years at risk, period prevalent patients, 2001-2003 combined

CAPD/CCPDMale Female White Black N. Am. Asian All

Acute M.I. 19.9 15.6 20.6 12.3 17.8 12.9 17.8Hyperkalemia 1.6 2.6 2.8 0.6 5.9 0.8 2.1Pericarditis 0.3 0.2 0.2 0.3 . 0.3 0.2Atherosclerotic H.D. 7.0 4.6 7.4 2.4 4.9 4.6 5.8Cardiomyopathy 12.4 6.9 12.6 4.2 4.0 4.1 9.7Cardiac arrhythmia 10.7 6.9 10.5 5.8 9.9 5.1 8.8Cardiac arrest 43.7 36.8 45.0 33.0 21.7 26.1 40.3Valvular heart disease 1.4 1.1 1.5 0.8 1.0 0.5 1.2Pulmonary edema 1.2 1.3 1.6 0.6 1.0 0.5 1.3AIDS 0.8 0.3 0.2 1.5 . . 0.5Cachexia 2.1 2.8 3.2 1.1 1.0 1.8 2.5Cerebrovascular disease 8.7 11.0 11.0 8.0 3.0 6.6 9.8G.I. hemorrhage 1.5 0.9 1.4 0.9 . 0.3 1.2Other hemorrhage 1.1 1.2 1.2 0.7 4.0 1.3 1.1Septicemia 25.4 33.4 30.9 26.4 32.6 19.0 29.3Pulmonary infection 4.2 3.2 4.5 2.1 2.0 2.3 3.7Viral infection 0.2 0.2 0.2 0.2 . 0.3 0.2Other infection 1.6 2.5 2.3 1.3 4.9 1.8 2.0Malignant disease 6.2 4.2 6.4 2.8 4.9 2.8 5.2Other cause 44.9 44.0 51.3 33.4 33.6 22.3 44.5Unknown cause 6.8 7.5 7.4 6.8 7.9 4.8 7.1

All 201.8 187.2 222.3 145.1 160.1 117.8 194.7

Years at risk 38,200 36,527 48,970 19,744 1,012 3,948 74,727Patients 48,014 45,158 62,456 23,471 1,233 4,685 93,172

"All" category includes patients of other & unknown races.U.S. only; patients of unknown age or gender are excluded so that rates can be calculated appropriately."." Zero values in this cell.

Table H.29 (continued)Mortality rates by primary cause of mortality, unadjustedrates per ,000 patient years at risk, period prevalent patients, 200-2003 combined

557


Table H.30Mortality rates by cause of withdrawal, unadjustedrates per ,000 patient years at risk, period prevalent dialysis patients, 200-2003 combined

Table H.30Mortality rates by cause of withdrawal, unadjustedrates per 1,000 patient years at risk, period prevalent dialysis patients, 2001-2003 combined

0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59Withdraw, access failure . 2.5 1.1 . 0.4 0.3 0.4 0.6Withdraw, transplant failure . . . . 0.2 0.1 0.1 0.1Withdraw, failure to thrive 5.3 1.3 1.1 0.3 1.1 2.6 4.8 8.7Withdraw, med. complication 8.0 2.5 2.3 1.8 2.6 4.3 6.2 9.7Withdraw, other 1.3 1.3 2.8 0.5 1.0 2.3 3.1 5.0Did not withdraw 82.4 25.2 21.5 31.5 46.4 69.8 97.9 131.6Missing data 10.6 8.8 3.4 2.3 4.1 5.8 8.3 10.9Other cause . . . . . . . .

All 107.6 41.6 32.3 36.4 55.9 85.2 120.8 166.7

Years at risk 753 793 1,765 3,904 28,207 67,691 125,167 178,713Patients 947 984 2,189 4,709 32,597 78,460 148,370 218,847

60-64 65-69 70-79 80+ Male Female White BlackWithdraw, access failure 0.7 0.9 1.4 2.5 0.7 1.2 1.1 0.7Withdraw, transplant failure 0.1 <0.05 0.1 0.1 0.1 0.1 0.1 <0.05Withdraw, failure to thrive 13.9 21.1 37.4 70.5 18.8 23.6 30.9 8.6Withdraw, med. complication 15.0 20.0 29.1 45.1 15.7 19.9 24.5 8.7Withdraw, other 7.1 10.4 17.1 30.3 9.4 10.9 14.2 4.9Did not withdraw 164.4 189.8 230.4 298.0 163.9 165.9 179.6 148.1Missing data 13.7 18.5 25.1 43.4 17.1 16.9 21.3 12.4Other cause . . . . . . . .

All 214.9 260.8 340.5 489.9 225.5 238.4 271.6 183.4

Years at risk 96,703 102,011 186,063 77,488 464,855 404,402 480,284 328,078Patients 121,728 131,400 249,692 111,560 587,994 513,489 629,205 397,398

Other †Non- Hyper- Glomerulo- Other race †Hispanic Hispanic Diabetes tension nephritis cause All

Withdraw, access failure 0.7 0.6 1.0 1.1 0.9 0.4 0.9 0.9Withdraw, transplant failure <0.05 <0.05 0.1 <0.05 0.1 0.1 0.2 0.1Withdraw, failure to thrive 10.4 11.5 22.5 23.0 21.6 12.4 22.0 21.0Withdraw, med. complication 11.5 11.4 18.6 20.6 16.8 10.5 17.2 17.6Withdraw, other 5.6 7.7 10.4 10.9 10.4 6.0 10.7 10.1Did not withdraw 138.5 142.4 168.3 194.3 167.5 100.5 140.8 164.8Missing data 8.0 8.7 18.3 15.8 17.7 9.8 23.8 17.0Other cause . . . . . . . .

All 174.8 182.3 239.1 265.8 234.9 139.8 215.6 231.5

Years at risk 60,895 115,921 753,336 354,370 242,076 113,296 159,515 869,257Patients 74,880 143,474 958,009 461,555 306,381 132,684 200,863 1,101,483

"All" category includes patients of other & unknown races.Age is determined as of January 1 of each calendar year.U.S. only; patients of unknown age or gender are excluded.†CMS began collecting Hispanic ethnicity data in April 1995."." Zero values in this cell.


558

Reference section H

Table H.31Expected remaining lifetimes* of the general U.S. population, & of prevalent dialysis & transplant patientsgeneral U.S. population, 2002

All races White BlackAll M F All M F All M F

0-14 70.9 68.2 73.4 71.3 68.7 73.7 66.4 62.9 69.715-19 61.1 58.4 63.6 61.4 58.9 63.9 56.7 53.3 59.920-24 56.3 53.8 58.7 56.7 54.2 59.0 52.0 48.7 55.025-29 51.6 49.1 53.9 51.9 49.5 54.2 47.4 44.3 50.230-34 46.8 44.4 49.0 47.1 44.8 49.3 42.8 39.8 45.535-39 42.1 39.8 44.2 42.4 40.1 44.5 38.3 35.4 40.840-44 37.5 35.2 39.5 37.7 35.6 39.7 33.9 31.1 36.345-49 33.0 30.8 34.9 33.2 31.1 35.1 29.7 26.9 32.050-54 28.6 26.6 30.4 28.8 26.8 30.5 25.7 23.1 27.855-59 24.4 22.5 26.0 24.5 22.7 26.1 22.0 19.6 23.960-64 20.4 18.7 21.9 20.5 18.8 21.9 18.5 16.4 20.165-69 16.8 15.2 18.0 16.8 15.2 18.0 15.3 13.5 16.770-74 13.4 12.0 14.4 13.4 12.0 14.4 12.4 10.8 13.575-79 10.4 9.3 11.1 10.3 9.2 11.1 9.9 8.6 10.780-84 7.8 6.9 8.3 7.7 6.9 8.2 7.8 6.8 8.385+ 4.3 3.8 4.5 4.2 3.7 4.3 4.6 4.2 4.8

Overall 25.2 23.4 26.6 25.3 23.5 26.7 23.0 20.8 24.7

Dialysis All races White Black N Am Asian2003 All Male Female All Male Female All Male Female All Male Female All Male Female0-14 18.3 19.2 17.3 19.2 20.0 18.4 15.6 16.7 14.4 18.1 17.3 18.4 31.6 32.5 30.315-19 16.0 16.9 15.1 16.3 17.0 15.5 15.0 16.1 13.9 15.6 16.0 15.3 25.1 26.0 24.220-24 13.9 14.8 12.9 13.9 14.6 13.1 13.3 14.4 12.2 13.4 13.9 13.0 22.0 22.8 21.225-29 12.0 12.7 11.3 11.8 12.3 11.1 11.9 12.7 11.0 11.5 11.6 11.4 19.2 19.8 18.630-34 10.5 10.8 10.0 10.0 10.2 9.7 10.6 11.1 10.0 10.0 10.0 10.1 16.6 17.1 16.235-39 9.0 9.2 8.7 8.4 8.5 8.3 9.3 9.7 8.8 8.6 8.4 8.7 14.0 14.3 13.740-44 7.8 8.0 7.6 7.2 7.3 7.1 8.3 8.6 7.8 7.4 7.3 7.5 11.8 12.0 11.645-49 6.8 7.0 6.7 6.3 6.4 6.2 7.3 7.5 7.0 6.7 6.6 6.8 9.9 10.1 9.850-54 5.9 6.0 5.9 5.4 5.5 5.4 6.4 6.5 6.3 6.2 6.0 6.4 8.4 8.5 8.255-59 5.0 5.0 5.0 4.6 4.6 4.6 5.6 5.6 5.5 5.3 5.2 5.4 6.9 7.0 6.760-64 4.3 4.3 4.4 3.9 3.9 3.9 4.9 4.9 4.9 4.6 4.5 4.8 5.9 5.9 5.865-69 3.7 3.6 3.7 3.4 3.3 3.4 4.1 4.1 4.2 4.1 4.0 4.2 5.0 4.9 5.070-74 3.1 3.1 3.1 2.9 2.9 2.9 3.5 3.5 3.5 3.5 3.3 3.6 4.1 4.2 4.175-79 2.6 2.6 2.7 2.5 2.5 2.5 3.0 2.9 3.0 3.0 2.8 3.1 3.4 3.5 3.380-84 2.2 2.2 2.2 2.1 2.1 2.1 2.5 2.5 2.5 2.5 2.4 2.6 2.8 2.9 2.885+ 1.8 1.7 1.8 1.7 1.7 1.7 2.0 1.9 2.0 2.1 1.9 2.2 2.2 2.2 2.2

Overall 5.5 5.6 5.4 5.2 5.2 5.1 5.9 6.0 5.7 5.7 5.5 5.8 8.0 8.2 7.9

Transplant All races White Black N Am Asian2003 All Male Female All Male Female All Male Female All Male Female All Male Female0-14 50.0 50.2 49.9 50.7 50.9 50.5 46.6 46.8 46.2 36.9 39.8 33.3 59.5 57.9 62.115-19 39.7 39.6 39.8 40.1 40.1 40.2 37.1 37.1 37.2 32.1 34.6 29.7 48.3 46.6 50.920-24 36.2 36.1 36.4 36.5 36.4 36.7 33.9 33.9 34.0 30.3 32.5 28.4 44.5 42.9 47.225-29 32.3 32.1 32.6 32.5 32.4 32.9 30.2 30.1 30.5 27.5 29.6 25.6 40.4 38.7 43.130-34 28.5 28.3 28.9 28.7 28.5 29.1 26.7 26.4 27.0 24.6 26.5 22.9 36.2 34.6 39.035-39 25.2 24.8 25.8 25.4 25.0 25.9 23.5 23.2 24.1 22.5 23.9 21.1 32.4 30.8 35.240-44 21.9 21.5 22.7 22.1 21.7 22.8 20.4 20.0 21.0 20.0 20.9 18.9 28.6 26.9 31.445-49 19.0 18.5 19.8 19.1 18.7 20.0 17.4 17.0 18.1 17.6 18.4 16.6 24.9 23.2 27.750-54 16.3 15.7 17.2 16.5 15.9 17.4 14.7 14.3 15.4 15.4 16.1 14.5 21.4 19.9 24.255-59 13.8 13.2 14.7 14.0 13.4 15.0 12.3 11.9 13.0 13.4 14.1 12.6 18.3 16.8 21.060-64 11.5 11.0 12.5 11.7 11.1 12.7 10.2 9.8 10.9 11.7 12.3 11.3 15.5 14.1 18.165-69 9.6 9.1 10.6 9.7 9.2 10.7 8.6 8.1 9.3 10.4 10.7 10.1 13.0 11.8 15.570-74 7.9 7.4 8.9 7.9 7.4 9.0 7.0 6.5 7.8 8.9 9.1 8.8 10.8 9.7 13.375-79 6.7 6.2 7.7 6.7 6.2 7.7 6.0 5.4 6.9 8.0 7.8 8.3 9.3 8.4 11.6

Overall 15.1 14.6 15.9 15.2 14.7 16.1 13.7 13.3 14.4 14.4 15.1 13.8 19.7 18.4 22.4

*Years

*Years

Table H.31Expected remaining lifetimes* of the general U.S. population, & of prevalent dialysis & transplant patientsgeneral U.S. population, 2002

559


Table H.32First-year mortality rates, ESRD per 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 164.9 200.0 116.9 144.0 123.2 124.8 88.0 106.0 121.6 134.4 169.9 117.8 104.75-9 29.4 16.4 24.5 46.9 . 28.2 43.8 38.9 . 39.7 33.2 20.2 64.410-14 37.4 25.3 54.5 42.6 7.9 26.0 30.3 21.8 22.6 20.4 26.4 19.7 30.215-19 24.9 38.3 36.8 29.2 41.4 25.0 31.8 17.2 36.2 22.1 21.3 21.2 23.620-29 75.6 72.4 63.4 69.6 74.9 76.3 58.4 46.8 50.5 46.6 63.2 51.4 62.430-39 101.6 108.9 105.0 112.4 106.1 119.5 101.5 92.8 91.3 94.4 92.9 88.7 86.040-49 116.6 127.3 124.5 117.8 121.9 114.5 110.2 103.5 115.4 109.3 109.1 114.4 116.550-59 169.5 170.5 159.0 160.9 152.1 152.8 157.0 151.6 155.5 149.8 155.4 151.1 152.360-64 242.1 230.7 230.5 210.6 213.3 221.2 201.2 199.7 221.1 208.5 212.1 201.8 209.565-69 280.1 284.4 279.6 258.9 269.4 260.6 249.4 262.7 268.8 266.4 258.5 263.0 262.470-79 378.8 382.1 378.5 357.0 355.7 352.9 343.6 358.9 356.7 362.2 363.5 360.2 361.880+ 517.6 522.4 536.9 493.6 494.8 505.2 507.6 519.3 553.2 536.9 546.2 546.5 528.8

Male 228.6 234.9 236.5 221.2 225.5 227.8 221.8 226.3 233.0 230.8 235.6 232.2 238.3Female 229.1 236.1 231.4 227.8 228.0 228.1 228.4 236.6 246.9 247.9 250.9 250.6 254.4

White 259.5 269.1 269.3 255.0 256.7 256.0 254.1 264.9 269.7 267.1 270.4 272.4 276.2Black 176.4 180.1 174.8 176.1 179.6 184.6 175.0 175.2 190.0 191.2 198.9 191.7 198.7Other race 140.9 132.6 146.3 135.8 149.0 168.9 181.4 168.8 184.8 182.0 171.9 159.3 168.4



All 228.8 235.5 234.0 224.3 226.7 228.0 224.8 231.1 239.5 238.7 242.7 240.6 245.6

ADJUSTED0-19 95.9 124.5 105.3 109.4 79.3 84.2 86.7 70.2 84.2 80.0 96.7 75.0 87.820-44 106.6 112.8 110.7 114.0 109.7 114.8 98.3 91.3 95.6 94.2 95.7 93.3 94.745-64 184.5 181.0 172.6 164.5 161.7 162.1 157.1 151.0 161.5 153.5 157.0 153.4 156.665-74 309.0 313.1 305.8 280.7 292.1 282.0 271.3 283.1 284.7 282.5 280.7 281.6 286.375+ 455.8 455.5 463.5 443.5 431.1 438.9 432.7 447.3 459.2 457.2 459.9 457.3 448.6

Male 274.0 275.1 272.0 251.0 252.2 253.2 238.0 237.6 242.9 235.8 239.5 235.7 237.5Female 252.0 253.2 244.7 239.1 234.9 232.4 228.2 232.0 241.5 240.2 239.6 238.2 238.6



All 262.9 264.0 258.1 244.7 243.3 242.5 232.9 234.5 241.8 237.6 239.2 236.5 237.6

Reference cohort is 1996 incident ESRD patients.Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.Mortality rates for one of the four variables are adjusted for the remaining three. Hispanic & non-Hispanic mortality rates are unadjusted.The age of the incident patient is determined as of the date of ESRD initiation.The 90-day rule has been applied.U.S. patients only; patients of unknown age or gender, or age >110, are excluded.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. "." Zero values in this cell.

Reference cohort is 1996 incident ESRD patients.Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.Mortality rates for one of the four variables are adjusted for the remaining three. Hispanic & non-Hispanic mortality rates are unadjusted.The age of the incident patient is determined as of the date of ESRD initiation.The 90-day rule has been applied.U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank. "." Zero values in this cell.

Table H.32First-year mortality rates, ESRD per ,000 patient years at risk, incident patients, by modality & demographic characteristics


560

Reference section H

Table H.33First-year mortality rates, dialysisper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 233.1 250.0 148.2 186.8 164.1 163.5 134.5 151.3 158.0 200.1 221.6 160.0 129.45-9 62.9 43.4 62.2 80.8 . 22.2 84.1 26.5 . 31.8 44.1 31.5 90.810-14 46.1 29.0 82.1 58.4 12.7 26.3 41.9 37.5 28.1 33.7 37.3 24.2 47.915-19 29.7 44.8 35.0 35.1 47.9 28.5 38.2 22.3 46.1 27.2 27.2 31.0 33.320-29 90.6 83.2 75.7 85.4 86.9 89.2 68.7 52.7 60.4 55.1 73.6 59.6 71.830-39 116.9 127.0 119.9 127.8 119.8 136.0 114.4 104.1 103.8 105.4 103.8 100.3 96.640-49 123.7 140.4 136.0 127.3 131.1 122.1 118.2 111.6 125.2 118.1 119.1 124.2 126.150-59 174.3 176.9 164.4 165.6 155.5 158.5 161.9 158.3 162.3 155.9 162.8 158.3 159.860-64 244.7 234.4 233.9 213.2 215.4 225.8 204.4 203.9 225.2 211.7 216.8 206.5 215.565-69 280.9 285.5 280.5 260.1 271.2 262.6 251.1 265.6 271.2 269.4 262.1 267.1 267.370-79 379.4 382.3 378.9 357.6 356.1 353.6 343.9 359.4 357.3 363.1 364.5 361.7 363.380+ 517.2 521.8 536.9 493.6 494.8 505.2 507.6 519.3 553.5 537.0 546.4 546.7 529.0

Male 243.7 250.6 250.5 234.2 236.7 240.8 233.2 237.9 244.7 241.7 247.1 243.8 250.0Female 240.7 248.4 242.9 237.7 237.7 237.8 236.9 246.0 257.2 257.7 261.5 261.1 264.9




All 242.3 249.6 246.9 235.8 237.2 239.4 234.9 241.7 250.6 249.2 253.8 251.8 256.8

ADJUSTED0-19 123.3 148.8 122.9 132.4 98.4 96.5 110.3 87.5 107.3 98.5 121.0 96.9 109.520-44 119.7 129.9 126.4 131.4 125.1 130.8 112.1 103.7 109.1 106.1 108.5 106.5 108.045-64 191.0 189.8 181.0 171.5 168.2 170.7 164.9 159.5 170.9 161.9 166.1 162.4 166.065-74 309.7 313.8 306.8 282.1 293.6 283.9 272.8 285.4 286.9 285.1 283.8 285.3 290.575+ 455.9 455.2 463.5 443.6 431.1 439.1 432.8 447.5 459.5 457.4 460.2 457.9 449.0

Male 273.0 275.4 272.8 252.2 252.6 255.2 240.1 240.8 246.5 239.2 243.3 240.2 242.5Female 254.7 258.1 249.8 243.7 240.5 238.0 233.9 238.9 248.9 247.2 247.6 246.4 247.1



All 263.8 266.8 261.3 247.8 246.4 246.5 236.9 239.7 247.4 242.8 245.1 242.9 244.4


Table H.33First-year mortality rates, dialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics

561


Table H.34First-year mortality rates, hemodialysisper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 395.1 197.2 186.8 333.9 581.2 316.6 . 157.2 189.5 306.3 500.5 320.4 289.05-9 93.9 . . 166.0 . 30.8 184.3 . . 63.1 91.6 52.0 203.310-14 33.9 19.8 113.1 58.3 28.2 26.3 33.6 70.1 50.5 70.6 29.5 34.3 75.515-19 34.3 51.0 37.8 33.8 34.3 29.0 47.8 23.3 46.8 28.1 31.9 36.7 38.720-29 92.8 85.6 83.3 86.8 88.9 94.5 72.5 61.2 63.9 60.9 77.6 61.7 74.830-39 123.8 138.4 124.6 136.4 122.1 145.6 120.8 109.5 110.8 114.8 114.1 108.0 103.240-49 129.9 150.2 138.0 129.2 135.0 131.5 124.4 115.9 131.8 123.5 125.0 132.9 130.150-59 178.9 179.9 165.6 162.9 156.0 160.9 164.5 162.6 164.5 161.1 166.9 164.7 164.960-64 249.6 239.7 233.8 204.8 210.3 225.6 203.4 204.8 224.8 209.3 219.5 208.1 219.865-69 280.9 284.8 282.9 259.0 265.9 260.1 251.8 265.6 275.8 270.7 266.4 267.9 270.470-79 374.8 380.6 373.8 348.3 351.8 353.9 346.4 358.7 358.4 366.8 368.7 365.8 366.080+ 509.7 520.7 521.1 471.8 486.8 505.3 510.5 511.8 552.1 537.8 552.1 544.5 528.1

Male 251.5 259.5 255.3 236.1 239.9 247.3 238.9 243.7 249.3 247.8 253.5 250.9 255.2Female 248.4 256.4 248.2 237.5 240.0 245.7 244.5 250.9 265.8 264.9 270.7 268.8 273.1




All 250.1 258.0 251.9 236.8 240.0 246.5 241.6 247.1 257.0 255.8 261.5 259.2 263.4

ADJUSTED0-19 119.9 110.5 120.4 130.8 108.6 105.0 112.7 85.9 108.7 104.4 129.9 119.6 147.820-44 126.2 140.5 132.0 138.0 129.7 140.4 119.8 111.2 116.5 113.9 117.3 114.4 114.145-64 198.4 197.5 185.3 170.0 169.5 176.0 169.1 164.4 174.9 166.7 171.3 169.0 171.865-74 309.7 313.6 307.2 280.0 292.0 283.6 276.3 287.3 291.2 289.0 289.4 290.2 293.875+ 449.9 457.0 455.8 428.1 424.1 441.8 436.0 443.7 460.3 460.1 466.0 457.9 451.7

Male 276.0 280.8 274.5 250.4 252.5 259.2 244.2 244.6 249.2 244.1 248.6 245.7 245.9Female 257.1 260.9 250.0 238.7 238.7 241.4 237.9 240.5 254.2 251.5 253.9 250.7 252.7



All 266.4 270.6 262.0 244.3 245.4 250.0 240.8 242.3 251.3 247.3 250.8 247.7 248.7

Table H.34First-year mortality rates, hemodialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics



562

Reference section H

Table H.35First-year mortality rates, CAPD/CCPDper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 209.9 269.0 140.1 160.8 108.7 124.4 153.1 159.6 154.9 182.0 170.9 119.4 102.55-9 31.7 . 103.2 75.3 . 19.8 52.0 40.2 . 16.5 20.2 18.7 23.010-14 36.1 37.1 44.5 33.6 . 36.6 59.9 14.2 12.1 . 39.0 13.2 13.115-19 . 49.8 35.0 32.1 68.6 26.7 19.2 10.0 39.5 11.3 14.6 12.7 13.820-29 105.3 72.9 61.8 65.7 59.3 59.9 63.1 11.2 37.6 17.5 45.4 43.7 49.230-39 101.8 77.8 98.5 89.0 85.8 100.6 75.9 66.7 62.7 42.8 41.6 35.4 48.640-49 108.6 108.1 109.4 98.3 100.1 80.9 79.6 80.6 73.4 73.5 68.2 47.6 85.250-59 155.8 163.7 138.9 143.9 121.1 132.1 135.0 110.8 135.8 101.3 113.8 93.4 92.960-64 239.9 194.1 211.2 188.7 199.1 206.4 195.3 185.8 175.9 207.0 168.3 173.0 127.965-69 279.3 254.4 208.6 223.8 245.8 221.5 215.6 247.3 213.6 219.3 224.5 225.4 212.970-79 437.4 366.7 375.4 354.4 351.6 291.6 307.3 311.9 292.6 313.3 325.0 249.3 277.180+ 513.5 489.1 510.8 545.4 522.2 422.0 499.6 570.5 510.8 515.7 472.9 460.8 539.6

Male 195.0 175.5 174.0 172.1 167.3 158.8 160.9 147.8 154.2 145.7 150.1 127.9 147.4Female 196.5 172.8 167.2 163.2 165.6 152.7 152.3 158.3 148.1 148.0 149.4 139.8 132.9




All 195.6 174.3 170.8 167.9 166.5 156.0 156.8 152.8 151.2 146.8 149.8 133.6 140.6

ADJUSTED0-19 135.3 241.5 149.3 172.1 107.8 121.0 147.3 117.5 134.6 120.4 153.0 97.7 87.820-44 110.6 91.4 102.0 95.7 91.3 90.9 75.2 61.0 60.0 50.5 52.1 40.3 56.345-64 168.3 153.6 145.0 140.1 131.4 132.9 131.2 117.1 126.7 112.9 112.0 99.4 97.465-74 310.2 282.2 256.2 236.3 267.8 242.0 226.8 238.5 207.0 233.0 234.6 198.2 231.175+ 541.2 437.2 479.2 509.1 463.2 342.9 421.7 444.1 436.1 404.1 409.7 385.7 371.7

Male 264.5 235.8 230.1 223.9 214.4 201.9 200.5 177.6 186.8 173.3 176.0 148.4 174.3Female 260.9 235.4 227.8 217.4 220.8 199.5 199.2 208.0 190.6 188.6 193.3 177.2 163.7



All 263.0 235.5 228.8 220.8 217.0 200.5 199.5 190.7 188.2 179.9 182.8 161.0 169.0

Table H.35First-year mortality rates, CAPD/CCPD per ,000 patient years at risk, incident patients, by modality & demographic characteristics


563


Table H.36First-year mortality rates, transplantper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 163.9 75.7 76.5 42.9 85.8 44.5 27.9 33.3 10.9 42.2 32.1 23.2 42.95-9 92.4 16.9 10.0 35.7 22.2 42.9 16.3 9.2 25.8 17.9 10.8 8.4 7.410-14 80.6 25.2 24.4 18.1 17.0 26.0 21.3 5.7 10.4 13.4 10.6 14.5 4.915-19 64.1 25.0 30.9 22.7 36.7 11.3 3.1 9.8 10.6 8.3 6.0 8.7 3.020-29 27.1 22.8 31.5 26.3 15.8 20.7 13.0 14.6 10.5 16.0 12.6 13.5 16.530-39 47.7 34.6 37.8 32.3 37.4 25.9 32.4 27.0 26.9 24.0 24.7 20.8 23.240-49 71.8 51.1 51.9 45.9 50.2 47.0 41.4 42.9 33.9 35.0 34.9 32.8 32.450-59 95.2 72.3 85.0 84.4 77.4 73.7 66.7 79.3 57.5 64.5 69.2 53.7 55.560-64 136.6 107.2 113.3 98.0 84.6 98.4 92.1 78.7 95.1 91.4 89.3 87.7 70.565-69 150.4 143.4 141.4 147.1 102.6 150.7 127.1 123.2 98.0 102.1 109.4 99.4 79.570-79 171.0 188.1 129.5 218.7 173.3 113.8 97.6 158.7 169.7 128.7 118.8 128.5 115.980+ . 287.7 693.1 405.5 693.1 . . . 133.5 133.5 95.3 . 117.8

Male 74.6 54.9 59.2 55.3 57.6 54.9 48.8 48.7 46.0 48.3 52.8 46.8 46.5Female 63.6 47.2 56.4 52.9 44.9 45.1 46.4 54.4 43.3 45.2 44.8 42.2 40.8




All 70.1 51.8 58.0 54.3 52.5 51.1 47.8 51.0 44.9 47.1 49.5 44.9 44.2

ADJUSTED0-19 93.8 34.3 35.9 29.5 37.4 25.8 14.9 13.8 14.1 17.3 12.1 13.7 11.020-44 57.1 43.8 49.5 39.1 40.0 33.9 33.7 32.8 28.7 30.8 30.3 27.8 27.145-64 111.6 81.0 89.4 86.4 79.5 79.6 71.2 76.7 64.2 68.0 70.4 59.9 59.065-74 174.8 172.6 146.6 170.7 127.8 146.6 129.0 139.7 117.5 110.0 116.9 106.6 90.675+ 174.8 172.6 146.6 170.7 127.8 146.6 129.0 139.7 117.5 110.0 116.9 106.6 90.6

Male 195.5 142.0 147.9 134.7 136.1 126.3 108.9 106.3 96.6 100.4 105.4 92.2 88.4Female 186.4 132.9 153.8 141.7 117.0 116.5 113.1 132.7 102.9 107.7 101.6 93.0 86.1



All 189.7 136.9 148.5 135.8 127.4 121.2 109.1 114.8 97.7 101.7 102.6 91.2 86.3

Table H.36First-year mortality rates, transplant per ,000 patient years at risk, incident patients, by modality & demographic characteristics



564

Reference section H

Table H.37Second-year mortality rates, ESRD per 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 50.4 58.3 29.0 31.5 66.7 67.8 50.2 43.9 40.3 41.7 27.8 63.7 41.25-9 8.4 30.3 8.3 . 40.8 25.8 7.2 7.5 8.0 22.1 20.5 6.8 13.710-14 21.4 24.1 12.9 21.8 26.4 8.0 19.0 11.6 18.6 15.3 6.9 10.1 20.515-19 20.0 21.2 28.6 13.9 30.1 14.2 18.2 36.6 31.3 21.5 26.1 32.8 21.920-29 47.6 55.6 59.3 55.6 46.4 45.4 51.0 45.2 48.2 39.8 43.4 49.1 47.130-39 86.1 91.7 97.0 90.0 82.9 94.1 77.6 83.1 76.2 78.9 71.9 70.6 68.640-49 121.9 107.1 124.1 108.7 117.3 109.4 104.5 109.2 100.7 98.3 103.9 102.7 96.950-59 166.6 174.8 168.2 164.3 157.9 151.0 157.9 149.0 148.8 156.0 147.3 143.4 141.660-64 230.9 230.5 229.0 225.6 211.9 205.4 210.4 200.0 201.1 202.1 190.3 184.7 183.665-69 276.0 287.1 279.1 260.7 249.5 259.2 253.3 244.0 256.5 249.7 245.3 230.8 206.270-79 343.2 354.6 344.9 333.2 335.7 329.9 324.0 314.6 334.5 314.5 308.8 314.7 296.080+ 430.3 476.1 497.0 459.5 484.5 459.1 450.6 450.9 471.9 439.0 447.3 441.1 426.6

Male 196.4 205.3 208.0 200.0 196.1 195.8 190.3 194.3 198.7 193.2 192.5 187.6 183.7Female 195.5 204.6 209.9 200.8 205.3 203.6 206.5 200.6 210.6 206.1 202.8 206.5 191.9




All 196.0 204.9 208.9 200.4 200.4 199.5 197.9 197.2 204.2 199.1 197.2 196.3 187.4

ADJUSTED0-19 46.7 57.4 47.1 33.6 74.4 43.4 44.5 58.6 54.1 46.7 42.6 58.2 48.420-44 90.9 93.1 102.4 94.3 92.0 91.7 85.2 86.8 77.9 80.5 79.1 78.0 78.145-64 184.1 183.8 181.3 173.1 165.7 158.2 160.4 153.6 152.7 153.9 147.7 143.6 140.465-74 296.5 308.0 296.7 279.8 281.5 279.8 266.9 263.4 275.8 262.0 256.6 252.4 227.275+ 397.5 421.3 422.4 403.2 401.3 396.3 400.8 379.8 405.2 378.6 376.8 376.4 365.2

Male 260.2 266.8 264.4 249.6 239.6 235.4 227.8 224.2 225.7 217.2 211.6 205.4 200.5Female 235.3 241.6 240.5 227.1 230.0 223.8 224.0 213.2 220.8 214.9 210.4 210.4 194.4



All 247.7 254.2 252.2 238.0 234.5 229.3 225.5 218.5 223.0 215.7 210.7 207.5 197.2

Table H.37Second-year mortality rates, ESRD per ,000 patient years at risk, incident patients, by modality & demographic characteristics


565


Table H.38Second-year mortality rates, dialysisper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 80.0 108.9 34.5 38.1 91.9 100.3 66.6 59.0 67.6 77.4 14.6 124.9 94.05-9 31.7 79.0 . . 72.5 39.7 . 21.1 . 60.8 41.9 . 35.210-14 12.7 48.9 12.0 47.8 40.2 21.6 32.2 30.0 44.2 40.5 . 17.5 48.415-19 26.1 30.9 38.5 19.9 49.0 24.5 33.8 64.3 53.4 38.3 48.7 61.4 36.420-29 74.6 85.9 87.7 76.8 65.4 63.4 70.2 65.3 66.9 52.4 57.4 63.8 61.730-39 118.6 123.3 130.8 119.8 109.2 121.6 101.5 106.5 95.4 102.5 91.1 89.3 85.340-49 147.4 123.9 153.5 130.6 142.4 128.5 122.6 127.6 119.0 116.4 120.3 119.0 113.250-59 182.6 190.8 185.9 180.4 173.0 165.3 173.2 162.0 164.0 172.2 161.0 157.0 156.160-64 242.4 241.5 237.5 235.0 219.0 213.5 219.9 209.3 210.6 213.6 199.7 196.1 193.865-69 279.3 291.1 283.9 263.5 253.2 262.4 259.1 249.3 263.6 255.3 252.5 238.2 214.470-79 344.2 356.2 345.4 333.5 336.9 330.9 325.9 316.0 335.9 316.0 310.8 317.7 298.480+ 429.6 476.4 497.0 458.9 484.5 459.1 450.7 451.2 471.7 439.1 447.6 441.2 426.7

Male 234.4 241.8 242.7 230.8 225.3 222.4 217.3 219.4 224.0 217.0 213.6 208.5 204.9Female 222.9 229.5 236.2 223.4 227.5 224.1 226.8 218.6 230.4 225.7 221.9 226.2 208.7




All 228.9 235.9 239.6 227.2 226.4 223.2 221.9 219.1 227.0 221.1 217.4 216.7 206.7

ADJUSTED0-19 56.5 92.8 56.0 49.0 105.3 68.8 69.6 101.0 93.5 87.4 62.9 102.1 88.320-44 125.9 124.4 139.8 125.1 123.7 120.7 111.7 113.2 99.8 104.4 98.8 97.6 98.245-64 203.4 200.9 200.7 192.0 182.6 174.4 177.9 170.0 170.0 172.0 163.6 159.2 156.265-74 298.4 311.0 299.7 281.9 284.8 282.6 271.5 267.6 280.9 266.5 262.3 258.9 233.775+ 397.7 421.9 422.3 402.8 401.7 396.6 401.3 380.2 405.7 378.9 377.1 377.0 366.0

Male 271.4 278.2 274.6 259.7 249.1 244.3 238.0 233.7 236.0 227.4 219.8 213.7 210.2Female 245.3 250.0 252.2 236.5 240.4 233.6 234.1 222.6 231.7 225.9 221.1 221.9 204.5



All 258.4 264.2 263.4 248.0 244.7 238.9 235.9 228.2 233.8 226.5 220.2 217.4 207.3

Table H.38Second-year mortality rates, dialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics



566

Reference section H

Table H.39Second-year mortality rates, hemodialysisper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 287.7 182.3 117.8 287.7 268.3 . . 223.1 . 287.7 . 149.0 235.65-9 117.8 80.0 . . 223.1 . . 64.5 . 51.3 74.1 . .10-14 . . . 24.7 66.7 21.1 22.5 19.8 19.4 72.1 . 14.8 46.315-19 30.8 33.3 36.1 18.3 44.4 22.3 36.3 67.1 57.1 29.9 55.5 61.2 38.120-29 74.7 85.1 85.5 75.8 66.9 64.6 72.1 65.7 64.2 51.2 58.6 68.5 61.030-39 116.4 121.8 130.4 120.2 111.5 118.4 103.2 109.0 95.4 102.9 91.0 91.7 84.040-49 143.9 127.7 149.4 127.3 135.8 120.7 120.2 128.4 116.4 114.9 119.9 120.1 114.950-59 182.1 189.7 177.5 172.3 166.0 154.5 166.0 156.1 159.3 169.3 161.0 155.3 153.660-64 234.2 235.8 226.6 219.1 213.9 202.7 209.4 201.1 204.0 207.5 196.4 196.2 191.465-69 272.0 293.6 273.2 249.0 241.7 262.9 251.0 242.5 253.7 248.3 246.9 233.7 213.770-79 332.6 349.8 334.7 324.5 329.6 318.8 313.7 310.0 333.9 310.6 304.4 312.0 297.480+ 421.8 482.8 485.2 435.7 470.0 449.1 438.0 449.4 468.7 439.2 442.8 436.1 426.7

Male 232.8 244.3 238.1 224.7 223.8 218.2 212.3 217.3 221.7 215.1 211.5 207.2 204.3Female 222.4 234.7 233.6 220.0 225.0 220.2 224.6 218.0 230.6 225.3 222.9 227.2 211.9




All 227.8 239.7 235.9 222.4 224.4 219.2 218.2 217.6 225.9 219.9 216.8 216.4 207.8

ADJUSTED0-19 76.1 72.3 68.8 48.2 137.4 40.0 68.2 136.1 96.9 97.0 94.5 116.5 99.320-44 124.7 126.0 139.8 126.3 124.2 118.0 113.2 114.6 98.9 104.3 100.4 99.9 98.145-64 201.4 200.5 193.7 184.3 178.1 165.7 172.4 167.2 167.0 170.1 163.7 160.0 155.865-74 290.5 309.5 292.1 272.4 276.0 279.1 263.7 261.0 277.8 261.8 258.0 255.2 232.975+ 386.4 423.7 409.6 387.5 395.8 385.3 388.4 380.0 401.6 376.1 371.1 372.2 367.0

Male 265.2 276.0 266.1 250.3 244.3 237.2 230.5 230.6 232.2 224.4 217.0 211.8 208.9Female 239.4 250.4 244.7 228.0 233.0 225.5 227.9 219.1 229.1 222.9 219.7 221.1 205.2



All 252.1 263.1 255.2 238.8 238.5 231.2 229.0 224.7 230.5 223.4 218.0 216.0 206.9

Table H.39Second-year mortality rates, hemodialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics


567


Table H.40Second-year mortality rates, CAPD/CCPDper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 . 137.0 . 29.9 43.7 74.3 123.5 53.8 101.0 51.5 18.0 126.0 61.95-9 . 107.1 . . . 89.1 . . . 46.5 29.9 . 75.310-14 32.8 102.8 . 110.3 39.2 . 30.8 48.6 69.9 18.0 . 23.0 40.615-19 20.6 21.1 . 17.7 107.6 23.0 42.4 73.0 35.6 86.4 20.6 53.9 37.520-29 86.2 100.7 93.9 69.2 62.1 73.0 48.5 71.7 74.3 44.6 51.0 28.6 67.530-39 123.1 128.1 116.8 117.7 106.4 122.0 71.3 92.6 100.6 91.5 75.2 57.3 83.740-49 165.9 113.3 180.1 123.9 145.1 144.4 132.9 112.2 115.6 118.0 119.4 103.2 86.650-59 206.6 211.5 232.3 199.2 177.6 190.0 190.0 175.7 180.3 175.5 162.1 152.4 167.460-64 273.9 312.3 294.6 285.8 225.1 236.4 256.2 256.0 214.3 257.3 208.8 189.1 190.165-69 345.7 301.3 345.8 314.6 271.6 239.8 271.0 273.8 331.6 254.6 291.4 276.3 179.270-79 452.3 455.6 356.0 366.6 367.4 376.8 380.0 368.0 343.5 350.4 358.0 394.6 280.880+ 432.1 524.1 536.8 594.7 559.6 576.4 644.4 467.0 557.5 405.5 508.1 453.1 433.2

Male 235.3 241.3 246.3 222.7 192.1 206.7 201.6 202.2 201.1 199.2 187.7 174.3 177.1Female 211.4 205.0 205.4 189.8 200.1 197.0 200.8 181.3 188.9 181.4 178.3 182.0 151.8




All 224.1 223.9 227.5 207.0 195.9 202.1 201.2 192.1 195.3 190.5 183.2 177.9 164.7

ADJUSTED0-19 31.2 163.1 . 71.8 118.3 86.1 104.1 96.7 107.8 99.3 31.5 108.7 96.720-44 133.3 126.9 141.2 114.1 117.1 124.9 91.3 107.7 100.7 104.8 77.8 68.3 89.545-64 223.0 222.3 237.3 205.6 183.6 191.7 189.2 170.3 170.9 173.7 161.4 145.4 148.865-74 380.2 355.4 324.3 314.9 300.8 279.8 281.2 295.6 291.3 279.9 296.0 295.1 215.275+ 497.6 513.9 483.6 506.3 438.6 503.6 568.4 428.5 490.2 376.0 432.6 455.6 342.3

Male 321.9 336.4 336.2 299.6 251.4 268.3 259.6 256.2 247.4 242.2 226.4 209.0 205.4Female 310.8 284.7 286.4 268.1 278.7 273.4 269.8 241.9 258.2 240.2 239.2 242.8 197.6



All 316.1 311.8 313.6 284.5 263.6 269.9 263.8 249.1 251.3 240.7 231.2 222.9 201.2

Table H.40Second-year mortality rates, CAPD/CCPD per ,000 patient years at risk, incident patients, by modality & demographic characteristics



568

Reference section H

Table H.41Second-year mortality rates, transplantper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 12.6 . . 11.4 17.7 15.0 . 58.3 34.5 22.2 17.4 10.9 15.75-9 . . 8.6 . 18.3 . 8.8 16.5 9.3 . 18.2 10.9 .10-14 . 15.4 . . 6.1 5.7 5.3 . . . . 5.3 9.815-19 14.1 10.0 7.2 23.8 9.9 16.2 5.7 12.6 6.6 10.7 8.3 12.1 8.720-29 18.8 14.2 15.0 15.3 12.7 4.8 11.3 10.7 13.2 9.8 8.1 7.7 11.130-39 27.4 21.9 24.4 22.6 18.1 20.4 17.4 16.4 15.7 13.7 15.7 19.5 15.940-49 38.0 36.6 28.3 28.2 27.2 31.8 19.5 26.8 20.1 24.3 17.6 19.4 26.250-59 46.6 37.0 33.2 41.7 46.9 44.5 36.6 40.8 28.8 32.2 26.6 33.1 37.560-64 82.6 48.3 55.0 52.1 47.6 53.3 45.3 46.0 36.8 46.2 39.7 43.8 53.665-69 66.9 53.8 73.1 65.0 54.3 70.3 81.9 55.2 64.2 56.5 59.8 71.6 46.670-79 66.7 126.3 90.2 88.9 105.4 84.6 58.4 80.0 65.8 72.6 75.8 65.1 69.680+ . . . 405.5 693.1 . . . . 336.5 154.2 223.1 .

Male 34.7 28.1 27.5 29.2 29.1 31.6 26.6 26.5 24.9 27.5 25.1 28.8 29.5Female 31.7 29.4 27.0 29.7 27.1 26.5 21.9 30.5 21.3 22.7 19.6 25.5 29.5




All 33.5 28.6 27.3 29.4 28.3 29.6 24.8 28.1 23.5 25.5 22.9 27.4 29.5

ADJUSTED0-19 8.6 9.0 5.1 12.6 12.4 12.0 5.7 17.8 10.7 7.8 9.3 10.6 9.520-44 31.2 27.5 26.2 28.2 21.7 21.2 19.0 20.8 18.6 18.9 18.8 21.1 21.345-64 61.7 47.0 43.1 43.6 47.5 48.5 37.1 41.4 31.8 35.9 28.5 34.4 41.765-74 78.7 78.5 82.7 79.9 74.6 82.7 80.6 64.2 66.9 65.7 66.4 66.6 51.175+ 78.7 78.5 82.7 79.9 74.6 82.7 80.6 64.2 66.9 65.7 66.4 66.6 51.1

Male 98.1 76.1 73.4 75.3 73.4 77.0 63.1 60.8 56.1 59.4 53.9 59.4 59.9Female 95.6 87.5 77.2 82.5 73.9 69.5 57.1 75.2 52.6 54.9 47.1 58.7 65.7



All 96.2 79.6 74.1 77.4 72.8 73.4 60.3 65.7 54.2 57.0 50.7 58.5 61.4

Table H.41Second-year mortality rates, transplant per ,000 patient years at risk, incident patients, by modality & demographic characteristics


569


Table H.42Third-year mortality rates, ESRD per 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 29.3 26.2 10.1 22.3 32.5 42.3 8.8 14.8 39.2 42.0 7.1 21.4 47.75-9 10.5 . 23.3 . 8.3 16.8 13.2 14.5 46.2 . 7.5 6.9 20.610-14 14.7 10.9 9.8 21.9 22.3 22.6 28.5 7.7 15.7 11.3 . 6.9 10.215-19 19.2 30.8 19.5 13.5 16.1 20.6 14.4 26.1 20.7 28.2 22.0 28.6 17.320-29 37.2 43.4 45.7 40.2 41.4 42.7 40.7 44.2 35.6 35.3 35.9 44.5 40.630-39 71.8 72.4 72.1 74.8 82.4 71.9 68.3 70.8 64.5 67.6 63.0 66.6 60.740-49 102.7 111.0 111.1 108.6 108.3 107.3 103.1 103.4 101.5 99.4 103.2 96.5 100.650-59 167.5 171.3 166.2 168.4 177.6 164.2 165.8 158.0 159.7 149.1 144.9 145.8 138.760-64 219.2 229.5 231.4 224.7 231.0 227.4 214.2 214.1 218.6 194.5 195.6 204.6 188.665-69 270.1 289.3 293.3 283.0 284.9 274.0 264.3 255.4 269.8 252.9 249.5 246.1 234.870-79 346.4 344.6 366.6 346.2 365.5 337.9 353.3 344.9 334.5 333.5 333.6 326.3 307.880+ 506.2 496.4 505.7 497.1 480.7 489.1 502.3 502.9 451.4 475.4 503.6 481.7 445.3

Male 175.1 177.7 186.0 182.9 197.6 187.0 187.6 181.9 185.0 184.7 182.7 184.5 177.8Female 171.8 192.6 195.6 197.6 198.9 196.1 199.0 201.0 202.0 192.3 197.5 196.7 186.9




All 173.6 184.6 190.5 189.7 198.2 191.2 193.0 190.8 192.8 188.2 189.5 190.0 181.9

ADJUSTED0-19 35.2 41.7 32.0 29.2 35.2 45.1 32.7 35.8 48.0 41.6 23.4 36.3 38.120-44 79.4 79.0 81.0 79.9 83.8 80.3 77.7 80.2 71.4 73.3 71.8 75.6 74.345-64 181.8 186.8 183.8 179.8 184.9 174.3 167.2 162.5 164.5 150.7 150.1 149.8 141.665-74 299.2 313.0 317.8 308.1 308.0 293.1 297.2 283.2 280.5 277.4 273.2 263.7 249.875+ 436.7 412.7 449.6 412.4 441.1 415.5 424.6 429.6 407.9 403.0 414.1 406.3 379.1

Male 264.9 255.5 264.1 251.7 268.3 247.1 244.0 235.9 230.4 226.9 222.0 218.5 209.2Female 232.7 249.3 249.2 243.5 240.8 235.1 234.2 232.5 228.8 215.3 219.6 217.4 202.5



All 248.5 252.1 256.5 247.3 254.2 240.8 238.8 233.8 229.2 220.9 220.5 217.7 205.7

Table H.42Third-year mortality rates, ESRD per ,000 patient years at risk, incident patients, by modality & demographic characteristics



570

Reference section H

Table H.43Third-year mortality rates, dialysisper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 75.9 85.3 37.7 102.2 51.5 94.2 24.1 25.3 103.6 102.7 . 33.9 55.35-9 74.1 . 91.3 . 40.8 102.9 55.6 51.3 33.9 . 27.4 33.9 24.710-14 26.7 20.2 16.8 72.3 55.3 64.1 91.2 35.2 41.3 32.9 . 15.0 13.615-19 34.1 68.4 37.8 24.0 19.7 37.2 23.0 43.8 30.4 27.2 44.7 51.6 33.320-29 68.2 76.1 81.0 67.2 73.9 66.9 68.5 58.7 56.3 54.9 58.7 62.6 56.430-39 109.5 115.0 113.2 116.9 124.9 106.4 101.0 104.7 90.0 96.4 87.9 89.8 82.740-49 139.4 155.5 150.5 149.8 151.0 141.2 134.6 132.7 128.9 125.0 131.1 123.4 127.350-59 197.6 200.9 194.7 196.0 207.7 190.2 194.0 183.1 184.9 174.6 168.4 168.1 161.760-64 236.5 246.3 246.6 244.8 249.1 245.3 228.7 234.6 238.1 212.4 211.4 221.6 207.965-69 275.2 297.4 303.2 292.6 292.7 282.7 273.4 264.9 279.0 262.4 261.4 260.4 248.070-79 347.4 345.4 368.6 347.8 366.7 339.5 355.6 348.3 337.1 335.8 337.0 330.0 312.780+ 506.2 496.4 507.6 497.1 480.7 489.5 502.3 503.2 451.2 475.6 504.8 482.0 445.8

Male 235.0 236.3 243.1 236.4 251.6 234.5 231.6 224.8 225.0 222.5 219.5 219.0 211.2Female 213.9 236.6 237.0 238.7 238.7 230.7 234.7 234.0 232.4 222.9 228.8 226.9 215.5




All 224.5 236.5 240.1 237.5 245.2 232.6 233.1 229.3 228.6 222.7 223.9 222.7 213.2

ADJUSTED0-19 74.2 98.1 71.6 74.5 56.1 98.9 76.2 77.3 72.6 63.6 57.3 73.8 57.120-44 123.1 127.5 128.2 127.1 131.8 122.3 118.6 116.4 103.6 105.2 102.1 104.1 102.545-64 214.9 220.9 213.9 211.6 220.0 203.6 196.4 192.0 193.7 177.7 176.4 175.2 166.465-74 302.1 318.1 324.8 314.7 313.5 299.6 304.4 291.1 287.5 284.9 282.7 274.0 260.475+ 437.2 412.3 450.5 412.3 441.4 415.7 425.1 430.4 408.2 403.5 415.0 407.3 380.6

Male 290.7 281.8 290.0 275.6 293.4 267.9 264.6 256.4 248.9 244.7 240.0 234.9 225.3Female 250.4 268.4 267.5 263.4 260.5 252.2 252.9 249.4 244.7 232.1 236.9 233.8 218.7



All 270.2 275.1 278.8 269.5 276.7 260.0 258.7 252.9 246.7 238.4 238.3 234.2 222.0

Table H.43Third-year mortality rates, dialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics


571


Table H.44Third-year mortality rates, hemodialysisper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 287.7 223.1 . 182.3 . 95.3 . 87.0 . 87.0 . 182.3 287.75-9 . . . . . . 64.5 . 95.3 . . 95.3 .10-14 57.2 33.9 33.9 125.8 97.7 . 83.1 . 42.6 30.8 . 30.8 .15-19 38.3 72.1 36.0 24.8 22.0 42.8 24.8 41.6 36.5 22.3 33.1 40.8 23.020-29 73.5 79.2 71.7 62.5 70.5 66.6 68.2 56.2 54.7 57.4 60.3 63.6 51.730-39 98.6 112.4 114.9 114.1 119.1 102.8 91.1 104.4 90.4 98.9 87.9 89.5 82.640-49 132.3 150.6 135.9 142.8 138.4 129.3 132.1 130.5 126.5 123.6 128.7 123.1 124.950-59 195.8 197.9 190.0 182.7 205.9 178.4 186.7 175.2 179.9 166.6 165.7 165.3 161.260-64 221.9 249.6 242.1 242.7 236.6 234.4 217.9 222.2 230.4 208.2 207.4 216.4 200.565-69 261.3 291.0 291.2 276.9 283.3 269.1 259.2 255.3 273.2 257.9 251.7 252.4 245.170-79 338.7 346.6 359.5 333.0 352.1 332.0 345.5 342.8 336.9 331.0 335.1 325.8 310.080+ 510.2 499.0 505.3 483.3 476.6 483.4 480.1 492.6 444.4 464.2 505.9 475.5 442.4

Male 227.4 241.0 237.9 230.3 245.7 225.6 223.0 218.9 221.7 217.4 215.5 215.6 206.7Female 212.3 237.5 236.8 233.1 236.1 229.1 232.5 234.3 234.1 224.6 231.7 227.6 218.3




All 219.9 239.3 237.4 231.7 240.9 227.3 227.6 226.4 227.6 220.8 223.1 221.2 212.1

ADJUSTED0-19 98.5 132.4 68.7 90.0 71.1 83.9 84.6 83.8 86.1 55.4 59.0 92.9 46.120-44 114.4 127.0 122.0 125.6 124.8 116.5 115.0 117.4 104.4 108.7 101.3 104.4 100.445-64 209.4 220.6 208.1 203.2 214.6 193.3 189.2 184.2 189.8 172.9 174.8 173.4 164.665-74 289.1 313.0 314.2 303.1 304.3 288.4 292.4 285.7 284.7 281.0 278.0 268.7 260.275+ 434.2 420.0 445.7 393.3 427.8 413.3 413.8 422.2 407.8 397.0 414.4 402.5 375.6

Male 278.5 283.2 279.1 264.9 284.4 254.9 252.3 247.5 244.8 237.8 234.9 230.6 220.1Female 243.8 263.5 261.7 251.9 251.6 245.1 246.0 245.4 243.0 231.0 237.3 232.1 219.7



All 260.7 273.2 270.3 258.3 267.4 249.8 249.0 246.3 243.7 234.3 235.8 231.1 219.7

Table H.44Third-year mortality rates, hemodialysis per ,000 patient years at risk, incident patients, by modality & demographic characteristics



572

Reference section H

Table H.45Third-year mortality rates, CAPD/CCPDper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 . 69.0 60.6 117.8 . 82.7 30.8 . 128.1 127.8 . . 42.65-9 182.3 . 87.0 . . 87.0 64.5 80.0 . . 57.2 . 46.510-14 . . . . . 154.2 51.3 81.8 46.5 40.8 . . 36.415-19 44.5 88.8 69.0 42.6 22.5 40.8 . 24.7 19.8 51.3 57.7 124.4 76.220-29 57.8 74.7 111.7 83.4 85.7 62.6 40.8 61.1 59.3 55.6 52.2 81.3 72.330-39 140.1 127.8 103.3 114.3 157.5 148.1 125.6 101.0 87.3 70.0 84.6 80.5 83.640-49 193.2 195.5 211.4 168.8 203.6 172.6 151.0 140.3 147.3 131.0 141.6 105.2 153.850-59 236.7 235.4 209.7 264.0 206.3 241.9 229.3 203.1 208.9 231.1 172.1 189.3 150.860-64 356.3 256.2 292.3 248.8 273.7 287.0 244.8 282.2 258.7 226.5 231.4 290.6 252.365-69 315.0 379.0 349.6 350.2 314.1 342.1 367.5 271.5 280.1 331.3 368.4 360.3 288.270-79 359.8 457.2 516.1 412.8 501.7 355.0 428.5 348.0 355.1 415.7 365.1 407.6 350.180+ 539.0 777.7 439.4 418.7 503.9 583.9 781.7 775.8 630.2 621.2 693.1 590.5 470.4

Male 258.6 244.5 262.4 240.1 258.5 247.6 246.3 218.0 222.0 246.0 235.1 217.6 232.4Female 208.6 232.7 220.3 219.0 212.4 221.2 211.4 195.9 187.6 180.6 176.5 201.6 149.4




All 234.2 238.8 241.5 230.2 235.6 234.8 229.4 207.3 204.8 214.0 205.4 209.9 192.2

ADJUSTED0-19 65.5 85.8 97.5 82.6 17.5 139.7 50.7 74.1 77.8 95.4 44.0 64.8 85.020-44 163.3 144.9 144.9 121.2 163.9 158.3 123.2 105.2 105.1 82.0 105.1 97.3 123.445-64 276.5 248.1 253.0 255.4 231.7 242.6 225.4 215.7 206.6 211.6 178.9 189.3 169.265-74 348.4 434.9 422.9 361.0 371.1 351.3 383.3 287.7 302.5 364.0 350.7 365.8 298.075+ 466.4 548.5 535.1 519.0 633.8 431.6 606.4 553.7 474.3 497.2 492.6 487.2 419.1

Male 380.1 347.0 385.4 339.0 360.3 331.4 334.5 291.1 291.2 317.0 296.6 270.0 285.8Female 331.8 364.6 321.7 322.4 316.1 324.2 308.3 276.7 262.3 256.8 241.4 283.1 208.0



All 356.9 353.6 353.9 330.9 338.5 327.2 321.3 283.5 276.7 288.1 269.2 274.6 249.1

Table H.45Third-year mortality rates, CAPD/CCPD per ,000 patient years at risk, incident patients, by modality & demographic characteristics


573


Table H.46Third-year mortality rates, transplantper 1,000 patient years at risk, incident patients, by modality & demographic characteristics

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 26.7 12.7 13.8 . 11.6 18.0 . 11.4 . 8.8 11.3 . 22.25-9 . . . 8.7 10.1 . . 8.9 25.3 9.4 . 9.2 11.010-14 . 6.3 7.8 6.4 12.4 . . . . . 5.2 . 5.415-19 16.5 7.1 3.4 18.3 20.3 10.0 5.4 5.7 12.8 13.3 . 11.2 6.120-29 14.4 19.1 16.7 19.8 15.6 20.5 13.7 13.9 14.9 11.7 7.4 9.0 6.030-39 34.8 21.9 27.1 24.0 19.6 25.5 20.8 17.2 19.0 19.3 17.4 17.9 16.340-49 40.7 34.6 39.1 28.6 35.4 31.6 27.1 25.7 29.5 25.5 25.6 25.2 18.850-59 56.3 52.5 41.4 48.5 46.3 49.8 45.9 42.4 36.3 39.5 37.7 34.4 34.660-64 45.8 50.5 64.5 72.1 43.8 76.0 69.9 63.8 49.6 55.2 56.3 73.2 43.865-69 93.7 88.4 80.5 73.7 86.7 77.3 79.2 73.2 79.6 73.7 77.3 85.0 49.770-79 129.2 189.2 144.6 58.3 110.5 104.0 114.1 102.9 49.8 130.6 66.7 67.0 90.580+ . . . . . . . . . . 223.1 . .

Male 40.0 31.0 37.2 35.7 32.0 36.7 30.6 30.0 28.9 29.6 31.9 30.4 24.5Female 29.8 31.6 26.4 25.9 31.2 31.5 30.5 27.5 29.4 31.0 24.1 30.4 27.7




All 36.0 31.3 32.8 31.7 31.7 34.6 30.6 29.0 29.1 30.2 28.7 30.4 25.8

ADJUSTED0-19 12.8 7.3 5.7 12.6 17.3 8.2 3.2 6.0 11.0 9.7 3.3 7.0 9.620-44 37.9 29.3 30.7 27.8 26.9 29.7 25.9 23.0 22.1 21.7 19.8 19.9 17.245-64 59.1 55.6 56.3 55.7 50.5 57.1 46.8 44.7 43.4 43.9 42.5 44.9 36.165-74 117.3 109.4 95.7 80.3 101.7 84.1 92.8 85.0 79.3 91.0 78.1 86.5 66.575+ 117.3 109.4 95.7 80.3 101.7 84.1 92.8 85.0 79.3 91.0 78.1 86.5 66.5

Male 113.6 87.5 100.4 94.5 82.2 92.1 74.1 70.7 66.1 66.4 68.7 64.7 50.3Female 93.1 97.4 79.9 75.3 88.5 87.5 81.3 72.7 73.5 77.8 59.1 74.4 64.5



All 104.7 90.2 91.4 86.1 83.6 89.2 75.9 70.5 68.0 69.7 64.2 67.4 55.0

Table H.46Third-year mortality rates, transplant per ,000 patient years at risk, incident patients, by modality & demographic characteristics



574

Reference section H

Patientsurvival

IReferenceSec

tion

PATIENT SURVIVALI

576

Reference section I

I.1 . 5 78 Incident patient counts: ESRD patients by age, gender, race, ethnicity, & primary diagnosis

I.2 . 582 90-day survival probabilities: incident ESRD patientsby age, gender, race, ethnicity, & primary diagnosis

I.3 . 584 One-year survival probabilities: incident ESRD patientsfrom day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.4 . 586 Two-year survival probabilities: incident ESRD patientsfrom day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.5 . 588 Three-year survival probabilities: incident ESRD patientsfrom day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.6 . 590 Five-year survival probabilities: incident ESRD patientsfrom day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.7 . 592 Ten-year survival probabilities: incident ESRD patientsfrom day 9 to ten years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.8 . 593Incident patient counts: dialysis patients, unknowns dropped dialysis patients alive on day 9, by age, gender, race, ethnicity, & primary diagnosis

I.9 . 595 90-day survival probabilities: incident dialysis patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

I.10 . 597 One-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.11 . 599 Two-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.12 . 601 Three-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.13 . 603 Five-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.14 . 605 Ten-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to ten years + 90 days, by age, gender, race, & primary diagnosis

I.15 . 606 Incident patient counts: hemodialysis patients, unknowns dropped dialysis patients alive on day 9, by age, gender, race, ethnicity, & primary diagnosis

I.16 . 608 90-day survival probabilities: incident hemodialysis patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

I.17 . 610 One-year survival probabilities: incident hemodialysis patients censored at transplant, from day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.18 . 612 Two-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.19 . 614 Three-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.20 . 616 Five-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.21 . 617 Ten-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to ten years + 90 days, by age, gender, race, & primary diagnosis

I.22 . 618 Incident patient counts: CAPD/CCPD patients, unknowns dropped dialysis patients alive on day 9, by age, gender, race, ethnicity, & primary diagnosis

577

2005 Annual Data Report IPATIENT SURVIVAL

I.23 . 620 90-day survival probabilities: incident CAPD/CCPD patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

I.24 . 622 One-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.25 . 624 Two-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.26 . 626 Three-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.27 . 628 Five-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

I.28 . 630 Ten-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to ten years + 90 days, by age, gender, race, & primary diagnosis

I.29 . 631 90-day patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

I.30 . 633One-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

I.31 . 635 Two-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

I.32 . 637 Three-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

I.33 . 639 Five-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

I.34 . 641 Ten-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

I.35 . 642 90-day patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

I.36 . 643 One-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

I.37 . 645 Two-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

I.38 . 647 Three-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

I.39 . 649 Five-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

I.40 . 651 Ten-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

PATIENT SURVIVALI

578

Reference section I

Table I.1Incident patient counts: ESRD patients by age, gender, race, ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 46 66 98 106 107 134 132 137 135 144 1255-9 94 94 105 87 108 101 122 112 99 124 13810-14 178 185 222 210 221 213 207 217 220 197 21815-19 425 467 455 438 424 433 452 468 497 512 48820-29 1,502 1,662 1,869 1,804 1,956 2,049 2,109 2,129 2,324 2,501 2,55530-39 2,166 2,430 2,697 2,788 2,996 3,220 3,561 3,703 4,141 4,493 4,69240-49 2,379 2,663 2,810 3,138 3,300 3,595 3,870 4,374 4,850 5,500 6,03250-59 3,610 4,218 4,505 4,631 4,932 5,250 5,559 6,032 6,863 7,416 7,97260-64 1,999 2,317 2,616 3,025 3,338 3,695 3,855 4,382 4,762 5,203 5,73565-69 1,968 2,055 2,325 3,041 3,155 3,535 4,069 4,654 5,215 6,010 6,66970-79 2,182 2,403 2,955 4,128 4,307 5,030 5,791 6,651 7,318 8,670 9,67580+ 359 404 541 842 914 1,137 1,401 1,622 1,960 2,432 2,813Unknown . * * * * 17 11 * * * *

Male 9,423 10,476 11,658 13,294 14,225 15,396 16,981 18,633 20,536 23,232 25,226Female 7,485 8,488 9,548 10,951 11,541 13,009 14,157 15,853 17,852 19,979 21,893Unknown . * . * * * * * * . .

White 11,766 13,146 14,672 16,369 17,451 19,179 21,138 23,126 25,330 28,389 31,037Black 4,657 5,275 5,956 7,164 7,524 8,315 8,952 10,166 11,600 13,292 14,230Other race 426 485 559 692 768 892 1,005 1,164 1,413 1,497 1,801Unknown 59 59 19 22 24 23 44 31 46 33 51


Diabetes 2,577 3,845 5,002 5,831 7,080 8,166 9,471 10,802 12,304 14,862 17,015Hypertension 2,988 4,266 5,414 5,893 6,610 7,581 8,227 9,519 11,004 12,764 13,956Glomerulonephritis 2,716 3,524 4,112 4,322 4,614 4,874 5,103 5,586 5,982 6,286 6,674Cystic kidney 753 927 1,065 1,081 1,122 1,196 1,285 1,340 1,363 1,390 1,537Other urologic 451 638 819 907 920 1,092 1,129 1,250 1,270 1,293 1,200Other cause 1,709 2,128 2,674 2,953 3,123 3,365 3,471 3,484 3,626 4,107 4,238Missing cause 4,209 2,110 835 1,949 943 735 783 668 843 563 459Unknown cause 1,505 1,527 1,285 1,311 1,355 1,400 1,670 1,838 1,997 1,946 2,040

All 16,908 18,965 21,206 24,247 25,767 28,409 31,139 34,487 38,389 43,211 47,119

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.The age of the incident patient is determined as of the date of ESRD initiation.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed.


Table I.1Incident patient counts: ESRD patients by age, gender, race, ethnicity, & primary diagnosis

579


Table I.1 (continued)Incident patient counts: ESRD patients by age, gender, race, ethnicity, & primary diagnosis

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 171 145 179 138 162 178 170 166 167 192 198 1775-9 123 124 131 157 144 140 131 137 154 153 150 17810-14 240 245 240 253 273 268 278 269 298 307 307 34215-19 479 526 521 518 567 575 528 535 597 571 573 57520-29 2,576 2,719 2,768 2,745 2,629 2,663 2,603 2,699 2,615 2,645 2,677 2,55330-39 4,994 5,347 5,422 5,721 5,648 5,718 5,657 5,691 5,831 5,675 5,626 5,68540-49 6,799 7,325 7,761 8,184 8,734 9,404 9,393 10,184 10,386 10,655 10,672 10,97850-59 8,653 9,617 10,122 11,331 11,552 12,225 13,283 14,424 15,516 16,066 16,860 17,50560-64 6,300 6,622 6,965 7,329 7,620 8,008 8,420 8,877 9,131 9,421 9,738 10,01365-69 7,386 7,990 8,333 8,912 8,923 9,713 10,014 10,288 10,407 10,510 10,769 11,04870-79 11,349 12,713 13,368 14,882 15,281 17,217 18,399 19,415 20,613 21,069 21,182 22,29780+ 3,284 3,874 4,199 4,731 5,125 6,088 6,946 7,613 8,583 9,269 9,656 11,218Unknown * * * * * . . * . . . .

Male 27,885 30,172 31,930 34,285 35,140 38,491 40,387 42,710 45,078 46,366 47,543 50,351Female 24,470 27,076 28,076 30,620 31,518 33,705 35,435 37,589 39,218 40,166 40,865 42,217Unknown * * * . * * . . * * . *

White 34,337 37,303 38,661 41,573 41,937 45,771 48,400 50,965 54,184 55,886 56,877 59,424Black 15,927 17,521 18,613 20,152 20,788 22,048 22,871 24,404 24,878 25,055 25,849 27,117Other race 2,032 2,335 2,630 3,000 3,763 4,270 4,460 4,830 5,140 5,473 5,610 5,956Unknown 61 90 106 180 173 108 91 100 96 119 72 72

†Hispanic 8,362 8,565 9,134 9,923 10,666 10,976 11,882†Non-Hispanic 63,835 67,257 71,165 74,375 75,867 77,432 80,687

Diabetes 19,534 21,711 23,136 25,747 28,048 31,369 33,627 35,757 37,587 39,113 40,184 41,649Hypertension 15,571 17,426 18,076 19,542 17,560 18,684 19,860 20,925 22,150 22,557 23,311 24,775Glomerulonephritis 6,949 7,157 7,376 7,919 8,040 8,406 8,317 8,466 8,503 8,276 8,147 8,369Cystic kidney 1,599 1,691 1,766 1,804 1,902 1,851 1,935 2,127 2,144 2,152 2,198 2,202Other urologic 1,381 1,441 1,250 1,294 1,912 2,151 2,193 2,203 2,585 2,424 2,469 2,669Other cause 4,613 4,979 5,216 5,623 6,438 6,729 6,882 7,507 7,734 8,091 8,208 8,878Missing cause 419 381 469 300 255 247 211 310 412 482 359 393Unknown cause 2,291 2,463 2,721 2,676 2,506 2,760 2,797 3,004 3,183 3,438 3,532 3,634

All 52,357 57,249 60,010 64,905 66,661 72,197 75,822 80,299 84,298 86,533 88,408 92,569

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age, gender, race, or primary cause of ESRD are excluded.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.1 (continued)Incident patient counts: ESRD patients by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

580

Reference section I

Table I.1 (continued)Incident patient counts: ESRD patients, unknowns dropped by age, gender, race, ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 41 57 88 104 101 131 120 128 126 135 1175-9 83 82 99 82 104 92 112 103 96 119 12910-14 161 164 207 197 208 199 194 204 207 178 20015-19 384 431 422 430 404 413 422 445 468 479 46020-29 1,384 1,554 1,768 1,713 1,885 1,943 2,023 2,013 2,168 2,379 2,41230-39 2,020 2,291 2,570 2,668 2,881 3,083 3,379 3,548 3,923 4,266 4,47540-49 2,205 2,504 2,688 3,014 3,172 3,464 3,717 4,203 4,693 5,305 5,79150-59 3,291 3,935 4,294 4,422 4,716 5,061 5,314 5,777 6,603 7,161 7,70160-64 1,819 2,131 2,463 2,871 3,161 3,519 3,666 4,172 4,553 5,005 5,52465-69 1,751 1,849 2,135 2,820 2,961 3,356 3,850 4,377 4,929 5,754 6,39370-79 1,925 2,087 2,679 3,809 3,976 4,663 5,362 6,185 6,788 8,197 9,19780+ 315 339 489 769 815 1,035 1,267 1,450 1,791 2,246 2,627

Male 8,541 9,599 10,876 12,538 13,453 14,555 16,012 17,570 19,367 22,103 23,986Female 6,838 7,825 9,026 10,361 10,931 12,404 13,414 15,035 16,978 19,121 21,040

White 10,662 11,971 13,712 15,415 16,446 18,141 19,926 21,799 23,950 27,059 29,621Black 4,279 4,949 5,651 6,821 7,202 7,959 8,523 9,693 11,029 12,724 13,639Other race 438 504 539 663 736 859 977 1,113 1,366 1,441 1,766


Diabetes 2,573 3,845 4,998 5,823 7,072 8,147 9,455 10,789 12,290 14,849 17,000Hypertension 2,985 4,262 5,409 5,878 6,601 7,566 8,215 9,502 10,990 12,751 13,937Glomerulonephritis 2,713 3,522 4,109 4,319 4,613 4,867 5,097 5,581 5,977 6,282 6,666Cystic kidney 753 927 1,063 1,080 1,121 1,195 1,285 1,340 1,363 1,389 1,537Other urologic 450 638 819 905 918 1,092 1,128 1,249 1,264 1,290 1,200Other cause 1,708 2,125 2,672 2,948 3,120 3,359 3,468 3,477 3,620 4,102 4,228Missing cause 4,197 2,105 832 1,946 939 733 778 667 841 561 458

All 15,379 17,424 19,902 22,899 24,384 26,959 29,426 32,605 36,345 41,224 45,026



581



1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 157 132 155 124 156 173 162 163 160 185 193 1675-9 117 111 111 137 137 136 129 128 144 138 141 16510-14 221 222 209 235 257 256 249 244 269 281 264 31015-19 443 491 486 467 528 530 501 491 550 520 516 50720-29 2,429 2,553 2,570 2,571 2,487 2,500 2,445 2,530 2,450 2,476 2,476 2,36130-39 4,730 5,080 5,093 5,421 5,379 5,460 5,419 5,421 5,579 5,393 5,373 5,41640-49 6,543 7,038 7,431 7,855 8,464 9,057 9,067 9,815 10,018 10,288 10,268 10,56950-59 8,369 9,309 9,793 10,993 11,246 11,890 12,963 14,030 15,106 15,623 16,373 17,00460-64 6,084 6,390 6,715 7,126 7,403 7,754 8,202 8,661 8,886 9,145 9,480 9,73265-69 7,092 7,706 8,008 8,608 8,630 9,432 9,704 9,986 10,117 10,168 10,429 10,70870-79 10,789 12,117 12,744 14,211 14,613 16,485 17,646 18,671 19,757 20,171 20,281 21,38080+ 3,034 3,584 3,930 4,438 4,791 5,699 6,461 7,084 8,009 8,617 8,987 10,503

Male 26,500 28,667 30,318 32,665 33,646 36,903 38,710 40,942 43,204 44,286 45,468 48,198Female 23,508 26,066 26,927 29,521 30,445 32,469 34,238 36,282 37,841 38,719 39,313 40,624

White 32,708 35,555 36,827 39,699 40,228 43,883 46,365 48,859 51,845 53,392 54,300 56,761Black 15,320 16,876 17,828 19,447 20,097 21,294 22,192 23,628 24,150 24,255 25,053 26,278Other race 1,980 2,302 2,590 3,040 3,766 4,195 4,391 4,737 5,050 5,358 5,428 5,783


Diabetes 19,515 21,685 23,123 25,729 28,025 31,343 33,601 35,727 37,558 39,075 40,145 41,596Hypertension 15,547 17,409 18,062 19,530 17,535 18,662 19,833 20,905 22,130 22,527 23,284 24,742Glomerulonephritis 6,945 7,155 7,374 7,915 8,037 8,402 8,312 8,455 8,496 8,271 8,142 8,362Cystic kidney 1,598 1,691 1,766 1,803 1,901 1,850 1,935 2,127 2,144 2,152 2,197 2,201Other urologic 1,377 1,439 1,248 1,292 1,908 2,147 2,191 2,199 2,582 2,422 2,466 2,664Other cause 4,607 4,973 5,206 5,618 6,431 6,721 6,865 7,501 7,724 8,077 8,188 8,866Missing cause 419 381 466 299 254 247 211 310 411 481 359 391

All 50,008 54,733 57,245 62,186 64,091 69,372 72,948 77,224 81,045 83,005 84,781 88,822



PATIENT SURVIVALI

582

Reference section I

Table I.290-day survival probabilities: incident ESRD patientsby age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 97.9 98.5 98.0 100.0 98.2 100.0 97.1 96.5 97.1 96.6 85.65-9 100.0 98.9 100.0 98.9 99.1 99.0 100.0 100.0 96.1 97.6 92.010-14 99.4 100.0 100.0 100.0 98.7 100.0 98.6 100.0 100.0 99.0 88.615-19 99.5 99.4 100.0 99.5 99.8 99.8 99.6 100.0 99.2 98.8 91.420-29 99.1 99.2 99.3 98.8 98.7 99.2 99.2 98.9 98.9 98.7 98.030-39 98.2 98.7 98.5 98.8 98.6 98.5 98.1 98.2 98.5 98.3 97.440-49 98.3 98.0 98.3 97.8 98.2 98.1 98.2 97.9 98.2 97.9 97.350-59 97.2 97.1 96.9 96.3 97.2 96.4 96.8 97.0 96.8 97.0 96.460-64 95.1 95.2 94.7 95.0 95.2 94.3 94.0 95.2 94.7 95.0 94.265-69 90.9 91.1 90.0 91.6 90.0 90.3 91.6 91.2 92.3 92.1 92.270-79 87.2 88.4 87.7 88.5 87.8 87.2 88.0 89.3 88.2 88.7 89.180+ 83.7 84.7 84.5 83.4 83.5 82.6 84.5 83.7 85.8 83.8 83.9

Male 94.9 95.1 94.5 94.2 94.2 93.5 93.7 93.9 93.7 93.7 93.0Female 95.1 95.6 95.1 94.5 94.3 93.9 94.2 94.4 94.4 94.0 93.6




All 95.0 95.3 94.8 94.4 94.2 93.7 93.9 94.1 94.0 93.8 93.3

ADJUSTED0-19 99.0 98.8 99.6 99.3 98.4 99.6 98.1 99.0 97.6 96.9 81.920-44 98.8 98.8 98.8 98.8 98.8 98.7 98.5 98.4 98.6 98.4 97.745-64 97.2 97.0 96.6 96.2 96.7 96.0 96.1 96.5 96.3 96.5 95.865-74 91.1 91.2 89.9 91.4 89.9 89.8 91.0 91.3 91.3 91.6 91.575+ 87.5 88.0 87.7 87.2 87.2 86.3 87.0 87.4 87.4 86.5 87.1

Male 94.2 94.1 93.4 93.6 93.5 92.8 93.1 93.4 93.3 93.3 92.7Female 94.4 94.5 94.0 94.0 93.6 93.3 93.8 94.0 94.0 93.8 93.4



All 94.3 94.3 93.7 93.8 93.5 93.0 93.4 93.7 93.6 93.5 93.0

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.290-day survival probabilities: incident ESRD patientsby age, gender, race, ethnicity, & primary diagnosis

583


Table I.2 (continued)90-day survival probabilities: incident ESRD patientsby age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 96.6 96.7 97.3 95.8 97.0 97.3 97.1 96.0 93.3 97.5 96.6 97.85-9 98.4 100.0 99.2 98.7 98.6 97.9 99.2 100.0 98.7 99.4 98.7 98.910-14 97.6 100.0 99.6 98.4 99.6 99.6 99.3 100.0 99.7 99.4 99.4 99.715-19 98.8 99.6 99.4 98.9 99.8 99.3 99.4 99.3 98.8 99.3 98.5 99.120-29 98.5 97.9 98.4 97.9 97.4 98.4 98.2 98.7 98.6 98.4 98.8 98.330-39 97.7 97.6 97.3 97.1 97.6 97.3 97.7 97.7 97.9 97.6 97.9 97.840-49 98.0 97.6 97.3 97.0 96.8 96.8 96.7 96.9 96.7 97.0 97.0 96.750-59 96.7 96.9 96.0 95.7 95.8 95.8 96.0 95.7 95.3 95.7 95.3 95.860-64 94.7 94.5 94.5 93.8 93.9 93.8 93.7 93.4 93.9 93.8 93.4 93.965-69 92.2 92.5 92.8 92.6 92.7 92.8 92.1 92.3 92.5 91.9 92.3 92.670-79 89.5 89.6 89.1 89.6 89.2 89.0 88.5 88.7 88.7 88.9 88.2 88.780+ 84.9 85.3 84.7 84.0 83.8 84.3 82.9 82.4 82.4 82.8 82.3 83.0

Male 93.5 93.3 93.2 92.9 92.9 92.7 92.3 92.2 92.2 92.3 91.8 92.2Female 94.0 94.1 93.5 93.3 93.0 92.9 92.3 92.4 92.1 92.0 91.9 91.8




All 93.7 93.7 93.3 93.1 92.9 92.8 92.3 92.3 92.1 92.2 91.9 92.1

ADJUSTED0-19 96.3 98.7 98.2 96.7 98.5 97.8 98.1 98.1 96.6 98.1 97.0 98.220-44 98.1 97.9 97.8 97.5 97.5 97.6 97.8 97.9 97.9 97.9 98.0 97.945-64 96.2 96.2 95.7 95.3 95.3 95.3 95.3 95.1 95.1 95.3 95.0 95.365-74 91.5 91.8 91.9 92.0 91.6 91.6 91.1 91.3 91.4 91.2 91.0 91.475+ 87.9 87.8 87.0 86.8 86.7 86.8 85.8 85.6 85.7 85.9 85.4 85.9

Male 93.3 93.2 93.1 92.8 92.9 92.9 92.7 92.6 92.7 92.9 92.4 92.9Female 93.9 94.1 93.5 93.3 93.1 93.2 92.8 92.8 92.7 92.7 92.7 92.7



All 93.6 93.6 93.3 93.1 93.0 93.0 92.7 92.7 92.7 92.8 92.5 92.8


Table I.2 (continued)90-day survival probabilities: incident ESRD patientsby age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

584

Reference section I

Table I.3One-year survival probabilities: incident ESRD patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 93.5 92.4 89.8 89.6 86.9 89.6 90.8 90.5 81.5 84.7 84.85-9 93.6 94.7 95.2 97.7 95.4 95.0 98.4 99.1 99.0 96.8 97.110-14 97.7 97.8 98.6 98.1 97.3 97.6 99.5 98.6 95.5 95.9 96.315-19 96.5 95.9 96.3 95.0 96.7 95.8 95.8 96.6 98.0 98.6 97.520-29 91.9 93.4 93.7 93.6 93.7 92.4 94.4 92.4 93.1 92.9 92.730-39 89.7 89.0 89.2 90.3 88.8 89.4 89.7 89.3 89.9 89.6 90.340-49 88.1 87.5 87.0 87.7 88.3 88.0 87.7 88.1 88.8 88.6 89.050-59 83.9 83.4 84.1 81.8 82.0 82.3 82.8 83.6 83.9 83.6 84.460-64 78.6 77.9 78.3 77.8 76.2 76.6 77.4 76.6 77.2 78.0 78.565-69 72.8 73.6 74.0 72.1 73.0 71.4 73.1 73.1 73.5 74.1 75.670-79 67.1 68.2 68.6 65.3 66.6 67.0 66.2 65.4 66.2 67.5 68.580+ 57.9 53.6 62.0 54.9 56.2 58.0 58.6 55.3 55.7 58.0 59.6

Male 81.5 82.0 81.8 79.3 79.3 78.9 78.7 78.5 78.4 78.8 79.6Female 82.3 81.6 82.1 79.7 80.0 79.5 79.9 78.5 79.6 79.2 79.5




All 81.8 81.8 81.9 79.5 79.6 79.2 79.3 78.5 79.0 79.0 79.5

ADJUSTED0-19 92.9 92.4 92.5 91.3 91.6 91.3 93.2 93.5 91.3 92.6 92.120-44 88.2 88.5 88.9 89.5 89.1 89.0 89.5 89.0 89.7 89.3 89.945-64 80.4 80.2 81.1 80.1 80.0 80.3 81.2 81.4 82.0 82.7 83.365-74 70.0 70.8 72.4 69.1 70.3 69.4 70.3 70.4 71.2 72.0 73.575+ 61.1 62.2 62.1 58.8 61.0 62.3 62.0 59.4 60.2 62.5 63.5

Male 73.9 74.5 74.9 73.3 73.5 73.7 74.2 74.2 74.5 75.6 76.9Female 75.4 75.2 76.7 75.3 76.0 75.9 77.1 76.2 77.4 77.8 78.5



All 74.6 74.8 75.7 74.2 74.7 74.8 75.6 75.2 75.9 76.7 77.7

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.3One-year survival probabilities: incident ESRD patientsfrom day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

585


Table I.3 (continued)One-year survival probabilities: incident ESRD patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 81.9 89.0 86.6 88.4 88.3 91.6 89.9 88.6 87.4 84.4 88.9 90.15-9 98.4 97.6 95.4 100.0 97.2 95.7 96.2 100.0 96.1 96.7 98.0 93.810-14 97.5 94.7 95.8 99.2 97.4 97.0 97.8 97.8 98.0 97.4 98.0 97.015-19 96.2 96.4 97.1 95.9 97.5 96.9 98.3 96.4 97.8 97.9 97.9 97.720-29 93.0 93.9 93.3 92.8 92.7 94.3 95.4 95.1 95.4 93.9 95.0 94.030-39 89.7 90.0 89.4 89.9 88.7 90.3 91.1 91.3 91.0 91.1 91.5 91.840-49 88.0 88.3 88.9 88.5 89.2 89.6 90.2 89.1 89.6 89.7 89.2 89.050-59 84.3 85.3 85.1 85.9 85.8 85.5 85.9 85.6 86.1 85.6 86.0 85.960-64 79.4 79.4 81.0 80.8 80.2 81.8 81.9 80.2 81.2 80.9 81.7 81.165-69 75.2 75.6 77.2 76.4 77.1 77.9 76.9 76.4 76.6 77.2 76.9 76.970-79 68.2 68.5 70.0 70.1 70.3 70.9 69.8 70.0 69.6 69.5 69.8 69.680+ 59.3 58.5 61.0 61.0 60.3 60.2 59.5 57.5 58.5 57.9 57.9 58.9

Male 79.1 78.9 80.2 79.8 79.6 80.1 79.8 79.2 79.4 79.0 79.3 78.8Female 79.0 79.3 79.6 79.6 79.6 79.6 78.9 78.1 78.0 77.8 77.8 77.5




All 79.0 79.1 79.9 79.7 79.6 79.9 79.4 78.7 78.8 78.5 78.6 78.2

ADJUSTED0-19 89.9 91.4 91.0 93.4 93.1 92.8 94.1 93.0 93.3 92.0 93.7 92.720-44 89.4 89.6 89.3 89.6 89.2 90.6 91.2 90.9 91.0 90.8 91.1 90.945-64 83.6 84.3 84.9 85.2 85.2 85.6 86.1 85.2 85.9 85.6 85.9 85.665-74 73.2 73.7 75.6 74.7 75.5 76.3 75.4 75.3 75.5 75.6 75.6 75.275+ 63.5 63.0 64.3 65.1 64.5 65.0 64.0 63.3 63.4 63.2 63.4 63.9

Male 76.8 77.0 78.6 78.5 78.4 79.5 79.6 79.2 79.7 79.4 79.7 79.6Female 78.4 79.1 79.5 79.8 80.0 80.3 80.0 79.3 79.4 79.5 79.6 79.5



All 77.6 78.0 79.0 79.1 79.2 79.9 79.8 79.3 79.6 79.5 79.7 79.6

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

TTable I.3 (continued)One-year survival probabilities: incident ESRD patientsfrom day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

586

Reference section I

Table I.4Two-year survival probabilities: incident ESRD patientsfrom day 91 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 87.0 90.9 85.7 83.0 85.0 82.8 84.7 86.1 77.0 80.6 80.05-9 92.6 91.5 93.3 94.3 93.5 94.1 94.3 97.3 97.0 96.0 94.210-14 95.5 95.1 96.8 97.1 95.5 95.3 96.1 98.2 93.6 93.9 94.015-19 95.1 92.9 93.4 92.7 93.9 93.8 93.1 95.1 95.2 96.7 95.520-29 86.4 87.7 88.8 87.5 88.2 86.8 89.0 86.2 88.4 88.6 87.730-39 80.8 81.3 80.7 82.6 80.3 80.7 81.1 81.3 82.7 82.2 82.440-49 77.4 77.1 76.8 76.5 77.8 78.1 77.4 78.1 79.1 78.4 80.050-59 70.9 70.7 71.0 68.6 67.9 68.1 68.7 69.3 69.7 70.7 70.960-64 63.9 62.1 62.0 62.1 59.5 59.3 61.1 60.0 61.2 61.9 62.365-69 55.0 56.0 55.9 52.4 55.4 53.1 53.9 55.4 56.2 56.2 56.770-79 47.0 49.1 49.5 44.4 46.7 47.0 46.4 45.7 46.7 47.9 48.080+ 30.9 33.4 37.8 30.4 36.6 35.8 35.1 32.9 33.3 37.7 37.0

Male 68.0 69.2 68.8 65.0 65.4 64.0 64.5 63.8 64.5 64.7 64.8Female 70.0 69.3 69.0 65.4 66.1 65.9 65.1 64.5 65.3 65.2 64.8




All 68.9 69.2 68.9 65.2 65.7 64.9 64.8 64.1 64.9 64.9 64.8

ADJUSTED0-19 89.6 87.5 88.0 86.8 87.6 86.6 87.3 90.6 86.8 89.1 87.820-44 78.1 79.7 80.2 80.6 80.3 80.2 81.0 80.3 82.0 81.8 82.145-64 66.1 65.6 66.4 65.4 64.9 65.2 66.4 66.6 67.7 69.1 69.665-74 50.5 52.4 53.6 48.6 51.8 50.4 51.0 52.0 53.3 53.7 54.275+ 38.9 41.8 40.4 36.1 40.3 41.0 40.2 38.2 38.9 42.2 41.8

Male 56.8 58.3 58.5 56.3 57.2 56.6 58.0 57.6 58.9 60.3 60.9Female 60.0 60.0 61.1 59.0 60.4 60.8 60.9 61.3 62.2 63.2 63.4



All 58.3 59.1 59.8 57.6 58.7 58.6 59.4 59.4 60.5 61.7 62.1


Table I.4Two-year survival probabilities: incident ESRD patientsfrom day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

587


Table I.4 (continued)Two-year survival probabilities: incident ESRD patientsfrom day 91 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 79.5 86.2 81.0 82.6 84.0 87.6 86.4 84.9 85.0 79.2 85.35-9 97.6 97.6 91.6 97.5 96.5 95.0 95.4 97.8 94.2 96.1 96.710-14 96.3 92.7 93.3 98.4 95.6 95.9 96.0 96.3 97.3 96.4 96.115-19 93.5 95.1 94.2 94.6 95.8 93.4 95.3 94.4 95.3 94.7 95.820-29 87.7 88.8 89.1 88.7 88.1 90.2 90.9 91.4 91.4 89.4 90.630-39 81.4 82.3 82.3 81.9 82.1 83.1 84.4 84.4 84.7 84.9 85.440-49 77.8 79.2 79.1 79.3 80.3 80.3 81.5 80.8 80.8 80.9 81.050-59 71.3 72.4 72.7 73.9 73.3 73.6 74.0 73.2 74.3 74.2 74.660-64 63.1 63.4 65.5 65.8 64.9 67.0 67.0 65.5 67.1 67.2 68.065-69 56.9 58.3 60.1 58.9 59.8 61.1 59.5 59.5 59.9 61.3 62.670-79 48.3 49.1 50.0 50.4 50.8 51.8 50.0 51.1 51.1 50.8 51.980+ 36.1 36.9 37.6 38.5 38.5 38.3 37.1 37.1 37.4 37.3 37.8

Male 64.2 64.6 65.9 65.6 65.8 66.0 65.4 65.3 65.5 65.5 66.0Female 64.0 64.9 64.8 65.0 64.8 65.1 63.9 63.6 63.7 63.3 64.2




All 64.1 64.8 65.4 65.3 65.3 65.6 64.7 64.5 64.7 64.5 65.2

ADJUSTED0-19 86.5 88.9 85.6 90.1 89.7 88.4 89.9 89.5 90.1 87.7 90.020-44 80.9 81.7 81.6 82.0 82.1 83.2 84.5 83.9 84.2 84.1 84.345-64 70.0 71.1 72.2 73.0 72.8 73.6 74.1 73.3 74.3 74.4 74.965-74 54.6 56.0 57.3 56.7 58.0 58.9 57.5 58.2 58.6 59.0 60.475+ 41.8 42.2 43.2 43.9 43.4 44.6 42.9 43.5 43.7 43.6 44.2

Male 61.0 61.9 63.6 63.8 64.1 65.2 65.1 65.3 66.0 66.2 66.7Female 63.4 64.6 64.8 65.4 65.5 66.4 65.8 65.6 65.9 65.9 66.9



All 62.2 63.3 64.2 64.6 64.8 65.8 65.5 65.5 66.0 66.1 66.8


Table I.4 (continued)Two-year survival probabilities: incident ESRD patientsfrom day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

588

Reference section I

Table I.5Three-year survival probabilities: incident ESRD patientsfrom day 91 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 84.8 89.4 84.7 80.2 82.2 82.1 80.9 82.5 74.8 78.5 79.25-9 92.6 90.4 92.4 92.0 91.7 92.1 93.4 95.5 96.0 96.0 92.010-14 94.4 90.3 93.7 94.8 93.7 93.4 94.7 96.3 92.3 92.9 93.115-19 92.7 91.0 92.1 91.8 92.2 91.2 91.2 92.9 93.4 93.8 93.620-29 82.2 83.4 84.6 83.9 84.0 82.9 84.5 82.5 85.2 84.8 83.830-39 76.0 75.4 73.3 76.1 74.2 74.6 75.4 74.8 77.0 76.5 76.740-49 69.1 69.2 68.9 67.9 69.6 70.0 69.1 70.3 71.4 70.2 71.550-59 60.5 60.0 59.2 57.3 57.1 56.2 57.3 58.7 58.9 59.6 60.060-64 51.9 50.0 48.7 49.3 46.8 46.8 47.2 47.4 49.1 49.2 49.565-69 40.5 43.1 42.3 38.3 41.6 39.9 40.2 41.5 42.9 42.1 42.370-79 33.6 34.3 35.0 30.0 32.5 32.6 31.9 32.0 33.1 33.9 33.380+ 18.7 20.7 18.9 18.2 21.3 21.8 20.9 21.5 20.1 23.0 22.3

Male 58.6 59.4 58.4 54.5 55.2 53.2 53.4 53.4 54.1 54.2 53.8Female 60.2 59.7 58.3 54.8 55.3 55.4 54.3 53.9 55.0 53.8 53.3




All 59.3 59.5 58.3 54.6 55.3 54.2 53.8 53.6 54.5 54.0 53.6

ADJUSTED0-19 86.7 83.4 85.1 84.1 84.5 83.3 84.1 86.9 84.2 85.8 85.420-44 72.0 73.1 72.9 73.9 74.1 73.8 74.8 74.0 76.0 75.8 76.045-64 54.5 54.2 54.2 53.4 53.2 53.4 54.2 55.5 56.8 57.7 58.365-74 36.4 38.6 38.9 34.1 38.1 36.8 36.6 38.0 39.8 39.6 39.875+ 25.3 27.5 25.9 22.8 24.9 26.2 26.3 25.6 25.3 28.1 26.9

Male 45.9 46.8 46.6 44.5 45.9 45.0 46.0 46.6 47.8 49.2 49.3Female 48.7 49.0 49.0 47.6 48.9 49.7 49.6 50.2 51.4 51.6 51.7



All 47.2 47.9 47.7 46.0 47.3 47.2 47.7 48.3 49.5 50.3 50.5

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.5Three-year survival probabilities: incident ESRD patientsfrom day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

589


Table I.5 (continued)Three-year survival probabilities: incident ESRD patientsfrom day 91 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 77.8 83.4 77.7 81.9 82.7 84.3 82.8 84.3 83.2 75.55-9 97.6 96.8 90.1 96.2 95.1 90.7 95.4 97.1 93.5 94.110-14 94.2 90.6 91.3 95.7 94.9 94.4 95.0 96.3 96.6 95.415-19 92.3 93.5 92.3 93.2 93.3 91.5 92.6 92.3 92.6 93.120-29 84.2 85.2 85.3 85.1 84.2 87.0 87.8 88.1 87.4 85.830-39 75.5 75.8 76.6 76.5 76.5 77.9 78.9 79.2 79.2 79.940-49 69.8 71.1 71.0 71.6 72.4 72.5 73.8 72.8 73.4 73.250-59 60.2 60.6 61.7 62.6 62.6 62.8 63.8 63.4 64.2 64.660-64 50.4 50.3 52.2 53.1 52.4 53.8 55.1 53.9 54.7 55.765-69 42.9 43.8 45.7 45.3 46.3 46.6 46.2 46.4 46.9 48.570-79 34.2 34.1 35.7 35.4 36.0 37.1 35.8 36.6 36.9 37.380+ 21.9 22.8 23.1 23.3 23.3 24.4 23.1 22.4 23.1 23.9

Male 53.5 53.0 54.6 54.4 54.9 54.8 54.4 54.4 54.5 54.8Female 52.5 53.2 53.3 53.2 53.0 53.2 52.8 52.2 52.3 52.5




All 53.0 53.1 54.0 53.8 54.0 54.1 53.6 53.4 53.5 53.7

ADJUSTED0-19 84.3 86.1 82.3 87.5 86.9 84.7 86.6 87.6 87.2 84.720-44 75.0 75.5 75.6 76.1 76.0 77.7 78.8 78.3 78.3 78.345-64 58.9 59.5 61.0 62.1 62.2 62.8 64.1 63.4 64.3 64.965-74 40.5 41.5 43.0 42.5 44.1 44.8 43.9 44.6 45.4 46.275+ 27.8 27.4 28.7 28.9 28.4 29.8 28.8 28.9 29.3 30.0

Male 49.9 49.9 52.0 52.3 52.9 53.9 54.1 54.4 55.1 55.7Female 52.0 53.0 53.4 53.9 54.1 54.9 55.0 54.7 55.0 55.7



All 50.9 51.4 52.7 53.1 53.5 54.4 54.6 54.6 55.1 55.7

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.5 (continued)Three-year survival probabilities: incident ESRD patientsfrom day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

590

Reference section I

Table I.6Five-year survival probabilities: incident ESRD patientsfrom day 91 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 80.4 80.3 80.6 77.4 76.6 79.1 76.3 78.1 74.1 77.1 76.05-9 88.3 88.3 86.7 89.7 89.8 90.1 90.2 95.5 93.9 91.9 89.110-14 88.1 85.4 91.4 91.4 91.0 90.6 91.8 95.4 89.5 88.3 88.515-19 89.9 87.4 87.9 89.0 86.8 85.2 87.6 88.5 88.3 89.3 89.820-29 77.5 76.3 78.6 76.3 76.5 75.9 78.8 76.9 78.7 77.8 77.730-39 65.3 65.9 64.5 65.7 65.2 64.9 66.4 64.1 67.8 68.1 67.640-49 56.0 55.5 55.7 53.8 57.0 56.7 57.3 58.2 58.7 57.4 58.150-59 42.4 43.2 41.9 40.6 40.3 40.0 41.7 43.2 42.1 42.2 42.260-64 32.0 32.2 30.4 30.3 28.0 28.6 30.2 29.2 31.1 30.7 31.465-69 23.6 25.2 24.4 20.9 22.7 22.8 22.3 23.4 23.7 23.9 23.770-79 16.1 16.4 17.5 14.1 15.5 15.8 15.1 15.8 15.9 16.5 15.980+ 7.5 6.5 6.5 6.4 7.5 8.0 7.6 7.7 7.1 9.1 9.0

Male 44.7 44.6 44.2 40.1 40.5 39.4 40.1 39.5 39.9 39.8 39.2Female 45.0 45.8 44.0 40.1 40.7 40.2 39.7 39.0 39.4 38.0 37.3




All 44.9 45.1 44.1 40.1 40.6 39.8 39.9 39.3 39.7 39.0 38.3

ADJUSTED0-19 80.9 77.4 79.4 80.1 78.3 77.1 79.2 82.4 79.3 80.2 80.020-44 61.5 62.4 62.9 62.4 64.0 63.6 65.6 64.0 65.9 66.6 66.645-64 36.1 36.8 36.9 36.1 36.1 36.4 38.5 39.2 40.2 40.5 40.765-74 19.2 20.8 21.0 17.4 19.4 19.8 19.1 20.6 21.2 21.6 21.675+ 10.8 11.0 11.0 8.9 10.5 11.1 10.9 10.7 10.4 12.2 11.2

Male 31.3 31.3 31.8 29.8 30.9 31.1 32.4 32.5 33.3 34.6 34.4Female 32.8 34.5 34.2 32.7 34.0 34.2 34.7 35.2 35.6 35.7 35.7



All 32.0 32.8 32.9 31.2 32.3 32.6 33.5 33.8 34.4 35.1 35.0

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.6Five-year survival probabilities: incident ESRD patientsfrom day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

591


Table I.6 (continued)Five-year survival probabilities: incident ESRD patientsfrom day 91 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 19980-4 76.6 81.4 75.4 79.7 79.0 82.0 79.9 80.75-9 95.1 93.5 87.8 94.9 93.8 90.0 95.4 94.910-14 91.7 87.8 88.3 92.9 93.4 92.9 92.4 92.615-19 87.7 90.9 88.7 90.3 90.3 88.0 89.6 88.320-29 78.4 78.8 79.7 79.8 78.8 81.4 82.0 81.830-39 66.3 66.5 67.8 67.4 67.8 68.6 70.1 70.240-49 56.9 58.6 58.6 58.6 59.9 59.2 60.7 60.050-59 43.7 43.4 44.9 45.5 45.5 45.5 46.9 46.760-64 31.1 32.1 33.3 33.9 33.3 34.7 36.1 35.665-69 22.9 24.7 25.2 26.1 25.9 26.6 26.0 27.370-79 16.3 16.1 16.9 16.8 17.5 18.2 17.5 18.480+ 7.9 7.7 8.1 8.4 8.9 8.8 8.4 8.4

Male 38.5 38.2 39.4 39.0 39.7 39.2 38.7 39.0Female 36.4 36.9 36.8 36.9 36.4 36.2 36.2 36.1




All 37.5 37.6 38.2 38.0 38.1 37.8 37.6 37.7

ADJUSTED0-19 79.8 82.4 78.2 83.9 83.4 81.4 83.2 82.520-44 65.5 65.9 66.6 67.0 66.9 67.8 69.0 68.645-64 41.9 42.7 44.2 45.0 45.3 45.9 47.5 47.265-74 21.3 22.6 23.2 23.7 24.1 25.0 24.4 25.675+ 11.7 10.7 11.6 11.5 12.3 12.8 12.3 12.9

Male 34.7 34.9 36.5 36.7 37.5 38.1 38.3 38.9Female 36.0 36.8 37.1 37.7 37.8 38.4 38.8 39.0



All 35.3 35.9 36.8 37.2 37.7 38.3 38.6 39.0

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.6 (continued)Five-year survival probabilities: incident ESRD patientsfrom day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

592

Reference section I

Table I.7Ten-year survival probabilities: incident ESRD patientsfrom day 91 to ten years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 19930-4 76.1 69.7 76.5 72.6 72.9 72.4 74.8 76.6 65.9 74.3 71.2 72.5 75.9 73.75-9 80.9 79.8 79.0 82.8 87.0 83.2 86.1 83.9 89.9 85.5 84.8 90.2 89.5 80.210-14 79.1 77.8 77.5 82.4 82.8 82.5 85.5 89.4 80.9 80.2 79.8 86.3 81.6 82.015-19 80.0 79.0 79.3 81.1 78.5 76.7 78.5 78.8 80.3 83.2 82.6 79.1 80.4 79.820-29 64.4 62.1 65.1 63.7 64.2 64.1 65.8 65.0 67.2 64.6 65.9 64.7 66.1 68.930-39 47.2 47.7 48.1 49.4 49.1 47.7 49.6 47.9 49.7 50.1 50.8 49.6 50.6 51.040-49 33.7 32.7 33.7 34.1 36.1 35.9 36.5 36.2 36.6 34.8 36.1 35.0 37.3 37.550-59 16.7 18.1 18.4 16.7 17.6 18.3 19.1 19.9 18.3 18.5 18.6 19.7 19.6 19.960-64 8.7 8.8 7.4 8.9 8.8 9.6 9.2 9.0 9.6 9.1 9.2 9.6 10.1 10.465-69 4.9 5.9 4.5 4.9 5.6 6.4 5.2 5.0 5.3 5.0 5.5 4.9 5.1 5.870-79 2.8 2.5 3.0 2.4 3.0 2.9 2.4 2.8 2.7 2.4 2.1 2.1 2.2 2.580+ 1.9 1.0 1.9 0.2 1.4 0.9 0.9 0.9 0.6 0.8 0.5 0.8 0.6 0.7

Male 25.5 25.6 26.0 23.6 24.2 23.5 23.8 22.9 22.5 21.9 22.0 20.8 21.2 21.7Female 25.7 25.6 24.7 22.2 23.0 22.5 21.5 20.6 21.0 19.4 18.6 18.3 18.3 18.2



All 25.6 25.6 25.4 23.0 23.6 23.0 22.8 21.9 21.8 20.7 20.4 19.6 19.8 20.0

ADJUSTED0-19 68.2 66.0 66.4 69.2 68.8 66.4 70.0 71.4 68.8 72.0 70.8 70.7 71.4 69.020-44 43.4 43.3 45.1 45.7 47.0 46.7 48.1 46.8 48.2 48.4 49.0 48.0 49.1 49.945-64 13.3 14.1 14.7 14.4 15.5 16.1 17.1 17.5 17.4 17.5 17.7 18.6 19.7 20.365-74 3.7 4.1 3.8 3.6 4.5 5.0 4.1 4.2 4.3 4.2 4.5 4.1 4.5 5.075+ 2.0 1.7 2.0 1.1 1.9 1.5 1.4 1.7 1.6 1.4 1.0 1.3 1.2 1.4

Male 14.9 14.9 15.7 15.2 16.1 16.6 17.1 17.0 16.9 17.2 17.6 17.4 18.1 18.8Female 16.1 16.8 16.7 16.3 17.6 17.6 17.3 17.6 17.9 17.5 17.4 17.9 18.2 18.6



All 15.5 15.8 16.2 15.7 16.8 17.1 17.2 17.3 17.3 17.3 17.5 17.6 18.1 18.7

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age, gender, or of age >110 are excluded. Includes U.S. & territories; no unknown or foreign states.


UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 19930-4 76.1 69.7 76.5 72.6 72.9 72.4 74.8 76.6 65.9 74.3 71.2 72.5 75.9 73.75-9 80.9 79.8 79.0 82.8 87.0 83.2 86.1 83.9 89.9 85.5 84.8 90.2 89.5 80.210-14 79.1 77.8 77.5 82.4 82.8 82.5 85.5 89.4 80.9 80.2 79.8 86.3 81.6 82.015-19 80.0 79.0 79.3 81.1 78.5 76.7 78.5 78.8 80.3 83.2 82.6 79.1 80.4 79.820-29 64.4 62.1 65.1 63.7 64.2 64.1 65.8 65.0 67.2 64.6 65.9 64.7 66.1 68.930-39 47.2 47.7 48.1 49.4 49.1 47.7 49.6 47.9 49.7 50.1 50.8 49.6 50.6 51.040-49 33.7 32.7 33.7 34.1 36.1 35.9 36.5 36.2 36.6 34.8 36.1 35.0 37.3 37.550-59 16.7 18.1 18.4 16.7 17.6 18.3 19.1 19.9 18.3 18.5 18.6 19.7 19.6 19.960-64 8.7 8.8 7.4 8.9 8.8 9.6 9.2 9.0 9.6 9.1 9.2 9.6 10.1 10.465-69 4.9 5.9 4.5 4.9 5.6 6.4 5.2 5.0 5.3 5.0 5.5 4.9 5.1 5.870-79 2.8 2.5 3.0 2.4 3.0 2.9 2.4 2.8 2.7 2.4 2.1 2.1 2.2 2.580+ 1.9 1.0 1.9 0.2 1.4 0.9 0.9 0.9 0.6 0.8 0.5 0.8 0.6 0.7

Male 25.5 25.6 26.0 23.6 24.2 23.5 23.8 22.9 22.5 21.9 22.0 20.8 21.2 21.7Female 25.7 25.6 24.7 22.2 23.0 22.5 21.5 20.6 21.0 19.4 18.6 18.3 18.3 18.2



All 25.6 25.6 25.4 23.0 23.6 23.0 22.8 21.9 21.8 20.7 20.4 19.6 19.8 20.0

ADJUSTED0-19 68.2 66.0 66.4 69.2 68.8 66.4 70.0 71.4 68.8 72.0 70.8 70.7 71.4 69.020-44 43.4 43.3 45.1 45.7 47.0 46.7 48.1 46.8 48.2 48.4 49.0 48.0 49.1 49.945-64 13.3 14.1 14.7 14.4 15.5 16.1 17.1 17.5 17.4 17.5 17.7 18.6 19.7 20.365-74 3.7 4.1 3.8 3.6 4.5 5.0 4.1 4.2 4.3 4.2 4.5 4.1 4.5 5.075+ 2.0 1.7 2.0 1.1 1.9 1.5 1.4 1.7 1.6 1.4 1.0 1.3 1.2 1.4

Male 14.9 14.9 15.7 15.2 16.1 16.6 17.1 17.0 16.9 17.2 17.6 17.4 18.1 18.8Female 16.1 16.8 16.7 16.3 17.6 17.6 17.3 17.6 17.9 17.5 17.4 17.9 18.2 18.6



All 15.5 15.8 16.2 15.7 16.8 17.1 17.2 17.3 17.3 17.3 17.5 17.6 18.1 18.7

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.


593


Table I.8Incident patient counts: dialysis patients, unknowns dropped dialysis patients alive on day 91, by age, gender, race, ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 27 44 59 82 80 104 99 96 96 108 915-9 62 56 69 64 76 55 78 75 67 77 9110-14 129 134 173 159 149 148 130 133 140 117 14615-19 331 370 351 369 336 343 324 341 387 402 37120-29 1,218 1,384 1,577 1,534 1,690 1,726 1,789 1,767 1,904 2,078 2,14830-39 1,869 2,095 2,368 2,450 2,655 2,832 3,011 3,180 3,548 3,904 4,09640-49 2,101 2,407 2,573 2,889 3,022 3,301 3,490 3,931 4,405 5,023 5,44350-59 3,242 3,892 4,222 4,360 4,639 4,986 5,188 5,610 6,440 7,019 7,51060-64 1,816 2,122 2,459 2,859 3,154 3,504 3,644 4,135 4,524 4,965 5,48865-69 1,749 1,848 2,135 2,819 2,956 3,347 3,843 4,364 4,921 5,740 6,37870-79 1,925 2,086 2,679 3,807 3,969 4,658 5,356 6,179 6,779 8,190 9,18880+ 314 339 489 769 814 1,033 1,265 1,449 1,791 2,246 2,625

Male 8,163 9,179 10,407 12,065 12,944 14,011 15,257 16,753 18,555 21,291 23,144Female 6,620 7,598 8,747 10,096 10,596 12,026 12,960 14,507 16,447 18,578 20,431




All 14,783 16,777 19,154 22,161 23,540 26,037 28,217 31,260 35,002 39,869 43,575

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90 day rule.The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age, gender, race, or primary cause of ESRD are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.8 (continued)Incident patient counts: dialysis patients, unknowns dropped dialysis patients alive on day 91, by age, gender, race, ethnicity, & primary diagnosis

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 128 109 120 105 126 128 128 138 122 152 154 1435-9 66 65 67 104 90 92 87 89 103 99 98 10710-14 158 169 160 179 179 191 186 175 198 205 197 24115-19 366 431 406 362 420 430 412 420 446 433 419 41020-29 2,181 2,330 2,326 2,357 2,269 2,310 2,253 2,311 2,218 2,273 2,248 2,19130-39 4,314 4,655 4,688 5,018 4,937 5,055 5,036 4,971 5,206 4,997 4,989 4,98640-49 6,153 6,650 7,114 7,489 8,046 8,594 8,631 9,317 9,493 9,716 9,685 9,99050-59 8,179 9,080 9,587 10,776 10,976 11,585 12,621 13,646 14,715 15,129 15,820 16,43860-64 6,039 6,336 6,654 7,068 7,332 7,674 8,107 8,569 8,778 9,003 9,320 9,53365-69 7,072 7,683 7,976 8,585 8,595 9,394 9,646 9,925 10,050 10,084 10,332 10,58870-79 10,784 12,107 12,733 14,199 14,597 16,475 17,633 18,661 19,726 20,131 20,225 21,32080+ 3,032 3,584 3,930 4,438 4,791 5,699 6,461 7,082 8,008 8,616 8,985 10,503

Male 25,599 27,813 29,440 31,822 32,636 35,832 37,667 39,845 42,044 43,052 44,122 46,819Female 22,873 25,386 26,321 28,858 29,722 31,795 33,534 35,459 37,019 37,786 38,350 39,631




All 48,472 53,199 55,761 60,680 62,358 67,627 71,201 75,304 79,063 80,838 82,472 86,450



PATIENT SURVIVALI

594

Reference section I


1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 27 44 59 82 80 104 99 96 96 108 915-9 62 56 69 64 76 55 78 75 67 77 9110-14 129 134 173 159 149 148 130 133 140 117 14615-19 331 370 351 369 336 343 324 341 387 402 37120-29 1,218 1,384 1,577 1,534 1,690 1,726 1,789 1,767 1,904 2,078 2,14830-39 1,869 2,095 2,368 2,450 2,655 2,832 3,011 3,180 3,548 3,904 4,09640-49 2,101 2,407 2,573 2,889 3,022 3,301 3,490 3,931 4,405 5,023 5,44350-59 3,242 3,892 4,222 4,360 4,639 4,986 5,188 5,610 6,440 7,019 7,51060-64 1,816 2,122 2,459 2,859 3,154 3,504 3,644 4,135 4,524 4,965 5,48865-69 1,749 1,848 2,135 2,819 2,956 3,347 3,843 4,364 4,921 5,740 6,37870-79 1,925 2,086 2,679 3,807 3,969 4,658 5,356 6,179 6,779 8,190 9,18880+ 314 339 489 769 814 1,033 1,265 1,449 1,791 2,246 2,625

Male 8,163 9,179 10,407 12,065 12,944 14,011 15,257 16,753 18,555 21,291 23,144Female 6,620 7,598 8,747 10,096 10,596 12,026 12,960 14,507 16,447 18,578 20,431




All 14,783 16,777 19,154 22,161 23,540 26,037 28,217 31,260 35,002 39,869 43,575



1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 128 109 120 105 126 128 128 138 122 152 154 1435-9 66 65 67 104 90 92 87 89 103 99 98 10710-14 158 169 160 179 179 191 186 175 198 205 197 24115-19 366 431 406 362 420 430 412 420 446 433 419 41020-29 2,181 2,330 2,326 2,357 2,269 2,310 2,253 2,311 2,218 2,273 2,248 2,19130-39 4,314 4,655 4,688 5,018 4,937 5,055 5,036 4,971 5,206 4,997 4,989 4,98640-49 6,153 6,650 7,114 7,489 8,046 8,594 8,631 9,317 9,493 9,716 9,685 9,99050-59 8,179 9,080 9,587 10,776 10,976 11,585 12,621 13,646 14,715 15,129 15,820 16,43860-64 6,039 6,336 6,654 7,068 7,332 7,674 8,107 8,569 8,778 9,003 9,320 9,53365-69 7,072 7,683 7,976 8,585 8,595 9,394 9,646 9,925 10,050 10,084 10,332 10,58870-79 10,784 12,107 12,733 14,199 14,597 16,475 17,633 18,661 19,726 20,131 20,225 21,32080+ 3,032 3,584 3,930 4,438 4,791 5,699 6,461 7,082 8,008 8,616 8,985 10,503

Male 25,599 27,813 29,440 31,822 32,636 35,832 37,667 39,845 42,044 43,052 44,122 46,819Female 22,873 25,386 26,321 28,858 29,722 31,795 33,534 35,459 37,019 37,786 38,350 39,631




All 48,472 53,199 55,761 60,680 62,358 67,627 71,201 75,304 79,063 80,838 82,472 86,450



595


Table I.990-day survival probabilities: incident dialysis patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 97.4 100.0 97.4 100.0 97.8 100.0 96.6 95.6 96.4 95.9 84.35-9 100.0 98.6 100.0 98.6 98.9 98.7 100.0 100.0 96.2 97.8 93.910-14 99.4 100.0 100.0 100.0 98.9 100.0 100.0 100.0 100.0 99.3 89.015-19 99.5 99.5 100.0 99.5 99.7 99.7 99.7 100.0 99.1 99.1 92.220-29 99.1 99.2 99.4 98.9 98.7 99.3 99.2 99.0 98.9 98.8 98.130-39 98.3 98.8 98.6 98.9 98.6 98.5 98.0 98.1 98.4 98.2 97.540-49 98.4 98.0 98.4 97.8 98.3 98.1 98.1 97.8 98.2 97.9 97.450-59 97.3 97.2 96.8 96.3 97.1 96.4 96.8 97.0 96.8 97.0 96.460-64 95.0 95.2 94.7 95.0 95.2 94.3 94.0 95.1 94.7 95.0 94.265-69 90.9 91.1 90.0 91.6 90.0 90.3 91.6 91.2 92.3 92.1 92.270-79 87.2 88.4 87.7 88.4 87.8 87.2 88.0 89.3 88.2 88.7 89.180+ 83.8 84.9 84.6 83.4 83.5 82.5 84.5 83.7 85.8 83.8 83.9

Male 94.8 95.0 94.4 94.1 94.1 93.4 93.5 93.7 93.6 93.5 93.0Female 95.1 95.5 95.0 94.5 94.2 93.8 94.1 94.2 94.3 93.9 93.6




All 94.9 95.3 94.7 94.3 94.1 93.6 93.8 94.0 93.9 93.7 93.2

ADJUSTED0-19 98.8 99.2 99.5 99.2 98.4 99.5 98.6 98.6 97.2 97.1 82.520-44 98.8 98.9 98.8 98.9 98.8 98.7 98.4 98.3 98.6 98.3 97.845-64 97.3 97.0 96.6 96.2 96.7 96.0 96.1 96.5 96.3 96.4 95.765-74 91.1 91.2 89.9 91.4 89.9 89.8 91.0 91.3 91.3 91.6 91.475+ 87.6 88.1 87.7 87.2 87.2 86.3 87.0 87.4 87.4 86.5 87.1

Male 94.2 94.1 93.4 93.6 93.4 92.8 93.1 93.4 93.3 93.3 92.8Female 94.4 94.6 94.0 94.0 93.6 93.3 93.7 94.0 94.0 93.8 93.4



All 94.3 94.3 93.7 93.8 93.5 93.0 93.4 93.7 93.6 93.5 93.1

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.990-day survival probabilities: incident dialysis patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

596

Reference section I

Table I.9 (continued)90-day survival probabilities: incident dialysis patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 97.3 96.7 97.3 96.0 96.5 97.8 97.1 96.0 92.8 97.0 96.4 97.55-9 98.8 100.0 100.0 98.4 99.1 98.0 100.0 100.0 98.2 99.2 98.2 98.410-14 97.9 100.0 99.5 98.1 99.5 100.0 99.1 100.0 99.6 99.1 99.6 99.615-19 98.8 99.8 99.3 98.6 99.8 99.2 99.3 99.4 98.6 99.2 98.3 99.220-29 98.5 97.8 98.3 97.7 97.2 98.3 98.1 98.6 98.5 98.3 98.7 98.230-39 97.7 97.5 97.2 97.0 97.4 97.2 97.5 97.6 97.8 97.5 97.8 97.740-49 98.0 97.6 97.2 97.0 96.7 96.7 96.6 96.8 96.6 96.9 96.9 96.650-59 96.7 96.9 96.0 95.7 95.8 95.7 96.0 95.6 95.2 95.7 95.2 95.760-64 94.7 94.5 94.5 93.7 93.9 93.8 93.6 93.4 93.8 93.7 93.4 93.865-69 92.2 92.4 92.8 92.6 92.7 92.8 92.1 92.3 92.5 91.9 92.3 92.570-79 89.5 89.6 89.1 89.6 89.2 89.0 88.5 88.7 88.7 88.9 88.2 88.780+ 84.9 85.3 84.7 84.0 83.8 84.3 82.9 82.4 82.4 82.8 82.3 83.0

Male 93.4 93.2 93.1 92.7 92.8 92.6 92.2 92.0 92.0 92.2 91.7 92.1Female 93.9 94.0 93.4 93.1 92.9 92.8 92.2 92.2 92.0 91.8 91.8 91.7




All 93.6 93.6 93.2 92.9 92.8 92.7 92.2 92.1 92.0 92.0 91.7 91.9

ADJUSTED0-19 96.7 98.8 98.2 96.2 98.2 98.1 98.0 98.0 96.0 97.7 96.7 98.020-44 98.1 97.8 97.7 97.4 97.4 97.5 97.7 97.8 97.8 97.8 97.9 97.845-64 96.2 96.1 95.6 95.2 95.3 95.2 95.2 95.0 95.0 95.2 94.9 95.265-74 91.5 91.8 91.8 91.9 91.6 91.6 91.1 91.3 91.3 91.1 91.0 91.375+ 87.9 87.8 87.0 86.8 86.7 86.8 85.8 85.6 85.7 85.9 85.4 85.9

Male 93.3 93.2 93.1 92.8 92.9 92.9 92.6 92.5 92.7 92.8 92.3 92.8Female 93.9 94.0 93.5 93.3 93.1 93.1 92.7 92.8 92.6 92.6 92.6 92.6



All 93.6 93.6 93.2 93.0 93.0 93.0 92.7 92.6 92.6 92.7 92.5 92.8


Table I.9 (continued)90-day survival probabilities: incident dialysis patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

597


Table I.10One-year survival probabilities: incident dialysis patientscensored at transplant, from day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 96.2 92.7 89.4 89.8 85.3 85.2 90.3 92.5 79.4 83.6 79.25-9 93.1 92.3 95.9 98.1 90.2 90.1 100.0 100.0 98.4 98.6 93.910-14 96.4 98.5 97.8 98.4 96.8 97.7 99.0 99.0 95.5 97.1 95.515-19 96.0 94.6 95.4 94.6 96.8 93.5 94.2 95.7 98.0 98.4 97.120-29 90.9 92.6 92.4 92.5 92.6 90.9 93.3 90.7 92.0 91.5 91.330-39 89.2 89.1 88.5 89.6 87.2 88.1 88.2 87.7 88.4 88.1 89.040-49 87.8 87.5 86.6 87.4 87.5 87.0 86.6 87.0 87.8 87.9 88.450-59 83.9 83.6 84.0 81.6 81.8 82.1 82.3 83.1 83.5 83.2 84.060-64 78.5 77.8 78.3 77.7 76.1 76.4 77.2 76.3 77.0 77.7 78.365-69 72.9 73.6 74.0 72.1 72.9 71.3 73.0 73.0 73.4 74.0 75.570-79 67.1 68.1 68.6 65.3 66.6 66.9 66.2 65.3 66.2 67.4 68.480+ 58.1 53.6 62.0 54.9 56.3 57.9 58.6 55.3 55.7 58.0 59.6

Male 80.4 80.9 80.5 77.7 77.7 77.2 76.9 76.8 76.8 77.5 78.4Female 81.4 81.0 81.1 78.7 78.9 78.3 78.8 77.2 78.7 78.3 78.6




All 80.8 80.9 80.8 78.2 78.2 77.7 77.7 77.0 77.7 77.8 78.5

ADJUSTED0-19 92.4 90.9 91.6 91.0 89.7 87.2 91.3 93.3 90.4 92.8 89.220-44 87.7 88.6 88.3 88.7 87.8 87.7 88.2 87.6 88.4 87.8 88.745-64 81.2 80.7 81.3 80.1 79.9 80.1 80.7 80.8 81.4 82.1 82.765-74 70.2 70.9 72.5 69.3 70.4 69.4 70.4 70.4 71.2 72.0 73.475+ 61.2 62.2 62.1 58.8 61.1 62.3 62.0 59.4 60.2 62.5 63.5

Male 75.2 75.8 75.8 73.7 73.9 73.9 74.1 74.2 74.4 75.5 76.8Female 76.4 76.2 77.2 75.6 76.1 75.9 76.9 75.8 77.2 77.5 78.1



All 75.8 76.0 76.5 74.6 74.9 74.9 75.5 75.0 75.7 76.5 77.4

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.10One-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

598

Reference section I

Table I.10 (continued)One-year survival probabilities: incident dialysis patientscensored at transplant, from day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 77.9 86.2 83.0 84.9 84.9 87.4 86.0 85.4 81.9 80.1 85.2 87.95-9 95.8 94.0 92.2 100.0 97.8 91.9 97.4 100.0 96.9 95.7 96.9 91.310-14 97.1 92.1 94.3 98.7 97.4 95.9 96.3 97.2 96.7 96.3 97.6 95.315-19 95.6 96.6 96.6 95.3 97.2 96.3 97.8 95.5 97.3 97.3 96.9 96.720-29 92.0 92.7 91.8 91.7 91.5 93.4 94.9 94.1 94.6 92.9 94.2 93.130-39 88.1 88.7 88.0 88.7 87.3 89.2 90.1 90.1 90.0 90.1 90.5 90.840-49 86.9 87.3 88.0 87.7 88.5 88.9 89.4 88.2 88.9 88.8 88.3 88.250-59 83.8 84.8 84.7 85.6 85.3 85.0 85.4 85.0 85.6 85.0 85.4 85.260-64 79.1 79.1 80.8 80.6 79.8 81.5 81.6 79.8 80.9 80.5 81.3 80.665-69 75.2 75.5 77.1 76.2 76.9 77.8 76.7 76.2 76.4 76.9 76.6 76.570-79 68.2 68.5 69.9 70.0 70.2 70.9 69.8 70.0 69.6 69.5 69.7 69.580+ 59.3 58.5 61.0 61.0 60.3 60.2 59.5 57.5 58.4 57.9 57.9 58.9

Male 77.8 77.8 79.1 78.9 78.6 79.2 78.8 78.3 78.5 78.1 78.4 77.9Female 78.0 78.4 78.8 78.8 78.8 78.9 78.2 77.3 77.3 77.0 77.0 76.7




All 77.9 78.1 79.0 78.9 78.7 79.1 78.5 77.8 77.9 77.6 77.7 77.4

ADJUSTED0-19 87.2 89.2 88.5 91.3 91.4 90.3 92.2 90.5 91.2 89.4 91.4 90.320-44 87.8 88.1 87.7 88.2 87.7 89.4 90.1 89.6 89.9 89.7 89.8 89.745-64 82.8 83.6 84.4 84.6 84.5 84.9 85.4 84.5 85.2 84.8 85.2 84.965-74 73.1 73.7 75.5 74.6 75.4 76.2 75.3 75.2 75.3 75.4 75.3 74.975+ 63.5 63.0 64.3 65.1 64.5 64.9 64.0 63.3 63.4 63.2 63.4 63.9

Male 76.6 76.8 78.3 78.3 78.1 79.2 79.2 78.8 79.3 79.0 79.2 79.1Female 77.9 78.5 79.0 79.2 79.4 79.7 79.4 78.6 78.7 78.7 78.8 78.7



All 77.2 77.6 78.6 78.7 78.7 79.5 79.3 78.7 79.0 78.9 79.0 78.9

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.10 (continued)One-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

599


Table I.11Two-year survival probabilities: incident dialysis patientscensored at transplant, from day 91 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 84.5 90.0 86.2 82.6 83.2 77.7 79.0 82.4 71.5 77.1 71.05-9 89.5 92.3 91.1 89.2 85.7 90.1 86.7 100.0 98.4 95.5 86.810-14 95.0 94.8 94.3 96.9 90.8 94.9 95.8 99.0 90.2 95.9 90.915-19 94.2 90.2 91.8 90.1 93.6 90.7 89.6 93.8 94.3 95.9 94.120-29 82.8 84.6 84.8 83.4 84.3 80.8 85.0 81.7 85.3 84.9 83.830-39 78.8 79.8 77.7 80.2 75.9 75.9 75.9 76.8 78.9 78.2 78.640-49 76.6 75.8 75.5 75.0 75.2 75.2 74.2 74.2 76.2 75.8 78.150-59 70.8 70.4 70.5 67.8 66.8 66.8 66.9 67.4 68.1 69.3 69.460-64 64.1 61.9 61.9 61.9 59.1 58.8 60.6 59.3 60.5 61.0 61.565-69 55.0 55.9 55.9 52.3 55.3 53.0 53.8 55.2 56.0 55.9 56.470-79 47.0 49.0 49.5 44.4 46.6 47.0 46.4 45.6 46.7 47.8 47.980+ 31.0 33.6 37.8 30.4 36.6 35.8 35.1 32.9 33.3 37.7 37.0

Male 65.2 66.0 65.1 61.2 61.4 59.4 59.9 59.5 60.6 61.3 61.5Female 67.9 67.2 66.6 63.0 63.2 62.9 62.0 61.4 62.7 62.6 62.5




All 66.4 66.6 65.8 62.0 62.2 61.1 60.9 60.4 61.6 61.9 62.0

ADJUSTED0-19 88.3 84.6 85.7 83.4 83.5 82.0 81.2 89.2 83.5 88.2 82.220-44 75.7 78.1 77.3 77.8 75.8 75.1 76.3 75.9 78.2 77.7 78.645-64 67.0 65.7 66.3 65.0 63.9 63.9 64.8 64.7 65.9 67.3 68.065-74 50.9 52.6 53.8 48.7 51.9 50.5 51.0 52.0 53.2 53.6 54.075+ 38.9 41.9 40.5 36.2 40.3 40.9 40.2 38.1 38.9 42.2 41.8

Male 57.9 59.0 58.8 56.0 56.6 55.6 56.8 56.4 57.7 59.2 59.7Female 60.9 60.7 61.2 58.8 59.7 60.0 59.9 60.0 61.1 62.0 62.2



All 59.3 59.8 59.9 57.3 58.1 57.7 58.2 58.1 59.4 60.5 60.9

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.11Two-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

600

Reference section I

Table I.11 (continued)Two-year survival probabilities: incident dialysis patientscensored at transplant, from day 91 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 75.2 83.0 75.7 76.8 79.4 82.4 80.3 79.0 80.7 70.7 77.65-9 95.8 94.0 85.8 96.1 97.8 90.0 97.4 94.1 92.9 95.7 93.610-14 96.0 87.8 90.6 96.6 94.3 93.1 92.2 93.4 96.7 94.7 93.015-19 92.0 94.7 91.9 93.0 94.0 90.3 92.7 91.9 92.7 91.5 93.520-29 84.3 85.9 86.0 86.0 85.3 87.5 88.7 89.3 89.4 87.2 88.630-39 77.3 78.7 78.9 78.6 78.9 80.2 81.9 81.4 82.2 82.4 83.140-49 74.5 76.6 76.4 77.1 78.3 78.2 79.4 78.5 78.8 78.8 78.950-59 69.6 70.8 71.3 72.6 71.8 72.3 72.4 71.6 72.8 72.6 73.060-64 62.4 62.6 64.9 65.1 64.0 66.1 66.1 64.5 66.3 66.2 67.065-69 56.6 58.0 59.8 58.6 59.4 60.6 58.9 59.1 59.3 60.6 61.870-79 48.3 49.0 49.9 50.3 50.7 51.7 49.9 51.0 51.0 50.6 51.780+ 36.1 36.9 37.6 38.5 38.4 38.3 37.1 37.1 37.4 37.2 37.8

Male 61.1 61.8 63.2 63.2 63.2 63.6 63.0 63.0 63.4 63.4 63.8Female 61.6 62.7 62.8 63.0 62.8 63.4 62.1 61.7 61.9 61.4 62.5




All 61.3 62.2 63.0 63.1 63.0 63.5 62.6 62.4 62.7 62.5 63.2

ADJUSTED0-19 83.0 85.5 80.6 85.8 85.9 82.5 84.7 83.8 86.3 81.6 84.420-44 76.7 78.0 77.7 78.4 78.6 79.9 81.7 80.8 81.5 81.5 81.645-64 68.1 69.3 70.6 71.4 71.0 71.9 72.3 71.4 72.6 72.6 73.165-74 54.4 55.8 57.0 56.5 57.7 58.6 57.1 57.8 58.2 58.4 59.875+ 41.8 42.3 43.2 43.9 43.4 44.6 42.8 43.5 43.7 43.5 44.1

Male 59.8 60.7 62.4 62.7 62.9 64.0 63.8 64.0 64.9 65.0 65.4Female 62.0 63.3 63.4 64.0 64.1 65.1 64.2 64.0 64.4 64.3 65.4



All 60.8 62.0 62.9 63.3 63.5 64.5 64.0 64.0 64.6 64.7 65.4

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.11 (continued)Two-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

601


Table I.12Three-year survival probabilities: incident dialysis patientscensored at transplant, from day 91 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 84.5 85.9 86.2 75.1 73.9 77.7 76.5 72.5 66.3 70.8 68.45-9 89.5 92.3 91.1 80.3 85.7 84.1 82.1 89.5 91.4 95.5 79.210-14 95.0 85.9 94.3 92.8 90.8 90.3 89.9 90.2 87.8 94.0 89.415-19 90.0 87.4 91.0 88.7 91.9 86.7 83.4 90.3 91.1 89.6 90.620-29 77.3 79.2 78.7 77.7 76.8 73.5 77.0 75.8 79.7 78.7 77.330-39 73.1 72.0 67.2 71.7 67.4 66.7 66.6 67.3 70.7 69.7 70.240-49 67.3 66.6 66.0 64.0 64.4 64.8 63.5 64.0 66.3 64.9 67.250-59 59.8 59.1 58.0 55.6 54.9 53.5 53.8 55.4 55.9 56.7 57.160-64 51.9 49.7 48.4 48.7 46.0 45.7 46.1 46.1 47.8 47.7 48.165-69 40.5 42.9 42.3 38.3 41.4 39.6 39.9 41.2 42.5 41.6 41.770-79 33.6 34.3 35.0 30.0 32.3 32.5 31.9 31.9 33.0 33.8 33.180+ 18.6 20.8 18.9 18.2 21.4 21.8 20.8 21.5 20.1 23.0 22.3

Male 53.9 54.0 52.3 48.2 48.5 45.7 45.9 46.8 47.9 48.4 48.3Female 56.8 56.2 54.0 50.6 50.6 50.6 49.2 48.9 50.7 49.4 49.3




All 55.2 55.0 53.1 49.3 49.5 48.0 47.5 47.8 49.2 48.9 48.8

ADJUSTED0-19 83.9 78.4 85.0 78.8 80.5 76.4 73.5 80.2 78.2 80.7 77.320-44 68.4 69.6 67.3 68.8 66.6 65.1 66.5 66.5 69.5 68.8 69.545-64 55.1 53.8 53.3 52.0 51.1 50.7 51.1 52.1 53.6 54.4 55.365-74 36.8 38.8 39.1 34.3 38.0 36.8 36.5 37.9 39.6 39.3 39.475+ 25.3 27.6 25.9 22.9 24.9 26.1 26.3 25.6 25.3 28.1 26.8

Male 46.0 46.5 45.7 43.0 43.9 42.3 43.2 44.0 45.3 46.7 46.8Female 49.1 49.0 48.3 46.5 47.2 47.9 47.4 47.9 49.4 49.3 49.5



All 51.3 50.8 50.6 48.6 49.2 48.4 48.7 49.6 51.0 51.8 52.047.4 47.7 46.9 44.6 45.5 45.0 45.2 45.9 47.2 47.9 48.1

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.12Three-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

602

Reference section I

Table I.12 (continued)Three-year survival probabilities: incident dialysis patientscensored at transplant, from day 91 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 67.9 78.8 68.9 74.9 77.5 74.3 72.5 79.0 78.0 66.95-9 95.8 90.2 77.4 90.9 92.9 87.0 97.4 91.6 89.8 93.410-14 89.3 83.1 85.0 88.2 91.1 89.3 89.2 93.4 95.2 93.415-19 89.8 92.8 88.6 90.9 89.9 87.6 90.2 87.9 88.0 88.520-29 78.8 79.7 80.4 80.3 80.4 82.7 84.0 84.2 83.9 82.430-39 68.7 69.5 70.9 71.0 71.0 73.3 74.4 74.5 75.1 75.940-49 64.2 65.9 66.3 67.4 68.6 68.8 70.1 68.9 69.6 69.450-59 57.2 57.5 58.9 59.8 59.8 60.1 60.8 60.5 61.6 61.860-64 48.8 48.8 50.8 51.8 50.6 52.1 53.4 52.2 53.1 53.865-69 42.2 43.3 45.1 44.6 45.5 45.9 45.3 45.5 45.7 47.370-79 34.1 34.0 35.6 35.3 35.8 36.9 35.7 36.4 36.6 37.080+ 22.0 22.8 23.0 23.3 23.2 24.4 23.1 22.4 23.1 23.9

Male 48.2 48.0 50.0 50.1 50.5 50.8 50.4 50.6 50.9 51.3Female 48.5 49.4 49.9 49.8 49.7 50.3 49.7 49.1 49.3 49.5




All 48.4 48.7 49.9 50.0 50.1 50.5 50.1 49.9 50.2 50.5

ADJUSTED0-19 77.7 81.3 73.9 80.2 80.2 77.4 80.0 79.7 80.7 77.620-44 67.9 68.8 69.1 70.0 70.3 72.3 73.7 73.2 73.7 73.845-64 55.6 56.0 58.0 59.0 59.0 59.7 60.9 60.3 61.3 61.965-74 40.1 41.1 42.6 42.0 43.4 44.2 43.3 43.9 44.5 45.475+ 27.8 27.4 28.7 28.9 28.4 29.8 28.8 28.9 29.3 29.9

Male 47.4 47.4 49.7 50.0 50.5 51.7 51.7 52.1 53.0 53.5Female 49.5 50.6 51.1 51.5 51.8 52.7 52.6 52.2 52.6 53.2



All 52.1 52.8 53.5 54.2 54.3 55.0 55.4 55.2 55.9 56.148.4 48.9 50.4 50.7 51.1 52.1 52.2 52.1 52.8 53.4


Table I.12 (continued)Three-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

603


Table I.13Five-year survival probabilities: incident dialysis patientscensored at transplant, from day 91 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 84.5 79.3 86.2 75.1 60.9 67.7 72.0 72.5 66.3 70.8 57.95-9 89.5 92.3 69.4 80.3 85.7 75.7 77.0 89.5 91.4 76.4 79.210-14 82.3 76.4 88.1 92.8 84.7 90.3 80.9 86.6 73.3 85.3 84.915-19 87.7 81.0 79.9 85.4 84.6 72.9 76.0 84.0 79.6 79.6 84.220-29 73.4 68.1 68.9 66.1 63.2 60.9 66.7 64.7 68.4 65.3 66.330-39 60.0 59.5 53.9 56.5 54.4 52.8 52.2 50.7 56.5 56.8 55.440-49 53.2 50.6 50.3 46.8 48.9 47.9 47.6 48.3 49.7 47.4 48.850-59 40.7 40.9 39.6 37.2 35.9 35.1 36.2 37.4 36.5 36.3 36.260-64 32.0 31.5 29.7 29.5 26.6 27.0 28.4 26.8 28.7 28.1 28.865-69 23.6 25.1 24.3 20.7 22.4 22.4 21.9 22.8 23.0 22.9 22.870-79 16.1 16.4 17.4 14.0 15.3 15.7 14.9 15.7 15.8 16.3 15.780+ 7.6 6.5 6.5 6.4 7.4 7.9 7.5 7.8 7.1 9.2 9.0

Male 37.3 35.6 34.2 30.2 29.8 28.5 28.9 29.1 30.0 30.2 29.9Female 39.3 39.7 36.8 33.2 32.8 32.3 31.5 31.1 31.9 30.6 30.5




All 38.2 37.5 35.5 31.6 31.2 30.3 30.1 30.1 31.0 30.4 30.2

ADJUSTED0-19 77.8 69.5 70.9 . 71.0 63.0 65.1 74.3 66.2 68.9 70.120-44 56.5 55.5 53.1 52.3 52.2 50.0 52.3 51.2 54.0 54.1 54.345-64 35.6 35.1 34.6 33.1 31.9 31.8 33.4 33.5 34.5 34.4 34.965-74 19.5 20.9 21.1 17.4 19.2 19.6 18.9 20.3 20.7 20.9 21.075+ 10.9 11.1 11.0 8.9 10.6 11.0 10.8 10.7 10.4 12.2 11.1

Male 30.0 29.0 28.9 26.2 26.6 26.6 27.5 27.7 28.5 29.7 29.4Female 31.9 32.9 31.9 30.0 30.6 30.6 30.7 31.2 31.6 31.5 31.7



All 30.9 30.8 30.3 28.0 28.5 28.5 29.0 29.3 30.0 30.5 30.5


Table I.13Five-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

604

Reference section I

Table I.13 (continued)Five-year survival probabilities: incident dialysis patientscensored at transplant, from day 91 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 19980-4 62.0 68.7 62.8 66.4 70.8 66.7 67.3 70.85-9 95.8 78.9 71.9 88.2 78.4 87.0 97.4 87.910-14 83.3 78.8 78.6 81.1 86.0 86.7 86.8 81.215-19 82.6 87.0 79.7 83.3 85.2 81.5 84.2 79.220-29 67.3 69.3 70.9 71.2 72.1 73.9 74.4 74.230-39 54.8 56.1 58.4 57.8 58.3 59.7 61.7 61.440-49 47.4 48.8 49.4 50.5 52.1 51.5 53.0 52.050-59 37.8 37.7 39.5 39.9 40.0 39.9 40.9 41.060-64 28.6 29.2 30.6 31.3 29.9 31.4 32.7 32.365-69 21.8 23.7 24.0 24.9 24.4 25.1 24.3 25.770-79 16.2 15.9 16.7 16.6 17.3 17.9 17.2 18.180+ 7.9 7.7 8.1 8.4 8.9 8.8 8.4 8.4

Male 29.7 29.8 31.3 31.6 32.1 32.0 31.8 32.3Female 29.7 30.4 30.8 30.9 30.7 30.8 30.7 30.7




All 29.7 30.1 31.0 31.2 31.4 31.4 31.3 31.5

ADJUSTED0-19 69.5 72.9 64.1 70.9 72.9 70.8 73.9 68.020-44 53.2 54.6 55.5 56.4 56.8 57.8 59.3 58.945-64 36.1 36.5 38.5 39.2 39.3 39.9 41.4 41.265-74 20.5 22.0 22.4 22.9 23.1 24.0 23.2 24.575+ 11.7 10.7 11.5 11.4 12.2 12.8 12.2 12.8

Male 30.0 30.1 31.8 32.2 32.8 33.7 33.7 34.4Female 31.7 32.6 32.9 33.5 33.7 34.3 34.6 34.8



All 30.7 31.3 32.4 32.8 33.2 33.9 34.1 34.6


Table I.13 (continued)Five-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

605


Table I.14Ten-year survival probabilities: incident dialysis patientscensored at transplant, from day 91 to ten years + 90 days, by age, gender, race, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 19930-4 72.4 68.0 69.0 62.6 53.3 37.0 72.0 65.9 45.0 63.0 42.2 57.6 60.2 56.35-9 89.5 71.2 52.1 80.3 85.7 63.0 77.0 78.3 91.4 66.9 67.9 42.6 71.8 35.910-14 61.4 60.8 63.0 83.0 67.2 82.1 65.9 86.6 54.4 64.5 61.5 72.2 65.1 73.015-19 79.1 63.1 64.6 73.8 65.8 58.5 58.2 60.1 68.2 69.1 65.5 68.4 64.2 65.920-29 54.5 47.5 48.3 46.7 44.9 44.0 46.3 45.1 46.9 44.3 46.3 45.2 48.3 52.930-39 38.7 36.5 32.5 34.5 33.5 31.3 30.0 29.6 31.3 33.7 32.8 32.6 33.6 34.840-49 26.7 23.8 23.7 22.7 25.0 22.6 21.5 22.5 24.1 20.5 21.8 20.5 22.4 22.550-59 13.8 14.3 14.4 12.0 12.0 12.9 12.0 12.1 11.4 11.2 11.0 12.0 11.6 11.760-64 8.3 8.1 6.7 7.7 7.3 7.9 7.4 6.7 7.3 6.4 6.5 6.8 6.9 7.565-69 4.9 5.7 4.4 4.8 5.3 5.9 4.7 4.3 4.6 4.3 4.7 4.0 4.4 4.870-79 2.8 2.5 3.0 2.4 3.0 2.8 2.3 2.7 2.6 2.3 2.0 1.9 2.1 2.380+ 2.0 1.0 1.9 0.2 1.3 0.9 0.8 0.9 0.6 0.8 0.5 0.8 0.6 0.7

Male 14.4 13.0 12.2 10.9 11.3 10.7 10.5 10.3 10.2 9.8 10.2 9.7 10.2 10.6Female 16.5 15.8 13.8 12.5 12.2 11.9 10.4 10.1 10.9 9.8 9.2 9.2 9.2 9.6



All 15.4 14.4 13.0 11.7 11.7 11.3 10.4 10.2 10.6 9.8 9.7 9.4 9.7 10.1

ADJUSTED0-19 62.4 48.2 47.0 62.4 51.6 46.0 49.1 54.0 51.5 54.6 49.1 52.5 50.9 49.520-44 34.5 31.3 29.3 30.3 30.6 28.8 29.0 28.5 29.6 30.1 30.3 29.7 30.8 31.845-64 11.2 10.9 11.1 10.0 10.4 10.8 10.7 10.6 10.8 10.3 10.6 11.4 11.6 12.165-74 3.7 4.1 3.7 3.6 4.3 4.8 3.8 3.8 3.9 3.8 3.9 3.5 4.0 4.375+ 2.0 1.7 2.0 1.1 1.9 1.5 1.4 1.6 1.6 1.4 0.9 1.3 1.1 1.3

Male 11.3 10.4 10.6 9.8 10.6 11.2 11.0 10.7 10.5 10.6 10.9 10.9 11.3 11.9Female 12.9 12.9 12.3 11.8 12.5 12.4 11.4 11.7 12.3 11.8 11.4 11.8 12.0 12.5



All 12.0 11.6 11.4 10.7 11.5 11.7 11.1 11.2 11.3 11.1 11.1 11.3 11.6 12.1

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.

Table I.14Ten-year survival probabilities: incident dialysis patientscensored at transplant, from day 9 to ten years + 90 days, by age, gender, race, & primary diagnosis

PATIENT SURVIVALI

606

Reference section I

Table I.15Incident patient counts: hemodialysis patients, unknowns dropped dialysis patients alive on day 91, by age, gender, race, ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 14 13 11 14 * 18 25 15 15 25 225-9 36 34 33 20 20 11 16 26 16 20 3110-14 103 95 91 83 61 77 60 61 61 58 6115-19 303 325 270 276 245 243 224 230 283 284 24620-29 1,093 1,182 1,308 1,239 1,311 1,372 1,367 1,333 1,412 1,587 1,59630-39 1,600 1,751 1,881 1,880 2,067 2,139 2,263 2,390 2,696 2,901 2,99940-49 1,844 2,084 2,055 2,302 2,379 2,542 2,657 3,016 3,433 3,820 4,15550-59 2,823 3,319 3,484 3,540 3,714 3,954 4,126 4,459 5,225 5,608 5,90060-64 1,630 1,791 2,047 2,351 2,604 2,820 2,953 3,314 3,696 4,083 4,42965-69 1,552 1,580 1,827 2,417 2,421 2,618 3,032 3,463 3,996 4,721 5,20870-79 1,683 1,827 2,286 3,255 3,362 3,777 4,385 5,010 5,623 6,929 7,70680+ 273 287 415 655 677 826 1,042 1,232 1,526 1,949 2,297

Male 7,220 7,910 8,627 9,878 10,364 11,007 11,991 13,134 14,843 17,014 18,375Female 5,734 6,378 7,081 8,154 8,506 9,390 10,159 11,415 13,139 14,971 16,275

White 8,791 9,548 10,554 11,769 12,294 13,107 14,401 15,722 17,640 20,087 21,784Black 3,796 4,296 4,710 5,723 5,998 6,583 6,970 7,937 9,210 10,719 11,409Other race 367 444 444 540 578 707 779 890 1,132 1,179 1,457


Diabetes 2,016 2,979 3,734 4,341 5,308 6,064 7,013 8,046 9,450 11,522 13,140Hypertension 2,576 3,645 4,485 4,869 5,474 6,099 6,612 7,723 9,017 10,536 11,414Glomerulonephritis 2,212 2,879 3,198 3,315 3,474 3,558 3,711 4,000 4,333 4,529 4,776Cystic kidney 661 750 866 874 842 897 916 939 971 970 1,009Other urologic 367 518 655 731 711 839 879 985 1,006 1,045 942Other cause 1,396 1,743 2,119 2,264 2,368 2,465 2,547 2,484 2,714 3,055 3,133Missing cause 3,726 1,774 651 1,638 693 475 472 372 491 328 236

All 12,954 14,288 15,708 18,032 18,870 20,397 22,150 24,549 27,982 31,985 34,650


Table I.15Incident patient counts: hemodialysis patients, unknowns dropped dialysis patients alive on day 9, by age, gender, race, ethnicity, & primary diagnosis

607


Table I.15 (continued)Incident patient counts: hemodialysis patients, unknowns dropped dialysis patients alive on day 91, by age, gender, race, ethnicity, & primary diagnosis

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 17 17 23 19 29 12 32 21 26 31 35 285-9 19 17 18 31 33 28 28 35 40 34 38 4710-14 50 80 72 82 78 77 88 87 102 107 109 13615-19 258 281 270 238 287 302 292 313 348 323 324 33020-29 1,615 1,719 1,726 1,759 1,768 1,819 1,841 1,932 1,899 1,942 1,951 1,92430-39 3,085 3,381 3,404 3,686 3,754 4,028 4,116 4,149 4,380 4,291 4,320 4,33240-49 4,529 5,013 5,370 5,752 6,287 6,940 7,204 7,996 8,192 8,480 8,546 8,94550-59 6,416 7,058 7,591 8,554 8,883 9,574 10,684 11,799 12,904 13,413 14,039 14,74360-64 4,840 5,054 5,407 5,743 6,046 6,541 7,090 7,605 7,800 8,050 8,435 8,66365-69 5,633 6,185 6,390 7,017 7,072 7,933 8,358 8,741 8,872 8,944 9,312 9,55670-79 8,804 9,885 10,588 11,703 12,475 14,136 15,585 16,742 17,701 18,160 18,561 19,64680+ 2,605 3,072 3,403 3,841 4,241 5,070 5,850 6,549 7,402 7,976 8,416 9,900

Male 19,825 21,733 23,285 25,306 26,540 29,859 32,370 34,938 37,102 38,277 39,702 42,389Female 18,046 20,029 20,977 23,119 24,413 26,601 28,798 31,031 32,564 33,474 34,384 35,861



Diabetes 14,826 16,572 18,012 20,169 22,479 25,699 28,500 30,938 32,765 34,389 35,812 37,254Hypertension 12,577 14,234 14,831 16,135 14,799 16,124 17,469 18,693 19,859 20,296 21,189 22,627Glomerulonephritis 4,874 4,996 5,241 5,635 5,827 6,228 6,384 6,584 6,720 6,537 6,467 6,746Cystic kidney 1,022 1,076 1,143 1,197 1,252 1,229 1,334 1,491 1,512 1,501 1,486 1,519Other urologic 1,063 1,102 937 976 1,455 1,741 1,774 1,868 2,215 2,022 2,087 2,256Other cause 3,311 3,632 3,846 4,231 5,050 5,363 5,651 6,325 6,507 6,899 6,949 7,670Missing cause 198 150 252 82 91 76 56 70 88 107 96 178

All 37,871 41,762 44,262 48,425 50,953 56,460 61,168 65,969 69,666 71,751 74,086 78,250


Table I.15 (continued)Incident patient counts: hemodialysis patients, unknowns dropped dialysis patients alive on day 9, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

608

Reference section I

Table I.1690-day survival probabilities: incident hemodialysis patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 94.4 93.0 92.45-9 100.0 100.0 100.0 95.8 100.0 100.0 100.0 100.0 100.0 100.0 97.210-14 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.015-19 100.0 99.7 100.0 99.7 100.0 100.0 99.6 100.0 100.0 99.3 99.620-29 99.8 99.7 99.9 99.9 99.7 99.8 99.7 99.7 99.5 99.5 99.530-39 99.5 99.6 99.1 99.3 99.3 99.2 98.9 99.1 99.3 99.3 98.840-49 99.3 99.0 99.4 98.9 99.2 99.2 99.1 98.9 99.0 99.0 98.950-59 98.9 98.6 98.6 98.5 98.8 98.3 98.5 98.7 98.8 98.7 98.260-64 98.1 97.8 97.7 97.4 98.1 97.8 97.3 97.5 97.6 98.0 97.365-69 96.7 96.7 96.6 96.4 95.8 96.0 96.4 96.1 96.8 96.6 96.570-79 95.5 95.9 95.6 95.5 94.5 94.4 94.8 95.0 94.2 94.6 95.280+ 94.8 94.9 94.0 93.5 92.6 91.8 93.0 91.6 93.6 92.4 93.0

Male 98.1 98.1 97.8 97.5 97.4 97.3 97.1 97.1 97.0 97.0 97.0Female 98.3 98.2 98.1 97.6 97.4 97.1 97.3 97.1 97.5 97.2 97.0




All 98.2 98.1 98.0 97.6 97.4 97.2 97.2 97.1 97.2 97.1 97.0

ADJUSTED0-19 . 99.5 . 98.8 . . 99.3 . 99.3 97.8 97.620-44 99.6 99.6 99.5 99.5 99.5 99.4 99.2 99.3 99.3 99.2 99.145-64 98.9 98.5 98.5 98.2 98.6 98.3 98.2 98.3 98.4 98.5 97.965-74 96.8 96.8 96.5 96.3 95.6 95.6 96.0 96.1 96.0 96.0 96.275+ 95.6 95.7 95.5 95.3 94.2 93.7 94.3 93.5 94.1 93.9 94.3

Male 97.8 97.7 97.4 97.3 97.2 97.0 96.9 97.0 96.9 96.9 96.9Female 98.1 97.8 97.8 97.4 97.2 96.9 97.2 97.0 97.4 97.2 97.0



All 98.0 97.7 97.6 97.4 97.2 96.9 97.0 97.0 97.1 97.0 96.9

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.1690-day survival probabilities: incident hemodialysis patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

609


Table I.16 (continued)90-day survival probabilities: incident hemodialysis patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 95.0 94.4 100.0 95.5 100.0 100.0 100.0 95.8 96.4 97.1 97.4 94.05-9 100.0 100.0 100.0 97.5 100.0 100.0 100.0 100.0 97.7 100.0 100.0 100.010-14 100.0 100.0 100.0 100.0 100.0 100.0 99.0 100.0 100.0 99.2 99.2 99.415-19 100.0 100.0 99.7 99.3 99.7 99.7 100.0 99.7 99.5 99.7 98.9 99.720-29 99.6 98.8 99.3 99.1 99.0 99.3 99.2 99.3 99.2 99.4 99.3 99.030-39 98.7 98.7 98.6 98.6 99.0 98.9 98.9 98.9 99.0 98.8 98.8 99.040-49 99.0 99.1 98.9 98.4 98.5 98.7 98.7 98.5 98.6 98.8 98.7 98.750-59 98.7 98.5 98.3 98.3 98.2 98.1 98.2 98.1 98.1 98.4 98.1 98.160-64 97.8 97.6 97.9 97.3 97.4 97.4 97.3 97.1 97.4 97.4 97.2 97.465-69 96.6 96.7 96.8 96.9 96.6 96.8 96.6 96.6 96.7 96.4 96.6 96.970-79 94.9 95.0 95.4 95.1 95.3 95.1 94.8 95.0 95.0 94.9 94.7 95.080+ 92.9 93.8 93.2 93.6 92.7 93.3 92.3 92.5 92.7 92.6 92.6 92.9

Male 97.1 96.8 97.1 96.8 96.9 96.8 96.6 96.6 96.8 96.7 96.4 96.7Female 97.0 97.2 97.0 97.0 96.7 96.8 96.5 96.4 96.4 96.4 96.5 96.4




All 97.0 97.0 97.1 96.9 96.8 96.8 96.6 96.5 96.6 96.5 96.4 96.5

ADJUSTED0-19 99.3 99.4 99.4 97.7 99.4 99.5 99.4 99.0 98.4 98.7 97.4 98.420-44 99.0 99.0 99.0 98.8 98.9 99.0 99.1 99.0 99.0 99.1 99.0 99.045-64 98.4 98.2 98.2 97.9 98.0 97.9 97.9 97.8 97.9 98.1 97.9 98.065-74 96.0 96.2 96.4 96.4 96.1 96.1 96.1 96.2 96.1 96.0 96.0 96.275+ 94.2 94.4 94.4 94.1 94.2 94.4 93.6 93.6 93.9 93.8 93.7 94.0

Male 97.0 96.8 97.1 96.8 97.0 96.9 96.8 96.8 97.0 96.9 96.7 97.0Female 97.0 97.2 97.1 97.1 96.8 97.0 96.7 96.7 96.7 96.7 96.8 96.8



All 97.0 97.0 97.1 96.9 96.9 96.9 96.8 96.7 96.8 96.8 96.7 96.9


Table I.16 (continued)90-day survival probabilities: incident hemodialysis patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

610

Reference section I

Table I.17One-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 100.0 90.0 88.9 91.7 90.9 93.8 86.2 85.9 55.5 72.0 67.45-9 90.9 90.3 100.0 94.1 100.0 100.0 100.0 100.0 92.9 100.0 91.010-14 96.9 98.0 98.7 96.9 96.5 96.8 100.0 98.0 94.2 98.4 96.715-19 96.0 94.5 96.2 95.0 97.7 92.9 95.2 96.1 97.3 99.1 96.620-29 91.1 92.9 92.7 93.0 92.8 90.8 93.3 90.9 91.4 91.0 91.130-39 90.4 90.1 88.9 90.3 87.4 89.0 88.4 87.5 88.5 87.8 88.440-49 88.4 88.1 87.2 88.4 88.0 87.8 87.3 87.1 87.7 87.5 87.850-59 84.5 84.4 84.8 82.1 82.2 83.1 82.8 83.3 83.7 83.3 83.660-64 80.0 78.7 79.0 78.8 76.7 76.6 77.7 76.8 77.1 77.8 77.965-69 73.7 74.3 74.9 72.6 73.8 71.9 73.5 73.6 73.2 74.4 75.570-79 68.6 68.9 69.5 66.1 67.4 67.0 66.7 65.6 66.3 67.3 68.780+ 58.0 54.1 64.4 56.7 57.6 59.1 59.5 56.3 55.2 59.0 60.1

Male 81.1 81.4 80.5 77.9 77.8 77.3 76.8 76.7 76.3 76.9 77.8Female 82.4 81.8 82.2 79.3 79.4 78.9 79.2 77.3 78.4 78.1 78.0




All 81.7 81.6 81.3 78.5 78.5 78.1 77.9 77.0 77.3 77.4 77.9

ADJUSTED0-19 92.5 90.2 93.8 90.6 . 88.9 92.2 93.0 90.5 95.2 90.220-44 88.5 89.4 88.8 89.3 87.9 88.2 88.2 87.2 88.2 87.3 88.145-64 82.3 81.6 82.0 80.9 80.3 80.6 81.2 81.0 81.4 81.9 82.165-74 71.8 71.6 73.6 70.2 71.3 69.8 70.8 70.9 71.1 72.0 73.475+ 62.1 63.8 63.4 59.7 62.2 62.9 62.8 59.9 60.1 62.9 63.8

Male 76.3 76.5 76.2 74.4 74.4 74.3 74.4 74.4 74.2 75.3 76.5Female 78.0 77.6 78.9 76.6 77.0 76.8 77.7 76.2 77.3 77.7 77.9



All 77.1 77.0 77.5 75.5 75.7 75.5 76.0 75.3 75.7 76.5 77.2


Table I.17One-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

611


Table I.17 (continued)One-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 82.1 83.0 71.6 55.9 72.9 100.0 85.5 82.7 73.6 60.6 72.6 74.95-9 100.0 100.0 84.7 100.0 97.0 83.2 100.0 100.0 93.9 91.2 94.9 81.610-14 98.0 89.3 94.3 97.2 97.4 96.7 93.2 95.1 93.2 97.1 96.6 92.715-19 95.0 96.3 96.7 96.6 97.1 95.3 97.7 95.4 97.2 96.9 96.4 96.220-29 91.8 92.0 91.7 91.5 91.0 93.0 94.1 93.8 94.1 92.5 94.0 92.830-39 87.1 88.3 87.2 88.5 86.5 88.6 89.6 89.5 89.2 89.2 89.8 90.240-49 86.1 87.1 87.9 87.4 87.7 88.3 89.1 87.6 88.4 88.3 87.6 87.850-59 83.5 84.7 85.0 85.6 85.1 84.8 85.0 84.8 85.1 84.6 84.8 84.860-64 78.7 79.1 81.5 81.0 79.8 81.6 81.5 79.9 81.1 80.3 81.2 80.365-69 75.2 75.4 77.2 76.6 77.1 77.7 76.7 75.9 76.3 76.6 76.5 76.370-79 68.3 68.8 70.6 70.3 70.2 70.7 69.9 69.9 69.3 69.2 69.4 69.380+ 59.4 59.4 62.4 61.5 60.3 60.0 59.9 57.6 58.4 57.6 58.0 59.0

Male 77.1 77.5 79.0 78.7 78.1 78.7 78.4 77.9 78.0 77.6 77.8 77.5Female 77.4 78.0 78.9 78.7 78.2 78.3 77.8 76.7 76.7 76.3 76.4 76.1




All 77.3 77.7 78.9 78.7 78.2 78.5 78.1 77.3 77.4 77.0 77.2 76.8

ADJUSTED0-19 91.0 90.2 89.4 91.1 91.5 90.9 92.9 91.2 91.5 89.5 90.4 88.220-44 86.9 87.6 87.1 87.8 86.8 88.6 89.4 88.9 89.2 88.9 89.1 89.145-64 82.2 83.2 84.5 84.5 84.0 84.6 85.0 84.1 84.8 84.4 84.6 84.465-74 73.1 73.6 75.6 74.8 75.4 75.9 75.1 74.8 75.0 75.0 74.9 74.775+ 63.4 63.4 65.2 65.5 64.3 64.7 64.2 63.2 63.2 62.8 63.3 63.7

Male 76.2 76.7 78.4 78.3 77.8 78.9 78.9 78.5 78.9 78.6 78.8 78.8Female 77.7 78.5 79.3 79.3 79.2 79.4 79.2 78.2 78.4 78.2 78.5 78.3



All 76.9 77.6 78.9 78.8 78.5 79.2 79.1 78.4 78.7 78.4 78.7 78.6


Table I.17 (continued)One-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

612

Reference section I

Table I.18Two-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 91 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 100.0 90.0 88.9 91.7 90.9 78.1 62.2 64.5 55.5 54.0 56.15-9 90.9 90.3 90.0 94.1 100.0 100.0 88.9 100.0 92.9 88.9 84.010-14 96.9 98.0 94.0 94.0 89.1 94.0 97.1 98.0 86.0 98.4 96.715-19 93.9 89.9 92.8 89.8 95.9 91.2 90.2 94.2 93.0 96.1 93.520-29 83.7 85.4 85.9 83.2 85.4 81.2 84.3 82.5 84.9 84.4 83.730-39 81.2 81.3 77.7 80.8 76.2 76.8 76.3 76.4 79.3 78.2 78.240-49 77.9 77.1 76.9 76.4 76.7 76.5 75.1 74.4 76.0 75.8 77.350-59 71.9 71.3 71.8 68.8 67.3 67.9 67.8 68.4 68.4 69.4 69.260-64 65.0 63.2 63.2 63.6 60.6 59.3 61.9 60.3 61.1 61.5 61.565-69 56.2 56.3 57.0 53.1 56.5 54.4 55.1 56.2 56.1 56.7 56.370-79 48.3 50.1 50.3 45.3 48.2 47.2 47.3 46.1 47.0 48.3 48.580+ 31.9 34.3 40.2 30.7 37.7 36.2 36.4 33.8 33.7 38.7 37.1

Male 66.1 66.5 65.1 61.2 61.9 59.7 60.3 59.3 60.4 60.9 60.9Female 69.3 68.5 68.2 63.7 64.0 63.6 62.7 61.9 62.5 62.5 61.7




All 67.6 67.4 66.5 62.4 62.9 61.6 61.4 60.5 61.4 61.7 61.3

ADJUSTED0-19 90.1 84.6 87.1 83.0 . . 81.4 88.4 83.2 89.3 85.220-44 77.7 79.4 77.8 77.9 76.2 75.6 75.8 75.5 78.1 77.3 77.945-64 68.4 67.0 67.6 66.2 65.0 64.7 65.8 65.3 66.0 67.2 67.565-74 52.6 53.4 55.1 49.7 53.4 51.2 52.1 52.6 53.3 54.0 54.175+ 40.0 43.6 41.7 36.8 41.6 41.5 41.4 38.9 39.4 42.9 41.9

Male 59.2 59.8 59.2 56.6 57.8 56.1 57.6 56.7 57.9 59.3 59.6Female 63.0 62.5 63.5 60.2 61.1 61.0 61.0 60.8 61.3 62.4 62.0



All 61.0 61.1 61.2 58.3 59.4 58.5 59.2 58.7 59.5 60.8 60.8

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.18Two-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

613


Table I.18 (continued)Two-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 91 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 73.0 62.2 54.8 55.9 72.9 80.0 85.5 62.1 73.6 52.2 57.45-9 100.0 100.0 67.8 100.0 97.0 78.0 100.0 95.0 87.2 91.2 94.910-14 98.0 87.1 88.2 95.2 95.2 94.8 91.4 88.5 93.2 95.7 92.315-19 91.7 94.5 92.5 94.5 93.7 89.1 92.3 92.6 92.0 91.1 92.820-29 84.3 85.3 85.7 85.8 84.7 87.1 88.2 89.1 88.7 86.4 88.530-39 76.4 78.3 78.0 78.6 78.0 79.5 81.5 80.8 81.4 81.4 82.540-49 74.1 76.7 76.7 77.4 77.7 77.7 79.3 78.1 78.4 78.3 78.150-59 69.9 71.3 72.0 73.3 72.1 72.6 72.5 71.6 72.5 72.5 72.760-64 62.7 63.6 65.8 66.2 64.7 66.7 66.4 64.9 66.6 66.0 67.165-69 57.2 58.7 60.6 58.9 60.0 61.0 59.5 59.2 59.6 60.6 61.870-79 48.9 49.7 50.8 51.1 51.3 51.9 50.0 51.2 51.1 50.6 51.580+ 36.6 38.4 39.0 39.2 38.9 38.3 37.5 37.1 37.5 37.2 37.9

Male 60.8 61.9 63.1 63.2 63.2 63.4 62.8 62.9 63.2 63.1 63.4Female 61.3 62.6 63.0 63.1 62.5 63.0 61.8 61.2 61.4 60.8 61.8




All 61.0 62.2 63.1 63.2 62.8 63.2 62.3 62.1 62.3 62.0 62.7

ADJUSTED0-19 86.1 86.9 80.0 88.3 86.7 81.5 85.9 84.5 84.8 81.6 83.520-44 75.8 77.4 77.1 78.2 77.7 79.2 81.1 80.2 80.7 80.5 80.945-64 68.0 69.5 71.0 71.9 71.0 71.8 72.2 71.2 72.3 72.2 72.765-74 54.8 56.3 57.6 56.7 58.1 58.7 57.1 57.8 58.2 58.3 59.675+ 42.2 43.2 44.1 44.7 43.8 44.4 43.2 43.5 43.8 43.5 44.1

Male 59.9 61.1 62.8 63.1 63.1 63.9 63.8 64.0 64.7 64.8 65.1Female 62.2 63.7 64.1 64.5 64.3 65.0 64.3 63.8 64.2 63.9 65.0



All 61.0 62.4 63.4 63.8 63.7 64.4 64.0 63.9 64.5 64.4 65.1

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.18 (continued)Two-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

614

Reference section I

Table I.19Three-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 91 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 100.0 90.0 88.9 55.0 60.6 78.1 54.4 43.0 41.6 43.2 56.15-9 90.9 90.3 90.0 94.1 100.0 100.0 74.1 81.8 92.9 88.9 84.010-14 96.9 90.9 94.0 90.2 89.1 85.3 86.5 91.5 81.2 95.1 93.415-19 89.3 87.9 92.8 88.9 95.9 89.9 82.2 89.8 89.5 89.4 90.220-29 78.9 80.1 80.1 77.6 77.0 73.3 76.5 76.7 78.9 78.0 77.930-39 75.7 73.9 67.1 72.8 67.2 67.9 66.7 67.1 71.8 69.8 69.740-49 68.9 68.0 68.0 66.1 65.9 65.4 63.9 64.7 66.6 65.2 67.550-59 61.0 59.9 59.0 56.4 55.6 54.4 55.2 56.2 56.2 56.9 57.260-64 53.3 50.7 49.9 50.2 47.1 46.2 46.9 47.1 49.0 48.0 48.365-69 41.5 42.6 42.9 39.3 42.1 41.0 41.5 42.2 43.2 42.4 42.170-79 34.7 35.1 35.6 30.4 33.5 32.6 33.0 32.7 33.5 34.1 33.880+ 19.1 22.5 20.3 18.4 21.3 22.3 20.9 22.1 20.2 23.5 22.4

Male 54.9 54.4 52.1 48.1 48.8 45.8 46.4 46.9 48.2 47.9 48.0Female 58.4 57.2 55.3 51.3 50.6 51.1 49.6 49.3 50.5 49.3 48.7




All 56.5 55.7 53.6 49.6 49.7 48.3 47.9 48.0 49.3 48.5 48.3

ADJUSTED0-19 84.7 80.1 . . . 80.7 69.5 77.3 77.2 80.3 .20-44 70.7 71.2 68.1 69.0 66.5 65.2 65.9 66.4 69.9 68.4 69.345-64 56.8 54.9 54.5 53.2 52.0 51.3 52.0 52.8 53.9 54.3 55.265-74 38.1 39.2 40.0 35.2 39.1 37.5 37.7 38.9 40.1 39.8 39.875+ 26.5 28.9 26.6 23.1 25.5 26.4 27.2 26.2 25.7 28.3 27.0

Male 47.3 47.2 46.1 43.5 44.9 42.7 44.1 44.6 45.8 46.7 47.1Female 51.2 50.6 50.2 47.7 48.0 48.7 48.3 48.8 49.7 49.7 49.5



All 49.1 48.8 48.0 45.5 46.4 45.6 46.1 46.6 47.7 48.1 48.3

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110, are excluded.Includes residents of the 50 states, the District of Columbia Puerto Rico, & the Territories.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.19Three-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

615


Table I.19 (continued)Three-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 91 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 60.8 62.2 49.8 55.9 66.8 80.0 78.3 62.1 61.3 39.25-9 100.0 100.0 67.8 93.8 97.0 70.9 100.0 95.0 79.3 91.210-14 86.5 79.0 88.2 87.6 95.2 90.8 88.7 88.5 90.4 95.715-19 89.4 92.5 88.6 92.2 89.9 86.0 90.2 89.6 88.3 89.020-29 79.2 79.5 80.2 80.1 80.0 82.5 83.3 83.9 83.3 82.130-39 68.2 69.5 70.4 71.8 70.2 72.6 73.8 74.0 74.4 74.940-49 64.2 66.8 67.4 67.9 68.2 68.4 70.0 68.7 69.3 69.150-59 58.3 58.1 60.2 60.8 60.5 60.6 61.4 60.7 61.4 61.760-64 49.2 50.2 52.0 53.2 51.8 53.0 54.0 52.7 53.7 54.065-69 43.4 44.3 46.3 45.5 46.5 46.4 46.0 46.0 46.3 47.570-79 35.1 35.0 36.4 36.2 36.4 37.0 35.9 36.6 36.9 37.180+ 22.6 23.8 24.0 24.3 23.8 24.6 23.6 22.4 23.3 23.9

Male 48.3 48.4 50.4 50.6 50.7 50.8 50.5 50.7 50.9 51.3Female 48.5 49.4 50.1 50.0 49.4 49.8 49.4 48.5 48.9 48.9




All 48.4 48.9 50.2 50.3 50.1 50.3 50.0 49.7 50.0 50.2

ADJUSTED0-19 80.1 82.1 75.1 82.5 . 76.4 82.3 80.8 78.9 78.820-44 67.2 68.7 68.9 70.0 69.4 71.5 73.0 72.7 72.9 73.145-64 55.9 56.4 58.8 59.8 59.4 59.8 61.1 60.2 61.1 61.665-74 40.8 41.8 43.4 42.7 44.0 44.5 43.4 44.1 44.8 45.275+ 28.6 28.3 29.3 29.7 28.9 29.7 29.2 29.0 29.5 30.0

Male 47.9 48.0 50.4 50.8 51.0 51.8 52.0 52.3 53.0 53.5Female 50.1 51.2 51.8 52.1 51.9 52.6 52.6 52.0 52.5 52.9



All 48.9 49.6 51.1 51.4 51.5 52.2 52.3 52.1 52.8 53.2

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110, are excluded.Includes residents of the 50 states, the District of Columbia Puerto Rico, & the Territories.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.19 (continued)Three-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

616

Reference section I

Table I.20Five-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 91 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 19980-4 100.0 72.0 88.9 55.0 . 78.1 45.3 43.0 41.6 43.2 28.1 22.8 62.2 49.8 28.0 66.8 40.0 78.3 62.15-9 90.9 90.3 60.0 94.1 100.0 100.0 74.1 81.8 92.9 88.9 84.0 100.0 80.0 45.2 93.8 97.0 70.9 100.0 95.010-14 84.2 81.1 87.8 90.2 89.1 85.3 72.1 91.5 58.2 87.2 93.4 86.5 72.6 83.6 81.1 90.9 85.8 85.1 88.515-19 86.7 81.2 79.8 84.6 92.0 79.3 75.4 83.7 77.8 78.9 86.7 81.3 85.9 76.9 85.4 87.1 80.3 83.1 80.120-29 75.3 69.6 71.2 66.7 64.0 60.4 66.2 65.3 67.2 66.1 67.7 67.2 69.3 70.3 71.3 72.3 73.9 73.3 73.930-39 63.0 61.5 54.0 58.9 55.2 53.7 53.0 50.7 57.3 57.0 55.4 54.9 57.0 58.4 58.6 58.4 59.3 61.4 61.440-49 55.2 52.3 52.3 48.7 50.3 48.7 47.6 49.7 50.0 48.0 49.5 48.3 50.5 50.5 50.9 52.0 51.6 53.4 52.050-59 41.7 41.1 40.4 37.2 36.5 36.2 36.7 37.5 37.2 36.8 37.2 39.1 38.6 40.5 41.1 41.1 40.6 41.6 41.260-64 32.8 32.7 30.4 30.5 27.8 27.9 28.9 27.2 29.8 28.7 29.3 29.4 30.7 31.7 32.2 30.8 32.2 33.3 33.165-69 24.1 25.1 24.8 21.3 22.9 23.3 23.0 23.5 23.6 23.6 23.2 22.8 24.7 25.1 25.9 25.2 25.6 24.9 26.270-79 16.7 16.6 17.9 14.3 16.2 16.1 15.7 15.9 16.3 16.6 16.4 16.8 16.6 17.4 17.3 17.8 18.1 17.5 18.380+ 7.9 7.0 7.0 6.3 7.5 8.4 7.6 8.0 7.1 9.3 9.1 8.4 8.0 8.5 8.7 9.0 8.8 8.6 8.4

Male 38.2 36.0 34.1 30.0 30.2 28.6 29.0 28.9 30.3 30.0 30.0 30.0 30.4 31.6 32.1 32.5 32.3 32.0 32.5Female 40.4 40.3 37.4 33.3 32.7 33.1 31.4 31.1 31.8 30.5 30.2 29.7 30.4 30.9 31.0 30.5 30.3 30.5 30.3

White 36.3 33.7 31.6 27.2 26.7 25.9 25.0 24.3 24.4 24.0 23.7 23.3 23.8 24.7 25.0 24.8 24.7 24.2 25.1Black 45.4 46.9 43.3 38.9 40.0 39.1 39.1 39.0 41.6 39.7 40.2 39.8 40.3 40.8 41.3 41.4 41.5 41.9 40.8Other race 38.7 37.8 45.9 42.1 35.7 36.0 37.2 41.7 41.8 42.9 40.8 42.1 42.5 42.7 42.0 39.6 39.2 41.6 41.6


Diabetes 28.5 24.3 20.7 21.5 20.2 20.0 21.5 21.8 23.3 22.6 23.3 23.8 24.8 25.7 26.2 25.9 26.0 26.1 26.5Hypertension 46.2 40.4 36.4 33.7 33.0 32.7 30.5 30.1 32.0 31.3 30.8 30.2 30.8 30.8 31.5 32.7 32.5 31.9 31.8Glomerulonephritis 59.0 53.0 49.6 46.1 44.9 40.9 41.6 42.0 44.6 42.8 43.4 43.4 43.3 46.9 45.5 46.7 46.9 47.5 48.8Other cause 34.7 37.4 38.9 30.5 33.4 35.0 34.5 34.4 33.6 35.0 34.8 34.8 35.1 36.5 36.9 35.3 35.2 36.1 36.0

All 39.1 38.0 35.6 31.6 31.4 30.7 30.2 29.9 31.0 30.2 30.1 29.9 30.4 31.2 31.5 31.5 31.3 31.2 31.4

ADJUSTED0-19 78.1 69.9 69.6 . 81.8 70.0 60.9 71.9 62.6 . 75.4 69.8 73.1 62.3 73.7 77.9 69.2 74.3 70.320-44 59.2 57.0 53.8 53.0 52.5 49.7 51.9 50.9 54.1 54.0 54.6 53.0 55.2 55.3 56.5 56.5 57.3 58.8 58.645-64 36.9 36.0 35.5 33.5 32.7 32.7 33.7 33.6 34.8 34.5 35.4 36.8 37.1 39.2 39.8 39.7 40.0 41.6 41.165-74 20.3 21.2 21.7 17.9 20.0 20.2 19.9 20.8 21.3 21.4 21.3 21.2 22.6 23.1 23.6 23.5 24.2 23.5 24.775+ 11.3 11.5 11.4 9.1 11.0 11.5 11.2 10.9 10.6 12.2 11.6 12.1 11.2 11.9 11.8 12.5 12.6 12.4 12.9

Male 31.1 29.5 29.3 26.6 27.6 26.9 28.1 27.9 28.9 29.9 30.0 30.6 30.9 32.4 32.9 33.3 33.9 34.0 34.6Female 33.3 34.0 33.0 30.7 31.2 31.6 31.2 31.5 32.0 31.9 32.0 32.2 33.2 33.5 34.0 33.9 34.1 34.6 34.7

White 28.9 27.7 27.6 25.1 25.9 25.9 26.1 25.9 26.4 27.4 27.2 27.6 28.4 29.5 30.1 30.1 30.7 30.7 31.7Black 38.0 38.6 36.2 33.7 34.8 34.0 35.0 35.2 37.0 35.7 36.6 36.9 37.1 37.8 38.3 38.7 39.0 39.6 38.7Other race 30.9 32.5 36.8 35.9 30.4 33.8 35.1 39.0 39.1 41.9 40.5 42.8 43.1 43.1 43.0 41.6 41.9 44.1 43.7

Diabetes 24.2 20.9 18.5 19.2 18.8 18.7 20.3 20.7 22.0 22.0 22.7 23.5 24.7 25.6 26.3 26.2 26.6 26.9 27.4Hypertension 41.9 38.1 36.7 34.7 34.7 35.2 34.6 34.7 35.8 36.0 36.0 35.8 36.0 36.6 36.9 38.2 38.4 38.3 38.4Glomerulonephritis 48.6 44.7 43.6 40.7 41.2 38.1 39.2 39.0 41.8 40.8 41.1 42.0 41.4 44.2 43.9 44.1 44.7 45.1 46.2Other cause 32.1 33.9 35.9 30.8 33.7 34.7 34.8 34.7 33.5 40.8 34.9 35.3 35.6 36.5 37.0 35.6 35.8 36.9 36.7

All 32.1 31.6 31.0 28.5 29.3 29.1 29.5 29.7 30.4 30.8 30.9 31.4 32.0 32.9 33.4 33.6 34.0 34.3 34.7

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110, are excluded.Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.20Five-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

617


Table I.21Ten-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 91 to ten years + 90 days, by age, gender, race, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 19930-4 50.0 72.0 . 36.7 . . 45.3 21.5 20.8 43.2 28.1 22.8 62.2 49.85-9 90.9 67.8 60.0 94.1 100.0 100.0 74.1 65.5 92.9 88.9 84.0 33.3 80.0 .10-14 64.1 63.4 62.7 80.7 59.4 85.3 72.1 91.5 29.1 81.3 76.7 76.8 59.2 73.215-19 77.2 64.9 62.8 71.9 77.2 66.2 59.7 51.1 65.6 68.5 70.5 70.6 65.2 64.720-29 55.0 48.7 50.2 48.3 45.9 43.4 46.2 45.2 46.3 45.3 46.8 45.3 47.8 52.930-39 41.4 38.3 32.0 36.4 33.8 32.4 29.9 29.6 32.1 34.2 32.7 33.0 34.9 33.740-49 27.7 24.8 25.7 23.0 25.3 23.4 21.9 22.7 23.9 20.5 21.9 20.8 22.8 22.550-59 14.0 14.4 15.0 11.9 12.5 12.9 12.1 12.0 11.5 11.5 11.1 12.4 11.7 11.760-64 8.5 7.9 6.8 8.2 7.4 8.4 7.6 7.0 7.5 6.5 6.5 7.0 7.2 7.565-69 5.2 5.6 4.6 5.0 5.1 6.0 5.1 4.7 4.7 4.4 4.9 4.2 4.4 4.970-79 2.7 2.4 3.0 2.4 3.4 3.0 2.3 2.6 2.5 2.1 2.0 1.9 2.1 2.380+ 1.6 0.9 2.0 0.3 1.2 0.9 0.8 1.0 0.5 0.7 0.4 0.7 0.6 0.6

Male 14.6 12.9 12.0 10.5 11.2 10.7 10.3 10.0 10.1 9.6 10.1 9.7 10.2 10.3Female 16.9 16.0 14.0 12.4 11.8 12.0 10.2 9.8 10.5 9.5 8.8 8.9 8.9 9.1



All 15.6 14.4 12.9 11.4 11.5 11.3 10.2 9.9 10.3 9.5 9.4 9.3 9.5 9.7

ADJUSTED0-19 62.2 50.3 45.4 60.2 59.5 56.8 . 42.4 48.8 58.3 58.9 55.4 52.3 50.720-44 35.9 31.9 29.8 30.6 30.2 28.6 28.3 27.6 29.3 30.0 30.0 29.6 31.0 30.745-64 11.5 10.9 11.4 9.9 10.5 11.0 10.7 10.5 10.7 10.1 10.6 11.4 11.4 11.965-74 3.9 4.1 3.9 3.7 4.3 4.8 4.0 3.9 3.9 3.6 3.9 3.4 3.9 4.275+ 1.8 1.6 2.1 1.1 2.1 1.5 1.3 1.6 1.5 1.3 0.9 1.2 1.0 1.3

Male 11.5 10.4 10.9 9.8 10.9 11.2 11.1 10.8 10.5 10.5 11.0 11.1 11.3 11.7Female 13.3 13.2 12.7 12.0 12.5 12.6 11.4 11.6 12.1 11.6 11.3 11.7 11.9 12.2



All 12.3 11.7 11.7 10.8 11.6 11.8 11.2 11.1 11.2 11.0 11.1 11.3 11.6 11.9

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories."." Zero values in this cell.

Table I.21Ten-year survival probabilities: incident hemodialysis patientscensored at transplant, from day 9 to ten years + 90 days, by age, gender, race, & primary diagnosis

PATIENT SURVIVALI

618

Reference section I

Table I.22Incident patient counts: CAPD/CCPD patients, unknowns droppeddialysis patients alive on day 91, by age, gender, race, ethnicity, & primary diagnosis

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 * 23 36 52 53 75 62 59 64 57 505-9 * 14 27 33 48 32 42 35 33 41 4010-14 * 20 51 60 73 51 53 56 52 45 6315-19 * 21 53 65 64 71 62 76 65 86 8220-29 54 107 174 198 235 221 267 264 304 300 36130-39 107 191 326 398 389 442 455 499 569 649 70640-49 114 182 362 411 434 489 540 564 621 772 88950-59 158 332 503 558 625 646 651 704 750 918 1,00060-64 60 196 282 349 341 420 397 447 482 523 64165-69 47 145 236 217 228 276 296 345 347 422 54070-79 45 129 310 271 265 336 290 389 397 490 59480+ * 25 59 54 52 60 64 69 92 115 118

Male 326 694 1,263 1,429 1,535 1,652 1,738 1,868 2,035 2,380 2,714Female 297 691 1,156 1,237 1,272 1,467 1,441 1,639 1,741 2,038 2,370

White 497 1,051 1,762 1,953 2,073 2,387 2,393 2,630 2,799 3,212 3,715Black 107 313 617 655 660 661 701 789 858 1,074 1,210Other race 19 21 40 58 74 71 85 88 119 132 159


Diabetes 173 425 788 851 928 1,039 1,143 1,291 1,327 1,696 1,992Hypertension 131 314 627 587 579 685 688 727 898 1,023 1,265Glomerulonephritis 161 290 466 507 579 625 629 700 774 859 926Cystic kidney 42 86 114 114 156 145 161 174 173 203 243Other urologic 13 57 90 95 88 107 80 93 95 90 100Other cause 87 167 304 377 392 434 397 440 404 478 523Missing cause 16 46 30 135 85 84 81 82 105 69 35

All 623 1,385 2,419 2,666 2,807 3,119 3,179 3,507 3,776 4,418 5,084

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90 day rule.The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age, gender, race, or primary cause of ESRD are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed.

Table I.22Incident patient counts: CAPD/CCPD patients, unknowns dropped dialysis patients alive on day 9, by age, gender, race, ethnicity, & primary diagnosis

619


Table I.22 (continued)Incident patient counts: CAPD/CCPD patients, unknowns droppeddialysis patients alive on day 91, by age, gender, race, ethnicity, & primary diagnosis

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 75 67 76 64 77 104 89 108 93 113 108 1015-9 29 31 34 57 49 56 55 49 59 56 55 5210-14 66 52 58 71 75 94 84 78 83 86 75 9415-19 68 101 90 87 95 106 101 86 85 93 84 6720-29 318 330 365 341 333 322 285 269 242 232 220 17930-39 775 807 789 834 816 754 655 621 627 551 491 50740-49 1,029 1,014 1,130 1,094 1,288 1,230 1,077 997 993 949 921 83050-59 1,048 1,205 1,205 1,353 1,445 1,399 1,446 1,379 1,343 1,264 1,386 1,28760-64 658 706 711 757 828 749 721 672 648 644 646 62365-69 499 464 616 574 630 552 519 533 510 515 518 49070-79 615 650 694 791 750 805 769 747 736 729 758 71480+ 96 131 146 170 163 193 202 172 194 196 237 223

Male 2,910 2,931 3,159 3,284 3,477 3,348 3,159 2,976 2,919 2,881 2,880 2,765Female 2,366 2,627 2,755 2,909 3,072 3,016 2,844 2,735 2,694 2,547 2,619 2,402

White 3,850 4,008 4,164 4,361 4,559 4,533 4,345 4,073 4,087 3,909 3,892 3,608Black 1,249 1,324 1,485 1,495 1,574 1,421 1,277 1,247 1,195 1,135 1,196 1,154Other race 177 226 265 337 416 410 381 391 331 384 411 405

†Hispanic 695 594 591 615 622 597 639†Non-Hispanic 5,669 5,409 5,120 4,998 4,806 4,902 4,528

Diabetes 2,145 2,333 2,436 2,598 2,914 2,931 2,711 2,596 2,565 2,447 2,440 2,314Hypertension 1,212 1,246 1,401 1,423 1,288 1,115 1,143 1,088 1,067 1,052 1,073 1,060Glomerulonephritis 974 1,010 1,032 1,121 1,177 1,172 1,069 998 920 940 895 789Cystic kidney 279 280 316 325 329 321 319 285 318 279 317 274Other urologic 98 122 123 107 170 150 167 136 149 156 155 160Other cause 539 544 579 600 658 662 585 601 587 551 614 554Missing cause 29 23 27 19 13 13 9 * * * * 16

All 5,276 5,558 5,914 6,193 6,549 6,364 6,003 5,711 5,613 5,428 5,499 5,167

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90 day rule.The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age, gender, race, or primary cause of ESRD are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed.

Table I.22 (continued)Incident patient counts: CAPD/CCPD patients, unknowns dropped dialysis patients alive on day 9, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

620

Reference section I

Table I.2390-day survival probabilities: incident CAPD/CCPD patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 100.0 100.0 97.6 100.0 98.2 100.0 100.0 98.5 100.0 100.0 94.8 98.85-9 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 97.7 100.010-14 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 98.6 100.015-19 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 98.9 100.020-29 100.0 99.1 99.5 99.5 99.6 99.1 99.6 98.9 100.0 99.4 99.0 99.430-39 99.1 98.6 98.6 99.3 99.0 98.9 98.4 98.9 98.8 98.8 99.1 99.040-49 100.0 99.0 99.2 98.9 98.7 99.0 98.8 98.8 99.5 99.8 99.4 99.550-59 98.8 98.4 98.3 98.5 98.8 97.9 98.8 98.8 98.3 98.8 99.1 98.560-64 98.6 99.5 98.7 98.6 98.1 95.7 97.0 97.3 97.7 99.3 98.4 98.365-69 96.4 97.6 94.3 94.8 94.5 97.0 97.8 95.7 96.8 96.5 97.6 98.170-79 96.2 95.9 92.6 93.4 95.2 95.5 94.4 95.9 94.9 96.3 95.6 97.180+ 100.0 100.0 94.1 89.9 93.4 87.8 88.6 89.8 93.6 96.1 94.8 90.7

Male 99.4 98.6 97.1 97.7 98.1 97.4 97.8 98.0 98.2 98.6 98.3 98.6Female 98.2 98.3 97.6 97.9 97.9 97.8 98.1 97.7 98.0 98.5 98.2 98.3




All 98.8 98.5 97.3 97.8 98.0 97.6 97.9 97.8 98.1 98.5 98.3 98.5

ADJUSTED0-19 . . 99.5 . 99.6 . . 99.6 . . 97.8 99.620-44 99.5 98.5 98.8 99.3 99.1 99.0 98.7 98.7 99.4 99.2 99.0 99.345-64 99.0 99.0 98.6 98.6 98.6 97.4 98.3 98.4 98.3 99.2 99.0 98.765-74 95.9 96.3 94.4 95.4 94.8 96.2 96.7 96.5 95.7 96.8 96.9 98.075+ . . 91.9 90.1 95.6 94.2 92.3 92.8 95.8 96.0 95.6 94.7

Male 99.1 98.1 96.2 96.8 97.3 96.3 96.8 97.1 97.5 98.0 97.6 98.0Female 96.9 97.5 96.6 96.8 96.7 96.7 97.0 96.6 96.9 97.8 97.6 97.6

White 97.7 97.4 95.6 96.4 96.8 96.0 96.5 96.7 97.0 97.7 97.5 97.8Black 98.4 98.7 98.0 97.6 97.4 98.0 97.8 96.9 97.4 98.3 97.6 97.4Other race . . . 94.0 98.0 94.2 96.6 . . 98.2 97.2 99.2

Diabetes 96.3 98.5 95.4 96.2 97.3 96.4 96.3 97.1 96.6 98.0 97.8 97.3Hypertension . 97.5 96.0 96.1 95.5 97.2 97.1 96.3 97.8 97.2 97.1 98.5Glomerulonephritis 98.7 98.7 96.9 97.9 98.3 96.9 97.1 98.2 98.4 99.2 98.5 99.1Other cause 97.2 96.9 97.4 97.1 97.1 95.4 97.2 96.4 96.6 98.1 97.5 97.1

All 98.1 97.8 96.4 96.8 97.0 96.5 96.9 96.9 97.2 97.9 97.6 97.8

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.2390-day survival probabilities: incident CAPD/CCPD patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

621


Table I.23 (continued)90-day survival probabilities: incident CAPD/CCPD patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 98.6 100.0 98.7 97.6 99.1 96.9 97.3 96.0 98.3 100.0 99.15-9 100.0 100.0 100.0 100.0 98.4 100.0 100.0 98.5 100.0 98.3 100.010-14 100.0 98.4 98.8 98.8 100.0 99.0 100.0 100.0 100.0 100.0 100.015-19 100.0 100.0 100.0 100.0 99.1 100.0 100.0 100.0 98.0 98.9 100.020-29 98.9 99.7 99.7 100.0 99.4 100.0 99.7 99.2 100.0 99.6 100.030-39 98.9 99.2 99.0 99.4 99.6 99.3 99.8 99.2 99.6 99.8 99.340-49 99.1 98.8 99.4 99.2 99.1 99.0 99.5 99.3 99.4 99.6 99.650-59 99.0 98.9 98.9 99.1 99.0 99.5 98.8 99.4 99.0 99.2 99.260-64 98.6 98.8 98.4 98.4 98.9 98.8 98.7 99.1 98.8 98.9 99.165-69 97.8 99.1 98.5 98.2 97.3 98.9 98.0 98.1 98.9 99.4 99.470-79 97.0 96.2 98.1 97.4 96.8 97.7 97.4 97.1 97.1 97.4 97.680+ 93.5 92.9 92.2 94.8 92.8 96.3 93.9 96.7 95.4 97.4 95.2

Male 98.4 98.4 98.8 98.8 98.5 98.9 98.6 98.8 98.7 99.0 98.7Female 98.6 98.6 98.5 98.7 98.5 98.9 98.8 98.7 98.8 99.1 99.2




All 98.5 98.5 98.7 98.7 98.5 98.9 98.7 98.8 98.7 99.0 98.9

ADJUSTED0-19 99.6 99.7 99.4 99.2 99.3 99.0 99.2 98.7 99.1 99.6 99.820-44 98.9 99.1 99.2 99.6 99.4 99.5 99.8 99.3 99.6 99.6 99.545-64 99.0 98.9 98.9 98.9 99.0 99.2 98.9 99.3 99.1 99.3 99.365-74 98.0 98.3 98.3 98.1 97.4 98.3 98.1 97.5 98.3 98.5 98.775+ 94.8 94.2 96.3 96.0 94.7 97.5 95.5 97.5 96.2 97.5 96.7

Male 97.7 97.8 98.4 98.3 97.9 98.5 98.1 98.4 98.3 98.7 98.4Female 98.0 98.1 97.8 98.1 97.8 98.5 98.3 98.2 98.3 98.7 98.9



All 97.8 97.9 98.1 98.2 97.9 98.5 98.2 98.3 98.3 98.7 98.6

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.23 (continued)90-day survival probabilities: incident CAPD/CCPD patientscensored at transplant, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

622

Reference section I

Table I.24One-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 85.7 100.0 85.5 85.9 81.6 82.7 93.2 96.4 80.5 90.4 81.15-9 80.0 100.0 89.9 100.0 84.7 83.3 100.0 100.0 100.0 100.0 96.910-14 75.0 100.0 98.0 100.0 96.2 98.1 97.6 100.0 94.2 94.9 96.515-19 100.0 100.0 91.0 93.3 93.8 92.7 94.7 95.0 100.0 97.0 100.020-29 95.8 90.8 90.5 88.5 91.0 91.8 94.8 89.1 92.7 91.5 90.030-39 81.3 87.6 85.5 88.4 86.7 86.3 84.6 87.6 88.3 88.9 90.340-49 85.4 83.5 84.0 85.1 84.9 85.0 83.5 87.7 87.8 87.6 89.750-59 81.0 81.5 80.3 79.9 81.5 78.3 79.8 82.4 83.0 82.6 85.660-64 77.9 73.6 75.7 74.1 71.8 76.6 76.8 74.7 78.1 77.6 78.765-69 69.2 68.9 67.7 71.6 67.1 68.5 68.6 67.8 74.4 73.9 75.670-79 52.0 65.0 63.6 60.3 63.1 71.0 65.2 65.3 65.1 67.0 64.680+ 62.5 61.5 51.6 40.3 44.1 48.5 50.0 44.2 50.0 46.3 59.8

Male 79.2 78.8 79.7 78.1 78.7 79.5 79.9 80.9 80.4 80.7 82.3Female 79.9 79.5 75.6 78.9 78.5 78.6 78.6 77.9 82.0 81.4 82.2




All 79.6 79.1 77.7 78.5 78.6 79.1 79.3 79.5 81.1 81.0 82.2

ADJUSTED0-19 75.7 . 84.4 89.1 81.0 80.1 91.9 94.5 85.6 90.9 88.620-44 84.8 87.2 86.4 87.2 86.3 87.0 86.9 88.0 88.2 88.3 89.745-64 79.2 77.7 78.7 78.4 78.8 78.8 79.3 80.8 82.6 82.9 84.765-74 59.8 66.9 66.0 65.6 64.9 68.2 67.5 67.5 71.2 73.1 73.475+ 54.9 56.1 53.7 49.6 53.1 63.2 56.9 55.4 56.0 54.8 58.6

Male 70.5 72.1 73.6 71.0 71.4 73.8 73.9 75.3 74.9 75.9 77.8Female 69.5 72.3 69.4 71.8 71.0 71.7 71.7 72.3 76.1 76.2 78.1



All 70.1 72.1 71.5 71.3 71.2 72.8 72.9 73.8 75.5 76.1 77.9

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.24One-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

623


Table I.24 (continued)One-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 76.4 86.9 85.1 89.7 88.3 85.8 85.2 85.6 83.4 84.3 88.7 90.35-9 100.0 90.2 92.7 100.0 98.0 94.9 96.1 100.0 98.4 98.0 98.1 97.710-14 96.4 95.6 96.7 100.0 96.4 94.2 98.6 98.8 100.0 96.2 98.7 98.715-19 95.1 96.6 96.8 93.4 97.4 98.1 99.0 96.1 98.9 98.6 98.7 98.620-29 93.0 94.0 93.6 94.2 94.2 93.9 98.9 96.3 98.3 95.6 95.7 95.230-39 92.5 90.6 91.5 91.8 90.4 92.7 93.5 93.9 95.8 95.9 96.5 95.340-49 89.8 89.6 90.6 90.5 92.2 92.3 92.3 92.9 92.9 93.4 95.4 91.850-59 84.9 87.0 86.6 88.6 87.6 87.4 89.5 87.3 90.4 89.2 91.1 91.160-64 82.4 81.0 82.8 81.9 81.3 82.3 83.0 83.9 81.3 84.5 84.1 88.065-69 77.5 81.2 79.9 78.2 80.1 80.6 78.1 80.8 80.3 79.9 79.8 80.870-79 69.3 68.7 70.2 70.4 74.7 73.5 73.2 74.6 73.1 72.3 77.9 75.880+ 61.3 60.0 58.0 59.3 65.6 60.7 56.5 60.0 59.7 62.3 63.1 58.3

Male 83.9 84.0 84.2 84.6 85.3 85.1 86.3 85.7 86.4 86.1 88.0 86.3Female 84.1 84.6 84.9 84.7 85.8 85.9 85.4 86.2 86.2 86.1 87.0 87.6




All 84.0 84.3 84.5 84.7 85.6 85.5 85.8 86.0 86.3 86.1 87.5 86.9

ADJUSTED0-19 80.8 87.4 85.7 90.7 89.6 87.4 89.9 88.5 89.6 87.1 91.4 92.220-44 91.4 90.4 91.0 91.4 91.4 92.8 94.1 94.2 95.1 95.0 96.1 94.645-64 85.9 86.6 87.0 87.8 87.7 87.8 89.0 88.2 89.4 89.5 90.6 90.865-74 75.5 77.4 78.9 76.6 78.6 79.7 78.8 81.3 79.3 79.1 82.0 79.475+ 64.9 62.3 60.4 63.2 71.2 65.8 64.3 64.8 66.9 66.5 68.1 69.1

Male 79.8 80.3 80.7 81.4 82.4 82.5 84.2 83.5 84.5 84.3 86.6 84.5Female 79.9 80.5 81.3 81.0 82.7 82.7 82.0 83.3 83.4 83.1 84.3 85.4



All 79.9 80.4 81.0 81.2 82.5 82.6 83.2 83.4 84.1 83.8 85.6 84.9

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.The age of the incident patient is determined as of the date of ESRD initiation. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.24 (continued)One-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

624

Reference section I

Table I.25Two-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 91 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 42.9 95.5 80.5 76.0 78.2 75.8 90.1 92.2 72.0 90.4 70.75-9 80.0 100.0 89.9 91.7 77.0 83.3 83.1 100.0 100.0 100.0 87.010-14 75.0 78.8 98.0 100.0 89.5 98.1 93.3 100.0 94.2 91.9 87.015-19 100.0 100.0 88.0 89.8 87.0 87.9 88.7 92.4 97.0 95.0 97.920-29 80.8 78.1 82.7 81.7 76.4 80.8 87.1 78.2 86.5 83.9 81.430-39 66.0 76.7 75.2 80.5 75.1 73.3 71.9 76.3 79.2 78.6 79.540-49 72.7 70.1 68.9 70.1 69.5 73.3 70.0 75.2 75.9 74.2 80.150-59 65.8 67.3 64.2 64.5 66.0 61.3 61.8 62.7 66.4 67.2 69.360-64 66.2 52.5 52.8 54.6 52.6 55.7 55.8 57.7 60.4 59.0 57.665-69 40.4 54.9 47.5 51.3 51.2 48.1 42.9 46.4 52.9 52.3 56.070-79 46.0 42.9 43.2 38.1 37.5 47.4 38.2 43.0 42.4 42.6 40.980+ 12.5 35.9 21.9 22.6 25.2 32.9 25.7 16.9 23.5 30.1 35.4

Male 65.1 64.0 63.8 61.8 61.8 60.2 61.1 63.5 64.0 63.8 64.6Female 63.3 62.9 57.5 63.2 62.2 63.8 60.0 60.9 66.3 65.9 66.9




All 64.2 63.4 60.7 62.5 61.9 62.0 60.6 62.3 65.1 64.7 65.7

ADJUSTED0-19 54.4 . . . 71.6 73.7 80.5 90.6 78.5 . 76.020-44 67.8 75.7 75.0 77.2 73.9 74.5 75.9 76.4 78.3 77.7 79.445-64 64.8 60.2 60.4 61.5 60.9 61.1 60.4 63.4 66.7 67.0 68.465-74 40.8 48.7 45.1 44.6 44.6 47.3 41.3 46.5 50.3 50.6 52.075+ 29.1 33.8 30.9 28.0 30.0 39.7 31.2 29.6 29.5 33.9 35.6

Male 53.7 55.5 55.4 52.9 52.3 53.0 53.3 55.9 56.9 57.5 58.0Female 48.8 52.8 50.1 54.1 52.4 55.1 50.8 53.8 57.9 58.7 61.2

White 47.0 51.0 49.6 51.1 49.2 51.8 48.9 52.2 55.1 55.9 56.1Black 59.0 57.5 56.8 55.0 56.4 56.0 57.3 58.1 60.0 59.6 63.6Other race 67.1 . 50.7 . 54.4 52.0 60.5 49.1 56.8 69.0 78.0


All 51.6 54.0 52.7 53.4 52.3 54.1 52.2 54.8 57.4 58.1 59.5

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110 are excluded.Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.25Two-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

625


Table I.25 (continued)Two-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 91 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 76.4 84.4 81.5 83.3 78.0 81.3 77.1 81.4 81.9 74.3 83.45-9 100.0 90.2 92.7 91.5 98.0 94.9 96.1 95.5 95.5 98.0 91.010-14 96.4 85.7 93.0 100.0 93.5 89.7 91.9 97.0 100.0 94.0 94.815-19 95.1 94.9 87.0 91.2 93.3 91.2 95.5 88.2 96.9 93.4 95.120-29 84.6 87.7 88.0 87.6 89.7 87.4 91.8 92.1 93.4 92.9 89.530-39 82.3 80.6 82.3 81.2 84.2 84.5 84.6 85.7 88.9 90.6 88.840-49 75.0 79.2 78.4 78.3 80.8 82.5 82.2 82.6 82.5 84.2 87.450-59 67.3 71.3 72.5 73.3 72.5 73.3 74.7 73.2 76.8 76.6 77.060-64 61.3 60.8 66.1 64.7 63.0 63.7 67.0 64.8 66.0 69.9 69.665-69 54.9 59.3 60.9 61.5 61.1 61.3 56.1 62.6 60.0 60.6 66.770-79 48.5 47.6 48.6 48.3 51.1 50.9 51.9 52.6 51.1 48.7 58.980+ 35.8 33.1 33.1 33.3 34.4 38.0 32.4 40.0 35.9 39.6 40.9

Male 65.6 67.3 69.5 68.8 69.7 69.6 70.5 70.2 71.6 72.3 73.7Female 68.5 70.0 69.5 69.6 70.2 71.6 70.7 71.9 72.2 71.8 74.7




All 66.9 68.5 69.5 69.2 70.0 70.5 70.6 71.1 71.9 72.1 74.2

ADJUSTED0-19 . 81.6 76.7 83.5 81.1 79.7 81.1 80.5 . 78.5 83.220-44 79.8 81.0 81.3 81.0 83.7 83.6 85.3 85.1 88.2 88.8 88.045-64 68.3 71.0 72.9 72.9 73.0 74.5 75.4 74.5 76.4 77.7 78.465-74 55.0 56.9 58.8 58.3 59.7 59.7 59.3 61.8 59.3 59.3 66.475+ 40.6 38.1 39.4 38.7 40.9 43.3 39.8 44.9 43.7 42.5 48.6

Male 59.5 61.6 64.5 64.1 65.3 65.5 67.3 67.1 68.8 69.7 71.6Female 62.4 63.8 63.8 63.9 65.3 66.8 65.4 67.4 67.5 67.1 70.7



All 60.8 62.6 64.2 64.0 65.3 66.2 66.5 67.3 68.3 68.6 71.2

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three. The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110 are excluded.Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories. †CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.25 (continued)Two-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to two years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

626

Reference section I

Table I.26Three-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 91 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 42.9 95.5 80.5 76.0 78.2 75.8 90.1 86.5 72.0 84.4 66.5 67.95-9 80.0 100.0 89.9 91.7 77.0 69.4 83.1 100.0 83.3 100.0 79.8 100.010-14 75.0 52.5 98.0 93.8 89.5 98.1 93.3 94.1 94.2 91.9 87.0 96.415-19 100.0 100.0 88.0 85.7 82.6 77.9 85.1 89.7 92.8 87.0 91.4 91.220-29 74.9 70.1 73.0 76.5 72.0 76.2 78.8 71.9 81.6 77.9 72.8 77.930-39 57.6 65.5 64.3 69.9 68.6 63.5 63.1 65.7 68.9 69.2 71.7 73.440-49 57.0 61.0 56.9 57.3 57.9 63.6 60.5 62.4 62.5 61.0 64.8 63.350-59 55.1 56.8 52.4 51.2 53.3 48.3 47.8 48.1 52.4 53.1 56.2 51.760-64 49.9 39.7 38.7 42.8 39.1 42.1 44.1 43.8 42.3 45.7 43.0 47.865-69 30.8 43.9 36.4 35.2 36.5 35.6 30.5 32.4 38.6 35.8 39.4 38.770-79 38.0 28.8 29.3 26.5 23.2 31.8 21.1 26.2 29.6 27.0 24.4 32.180+ . 15.4 10.9 12.9 19.4 12.5 16.8 10.4 13.7 13.8 22.8 23.6

Male 51.8 51.9 51.9 49.5 48.6 47.3 47.4 47.8 49.4 49.9 49.7 51.6Female 54.1 51.8 45.0 50.6 51.5 51.1 49.3 49.3 53.8 52.2 53.7 55.0




All 52.9 51.9 48.5 50.1 50.0 49.2 48.3 48.6 51.5 51.0 51.6 53.2

ADJUSTED0-19 . 82.3 . 75.1 . 65.2 . . . . 68.7 .20-44 58.5 65.1 64.3 68.1 66.2 65.8 66.9 65.8 67.3 67.9 69.4 71.245-64 50.3 48.8 47.4 47.9 47.5 48.1 47.9 49.5 51.6 53.2 54.0 53.965-74 . 35.5 32.0 31.0 30.4 33.6 27.5 30.7 36.3 33.7 35.0 39.175+ . 20.0 19.9 17.0 18.5 23.0 16.1 17.9 18.9 20.2 21.4 24.8

Male 40.1 43.3 43.3 40.7 39.1 40.7 39.8 40.2 42.3 43.7 42.8 45.4Female 39.1 41.3 38.2 41.4 41.7 42.5 40.1 42.5 45.1 44.6 47.8 48.6

White 34.5 38.2 37.6 37.4 37.4 39.1 36.0 37.8 40.4 41.2 41.4 43.8Black 51.1 48.8 44.3 45.9 43.2 44.3 46.1 46.0 48.4 47.8 49.6 50.6Other race . 37.3 . . . 36.4 54.3 . 47.2 53.3 67.7 59.6


All 39.8 42.2 40.6 41.0 40.3 41.6 39.9 41.2 43.6 44.2 45.1 46.8

Reference cohort is 1996 incident ESRD patients. Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of ESRD initiation.Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.26Three-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

627


Table I.26 (continued)Three-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 91 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 84.4 75.0 80.8 78.0 71.5 67.8 81.4 81.9 71.25-9 90.2 85.0 85.8 90.5 94.9 96.1 90.2 95.5 93.510-14 85.7 79.7 95.0 86.1 85.6 88.3 97.0 100.0 90.615-19 92.8 83.5 91.2 91.0 89.4 90.8 83.2 85.5 86.520-29 80.5 82.7 84.1 84.4 82.4 86.8 87.4 86.1 86.430-39 68.8 70.9 71.7 76.1 77.4 78.9 78.8 82.0 83.340-49 64.6 66.0 67.3 70.2 71.2 72.1 71.7 74.2 72.250-59 58.0 56.9 58.3 59.1 59.5 59.3 61.7 63.6 65.960-64 46.3 49.6 50.6 47.5 49.2 53.4 51.4 49.3 54.365-69 43.3 43.3 42.6 46.6 46.3 40.2 43.3 41.9 45.470-79 28.8 34.1 31.4 36.1 35.7 34.3 36.5 34.0 34.380+ 20.0 18.5 15.3 15.8 20.3 17.4 20.0 19.9 24.7

Male 51.9 54.2 53.8 56.1 55.7 55.2 55.5 57.6 57.3Female 56.6 55.7 56.3 57.7 59.4 59.0 60.3 59.0 61.8




All 54.2 55.0 55.0 56.9 57.5 57.0 57.9 58.3 59.5

ADJUSTED0-19 . 66.4 78.9 . 73.2 73.2 76.6 . 71.720-44 69.5 70.0 72.2 75.7 75.7 78.9 77.0 80.3 78.945-64 57.2 58.0 59.0 59.6 61.3 61.7 62.9 63.8 66.165-74 40.1 42.1 40.5 45.4 44.7 41.9 44.2 41.9 44.775+ 20.8 26.0 21.7 24.1 27.4 24.7 27.9 27.4 28.4

Male 46.1 49.1 48.7 51.3 51.5 51.7 52.4 54.7 54.7Female 49.8 49.5 50.1 52.4 54.1 53.3 55.4 53.8 56.6



All 47.8 49.3 49.4 51.8 52.7 52.5 53.8 54.4 55.7


Table I.26 (continued)Three-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to three years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

628

Reference section I

Table I.27Five-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 91 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 42.9 95.5 80.5 76.0 78.2 62.0 90.1 86.5 72.0 84.4 66.55-9 80.0 100.0 89.9 91.7 77.0 52.1 69.2 100.0 83.3 81.8 79.810-14 75.0 26.3 87.1 93.8 79.5 98.1 93.3 87.4 84.8 73.5 80.315-19 100.0 100.0 78.2 85.7 67.6 64.3 75.6 85.5 83.9 78.1 77.220-29 70.8 54.4 57.5 65.9 52.3 62.5 64.0 59.8 70.9 60.7 56.130-39 47.0 49.7 47.0 49.7 51.4 47.8 46.4 47.5 54.1 54.8 53.840-49 41.4 43.1 42.8 39.8 40.3 47.3 44.6 41.1 46.7 43.5 45.350-59 35.5 39.3 34.7 34.4 33.9 30.3 32.4 31.3 30.5 33.1 32.160-64 36.3 21.6 22.1 22.7 19.2 22.0 27.0 25.0 24.6 24.5 22.165-69 19.2 21.3 17.6 16.5 19.3 21.9 17.1 17.1 19.3 16.8 21.870-79 18.0 12.9 11.6 10.3 8.2 15.9 7.1 14.2 11.4 12.7 9.980+ . 2.6 3.1 . 7.8 1.6 9.2 1.3 4.9 6.5 7.1

Male 36.2 31.4 31.9 30.3 29.2 31.2 31.5 30.7 30.4 31.8 29.7Female 39.5 35.9 30.1 33.2 33.7 31.9 33.4 32.2 36.0 33.4 33.6




All 37.8 33.7 31.1 31.7 31.4 31.6 32.4 31.4 33.1 32.5 31.6

ADJUSTED0-19 . . . . 59.7 51.1 . 78.3 . 66.8 60.220-44 46.6 49.6 49.4 49.4 48.2 51.0 51.2 50.2 52.3 52.0 51.045-64 32.8 30.3 30.1 30.1 28.0 28.9 31.6 30.4 32.3 33.0 31.265-74 16.8 16.1 13.9 14.1 14.3 20.3 13.3 16.6 17.2 15.7 18.675+ . 6.6 7.5 4.0 7.1 7.8 6.1 8.0 6.1 9.7 6.8

Male 25.9 24.9 25.6 23.8 22.2 26.7 25.4 24.7 25.0 27.1 24.4Female 26.1 26.8 24.9 25.8 26.1 25.6 25.9 27.3 28.8 27.4 29.4

White 20.8 21.9 22.6 21.7 21.8 23.8 22.1 23.0 23.5 24.4 23.1Black 42.1 32.5 27.7 29.2 25.4 28.9 30.6 29.6 32.3 31.1 32.0Other race 40.0 . 25.3 31.7 28.9 24.0 44.8 30.1 30.7 33.9 42.7


All 26.1 25.7 25.1 24.7 24.0 26.2 25.6 25.9 26.8 27.2 26.7


Table I.27Five-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

629


Table I.27 (continued)Five-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 91 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 19980-4 67.9 68.3 61.7 72.2 64.4 65.3 64.2 70.75-9 100.0 90.2 85.0 80.0 67.0 94.9 96.1 82.010-14 72.3 85.7 63.8 84.4 86.1 85.6 88.3 67.915-19 81.3 89.2 83.5 81.2 87.9 82.2 87.7 76.820-29 67.2 70.1 73.3 75.5 71.6 74.3 82.1 75.730-39 53.5 52.3 55.3 59.0 58.8 62.2 64.3 62.940-49 45.9 42.6 49.9 49.1 52.2 50.8 50.5 51.950-59 30.4 36.8 38.2 36.0 36.9 38.1 37.5 41.660-64 25.9 26.0 28.6 29.5 26.7 27.2 31.1 27.065-69 16.8 23.2 23.5 21.8 23.6 23.2 20.9 22.770-79 13.8 13.5 13.3 12.3 16.8 15.7 14.7 16.080+ 6.6 6.9 4.5 6.8 4.9 5.4 5.8 5.4

Male 30.8 32.2 35.0 34.0 35.6 34.3 34.1 34.1Female 34.6 37.1 36.9 36.7 37.4 39.8 39.5 40.1




All 32.5 34.6 35.9 35.3 36.5 37.0 36.7 37.0

ADJUSTED0-19 62.5 71.0 58.9 65.9 . 67.0 . 59.820-44 52.9 52.5 56.2 58.3 58.5 59.6 62.2 60.145-64 33.0 36.0 38.7 37.7 38.6 40.0 40.5 42.165-74 18.0 21.7 21.6 19.9 23.5 22.2 21.3 22.575+ 8.8 7.2 8.0 8.0 9.2 11.3 9.7 11.4

Male 26.4 27.9 31.2 30.4 31.8 31.1 31.6 32.1Female 29.5 31.6 31.9 31.4 33.2 35.4 34.9 36.3



All 27.8 29.6 31.5 30.9 32.5 33.2 33.2 34.1


Table I.27 (continued)Five-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to five years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

PATIENT SURVIVALI

630

Reference section I

Table I.28Ten-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 91 to ten years + 90 days, by age, gender, race, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 19930-4 42.9 95.5 80.5 76.0 67.0 49.6 90.1 86.5 48.0 70.3 35.5 60.4 54.6 52.95-9 80.0 80.0 67.4 91.7 77.0 34.7 69.2 100.0 83.3 65.5 59.8 100.0 75.2 34.010-14 . 26.3 56.5 82.0 79.5 65.4 35.0 87.4 70.7 36.7 40.2 72.3 85.7 63.815-19 100.0 57.1 68.4 71.4 25.4 38.7 52.0 79.8 77.9 67.4 46.5 44.7 58.4 46.420-29 56.6 34.5 33.0 48.0 39.6 38.9 41.4 36.3 44.9 39.2 38.4 38.4 46.4 50.730-39 25.4 26.0 24.2 27.5 29.4 24.8 28.3 24.2 28.3 29.3 31.4 29.0 23.5 31.440-49 19.9 19.7 15.0 21.4 20.0 19.5 17.4 19.3 21.8 19.8 18.5 19.7 16.8 22.250-59 14.6 13.6 9.7 11.1 9.6 11.1 8.3 9.5 9.0 9.4 10.0 8.2 10.0 9.660-64 7.6 7.4 4.6 4.8 5.1 5.1 6.9 4.5 6.2 4.7 3.3 4.3 5.4 5.665-69 5.8 4.3 2.7 3.8 4.6 7.9 4.0 1.7 2.6 3.4 3.9 2.6 4.1 3.870-79 6.0 1.2 1.7 1.9 0.7 3.3 1.9 1.9 0.9 1.4 1.3 1.9 1.8 1.180+ . 2.6 . . 3.9 . . . 1.0 0.8 0.8 0.9 1.4 .

Male 15.6 12.7 10.7 12.7 10.8 11.0 11.4 10.8 10.3 10.7 10.0 9.9 10.5 11.5Female 18.5 13.5 9.8 13.7 14.6 13.1 12.6 11.8 14.9 13.1 12.1 12.4 12.2 12.9



All 16.9 13.1 10.2 13.1 12.6 12.0 12.0 11.3 12.5 11.9 11.0 11.0 11.4 12.2

ADJUSTED0-19 . 42.0 42.0 . 38.9 28.9 43.1 . . 44.5 27.5 39.1 43.9 33.220-44 27.7 27.7 23.3 28.7 29.2 27.0 28.4 27.5 28.7 28.1 27.3 26.9 25.7 30.245-64 11.8 10.4 8.4 10.2 8.6 9.3 9.0 9.1 10.6 10.0 9.0 9.5 10.4 11.765-74 4.6 2.5 2.6 3.1 3.1 6.2 3.5 2.3 2.4 3.2 3.4 3.4 3.6 3.575+ . 1.5 0.6 . 1.9 3.1 0.9 1.3 1.1 0.3 0.6 0.6 1.6 0.3

Male 11.3 10.4 8.8 10.1 7.8 10.6 9.5 8.7 8.3 9.0 8.2 8.7 9.4 10.7Female 11.3 10.3 8.7 10.6 12.0 11.4 9.9 10.9 12.4 11.1 11.2 11.2 11.2 11.6



All 11.4 10.2 8.7 10.2 9.8 11.0 9.7 9.6 10.2 10.0 9.6 9.8 10.2 11.1


Table I.28Ten-year survival probabilities: incident CAPD/CCPD patientscensored at transplant, from day 9 to ten years + 90 days, by age, gender, race, & primary diagnosis

631


Table I.2990-day patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 92.9 92.0 94.4 94.1 95.7 95.0 97.8 94.6 100.0 97.9 92.5 97.55-9 97.0 98.2 98.1 100.0 97.8 100.0 100.0 100.0 98.5 98.5 91.5 100.010-14 96.7 98.7 100.0 98.3 99.2 97.6 97.6 96.7 97.6 97.8 98.1 98.015-19 98.0 96.9 97.1 96.7 97.3 97.5 97.7 97.5 98.7 96.6 96.7 99.120-29 95.1 97.2 97.1 97.4 97.2 98.0 97.0 97.7 97.5 97.1 98.4 98.630-39 93.1 94.1 94.8 95.5 97.0 96.7 96.3 97.0 97.0 97.0 96.8 97.940-49 92.2 92.5 95.2 94.1 95.7 95.2 95.5 94.8 96.2 95.9 95.9 97.050-59 90.2 90.3 89.9 93.0 93.2 90.8 92.3 92.8 93.4 94.1 95.0 95.660-64 100.0 95.5 90.9 91.5 90.8 94.6 92.1 94.8 91.0 94.6 93.9 96.365+ 88.9 87.5 80.0 100.0 95.5 93.1 84.8 82.8 89.6 91.9 93.1 92.0

Male 94.2 94.6 95.3 95.7 96.0 95.8 95.2 95.3 95.5 95.7 96.1 97.1Female 92.8 94.4 94.9 95.2 96.6 96.1 96.4 96.4 96.6 96.7 96.3 97.3




All 93.7 94.5 95.2 95.5 96.2 95.9 95.7 95.7 95.9 96.1 96.2 97.2

ADJUSTED0-19 95.9 95.9 97.4 97.1 97.7 98.7 98.3 96.0 97.6 96.6 93.1 98.020-44 92.6 93.8 94.8 95.0 96.4 96.7 96.3 96.1 96.7 96.5 96.9 97.845-64 88.1 89.8 90.9 92.2 92.6 91.2 92.1 93.3 93.6 94.3 94.3 95.865+ 93.0 . 85.9 90.5 92.9 93.4 86.4 87.3 87.4 89.1 94.1 92.6

Male 84.5 85.5 87.6 88.6 89.8 89.7 88.8 89.4 90.3 90.6 91.9 94.0Female 80.5 84.4 86.8 87.9 91.4 90.5 91.4 91.8 92.6 92.7 92.2 94.5

White 82.6 85.1 86.7 87.6 90.4 89.9 88.9 89.7 90.8 90.9 91.3 94.2Black 83.8 86.4 90.1 90.6 90.9 91.5 92.2 92.2 92.7 93.6 94.7 94.8Other race . 83.6 83.8 88.6 91.6 81.0 94.9 92.8 90.4 91.2 91.1 93.0


All 83.1 85.3 87.4 88.4 90.5 90.0 89.8 90.4 91.2 91.5 92.0 94.2


Table I.2990-day patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

PATIENT SURVIVALI

632

Reference section I

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of transplant. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.29 (continued)90-day patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis

Table I.29 (continued)90-day patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 96.0 93.3 97.5 97.6 96.4 96.4 97.7 96.6 97.4 100.0 98.25-9 100.0 98.2 96.2 96.3 98.5 98.3 96.4 98.1 96.0 100.0 100.010-14 98.9 100.0 99.4 98.3 97.1 99.1 100.0 99.3 99.1 97.6 100.015-19 99.1 97.8 99.2 99.1 98.9 98.3 99.5 98.8 99.5 99.4 99.420-29 97.8 98.9 99.0 98.9 99.2 99.1 98.9 99.2 98.7 98.9 98.130-39 97.8 98.4 98.0 98.0 98.1 97.8 98.2 98.0 98.4 98.7 98.740-49 97.1 97.1 97.4 97.5 96.7 97.1 97.7 97.4 97.6 97.7 97.350-59 95.5 95.5 96.0 95.9 96.3 95.8 96.9 95.9 96.0 96.4 96.560-64 93.2 95.3 96.2 93.4 94.7 96.4 97.0 95.0 94.6 95.4 96.165+ 93.3 92.5 95.5 94.2 95.2 93.9 95.7 94.1 94.7 94.5 94.9

Male 96.8 97.0 97.3 97.0 96.9 97.2 97.8 97.2 96.9 97.2 97.3Female 96.8 97.4 97.7 97.3 97.4 96.8 97.4 97.0 97.4 97.7 97.2




All 96.8 97.2 97.4 97.1 97.1 97.1 97.7 97.1 97.1 97.4 97.3

ADJUSTED0-19 97.9 97.2 98.1 98.3 97.7 98.0 98.5 98.1 . 98.2 .20-44 97.3 98.4 98.2 98.1 98.2 98.2 98.4 98.1 98.3 98.6 98.545-64 95.6 95.6 96.3 96.1 96.0 96.1 97.0 96.3 96.5 96.8 96.665+ 92.5 93.3 94.7 92.5 93.9 93.6 95.4 94.1 93.8 94.2 94.9

Male 93.6 94.2 94.8 94.5 94.5 95.1 96.3 95.2 95.0 95.5 95.8Female 93.6 94.9 95.6 94.9 95.3 94.4 95.6 94.8 95.7 96.2 95.7



All 93.6 94.5 95.1 94.7 94.9 94.8 96.0 95.1 95.3 95.8 95.8

633


Table I.30One-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 71.4 88.0 94.4 91.2 91.5 91.7 97.8 91.1 86.0 95.7 84.9 90.05-9 97.0 98.2 98.1 100.0 97.8 98.4 96.3 98.5 98.5 95.6 91.5 98.110-14 91.3 96.1 100.0 94.9 98.3 95.3 97.6 95.9 96.0 94.4 93.5 97.115-19 95.9 93.8 95.2 96.3 94.9 96.3 95.1 94.6 98.3 94.0 96.0 97.920-29 90.6 93.5 93.9 94.4 94.2 96.1 93.8 95.2 94.4 95.4 96.6 96.830-39 86.2 89.0 90.6 89.9 92.9 93.5 92.5 93.4 94.0 94.3 93.9 95.340-49 83.5 83.9 88.6 87.3 88.7 90.1 89.7 89.2 91.9 91.4 91.5 94.350-59 81.9 79.9 78.0 83.5 85.9 83.0 84.8 85.8 87.9 89.5 90.1 91.460-64 75.0 72.7 81.8 78.7 84.6 88.2 86.5 87.0 84.4 88.3 87.8 90.665+ 77.8 62.5 40.0 90.0 63.6 72.4 69.7 81.0 83.0 87.4 83.1 84.7

Male 87.3 88.6 90.0 91.1 90.9 91.3 90.6 90.8 91.3 92.1 91.9 93.9Female 86.6 88.6 90.3 88.5 92.1 92.9 91.8 92.2 93.0 93.3 93.2 94.6




All 87.1 88.6 90.2 90.2 91.4 91.9 91.0 91.3 92.0 92.6 92.4 94.1

ADJUSTED0-19 90.2 93.1 96.9 94.3 95.5 96.2 96.7 92.8 93.6 93.6 90.2 94.920-44 85.4 87.6 89.6 89.7 91.4 93.6 92.1 92.1 93.0 93.4 93.7 95.045-64 76.3 77.9 81.2 82.2 84.7 83.4 84.0 86.1 88.1 88.9 89.0 91.965+ . 65.9 46.1 72.0 61.6 71.6 77.9 81.0 77.2 82.9 83.7 84.5

Male 68.8 71.6 75.1 77.9 78.2 79.6 79.0 80.0 82.0 83.4 83.7 87.7Female 66.7 70.6 76.1 73.0 80.9 83.2 81.2 83.0 85.1 85.9 85.9 89.0



All 68.2 71.5 75.6 76.2 79.3 81.0 79.9 81.2 83.2 84.4 84.6 88.2


Table I.30One-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

PATIENT SURVIVALI

634

Reference section I

Table I.30 (continued)One-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 92.0 91.1 92.5 95.2 96.4 94.5 97.7 93.1 97.4 97.8 94.55-9 100.0 94.6 94.3 92.6 98.5 98.3 96.4 96.3 94.0 100.0 98.410-14 98.9 99.0 95.5 98.3 96.2 98.3 99.0 97.9 98.1 97.6 100.015-19 97.7 96.0 96.7 97.8 98.4 96.6 97.3 97.9 99.1 98.9 98.920-29 95.8 97.1 97.3 97.5 97.5 97.4 97.8 97.6 97.4 96.9 96.530-39 95.1 95.8 94.9 96.2 96.0 96.0 96.5 96.6 96.4 97.6 96.940-49 93.8 94.2 93.8 94.2 93.9 94.5 95.3 94.3 94.6 95.2 94.750-59 90.2 91.4 91.6 91.7 92.3 91.0 92.6 92.5 90.6 92.3 93.060-64 88.2 87.4 89.9 87.7 89.7 90.8 89.2 88.9 89.0 90.6 90.965+ 88.8 82.5 87.6 87.4 90.6 85.8 88.9 87.6 88.5 86.6 89.2

Male 93.3 93.7 93.4 93.8 94.1 93.9 94.5 94.1 93.3 94.1 94.1Female 93.8 93.9 94.3 94.5 94.5 93.8 94.6 94.1 94.2 94.6 94.8




All 93.5 93.8 93.8 94.1 94.2 93.9 94.6 94.1 93.6 94.3 94.3

ADJUSTED0-19 96.4 94.4 93.7 . . 96.6 97.4 96.1 . . 97.720-44 94.4 95.8 95.3 96.1 95.9 96.3 96.6 96.5 96.3 96.9 96.945-64 90.8 91.1 91.7 91.7 92.4 91.9 93.0 92.3 91.8 93.1 93.265+ 87.4 83.4 86.4 85.5 87.5 85.6 88.1 87.4 87.4 87.4 88.8

Male 87.0 88.0 87.8 88.8 89.5 89.5 90.8 90.2 89.3 90.8 90.8Female 87.8 88.4 89.3 89.8 90.3 89.2 90.9 89.9 90.6 91.3 91.8



All 87.3 88.2 88.4 89.2 89.9 89.4 90.8 90.1 89.8 91.0 91.3


Table I.30 (continued)One-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis

635


Table I.31Two-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 19910-4 64.3 80.0 94.4 91.2 91.5 90.0 91.1 91.1 84.0 93.6 84.9 87.55-9 97.0 92.9 94.3 100.0 97.8 96.7 94.4 98.5 97.1 95.6 89.8 98.110-14 89.1 93.5 97.9 90.6 98.3 93.7 95.2 95.1 95.2 93.3 91.7 97.115-19 93.9 93.3 93.2 93.8 93.4 92.9 91.7 93.3 97.0 92.1 94.5 96.620-29 86.1 90.4 89.3 91.4 90.7 93.8 91.3 92.4 92.2 93.6 94.5 94.830-39 81.0 83.1 85.5 85.2 88.4 88.5 88.6 88.8 90.2 91.4 91.7 92.940-49 77.3 78.3 82.7 80.1 83.0 86.6 84.3 84.2 87.9 87.3 87.9 91.250-59 73.9 73.8 72.4 74.1 79.0 77.7 79.6 79.9 83.5 84.2 86.1 88.160-64 65.0 72.7 78.8 68.1 80.0 81.7 78.6 77.6 77.2 82.9 84.8 84.865+ 66.7 62.5 20.0 80.0 54.5 55.2 63.6 75.9 79.2 81.1 76.9 80.1

Male 81.7 83.6 85.8 85.2 86.0 87.0 86.1 85.7 87.3 88.5 89.0 91.0Female 82.2 84.7 84.5 84.4 88.4 89.4 88.2 89.0 89.9 89.9 90.2 91.8




All 81.9 84.0 85.3 84.9 86.9 87.9 86.8 86.9 88.3 89.0 89.5 91.3

ADJUSTED0-19 88.5 89.2 94.9 91.5 . 93.3 92.2 92.4 92.4 91.6 88.5 93.420-44 79.0 82.0 83.6 84.4 86.0 89.1 88.0 87.7 89.5 90.5 90.8 92.545-64 68.2 71.1 74.5 72.6 78.3 78.2 77.9 79.4 82.6 83.3 84.9 87.965+ 59.2 . . 62.9 51.6 . 67.9 72.1 70.9 76.7 78.4 78.2

Male 57.9 61.5 66.2 65.6 68.2 70.8 70.2 70.3 74.5 76.6 78.3 82.2Female 57.8 62.3 64.0 64.7 72.8 75.9 73.9 76.5 78.9 79.2 80.2 83.7

White 56.6 62.3 64.2 64.3 69.7 72.8 70.6 72.0 75.7 77.1 78.2 82.4Black 63.7 61.6 71.3 69.0 71.4 73.5 74.9 75.1 78.9 80.0 82.7 84.5Other race 57.4 64.7 . 65.1 72.7 69.7 73.5 73.7 . 79.9 79.5 85.4


All 58.0 62.0 65.5 65.4 70.0 72.8 71.6 72.7 76.2 77.7 79.1 82.8


Table I.31Two-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

PATIENT SURVIVALI

636

Reference section I

Table I.31 (continued)Two-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 90.0 86.7 90.0 95.2 92.7 92.7 97.7 93.1 94.7 95.65-9 100.0 94.6 94.3 90.7 95.4 98.3 96.4 96.3 94.0 98.410-14 95.6 98.0 92.9 97.5 94.2 97.4 98.0 97.9 97.2 95.215-19 96.7 93.8 95.9 97.8 96.8 94.9 96.3 96.7 98.1 98.320-29 93.9 95.6 96.7 96.0 96.1 95.8 96.6 96.5 95.9 95.230-39 92.2 93.7 92.0 94.2 93.9 93.6 94.7 94.6 93.7 94.840-49 90.5 90.2 90.3 92.1 90.8 92.1 92.4 92.2 92.3 91.750-59 86.0 87.2 87.2 87.7 88.3 87.6 88.9 88.9 87.0 87.560-64 82.2 83.3 84.8 83.6 84.8 86.4 84.6 83.9 83.4 85.365+ 83.9 75.4 81.6 80.9 84.9 80.1 82.0 83.4 82.7 81.8

Male 90.1 90.3 89.9 91.0 91.2 91.0 91.4 91.4 90.2 90.5Female 90.4 91.0 91.6 92.3 91.2 91.3 92.1 91.8 91.1 91.1




All 90.2 90.6 90.6 91.5 91.2 91.1 91.7 91.5 90.6 90.7

ADJUSTED0-19 94.3 92.1 91.2 96.2 94.5 95.6 96.9 . 95.7 95.520-44 91.4 93.4 93.0 94.3 93.9 94.1 94.7 94.5 94.0 94.445-64 86.5 86.5 87.2 88.3 88.3 88.6 89.3 89.4 88.6 88.665+ 80.8 77.2 80.2 79.2 81.5 79.2 81.8 81.3 80.8 82.3

Male 81.1 82.0 81.7 83.9 84.6 84.7 85.7 85.8 84.6 85.2Female 81.6 83.0 84.5 85.9 84.7 85.0 86.6 86.1 85.8 85.9

White 80.8 81.7 82.0 83.7 84.2 84.5 86.4 86.2 86.0 85.9Black 83.0 84.2 84.5 87.4 85.6 85.9 85.5 85.7 83.1 85.0Other race 86.2 89.5 . 87.8 89.1 86.8 89.3 87.4 87.8 87.7


All 81.4 82.5 82.8 84.7 84.7 84.9 86.2 86.0 85.1 85.6


Table I.31 (continued)Two-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis

637


Table I.32Three-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 64.3 76.0 91.7 91.2 89.4 88.3 86.7 89.3 80.0 93.6 83.05-9 97.0 91.1 94.3 97.6 93.5 93.4 94.4 98.5 97.1 94.1 89.810-14 88.0 92.2 92.6 89.7 97.5 89.8 92.1 95.1 95.2 91.0 90.715-19 93.4 89.2 90.8 92.5 91.4 91.7 89.4 93.3 94.8 90.2 92.620-29 83.2 88.3 85.8 88.4 88.1 90.4 88.8 90.6 90.0 91.4 92.330-39 76.3 79.3 80.2 80.7 83.9 84.8 84.4 85.2 86.5 89.1 89.040-49 71.4 74.1 77.3 73.6 78.4 80.5 78.5 80.0 84.0 83.6 84.150-59 67.8 68.5 65.6 66.8 71.6 72.1 74.6 73.5 78.5 79.8 82.260-64 55.0 68.2 72.7 63.8 72.3 68.8 71.4 71.4 72.7 77.8 79.065+ 44.4 50.0 20.0 70.0 54.5 48.3 54.5 67.2 70.8 73.0 70.0

Male 78.1 80.0 80.1 80.1 81.4 82.2 81.2 81.6 83.3 85.3 85.4Female 76.8 81.2 81.3 81.0 84.8 85.4 85.1 85.9 86.8 86.7 87.5




All 77.6 80.4 80.6 80.4 82.7 83.4 82.6 83.2 84.7 85.9 86.2

ADJUSTED0-19 . 86.1 92.1 90.3 93.0 89.8 88.8 92.2 . 90.5 87.520-44 74.1 78.1 78.1 79.5 81.2 84.5 83.4 84.3 85.8 87.6 88.045-64 61.8 65.6 67.4 65.3 72.3 71.5 72.3 73.3 77.7 78.8 80.265+ 28.2 . . . 47.9 45.4 59.4 65.6 63.3 68.1 70.9

Male 51.8 55.1 55.8 56.3 59.7 62.0 61.5 63.2 67.5 70.9 72.0Female 48.3 55.4 57.9 58.3 65.5 67.7 67.8 70.4 73.0 73.3 75.0

White 48.8 55.3 55.9 56.4 61.1 64.8 63.3 65.6 69.6 71.6 71.9Black 58.1 56.3 60.4 60.1 65.1 63.6 65.4 67.2 70.8 73.2 77.7Other race . . . 54.7 65.6 59.0 . . 66.4 . .


All 50.7 55.5 56.7 57.2 62.0 64.2 63.9 66.0 69.6 71.9 73.2

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of transplant. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.32Three-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

PATIENT SURVIVALI

638

Reference section I

Table I.32 (continued)Three-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 87.5 90.0 86.7 90.0 92.9 92.7 89.1 95.5 91.4 92.15-9 94.4 100.0 94.6 94.3 90.7 92.3 98.3 96.4 96.3 94.010-14 94.1 92.2 97.0 92.9 96.7 94.2 97.4 98.0 96.4 95.315-19 94.4 94.4 92.1 95.5 97.0 94.6 93.2 96.3 96.3 97.620-29 92.3 92.7 93.4 94.5 94.5 94.1 93.9 95.6 95.2 94.530-39 90.5 89.6 90.7 89.8 91.6 92.0 91.7 92.9 92.1 91.440-49 88.1 87.0 86.5 87.4 89.4 87.4 89.2 89.1 89.5 90.050-59 83.0 81.6 83.4 83.0 83.1 84.1 83.1 84.3 84.7 83.660-64 79.8 78.6 76.3 80.1 78.4 79.3 80.7 79.2 77.6 78.665+ 75.0 75.0 69.4 74.2 73.5 78.9 72.0 76.1 77.4 77.4

Male 87.3 86.9 86.8 86.9 87.7 88.0 87.8 87.9 88.2 87.7Female 89.1 87.3 87.7 88.6 89.2 87.9 87.9 89.4 88.6 87.9




All 88.0 87.0 87.1 87.6 88.3 88.0 87.8 88.5 88.3 87.8

ADJUSTED0-19 91.2 . . . 95.1 92.9 94.2 96.5 94.7 94.420-44 89.8 88.9 90.6 90.4 91.8 91.7 92.0 92.9 92.4 91.945-64 83.0 81.9 81.7 83.4 84.2 84.1 84.4 85.1 85.4 85.265+ 71.9 72.9 70.7 72.9 72.3 74.8 71.4 75.2 74.1 75.7

Male 75.6 75.5 75.9 76.7 78.5 79.4 79.5 80.3 80.8 80.8Female 78.5 75.8 77.2 79.3 80.5 79.3 79.4 82.2 80.9 80.7



All 76.8 75.7 76.5 77.7 79.4 79.4 79.6 81.1 80.9 80.8

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of transplant. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.32 (continued)Three-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis

639


Table I.33Five-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 64.3 72.0 88.9 88.2 85.1 86.7 84.4 87.5 80.0 91.5 83.05-9 97.0 87.5 81.1 97.6 89.1 90.2 92.6 95.5 91.2 89.7 89.810-14 84.8 87.0 87.4 86.3 93.3 85.8 84.9 91.8 92.8 88.8 89.815-19 90.8 82.6 86.5 90.0 89.1 83.8 86.4 90.8 88.8 88.3 90.820-29 77.6 82.0 80.7 81.3 82.4 84.8 82.2 85.4 85.3 85.8 87.630-39 68.1 69.9 73.8 72.6 72.9 77.0 75.9 76.5 80.1 83.0 83.640-49 61.4 65.7 65.7 63.2 69.3 68.7 67.0 69.0 74.6 76.0 76.350-59 52.2 58.1 53.1 54.7 59.7 61.8 61.9 61.8 66.6 69.0 71.760-64 20.0 45.5 57.6 53.2 52.3 54.8 50.0 58.9 57.8 66.5 68.065+ 33.3 25.0 . 50.0 40.9 27.6 39.4 51.7 60.4 63.1 53.8

Male 69.7 71.2 71.6 71.9 72.0 73.3 70.9 72.4 74.8 77.4 78.0Female 68.8 74.2 74.4 72.7 77.0 77.4 77.3 78.0 79.0 80.5 81.0




All 69.4 72.2 72.6 72.2 73.9 74.9 73.2 74.5 76.5 78.6 79.2

ADJUSTED0-19 85.7 80.0 84.2 86.9 89.3 83.7 84.8 89.6 85.6 86.7 85.720-44 65.6 68.8 71.0 70.8 71.6 75.7 74.5 75.8 78.2 81.1 82.245-64 46.8 54.2 52.9 52.5 59.1 59.1 58.1 60.5 65.9 68.0 69.665+ . 25.0 10.7 37.5 35.6 29.4 39.2 47.7 50.0 57.4 55.8

Male 39.5 41.7 42.6 43.6 45.1 47.8 46.1 49.0 54.3 58.1 60.0Female 36.9 43.9 46.6 45.2 52.1 53.9 54.6 57.1 59.9 62.6 63.8



All 38.7 42.7 44.2 44.4 47.7 50.2 49.2 52.1 56.5 59.9 61.6


Table I.33Five-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

PATIENT SURVIVALI

640

Reference section I

Table I.33 (continued)Five-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 19980-4 87.5 88.0 82.2 90.0 90.5 92.7 87.3 90.95-9 92.6 98.1 91.1 92.5 88.9 87.7 98.3 94.610-14 90.2 91.1 94.1 90.9 95.0 93.3 95.7 93.915-19 91.5 92.1 89.4 92.2 93.5 91.4 88.1 94.720-29 88.8 88.0 88.6 91.1 90.3 88.7 90.2 92.430-39 83.4 83.3 84.4 83.7 85.7 87.2 86.8 89.140-49 80.2 77.3 80.2 79.3 81.5 79.5 82.3 82.750-59 71.7 70.5 72.1 73.6 73.5 74.5 72.7 75.360-64 64.8 67.6 61.6 64.4 65.3 69.4 69.9 66.765+ 58.0 58.5 54.4 60.3 56.3 62.8 58.7 64.7

Male 78.5 78.6 78.7 79.1 79.9 80.4 80.8 81.2Female 82.5 79.4 80.6 81.4 81.8 80.7 80.3 82.9




All 80.1 78.9 79.5 80.0 80.6 80.5 80.6 81.9

ADJUSTED0-19 87.5 90.1 88.0 89.0 92.3 89.9 92.4 91.720-44 83.4 82.3 84.6 84.4 86.2 86.2 86.7 88.845-64 71.3 70.2 71.1 73.3 73.6 74.2 75.0 76.165+ 56.1 57.0 54.7 58.2 57.7 61.2 58.5 63.7

Male 61.2 62.1 63.1 64.5 66.3 67.7 68.9 70.3Female 67.2 62.9 65.7 67.7 68.4 68.2 68.0 72.2



All 63.6 62.5 64.3 65.9 67.3 68.0 68.6 71.2

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of transplant. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

Table I.33 (continued)Five-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, primary diagnosis

641


Table I.34Ten-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 19930-4 57.1 68.0 80.6 85.3 78.7 81.7 84.4 83.9 72.0 89.4 79.2 85.0 82.0 71.15-9 87.9 80.4 69.8 85.7 73.9 85.2 87.0 85.1 82.4 83.8 78.0 87.0 96.2 83.910-14 80.4 76.6 75.8 76.9 81.7 76.4 73.8 82.8 80.8 80.9 83.3 77.5 86.7 84.215-19 78.6 71.8 77.8 82.2 81.6 71.7 77.7 82.1 82.0 80.5 82.0 82.5 82.8 79.720-29 63.9 68.6 67.2 69.5 68.2 72.3 68.4 72.3 72.3 73.1 74.2 75.7 72.4 76.130-39 49.6 49.9 55.3 55.3 55.4 58.5 56.6 58.2 63.1 63.8 64.5 64.2 65.4 67.140-49 40.2 42.2 43.7 42.7 44.9 45.9 45.4 47.8 51.8 53.5 55.1 55.2 55.0 58.650-59 29.7 30.5 29.1 30.8 32.8 29.9 32.8 36.5 39.5 42.4 43.9 43.8 41.7 46.160-64 10.0 9.1 30.3 21.3 16.9 29.0 23.0 29.2 24.9 34.6 32.3 33.3 31.7 30.565+ 11.1 . . 10.0 18.2 6.9 9.1 31.0 27.4 30.6 20.0 22.7 24.1 20.6

Male 50.8 52.1 52.5 53.8 52.4 54.2 51.4 53.6 54.4 56.7 56.9 56.4 56.0 58.0Female 54.6 56.3 59.2 58.3 59.5 58.2 58.3 59.7 59.8 61.6 60.8 61.3 59.0 60.8



All 52.2 53.6 55.0 55.5 55.0 55.7 53.9 55.9 56.5 58.6 58.4 58.3 57.2 59.1

ADJUSTED0-19 75.4 66.3 70.9 75.7 77.5 71.8 74.5 77.0 75.3 76.6 76.3 77.6 81.8 75.320-44 46.3 49.2 52.9 53.2 53.2 57.1 55.8 57.3 60.5 62.6 63.5 63.6 63.6 67.345-64 26.2 28.7 28.1 29.8 31.4 31.0 31.3 36.0 38.1 40.8 41.6 42.8 41.1 44.965+ . . . 3.3 12.7 7.8 14.4 19.6 17.5 24.1 20.6 20.3 20.8 19.8

Male 20.4 21.8 22.2 23.6 23.7 25.6 24.7 27.5 30.0 32.2 33.5 33.4 33.8 36.8Female 21.8 23.3 27.7 27.5 29.4 29.4 30.3 33.0 34.3 36.8 36.3 38.0 35.9 39.0



All 21.1 22.5 24.3 25.1 25.8 27.1 26.8 29.6 31.7 34.0 34.7 35.3 34.7 37.8

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of transplant. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories."." Zero values in this cell.

Table I.34Ten-year patient survival probabilities: first transplants, deceased donorsby age, gender, race/ethnicity, & primary diagnosis

PATIENT SURVIVALI

642

Reference section I

Table I.3590-day patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 100.0 100.0 95.2 100.0 95.1 100.0 100.0 100.0 94.3 100.0 92.25-9 100.0 100.0 100.0 96.7 100.0 100.0 97.6 100.0 97.2 98.2 92.710-14 100.0 100.0 98.5 98.8 99.0 100.0 98.0 100.0 100.0 99.0 92.015-19 97.6 97.6 100.0 98.8 99.3 98.2 99.4 100.0 100.0 100.0 94.520-29 99.3 98.7 98.9 98.3 98.1 98.7 98.8 99.4 99.1 98.3 99.230-39 97.3 97.4 98.4 97.0 98.9 98.3 99.0 98.7 98.4 99.6 97.840-49 98.5 96.3 94.9 97.7 97.6 97.0 98.6 98.6 98.8 99.7 97.750-59 94.4 91.8 98.4 95.8 95.7 96.6 98.1 98.5 96.2 97.6 96.260-64 100.0 100.0 80.0 90.9 100.0 100.0 95.0 98.4 95.2 94.6 96.865+ 100.0 100.0 . 100.0 100.0 100.0 90.0 100.0 100.0 75.0 95.0

Male 98.2 97.9 98.1 97.5 98.9 98.5 98.3 99.0 98.6 98.7 97.3Female 98.6 97.0 97.9 98.0 97.0 97.5 99.0 99.1 98.5 99.1 96.9




All 98.4 97.5 98.0 97.7 98.2 98.1 98.6 99.0 98.6 98.9 97.1

ADJUSTED0-19 97.6 99.1 98.5 98.7 97.7 . 98.3 . 97.8 . 87.720-44 97.7 96.2 97.4 96.8 98.0 97.9 98.7 98.7 98.4 98.6 98.145-64 . 94.0 96.2 95.4 95.9 95.9 97.1 98.4 96.9 98.0 95.965+ . . . . . . 91.4 96.9 . . 90.0

Male 93.1 91.7 93.2 91.3 96.1 95.5 94.8 96.9 95.2 95.7 91.1Female 94.7 90.2 93.3 93.6 91.0 93.0 97.2 97.5 95.3 97.2 91.3

White 92.6 91.8 92.9 91.3 94.9 94.7 95.8 97.3 94.3 96.3 91.1Black . 89.0 95.6 95.4 88.7 95.8 97.1 97.3 . 95.8 90.5Other race . 86.9 . . . 88.4 92.7 95.8 . . .

Diabetes 95.7 92.7 89.8 89.8 93.9 90.6 95.8 95.3 97.0 . 95.1Hypertension 97.0 95.7 95.8 94.9 97.0 97.0 97.6 . 94.2 97.6 89.6Glomerulonephritis 96.6 95.1 96.4 98.3 95.3 97.5 97.1 97.6 96.2 97.0 93.5Other cause 93.6 90.8 95.8 92.3 95.5 96.9 96.5 98.6 96.2 95.3 91.1

All 93.7 91.0 93.2 92.2 94.0 94.4 95.8 97.1 95.2 96.3 91.1


Table I.3590-day patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

643


Table I.35 (continued)90-day patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 19990-4 95.7 93.5 98.9 95.7 95.8 100.0 100.0 100.0 100.05-9 98.7 100.0 100.0 100.0 96.1 98.6 100.0 98.5 100.010-14 98.0 98.1 100.0 100.0 100.0 99.2 100.0 99.2 98.615-19 98.8 98.1 100.0 100.0 99.5 99.5 100.0 98.9 100.020-29 99.8 99.4 99.0 99.8 99.3 99.7 99.5 100.0 99.730-39 98.8 99.2 98.8 99.1 99.2 99.2 99.4 98.9 99.440-49 99.3 99.4 99.8 99.5 99.1 98.7 98.9 99.2 99.250-59 98.2 98.3 97.9 98.6 97.2 97.0 97.5 98.8 98.060-64 91.5 93.8 100.0 96.6 96.1 98.7 98.0 97.4 98.165+ 94.1 100.0 97.6 100.0 95.9 96.8 97.4 96.1 98.2

Male 98.7 98.8 99.2 99.2 98.4 98.7 99.0 98.9 98.9Female 98.8 98.6 99.0 99.4 98.8 98.9 98.7 99.1 99.1


†Hispanic 98.2 99.3 99.0 99.2†Non-Hispanic 98.8 98.8 98.9 99.0


All 98.7 98.7 99.1 99.3 98.6 98.7 98.9 99.0 99.0

ADJUSTED0-19 96.4 96.0 . . 97.2 98.8 . 98.4 99.320-44 99.0 99.1 98.7 99.3 98.9 99.1 99.2 98.9 99.345-64 98.1 98.1 98.7 98.5 97.6 97.7 97.7 98.7 98.265+ 89.2 92.4 . . 95.8 95.4 95.9 95.7 98.1

Male 95.7 96.3 97.5 97.6 95.6 96.6 97.6 97.3 97.5Female 96.8 96.4 97.4 98.5 97.2 97.3 96.9 97.9 98.1

White 96.0 96.5 97.6 98.0 95.8 96.5 97.1 97.3 97.7Black . 95.5 97.0 97.5 98.2 98.1 97.7 98.6 98.0Other race . . . . . . 98.8 98.0 .

Diabetes 95.3 96.8 97.6 96.9 95.7 96.7 96.0 96.6 98.3Hypertension . 97.6 99.0 99.1 97.6 98.5 98.2 98.8 97.7Glomerulonephritis 98.7 97.7 98.2 98.3 98.4 98.3 99.1 99.2 97.6Other cause 95.4 96.3 97.2 99.1 96.3 96.6 97.6 97.6 98.5

All 96.2 96.3 97.4 98.0 96.3 96.9 97.2 97.5 97.7


Table I.35 (continued)90-day patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, primary diagnosis

PATIENT SURVIVALI

644

Reference section I

Table I.36One-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 100.0 100.0 90.5 93.3 92.7 100.0 91.8 98.5 88.7 96.4 88.25-9 96.2 100.0 97.1 93.3 97.9 98.1 97.6 100.0 97.2 98.2 92.710-14 100.0 100.0 98.5 97.6 98.1 98.8 98.0 100.0 97.1 98.0 89.715-19 96.4 96.0 97.5 96.3 98.6 98.2 98.9 97.7 98.7 98.5 93.320-29 97.0 96.5 96.2 97.3 96.2 97.4 97.6 97.9 98.3 96.4 98.430-39 94.2 94.6 94.8 94.8 97.4 95.6 97.0 96.2 96.6 99.1 97.440-49 93.3 91.4 91.1 93.4 95.2 95.4 96.6 95.9 96.4 97.6 96.650-59 88.9 87.7 93.4 92.3 93.3 95.3 95.9 96.9 93.1 93.5 93.060-64 100.0 100.0 70.0 90.9 100.0 100.0 93.3 93.4 90.5 94.6 90.365+ . 100.0 . 100.0 100.0 88.9 86.7 100.0 85.7 75.0 90.0

Male 94.5 95.0 94.8 94.9 97.0 96.9 96.3 96.7 96.8 96.8 95.9Female 96.6 94.7 94.8 95.9 95.4 95.7 97.5 97.3 96.5 97.8 95.7




All 95.4 94.8 94.8 95.3 96.4 96.5 96.8 97.0 96.6 97.2 95.8

ADJUSTED0-19 95.3 97.2 95.6 93.4 96.0 98.2 95.6 97.9 93.4 96.8 84.920-44 93.2 92.6 92.7 94.1 95.5 95.3 96.6 95.7 97.0 96.7 97.045-64 90.4 87.5 91.1 91.2 93.1 94.2 94.7 95.8 92.6 95.0 93.465+ 60.2 . . . . . 85.8 . 76.2 . 85.1

Male 80.2 81.7 82.9 83.1 90.0 91.0 89.3 90.5 89.1 89.5 87.0Female 87.9 83.4 83.7 87.6 86.3 88.2 93.2 92.9 89.6 93.7 88.1

White 83.1 82.2 84.0 84.5 89.2 89.6 90.8 90.9 88.4 90.9 86.8Black 84.5 84.9 84.7 86.6 . . 94.9 93.9 94.5 91.9 .Other race 88.9 . 70.4 90.1 95.5 . 83.7 . . . .

Diabetes 81.8 83.1 77.4 79.0 85.5 82.3 87.9 88.4 90.6 96.6 90.8Hypertension 91.1 89.4 90.5 92.9 . . 94.5 97.5 91.9 94.2 88.6Glomerulonephritis 93.4 92.7 92.4 95.0 93.0 94.3 95.2 93.2 . 90.3 90.4Other cause 83.4 81.1 85.9 85.6 90.3 94.9 93.3 94.6 87.9 91.7 88.0

All 83.2 82.2 83.2 84.9 88.5 89.8 90.9 91.4 89.2 91.3 87.3

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of transplant.Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank."." Zero values in this cell.

Table I.36One-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

645


Table I.36 (continued)One-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-4 95.7 93.5 97.8 91.3 94.4 98.7 98.9 100.0 100.0 97.0 98.2 97.95-9 98.7 100.0 98.3 98.3 96.1 98.6 100.0 98.5 100.0 100.0 98.7 98.910-14 97.0 96.3 97.3 99.0 98.3 98.3 100.0 99.2 98.6 100.0 98.6 100.015-19 97.6 96.2 99.5 98.4 98.9 99.5 99.1 98.9 99.5 99.1 100.0 99.620-29 99.2 98.6 98.1 99.5 99.0 99.5 98.8 99.4 99.1 99.1 99.2 99.130-39 98.4 98.0 97.5 98.3 98.2 98.3 98.0 98.6 98.6 98.1 97.9 98.640-49 97.4 97.9 97.8 97.2 97.7 98.1 97.2 97.4 97.8 97.9 98.3 98.050-59 94.1 95.5 94.3 96.1 94.4 95.6 95.2 97.1 96.3 95.9 96.2 96.560-64 87.2 83.8 96.4 93.3 92.2 93.6 96.0 95.2 95.8 97.1 94.6 96.165+ 94.1 96.4 87.8 100.0 91.9 95.7 93.9 89.5 94.6 93.9 94.8 95.5

Male 97.3 97.2 97.3 97.1 96.7 97.9 97.9 97.6 97.5 97.4 97.4 97.6Female 97.7 96.8 97.2 98.8 97.8 97.7 96.7 97.8 98.3 97.8 97.7 97.9




All 97.5 97.0 97.3 97.8 97.2 97.8 97.4 97.7 97.8 97.5 97.5 97.7

ADJUSTED0-19 95.5 94.0 97.1 96.3 95.6 98.0 99.2 . . 98.8 98.6 99.020-44 97.9 97.7 97.4 98.1 97.9 98.5 97.7 98.3 97.9 98.1 97.7 98.145-64 94.8 95.0 95.0 95.5 94.9 96.0 95.1 96.4 96.4 96.1 96.3 96.665+ . 77.6 87.1 . 90.7 92.6 92.7 89.7 95.2 93.2 94.3 94.8

Male 91.7 91.6 92.1 91.9 91.3 94.8 94.7 94.4 94.3 94.3 94.5 95.1Female 93.9 91.7 92.9 96.9 94.8 94.8 92.3 95.0 96.3 95.2 95.3 95.8

White 92.4 91.9 92.7 94.2 91.9 94.3 93.3 95.0 95.2 94.9 94.7 95.4Black 92.2 89.8 91.1 94.1 95.6 95.4 94.2 93.1 94.9 94.3 95.0 95.2Other race . . . 95.2 . . . 96.1 96.1 95.3 97.6 97.1


All 92.6 91.6 92.4 94.1 92.8 94.7 93.6 94.6 95.1 94.7 94.8 95.4


Table I.36 (continued)One-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, primary diagnosis

PATIENT SURVIVALI

646

Reference section I

Table I.37Two-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 100.0 100.0 85.7 90.0 92.7 100.0 91.8 97.0 84.9 96.4 88.25-9 96.2 100.0 97.1 90.0 97.9 98.1 92.9 97.5 97.2 98.2 92.710-14 91.8 98.0 98.5 96.4 97.1 98.8 95.0 97.8 95.1 98.0 88.515-19 94.0 94.4 96.8 95.7 97.1 97.6 97.7 97.1 97.4 98.5 93.320-29 95.7 94.3 94.9 95.8 95.1 96.6 96.1 95.8 97.0 94.3 97.730-39 93.3 90.1 92.6 91.3 95.7 93.0 95.4 94.6 95.0 97.4 96.240-49 88.1 89.0 88.6 89.9 92.7 94.0 94.8 92.1 95.6 95.5 93.750-59 88.9 86.3 89.3 89.4 90.9 92.7 94.0 93.8 88.5 91.2 90.360-64 100.0 100.0 70.0 90.9 95.2 100.0 91.7 91.8 85.7 94.6 90.365+ . 100.0 . 100.0 100.0 55.6 86.7 100.0 85.7 75.0 85.0

Male 92.9 92.0 92.7 92.5 95.6 95.2 94.6 94.5 94.9 95.1 94.7Female 93.5 92.4 93.5 93.6 93.6 94.3 96.0 94.8 95.1 96.5 94.1




All 93.2 92.2 93.0 92.9 94.8 94.9 95.1 94.6 95.0 95.7 94.4

ADJUSTED0-19 89.5 . . 90.8 95.4 97.6 93.0 95.3 90.7 . .20-44 91.2 87.3 90.0 90.5 93.5 93.5 94.4 93.5 95.3 94.2 95.845-64 83.3 86.0 87.9 88.3 89.3 91.4 92.5 90.8 88.7 92.3 89.365+ . . . . . 77.5 . . . . .

Male 75.1 72.6 76.6 76.1 85.4 86.2 84.5 84.5 83.3 84.2 83.4Female 78.0 76.9 80.0 81.1 81.4 84.5 89.1 86.5 85.7 89.9 84.1

White 76.5 73.9 78.7 78.0 84.4 85.9 86.2 84.5 84.1 86.2 83.2Black 78.6 78.8 79.3 78.2 80.9 86.7 91.2 88.6 86.5 . 85.2Other race 69.9 74.8 66.3 . . 77.8 . . 85.4 . .

Diabetes 72.7 68.3 69.7 67.9 79.4 77.9 82.4 79.5 84.0 89.5 87.1Hypertension 88.3 87.3 . 89.9 91.2 93.3 . 92.5 88.5 . 85.6Glomerulonephritis 87.3 91.3 89.7 92.3 90.0 91.6 91.6 91.0 91.5 86.9 87.6Other cause 78.4 73.1 81.5 79.9 87.6 90.9 90.6 90.0 84.2 . 84.8

All 76.1 74.2 77.9 78.0 83.7 85.4 86.3 85.2 84.2 86.5 83.5


Table I.37Two-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

647


Table I.37 (continued)Two-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 20010-4 95.7 93.5 97.8 91.3 94.4 94.9 95.7 97.4 96.7 97.0 97.35-9 98.7 100.0 94.8 98.3 96.1 98.6 98.1 98.5 98.6 98.5 98.710-14 97.0 95.3 97.3 99.0 98.3 97.5 100.0 99.2 98.6 100.0 97.915-19 97.0 95.0 98.9 97.9 97.9 99.5 98.2 97.8 98.6 97.8 99.620-29 98.0 97.8 97.6 98.6 97.6 98.5 98.3 98.2 98.6 97.9 97.930-39 96.3 97.0 96.1 97.7 97.0 96.8 97.5 97.2 97.7 97.3 97.340-49 94.8 96.6 97.0 94.5 96.2 96.1 96.1 95.8 96.3 96.0 96.950-59 92.2 93.7 91.9 93.4 91.3 92.8 93.6 95.2 95.1 93.3 93.860-64 85.1 82.5 92.9 88.8 87.6 91.7 94.4 93.9 93.2 94.1 92.265+ 88.2 92.9 85.4 90.7 86.5 92.6 90.4 86.8 89.9 89.3 90.0

Male 95.7 96.2 96.3 95.8 95.0 96.3 96.8 96.1 95.9 95.3 95.9Female 96.0 95.6 95.8 96.7 96.1 95.8 95.7 96.3 97.4 96.2 95.9




All 95.8 95.9 96.1 96.2 95.5 96.1 96.3 96.2 96.5 95.7 95.9

ADJUSTED0-19 . 92.6 . . . . 97.2 . . 97.6 97.920-44 95.6 96.4 96.3 97.0 96.2 96.5 96.8 96.6 96.6 96.6 96.645-64 92.0 93.2 92.7 91.8 91.9 93.5 93.4 94.2 94.7 93.3 93.965+ . . 82.7 . 83.4 88.9 89.4 86.7 90.8 87.6 90.0

Male 87.0 88.6 89.4 88.4 87.0 90.8 91.8 90.9 90.7 89.9 91.4Female 89.4 88.8 89.3 91.8 90.7 90.6 90.1 91.8 94.1 92.0 91.8

White 87.6 89.1 89.7 90.3 87.6 90.5 90.6 91.7 92.1 90.9 91.3Black 87.9 86.1 86.9 88.6 92.5 89.7 91.8 89.3 91.8 90.9 91.6Other race . . . . 92.9 . . . . 92.0 .

Diabetes 83.6 87.1 87.5 90.8 87.0 89.8 88.5 88.4 91.8 88.7 90.6Hypertension 93.5 92.8 . 91.3 92.5 92.2 93.7 94.4 94.7 91.3 93.2Glomerulonephritis 93.3 93.4 94.8 93.2 92.7 94.9 . 96.3 93.2 94.5 94.9Other cause 91.2 89.8 91.2 90.8 90.2 91.6 92.0 92.3 93.9 93.7 92.7

All 87.9 88.5 89.2 89.8 88.5 90.6 91.0 91.2 92.0 90.7 91.5


Table I.37 (continued)Two-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, primary diagnosis

PATIENT SURVIVALI

648

Reference section I

Table I.38Three-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 100.0 100.0 85.7 76.7 90.2 100.0 89.8 95.5 84.9 94.6 88.25-9 96.2 92.0 94.1 90.0 97.9 98.1 90.5 97.5 97.2 98.2 92.710-14 89.8 94.1 97.0 96.4 96.2 98.8 95.0 97.8 94.1 98.0 88.515-19 94.0 93.6 96.8 94.5 95.7 96.4 97.2 95.4 96.1 97.8 92.720-29 94.7 91.5 92.5 93.1 94.1 95.7 94.8 93.7 96.0 94.0 97.130-39 90.6 86.3 89.3 88.4 93.2 91.2 94.3 93.3 92.8 96.3 93.940-49 83.0 82.2 85.2 87.5 87.9 90.5 93.8 91.1 94.8 92.4 90.850-59 80.6 80.8 82.8 85.2 87.8 90.6 91.7 91.3 85.5 86.5 88.660-64 50.0 100.0 70.0 90.9 90.5 100.0 90.0 86.9 85.7 91.9 90.365+ . 100.0 . 100.0 100.0 55.6 83.3 88.0 85.7 75.0 80.0

Male 90.2 88.1 89.8 89.7 93.5 93.1 93.1 92.6 93.2 93.9 92.9Female 91.6 88.9 90.9 91.1 90.7 93.1 94.9 93.3 94.0 94.6 93.0




All 90.8 88.4 90.2 90.3 92.5 93.1 93.8 92.9 93.5 94.2 92.9

ADJUSTED0-19 . 91.7 93.5 87.7 93.2 96.4 91.4 93.8 . . .20-44 88.4 82.8 86.2 86.6 91.3 91.6 93.0 91.5 93.2 92.9 93.645-64 74.0 76.7 82.4 84.9 82.9 87.7 90.4 88.4 86.6 87.7 86.865+ 26.9 . . . . . . 84.5 . . .

Male 67.0 61.9 68.8 68.6 79.3 80.5 80.8 79.5 78.4 80.7 78.3Female 71.9 67.9 72.7 74.3 73.8 81.2 86.1 82.8 82.6 84.6 81.2

White 68.7 63.5 71.5 70.2 78.0 81.4 82.8 80.0 80.5 81.9 79.1Black . . 67.5 72.2 72.6 81.1 86.9 85.3 79.0 . .Other race . . . . 83.6 . 78.2 86.3 . . .

Diabetes . 55.8 58.7 57.7 70.7 70.1 77.6 73.9 77.7 . 80.9Hypertension . . . 85.3 87.6 90.5 . 89.0 84.4 87.7 .Glomerulonephritis 79.5 85.2 86.9 87.6 84.4 88.9 89.2 87.4 89.5 85.0 85.4Other cause 73.6 62.5 75.5 74.6 83.4 88.5 88.0 87.4 . 85.3 81.7

All 68.8 64.1 70.2 70.8 77.0 80.7 82.8 80.8 80.0 82.2 79.3


Table I.38Three-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

649


Table I.38 (continued)Three-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 20000-4 95.7 91.9 95.7 91.3 94.4 94.9 95.7 97.4 96.7 95.55-9 98.7 98.6 94.8 98.3 94.8 97.2 98.1 98.5 98.6 96.910-14 97.0 93.5 97.3 99.0 98.3 97.5 100.0 98.5 97.8 100.015-19 95.8 92.5 98.4 96.9 97.9 98.5 96.4 97.8 97.7 97.420-29 96.9 96.6 95.9 97.3 96.2 96.6 97.5 97.1 97.0 97.630-39 94.1 95.7 94.2 96.3 96.3 95.9 96.2 95.5 96.7 96.740-49 92.4 94.5 95.1 93.1 94.5 94.4 94.0 94.3 94.9 94.350-59 89.5 91.3 86.8 88.4 88.5 91.1 91.5 93.2 91.8 90.860-64 83.0 80.0 86.9 79.8 83.7 87.3 91.4 90.0 85.3 90.965+ 88.2 85.7 78.0 81.4 82.4 88.3 85.1 82.2 86.9 84.7

Male 93.9 94.4 93.7 93.9 93.5 94.7 95.1 94.3 93.9 93.5Female 94.5 93.7 94.0 94.3 94.5 94.3 93.9 94.9 95.2 94.7




All 94.2 94.1 93.8 94.1 94.0 94.5 94.6 94.6 94.4 94.0

ADJUSTED0-19 . 90.2 94.7 94.9 . . 96.0 . 96.3 .20-44 93.6 94.2 93.9 95.3 94.9 94.9 95.1 94.7 95.1 95.845-64 88.5 90.5 88.1 87.3 88.9 91.0 90.7 91.9 90.8 90.665+ . 67.8 . 79.1 . 84.2 83.6 81.3 86.0 82.7

Male 81.8 83.6 82.3 83.4 83.4 86.8 87.8 86.7 86.3 86.3Female 85.4 84.1 84.9 86.0 87.0 87.2 86.1 88.6 89.2 88.9

White 83.3 84.9 83.2 85.0 83.8 86.6 86.6 87.7 87.6 87.1Black 81.4 78.0 83.5 83.9 88.6 86.3 88.7 86.2 86.2 88.7Other race . 87.9 . 84.8 . . 92.3 . . .

Diabetes 75.9 81.2 80.6 84.0 82.1 85.1 82.5 83.8 86.0 84.7Hypertension . 89.4 85.1 86.6 89.9 88.4 90.2 91.0 91.5 88.5Glomerulonephritis 90.9 89.2 91.4 89.4 90.1 92.1 94.5 94.5 90.5 92.2Other cause 89.3 86.8 86.7 87.5 87.7 89.7 89.3 89.3 90.0 91.1

All 83.2 83.6 83.2 84.4 84.8 86.9 86.9 87.4 87.4 87.3


Table I.38 (continued)Three-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, primary diagnosis

PATIENT SURVIVALI

650

Reference section I

Table I.39Five-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 19900-4 90.0 93.3 71.4 70.0 90.2 100.0 85.7 88.1 83.0 94.6 88.25-9 96.2 92.0 85.3 90.0 97.9 96.2 90.5 97.5 91.7 98.2 89.110-14 85.7 90.2 97.0 92.9 94.3 97.6 93.1 97.8 93.1 96.0 85.115-19 91.6 89.6 95.6 92.7 93.5 92.8 93.7 94.9 92.8 96.3 91.520-29 92.3 88.6 89.0 87.6 90.9 90.9 89.9 90.1 93.4 91.9 95.130-39 83.9 78.0 83.6 84.2 88.3 86.2 90.4 88.9 86.5 92.1 90.340-49 75.6 75.5 77.6 81.3 82.4 84.2 88.7 87.2 87.3 86.2 85.950-59 66.7 72.6 73.0 78.9 79.3 82.8 86.7 84.5 81.7 78.2 80.060-64 50.0 75.0 60.0 72.7 90.5 83.9 86.7 78.7 61.9 73.0 74.265+ . 100.0 . 100.0 66.7 44.4 70.0 80.0 85.7 75.0 70.0

Male 84.9 81.3 84.7 84.2 89.4 87.3 88.7 88.3 89.1 90.3 89.7Female 87.4 85.0 85.4 87.1 86.4 88.6 90.4 89.4 88.4 90.0 88.2




All 85.9 82.8 85.0 85.4 88.2 87.8 89.4 88.7 88.9 90.1 89.0

ADJUSTED0-19 84.1 87.3 89.2 83.4 90.5 92.8 87.3 . 86.0 94.2 81.120-44 81.3 74.9 79.6 80.0 86.2 85.1 87.4 86.2 87.3 88.3 89.745-64 65.0 66.3 72.0 76.7 73.8 79.0 84.0 82.3 77.6 77.9 77.565+ . . . . . . 70.6 72.1 . . .

Male 53.8 47.1 56.9 55.8 67.9 66.7 70.1 69.2 67.2 70.6 69.8Female 60.4 58.6 59.4 64.4 63.1 69.9 74.8 73.4 68.4 72.5 69.5

White 56.1 50.6 58.9 58.3 67.1 68.5 71.6 70.6 69.9 71.6 68.7Black 63.1 56.6 56.0 62.1 60.3 69.2 76.2 73.0 59.5 66.0 74.8Other race . . 58.6 76.4 79.1 63.4 . 78.3 61.2 96.3 .


All 56.2 51.4 57.8 59.1 65.9 67.9 71.9 70.8 67.6 71.3 69.4


Table I.39Five-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

651


Table I.39 (continued)Five-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, primary diagnosis

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 19980-4 95.7 90.3 94.6 91.3 91.7 93.6 92.4 97.45-9 96.2 98.6 93.1 98.3 94.8 97.2 98.1 96.910-14 93.9 92.5 94.7 97.9 96.6 95.8 97.3 97.715-19 95.2 91.2 95.2 95.8 96.3 96.6 91.4 96.120-29 95.5 94.5 94.0 94.8 92.5 94.3 94.8 94.530-39 90.6 92.7 90.8 91.7 93.1 92.4 91.5 92.340-49 86.3 87.6 89.2 88.4 90.0 89.3 90.3 90.150-59 81.7 86.7 77.8 81.5 82.5 84.3 84.5 85.060-64 76.6 68.8 75.0 65.2 75.2 82.8 79.8 79.565+ 82.4 78.6 65.9 69.8 73.0 79.8 74.6 66.4

Male 90.5 91.0 89.4 89.2 89.6 90.6 90.0 89.1Female 90.5 89.5 89.3 90.4 90.2 90.2 89.1 90.3




All 90.5 90.3 89.3 89.7 89.8 90.4 89.6 89.6

ADJUSTED0-19 92.8 88.3 91.1 . 92.9 92.7 90.6 .20-44 89.8 90.2 90.0 90.3 89.8 90.4 89.7 90.445-64 79.9 82.9 78.6 79.5 82.7 84.3 83.4 83.765+ . 55.8 59.1 66.9 67.6 75.7 72.1 65.9

Male 72.7 74.5 71.6 72.0 74.2 77.4 76.3 75.8Female 75.5 74.1 73.6 77.0 77.2 78.3 75.5 78.6



All 73.7 74.1 72.2 74.0 75.3 77.6 75.8 76.8


Table I.39 (continued)Five-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, primary diagnosis

PATIENT SURVIVALI

652

Reference section I

Table I.40Ten-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 19930-4 80.0 80.0 66.7 66.7 85.4 91.4 85.7 85.1 77.4 92.9 86.3 91.3 83.9 90.35-9 84.6 92.0 70.6 80.0 93.7 94.2 83.3 85.0 88.9 96.4 85.5 92.4 92.9 91.410-14 77.6 80.4 89.4 83.3 85.7 95.2 84.2 90.1 88.2 87.0 79.3 86.9 86.9 85.015-19 81.9 86.4 87.3 89.0 84.2 86.7 84.1 84.6 90.2 90.3 84.2 88.5 80.5 87.620-29 86.3 80.1 79.5 77.7 81.1 80.8 80.8 79.2 88.3 84.0 87.3 86.9 83.6 85.130-39 69.5 65.8 68.3 71.8 73.3 71.4 76.7 75.3 72.5 79.9 79.2 77.3 80.5 78.540-49 56.3 54.6 60.3 64.2 64.0 65.9 68.6 66.0 65.1 71.0 67.8 69.5 71.1 71.350-59 38.9 52.1 43.4 62.0 64.0 57.5 57.8 64.1 58.8 53.5 51.9 53.9 59.1 54.560-64 . 75.0 50.0 45.5 61.9 58.1 65.0 44.3 47.6 40.5 35.5 53.2 38.8 45.265+ . 100.0 . 25.0 33.3 11.1 30.0 52.0 28.6 25.0 50.0 64.7 50.0 24.4

Male 73.7 69.3 70.5 72.3 75.1 72.4 71.9 72.3 77.3 77.6 76.9 78.1 76.4 75.3Female 74.4 74.4 72.8 75.5 75.5 75.7 77.2 74.8 77.5 79.0 75.7 76.3 74.6 75.1



All 74.0 71.3 71.3 73.6 75.3 73.7 74.0 73.3 77.4 78.2 76.4 77.3 75.6 75.3

ADJUSTED0-19 67.7 78.1 75.1 72.5 80.2 86.5 77.5 78.0 79.1 86.1 72.9 83.1 77.8 81.220-44 67.3 60.2 63.8 65.8 68.4 69.0 70.7 70.1 73.5 75.1 77.2 74.4 74.1 74.945-64 38.3 44.4 45.7 54.8 55.1 53.5 57.0 55.7 54.0 52.6 46.8 55.9 55.2 53.965+ . . . 41.1 50.6 22.5 32.8 34.3 26.1 36.5 40.0 52.6 38.1 23.5

Male 35.6 30.6 34.9 37.6 42.0 42.2 42.1 42.8 44.8 46.3 45.8 48.7 47.4 46.4Female 35.4 39.2 37.0 41.8 42.0 45.0 48.7 46.2 46.3 49.3 45.3 47.7 46.1 46.8



All 35.4 33.8 35.7 39.3 42.1 43.3 44.7 44.1 45.4 47.5 45.5 48.1 46.7 46.5

Reference cohort is 1996 incident ESRD patients.Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis. Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule. The age of the incident patient is determined as of the date of transplant. Patients of unknown age or gender, or of age >110, are excluded. Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories."." Zero values in this cell.

Table I.40Ten-year patient survival probabilities: first transplants, living donorsby age, gender, race/ethnicity, & primary diagnosis

Providercharacteristics

JReferenceSec

tion

PROVIDER CHARACTERISTICSJ

654

Reference section J

J.1 . 655Certified dialysis & transplant facilities: by Medicare certification

J.2 . 655Transplant facilities, patients transplanted, & donor types

J.3 . 655Dialysis facilities, stations, & patient flow J.4 . 656Dialysis & transplant facilities: by state & territory

J.5 . 657Dialysis & transplant facilities: by ESRD network

J.6 . 657Dialysis & transplant facilities: by certification type

J.7 . 657Dialysis & transplant facilities: by service type J.8 . 658Dialysis & transplant facilities: by ownership type

J.9 . 658Dialysis treatments: by modality

J.10 . 659Median number of patients: by certification type

J.11 . 659 Dialysis & transplant patients: by Medicare entitlement

J.12 . 660Dialysis patients: by state & territory

J.13 . 661Dialysis patients: by ESRD network

J.14 . 661Dialysis patients: by certification type

J.15 . 661Dialysis patients: by treatment modality

J.16 . 662Patient & treatment counts: by detailed facility survey field

655

JPROVIDER CHARACTERISTICS2005 Annual Data Report


Table J.1 Certified dialysis & transplant facilities: by Medicare certification

Table J.2 Transplant facilities, patients transplanted, & donor types

Table J.3Dialysis facilities, stations, & patient flow

Table J.1Certified dialysis & transplant facilities: by Medicare certificationby ownership type #

Certified units VA Total TotalDialysis Patients Dialysis Patients Total Dialysis Patients

Facilities Patients Transplanted Facilities Patients Transplanted Facilities Patients Transplanted1991 2,148 141,942 9,997 12 546 14 2,160 142,488 10,0111992 2,292 156,834 10,090 12 520 11 2,304 157,354 10,1011993 2,456 170,958 10,903 13 521 7 2,469 171,479 10,9101994 2,624 186,316 11,295 13 506 1 2,637 186,822 11,2961995 2,876 199,711 11,885 12 451 . 2,888 200,162 11,8851996 3,083 213,731 12,179 12 372 . 3,095 214,103 12,1791997 3,344 229,834 12,367 11 356 . 3,355 230,190 12,3671998 3,576 245,365 13,316 11 345 . 3,587 245,710 13,3161999 3,833 259,159 13,479 10 334 . 3,843 259,493 13,4792000 4,013 273,009 14,300 10 324 . 4,023 273,333 14,3002001 4,175 285,645 14,608 10 337 . 4,185 285,982 14,6082002 4,379 296,322 15,055 54 2,030 22 4,433 298,352 15,0772003 4,530 307,909 15,661 61 2,186 51 4,591 310,095 15,712

Table J.2Transplant facilities, patients transplanted, & donor typesby type & year

Facilities Patients Performing Patients Living Cadaveric Total AwaitingTransplants Transplanted Donors Transplants Transplants Transplant

1991 222 10,011 2,382 7,644 10,026 18,2011992 223 10,101 2,536 7,579 10,115 21,6091993 228 10,910 2,828 8,106 10,934 22,9101994 233 11,296 3,000 8,312 11,312 26,5921995 233 11,885 3,416 8,486 11,902 28,8831996 236 12,179 3,703 8,495 12,198 32,7391997 234 12,367 3,905 8,468 12,373 35,8931998 233 13,316 4,520 8,752 13,272 38,3001999 238 13,479 4,644 8,839 13,483 40,7392000 235 14,300 5,427 8,884 14,311 41,1222001 233 14,608 5,804 8,824 14,628 47,2562002 236 15,077 5,893 9,213 15,106 47,5252003 237 15,712 6,244 9,494 15,738 51,002


Facilities with PatientsPatients Patients Beginning Added Lost Lost-to- Ending

During Year at End of Year Stations of Year During Year During Year Followup Year1991 2,154 2,046 28,985 129,706 82,345 69,209 354 142,4881992 2,289 2,181 30,641 142,780 91,011 76,138 299 157,3541993 2,469 2,353 35,240 157,525 99,821 85,637 230 171,4791994 2,637 2,523 38,169 171,536 108,534 92,921 327 186,8221995 2,888 2,751 41,809 186,649 115,940 102,035 392 200,1621996 3,095 2,957 45,728 199,974 122,943 108,483 331 214,1031997 3,355 3,196 50,569 214,179 133,695 117,305 379 230,1901998 3,587 3,407 54,575 230,181 142,609 126,698 382 245,7101999 3,824 3,630 58,895 245,575 149,445 135,065 462 259,4932000 4,023 3,832 61,537 259,824 154,764 140,766 489 273,3332001 4,181 3,991 68,133 273,169 159,114 145,580 721 285,9822002 4,432 4,204 72,115 287,263 167,568 155,886 593 298,3522003 4,586 4,373 76,294 299,644 170,306 159,111 744 310,095







1991 222 10,011 2,382 7,644 10,026 18,2011992 223 10,101 2,536 7,579 10,115 21,6091993 228 10,910 2,828 8,106 10,934 22,9101994 233 11,296 3,000 8,312 11,312 26,5921995 233 11,885 3,416 8,486 11,902 28,8831996 236 12,179 3,703 8,495 12,198 32,7391997 234 12,367 3,905 8,468 12,373 35,8931998 233 13,316 4,520 8,752 13,272 38,3001999 238 13,479 4,644 8,839 13,483 40,7392000 235 14,300 5,427 8,884 14,311 41,1222001 233 14,608 5,804 8,824 14,628 47,2562002 236 15,077 5,893 9,213 15,106 47,5252003 237 15,712 6,244 9,494 15,738 51,002










1991 222 10,011 2,382 7,644 10,026 18,2011992 223 10,101 2,536 7,579 10,115 21,6091993 228 10,910 2,828 8,106 10,934 22,9101994 233 11,296 3,000 8,312 11,312 26,5921995 233 11,885 3,416 8,486 11,902 28,8831996 236 12,179 3,703 8,495 12,198 32,7391997 234 12,367 3,905 8,468 12,373 35,8931998 233 13,316 4,520 8,752 13,272 38,3001999 238 13,479 4,644 8,839 13,483 40,7392000 235 14,300 5,427 8,884 14,311 41,1222001 233 14,608 5,804 8,824 14,628 47,2562002 236 15,077 5,893 9,213 15,106 47,5252003 237 15,712 6,244 9,494 15,738 51,002






656

Reference section J


Table J.4Dialysis & transplant facilities: by state & territoryby ownership type #

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 42 46 49 52 66 76 80 93 96 95 99 101 106Alaska 3 3 2 2 2 2 2 2 2 2 2 2 2Arizona 43 47 55 57 64 68 76 77 80 81 87 91 94Arkansas 35 35 38 38 41 42 46 52 58 58 64 64 65California 249 250 261 276 296 313 328 346 354 355 366 383 408Colorado 21 21 20 20 22 25 28 32 34 37 39 42 42Connecticut 20 20 21 23 24 23 23 23 33 34 33 32 32Delaware 6 6 7 7 8 8 8 10 11 12 13 15 15District of Columbia 21 21 21 21 23 23 23 23 23 22 23 23 24Florida 146 157 167 177 185 201 216 228 248 253 262 264 269Georgia 84 88 97 100 115 126 140 151 165 182 199 216 219Hawaii 12 12 12 12 14 13 13 14 14 16 18 19 18Idaho 7 7 7 7 6 6 7 8 10 8 7 7 7Illinois 87 96 99 102 105 109 110 109 113 133 148 158 172Indiana 38 41 40 46 47 51 62 64 72 77 82 93 93Iowa 15 18 19 23 25 29 41 42 43 47 49 51 55Kansas 18 20 22 24 25 30 36 38 41 42 40 42 43Kentucky 28 32 32 35 36 40 45 48 49 50 51 57 65Louisiana 72 75 76 86 86 95 96 101 118 126 132 135 134Maine 6 6 6 6 7 8 9 9 13 13 13 15 18Maryland 53 57 61 63 72 73 89 92 103 106 106 115 116Massachusetts 39 46 49 51 55 61 64 66 68 66 70 73 75Michigan 54 60 65 73 81 84 92 105 107 111 118 125 139Minnesota 34 37 44 46 55 57 68 68 67 75 69 74 72Mississippi 33 39 44 47 48 50 52 56 59 64 65 66 67Missouri 52 54 59 60 64 72 77 89 98 104 102 108 111Montana 7 7 7 9 12 13 13 14 16 14 15 15 15Nebraska 12 12 14 14 14 17 18 20 21 24 25 31 36Nevada 6 7 7 6 7 8 10 12 14 17 19 22 22New Hampshire 6 6 6 6 6 6 9 9 10 10 10 11 10New Jersey 37 41 41 47 63 70 76 77 85 91 93 101 108New Mexico 19 19 20 20 25 27 27 29 28 28 30 30 31New York 116 125 124 133 142 151 164 186 204 220 223 239 239North Carolina 62 66 70 81 88 91 95 98 107 110 118 130 138North Dakota 10 11 11 11 12 13 14 14 14 13 13 14 14Ohio 53 57 65 71 86 104 123 135 141 152 160 173 186Oklahoma 34 41 46 49 52 54 57 58 67 61 58 62 62Oregon 16 18 23 25 31 32 33 42 43 44 43 46 45Pennsylvania 102 106 119 126 139 150 166 180 193 209 223 231 232Rhode Island 6 8 10 10 10 10 10 11 13 13 13 14 14South Carolina 45 47 50 53 56 62 66 66 72 77 82 86 92South Dakota 8 7 8 10 14 16 17 18 19 21 21 22 22Tennessee 64 67 73 74 78 82 92 108 113 111 116 127 130Texas 152 161 176 201 228 235 250 260 281 297 309 324 341Utah 16 16 16 16 16 16 15 19 21 21 23 27 25Vermont 2 2 2 2 2 3 4 4 4 6 6 6 6Virginia 72 78 84 91 95 100 107 109 116 122 125 126 131Washington 24 25 29 31 33 34 38 41 41 43 49 53 50West Virginia 15 15 17 18 18 21 20 23 22 23 22 23 22Wisconsin 34 39 44 45 50 53 56 63 71 79 82 90 98Wyoming 2 2 3 3 5 6 6 7 10 9 9 9 9

American Samoa 1 1 1 1 1 1 1 1 1 1 1 1 1Guam 1 1 2 2 2 3 3 3 3 3 3 3 3Northern Marianas 1 1 1 1 1 1 1 1 1 1 . . .Puerto Rico 18 23 26 26 28 29 31 31 31 32 34 42 42Virgin Islands 1 1 1 1 2 2 2 2 2 2 2 2 3

All 2,160 2,304 2,469 2,637 2,888 3,095 3,355 3,587 3,843 4,023 4,184 4,431 4,588

Table J.4Dialysis & transplant facilities: by state & territory

657


Table J.6Dialysis & transplant facilities: by certification typeby unit type

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2,003Freestanding for-profit 1,173 1,281 1,431 1,561 1,775 1,979 2,226 2,523 2,790 2,949 3,124 3,148 3,272Freestanding non-profit 214 230 244 264 283 282 277 243 244 258 265 370 392Unknown profit status . . . . . . . . . . . 32 37Hospital center 333 348 341 340 337 330 328 312 304 290 267 329 346Hospital facility 209 213 216 235 255 265 281 271 259 280 287 313 306Transplant center only 65 66 67 73 76 82 86 88 98 96 104 110 108Transplant & dialysis center 165 164 169 164 162 157 156 150 148 148 134 129 129Other 1 2 1 . . . 1 . . 2 4 2 1

All 2,160 2,304 2,469 2,637 2,888 3,095 3,355 3,587 3,843 4,023 4,185 4,433 4,591


Table J.7Dialysis & transplant facilities: by service type

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Short stay hospitals 626 644 640 644 646 632 623 604 604 585 570 601 588Long stay hospitals 3 1 1 2 3 3 3 3 3 3 3 3 3Hospital-based chronic renal care facilities . . . . 2 . 1 1 1 2 1 1 .Renal disease treatment Center (hospital satellites) 120 123 126 142 156 176 205 221 217 226 226 236 229Children's hospitals 24 25 28 28 30 30 30 30 30 31 30 31 33Non-hospital renal disease treatment centers 1,386 1,511 1,674 1,821 2,050 2,253 2,492 2,727 2,987 3,175 3,351 3,555 3,731Hospital-based special purpose renal dialysis facilities . . . . . . . . . 1 3 1 .Independent special purpose renal dialysis facilities . . . . . . . . . . . . .Unknown 1 . . . 1 1 1 1 1 . 1 5 7

All 2,160 2,304 2,469 2,637 2,888 3,095 3,355 3,587 3,843 4,023 4,185 4,433 4,591



Table J.5Dialysis & transplant facilities: by ESRD networkby ownership type #

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2,0031 CT, MA, ME, NH, RI, VT 79 88 94 98 104 111 119 122 141 142 145 151 1552 NY 116 125 124 133 142 151 164 186 204 220 223 239 2393 NJ, PR , VI 56 65 68 74 93 101 109 110 118 125 129 145 1534 DE, PA 108 112 126 133 147 158 174 190 204 221 236 246 2475 MD, DC, VA, WV 161 171 183 193 208 217 239 247 264 273 276 287 2936 NC, SC, GA 191 201 217 234 259 279 301 315 344 369 399 432 4497 FL 146 157 167 177 185 201 216 228 248 253 262 264 2698 AL, MS, TN 139 152 166 173 192 208 224 257 268 270 280 295 3049 IN, KY, OH 119 130 137 152 169 195 230 247 262 279 293 323 34510 IL 87 96 99 102 105 109 110 109 113 133 148 157 17111 MI, MN, ND, SD, WI 140 154 172 185 212 223 247 268 278 299 303 325 34512 IA, KS, MO, NE 97 103 114 121 128 148 172 189 203 217 216 233 24613 AR, LA, OK 142 153 160 173 179 191 199 211 243 245 254 261 26114 TX 152 161 176 201 228 235 250 260 281 297 309 324 34115 AZ, CO, NV, NM, UT, WY 107 112 121 122 139 150 162 176 187 193 207 221 22316 AK, ID, MT, OR, WA 56 59 68 74 84 87 93 107 112 111 116 123 11917 N. CA, HI , Guam, AS 106 107 112 119 131 136 139 145 148 149 154 162 16818 S. CA 158 158 165 173 183 195 207 220 225 227 235 245 263

All 2,160 2,304 2,469 2,637 2,888 3,095 3,355 3,587 3,843 4,023 4,185 4,433 4,591

Table J.5Dialysis & transplant facilities: by ESRD network

Table J.6Dialysis & transplant facilities: by certification type

Table J.7Dialysis & transplant facilities: by service type


658

Reference section J


Table J.8Dialysis & transplant facilities: by ownership typeby ownership type #

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001City govt. non-federal 15 15 18 19 21 21 20 19 19 19 16City/county govt. non-federal 6 6 7 6 6 6 5 5 5 5 5Corporation for profit 920 1,003 1,174 1,279 1,426 1,517 1,647 1,836 1,999 2,077 2,200Corporation not for profit 692 722 763 796 827 816 809 761 747 725 686County govt. non-federal 27 28 26 28 28 28 27 22 22 23 22Hospital district/auth govt. non-federal 30 32 33 34 37 30 30 27 27 27 27Individual for profit 46 56 61 64 67 66 67 62 67 155 248Individual not for profit 7 7 5 5 4 4 4 4 5 29 65Other for profit 137 146 108 125 177 312 464 596 706 716 677Other govt. federal 2 2 1 1 1 1 1 1 1 1 1Other govt. non-federal 7 7 4 3 3 3 3 2 2 2 2Other not for profit 110 110 77 76 77 77 71 65 66 65 59Partnership for profit 97 105 121 128 142 144 139 123 118 117 115Partnership/not for profit . . 2 2 3 3 4 2 3 4 4Public health service govt. federal 3 3 3 3 3 2 2 2 2 4 4State govt. non-federal 48 49 53 55 54 53 51 48 43 43 43Veterans Administration govt. ederal f 13 13 13 13 12 12 11 11 10 10 11Unknown . . . . . . . 1 1 1 .

All 2,160 2,304 2,469 2,637 2,888 3,095 3,355 3,587 3,843 4,023 4,185


Table J.9Dialysis treatments: by modalityby ownership type #

1991 1992 1993 1994 1995 1996 1997Outpatient

HD 16,104,132 17,578,766 19,407,490 21,251,535 23,513,163 25,655,177 27,908,131IPD 54,919 51,126 64,080 43,382 103,165 24,443 84,763

TrainingHD 27,760 28,262 29,702 38,218 40,432 15,159 13,104IPD 848 705 653 902 745 704 817CAPD 126,476 133,450 112,347 112,936 155,201 76,423 98,262CCPD 30,987 34,402 27,433 27,514 71,230 41,103 70,092

1998 1999 2000 2001 2002 2003Outpatient

HD 30,611,792 32,993,464 35,320,743 36,838,702 39,034,690 41,022,561IPD 67,290 116,040 18,447 9,180 3,661 3,372

TrainingHD 11,303 8,940 11,183 31,409 21,802 8,139IPD 422 422 160 79 240 67CAPD 76,275 74,950 84,922 114,965 82,376 55,793CCPD 62,283 51,413 75,618 122,171 76,558 63,146

Table J.8Dialysis & transplant facilities: by ownership type

Table J.9Dialysis treatments: by modality

659



Table J.11Dialysis & transplant patients: by Medicare entitlementby ownership type

Dialysis patients Transplant patientsMedicare Medicare Medicare Medicare

approved pending Non-Medicare approved pending Non-Medicare1991 123,751 8,500 10,237 8,465 732 8141992 135,883 9,516 11,955 8,385 708 1,0081993 148,899 9,759 12,821 9,107 729 1,0741994 161,235 11,263 14,324 9,358 888 1,0501995 172,261 11,324 16,577 9,588 984 1,3131996 183,588 12,599 17,916 9,659 1,107 1,4131997 196,368 13,042 20,780 9,884 852 1,6311998 207,218 14,512 23,980 10,241 1,115 1,9601999 216,232 16,279 26,982 9,900 1,183 2,3962000 227,238 18,763 27,332 10,260 1,540 2,5002001 238,838 23,064 24,080 10,669 1,777 2,1622002 266,632 18,643 13,077 12,969 1,188 9202003 275,830 20,363 13,902 13,427 1,272 1,013

Table J.10Median number of patients: by certification typeby ownership type

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Dialysis Facility Freestanding for-profit 54 58 59 60 57 58 58 59 59 60 61 63 63 Freestanding non-profit 67 69 67 68 64 68 73 73 72 70 70 56 57 Unknown profit status . . . . . . . . . . . 26 12Hospital center 62 61 64 67 67 62 64 64 59 60 61 49 47Hospital facility 31 34 32 32 32 33 32 31 35 35 38 36 39Transplant center only . . . . . . . . . . . . .Transplant & dialysis center 56 56 50 53 49 41 41 32 27 27 30 21 22Other . . . . . . 121 . . 8 1 36 80

Median for all facilities 52 55 55 56 55 55 56 57 56 57 57 57 57


Table J.10Median number of patients: by certification type

Table J.11Dialysis & transplant patients: by Medicare entitlement

PROVIDER CHARACTERISTICS

660

Reference section JJ


Table J.12Dialysis patients: by state & territoryTable J.12Dialysis patients: by state & territory

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Alabama 3,012 3,275 3,553 3,787 4,110 4,541 4,946 5,157 5,378 5,695 5,959 6,072 6,297Alaska 89 105 96 124 134 151 184 185 191 205 230 229 264Arizona 2,186 2,559 2,881 3,114 3,350 3,570 3,902 4,219 4,564 4,859 5,105 5,315 5,619Arkansas 1,170 1,222 1,364 1,603 1,771 1,887 2,069 2,191 2,297 2,374 2,504 2,554 2,584California 16,416 17,904 19,325 21,346 22,729 24,279 25,848 27,698 29,653 31,688 34,034 36,332 38,047Colorado 1,237 1,387 1,531 1,690 1,721 1,852 1,973 2,187 2,317 2,456 2,532 2,663 2,781Connecticut 1,748 1,924 2,064 2,171 2,288 2,402 2,570 2,653 2,847 2,992 3,030 3,133 3,184Delaware 451 538 582 601 647 678 686 707 745 782 814 895 922District of Columbia 1,276 1,372 1,446 1,461 1,474 1,548 1,664 1,680 1,632 1,677 1,645 1,716 1,741Florida 7,858 8,737 9,757 10,662 11,274 12,075 12,988 13,775 14,858 15,726 16,512 17,119 17,961Georgia 4,690 5,314 5,813 6,582 7,157 7,756 8,353 8,983 9,510 10,156 10,756 11,339 11,870Hawaii 834 894 1,024 1,184 1,247 1,320 1,444 1,513 1,561 1,701 1,794 1,870 1,970Idaho 247 264 302 353 361 393 450 470 520 542 605 629 632Illinois 6,588 7,099 7,842 8,328 8,912 9,391 10,105 10,684 11,064 11,782 11,944 12,719 13,091Indiana 2,908 3,275 3,593 3,817 4,071 4,304 4,697 5,061 5,318 5,586 5,810 6,035 6,162Iowa 1,001 1,181 1,214 1,302 1,350 1,472 1,580 1,679 1,839 1,916 2,044 2,065 2,185Kansas 1,012 1,157 1,178 1,275 1,356 1,419 1,623 1,704 1,821 1,922 1,968 2,047 2,082Kentucky 1,599 1,797 1,924 2,042 2,179 2,282 2,460 2,747 2,848 3,140 3,254 3,328 3,599Louisiana 3,383 3,772 4,065 4,418 4,746 5,050 5,529 5,982 6,417 6,599 6,827 7,098 7,369Maine 317 346 410 461 517 553 630 666 711 740 754 806 870Maryland 3,172 3,445 3,724 4,174 4,544 4,920 5,376 5,652 5,801 5,877 6,186 6,505 6,870Massachusetts 2,705 3,060 3,384 3,645 3,877 4,024 4,253 4,452 4,442 4,508 4,565 4,698 4,783Michigan 4,907 5,405 5,963 6,485 6,982 7,663 8,015 8,613 8,893 9,223 9,740 10,080 10,552Minnesota 1,715 1,852 2,030 2,160 2,198 2,264 2,395 2,552 2,626 2,662 2,816 2,977 3,011Mississippi 2,072 2,286 2,533 2,824 3,019 3,298 3,553 3,786 3,993 4,154 4,373 4,570 4,712Missouri 2,829 3,104 3,428 3,621 3,872 4,227 4,504 4,901 5,230 5,447 5,725 5,904 6,032Montana 306 329 352 366 396 396 429 447 517 523 564 587 602Nebraska 619 677 776 810 832 887 973 1,071 1,134 1,159 1,269 1,357 1,170Nevada 508 560 610 693 777 893 960 1,062 1,200 1,272 1,399 1,528 1,688New Hampshire 357 377 402 421 457 451 493 531 604 648 682 732 751New Jersey 5,043 5,511 5,947 6,364 6,837 7,148 7,571 8,088 8,468 8,810 8,969 9,338 9,597New Mexico 902 1,012 1,109 1,186 1,319 1,429 1,589 1,660 1,770 1,947 2,047 2,093 2,189New York 11,541 12,655 13,653 14,579 15,359 16,148 17,131 18,228 19,391 20,407 20,749 21,438 22,040North Carolina 4,466 5,173 5,748 6,330 6,790 7,393 7,993 8,657 9,061 9,611 10,154 10,679 11,012North Dakota 260 318 326 344 370 376 406 408 420 422 462 506 514Ohio 5,340 5,850 6,296 7,032 7,586 8,231 8,994 9,614 9,994 10,989 11,668 11,797 12,445Oklahoma 1,335 1,439 1,635 1,783 1,925 2,072 2,313 2,488 2,609 2,782 2,860 2,992 3,177Oregon 1,187 1,253 1,355 1,464 1,583 1,656 1,740 1,857 1,905 2,000 2,130 2,232 2,349Pennsylvania 7,449 7,901 8,353 9,002 9,633 10,161 10,911 11,543 11,979 12,383 12,754 12,838 12,994Rhode Island 600 608 678 739 750 783 788 881 886 898 889 894 903South Carolina 2,600 2,880 3,231 3,584 3,901 4,180 4,515 4,802 5,121 5,289 5,520 5,743 6,101South Dakota 211 222 248 326 449 536 582 588 627 647 651 661 688Tennessee 3,119 3,427 3,612 4,057 4,443 4,696 5,020 5,355 5,728 5,989 6,196 6,406 6,561Texas 10,334 11,608 12,695 13,880 15,082 16,477 17,869 19,155 20,612 22,053 23,359 24,689 26,099Utah 432 465 535 581 620 634 647 731 787 863 937 960 1,010Vermont 127 127 121 134 153 165 182 221 213 241 266 272 288Virginia 3,690 4,367 4,805 5,182 5,593 5,996 6,571 7,025 7,372 7,524 7,873 8,319 8,474Washington 1,909 2,052 2,215 2,447 2,685 2,788 2,977 3,155 3,377 3,556 3,792 4,006 4,171West Virginia 797 838 929 994 1,080 1,180 1,249 1,330 1,362 1,476 1,562 1,549 1,613Wisconsin 1,793 2,016 2,200 2,412 2,590 2,762 2,940 3,171 3,370 3,469 3,627 3,806 4,087Wyoming 53 47 48 63 97 114 136 146 181 205 210 216 229

American Samoa 28 31 35 39 44 51 47 41 54 63 69 73 76Guam 83 99 121 131 153 170 205 228 259 262 287 314 319Northern Marianas 20 26 30 32 40 47 53 68 77 89 . . .Puerto Rico 1,926 2,174 2,349 2,575 2,657 2,875 3,005 3,146 3,207 3,236 3,300 3,366 3,484Virgin Islands 31 38 39 42 75 89 104 116 132 111 122 136 135

All 142,488 157,354 171,479 186,822 200,162 214,103 230,190 245,710 259,493 273,333 285,893 298,225 309,956


661



Table J.13Dialysis patients: by ESRD networkby network

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2,0031 CT, MA, ME, NH, RI, VT 5,854 6,442 7,059 7,571 8,042 8,378 8,916 9,404 9,703 10,027 10,186 10,535 10,7792 NY 11,541 12,655 13,653 14,579 15,359 16,148 17,131 18,228 19,391 20,407 20,749 21,438 22,0403 NJ, PR , VI 7,000 7,723 8,335 8,981 9,569 10,112 10,680 11,350 11,807 12,157 12,391 12,840 13,2164 DE, PA 7,900 8,439 8,935 9,603 10,280 10,839 11,597 12,250 12,724 13,165 13,568 13,733 13,9165 MD, DC, VA, WV 8,935 10,022 10,904 11,811 12,691 13,644 14,860 15,687 16,167 16,554 17,266 18,089 18,6986 NC, SC, GA 11,756 13,367 14,792 16,496 17,848 19,329 20,861 22,442 23,692 25,056 26,430 27,761 28,9837 FL 7,858 8,737 9,757 10,662 11,274 12,075 12,988 13,775 14,858 15,726 16,512 17,119 17,9618 AL, MS, TN 8,203 8,988 9,698 10,668 11,572 12,535 13,519 14,298 15,099 15,838 16,528 17,086 17,6069 IN, KY, OH 9,847 10,922 11,813 12,891 13,836 14,817 16,151 17,422 18,160 19,715 20,732 21,160 22,20610 IL 6,588 7,099 7,842 8,328 8,912 9,391 10,105 10,684 11,064 11,782 11,944 12,699 13,07111 MI, MN, ND, SD, WI 8,886 9,813 10,767 11,727 12,589 13,601 14,338 15,332 15,936 16,423 17,296 18,030 18,85212 IA, KS, MO, NE 5,461 6,068 6,596 7,008 7,410 8,005 8,680 9,355 10,024 10,444 11,006 11,393 11,48913 AR, LA, OK 5,901 6,499 7,064 7,804 8,442 9,009 9,911 10,661 11,323 11,755 12,191 12,644 13,13014 TX 10,334 11,608 12,695 13,880 15,082 16,477 17,869 19,155 20,612 22,053 23,359 24,689 26,09915 AZ, CO, NV, NM, UT, WY 5,318 6,030 6,714 7,327 7,884 8,492 9,207 10,005 10,819 11,602 12,230 12,775 13,51616 AK, ID, MT, OR, WA 3,725 3,988 4,320 4,754 5,159 5,384 5,780 6,114 6,510 6,826 7,321 7,683 8,01817 N. CA, HI , Guam, AS 6,901 7,489 8,213 9,093 9,608 10,251 11,062 11,829 12,695 13,752 14,686 15,382 16,05618 S. CA 10,480 11,465 12,322 13,639 14,605 15,616 16,535 17,719 18,909 20,051 21,587 23,296 24,459

All 142,488 157,354 171,479 186,822 200,162 214,103 230,190 245,710 259,493 273,333 285,982 298,352 310,095


Table J.14Dialysis patients: by certification typeby unit type

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Freestanding for-profit 79,324 90,558 101,901 113,512 125,452 139,047 155,185 177,044 194,605 208,044 221,789 227,386 237,457Freestanding non-profit 16,915 18,748 20,442 22,149 23,627 24,881 25,516 22,799 21,368 22,313 22,680 26,867 27,689Unknown profit status . . . . . . . . . . . 1,194 812Hospital center 24,428 25,331 26,142 26,716 26,429 25,286 24,988 23,141 21,259 20,735 19,094 20,274 21,379Hospital facility 9,478 9,812 10,414 11,666 12,082 12,919 12,803 12,599 12,678 13,469 14,494 15,719 16,325Transplant center only 4 179 . . . . 12 . . . . 424 .Transplant & dialysis center 12,339 12,726 12,580 12,779 12,572 11,970 11,565 10,127 9,583 8,756 7,836 6,416 6,353Other . . . . . . 121 . . 16 89 72 80

All 142,488 157,354 171,479 186,822 200,162 214,103 230,190 245,710 259,493 273,333 285,982 298,352 310,095


Table J.15Dialysis patients: by treatment modalityby ownership type #

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003Outpatient

Hemodialysis 116,699 128,458 139,835 153,100 166,109 181,000 198,416 215,899 230,649 244,950 257,872 269,968 281,340IPD 230 193 141 145 88 77 102 35 48 43 29 22 13

TrainingHemodialysis 120 226 224 90 64 125 56 61 35 37 28 12 14IPD 4 2 5 . 2 1 6 3 . . 1 . .CAPD 266 266 401 275 194 231 257 181 203 90 143 106 72CCPD 52 57 74 64 114 99 131 131 97 87 122 31 21

HomeHemodialysis 2,266 2,161 2,256 2,328 2,086 1,897 1,884 1,607 1,521 1,480 1,277 1,273 1,396IPD 173 205 164 181 137 111 100 75 44 19 28 34 17CAPD 18,881 20,872 22,573 23,708 21,369 19,187 16,703 14,817 13,276 12,529 11,614 11,199 10,630CCPD 3,797 4,914 5,806 6,931 9,999 11,375 12,535 12,901 13,620 14,098 14,868 15,707 16,592

All 142,488 157,354 171,479 186,822 200,162 214,103 230,190 245,710 259,493 273,333 285,982 298,352 310,095


Table J.13Dialysis patients: by ESRD network

Table J.14Dialysis patients: by certification type

Table J.15Dialysis patients: by treatment modality


662

Reference section JJ

Table J.16Patient & treatment counts: by detailed facility survey fieldTable J.16Patient & treatment counts: by detailed facility survey fieldby ownership type

1991 1992 1993 1994 1995 1996 199701 Beginning in-unit 106,959 117,491 129,033 140,626 153,558 166,518 181,49502 Beginning home 22,747 25,289 28,492 30,910 33,091 33,456 32,68403 Beginning total 129,706 142,780 157,525 171,536 186,649 199,974 214,17904A In-unit - started for first time 44,515 49,604 52,699 57,407 59,077 64,366 70,88404B Home - started for first time 8,919 9,202 9,883 10,127 10,071 9,683 9,10005A In-unit - restarted 727 789 880 968 1,054 1,060 1,13405B Home - restarted 125 106 104 135 163 144 16506A In-Unit - transferred in 22,186 24,511 27,925 30,886 35,407 38,013 42,45006B Home - transferred in 3,242 4,187 5,404 6,059 7,139 6,639 6,77207A In-unit - returned after transplant 2,194 2,148 2,437 2,450 2,557 2,615 2,76207B Home - returned after transplant 437 464 489 502 472 423 42808A In-unit - deaths 26,371 29,859 32,685 34,699 37,467 41,039 44,68708B Home - deaths 4,793 5,541 6,365 6,958 7,441 7,276 7,04209A In-unit - recovered kidney function 1,696 1,774 1,962 2,260 2,409 2,464 2,72109B Home - recovered kidney function 242 261 279 302 341 284 28010A In-unit - received transplant 6,197 6,286 6,628 6,776 7,401 7,604 8,03010B Home - received transplant 2,412 2,442 2,785 2,958 2,950 2,957 2,80311A In-unit - transfer to other dialysis unit 22,517 24,732 28,351 31,469 34,607 37,836 42,20911B Home - transfer to other dialysis unit 3,263 3,802 5,034 5,783 7,013 6,739 7,07912A In-unit - discontinued dialysis 1,500 1,293 1,362 1,525 2,115 1,982 2,17712B Home - discontinued dialysis 218 148 186 191 291 302 27713A In-unit - other (lost-to-followup) 309 259 205 285 336 274 31313B Home - other (lost-to-followup) 45 40 25 42 56 57 6614 Outpatient dialysis - HD 116,699 128,458 139,835 153,100 166,109 181,000 198,41615 Outpatient dialysis - IPD 230 193 141 145 88 77 10216 Self-dialysis training - HD 120 226 224 90 64 125 5617 Self-dialysis training - IPD 4 2 5 . 2 1 618 Self-dialysis training - CAPD 266 266 401 275 194 231 25719 Self-dialysis training - CCPD 52 57 74 64 114 99 13120 Total in-unit patients, sum (14-19) 117,371 129,202 140,680 153,674 166,571 181,533 198,96821 Home dialysis - hemodialysis 2,266 2,161 2,256 2,328 2,086 1,897 1,88422 Home dialysis - IPD 173 205 164 181 137 111 10023 Home dialysis - CAPD 18,881 20,872 22,573 23,708 21,369 19,187 16,70324 Home dialysis - CCPD 3,797 4,914 5,806 6,931 9,999 11,375 12,53525 Total home patients, sum (21-24) 25,117 28,152 30,799 33,148 33,591 32,570 31,22226 Total patients, sum 20 & 25 142,488 157,354 171,479 186,822 200,162 214,103 230,19027 Currently enrolled in Medicare 123,751 135,883 148,899 161,235 172,261 183,588 196,36828 Medicare application pending 8,500 9,516 9,759 11,263 11,324 12,599 13,04229 Non-Medicare 10,237 11,955 12,821 14,324 16,577 17,916 20,78030 HD completed training 681 854 651 587 524 530 42231 IPD completed training 138 99 77 137 114 104 9032 CAPD completed training 11,753 12,271 13,428 14,179 12,550 12,406 10,49333 CCPD completed training 2,680 3,394 3,842 4,408 7,221 7,338 7,43934 Transient patients treated 34,905 37,978 40,136 43,013 47,411 55,734 61,88135 Transient patient treatments 146,016 166,669 181,041 218,517 228,668 269,015 295,79836 HD outpatient treatments 16,104,132 17,578,766 19,407,490 21,251,535 23,513,163 25,655,177 27,908,13137 IPD outpatient treatments 54,919 51,126 64,080 43,382 103,165 24,443 84,76338 HD training treatments 27,760 28,262 29,702 38,218 40,432 15,159 13,10439 IPD training treatments 848 705 653 902 745 704 81740 CAPD training treatments 126,476 133,450 112,347 112,936 155,201 76,423 98,26241 CCPD training treatments 30,987 34,402 27,433 27,514 71,230 41,103 70,09242 Patients transplanted at this facility 10,011 10,101 10,910 11,296 11,885 12,179 12,36743 Patients transplanted & enrolled in Medicare 8,465 8,385 9,107 9,358 9,588 9,659 9,88444 Patients transplanted & Medicare app. pending 732 708 729 888 984 1,107 85245 Patients transplanted & non-Medicare -US residents 663 860 931 957 1,201 1,227 1,49746 Patients transplanted & non-Medicare-other 151 148 143 93 112 186 13447 Living-related donor transplant performed 2,296 2,391 2,631 2,738 2,992 3,084 3,21048 Living-unrelated donor transplant performed 86 145 197 262 424 619 70549 Cadaveric donor transplant performed 7,644 7,579 8,106 8,312 8,486 8,495 8,51250 Total transplant performed 10,026 10,115 10,934 11,312 11,902 12,198 12,42751 Dialysis patients awaiting transplant 17,018 19,970 21,165 24,130 26,539 29,725 32,60852 Non-dialysis patients awaiting transplant 1,218 1,648 1,809 2,465 2,344 3,014 3,37153 Cadaver harvest & transplant at this facility 1,108 1,055 1,072 1,036 967 864 354 Cadaver harvest sent to other US facility 1,338 1,398 1,593 1,702 1,777 1,724 .55 Cadaver harvest sent outside US * 9 4 7 1 . .56 Cadaver harvest & nonviable 188 169 213 230 270 347 .57 Total cadaver harvest at this facility 2,636 2,631 2,882 2,975 3,015 2,935 3


663


PROVIDER CHARACTERISTICSJ Reference section J

Table J.16 (continued)Patient & treatment counts: by detailed facility survey fieldTable J.16 (continued)Patient & treatment counts: by detailed facility survey fieldby ownership type #

1998 1999 2000 2001 2002 200301 Beginning in-unit 198,993 216,324 231,248 245,072 259,125 271,32202 Beginning home 31,188 29,251 28,576 28,097 28,138 28,32203 Beginning total 230,181 245,575 259,824 273,169 287,263 299,64404A In-unit - started for first time 76,272 80,953 83,827 87,313 90,278 92,64504B Home - started for first time 8,194 7,876 7,852 7,392 6,420 6,79205A In-unit - restarted 1,191 1,323 1,353 1,545 1,687 1,85605B Home - restarted 156 123 128 120 121 12906A In-Unit - transferred in 46,746 49,524 50,853 51,978 57,637 57,33306B Home - transferred in 6,604 5,961 6,585 6,268 6,613 6,65507A In-unit - returned after transplant 3,060 3,274 3,744 4,021 4,361 4,44907B Home - returned after transplant 386 411 422 477 451 44708A In-unit - deaths 49,886 55,545 58,090 61,636 65,565 68,53108B Home - deaths 6,423 5,868 5,899 5,660 5,441 5,51109A In-unit - recovered kidney function 2,841 3,137 3,533 3,841 4,195 4,46309B Home - recovered kidney function 196 202 221 279 255 25710A In-unit - received transplant 8,950 9,393 9,763 10,140 10,617 10,87510B Home - received transplant 2,757 2,532 2,610 2,605 2,675 2,67511A In-unit - transfer to other dialysis unit 46,599 49,649 51,733 52,471 58,646 58,83611B Home - transfer to other dialysis unit 6,983 6,283 6,760 6,528 6,927 6,74512A In-unit - discontinued dialysis 1,866 2,280 2,030 2,290 1,475 1,16012B Home - discontinued dialysis 197 176 127 130 90 5813A In-unit - other (lost-to-followup) 337 416 441 544 547 69113B Home - other (lost-to-followup) 45 46 48 177 46 5314 Outpatient dialysis - HD 215,899 230,649 244,950 257,872 269,968 281,34015 Outpatient dialysis - IPD 35 48 43 29 22 1316 Self-dialysis training - HD 61 35 37 28 12 1417 Self-dialysis training - IPD 3 . . 1 . .18 Self-dialysis training - CAPD 181 203 90 143 106 7219 Self-dialysis training - CCPD 131 97 87 122 31 2120 Total in-unit patients, sum (14-19) 216,310 231,032 245,207 258,195 270,139 281,46021 Home dialysis - hemodialysis 1,607 1,521 1,480 1,277 1,273 1,39622 Home dialysis - IPD 75 44 19 28 34 1723 Home dialysis - CAPD 14,817 13,276 12,529 11,614 11,199 10,63024 Home dialysis - CCPD 12,901 13,620 14,098 14,868 15,707 16,59225 Total home patients, sum (21-24) 29,400 28,461 28,126 27,787 28,213 28,63526 Total patients, sum 20 & 25 245,710 259,493 273,333 285,982 298,352 310,09527 Currently enrolled in Medicare 207,218 216,232 227,238 238,838 266,632 275,83028 Medicare application pending 14,512 16,279 18,763 23,064 18,643 20,36329 Non-Medicare 23,980 26,982 27,332 24,080 13,077 13,90230 HD completed training 418 358 309 372 241 44831 IPD completed training 29 54 17 16 35 732 CAPD completed training 9,350 8,519 8,619 8,728 9,140 7,70433 CCPD completed training 7,116 6,991 7,174 7,633 7,456 8,19434 Transient patients treated 65,422 71,436 78,117 76,461 78,770 81,27035 Transient patient treatments 298,627 324,152 290,130 355,086 286,142 281,00836 HD outpatient treatments 30,611,792 32,993,464 35,320,743 36,838,702 39,034,690 41,022,56137 IPD outpatient treatments 67,290 116,040 18,447 9,180 3,661 3,37238 HD training treatments 11,303 8,940 11,183 31,409 21,802 8,13939 IPD training treatments 422 422 160 79 240 6740 CAPD training treatments 76,275 74,950 84,922 114,965 82,376 55,79341 CCPD training treatments 62,283 51,413 75,618 122,171 76,558 63,14642 Patients transplanted at this facility 13,316 13,479 14,300 14,608 15,077 15,71243 Patients transplanted & enrolled in Medicare 10,241 9,900 10,260 10,669 12,969 13,42744 Patients transplanted & Medicare app. pending 1,115 1,183 1,540 1,777 1,188 1,27245 Patients transplanted & non-Medicare -US residents 1,796 2,262 2,381 2,042 888 99446 Patients transplanted & non-Medicare-other 164 134 119 120 32 1947 Living-related donor transplant performed 3,453 3,583 4,052 4,236 4,182 4,26248 Living-unrelated donor transplant performed 1,067 1,061 1,375 1,568 1,711 1,98249 Cadaveric donor transplant performed 8,752 8,839 8,884 8,824 9,213 9,49450 Total transplant performed 13,272 13,483 14,311 14,628 15,106 15,73851 Dialysis patients awaiting transplant 34,845 36,803 35,620 40,474 41,921 45,97452 Non-dialysis patients awaiting transplant 3,459 3,947 5,549 6,782 5,775 6,58053 Cadaver harvest & transplant at this facility 5,128 226 . . * *54 Cadaver harvest sent to other US facility . . . . * *55 Cadaver harvest sent outside US . . . . * *56 Cadaver harvest & nonviable . . . . * *57 Total cadaver harvest at this facility 5,128 206 . . * *

*Data was not collected in 2002 & 2003."." Zero values in this cell.


664

Reference section J

Medicare costs for ESRD

KReferenceSec

tion

K

666

MEDICARE COSTS FOR ESRDReference section K

K.1 . 667 Total Medicare costs ($) of reported ESRD per calendar year: by patient characteristics all ESRD patients with at least one Medicare claim

K.2 . 669 Total Medicare costs ($) of reported ESRD patients: by claim typeperiod prevalent ESRD patients

K.3 . 671 Medicare costs ($) for ESRD patients: by payor status & claim typeperiod prevalent ESRD patients, as-treated model

K.4 . 673 Per person per year costs: all ESRD patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

K.5 . 674 Per person per year costs; all dialysis patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

K.6 . 675 Per person per year costs; hemodialysis patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

K.7 . 676 Per person per year costs; CAPD/CCPD patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

K.8 . 677 Per person per year costs; all transplant patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

K.9 . 678 Per person per year costs: dialysis patients (model 2)period prevalent ESRD patients, primary payor only

K.10 . 679 Per person per year costs: transplant event within the year (model 2)period prevalent ESRD patients, primary payor only

K.11 . 680 Per person per year costs: functioning graft patients (model 2)period prevalent ESRD patients, primary payor only

K.12 . 681 Per person per year costs: graft failure within the year (model 2)period prevalent ESRD patients, primary payor only

K.13 . 682 Part B Medicare costs ($) per patient YAR: by physician/supplier specialtyperiod prevalent patients, as-treated model; Medicare primary payor only

667

2005 Annual Data ReportKMEDICARE COSTS FOR ESRD

Table K.1Total Medicare costs ($) of reported ESRD per calendar year: by patient characteristicsall ESRD patients with at least one Medicare claim

Table K.1Total Medicare costs ($) of reported ESRD per calendar year: by patient characteristicsall ESRD patients with at least one Medicare claim

1991 1992 1993 1994 1995 1996 19970-4 8,033,630 9,644,783 9,685,284 10,131,550 11,032,215 11,107,298 10,778,1555-9 10,404,252 8,173,896 9,188,963 11,214,556 9,360,857 10,741,388 10,982,34810-14 16,963,733 17,420,685 17,719,445 19,190,922 19,685,594 19,172,404 20,313,55415-19 40,945,037 40,428,177 41,392,282 46,430,784 46,987,449 48,198,046 46,664,00020-29 268,761,726 282,591,539 305,259,190 323,987,862 335,598,056 353,112,445 353,819,05630-39 554,134,631 620,037,610 680,186,521 759,056,053 815,068,863 864,087,855 885,722,14240-49 708,860,827 816,456,524 912,955,630 1,039,442,056 1,180,151,636 1,343,464,087 1,429,269,38050-59 877,062,110 1,005,491,602 1,146,588,142 1,319,942,112 1,475,822,862 1,682,292,599 1,825,324,86760-64 615,535,870 691,658,546 756,540,557 843,627,440 936,407,203 1,056,694,349 1,128,211,15665-69 832,514,800 960,634,146 1,072,692,842 1,228,317,263 1,357,641,191 1,509,465,057 1,593,205,69570-79 1,192,853,058 1,440,435,115 1,620,565,866 1,911,282,127 2,203,819,484 2,531,283,984 2,763,877,25980+ 331,399,251 399,671,139 483,090,702 588,853,500 692,440,134 825,659,262 934,801,568Unknown 1,048,409 1,113,422 367,498 530,495 814,615 311,214 264,581

0-19 76,346,652 75,667,541 77,985,974 86,967,813 87,066,115 89,219,136 88,738,05620-44 1,173,533,684 1,301,761,215 1,426,205,490 1,575,920,408 1,700,691,853 1,832,048,861 1,887,213,33545-64 1,850,821,479 2,114,474,606 2,375,324,550 2,710,135,115 3,042,356,767 3,467,602,474 3,735,133,26665-74 1,535,008,355 1,807,356,860 2,032,385,820 2,358,855,170 2,652,342,982 2,973,971,273 3,164,272,01775+ 821,758,753 993,383,541 1,143,963,591 1,369,597,721 1,601,557,826 1,892,437,030 2,127,612,505Unknown 1,048,409 1,113,422 367,498 530,495 814,615 311,214 264,581

Male 2,755,832,631 3,182,985,750 3,564,409,605 4,097,194,317 4,567,708,047 5,159,079,109 5,550,426,039Female 2,702,608,212 3,110,547,512 3,491,534,131 4,004,577,772 4,517,112,246 5,096,460,803 5,452,775,519Unknown 76,489 223,922 289,187 234,633 9,865 50,076 32,202

White 3,398,019,285 3,873,027,806 4,287,301,051 4,854,258,525 5,407,975,715 6,043,852,283 6,457,586,463Black 1,896,514,419 2,224,123,602 2,526,575,941 2,954,179,212 3,323,269,676 3,771,098,948 4,047,020,289Native American 57,995,562 68,171,998 83,409,850 98,842,547 111,856,183 131,093,262 139,806,972Asian 103,098,473 126,525,980 156,972,536 189,900,217 222,666,058 265,387,743 294,255,960Other/unknown 2,889,593 1,907,799 1,973,545 4,826,221 19,062,525 44,157,753 64,564,077

†Hispanic 959,381,774 1,099,270,166†Non-Hispanic 6,480,670,356 7,782,072,728Unknown 2,815,537,858 2,121,890,866

Diabetes 1,748,688,256 2,112,575,429 2,475,503,729 2,926,327,959 3,414,922,930 4,038,340,419 4,473,963,006Hypertension 1,613,142,034 1,893,544,099 2,138,377,348 2,458,040,559 2,696,895,141 2,929,726,474 3,077,002,916Glomerulonephritis 881,984,964 965,584,442 1,042,926,209 1,164,136,394 1,276,989,746 1,388,213,869 1,447,263,311Other cause 917,455,003 1,013,933,049 1,080,950,752 1,200,209,535 1,334,361,876 1,505,962,421 1,594,494,084Unknown 297,247,075 308,120,167 318,474,885 353,292,276 361,660,464 393,346,805 410,510,444

All 5,458,517,332 6,293,757,185 7,056,232,923 8,102,006,722 9,084,830,158 10,255,589,988 11,003,233,760

Includes all Medicare costs, beginning with the date of first ESRD service.Medicare hospital pass-through costs for indirect medical education, organ acquisition, etc. are included.†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.

K

668


Table K.1 (continued)Total Medicare costs ($) of reported ESRD per calendar year: by patient characteristicsall ESRD patients with at least one Medicare claim

Table K.1 (continued)Total Medicare costs ($) of reported ESRD per calendar year: by patient characteristicsall ESRD patients with at least one Medicare claim

1998 1999 2000 2001 2002 20030-4 8,742,724 7,829,121 7,687,179 7,941,125 9,950,262 10,920,3495-9 11,329,635 9,373,601 9,533,863 9,803,473 10,328,767 10,252,85810-14 18,833,801 17,052,693 16,674,110 18,364,175 21,124,657 24,471,60915-19 47,662,848 45,102,720 46,920,949 49,240,940 53,101,644 53,468,89220-29 345,740,666 351,207,482 354,421,227 377,195,417 394,136,676 399,829,25530-39 851,480,122 865,112,729 897,654,737 973,748,303 1,039,513,099 1,057,944,87340-49 1,423,674,163 1,483,094,334 1,602,389,506 1,781,543,856 1,942,712,565 2,034,785,28050-59 1,861,480,110 1,982,482,544 2,197,620,282 2,502,595,516 2,825,719,923 3,029,788,12260-64 1,140,307,512 1,187,906,430 1,287,522,303 1,457,561,988 1,627,375,685 1,764,947,68965-69 1,601,441,688 1,618,106,071 1,718,341,046 1,925,924,735 2,170,317,942 2,282,766,88470-79 2,884,527,759 3,013,032,527 3,245,882,676 3,648,961,673 3,996,158,152 4,146,760,31880+ 1,004,497,355 1,089,715,680 1,219,151,465 1,447,402,286 1,691,801,875 1,846,892,284Unknown 325,344 336,895 602,710 228,415 703,908 571,602

0-19 86,569,009 79,358,136 80,816,101 85,349,713 94,505,331 99,113,70820-44 1,846,536,782 1,885,277,757 1,964,165,383 2,137,309,335 2,289,898,978 2,333,728,89845-64 3,776,145,790 3,984,525,762 4,375,442,672 4,955,335,745 5,539,558,969 5,953,566,32065-74 3,214,472,842 3,273,135,737 3,483,930,351 3,897,660,457 4,308,977,518 4,489,817,34975+ 2,275,993,960 2,447,718,541 2,699,444,837 3,124,628,237 3,549,300,451 3,786,602,137Unknown 325,344 336,895 602,710 228,415 703,908 571,602

Male 5,674,675,040 5,925,213,433 6,426,805,665 7,265,452,989 8,126,906,143 8,637,932,791Female 5,525,311,388 5,745,108,978 6,177,544,382 6,935,012,942 7,655,974,714 8,025,310,684Unknown 57,299 30,417 52,006 45,973 64,297 156,538

White 6,517,813,617 6,701,958,936 7,249,534,643 8,194,942,928 9,096,250,589 9,581,099,199Black 4,150,114,599 4,387,803,790 4,714,223,419 5,287,354,437 5,850,585,340 6,201,087,326Native American 144,822,920 162,930,494 171,208,109 187,582,497 213,333,444 221,632,412Asian 310,224,309 333,567,701 373,271,653 425,272,230 497,579,865 521,418,411Other/unknown 77,068,282 84,091,907 96,164,229 105,359,810 125,195,916 138,162,666

†Hispanic 1,168,817,965 1,254,665,968 1,387,748,776 1,624,094,339 1,878,033,203 2,049,862,554†Non-Hispanic 8,521,177,874 9,330,564,223 10,440,635,317 12,008,844,534 13,457,536,379 14,291,399,669Unknown 1,510,047,889 1,085,122,637 776,017,960 567,573,031 447,375,573 322,137,790

Diabetes 4,651,129,356 4,888,304,763 5,376,738,971 6,168,769,252 6,918,523,463 7,412,248,690Hypertension 3,098,082,566 3,224,380,613 3,433,645,471 3,857,186,473 4,278,563,128 4,528,550,006Glomerulonephritis 1,434,929,291 1,464,650,664 1,531,621,520 1,660,116,516 1,792,624,295 1,842,840,958Other cause 1,604,555,621 1,667,033,732 1,799,950,224 2,011,859,720 2,226,808,824 2,315,372,607Unknown 411,346,895 425,983,057 462,445,867 502,579,942 566,425,445 564,387,753

All 11,200,043,727 11,670,352,828 12,604,402,053 14,200,511,904 15,782,945,154 16,663,400,013

Includes all Medicare costs, beginning with the date of first ESRD service.Medicare hospital pass-through costs for indirect medical education, organ acquisition, etc. are included.†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.

669


Table K.2Total Medicare costs ($) of reported ESRD patients: by claim typeperiod prevalent ESRD patients, all ESRD patients with at least one Medicare claim

Table K.2Total Medicare costs ($) of reported ESRD patients: by claim typeperiod prevalent ESRD patients, all ESRD patients with at least one Medicare claim

1991 1992 1993 1994 1995 1996 1997Patients 196,898 214,869 230,411 254,215 267,967 284,788 302,340

Patient years at risk 163,270 178,032 192,692 211,753 224,521 238,525 252,753

Total Medicare 5,458,517,332 6,293,757,185 7,056,232,923 8,102,006,722 9,084,830,158 10,255,589,988 11,003,233,760

Total inpatient ($) 2,246,679,753 2,664,135,417 2,897,820,522 3,269,734,886 3,601,353,482 4,049,958,824 4,357,588,782 Medical DRG 698,326,298 888,013,412 1,006,204,517 1,162,503,836 1,339,327,353 1,570,322,312 1,766,177,301 Surgical DRG 1,209,139,229 1,441,105,395 1,548,822,518 1,747,047,373 1,909,169,681 2,118,779,037 2,214,653,219 Other DRG 23,626,320 22,115,802 21,806,409 24,273,802 23,761,206 27,148,084 33,631,915 Transplant DRG 124,795,152 139,323,266 158,566,113 172,457,632 188,959,376 196,438,742 190,517,937 Non-transplant pass-throughs 179,664,867 163,588,790 152,134,314 153,504,400 131,228,125 129,659,908 144,660,891 Transplant pass-throughs 11,127,886 9,988,752 10,286,650 9,947,843 8,907,741 7,610,741 7,947,521

Total outpatient ($) 1,895,329,216 2,159,429,740 2,529,442,321 2,846,733,992 3,196,926,976 3,648,820,314 3,878,013,585 Outpatient hemodialysis 1,226,120,801 1,317,594,597 1,485,091,770 1,640,698,402 1,769,250,995 1,961,792,900 2,098,108,393 Outpatient peritoneal dialysis 156,825,285 172,225,708 199,506,160 225,273,473 243,211,060 241,824,537 222,684,970 Outpatient other dialysis 454,170 247,691 272,979 288,834 250,625 371,467 399,800 Outpatient EPO 245,809,935 338,964,231 422,262,824 469,808,327 567,512,877 701,813,547 735,478,803 Outpatient vitamin D hormones 138 5,295,447 34,202,577 72,233,365 92,309,164 117,958,373 133,423,862 Outpatient iron 0 81,420 13,424,494 34,664,019 49,471,181 85,256,370 121,713,654 Outpatient other injectables 22,098 289,781 5,209,060 13,210,852 18,640,602 25,292,383 32,290,420 Radiology 30,242,997 37,072,870 41,175,066 47,532,625 56,063,503 69,152,263 74,072,130 Pharmacy 56,591,816 71,674,582 75,838,707 51,155,236 62,743,167 61,626,643 64,456,353 Ambulance 2,373,465 2,891,041 3,314,941 4,239,650 4,914,290 5,557,262 6,539,183 Laboratory/pathology 67,950,872 80,635,406 87,900,752 94,245,618 101,405,063 107,754,466 109,788,945 Outpatient other 108,937,639 132,456,967 161,242,993 193,383,591 231,154,449 270,420,103 279,057,073

Skilled nursing facility 32,527,037 51,280,520 72,991,474 115,180,914 162,688,961 228,093,578 285,416,129Home health agency 63,483,830 101,290,542 149,570,940 217,007,766 288,875,148 348,884,078 382,277,803Hospice 2,075,663 3,879,094 5,474,301 7,777,479 8,544,483 10,110,897 12,184,741

Total physician/supplier ($) 1,218,421,833 1,313,741,872 1,400,933,365 1,645,571,685 1,826,441,107 1,969,722,298 2,087,752,720 Transplant surgery 18,446,022 15,128,168 15,913,965 18,373,072 20,079,545 19,146,930 18,995,220 Inpatient surgery 106,547,334 99,903,754 101,303,906 120,892,807 135,295,005 133,402,693 136,665,508 Outpatient surgery 42,643,405 44,065,513 50,583,978 64,183,789 79,880,743 84,811,555 89,641,065 ~E&M nephrology inpatient 53,751 45,884,100 53,288,058 62,845,107 69,384,283 71,406,697 76,914,233 ~E&M nephrology outpatient 6,114,572 6,537,493 7,646,925 9,321,028 11,039,781 11,038,095 11,632,879 ~E&M non-nephrology inpatient 463,797 92,152,579 103,381,474 130,689,498 155,034,057 169,224,804 193,000,138 ~E&M non-nephrology outpatient 16,080,478 31,892,629 38,507,667 51,006,338 63,988,664 69,916,483 80,989,906 Dialysis capitation 135,284,272 158,168,175 179,080,914 215,123,268 251,095,346 328,353,757 288,780,153 Inpatient dialysis 107,695,022 105,477,884 104,437,182 112,718,383 118,253,413 110,314,288 104,370,941 Home dialysis 111,899,584 126,873,735 117,106,079 127,995,700 123,894,420 132,437,654 135,804,383 Vascular access 92,415,361 98,518,056 107,875,730 127,462,988 146,051,643 145,763,103 156,744,281 Peritoneal access 3,369,011 3,017,540 3,063,647 3,414,226 5,278,600 5,516,279 4,958,064 Physician/supplier EPO 1,072,986 1,364,253 1,623,151 1,291,888 1,330,730 1,537,090 1,572,452 Physician/supplier iron 10,678 5,829 32,097 67,500 87,539 85,709 97,223 Immunosuppressive drugs 2,521,560 1,999,166 1,703,275 12,876,963 23,382,266 31,719,410 41,931,093 Durable medical equipment 69,703,420 88,648,935 89,918,082 88,029,345 68,907,080 73,438,373 86,504,218 Physician/supplier radiology 40,656,436 37,049,808 37,779,220 43,981,925 48,829,670 50,418,794 50,955,067 Physician/supplier lab/pathology 105,491,691 126,149,451 148,369,196 170,351,824 193,439,097 205,749,935 211,328,434 Physician/supplier ambulance 43,173,997 54,618,532 60,514,964 77,604,478 180,665,759 187,091,960 197,405,188 Other physician/supplier 314,778,455 176,286,270 178,803,858 207,341,559 130,523,465 138,348,687 199,462,276

~E & M refers to evaluation & management.Includes all Medicare costs, beginning with the date of first ESRD service.Medicare hospital pass-through costs for indirect medical education, organ acquisition, etc. are included.

K

670


Table K.2 (continued)Total Medicare costs ($) of reported ESRD patients: by claim typeperiod prevalent ESRD patients, all ESRD patients with at least one Medicare claim

Table K.2 (continued)Total Medicare costs ($) of reported ESRD patients: by claim typeperiod prevalent ESRD patients, all ESRD patients with at least one Medicare claim

1998 1999 2000 2001 2002 2003Patients 315,771 329,589 346,148 364,445 388,667 395,371

Patient years at risk 263,738 275,457 289,978 305,115 324,715 331,972

Total Medicare 11,200,043,727 11,670,352,828 12,604,402,053 14,200,511,904 15,782,945,154 16,663,400,013

Total inpatient ($) 4,428,755,540 4,711,968,805 4,959,859,104 5,527,499,314 6,100,920,415 6,147,474,107 Medical DRG 1,908,531,510 2,104,898,567 2,226,185,483 2,507,750,909 2,723,489,302 2,825,763,063 Surgical DRG 2,159,369,713 2,242,867,126 2,349,173,638 2,567,656,294 2,765,732,943 2,675,771,284 Other DRG 41,332,729 46,720,323 46,566,029 89,278,457 245,773,771 286,518,275 Transplant DRG 178,444,174 177,484,899 184,430,821 199,057,170 195,857,722 195,263,421 Non-transplant pass-throughs 134,496,160 134,223,554 147,968,919 157,837,134 164,591,228 157,932,957 Transplant pass-throughs 6,581,254 5,774,336 5,534,215 5,919,350 5,475,449 6,225,106

Total outpatient ($) 4,050,064,581 4,407,864,980 4,698,473,026 5,288,968,033 5,887,771,025 6,358,802,239 Outpatient hemodialysis 2,166,673,228 2,310,263,752 2,461,511,662 2,659,310,394 2,925,104,213 3,038,749,410 Outpatient peritoneal dialysis 176,747,571 158,923,669 149,748,277 151,408,218 177,959,507 227,188,097 Outpatient other dialysis 440,795 706,922 688,089 630,775 691,532 1,392,820 Outpatient EPO 843,547,988 1,006,329,155 1,082,911,194 1,178,325,134 1,398,823,515 1,555,190,080 Outpatient vitamin D hormones 143,649,641 146,667,738 253,810,610 368,565,475 373,277,139 379,257,724 Outpatient iron 133,383,836 142,480,279 149,721,298 214,238,303 232,679,956 250,428,164 Outpatient other injectables 48,018,334 61,469,241 78,597,372 83,374,224 74,629,839 56,488,404 Radiology 75,688,060 79,625,425 72,043,243 87,098,578 103,686,303 142,865,692 Pharmacy 75,998,134 110,139,721 63,780,390 89,427,286 67,920,001 56,683,976 Ambulance 6,602,116 6,551,460 7,417,256 8,801,182 12,514,852 15,797,131 Laboratory/pathology 103,234,142 101,763,345 104,659,469 114,098,455 115,562,639 126,424,285 Outpatient other 276,080,734 282,944,274 273,584,165 333,690,010 404,921,530 508,336,458

Skilled nursing facility 311,574,599 262,988,294 295,517,964 376,556,028 436,468,776 450,891,930Home health agency 265,870,051 81,839,375 233,011,604 257,364,011 290,295,195 290,797,909Hospice 13,638,720 16,698,144 19,767,709 26,507,461 34,791,908 43,211,041

Total physician/supplier ($) 2,130,140,237 2,188,993,229 2,397,772,645 2,723,617,056 3,032,697,837 3,372,222,786 Transplant surgery 17,791,194 16,836,821 17,027,468 18,045,079 18,449,789 19,437,322 Inpatient surgery 130,129,394 122,785,965 135,506,274 145,370,760 148,498,405 158,891,549 Outpatient surgery 89,526,340 88,354,777 100,250,727 111,983,138 121,008,126 135,341,608 ~E&M nephrology inpatient 84,452,705 88,417,974 92,655,258 98,884,904 106,689,254 121,075,208 ~E&M nephrology outpatient 11,723,356 12,443,393 13,908,713 14,706,759 17,314,885 19,408,274 ~E&M non-nephrology inpatient 214,271,012 234,768,378 259,130,889 304,036,171 327,391,205 371,358,195 ~E&M non-nephrology outpatient 88,538,001 98,336,057 117,527,048 136,996,956 152,207,795 169,217,333 Dialysis capitation 302,666,249 316,136,662 362,152,427 402,382,945 429,286,434 447,665,703 Inpatient dialysis 106,657,530 103,377,224 96,436,519 104,989,377 100,765,002 99,536,173 Home dialysis 135,810,349 130,227,634 135,986,762 137,818,663 108,143,909 56,739,450 Vascular access 162,743,044 173,720,202 177,194,198 191,939,901 201,365,749 226,315,000 Peritoneal access 4,250,885 3,873,634 3,775,899 3,876,811 3,609,484 3,767,485 Physician/supplier EPO 1,616,545 1,839,456 2,918,648 4,197,859 3,867,431 11,455,997 Physician/supplier iron 57,719 46,667 48,232 70,149 87,675 108,579 Immunosuppressive drugs 47,000,118 47,819,750 75,240,729 113,062,510 153,633,486 198,964,299 Durable medical equipment 89,031,027 93,616,013 83,085,257 91,737,763 114,912,422 133,551,247 Physician/supplier radiology 59,645,989 63,040,628 72,032,101 86,913,327 97,409,493 118,338,480 Physician/supplier lab/pathology 176,005,504 171,949,817 183,765,375 192,415,007 257,895,802 297,155,696 Physician/supplier ambulance 196,695,539 181,587,912 210,602,744 261,064,715 306,319,096 368,425,439 Other physician/supplier 211,527,737 239,814,262 258,527,378 303,124,262 363,842,395 415,469,746

~E & M refers to evaluation & management.Includes all Medicare costs, beginning with the date of first ESRD service.Medicare hospital pass-through costs for indirect medical education, organ acquisition, etc. are included.

671


Table K.3Medicare costs ($) for ESRD patients: by payor status & claim typeperiod prevalent ESRD patients, as-treated model

Table K.3Medicare costs ($) for ESRD patients: by payor status & claim typeperiod prevalent ESRD patients, as-treated model

1994-1998All Medicare Primary Payor Medicare Secondary Payor

Patient modality periods 701,482 588,108 113,374

Patient years at risk 1,187,928 1,047,136 140,792

Total Medicare 48,371,771,586 46,319,802,200 2,051,969,385

Total inpatient ($) 19,137,643,826 18,243,312,479 894,331,347 Medical DRG 7,515,804,512 7,189,915,034 325,889,477 Surgical DRG 9,866,620,856 9,439,146,377 427,474,479 Other DRG 145,293,537 138,485,191 6,808,347 Transplant DRG 896,221,001 797,564,198 98,656,803 Non-transplant pass-throughs 674,047,122 642,761,681 31,285,441 Transplant pass-throughs 39,656,798 35,439,998 4,216,800

Total outpatient ($) 17,212,995,070 16,587,831,169 625,163,900 Outpatient hemodialysis 9,417,513,501 9,105,319,203 312,194,299 Outpatient peritoneal dialysis 1,083,535,470 1,030,846,792 52,688,678 Outpatient other dialysis 1,712,432 1,647,115 65,318 Outpatient EPO 3,244,137,534 3,132,275,195 111,862,339 Outpatient vitamin D hormones 546,366,974 528,111,134 18,255,840 Outpatient iron 415,196,143 401,259,654 13,936,489 Outpatient other injectables 133,657,546 128,739,472 4,918,074 Radiology 314,584,251 300,478,268 14,105,983 Pharmacy 308,640,937 293,834,209 14,806,728 Ambulance 27,128,778 26,024,660 1,104,119 Laboratory/pathology 502,877,571 474,595,713 28,281,858 Outpatient other 1,217,643,931 1,164,699,755 52,944,177

Skilled nursing facility 1,068,083,428 1,030,048,510 38,034,919Home health agency 1,460,495,158 1,404,448,005 56,047,153Hospice 44,578,265 42,461,974 2,116,290

Total physician/supplier ($) 9,447,975,839 9,011,700,063 436,275,776 Transplant surgery 92,469,023 80,239,472 12,229,551 Inpatient surgery 584,475,020 555,031,022 29,443,997 Outpatient surgery 351,259,842 331,359,879 19,899,963 ~E&M nephrology inpatient 356,872,148 340,941,586 15,930,562 ~E&M nephrology outpatient 52,719,839 48,176,974 4,542,865 ~E&M non-nephrology inpatient 841,407,269 804,251,910 37,155,360 ~E&M non-nephrology outpatient 344,904,787 325,657,331 19,247,456 Dialysis capitation 1,358,577,137 1,304,623,123 53,954,014 Inpatient dialysis 540,620,900 519,199,477 21,421,423 Home dialysis 643,631,354 609,221,093 34,410,262 Vascular access 836,974,548 803,561,486 33,413,062 Peritoneal access 22,898,426 21,428,810 1,469,616 Physician/supplier EPO 6,607,260 6,140,009 467,251 Physician/supplier iron 379,247 357,710 21,537 Immunosuppressive drugs 154,216,369 138,470,352 15,746,017 Durable medical equipment 396,585,989 379,340,420 17,245,569 Physician/supplier radiology 239,710,723 226,995,289 12,715,434 Physician/supplier lab/pathology 935,761,337 897,312,317 38,449,020 Physician/supplier ambulance 822,003,627 796,089,039 25,914,588 Other physician/supplier 865,900,994 823,302,764 42,598,230

~E & M refers to evaluation & management.Patients of unknown age are excluded.The payment values include pro-rated Medicare costs, starting on the date of Medicare entitlement, as determined by the USRDS payor sequence. Patients are at risk until death, loss of Medicare entitlement, or the end of the period (12/31/03).Dialysis modality change or transplant results in a new modality period.

K

672


Table K.3 (continued)Medicare costs ($) for ESRD patients: by payor status & claim typeperiod prevalent ESRD patients, as-treated model

Table K.3 (continued)Medicare costs ($) for ESRD patients: by payor status & claim typeperiod prevalent ESRD patients, as-treated model

1999-2003All Medicare Primary Payor Medicare Secondary Payor

Patient modality periods 840,272 711,177 129,095

Patient years at risk 1,528,034 1,326,783 201,251

Total Medicare 69,494,175,419 66,616,291,721 2,877,883,698

Total inpatient ($) 26,787,922,245 25,592,572,863 1,195,349,382 Medical DRG 12,074,499,057 11,549,205,121 525,293,935 Surgical DRG 12,311,951,432 11,774,706,912 537,244,520 Other DRG 696,203,200 663,865,470 32,337,730 Transplant DRG 932,740,983 868,408,886 64,332,097 Non-transplant pass-throughs 744,294,652 710,145,962 34,148,690 Transplant pass-throughs 28,232,922 26,240,513 1,992,409

Total outpatient ($) 26,241,104,510 25,295,465,436 945,639,074 Outpatient hemodialysis 13,337,669,998 12,881,855,003 455,814,995 Outpatient peritoneal dialysis 855,938,092 822,229,740 33,708,351 Outpatient other dialysis 4,151,312 3,997,969 153,343 Outpatient EPO 6,069,707,715 5,852,604,907 217,102,807 Outpatient vitamin D hormones 1,463,050,327 1,411,814,756 51,235,572 Outpatient iron 967,249,951 934,132,284 33,117,667 Outpatient other injectables 340,720,283 326,730,642 13,989,642 Radiology 455,331,272 436,002,374 19,328,898 Pharmacy 308,945,202 295,404,527 13,540,675 Ambulance 50,280,111 48,095,550 2,184,562 Laboratory/pathology 520,558,320 494,710,010 25,848,310 Outpatient other 1,867,501,926 1,787,887,673 79,614,253

Skilled nursing facility 1,776,207,834 1,702,286,507 73,921,327Home health agency 1,125,068,121 1,080,956,167 44,111,954Hospice 119,007,557 112,828,148 6,179,409

Total physician/supplier ($) 13,444,865,152 12,832,182,600 612,682,552 Transplant surgery 88,335,579 80,485,144 7,850,435 Inpatient surgery 638,683,075 606,662,766 32,020,309 Outpatient surgery 490,050,558 463,037,932 27,012,626 ~E&M nephrology inpatient 498,135,973 475,378,798 22,757,175 ~E&M nephrology outpatient 75,136,437 69,118,434 6,018,003 ~E&M non-nephrology inpatient 1,465,363,471 1,399,006,453 66,357,017 ~E&M non-nephrology outpatient 656,313,032 620,117,877 36,195,155 Dialysis capitation 1,926,874,012 1,850,051,656 76,822,356 Inpatient dialysis 496,148,425 475,062,128 21,086,298 Home dialysis 560,120,665 536,688,453 23,432,212 Vascular access 1,082,118,065 1,037,100,876 45,017,189 Peritoneal access 18,522,225 17,405,819 1,116,406 Physician/supplier EPO 22,494,432 21,157,201 1,337,231 Physician/supplier iron 341,869 324,838 17,032 Immunosuppressive drugs 578,315,344 540,585,451 37,729,893 Durable medical equipment 505,200,592 483,150,727 22,049,865 Physician/supplier radiology 412,980,242 391,731,775 21,248,466 Physician/supplier lab/pathology 1,082,019,074 1,040,200,202 41,818,872 Physician/supplier ambulance 1,305,232,242 1,257,269,912 47,962,330 Other physician/supplier 1,542,479,840 1,467,646,158 74,833,681

~E & M refers to evaluation & management.Patients of unknown age are excluded.The payment values include pro-rated Medicare costs, starting on the date of Medicare entitlement, as determined by the USRDS payor sequence. Patients are at risk until death, loss of Medicare entitlement, or the end of the period (12/31/03).Dialysis modality change or transplant results in a new modality period.

673


Table K.4Per person per year costs: all ESRD patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

Table K.4Per person per year costs: all ESRD patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 33,696 40,453 39,043 36,089 39,169 43,267 39,742 39,110 39,646 37,322 39,969 46,526 47,2295-9 26,216 20,102 22,110 26,453 23,363 25,736 26,693 26,003 21,654 22,747 26,259 27,243 30,76410-14 23,707 24,668 24,202 26,301 26,558 25,121 25,758 24,543 21,737 21,784 23,991 27,988 31,80315-19 25,897 25,619 27,279 29,128 29,551 28,314 27,008 29,389 27,437 28,999 31,911 34,803 36,25520-29 27,848 28,390 29,667 30,729 31,970 33,059 32,702 32,602 33,478 33,611 36,062 38,036 39,53330-39 28,393 29,871 30,791 32,678 33,866 34,968 35,023 34,262 35,012 35,924 38,403 40,187 40,98740-49 30,333 31,702 32,553 34,077 36,183 38,204 38,049 37,550 38,216 39,401 42,200 44,283 45,04350-59 33,362 35,434 36,917 39,237 40,781 43,400 43,725 42,909 43,098 44,424 47,251 49,340 50,16960-64 36,814 38,938 39,936 42,124 44,447 46,884 47,195 46,974 46,877 48,008 51,327 53,879 55,11165-69 42,776 45,294 46,471 48,595 50,441 53,382 54,203 53,229 52,487 53,716 56,695 59,705 60,78270-79 45,353 48,460 49,350 51,449 53,963 57,332 58,464 57,249 56,856 58,638 62,344 64,757 65,59780+ 46,259 48,694 51,223 53,003 55,597 59,079 60,898 59,529 58,849 60,544 64,679 67,746 69,345

0-19 26,016 25,769 26,754 28,662 28,822 28,392 27,656 28,347 25,888 26,801 29,598 32,900 35,28420-44 28,615 29,820 30,791 32,377 33,985 35,304 35,259 34,727 35,430 36,117 38,809 40,853 41,69445-64 33,952 35,884 37,057 39,135 40,912 43,375 43,553 42,997 43,253 44,605 47,503 49,674 50,65665-74 43,733 46,474 47,559 49,691 51,769 54,829 55,843 54,705 54,089 55,679 58,906 61,405 62,32575+ 46,093 49,052 50,575 52,529 55,266 58,836 60,174 58,981 58,521 60,102 64,145 67,137 68,386

Male 34,165 36,246 37,362 39,396 41,189 43,594 44,184 43,850 44,024 45,353 48,498 50,940 52,215Female 38,412 40,708 42,078 44,305 46,836 49,624 50,265 49,527 49,588 51,029 54,539 57,239 58,098

White 35,358 37,392 38,493 40,378 42,620 44,989 45,745 45,252 44,980 46,331 49,518 52,007 53,117Black 38,096 40,657 42,013 44,573 46,478 49,367 49,700 49,054 49,712 51,149 54,877 57,504 58,786Native American 34,145 34,785 37,860 39,416 41,382 44,339 43,953 42,904 44,614 44,664 46,910 50,536 50,681Asian 30,871 32,512 34,359 36,096 37,855 40,542 41,650 41,374 42,133 43,402 45,810 48,391 47,812Other/unknown 33,920 23,679 24,829 41,005 56,204 55,812 53,044 53,933 53,262 56,915 57,880 59,875 58,452


Diabetes 42,421 44,883 46,841 49,239 51,566 55,147 55,727 54,756 54,241 55,927 59,708 62,245 63,150Hypertension 38,369 40,860 42,000 43,858 45,287 47,378 47,965 47,261 47,749 48,842 52,359 54,949 56,160Glomerulonephritis 29,510 30,640 31,179 32,785 34,548 35,902 35,843 35,416 35,610 36,135 38,061 39,849 40,528Other cause 31,549 33,104 33,540 35,209 37,827 39,922 40,340 39,915 40,161 41,595 44,514 46,857 48,007Unknown cause 33,806 35,436 35,671 37,970 38,662 40,666 41,522 41,415 41,380 42,800 44,290 47,199 47,048

All 36,165 38,346 39,583 41,709 43,841 46,420 47,026 46,497 46,618 47,984 51,288 53,831 54,904

Model 1: As-treated actuarial model. The standard USRDS as-treated economic model where all costs are attributed to the patients’ modality at the time the costs were incurred.If a modality changes, then the costs incurred after the change are attributed to the new modality. See economic methods section for further details.†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.

K

674


Table K.5Per person per year costs; all dialysis patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

Table K.5Per person per year costs; all dialysis patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 40,567 61,544 50,956 48,182 58,337 54,396 52,639 52,969 52,842 52,710 56,204 59,522 63,2165-9 42,751 35,913 41,102 43,996 38,999 46,532 52,743 51,321 44,725 50,343 50,580 48,462 45,70610-14 37,485 37,440 39,480 42,649 43,335 42,930 42,679 42,983 39,032 40,750 43,719 45,569 48,54415-19 36,128 35,109 37,403 40,174 42,149 41,624 39,088 43,284 39,690 43,826 46,520 50,283 47,88020-29 36,284 38,338 39,622 40,960 41,618 43,975 42,837 42,525 44,079 44,328 46,572 48,786 50,66230-39 36,978 39,113 40,671 43,026 44,380 46,543 46,679 45,887 47,247 48,119 50,929 52,741 53,85840-49 36,952 39,269 40,526 42,258 44,970 47,542 47,234 47,178 48,519 50,002 53,178 55,701 56,84350-59 38,337 41,104 43,099 45,885 47,324 50,801 51,204 50,846 51,895 53,210 56,619 58,980 60,18460-64 40,011 42,860 44,183 46,747 49,275 52,370 52,947 53,205 53,790 55,049 59,129 62,336 63,44565-69 44,606 47,516 49,249 51,919 54,020 57,635 58,891 58,097 57,707 59,337 63,021 66,623 68,44770-79 45,889 49,169 50,178 52,419 55,120 58,783 60,065 58,977 58,828 60,898 64,936 67,824 69,14280+ 46,346 48,793 51,276 53,096 55,704 59,215 61,072 59,722 59,100 60,842 65,043 68,199 69,900

0-19 37,476 37,700 39,343 41,794 43,565 43,514 42,148 44,541 40,818 44,351 47,006 49,765 49,04820-44 36,741 38,815 40,276 42,241 44,065 46,302 45,982 45,558 46,869 47,751 50,720 52,962 54,16745-64 38,691 41,441 43,024 45,491 47,422 50,635 50,967 50,855 51,863 53,242 56,741 59,354 60,55265-74 45,074 48,161 49,612 52,104 54,430 58,012 59,349 58,377 58,120 60,106 63,977 67,090 68,66075+ 46,297 49,245 50,775 52,804 55,584 59,272 60,696 59,537 59,158 60,900 64,999 68,162 69,665

Male 39,732 42,508 43,912 46,179 48,067 51,222 51,901 51,616 52,130 53,626 57,044 59,858 61,352Female 42,781 45,643 47,356 49,865 52,514 55,903 56,710 56,075 56,481 58,151 62,184 65,149 66,388




All 41,232 44,048 45,605 47,988 50,243 53,505 54,236 53,774 54,232 55,797 59,499 62,361 63,723


675


Table K.6Per person per year costs; hemodialysis patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

Table K.6Per person per year costs; hemodialysis patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 47,720 75,584 53,206 63,906 74,968 60,896 64,202 52,785 83,958 81,594 101,539 77,292 56,9845-9 42,852 38,813 48,759 46,587 48,059 55,026 59,312 56,998 58,401 51,961 62,673 60,997 60,13310-14 40,608 39,668 41,663 44,965 44,806 46,356 45,520 51,316 44,333 44,951 51,820 53,585 54,65515-19 36,748 36,468 38,382 40,506 44,226 43,484 40,652 45,571 40,572 45,888 48,648 52,942 50,52420-29 37,014 39,070 41,034 42,124 42,719 45,493 44,506 43,601 45,304 45,389 48,209 50,512 52,55230-39 37,796 39,949 41,996 44,341 45,793 48,020 47,885 46,796 48,506 49,252 52,378 54,263 55,53640-49 37,442 39,849 41,381 43,305 46,031 48,721 48,272 48,230 49,574 51,020 54,276 56,761 58,02250-59 38,708 41,858 43,860 46,794 48,071 51,620 52,144 51,393 52,668 53,887 57,477 59,883 61,28160-64 40,587 43,485 45,075 47,623 50,014 53,121 53,627 53,664 54,334 55,478 59,758 63,021 64,37065-69 44,814 47,906 49,755 52,599 54,626 58,605 59,531 58,532 58,218 59,952 63,312 67,103 69,09670-79 45,767 49,215 50,477 52,582 55,498 59,215 60,302 59,042 58,944 61,055 64,985 68,060 69,44080+ 45,916 48,255 50,959 52,822 55,584 59,272 60,863 59,312 58,676 60,459 64,572 67,632 69,428

0-19 38,222 38,536 40,184 42,646 45,876 45,229 43,303 47,433 43,352 46,990 51,224 54,201 51,89920-44 37,423 39,559 41,445 43,469 45,340 47,761 47,254 46,565 48,080 48,883 52,097 54,436 55,78445-64 39,173 42,126 43,876 46,424 48,247 51,501 51,864 51,509 52,641 53,917 57,607 60,234 61,61665-74 45,156 48,421 50,086 52,621 55,001 58,828 59,833 58,683 58,515 60,564 64,233 67,556 69,18875+ 46,006 48,997 50,705 52,638 55,623 59,363 60,674 59,311 58,918 60,720 64,704 67,885 69,523

Male 40,016 42,912 44,601 46,850 48,754 52,024 52,564 52,030 52,604 54,087 57,536 60,407 62,065Female 43,358 46,420 48,316 50,913 53,623 57,180 57,853 56,938 57,401 59,035 63,112 66,174 67,501




All 41,667 44,644 46,433 48,849 51,141 54,540 55,130 54,400 54,913 56,451 60,187 63,125 64,614


K

676


Table K.7Per person per year costs; CAPD/CCPD patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

Table K.7Per person per year costs; CAPD/CCPD patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 36,312 55,823 48,825 43,960 52,550 51,917 48,466 53,019 44,861 38,105 46,451 54,196 64,4675-9 41,403 35,374 34,884 43,448 36,762 43,357 48,923 46,145 33,650 46,729 41,384 40,091 38,10610-14 34,717 34,646 36,133 39,485 41,401 39,189 40,626 37,458 33,493 34,603 33,703 36,534 41,25115-19 34,011 33,104 34,894 39,269 37,656 38,153 36,331 38,298 37,948 37,915 40,779 42,687 40,08420-29 32,673 34,815 34,226 36,215 37,787 38,426 36,029 37,341 38,003 38,440 38,420 39,567 40,24930-39 33,102 35,313 35,464 37,451 38,640 40,394 41,035 40,680 39,652 41,045 41,366 42,560 42,26640-49 33,680 35,741 35,983 37,129 40,186 41,796 41,242 40,461 40,628 41,889 43,578 45,821 45,72450-59 34,639 35,895 37,545 39,704 42,515 45,311 44,578 45,595 44,160 45,484 46,300 48,118 47,03060-64 33,635 36,681 36,808 39,645 42,897 45,701 45,854 46,832 45,168 47,696 48,263 49,761 48,17165-69 36,032 38,108 39,652 41,401 45,270 46,254 48,747 48,211 46,665 47,000 51,676 52,147 52,50670-79 36,597 38,473 39,076 41,042 43,463 47,252 48,716 48,268 47,355 49,066 51,133 50,048 50,42280+ 36,215 36,651 39,204 40,268 43,281 44,682 45,530 44,624 45,333 45,935 47,433 50,375 51,445

0-19 35,568 36,436 37,075 40,498 40,579 41,272 40,759 40,738 37,126 38,160 39,821 42,269 44,21720-44 33,110 35,147 35,334 36,964 38,929 40,232 39,933 39,943 39,580 40,389 41,414 42,694 42,51845-64 34,158 36,238 36,973 39,176 42,053 44,703 44,169 44,614 43,543 45,395 46,116 48,079 47,23065-74 36,201 38,470 39,424 41,343 44,594 46,473 48,980 48,333 47,024 48,117 51,483 50,998 51,85875+ 36,658 37,338 39,046 40,497 43,032 46,886 47,012 46,745 46,560 47,611 49,613 50,501 50,247

Male 34,167 36,057 36,562 38,456 40,930 43,031 43,386 43,483 42,852 43,794 45,364 46,828 46,515Female 35,039 37,110 38,064 40,060 42,915 45,181 45,406 45,347 44,150 45,775 47,306 48,232 48,274




All 34,588 36,563 37,289 39,235 41,896 44,079 44,377 44,405 43,503 44,788 46,336 47,525 47,384


677


Table K.8Per person per year costs: by transplant patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

Table K.8Per person per year costs: by transplant patients, with unknowns dropped (model 1)period prevalent ESRD patients, as-treated model, primary payor only

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 27,930 24,830 29,681 25,201 23,609 33,017 30,413 30,908 30,754 26,987 27,396 36,150 35,0055-9 17,859 13,316 15,011 18,627 16,263 17,694 16,821 17,601 14,836 14,261 16,589 17,471 22,55110-14 14,079 16,757 14,816 16,780 16,228 15,288 16,952 15,296 13,534 13,314 14,691 17,974 21,85515-19 16,045 16,409 17,421 18,274 18,737 16,900 16,014 16,576 16,788 16,338 19,760 20,761 25,02020-29 16,731 15,819 16,704 16,905 18,426 17,772 18,190 17,907 17,638 17,363 19,701 20,714 21,18330-39 15,528 16,316 16,335 17,334 17,817 17,626 17,430 16,821 16,681 17,486 19,157 20,359 20,52940-49 16,523 16,425 16,871 17,730 18,101 19,034 19,107 17,531 16,963 17,700 19,643 20,605 20,53850-59 16,393 16,619 17,220 18,411 19,774 20,311 20,695 19,534 17,852 19,864 20,895 22,122 21,88460-64 16,649 16,149 16,901 17,943 19,315 20,214 20,715 19,835 18,947 20,517 21,476 21,989 24,44165-69 17,403 18,095 17,375 17,687 19,688 19,702 20,426 20,786 19,873 21,113 22,480 24,566 24,52870-79 14,717 16,037 17,846 18,027 18,366 18,004 19,149 19,820 19,433 21,024 24,129 23,973 24,62980+ 17,532 17,009 25,654 13,776 17,574 14,166 16,830 14,155 11,355 18,328 19,712 18,534 19,404

0-19 16,748 16,624 17,273 18,472 18,085 17,739 17,522 17,414 16,346 15,772 18,225 20,541 24,53320-44 16,059 16,247 16,418 17,167 17,988 17,958 18,077 17,180 16,915 17,307 19,254 20,428 20,60445-64 16,530 16,431 17,237 18,321 19,233 20,021 20,236 19,105 17,887 19,615 20,822 21,759 22,15865-74 17,031 17,379 17,453 17,885 19,408 19,257 20,140 20,483 19,629 21,305 22,879 24,137 24,52575+ 11,841 19,527 19,745 15,556 16,858 16,962 17,821 19,111 19,209 18,698 24,766 24,610 23,907

Male 15,994 16,064 16,586 17,567 18,436 18,554 18,770 18,127 17,426 18,467 20,465 21,179 21,967Female 16,809 16,973 17,299 17,990 18,930 19,516 19,852 18,895 18,088 19,396 20,681 22,462 22,398




All 16,311 16,420 16,868 17,736 18,629 18,932 19,199 18,433 17,691 18,841 20,551 21,698 22,142


K

678


Table K.9Per person per year costs: dialysis patients (model 2)period prevalent ESRD patients, primary payor only

Table K.9Per person per year costs: dialysis patients (model 2)period prevalent ESRD patients, primary payor only

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 38,608 54,700 44,301 44,494 51,958 54,681 47,615 43,244 47,081 36,520 48,725 54,086 50,1925-9 37,933 32,398 39,108 41,553 33,301 43,301 49,441 44,984 37,843 47,750 44,135 47,894 42,82610-14 35,013 33,659 37,594 39,852 39,017 35,985 37,627 37,676 36,451 38,067 36,429 42,876 45,38415-19 34,460 33,721 35,381 37,377 39,567 38,813 38,225 41,357 36,939 41,581 43,864 46,879 46,24920-29 35,013 37,084 38,452 39,925 40,276 42,675 41,839 41,300 42,564 43,223 45,196 47,536 49,32230-39 35,723 37,565 39,214 41,837 43,428 44,917 45,962 44,905 46,023 46,800 49,774 51,758 52,41240-49 35,969 37,904 39,207 41,259 43,830 46,446 46,623 46,121 47,139 48,557 52,044 54,955 55,54950-59 37,384 39,953 41,825 45,139 46,508 49,645 50,727 49,995 50,706 51,939 55,686 58,345 59,15760-64 38,995 41,514 42,982 45,966 48,704 51,244 52,310 52,586 52,773 54,105 58,490 62,284 62,98165-69 42,123 44,632 46,029 49,778 52,047 55,185 56,593 56,139 55,966 57,224 61,537 66,050 67,28770-79 43,524 46,157 46,674 50,286 53,253 56,419 57,571 56,947 57,004 58,749 63,569 67,199 67,76480+ 44,095 45,832 47,728 50,979 53,710 56,868 58,622 57,954 57,597 58,654 63,643 67,514 68,158

0-19 35,271 35,111 36,945 38,970 40,090 40,009 39,811 41,020 37,564 41,030 42,681 46,642 46,04220-44 35,450 37,292 38,882 41,175 42,974 44,960 45,345 44,547 45,603 46,491 49,562 52,085 52,84045-64 37,789 40,247 41,800 44,687 46,640 49,503 50,397 50,037 50,672 52,019 55,868 58,861 59,63365-74 42,662 45,232 46,216 49,874 52,441 55,588 56,970 56,408 56,355 57,962 62,550 66,487 67,45875+ 43,945 46,235 47,330 50,837 53,775 56,943 58,198 57,587 57,455 58,756 63,622 67,515 68,034

Male 38,118 40,566 41,797 44,759 46,731 49,687 50,731 50,394 50,763 52,051 55,912 59,262 60,078Female 41,569 44,001 45,452 48,804 51,561 54,430 55,568 54,972 55,356 56,855 61,455 65,028 65,800




All 39,816 42,256 43,600 46,752 49,106 52,012 53,092 52,618 52,989 54,359 58,562 61,992 62,767

Model 2: Categorical calendar year model. Patients are classified into four mutually exclusive modality groups, based on calendar year.Patients are classified into four mutually exclusive modality groups, based on calendar year. If a patient receives a transplant during a calendar year, they are placed into the transplant event modality and costs are aggregated for the entire time that the patient is alive, ESRD and Medicare entitled during the calendar year. Other modalities (dialysis, functioning graft, graft failure) are defined in a similar fashion. See economic methods section for further details.†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.

679


Table K.10Per person per year costs: transplant event within the year (model 2)period prevalent ESRD patients, primary payor only

Table K.10Per person per year costs: transplant event within the year (model 2)period prevalent ESRD patients, primary payor only

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 97,476 94,493 90,219 103,916 94,320 108,517 95,046 101,548 94,805 88,070 94,361 108,019 99,8165-9 97,221 84,173 93,779 95,945 89,344 95,534 101,420 98,394 88,985 92,637 82,365 74,343 85,49810-14 81,729 85,891 75,200 81,087 93,441 83,445 94,455 79,602 77,614 80,018 87,872 82,081 88,34315-19 76,790 77,060 82,131 86,907 84,687 85,812 82,531 89,794 79,854 81,078 87,158 90,864 88,38020-29 76,424 80,803 84,908 86,340 89,240 86,658 89,288 86,738 86,602 83,119 89,645 91,423 91,00430-39 79,478 83,058 87,441 89,495 93,078 94,353 91,406 87,840 91,018 92,358 92,283 93,789 94,16640-49 80,756 82,831 85,579 86,729 92,048 92,087 93,413 88,040 89,843 92,565 94,196 96,955 93,67350-59 81,817 83,344 87,047 90,936 93,796 93,664 95,421 92,091 91,720 95,202 94,374 97,657 95,71460-64 81,938 85,660 85,813 87,028 93,497 93,382 94,781 94,602 93,634 97,908 98,524 100,140 100,04465-69 85,746 85,425 89,040 92,410 97,535 98,134 107,760 99,275 97,891 97,818 103,721 103,561 101,61370-79 81,753 80,902 104,570 92,591 97,043 90,818 100,821 105,033 103,007 103,351 110,251 106,655 103,51080+ 91,065 93,110 147,155 75,313 104,276 71,019 88,063 77,466 71,440 97,088 118,903 74,185 90,558

0-19 83,258 82,527 83,702 88,078 88,205 89,571 90,346 89,617 81,952 82,802 87,416 88,131 89,49120-44 78,837 82,318 85,772 87,893 91,900 91,591 91,179 87,260 89,408 89,302 92,427 93,696 93,03445-64 81,518 83,644 86,973 89,024 92,961 93,158 94,872 91,791 91,685 95,639 94,846 98,292 96,29165-74 85,246 84,618 91,449 91,974 97,089 96,693 105,416 100,547 99,477 99,323 105,201 103,481 102,29675+ 74,782 80,531 135,940 109,237 105,403 74,709 114,792 102,328 91,312 102,274 117,859 116,430 100,634

Male 80,176 81,663 85,927 88,366 92,066 90,936 93,304 90,157 90,444 92,000 95,150 96,146 94,947Female 80,677 84,834 87,476 89,005 93,204 94,774 94,648 91,045 91,668 94,355 94,356 98,111 96,494

White 81,013 83,246 87,578 89,377 93,050 93,023 94,637 91,153 89,798 91,548 93,516 96,387 94,431Black 79,368 83,113 84,771 87,856 92,654 91,539 93,248 90,149 94,550 97,226 98,912 99,429 99,204Native American 71,913 74,132 77,199 89,952 89,172 88,746 88,975 80,749 83,715 83,478 82,484 86,377 92,797Asian 77,911 78,910 84,203 81,466 82,456 91,426 86,948 86,433 86,333 86,338 87,882 91,292 87,356Other/unknown 91,519 52,111 36,657 81,814 108,849 65,912 70,490 62,302 93,584 77,799 88,280 95,586



All 80,380 82,928 86,553 88,618 92,505 92,491 93,845 90,518 90,936 92,959 94,826 96,942 95,567


K

680


Table K.11Per person per year costs: functioning graft patients (model 2)period prevalent ESRD patients, primary payor only

Table K.11Per person per year costs: functioning graft patients (model 2)period prevalent ESRD patients, primary payor only

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 12,198 12,783 13,032 11,823 13,345 15,643 16,869 14,238 10,258 18,210 13,277 15,588 16,7425-9 8,271 7,510 6,568 10,563 8,712 7,988 7,614 9,947 9,329 8,738 9,173 11,762 13,47410-14 7,029 7,922 7,766 7,181 6,026 7,581 8,707 8,055 7,029 7,574 7,942 9,757 11,91315-19 7,191 7,370 7,028 6,784 8,769 7,856 7,448 7,284 7,709 8,864 10,433 9,954 13,76320-29 7,300 6,894 6,837 7,481 7,982 7,991 8,604 8,657 8,813 8,379 10,156 10,878 11,57130-39 8,040 8,509 8,486 9,281 9,350 9,971 10,094 9,708 9,642 9,991 11,303 12,200 12,52040-49 8,766 9,191 9,341 10,341 10,327 11,283 11,348 10,935 10,399 11,093 12,325 13,265 13,75150-59 8,841 9,722 10,037 11,113 12,160 12,655 13,192 12,526 11,689 13,144 14,050 14,848 15,37360-64 9,970 9,756 10,721 11,912 12,289 13,029 14,366 13,909 13,460 14,687 15,681 15,998 18,04865-69 10,492 11,357 11,543 12,205 13,856 14,017 14,132 14,348 14,470 15,313 16,731 18,159 18,36970-79 10,814 11,025 12,258 13,458 13,622 13,842 14,610 15,697 15,978 16,562 19,069 19,372 20,15980+ 10,747 11,746 10,181 9,558 15,945 11,907 16,035 12,556 10,765 15,069 16,552 16,924 17,840

0-19 7,689 7,922 7,576 7,974 8,408 8,282 8,499 8,470 7,958 9,004 9,619 10,533 13,46420-44 8,001 8,314 8,286 9,032 9,247 9,869 10,151 9,808 9,560 9,944 11,326 12,229 12,66145-64 9,098 9,553 10,024 11,217 11,727 12,389 12,895 12,413 11,843 13,008 14,030 14,750 15,64065-74 10,620 11,165 11,762 12,569 13,838 13,820 14,351 14,699 14,754 15,809 17,355 18,465 18,93775+ 9,926 12,991 11,411 12,341 13,237 15,500 13,914 16,063 17,256 15,779 20,175 19,874 20,332

Male 8,343 8,778 9,053 10,016 10,471 11,207 11,423 11,357 10,982 11,938 13,329 14,120 15,126Female 8,892 9,310 9,485 10,539 11,098 11,500 12,306 11,847 11,754 12,547 13,944 15,104 15,700




All 8,557 8,987 9,225 10,220 10,716 11,321 11,771 11,551 11,290 12,182 13,576 14,515 15,357


681


Table K.12Per person per year costs: graft failure within the year (model 2)period prevalent ESRD patients, primary payor only

Table K.12Per person per year costs: graft failure within the year (model 2)period prevalent ESRD patients, primary payor only

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 20030-4 67,902 58,071 85,107 65,344 . 59,837 . 146,176 82,778 . 80,221 71,423 38,5885-9 48,684 38,173 35,947 61,736 66,306 129,842 97,796 69,343 86,674 80,976 . 51,408 30,56810-14 40,229 59,264 50,154 53,872 48,036 45,235 64,234 48,846 46,415 39,833 58,190 52,778 65,23315-19 40,307 41,634 39,734 52,033 48,252 52,387 57,165 46,088 51,365 59,973 53,383 65,270 69,85920-29 47,423 43,203 47,279 48,273 45,559 57,615 49,312 51,691 53,312 54,085 54,793 63,105 59,35830-39 45,609 52,573 47,413 51,443 52,482 52,438 56,088 55,214 57,425 54,601 58,090 68,636 64,94440-49 46,898 51,158 51,203 51,429 54,303 56,576 59,791 58,194 59,717 58,861 65,296 65,160 65,60450-59 50,414 50,459 50,570 60,348 55,117 64,245 63,804 64,638 65,980 67,336 70,818 76,345 69,46460-64 52,438 52,847 56,996 59,877 61,354 69,655 72,071 72,336 71,024 72,243 76,853 74,279 88,57465-69 51,564 63,902 51,607 60,158 69,040 70,091 68,899 79,907 72,995 59,308 78,370 86,798 94,57170-79 67,330 50,087 57,860 69,651 62,321 98,748 80,769 54,873 62,739 66,248 92,764 83,666 87,57980+ 43,001 45,125 69,934 61,296 22,440 . . 38,299 52,007 60,836 175,320 126,020 70,941

0-19 41,773 45,899 44,476 53,516 48,303 55,504 61,992 51,060 54,751 57,395 54,685 62,318 64,88720-44 46,252 49,662 48,197 49,704 50,902 54,724 54,622 55,991 57,106 55,448 57,466 66,367 63,43745-64 49,824 50,734 51,872 58,447 56,260 62,668 65,374 62,285 64,553 66,048 72,079 72,823 72,28965-74 56,366 58,851 52,985 63,585 66,782 77,826 73,932 73,018 68,925 61,361 84,394 86,472 92,48275+ 36,792 56,792 68,843 56,694 52,035 84,110 69,396 55,504 70,997 67,490 94,109 84,793 86,514

Male 45,344 49,317 48,262 51,898 51,749 55,733 55,934 57,389 60,657 58,540 66,222 67,148 68,289Female 50,254 51,532 51,475 55,696 56,029 63,821 65,898 62,343 61,191 63,556 66,302 75,964 74,949

White 48,232 52,318 49,953 55,914 54,994 59,456 59,443 59,865 61,361 59,275 65,954 71,212 70,549Black 45,446 46,701 49,387 49,971 51,583 59,479 61,762 57,991 60,383 63,309 66,788 71,455 72,346Native American 52,099 42,320 39,262 53,334 56,057 50,687 70,524 50,267 44,698 52,863 58,672 76,254 81,094Asian 43,982 47,260 45,788 46,074 34,876 46,614 44,056 68,398 64,649 59,056 69,661 55,584 58,805Other/unknown . . . . 113,333 . 24,838 187,862 12,635 63,034 . 147,412 .



All 47,270 50,223 49,537 53,497 53,435 59,018 59,995 59,393 60,874 60,602 66,255 70,994 70,930

Model 2: Categorical calendar year model. Patients are classified into four mutually exclusive modality groups, based on calendar year.Patients are classified into four mutually exclusive modality groups, based on calendar year. If a patient receives a transplant during a calendar year, they are placed into the transplant event modality and costs are aggregated for the entire time that the patient is alive, ESRD and Medicare entitled during the calendar year. Other modalities (dialysis, functioning graft, graft failure) are defined in a similar fashion. See economic methods section for further details."." Zero values in this cell.†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.

K

682

MEDICARE COSTS FOR ESRDReference section KK MEDICARE COSTS FOR ESRDReference section K

ON OUR WEBSITE & CDMedicare payments ($) per person per year: 1999-2003, by claim type: model 1 (k.a-k.e).

Table K.13Part B Medicare costs ($) per patient YAR: by physician/supplier specialtyperiod prevalent patients, as-treated model; Medicare primary payor only

Table K.13Part B Medicare costs ($) per patient YAR: by physician/supplier specialtyperiod prevalent patients, as-treated model; Medicare primary payor only

1999 2000 2001 2002 2003All 8,522 8,885 9,588 10,143 10,921Nephrology 1,940 1,989 2,059 2,187 2,299Pediatric medicine 785 803 833 936 1,192Medical supply company 752 776 824 837 722Laboratory 613 620 611 799 895Ambulance service supplier 724 799 933 1,114 1,329Internal medicine 667 699 753 805 859General surgery 468 456 452 439 452Radiology (diagnostic and therapeutic) 469 472 502 536 612Cardiology 313 328 352 372 426Anesthesiology 255 252 248 235 243Multispecialty clinic/group practice 223 268 379 134 6Pharmacy 481 540 669 736 872Opthalmology 126 135 143 146 158Vascular surgery 148 149 154 168 187Thoracic surgery 89 81 81 74 73General and family practice 122 136 150 175 219Emergency medicine 125 141 158 180 211Gastroenterology 98 97 99 98 104Urology 73 72 76 77 81Pulmonary disease 97 100 107 121 139Orthopedic surgery 73 76 82 86 91Neurology 68 70 78 82 90Hematology/oncology 66 77 85 107 132Infectious disease 69 72 80 88 100Pathology 44 48 50 52 57Therapeutic services 60 66 70 72 82Podiatry 48 54 63 68 78Cardiac surgery 30 30 30 32 37Dermatology 33 38 41 46 51Ambulatory surgery center 31 35 38 45 52Psychiatry (includes neuropsychiatry) 25 24 24 24 25Obstetrics/gynecology 21 23 24 26 31Endocrinology 25 26 29 31 35Plastic and reconstructive surgery 18 19 21 20 21Otolaryngology 17 18 20 21 23Geriatric medicine 12 14 17 19 23Neurosurgery 13 14 15 15 16Peripheral vascular disease 7 7 9 9 9Rheumatology 8 8 9 9 10Optometry 10 13 10 11 12Home health agency 3 3 1 3 2Hospital 2 2 2 1 4Nuclear medicine 5 5 5 6 7Chiropractic 4 4 5 5 6Colorectal surgery 3 3 3 3 3Allergy/immunology 1 1 2 2 2Other nursing facility 2 1 1 1 1Maxillofacial and oral surgery 1 1 1 1 1Skilled nursing facility 1 0 1 1 1Intermediate care nursing facility 0 0 0 0 0Other medical care/supplies 12 17 26 26 33Unknown 32 12 8 12 18

Patients 300,502 314,420 331,323 350,074 359,311Total years at risk 239,602 251,534 264,872 279,819 290,957

Fertile female patients (age >13) 139,789 145,634 152,619 160,436 163,938Fertile female years at risk 110,920 115,738 121,428 127,457 132,021

Pediatric patients (age <20) 4,623 4,804 4,893 5,011 4,877Pediatric years at risk 4,101 4,217 4,254 4,327 4,274

Geriatric patients (age >64) 119,688 124,505 132,037 140,884 144,674Geriatric years at risk 85,820 90,028 95,365 101,671 106,014

Patients of unknown age are excluded.The pediatric medicine rate uses pediatric (age <20) years at risk, the geriatric medicine rate uses geriatric (age >64) years at risk, & the obstetrics/gynecology rate uses fertile female (age >13) years at risk. All other rates are calculated using total years at risk.

Vascularaccess

ReferenceSectio

nL

VASCULAR ACCESSL

684

Reference section L

L.1 . 685 Catheter insertions in prevalent hemodialysis patients, per 1,000 patient years, with unknowns droppedby age, gender, race, ethnicity, & primary diagnosis

L.2 . 686 Arteriovenous fistula insertions in prevalent hemodialysis patients, per 1,000 patient years, with unknowns droppedby age, gender, race, ethnicity, & primary diagnosis

L.3 . 687 Graft insertions in prevalent hemodialysis patients, per 1,000 patient years, with unknowns droppedby age, gender, race, ethnicity, & primary diagnosis

L.4 . 688 Catheter intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

L.5 . 690 Arteriovenous fistula intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

L.6 . 692 Graft intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

L.7 . 694 Catheter complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

L.8 . 696 Arteriovenous fistula complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

L.9 . 698 Graft complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

L.10 . 700 Peritoneal dialysis complications: prevalent peritoneal dialysis patients by age, gender, race, ethnicity, & primary diagnosis

L.11 . 702 Catheter insertions in hemodialysis patients, per 1,000 patient years, by ESRD vintageby age, gender, race, ethnicity, & primary diagnosis

L.12 . 703Arteriovenous fistula insertions in hemodialysis patients, per 1,000 patient years, by ESRD vintageby age, gender, race, ethnicity, & primary diagnosis

L.13 . 704 Graft insertions in hemodialysis patients, per 1,000 patient years, by ESRD vintageby age, gender, race, ethnicity, & primary diagnosis

685


VASCULAR ACCESSLTable L.1Catheter insertions in prevalent hemodialysis patients, per 1,000 patient years, with unknowns droppedby age, gender, race, ethnicity, & primary diagnosis

Table L.1Catheter insertions in prevalent hemodialysis patients, per 1,000 patient years, with unknowns droppedby age, gender, race, ethnicity, & primary diagnosis

1999 2000 2001 2002 20030-4 1,152 1,270 2,284 1,259 1,2415-9 1,155 937 731 691 76610-14 789 588 659 859 56815-19 545 621 594 600 63620-29 571 551 603 575 54830-39 581 561 562 556 51040-49 539 526 540 519 48350-59 528 514 510 501 47260-64 522 506 493 482 46565-69 531 530 502 502 48270-79 528 502 497 483 45880+ 525 515 495 492 450

0-19 639 647 642 668 64220-44 566 549 567 555 51745-64 528 513 509 495 46865-74 530 519 504 497 47475+ 525 504 491 482 450

Male 476 464 454 441 420Female 598 579 578 572 535

White 506 490 487 474 456Black 580 567 557 550 506Native American 422 415 427 443 410Asian 406 392 394 384 371

Hispanic 538 524 498 497 474Non-Hispanic 537 520 517 506 477

Diabetes 597 574 564 552 520Hypertension 505 489 473 463 430Glomerulonephritis 461 454 456 431 418Cystic kidney 434 432 427 426 395Other urologic 525 482 522 506 489Other cause 523 518 544 539 513Unknown cause 508 495 460 479 435Missing disease 392 578 268 342 18

All 534.5 518.8 512.9 502.2 473.2

VASCULAR ACCESSL

686

Reference section L

"."Zero values in this cell.

Table L.2Arteriovenous fistula insertions in prevalent hemodialysis patients, per 1,000 patient years, with unknowns droppedby age, gender, race, ethnicity, & primary diagnosis

Table L.2Arteriovenous fistula insertions in prevalent hemodialysis patients, per 1,000 patient years, with unknowns droppby age, gender, race, ethnicity, & primary diagnosis

1999 2000 2001 2002 20030-4 . . . 74.1 0.05-9 56.3 36.1 . 30.0 95.810-14 141.6 96.3 154.6 251.1 142.115-19 83.7 146.9 102.3 149.4 133.420-29 92.0 87.7 97.2 94.7 117.230-39 84.3 86.1 87.6 95.8 99.440-49 74.9 79.7 79.4 84.2 85.650-59 62.4 67.7 70.3 72.1 79.860-64 54.9 64.6 64.8 71.3 74.265-69 61.8 67.3 69.6 76.1 82.670-79 62.0 64.3 68.5 75.2 80.280+ 58.5 55.3 65.4 70.5 72.2

0-19 90.3 129.3 103.6 159.1 130.520-44 83.0 87.2 87.5 93.3 98.545-64 62.4 67.9 70.1 73.4 78.865-74 61.3 65.7 69.1 74.6 83.275+ 61.2 60.2 67.0 74.1 74.3

Male 75.5 78.9 80.5 85.7 89.9Female 54.2 57.9 62.3 67.5 72.7

White 67.9 70.5 75.5 81.5 86.6Black 62.8 67.7 68.1 71.9 76.2Native American 63.0 64.7 85.0 87.3 86.5Asian 51.8 57.8 56.2 70.3 73.1

Hispanic 60.1 63.7 66.4 71.6 75.5Non-Hispanic 68.8 71.3 73.7 78.9 83.8

Diabetes 61.6 66.3 70.0 75.0 78.9Hypertension 65.5 68.6 70.5 77.1 79.4Glomerulonephritis 68.0 69.5 73.4 75.6 86.5Cystic kidney 54.3 64.0 65.4 72.1 72.6Other urologic 79.2 77.6 76.2 83.2 90.5Other cause 74.9 80.8 84.3 84.6 98.3Unknown cause 69.7 69.0 73.8 91.6 88.9Missing disease 30.7 69.0 17.3 15.2 5.9

All 65.3 68.9 71.9 77.2 81.9

687


VASCULAR ACCESSL

"."Zero values in this cell.

Table L.3Graft insertions in prevalent hemodialysis patients, per 1,000 patient years, with unknowns droppedby age, gender, race, ethnicity, & primary diagnosis

Table L.3Graft insertions in prevalent hemodialysis patients, per 1,000 patient years, with unknowns droppedby age, gender, race, ethnicity, & primary diagnosis

1999 2000 2001 2002 20030-4 . . . 74.1 .5-9 56.3 72.1 58.4 120.1 63.910-14 50.6 32.1 82.4 57.9 56.815-19 131.5 130.1 122.8 142.3 111.220-29 173.4 149.4 140.0 134.9 121.530-39 181.6 159.5 153.6 138.1 132.940-49 177.7 159.8 150.2 140.3 132.550-59 176.8 159.7 154.7 142.5 137.260-64 172.4 158.2 146.8 148.6 133.265-69 182.8 172.0 156.8 149.3 144.070-79 172.8 160.6 153.9 148.3 138.480+ 152.5 140.0 135.7 132.9 124.5

0-19 109.8 107.5 109.3 124.1 97.020-44 177.3 157.8 149.9 138.4 131.845-64 176.3 159.3 151.5 143.8 134.765-74 177.7 167.1 157.0 150.7 144.575+ 163.6 150.1 143.4 138.7 127.8

Male 158.0 143.3 133.3 126.8 119.7Female 191.1 176.2 170.2 162.6 152.8

White 153.6 142.6 135.4 127.1 120.0Black 202.2 181.8 173.2 167.4 157.3Native American 127.6 123.5 106.6 107.6 104.8Asian 156.6 148.9 136.9 130.4 122.2

Hispanic 180.3 164.9 154.1 143.7 134.0Non-Hispanic 176.0 159.6 151.6 144.6 136.6

Diabetes 193.2 176.2 165.1 157.9 147.2Hypertension 171.6 157.8 149.1 142.8 133.3Glomerulonephritis 150.5 135.5 129.8 118.4 113.4Cystic kidney 139.9 125.9 114.5 101.8 103.7Other urologic 158.7 156.5 145.7 136.1 132.8Other cause 154.7 138.9 144.1 136.4 133.9Unknown cause 158.9 140.9 127.9 126.0 110.3Missing disease 69.1 69.0 34.6 45.6 0.0

All 173.9 158.9 150.8 143.6 135.1

VASCULAR ACCESSL

688

Reference section L

Table L.4Catheter intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.4Catheter intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

1999 2000 2001# pts % RM %RP %DC # pts % RM %RP %DC # pts % RM %RP %DC

0-4 . . . . . . . . . . . .5-9 . . . . . . . . . . . .10-14 . . . . . . . . . . . .15-19 . . . . 3 * * * . . . .20-29 2 * * * 13 23 46 . 14 7 43 .30-39 40 13 33 . 48 21 25 6 51 8 25 .40-49 55 20 24 2 71 11 24 4 81 20 27 450-59 80 13 24 4 94 20 35 4 109 16 27 560-64 43 16 21 2 56 16 23 5 73 15 15 365-69 59 12 24 3 77 8 14 4 68 15 22 370-79 149 7 16 1 157 13 25 1 180 13 19 380+ 68 9 18 . 80 18 24 3 94 13 17 3Unknown

0-19 3 * * *20-44 67 18 27 1 92 21 25 3 104 13 32 245-64 153 14 24 3 190 16 31 5 224 16 21 465-74 133 8 20 2 152 9 20 3 166 14 21 375+ 143 10 17 1 162 17 24 1 176 13 18 3


White 264 11 22 2 320 12 22 2 376 15 23 2Black 205 12 21 2 254 18 30 5 267 13 21 4Native American 11 9 36 . 7 * * * 10 10 40 .Asian 10 . . . 14 21 21 . 16 13 19 6Other/unknown 6 * * * 4 * * * 1 * * *

Hispanic 51 18 29 2 62 13 32 2 65 14 31 3Non-Hispanic 372 10 20 2 478 15 24 3 566 14 20 3

Diabetes 199 9 20 2 243 14 26 4 267 12 21 3Hypertension 138 11 19 1 161 13 26 3 184 17 25 3Glomerulonephritis 62 10 18 2 69 17 23 4 86 14 21 1Cystic kidney 13 15 23 8 14 21 36 0 16 25 38 6Other urologic 17 12 24 12 30 13 20 0 22 14 23 14Other cause 48 21 31 . 58 19 24 3 69 10 16 .Unknown cause 19 21 32 . 24 17 25 4 26 19 19 .Missing disease

All 496 11 21 2 599 15 25 3 670 14 22 3

RM: removal; RP: replacement; DC: declot.Data represents prevalent hemodialysis patients who are in the USRDS and CPM databases. Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.*Values for cells with 10 or fewer patients are suppressed."."Zero values in this cell.

689


VASCULAR ACCESSLTable L.4 (continued)Catheter intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.4 (continued)Catheter intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

2002 2003# pts % RM %RP %DC # pts % RM %RP %DC

0-4 . . . . . . . .5-9 . . . . . . . .10-14 . .15-19 2 * * * 1 * * *20-29 17 18 12 12 17 18 6 630-39 38 24 18 . 42 17 19 240-49 74 14 27 7 84 14 27 250-59 119 19 23 3 129 13 17 360-64 71 10 13 4 53 21 23 965-69 85 20 20 . 79 15 23 370-79 176 13 21 5 201 15 18 180+ 117 15 22 2 101 16 18 2Unknown

0-19 2 * * * 1 * * *20-44 91 19 22 2 95 16 21 345-64 228 15 20 5 230 15 20 465-74 173 16 23 3 191 16 20 275+ 205 14 20 2 190 14 18 2


White 387 14 20 3 382 17 19 2Black 287 16 22 3 296 13 19 4Native American 13 31 23 8 9 * * *Asian 9 * * * 20 25 35 .Other/unknown 3 * * *

Hispanic 52 17 21 6 65 17 18 5Non-Hispanic 624 16 21 3 611 16 19 2

Diabetes 269 18 25 3 308 14 18 3Hypertension 201 13 16 3 177 16 21 3Glomerulonephritis 84 10 13 1 87 17 18 2Cystic kidney 16 31 56 . 21 10 19 5Other urologic 28 18 14 7 16 19 31 .Other cause 73 12 21 5 70 13 17 3Unknown cause 28 25 29 7 28 21 32 .Missing disease

All 699 15 21 3 707 15 20 3


VASCULAR ACCESSL

690

Reference section L

Table L.5Arteriovenous fistula intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.5Arteriovenous fistula intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis


0-4 . . . . . . . . . . . .5-9 . . . . . . . . . . . .10-14 . . . . . . . . . . . .15-19 . . . . 2 * * * 4 * * *20-29 52 2 . 4 44 . 2 7 53 . . 430-39 111 2 1 1 94 . . 2 112 . 1 440-49 190 4 4 2 205 . . 4 199 . 1 450-59 208 . 1 4 213 . 2 4 238 . 2 360-64 102 . 1 3 101 1 2 . 124 . . 265-69 150 . 1 3 125 . 3 2 140 . 1 370-79 218 . 1 1 234 . 1 2 257 2 2 480+ 69 . 1 . 86 . 1 2 112 . 1 2Unknown

0-19 2 * * *20-44 248 3 2 2 238 . . 4 4 * * *45-64 415 1 1 3 419 . 2 3 264 . 1 465-74 273 . . 2 254 . 2 2 462 . 1 375+ 164 . 2 1 191 1 1 3 277 1 1 4

Male 799 1 2 3 748 . 1 2 838 1 1 3Female 301 1 1 2 356 1 2 4 401 . 1 3Unknown

White 612 1 2 2 642 . 2 2 698 1 1 2Black 398 2 1 4 383 . . 3 448 1 1 5Native American 41 . . . 35 . 3 3 36 . . 6Asian 40 3 . . 38 . . 8 46 . . 4Other/unknown 9 * * * 6 * * * 11 . . .

Hispanic 128 1 1 2 127 1 2 2 142 1 . 6Non-Hispanic 790 1 1 2 884 . 1 3 1,016 1 1 3

Diabetes 343 1 . 4 319 . 1 3 385 1 1 4Hypertension 312 1 2 2 323 1 1 2 373 1 1 4Glomerulonephritis 225 1 2 2 222 . 3 3 230 . 1 3Cystic kidney 45 2 . 2 42 . 2 . 58 . . 2Other urologic 38 3 5 . 48 . . 6 38 . . 3Other cause 95 2 3 1 95 . 2 3 113 1 1 3Unknown cause 42 . 2 . 55 . . 2 42 . . 2Missing disease

All 1,100 1 1 2 1,104 . 1 3 1,239 1 1 3


691


VASCULAR ACCESSLTable L.5 (continued)Arteriovenous fistula intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.5 (continued)Arteriovenous fistula intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis


0-4 . . . . . . . .5-9 . . . . . . . .10-14 . . . . . . . .15-19 . . . . 2 * * *20-29 47 . 2 2 49 2 . 630-39 139 1 3 8 135 1 1 540-49 210 . 2 3 249 1 2 550-59 277 1 1 5 337 1 2 560-64 143 1 1 4 142 . . 165-69 151 1 1 5 159 1 . 270-79 283 . . 2 280 1 2 480+ 112 1 . 8 155 1 . 3Unknown

0-19 2 * * *20-44 280 . 3 5 300 1 1 645-64 536 1 1 5 612 1 2 465-74 289 . . 4 307 1 1 375+ 257 . . 4 287 1 1 4

Male 950 . 1 4 1,045 1 1 4Female 412 1 1 6 463 1 2 5Unknown

White 773 1 1 4 888 1 1 3Black 498 . 2 6 511 . 2 5Native American 33 . . 9 39 3 . 10Asian 49 2 . 6 53 . . 4Other/unknown 9 * * * 17 . . 6

Hispanic 178 1 1 3 229 . . 4Non-Hispanic 1,111 1 1 5 1,225 1 1 4

Diabetes 487 1 1 6 530 1 . 5Hypertension 405 . 1 4 463 1 2 4Glomerulonephritis 243 . 2 3 249 1 2 4Cystic kidney 36 . . . 47 . . 2Other urologic 39 . . 3 45 . 2 2Other cause 100 . 1 4 113 2 . 4Unknown cause 52 . . 10 61 3 2 2Missing disease

All 1,362 1 1 5 1,508 1 1 4


VASCULAR ACCESSL

692

Reference section L

Table L.6Graft intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.6Graft intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis


0-4 . . . . . . . . . . . .5-9 . . . . . . . . . . . .10-14 . . . . . . . . .15-19 . . . . . . . . 1 * * *20-29 48 . 2 6 58 3 3 16 30 . . 1030-39 138 1 2 7 122 2 5 4 118 3 4 1040-49 294 2 4 5 264 3 2 7 267 2 3 1250-59 409 . 4 5 391 1 3 8 393 1 3 860-64 235 2 3 6 269 3 3 6 238 2 3 1065-69 306 . 3 5 305 1 3 10 288 1 3 1370-79 607 1 2 6 567 1 1 9 556 2 3 980+ 185 1 2 6 213 . 2 11 208 1 2 11Unknown

0-19 1 * * *20-44 309 2 3 6 286 3 3 7 251 2 3 1045-64 815 1 4 6 818 2 3 7 795 2 3 1065-74 663 1 2 6 631 1 2 11 582 2 3 1075+ 435 1 2 6 454 1 2 8 470 1 2 11

Male 1,034 1 3 6 1,022 2 3 8 940 2 3 10Female 1,188 1 3 6 1,167 2 2 9 1,159 1 3 10Unknown

White 1,048 1 3 6 1,069 1 2 8 1,020 2 2 10Black 1,034 1 3 6 993 2 3 9 964 1 3 11Native American 45 2 . 4 35 3 . 11 32 . 3 .Asian 75 . 5 . 81 . 1 7 66 . 5 12Other/unknown 20 5 5 . 11 9 9 9 17 . 6 .

Hispanic 239 1 4 6 218 2 4 7 246 2 3 11Non-Hispanic 1,611 1 2 6 1,758 1 2 9 1,708 1 3 10

Diabetes 906 . 3 7 890 2 2 9 914 1 2 9Hypertension 662 1 4 6 647 2 2 8 650 1 3 11Glomerulonephritis 293 2 3 4 294 1 3 9 233 3 3 12Cystic kidney 54 . . 2 77 . 3 6 51 . . .Other urologic 58 . 2 3 63 . 5 5 63 2 2 10Other cause 163 2 3 9 148 3 1 6 118 3 2 12Unknown cause 85 1 1 2 70 3 3 13 70 1 4 10Missing disease 1 * * *

All 2,222 1 3 6 2,189 2 2 8 2,099 2 3 10


693


VASCULAR ACCESSLTable L.6 (continued)Graft intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.6 (continued)Graft intervention events: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis


0-4 . . . . . . . .5-9 . . . . . . . .10-14 . . . . . . . .15-19 . 1 * * *20-29 28 . . 18 33 3 3 2130-39 121 1 1 21 111 3 3 1540-49 224 2 3 12 238 2 . 1350-59 371 2 3 9 367 1 2 1460-64 229 1 1 13 215 1 4 1465-69 292 1 2 14 273 . 3 1470-79 529 1 1 13 486 1 2 1280+ 219 1 . 14 221 2 2 14Unknown

0-19 1 * * *20-44 253 2 1 18 240 3 2 1945-64 720 2 2 10 724 1 2 1365-74 576 1 2 14 526 1 2 1375+ 464 1 . 13 454 1 2 13

Male 911 2 1 13 897 1 2 14Female 1,102 1 2 13 1,048 1 2 13Unknown

White 970 1 1 14 929 1 2 13Black 929 1 2 12 887 2 2 15Native American 27 7 . . 39 . . 10Asian 73 1 4 16 69 . 3 14Other/unknown 14 . . 21 21 . . 5

Hispanic 254 1 2 14 233 . 2 15Non-Hispanic 1,670 1 1 13 1,657 1 2 14

Diabetes 886 1 1 13 839 1 2 14Hypertension 567 1 3 12 593 2 3 13Glomerulonephritis 259 2 3 15 212 1 . 14Cystic kidney 61 5 . 5 49 . 4 16Other urologic 55 . 2 15 52 4 6 8Other cause 123 2 . 10 144 1 3 11Unknown cause 62 2 2 16 56 . . 20Missing disease

All 2,013 1 2 13 1,945 1 2 14


VASCULAR ACCESSL

694

Reference section L

Table L.7Catheter complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.7Catheter complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

1999 2000 2001# pts %H % I % S # pts %H % I % S # pts %H % I % S

0-4 . . . . . . . . . . . .5-9 . . . . . . . . . . . .10-14 . . . . . . . . .15-19 . 3 * * * . . . .20-29 2 * * * 13 . 8 . 14 7 21 2130-39 40 5 18 13 48 2 17 17 51 4 6 1040-49 55 . 18 15 71 3 11 8 81 4 12 1150-59 80 . 13 23 94 4 12 13 109 3 13 1260-64 43 . 7 7 56 2 7 9 73 4 12 1165-69 59 2 15 17 77 . 1 5 68 3 9 2170-79 149 1 8 9 157 3 6 10 180 4 13 1480+ 68 6 13 21 80 3 9 13 94 2 13 18Unknown

0-19 3 * * *20-44 67 4 16 12 92 2 14 13 104 5 10 1045-64 153 . 13 17 190 3 10 10 224 3 13 1365-74 133 2 10 11 152 3 5 10 166 3 11 1775+ 143 3 12 15 162 2 7 9 176 3 13 16


White 264 2 13 14 320 3 7 9 376 4 12 13Black 205 2 11 14 254 2 10 12 267 3 11 15Native American 11 . 45 55 7 * * * 10 10 40 50Asian 10 . . . 14 . 7 . 16 . . .Other/unknown 6 * * * 4 * * * 1 * * *

Hispanic 51 . 14 18 62 5 11 11 65 5 20 22Non-Hispanic 372 2 12 14 478 2 8 10 566 4 11 13

Diabetes 199 3 13 18 243 2 10 11 267 4 13 16Hypertension 138 1 12 12 161 2 6 5 184 3 12 16Glomerulonephritis 62 . 10 10 69 3 4 12 86 1 10 10Cystic kidney 13 . 23 . 14 7 14 21 16 . 13 13Other urologic 17 6 29 18 30 3 13 20 22 9 . .Other cause 48 2 6 13 58 5 9 10 69 4 9 10Unknown cause 19 5 11 21 24 . 8 13 26 4 19 15Missing disease

All 496 2 12 14 599 3 8 10 670 3 12 14

H: IP hospital stay with a diagnosis code of 996.1 "Mechanical complication of vascular device, implant, and graft."I: IP hospital stay with a diagnosis of a device infection.S: IP hospital stay with a diagnosis of sepsis.Data represents prevalent hemodialysis patients who are in the USRDS and CPM databases. Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.*Values for cells with 10 or fewer patients are suppressed."."Zero values in this cell.

695


VASCULAR ACCESSLTable L.7 (continued)Catheter complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.7 (continued)Catheter complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

2002 2003# pts %H % I % S # pts %H % I % S

0-4 . . . . . . . .5-9 . . . . . . . .10-14 . . . . . . . .15-19 2 * * * 1 * * *20-29 17 . 12 12 17 . 12 .30-39 38 3 21 18 42 . 10 1040-49 74 4 12 9 84 . 19 1150-59 119 7 17 13 129 2 16 1460-64 71 . 15 14 53 4 15 1165-69 85 5 11 9 79 4 10 1370-79 176 2 15 16 201 3 9 1580+ 117 2 12 16 101 1 14 15Unknown

0-19 2 * * * 1 * * *20-44 91 3 15 13 95 . 12 645-64 228 4 16 13 230 2 17 1365-74 173 5 12 12 191 4 9 1475+ 205 1 14 18 190 2 12 15


White 387 2 14 14 382 2 11 13Black 287 5 14 14 296 1 16 14Native American 13 . 23 8 9 * * *Asian 9 * * * 20 5 10 15Other/unknown 3 * * *

Hispanic 52 . 19 15 65 5 11 9Non-Hispanic 624 3 13 14 611 2 13 14

Diabetes 269 3 17 18 308 3 15 17Hypertension 201 4 13 12 177 3 12 12Glomerulonephritis 84 1 14 11 87 . 8 8Cystic kidney 16 . 13 13 21 . 10 10Other urologic 28 4 14 11 16 . 6 13Other cause 73 1 10 10 70 . 10 9Unknown cause 28 7 11 11 28 . 18 4Missing disease

All 699 3 14 14 707 2 13 13


Vascular accessL

696

Reference section L

Table L.8Arteriovenous fistula complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.8 Arteriovenous fistula complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis


0-4 . . . . . . . . . . . .5-9 . . . . . . . . . . . .10-14 . . . . . . . . . . . .15-19 . . . . 2 * * * 420-29 52 . . . 44 . 2 . 53 * * *30-39 111 . 3 2 94 . 2 2 112 . 2 240-49 190 1 2 3 205 . 1 2 199 . 3 250-59 208 . . 4 213 1 1 4 238 1 1 360-64 102 . . 2 101 . . 2 124 . 1 565-69 150 1 1 5 125 . 2 6 140 . . 570-79 218 1 . 2 234 1 1 6 257 1 2 480+ 69 . 1 7 86 . . 6 112 1 2 5Unknown

0-19 2 * * *20-44 248 . 2 1 238 . 2 1 4 * * *45-64 415 . 1 3 419 1 1 3 264 . 2 265-74 273 1 1 4 254 1 2 5 462 . 1 475+ 164 1 1 4 191 . 1 7 277 1 2 5

Male 799 . 1 3 748 . 1 4 838 . 1 4Female 301 1 1 5 356 1 2 4 401 1 3 5Unknown

White 612 . 1 3 642 . 1 4 698 . 1 4Black 398 1 . 4 383 1 3 4 448 . 2 5Native American 41 . 2 2 35 . . 9 36 . 3 .Asian 40 . 5 . 38 . 3 3 46 . . 4Other/unknown 9 * * * 6 * * * 11 . . .

Hispanic 128 1 1 4 127 1 1 7 142 1 1 5Non-Hispanic 790 . 1 3 884 1 2 3 1,016 . 2 4

Diabetes 343 . 1 5 319 1 1 5 385 1 1 5Hypertension 312 1 . 3 323 . 2 4 373 1 2 5Glomerulonephritis 225 1 2 2 222 . 2 4 230 . 1 4Cystic kidney 45 . . 4 42 . . 2 58 2 . 2Other urologic 38 . 3 3 48 2 . 4 38 . . .Other cause 95 . . 4 95 . . 1 113 . 1 5Unknown cause 42 2 . . 55 . . 2 42 . 2 .Missing disease

All 1,100 1 1 3 1,104 1 1 4 1,239 . 2 4


Table L.8 Arteriovenous fistula complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis


0-4 . . . . . . . . . . . .5-9 . . . . . . . . . . . .10-14 . . . . . . . . . . . .15-19 . . . . 2 * * * 420-29 52 . . . 44 . 2 . 53 * * *30-39 111 . 3 2 94 . 2 2 112 . 2 240-49 190 1 2 3 205 . 1 2 199 . 3 250-59 208 . . 4 213 1 1 4 238 1 1 360-64 102 . . 2 101 . . 2 124 . 1 565-69 150 1 1 5 125 . 2 6 140 . . 570-79 218 1 . 2 234 1 1 6 257 1 2 480+ 69 . 1 7 86 . . 6 112 1 2 5Unknown

0-19 2 * * *20-44 248 . 2 1 238 . 2 1 4 * * *45-64 415 . 1 3 419 1 1 3 264 . 2 265-74 273 1 1 4 254 1 2 5 462 . 1 475+ 164 1 1 4 191 . 1 7 277 1 2 5

Male 799 . 1 3 748 . 1 4 838 . 1 4Female 301 1 1 5 356 1 2 4 401 1 3 5Unknown

White 612 . 1 3 642 . 1 4 698 . 1 4Black 398 1 . 4 383 1 3 4 448 . 2 5Native American 41 . 2 2 35 . . 9 36 . 3 .Asian 40 . 5 . 38 . 3 3 46 . . 4Other/unknown 9 * * * 6 * * * 11 . . .

Hispanic 128 1 1 4 127 1 1 7 142 1 1 5Non-Hispanic 790 . 1 3 884 1 2 3 1,016 . 2 4

Diabetes 343 . 1 5 319 1 1 5 385 1 1 5Hypertension 312 1 . 3 323 . 2 4 373 1 2 5Glomerulonephritis 225 1 2 2 222 . 2 4 230 . 1 4Cystic kidney 45 . . 4 42 . . 2 58 2 . 2Other urologic 38 . 3 3 48 2 . 4 38 . . .Other cause 95 . . 4 95 . . 1 113 . 1 5Unknown cause 42 2 . . 55 . . 2 42 . 2 .Missing disease

All 1,100 1 1 3 1,104 1 1 4 1,239 . 2 4


697


VASCULAR ACCESSLTable L.8 (continued)Arteriovenous fistula complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.8 (continued)Arteriovenous fistula complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

2002 2003# pts %H % I % S # pts %H % I % S

0-4 . . . . . . . .5-9 . . . . . . . .10-14 . . . . . . . .15-19 . . . . 2 * * *20-29 47 . 2 . 49 2 2 230-39 139 . . 1 135 . 3 340-49 210 1 1 3 249 . 2 450-59 277 . 1 3 337 1 1 360-64 143 . 1 4 142 1 . 365-69 151 1 2 2 159 2 1 470-79 283 . . 5 280 1 1 380+ 112 2 1 4 155 . 1 4Unknown

0-19 2 * * *20-44 280 . 1 2 300 . 2 345-64 536 1 1 3 612 1 1 365-74 289 . 1 3 307 2 1 375+ 257 1 . 6 287 . 1 4

Male 950 1 1 3 1045 1 1 3Female 412 . 1 3 463 1 2 3Unknown

White 773 1 . 4 888 1 1 3Black 498 . 2 3 511 . 2 3Native American 33 . 3 . 39 3 . 8Asian 49 2 2 . 53 2 2 .Other/unknown 9 * * * 17 . . 6

Hispanic 178 1 1 2 229 1 2 4Non-Hispanic 1,111 . 1 3 1225 1 1 3

Diabetes 487 . 1 4 530 1 1 5Hypertension 405 . 1 3 463 . 2 3Glomerulonephritis 243 . 1 2 249 2 1 2Cystic kidney 36 3 3 8 47 2 . 6Other urologic 39 . . 3 45 . 2 .Other cause 100 1 1 1 113 1 3 2Unknown cause 52 . . 6 61 . . 3Missing disease

All 1,362 1 1 3 1,508 1 1 3


VASCULAR ACCESSL

698

Reference section L

Table L.9Graft complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.9Graft complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis


0-4 . . . . . . . . . . . .5-9 . . . . . . . . . . . .10-14 . . . . . . . . . . . .15-19 . . . . . . . . 1 * * *20-29 48 2 . . 58 . 7 3 30 . . .30-39 138 1 2 4 122 1 3 2 118 1 3 540-49 294 1 3 4 264 2 3 5 267 1 3 350-59 409 1 2 5 391 1 2 3 393 1 3 360-64 235 . 3 4 269 1 4 6 238 . 2 665-69 306 1 1 4 305 1 1 4 288 . 1 670-79 607 1 3 6 567 . 2 6 556 1 3 580+ 185 . 3 8 213 1 . 2 208 1 3 5Unknown . . . . . . . . . . . .

0-19 1 * * *20-44 309 1 2 3 286 1 4 3 251 1 2 445-64 815 1 2 5 818 1 3 5 795 1 2 465-74 663 1 2 6 631 1 1 5 582 1 3 775+ 435 1 3 6 454 1 1 4 470 1 3 4

Male 1,034 1 3 5 1,022 1 2 4 940 1 3 4Female 1,188 1 2 5 1,167 1 3 5 1,159 1 2 5Unknown . . . . . . . . . . . .

White 1,048 1 2 5 1,069 1 2 4 1,020 1 3 4Black 1,034 1 2 5 993 1 3 4 964 1 2 5Native American 45 2 9 9 35 3 6 6 32 . 3 13Asian 75 1 4 3 81 . . 4 66 . 2 .Other/unknown 20 . 5 . 11 9 . . 17 . . 12

Hispanic 239 1 3 5 218 1 1 3 246 2 3 6Non-Hispanic 1,611 1 2 5 1,758 1 2 5 1,708 1 2 4

Diabetes 906 1 2 5 890 1 2 5 914 1 2 6Hypertension 662 1 2 4 647 1 3 4 650 1 3 3Glomerulonephritis 293 1 3 5 294 1 3 3 233 . 2 5Cystic kidney 54 . 2 4 77 . . 4 51 . 2 10Other urologic 58 . 5 7 63 3 . 3 63 3 3 .Other cause 163 2 4 7 148 . 4 3 118 1 3 5Unknown cause 85 . 1 4 70 . 1 3 70 1 3 3Missing disease 1 * * *

All 2,222 1 2 5 2,189 1 2 4 2,099 1 2 5


699


VASCULAR ACCESSLTable L.9 (continued)Graft complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.9 (continued)Graft complications: prevalent hemodialysis patients by age, gender, race, ethnicity, & primary diagnosis

2002 2003# pts %H % I % S # pts %H % I % S

0-4 . . . . . . . .5-9 . . . . . . . .10-14 . . . . . . . .15-19 . . . . 1 * * *20-29 28 . 7 . 33 . 3 330-39 121 1 4 2 111 1 6 740-49 224 2 2 4 238 . 2 350-59 371 . 2 5 367 1 1 260-64 229 . 3 2 215 . 4 565-69 292 1 3 4 273 1 4 770-79 529 1 2 5 486 1 2 580+ 219 2 1 7 221 1 4 7Unknown

0-19 1 * * *20-44 253 2 4 3 240 . 5 545-64 720 . 3 4 724 . 2 465-74 576 1 2 5 526 1 3 675+ 464 2 2 6 454 1 2 6

Male 911 1 2 5 897 1 2 5Female 1,102 1 2 4 1,048 1 3 5Unknown

White 970 1 2 5 929 1 2 5Black 929 1 2 4 887 1 3 4Native American 27 . 7 11 39 3 3 3Asian 73 1 . 3 69 1 1 7Other/unknown 14 . . . 21 . . 5

Hispanic 254 1 2 5 233 . 2 6Non-Hispanic 1,670 1 2 4 1,657 1 3 5

Diabetes 886 2 2 6 839 1 3 6Hypertension 567 1 2 5 593 1 3 4Glomerulonephritis 259 . 3 2 212 1 2 5Cystic kidney 61 2 2 3 49 . . .Other urologic 55 . 2 2 52 . . 8Other cause 123 . 3 3 144 1 3 3Unknown cause 62 . 3 5 56 2 4 9Missing disease

All 2,013 1 2 5 1,945 1 3 5


VASCULAR ACCESSL

700

Reference section L

Table L.10Peritoneal dialysis complications: prevalent peritoneal dialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.10Peritoneal dialysis complications: prevalent peritoneal dialysis patientsby age, gender, race, ethnicity, & primary diagnosis

1999 2000 2001# pts % I % P % S # pts % I % P % S # pts % I % P % S

0-4 47 17 23 6 45 7 11 . 60 15 20 55-9 40 10 15 3 49 24 41 2 58 17 22 510-14 108 12 19 1 88 13 20 2 101 13 24 215-19 172 11 18 2 175 14 23 2 178 16 20 220-29 963 13 21 2 887 13 20 2 898 13 20 330-39 2,000 14 20 3 1,931 14 21 4 1,867 13 20 340-49 3,097 14 20 3 2,866 13 20 3 2,807 15 21 450-59 3,278 14 21 4 3,323 14 20 4 3,264 13 19 560-64 1,652 12 19 5 1,541 13 20 5 1,545 12 18 665-69 2,067 12 20 5 1,970 13 19 5 1,898 12 19 670-79 3,253 11 20 5 3,003 11 19 6 2,885 12 19 580+ 762 13 21 6 737 13 19 6 738 10 17 6Unknown

0-19 367 12 19 2 357 14 24 2 397 15 21 320-44 4,387 14 20 3 4,167 14 20 3 4,051 14 20 345-64 6,603 13 20 4 6,381 13 20 4 6,330 13 19 565-74 4,039 12 20 5 3,782 12 19 5 3,598 12 19 675+ 2,043 12 20 6 1,928 13 19 6 1,923 11 19 6

Male 8,787 12 19 4 8,291 12 18 4 8,182 12 18 4Female 8,652 14 21 4 8,324 14 21 5 8,117 14 21 5Unknown

White 11,596 12 18 4 11,012 12 18 4 10,736 11 17 5Black 4,773 16 25 4 4,551 15 24 4 4,494 16 24 5Native American 245 14 20 2 222 13 18 4 222 16 23 4Asian 665 12 17 5 676 11 16 5 699 13 16 5Other/unknown 160 13 21 7 154 14 17 5 148 20 22 7

Hispanic 1,862 15 20 4 1,883 14 20 5 1,938 15 20 5Non-Hispanic 13,776 12 20 4 13,675 13 20 4 13,734 13 19 5

Diabetes 5,700 14 21 6 5,427 13 20 6 5,304 13 19 7Hypertension 4,283 13 20 4 4,108 13 20 4 4,086 13 20 4Glomerulonephritis 3,627 12 19 3 3,346 12 19 3 3,305 12 18 3Cystic kidney 733 11 18 4 708 11 18 4 666 11 18 3Other urologic 486 14 19 2 483 15 21 3 488 12 17 5Other cause 1,885 12 20 4 1,878 14 21 5 1,802 14 20 4Unknown cause 711 14 22 3 653 13 20 4 636 12 18 4Missing disease 14 . . . 12 . . 8 12 8 17 8

All 17,439 13 20 4 16,615 13 20 4 16,299 13 19 5

I: IP hospital stay with a diagnosis of a device infection.P: IP hospital stay with a diagnosis of peritonitis.S: IP hospital stay with a diagnosis of sepsis.** PD not merged with CPM data.*Values for cells with 10 or fewer patients are suppressed."."Zero values in this cell.

701


VASCULAR ACCESSLTable L.10 (continued)Peritoneal dialysis complications: prevalent peritoneal dialysis patients by age, gender, race, ethnicity, & primary diagnosis

Table L.10 (continued)Peritoneal dialysis complications: prevalent peritoneal dialysis patientsby age, gender, race, ethnicity, & primary diagnosis

2002 2003# pts % I % P % S # pts % I % P % S

0-4 56 11 25 2 75 13 27 75-9 63 10 19 3 75 12 21 110-14 106 17 24 . 133 14 22 215-19 165 9 27 1 158 12 27 420-29 937 11 19 2 895 13 20 330-39 1,874 12 21 4 1,912 12 20 340-49 2,760 13 20 4 2,826 13 21 550-59 3,370 12 20 5 3,459 12 20 560-64 1,489 12 20 6 1,559 12 19 565-69 1,948 12 21 6 1,874 12 19 670-79 2,878 10 17 5 2,974 11 19 680+ 824 10 18 8 864 10 18 4Unknown

0-19 390 12 24 1 441 13 24 320-44 4,063 13 21 3 4,031 13 20 345-64 6,367 12 20 5 6,620 12 20 565-74 3,603 11 19 5 3,580 12 19 675+ 2,047 10 18 7 2,132 9 19 5

Male 8,283 11 19 4 8,533 11 19 5Female 8,187 12 21 5 8,271 13 20 5Unknown

White 10,897 11 18 5 11,078 11 18 5Black 4,436 14 24 5 4,515 14 23 5Native American 239 11 26 4 257 13 21 6Asian 732 11 16 3 763 9 14 5Other/unknown 166 16 25 6 191 13 22 5

Hispanic 1,929 13 20 5 2,087 13 21 6Non-Hispanic 14,136 11 20 5 14,437 12 19 5

Diabetes 5,430 12 21 6 5,568 12 20 7Hypertension 3,949 12 19 4 4,109 11 19 4Glomerulonephritis 3,290 11 19 4 3,314 11 19 4Cystic kidney 673 10 16 4 634 11 18 3Other urologic 546 10 19 6 551 9 16 4Other cause 1,897 13 22 5 1,954 14 22 4Unknown cause 675 9 18 3 651 12 19 4Missing disease 10 10 10 . 23 . . .

All 16,470 12 20 5 16,804 12 20 5

I: IP hospital stay with a diagnosis of a device infection.P: IP hospital stay with a diagnosis of peritonitis.S: IP hospital stay with a diagnosis of sepsis.** PD not merged with CPM data."."Zero values in this cell.

VASCULAR ACCESSL

702

Reference section L

Table L.11Catheter insertions in hemodialysis patients, per 1,000 patient years, by ESRD vintageby age, gender, race, ethnicity, & primary diagnosis

*Values for cells with 10 or fewer patients are suppressed."."Zero values in this cell.

Table L.11Catheter insertions in hemodialysis patients, per 1,000 patient years, by ESRD vintageby age, gender, race, ethnicity, & primary diagnosis

# Patients < 6 mo. 6 mo.-1 yr 1-2 yrs 2-5 yrs 5+ yrs0-4 21 * * * * .5-9 47 * * 647 1,064 *10-14 142 68 408 829 690 66315-19 531 726 450 719 605 65620-29 5,171 636 666 577 549 49130-39 13,461 678 595 570 505 45140-49 26,702 623 564 503 470 44150-59 39,535 643 521 487 460 42160-64 22,417 600 510 468 446 42565-69 27,478 665 518 468 449 44070-79 53,652 667 472 438 415 42280+ 26,378 675 475 430 397 379

0-19 741 693 447 723 651 65520-44 30,019 658 613 557 514 46145-64 77,267 623 520 480 452 42365-74 55,475 672 508 450 435 43675+ 52,033 665 460 438 402 395

Male 115,287 598 456 408 390 385Female 100,247 716 571 539 506 486

White 117,636 641 478 448 422 404Black 84,944 682 579 519 482 464Native American 3,339 624 462 393 385 369Asian 7,637 473 390 343 366 357Other/unknown 1,979 1,066 532 522 460 329

Hispanic 27,111 735 540 493 421 406Non-Hispanic 183,520 643 506 467 448 444

Diabetes 90,716 687 542 517 480 485Hypertension 62,994 612 478 404 396 401Glomerulonephritis 24,940 540 428 444 411 393Cystic kidney 5,430 457 433 402 403 369Other urologic 6,035 716 515 472 493 417Other cause 17,334 770 542 516 465 466Unknown cause 7,840 608 481 377 411 408Missing disease 246 . . . 31 .

All 215,535 653 509 469 444 431

703


VASCULAR ACCESSLTable L.12Arteriovenous fistula insertions in hemodialysis patients, per 1,000 patient years, by ESRD vintageby age, gender, race, ethnicity, & primary diagnosis


Table L.12Arteriovenous fistula insertions in hemodialysis patients, per 1,000 patient years, by ESRD vintageby age, gender, race, ethnicity, & primary diagnosis

# Patients < 6 mo. 6 mo.-1 yr 1-2 yrs 2-5 yrs 5+ yrs0-4 21 * * * * .5-9 47 * * 92 . *10-14 142 68 58 . 207 23215-19 531 299 156 90 99 12020-29 5,171 240 190 109 99 9130-39 13,461 228 134 97 89 7940-49 26,702 220 127 73 69 6850-59 39,535 203 108 70 65 6160-64 22,417 198 107 63 57 5165-69 27,478 234 104 73 51 5670-79 53,652 228 97 70 50 4680+ 26,378 197 81 58 43 41

0-19 741 216 124 76 114 14320-44 30,019 228 145 90 86 7845-64 77,267 204 110 69 62 6065-74 55,475 236 104 72 51 5375+ 52,033 207 84 62 45 42

Male 115,287 241 115 77 64 65Female 100,247 189 93 63 52 54

White 117,636 225 103 70 57 64Black 84,944 208 108 70 59 57Native American 3,339 179 109 102 71 59Asian 7,637 152 107 80 52 58Other/unknown 1,979 262 96 64 79 49

Hispanic 27,111 217 91 66 50 58Non-Hispanic 183,520 217 107 71 60 61

Diabetes 90,716 201 101 65 55 51Hypertension 62,994 220 102 66 56 56Glomerulonephritis 24,940 237 115 90 69 71Cystic kidney 5,430 173 80 85 60 63Other urologic 6,035 265 125 82 59 63Other cause 17,334 263 132 87 69 69Unknown cause 7,840 247 102 84 68 52Missing disease 246 18 . . . .

All 215,535 217 105 70 58 60

VASCULAR ACCESSL

704

Reference section LVASCULAR ACCESSL Reference section L

ON OUR WEBSITE & CDVascular access insertions in diabetic hemodialysis patients, per 1,000 patient years, by ESRD vintage (Table 13.a).Vascular access insertions in non-diabetic hemodialysis patients, per 1,000 patient years, by ESRD vintage (Table 13.b).

Table L.13Graft insertions in hemodialysis patients, per 1,000 patient years, by ESRD vintageby age, gender, race, ethnicity, & primary diagnosis


Table L.13Graft insertions in hemodialysis patients, per 1,000 patient years, by ESRD vintageby age, gender, race, ethnicity, & primary diagnosis

# Patients < 6 mo. 6 mo.-1 yr 1-2 yrs 2-5 yrs 5+ yrs0-4 21 * * * * .5-9 47 * * . 152 *10-14 142 68 . 69 34 10015-19 531 43 121 116 169 9020-29 5,171 168 139 127 126 10330-39 13,461 191 178 129 122 12440-49 26,702 198 170 124 124 12150-59 39,535 246 171 136 119 12060-64 22,417 240 158 137 114 11265-69 27,478 296 181 128 109 11970-79 53,652 271 159 127 109 11080+ 26,378 250 128 115 95 90

0-19 741 43 87 95 136 9420-44 30,019 184 167 131 126 12045-64 77,267 237 167 132 117 11865-74 55,475 291 172 132 110 11975+ 52,033 252 141 116 101 94

Male 115,287 218 139 109 102 105Female 100,247 288 185 149 125 127

White 117,636 233 137 110 96 96Black 84,944 293 206 160 136 132Native American 3,339 131 135 111 84 110Asian 7,637 212 136 102 108 119Other/unknown 1,979 230 182 113 92 76

†Hispanic 27,111 264 155 127 110 114†Non-Hispanic 183,520 250 162 128 114 118

Diabetes 90,716 266 172 141 118 123Hypertension 62,994 258 156 117 111 116Glomerulonephritis 24,940 197 138 114 99 106Cystic kidney 5,430 177 131 92 97 97Other urologic 6,035 246 135 125 119 116Other cause 17,334 242 163 127 114 113Unknown cause 7,840 174 128 91 94 107Missing disease 246 . . . . .

All 215,535 251 161 128 113 115

Censuspopulations

MReferenceSec

tion

CENSUS POPULATIONSM

706

Reference section M

M.1 . 707 U.S. resident population on July 1 from the 2000 census & P-25 total estimates population in thousands; used in computing incidence and prevalence rates: standard population for adjustment is 2002

M.2 . 715 Resident population estimates of the U.S.by gender, race, & Hispanic origin; population in thousands

2005 Annual Data ReportMCENSUS POPULATIONS

707

Table M.1U.S. resident population on July 1 from the 2000 census & P-25 total estimates population in thousands; used in computing incidence & prevalence rates: standard population for adjustment is 2002

Table M.1U.S. resident population on July 1 from the 2000 census & P-25 total estimates population in thousands; used in computing incidence & prevalence rates: standard population for adjustment is 2002

1993 Male FemaleAge White Black N Am Asian All White Black N Am Asian All0-4 7,964,173 1,636,763 115,933 379,953 10,096,822 7,564,224 1,594,969 112,395 360,865 9,632,4535-9 7,599,008 1,494,226 121,777 330,617 9,545,628 7,211,778 1,454,362 117,437 316,751 9,100,32810-14 7,657,445 1,464,928 117,766 352,514 9,592,653 7,245,204 1,428,055 114,997 340,494 9,128,75015-19 7,180,143 1,362,474 101,128 333,971 8,977,716 6,749,044 1,333,625 96,610 316,858 8,496,13720-24 7,813,730 1,330,099 103,915 414,414 9,662,158 7,448,399 1,385,931 93,962 399,474 9,327,76625-29 8,300,489 1,294,498 95,333 405,433 10,095,753 8,030,120 1,424,850 91,519 426,651 9,973,14030-34 9,443,797 1,340,524 97,077 421,855 11,303,253 9,222,821 1,515,266 99,298 442,865 11,280,25035-39 9,078,471 1,251,011 89,158 386,260 10,804,900 8,985,160 1,425,406 94,406 416,723 10,921,69540-44 8,040,722 1,027,935 75,209 327,647 9,471,513 8,061,909 1,196,487 80,205 374,841 9,713,44245-49 6,803,040 750,984 59,227 249,977 7,863,228 6,914,671 890,418 62,650 282,357 8,150,09650-54 5,427,312 598,040 44,556 188,842 6,258,750 5,617,539 721,123 48,032 205,181 6,591,87555-59 4,494,319 483,065 34,177 143,721 5,155,282 4,775,768 604,288 36,919 163,996 5,580,97160-64 4,265,734 430,200 26,615 113,790 4,836,339 4,719,106 558,799 29,941 148,033 5,455,87965-69 4,041,267 372,476 20,440 92,334 4,526,517 4,860,061 508,224 24,422 124,555 5,517,26270-74 3,376,362 274,399 14,410 72,133 3,737,304 4,389,209 413,841 18,851 89,635 4,911,53675-79 2,354,469 181,499 8,339 43,872 2,588,179 3,517,938 312,949 12,723 55,410 3,899,02080-84 1,367,779 104,893 4,623 25,371 1,502,666 2,526,390 209,363 8,138 29,870 2,773,76185+ 859,598 73,429 3,233 15,679 951,939 2,279,874 185,336 6,631 21,786 2,493,627

All 106,067,858 15,471,443 1,132,916 4,298,383 126,970,600 110,119,215 17,163,292 1,149,136 4,516,345 132,947,988

19940-4 7,968,973 1,643,519 115,442 393,827 10,121,761 7,568,646 1,600,475 111,930 374,050 9,655,1015-9 7,709,288 1,562,683 128,697 339,480 9,740,148 7,317,770 1,519,209 124,302 323,250 9,284,53110-14 7,761,341 1,484,466 122,509 367,135 9,735,451 7,345,293 1,445,863 119,654 355,025 9,265,83515-19 7,336,974 1,399,176 105,824 344,805 9,186,779 6,890,176 1,369,387 100,890 328,577 8,689,03020-24 7,632,587 1,324,916 105,366 425,430 9,488,299 7,275,679 1,384,092 96,101 411,893 9,167,76525-29 8,146,834 1,272,422 96,617 416,639 9,932,512 7,869,470 1,402,370 91,730 443,483 9,807,05330-34 9,431,303 1,353,052 99,412 433,316 11,317,083 9,188,494 1,525,942 101,354 457,116 11,272,90635-39 9,230,293 1,288,294 93,270 402,842 11,014,699 9,121,971 1,466,232 98,081 433,624 11,119,90840-44 8,228,157 1,069,369 79,387 343,689 9,720,602 8,245,884 1,241,965 84,970 390,838 9,963,65745-49 7,107,218 804,170 62,972 271,515 8,245,875 7,217,091 950,757 66,705 310,142 8,544,69550-54 5,641,067 620,865 47,240 201,592 6,510,764 5,832,653 746,753 50,819 221,202 6,851,42755-59 4,603,963 496,223 35,876 154,158 5,290,220 4,885,586 621,422 38,659 173,079 5,718,74660-64 4,201,063 431,647 27,432 120,147 4,780,289 4,627,851 557,471 30,773 153,787 5,369,88265-69 4,030,826 379,632 20,956 96,336 4,527,750 4,809,824 512,818 24,828 132,506 5,479,97670-74 3,436,461 274,157 15,003 77,517 3,803,138 4,444,626 418,065 19,411 96,825 4,978,92775-79 2,403,758 185,469 8,497 46,331 2,644,055 3,558,788 315,712 12,983 60,024 3,947,50780-84 1,413,422 106,617 4,765 27,026 1,551,830 2,578,774 216,334 8,440 33,040 2,836,58885+ 890,717 75,187 3,290 17,030 986,224 2,351,953 192,250 6,893 23,712 2,574,808

All 107,174,245 15,771,864 1,172,555 4,478,815 128,597,479 111,130,529 17,487,117 1,188,523 4,722,173 134,528,342

19950-4 7,895,976 1,630,851 113,756 403,885 10,044,468 7,499,024 1,587,540 110,267 385,206 9,582,0375-9 7,839,306 1,625,589 136,390 351,857 9,953,142 7,440,124 1,580,199 131,449 333,257 9,485,02910-14 7,836,074 1,498,977 126,491 379,298 9,840,840 7,418,207 1,458,221 123,573 366,208 9,366,20915-19 7,526,265 1,446,571 111,624 360,407 9,444,867 7,062,318 1,415,543 106,565 344,705 8,929,13120-24 7,464,041 1,312,034 105,887 432,319 9,314,281 7,096,032 1,371,957 97,197 420,747 8,985,93325-29 8,104,812 1,266,751 99,787 435,983 9,907,333 7,815,554 1,396,445 93,572 467,032 9,772,60330-34 9,315,742 1,355,233 100,863 442,060 11,213,898 9,059,561 1,525,929 102,169 470,630 11,158,28935-39 9,362,914 1,320,573 97,672 418,394 11,199,553 9,240,473 1,498,690 102,281 450,623 11,292,06740-44 8,434,726 1,110,268 83,575 360,837 9,989,406 8,445,547 1,286,983 89,671 407,541 10,229,74245-49 7,434,737 862,486 67,524 293,256 8,658,003 7,539,305 1,016,465 71,302 338,666 8,965,73850-54 5,845,029 644,015 49,938 216,613 6,755,595 6,035,263 773,262 53,605 238,773 7,100,90355-59 4,664,849 511,283 37,224 164,940 5,378,296 4,943,182 636,808 40,373 183,639 5,804,00260-64 4,189,515 435,204 28,526 127,132 4,780,377 4,604,971 561,115 31,873 159,388 5,357,34765-69 4,031,761 384,701 21,429 101,600 4,539,491 4,753,648 518,375 25,316 139,655 5,436,99470-74 3,483,264 275,209 15,665 81,528 3,855,666 4,489,681 420,423 19,994 103,839 5,033,93775-79 2,455,895 191,812 8,698 49,552 2,705,957 3,601,636 321,872 13,314 65,103 4,001,92580-84 1,469,516 107,115 4,969 29,012 1,610,612 2,638,708 220,133 8,640 36,519 2,904,00085+ 923,911 77,868 3,357 18,450 1,023,586 2,423,216 200,806 7,216 25,898 2,657,136

All 108,278,333 16,056,540 1,213,375 4,667,123 130,215,371 112,106,450 17,790,766 1,228,377 4,937,429 136,063,022

CENSUS POPULATIONSM

708

Reference section M

Table M.1 (continued)U.S. resident population on July 1 from the 2000 census & P-25 total estimates population in thousands; used in computing incidence & prevalence rates: standard population for adjustment is 2002


1993 AllAge White Black N Am Asian All0-4 15,528,397 3,231,732 228,328 740,818 19,729,2755-9 14,810,786 2,948,588 239,214 647,368 18,645,95610-14 14,902,649 2,892,983 232,763 693,008 18,721,40315-19 13,929,187 2,696,099 197,738 650,829 17,473,85320-24 15,262,129 2,716,030 197,877 813,888 18,989,92425-29 16,330,609 2,719,348 186,852 832,084 20,068,89330-34 18,666,618 2,855,790 196,375 864,720 22,583,50335-39 18,063,631 2,676,417 183,564 802,983 21,726,59540-44 16,102,631 2,224,422 155,414 702,488 19,184,95545-49 13,717,711 1,641,402 121,877 532,334 16,013,32450-54 11,044,851 1,319,163 92,588 394,023 12,850,62555-59 9,270,087 1,087,353 71,096 307,717 10,736,25360-64 8,984,840 988,999 56,556 261,823 10,292,21865-69 8,901,328 880,700 44,862 216,889 10,043,77970-74 7,765,571 688,240 33,261 161,768 8,648,84075-79 5,872,407 494,448 21,062 99,282 6,487,19980-84 3,894,169 314,256 12,761 55,241 4,276,42785+ 3,139,472 258,765 9,864 37,465 3,445,566

All 216,187,073 32,634,735 2,282,052 8,814,728 259,918,588

19940-4 15,537,619 3,243,994 227,372 767,877 19,776,8625-9 15,027,058 3,081,892 252,999 662,730 19,024,67910-14 15,106,634 2,930,329 242,163 722,160 19,001,28615-19 14,227,150 2,768,563 206,714 673,382 17,875,80920-24 14,908,266 2,709,008 201,467 837,323 18,656,06425-29 16,016,304 2,674,792 188,347 860,122 19,739,56530-34 18,619,797 2,878,994 200,766 890,432 22,589,98935-39 18,352,264 2,754,526 191,351 836,466 22,134,60740-44 16,474,041 2,311,334 164,357 734,527 19,684,25945-49 14,324,309 1,754,927 129,677 581,657 16,790,57050-54 11,473,720 1,367,618 98,059 422,794 13,362,19155-59 9,489,549 1,117,645 74,535 327,237 11,008,96660-64 8,828,914 989,118 58,205 273,934 10,150,17165-69 8,840,650 892,450 45,784 228,842 10,007,72670-74 7,881,087 692,222 34,414 174,342 8,782,06575-79 5,962,546 501,181 21,480 106,355 6,591,56280-84 3,992,196 322,951 13,205 60,066 4,388,41885+ 3,242,670 267,437 10,183 40,742 3,561,032

All 218,304,774 33,258,981 2,361,078 9,200,988 263,125,821

19950-4 15,395,000 3,218,391 224,023 789,091 19,626,5055-9 15,279,430 3,205,788 267,839 685,114 19,438,17110-14 15,254,281 2,957,198 250,064 745,506 19,207,04915-19 14,588,583 2,862,114 218,189 705,112 18,373,99820-24 14,560,073 2,683,991 203,084 853,066 18,300,21425-29 15,920,366 2,663,196 193,359 903,015 19,679,93630-34 18,375,303 2,881,162 203,032 912,690 22,372,18735-39 18,603,387 2,819,263 199,953 869,017 22,491,62040-44 16,880,273 2,397,251 173,246 768,378 20,219,14845-49 14,974,042 1,878,951 138,826 631,922 17,623,74150-54 11,880,292 1,417,277 103,543 455,386 13,856,49855-59 9,608,031 1,148,091 77,597 348,579 11,182,29860-64 8,794,486 996,319 60,399 286,520 10,137,72465-69 8,785,409 903,076 46,745 241,255 9,976,48570-74 7,972,945 695,632 35,659 185,367 8,889,60375-79 6,057,531 513,684 22,012 114,655 6,707,88280-84 4,108,224 327,248 13,609 65,531 4,514,61285+ 3,347,127 278,674 10,573 44,348 3,680,722

All 220,384,783 33,847,306 2,441,752 9,604,552 266,278,393


709



1996 Male FemaleAge White Black N Am Asian All White Black N Am Asian All0-4 7,803,866 1,604,625 116,811 407,721 9,933,023 7,410,480 1,561,290 113,087 390,392 9,475,2495-9 7,972,130 1,685,189 139,841 371,394 10,168,554 7,568,233 1,637,490 135,344 350,909 9,691,97610-14 7,913,265 1,525,160 130,601 389,458 9,958,484 7,492,096 1,482,057 127,370 375,102 9,476,62515-19 7,738,458 1,488,901 118,778 380,800 9,726,937 7,258,062 1,457,078 113,354 364,729 9,193,22320-24 7,279,709 1,285,788 106,027 434,761 9,106,285 6,900,199 1,346,300 98,308 425,553 8,770,36025-29 8,156,257 1,278,350 104,447 460,242 9,999,296 7,861,931 1,411,841 97,034 494,038 9,864,84430-34 9,096,950 1,356,426 102,434 449,791 11,005,601 8,831,484 1,521,561 102,904 483,615 10,939,56435-39 9,472,201 1,343,487 102,192 433,863 11,351,743 9,338,077 1,523,117 106,601 466,213 11,434,00840-44 8,641,407 1,153,738 88,141 379,726 10,263,012 8,647,658 1,332,404 94,755 427,683 10,502,50045-49 7,826,927 931,220 72,187 315,136 9,145,470 7,928,335 1,093,992 76,352 366,377 9,465,05650-54 5,971,991 662,160 53,233 232,586 6,919,970 6,160,996 793,557 57,059 257,857 7,269,46955-59 4,787,024 524,591 39,324 176,470 5,527,409 5,063,559 651,727 42,545 195,460 5,953,29160-64 4,172,998 438,999 29,863 135,450 4,777,310 4,568,631 564,647 33,110 165,588 5,331,97665-69 4,035,781 387,659 22,220 107,072 4,552,732 4,717,165 521,980 26,150 146,060 5,411,35570-74 3,466,014 278,315 16,152 85,082 3,845,563 4,459,349 424,268 20,459 110,762 5,014,83875-79 2,540,487 198,382 9,116 53,738 2,801,723 3,686,120 331,134 13,954 70,757 4,101,96580-84 1,520,290 107,983 5,198 30,970 1,664,441 2,684,309 222,166 8,915 40,150 2,955,54085+ 956,830 79,645 3,486 19,970 1,059,931 2,490,781 208,251 7,521 28,408 2,734,961

All 109,352,585 16,330,618 1,260,051 4,864,230 131,807,484 113,067,465 18,084,860 1,274,822 5,159,653 137,586,800

19970-4 7,730,763 1,584,153 119,118 409,966 9,844,000 7,338,334 1,540,070 115,311 394,956 9,388,6715-9 8,098,381 1,734,270 143,831 392,135 10,368,617 7,691,675 1,683,850 139,729 370,161 9,885,41510-14 7,958,434 1,552,144 134,700 398,065 10,043,343 7,537,853 1,506,979 130,730 381,792 9,557,35415-19 7,922,392 1,522,994 125,288 401,851 9,972,525 7,429,588 1,490,307 119,876 385,395 9,425,16620-24 7,293,135 1,287,882 108,228 439,901 9,129,146 6,895,088 1,351,027 100,570 434,245 8,780,93025-29 8,135,517 1,292,134 107,842 484,495 10,019,988 7,829,862 1,426,443 100,111 522,636 9,879,05230-34 8,852,301 1,341,280 103,725 458,886 10,756,192 8,583,182 1,502,539 103,711 500,299 10,689,73135-39 9,499,899 1,359,837 106,292 447,597 11,413,625 9,358,777 1,539,982 110,196 481,041 11,489,99640-44 8,849,785 1,205,684 92,894 400,149 10,548,512 8,845,308 1,383,494 99,618 447,862 10,776,28245-49 7,801,429 971,899 75,669 331,646 9,180,643 7,899,957 1,139,417 80,357 386,266 9,505,99750-54 6,547,925 709,292 58,225 253,728 7,569,170 6,729,950 845,302 61,821 284,625 7,921,69855-59 4,960,293 547,486 41,548 187,275 5,736,602 5,238,352 676,523 44,949 208,661 6,168,48560-64 4,205,372 445,402 31,250 145,914 4,827,938 4,587,032 570,885 34,280 174,089 5,366,28665-69 3,992,933 387,403 22,659 112,779 4,515,774 4,632,329 523,011 26,820 151,896 5,334,05670-74 3,454,388 282,332 16,431 88,807 3,841,958 4,424,261 429,111 20,814 117,900 4,992,08675-79 2,621,159 204,135 9,650 58,503 2,893,447 3,775,108 338,886 14,625 76,764 4,205,38380-84 1,564,123 109,734 5,206 32,804 1,711,867 2,721,758 227,041 9,026 43,689 3,001,51485+ 993,801 81,293 3,595 21,490 1,100,179 2,553,020 213,458 7,780 31,039 2,805,297

All 110,482,030 16,619,354 1,306,151 5,065,991 133,473,526 114,071,434 18,388,325 1,320,324 5,393,316 139,173,399

19980-4 7,689,418 1,570,017 122,869 414,689 9,796,993 7,302,203 1,524,897 118,440 402,390 9,347,9305-9 8,181,024 1,769,019 146,699 407,050 10,503,792 7,764,365 1,714,847 142,801 384,523 10,006,53610-14 8,021,105 1,590,753 138,733 407,728 10,158,319 7,599,325 1,544,543 134,355 388,639 9,666,86215-19 8,086,650 1,554,952 132,750 424,385 10,198,737 7,586,393 1,520,323 126,838 407,441 9,640,99520-24 7,406,255 1,299,133 111,950 448,550 9,265,888 6,986,138 1,366,116 104,300 444,661 8,901,21525-29 8,070,031 1,293,838 110,633 501,784 9,976,286 7,752,392 1,429,357 103,585 542,024 9,827,35830-34 8,616,655 1,327,076 105,214 464,763 10,513,708 8,337,467 1,484,415 104,369 512,909 10,439,16035-39 9,477,303 1,375,264 110,494 463,728 11,426,789 9,332,023 1,554,732 113,680 498,973 11,499,40840-44 9,036,103 1,253,414 97,984 417,290 10,804,791 9,017,592 1,429,965 104,481 465,328 11,017,36645-49 7,948,839 1,013,484 80,048 351,616 9,393,987 8,044,479 1,182,721 84,885 408,091 9,720,17650-54 6,785,086 755,839 62,620 275,634 7,879,179 6,962,250 896,810 66,574 312,881 8,238,51555-59 5,263,446 568,826 44,229 199,471 6,075,972 5,543,514 699,336 47,890 222,735 6,513,47560-64 4,298,739 457,289 33,024 156,084 4,945,136 4,674,315 583,948 35,917 182,192 5,476,37265-69 3,919,470 387,128 23,301 119,052 4,448,951 4,520,361 522,654 27,675 157,624 5,228,31470-74 3,487,578 287,754 16,705 92,303 3,884,340 4,425,978 436,949 21,240 124,475 5,008,64275-79 2,673,109 209,450 10,224 64,150 2,956,933 3,826,791 345,305 15,242 83,847 4,271,18580-84 1,602,731 110,908 5,252 34,387 1,753,278 2,750,898 227,785 9,128 47,170 3,034,98185+ 1,036,235 83,616 3,801 23,173 1,146,825 2,621,858 221,677 8,106 34,069 2,885,710

All 111,599,777 16,907,760 1,356,530 5,265,837 135,129,904 115,048,342 18,686,380 1,369,506 5,619,972 140,724,200

CENSUS POPULATIONSM

710

Reference section M



1996 AllAge White Black N Am Asian All0-4 15,214,346 3,165,915 229,898 798,113 19,408,2725-9 15,540,363 3,322,679 275,185 722,303 19,860,53010-14 15,405,361 3,007,217 257,971 764,560 19,435,10915-19 14,996,520 2,945,979 232,132 745,529 18,920,16020-24 14,179,908 2,632,088 204,335 860,314 17,876,64525-29 16,018,188 2,690,191 201,481 954,280 19,864,14030-34 17,928,434 2,877,987 205,338 933,406 21,945,16535-39 18,810,278 2,866,604 208,793 900,076 22,785,75140-44 17,289,065 2,486,142 182,896 807,409 20,765,51245-49 15,755,262 2,025,212 148,539 681,513 18,610,52650-54 12,132,987 1,455,717 110,292 490,443 14,189,43955-59 9,850,583 1,176,318 81,869 371,930 11,480,70060-64 8,741,629 1,003,646 62,973 301,038 10,109,28665-69 8,752,946 909,639 48,370 253,132 9,964,08770-74 7,925,363 702,583 36,611 195,844 8,860,40175-79 6,226,607 529,516 23,070 124,495 6,903,68880-84 4,204,599 330,149 14,113 71,120 4,619,98185+ 3,447,611 287,896 11,007 48,378 3,794,892

All 222,420,050 34,415,478 2,534,873 10,023,883 269,394,284

19970-4 15,069,097 3,124,223 234,429 804,922 19,232,6715-9 15,790,056 3,418,120 283,560 762,296 20,254,03210-14 15,496,287 3,059,123 265,430 779,857 19,600,69715-19 15,351,980 3,013,301 245,164 787,246 19,397,69120-24 14,188,223 2,638,909 208,798 874,146 17,910,07625-29 15,965,379 2,718,577 207,953 1,007,131 19,899,04030-34 17,435,483 2,843,819 207,436 959,185 21,445,92335-39 18,858,676 2,899,819 216,488 928,638 22,903,62140-44 17,695,093 2,589,178 192,512 848,011 21,324,79445-49 15,701,386 2,111,316 156,026 717,912 18,686,64050-54 13,277,875 1,554,594 120,046 538,353 15,490,86855-59 10,198,645 1,224,009 86,497 395,936 11,905,08760-64 8,792,404 1,016,287 65,530 320,003 10,194,22465-69 8,625,262 910,414 49,479 264,675 9,849,83070-74 7,878,649 711,443 37,245 206,707 8,834,04475-79 6,396,267 543,021 24,275 135,267 7,098,83080-84 4,285,881 336,775 14,232 76,493 4,713,38185+ 3,546,821 294,751 11,375 52,529 3,905,476

All 224,553,464 35,007,679 2,626,475 10,459,307 272,646,925

19980-4 14,991,621 3,094,914 241,309 817,079 19,144,9235-9 15,945,389 3,483,866 289,500 791,573 20,510,32810-14 15,620,430 3,135,296 273,088 796,367 19,825,18115-19 15,673,043 3,075,275 259,588 831,826 19,839,73220-24 14,392,393 2,665,249 216,250 893,211 18,167,10325-29 15,822,423 2,723,195 214,218 1,043,808 19,803,64430-34 16,954,122 2,811,491 209,583 977,672 20,952,86835-39 18,809,326 2,929,996 224,174 962,701 22,926,19740-44 18,053,695 2,683,379 202,465 882,618 21,822,15745-49 15,993,318 2,196,205 164,933 759,707 19,114,16350-54 13,747,336 1,652,649 129,194 588,515 16,117,69455-59 10,806,960 1,268,162 92,119 422,206 12,589,44760-64 8,973,054 1,041,237 68,941 338,276 10,421,50865-69 8,439,831 909,782 50,976 276,676 9,677,26570-74 7,913,556 724,703 37,945 216,778 8,892,98275-79 6,499,900 554,755 25,466 147,997 7,228,11880-84 4,353,629 338,693 14,380 81,557 4,788,25985+ 3,658,093 305,293 11,907 57,242 4,032,535

All 226,648,119 35,594,140 2,726,036 10,885,809 275,854,104


711



1999 Male FemaleAge White Black N Am Asian All White Black N Am Asian All0-4 7,672,039 1,571,904 128,050 417,814 9,789,807 7,289,975 1,524,030 123,319 408,413 9,345,7375-9 8,211,295 1,773,681 147,918 420,948 10,553,842 7,791,071 1,718,506 144,111 398,930 10,052,61810-14 8,144,247 1,650,063 144,583 418,807 10,357,700 7,717,223 1,600,922 140,084 397,435 9,855,66415-19 8,174,959 1,567,014 139,002 442,058 10,323,033 7,672,225 1,532,399 132,191 424,754 9,761,56920-24 7,581,135 1,330,173 117,865 463,641 9,492,814 7,127,585 1,400,773 109,530 460,727 9,098,61525-29 7,944,134 1,291,042 112,551 531,363 9,879,090 7,606,278 1,427,024 106,468 556,197 9,695,96730-34 8,447,156 1,308,656 107,912 490,502 10,354,226 8,155,146 1,458,386 105,924 529,667 10,249,12335-39 9,425,123 1,387,055 114,524 481,693 11,408,395 9,277,734 1,564,410 117,270 514,740 11,474,15440-44 9,169,012 1,291,354 103,043 435,269 10,998,678 9,135,045 1,468,119 108,927 483,359 11,195,45045-49 8,151,142 1,060,502 85,195 369,634 9,666,473 8,240,528 1,229,341 90,336 427,529 9,987,73450-54 7,099,852 811,874 67,122 300,193 8,279,041 7,271,943 957,589 71,341 343,698 8,644,57155-59 5,470,979 589,866 47,202 211,740 6,319,787 5,754,517 722,150 50,646 237,721 6,765,03460-64 4,407,170 471,350 34,766 166,190 5,079,476 4,784,689 600,993 37,824 190,223 5,613,72965-69 3,865,205 385,148 24,113 125,044 4,399,510 4,431,324 519,753 28,606 162,305 5,141,98870-74 3,485,993 294,812 17,090 96,080 3,893,975 4,386,249 444,367 21,795 131,025 4,983,43675-79 2,721,384 210,570 10,617 68,814 3,011,385 3,875,879 349,571 15,848 89,923 4,331,22180-84 1,645,730 114,685 5,413 36,503 1,802,331 2,787,768 231,410 9,395 51,404 3,079,97785+ 1,079,319 85,342 3,815 24,834 1,193,310 2,686,737 228,287 8,365 37,319 2,960,708

All 112,695,874 17,195,091 1,410,781 5,501,127 136,802,873 115,991,916 18,978,030 1,421,980 5,845,369 142,237,295

20000-4 7,685,508 1,584,529 134,846 425,574 9,830,457 7,303,354 1,530,817 130,215 417,469 9,381,8555-9 8,152,580 1,752,987 147,843 434,028 10,487,438 7,736,375 1,698,085 144,500 414,505 9,993,46510-14 8,266,736 1,702,103 152,621 431,870 10,553,330 7,832,426 1,652,270 147,799 408,097 10,040,59215-19 8,216,475 1,575,332 146,248 454,292 10,392,347 7,712,405 1,537,246 138,460 435,465 9,823,57620-24 7,801,689 1,377,286 126,816 483,515 9,789,306 7,315,937 1,446,736 117,937 480,845 9,361,45525-29 7,797,733 1,274,323 115,912 553,769 9,741,737 7,428,263 1,405,036 109,362 569,036 9,511,69730-34 8,402,379 1,308,049 113,661 530,842 10,354,931 8,099,679 1,454,915 110,123 554,717 10,219,43435-39 9,267,789 1,385,321 119,236 502,141 11,274,487 9,118,847 1,560,827 120,892 531,619 11,332,18540-44 9,283,584 1,325,449 110,294 454,230 11,173,557 9,240,322 1,498,972 115,759 500,696 11,355,74945-49 8,368,459 1,104,104 92,584 390,722 9,955,869 8,450,087 1,274,008 97,644 448,393 10,270,13250-54 7,446,638 875,412 74,794 325,841 8,722,685 7,615,196 1,027,023 78,830 376,841 9,097,89055-59 5,665,213 613,184 51,786 227,030 6,557,213 5,950,632 748,209 55,285 255,300 7,009,42660-64 4,465,825 483,846 37,957 178,106 5,165,734 4,843,618 613,650 41,036 201,823 5,700,12765-69 3,854,086 385,855 26,682 132,759 4,399,382 4,405,288 522,917 31,192 169,259 5,128,65670-74 3,480,420 299,087 19,103 102,656 3,901,266 4,330,054 449,794 23,942 140,000 4,943,79075-79 2,755,831 212,828 12,447 73,775 3,054,881 3,911,719 353,334 17,541 98,028 4,380,62280-84 1,685,103 119,864 6,499 40,319 1,851,785 2,820,458 237,031 10,746 57,571 3,125,80685+ 1,129,929 87,592 4,820 27,794 1,250,135 2,757,352 234,944 9,959 42,586 3,044,841

All 113,725,977 17,467,151 1,494,149 5,769,263 138,456,540 116,872,012 19,245,814 1,501,222 6,102,250 143,721,298

*20010-4 7,736,643 1,599,132 128,887 438,635 9,903,297 7,361,972 1,547,089 124,505 427,005 9,460,5715-9 8,061,095 1,716,185 144,120 441,182 10,362,582 7,647,907 1,661,300 140,584 425,721 9,875,51210-14 8,354,489 1,745,713 154,292 443,160 10,697,654 7,922,443 1,693,741 149,850 417,847 10,183,88115-19 8,234,593 1,591,186 147,995 453,298 10,427,072 7,721,189 1,541,225 141,091 431,742 9,835,24720-24 8,054,392 1,440,869 132,551 497,770 10,125,582 7,538,862 1,496,411 122,677 493,228 9,651,17825-29 7,676,960 1,263,922 117,089 565,638 9,623,609 7,270,052 1,384,146 109,285 581,804 9,345,28730-34 8,441,433 1,312,093 114,544 564,964 10,433,034 8,119,426 1,460,737 110,666 590,322 10,281,15135-39 9,100,492 1,378,208 118,827 522,413 11,119,940 8,920,903 1,550,409 119,095 549,058 11,139,46540-44 9,379,398 1,346,081 112,738 470,317 11,308,534 9,326,477 1,522,441 117,967 515,288 11,482,17345-49 8,581,768 1,142,749 95,934 411,365 10,231,816 8,657,322 1,318,857 101,675 469,437 10,547,29150-54 7,665,713 923,273 78,466 347,010 9,014,462 7,836,715 1,084,072 82,903 403,221 9,406,91155-59 5,929,034 638,672 54,982 242,615 6,865,303 6,209,945 779,315 58,762 274,251 7,322,27360-64 4,567,084 490,674 39,733 188,545 5,286,036 4,946,836 624,690 42,819 211,936 5,826,28165-69 3,848,908 394,485 28,101 140,967 4,412,461 4,385,076 533,650 32,777 176,701 5,128,20470-74 3,465,957 298,229 20,206 107,267 3,891,659 4,279,293 446,180 24,662 146,719 4,896,85475-79 2,755,636 215,759 13,226 77,574 3,062,195 3,885,143 360,182 18,274 105,431 4,369,03080-84 1,754,327 124,715 7,209 44,241 1,930,492 2,899,157 243,480 11,620 62,952 3,217,20985+ 1,187,342 90,152 5,125 30,226 1,312,845 2,819,984 238,535 10,818 47,442 3,116,779

All 114,795,264 17,712,097 1,514,025 5,987,187 140,008,573 117,748,702 19,486,460 1,520,030 6,330,105 145,085,297

*Data from the CDC's Bridged Race Database.

CENSUS POPULATIONSM

712

Reference section M



1999 AllAge White Black N Am Asian All0-4 14,962,014 3,095,934 251,369 826,227 19,135,5445-9 16,002,366 3,492,187 292,029 819,878 20,606,46010-14 15,861,470 3,250,985 284,667 816,242 20,213,36415-19 15,847,184 3,099,413 271,193 866,812 20,084,60220-24 14,708,720 2,730,946 227,395 924,368 18,591,42925-29 15,550,412 2,718,066 219,019 1,087,560 19,575,05730-34 16,602,302 2,767,042 213,836 1,020,169 20,603,34935-39 18,702,857 2,951,465 231,794 996,433 22,882,54940-44 18,304,057 2,759,473 211,970 918,628 22,194,12845-49 16,391,670 2,289,843 175,531 797,163 19,654,20750-54 14,371,795 1,769,463 138,463 643,891 16,923,61255-59 11,225,496 1,312,016 97,848 449,461 13,084,82160-64 9,191,859 1,072,343 72,590 356,413 10,693,20565-69 8,296,529 904,901 52,719 287,349 9,541,49870-74 7,872,242 739,179 38,885 227,105 8,877,41175-79 6,597,263 560,141 26,465 158,737 7,342,60680-84 4,433,498 346,095 14,808 87,907 4,882,30885+ 3,766,056 313,629 12,180 62,153 4,154,018

All 228,687,790 36,173,121 2,832,761 11,346,496 279,040,168

20000-4 14,988,862 3,115,346 265,061 843,043 19,212,3125-9 15,888,955 3,451,072 292,343 848,533 20,480,90310-14 16,099,162 3,354,373 300,420 839,967 20,593,92215-19 15,928,880 3,112,578 284,708 889,757 20,215,92320-24 15,117,626 2,824,022 244,753 964,360 19,150,76125-29 15,225,996 2,679,359 225,274 1,122,805 19,253,43430-34 16,502,058 2,762,964 223,784 1,085,559 20,574,36535-39 18,386,636 2,946,148 240,128 1,033,760 22,606,67240-44 18,523,906 2,824,421 226,053 954,926 22,529,30645-49 16,818,546 2,378,112 190,228 839,115 20,226,00150-54 15,061,834 1,902,435 153,624 702,682 17,820,57555-59 11,615,845 1,361,393 107,071 482,330 13,566,63960-64 9,309,443 1,097,496 78,993 379,929 10,865,86165-69 8,259,374 908,772 57,874 302,018 9,528,03870-74 7,810,474 748,881 43,045 242,656 8,845,05675-79 6,667,550 566,162 29,988 171,803 7,435,50380-84 4,505,561 356,895 17,245 97,890 4,977,59185+ 3,887,281 322,536 14,779 70,380 4,294,976

All 230,597,989 36,712,965 2,995,371 11,871,513 282,177,838

*20010-4 15,098,615 3,146,221 253,392 865,640 19,363,8685-9 15,709,002 3,377,485 284,704 866,903 20,238,09410-14 16,276,932 3,439,454 304,142 861,007 20,881,53515-19 15,955,782 3,132,411 289,086 885,040 20,262,31920-24 15,593,254 2,937,280 255,228 990,998 19,776,76025-29 14,947,012 2,648,068 226,374 1,147,442 18,968,89630-34 16,560,859 2,772,830 225,210 1,155,286 20,714,18535-39 18,021,395 2,928,617 237,922 1,071,471 22,259,40540-44 18,705,875 2,868,522 230,705 985,605 22,790,70745-49 17,239,090 2,461,606 197,609 880,802 20,779,10750-54 15,502,428 2,007,345 161,369 750,231 18,421,37355-59 12,138,979 1,417,987 113,744 516,866 14,187,57660-64 9,513,920 1,115,364 82,552 400,481 11,112,31765-69 8,233,984 928,135 60,878 317,668 9,540,66570-74 7,745,250 744,409 44,868 253,986 8,788,51375-79 6,640,779 575,941 31,500 183,005 7,431,22580-84 4,653,484 368,195 18,829 107,193 5,147,70185+ 4,007,326 328,687 15,943 77,668 4,429,624

All 232,543,966 37,198,557 3,034,055 12,317,292 285,093,870



713



*2002 Male FemaleAge White Black N Am Asian All White Black N Am Asian All0-4 7,816,256 1,619,647 123,011 449,652 10,008,566 7,445,550 1,567,526 119,160 434,734 9,566,9705-9 7,956,537 1,673,129 140,823 447,955 10,218,444 7,548,940 1,619,993 137,128 435,939 9,742,00010-14 8,414,121 1,781,594 154,844 454,452 10,805,011 7,981,301 1,728,593 150,851 427,989 10,288,73415-19 8,253,883 1,610,992 149,519 453,725 10,468,119 7,748,372 1,556,846 143,244 431,085 9,879,54720-24 8,280,085 1,500,081 138,202 512,299 10,430,667 7,732,926 1,534,207 127,883 504,283 9,899,29925-29 7,659,199 1,263,507 118,763 571,140 9,612,609 7,214,124 1,376,873 110,037 588,261 9,289,29530-34 8,453,956 1,323,363 116,299 602,542 10,496,160 8,107,049 1,469,240 111,519 628,619 10,316,42735-39 8,889,312 1,359,218 116,980 539,100 10,904,610 8,690,385 1,527,836 116,729 565,973 10,900,92340-44 9,429,375 1,358,995 114,722 489,028 11,392,120 9,360,050 1,539,308 119,490 530,969 11,549,81745-49 8,762,293 1,183,241 99,598 431,571 10,476,703 8,829,337 1,362,834 105,143 490,074 10,787,38850-54 7,771,369 962,180 80,921 364,634 9,179,104 7,942,782 1,133,861 86,132 422,813 9,585,58855-59 6,262,966 670,348 58,895 262,435 7,254,644 6,539,415 816,348 62,958 299,301 7,718,02260-64 4,773,900 503,964 41,970 198,982 5,518,816 5,163,123 644,385 45,266 224,097 6,076,87165-69 3,860,892 400,502 29,445 150,476 4,441,315 4,385,302 540,241 33,710 184,537 5,143,79070-74 3,435,320 299,667 21,088 112,047 3,868,122 4,214,645 446,993 25,784 152,674 4,840,09675-79 2,763,556 217,854 13,898 81,250 3,076,558 3,860,510 364,699 19,045 112,894 4,357,14880-84 1,818,576 130,367 7,938 48,443 2,005,324 2,972,542 251,046 12,498 68,703 3,304,78985+ 1,244,847 92,967 5,536 33,173 1,376,523 2,885,996 243,215 11,753 52,918 3,193,882

All 115,846,443 17,951,616 1,532,452 6,202,904 141,533,415 118,622,349 19,724,044 1,538,330 6,555,863 146,440,586

*20030-4 7,889,666 1,637,210 117,395 461,144 10,105,415 7,523,300 1,583,938 113,637 442,989 9,663,8645-9 7,887,082 1,640,152 138,699 453,974 10,119,907 7,487,677 1,587,289 134,828 445,575 9,655,36910-14 8,435,323 1,804,333 154,547 462,546 10,856,749 8,000,163 1,749,239 150,708 436,502 10,336,61215-19 8,275,292 1,632,697 150,102 460,589 10,518,680 7,795,394 1,583,322 144,926 436,147 9,959,78920-24 8,450,770 1,547,308 143,788 522,056 10,663,922 7,862,961 1,556,595 133,130 511,086 10,063,77225-29 7,784,835 1,289,611 122,223 576,042 9,772,711 7,294,715 1,394,320 112,534 593,674 9,395,24330-34 8,374,007 1,323,274 117,422 635,072 10,449,775 8,015,352 1,467,416 111,871 660,230 10,254,86935-39 8,714,212 1,339,996 115,453 556,887 10,726,548 8,478,198 1,503,136 114,337 585,785 10,681,45640-44 9,414,670 1,365,312 116,429 510,700 11,407,111 9,335,125 1,549,254 120,340 550,760 11,555,47945-49 8,949,574 1,226,834 103,075 451,396 10,730,879 9,005,159 1,408,560 108,883 507,707 11,030,30950-54 7,857,280 990,815 83,706 380,976 9,312,777 8,028,569 1,170,892 89,277 441,896 9,730,63455-59 6,598,781 712,977 63,206 285,760 7,660,724 6,871,244 866,646 67,401 328,035 8,133,32660-64 4,990,925 518,640 44,131 209,904 5,763,600 5,392,244 664,773 48,008 237,061 6,342,08665-69 3,928,400 406,144 31,125 159,872 4,525,541 4,445,652 547,197 35,400 192,293 5,220,54270-74 3,379,699 304,446 22,108 117,567 3,823,820 4,129,856 451,388 26,857 159,040 4,767,14175-79 2,779,916 219,081 14,860 85,105 3,098,962 3,844,813 368,591 19,940 120,287 4,353,63180-84 1,857,912 135,452 8,654 53,227 2,055,245 3,013,756 258,504 13,208 75,366 3,360,83485+ 1,306,751 95,911 6,031 36,231 1,444,924 2,950,147 246,859 12,828 58,709 3,268,543

All 116,875,095 18,190,193 1,552,954 6,419,048 143,037,290 119,474,325 19,957,919 1,558,113 6,783,142 147,773,499


CENSUS POPULATIONSM

714

Reference section M



*2002 AllAge White Black N Am Asian All0-4 15,261,806 3,187,173 242,171 884,386 19,575,5365-9 15,505,477 3,293,122 277,951 883,894 19,960,44410-14 16,395,422 3,510,187 305,695 882,441 21,093,74515-19 16,002,255 3,167,838 292,763 884,810 20,347,66620-24 16,013,011 3,034,288 266,085 1,016,582 20,329,96625-29 14,873,323 2,640,380 228,800 1,159,401 18,901,90430-34 16,561,005 2,792,603 227,818 1,231,161 20,812,58735-39 17,579,697 2,887,054 233,709 1,105,073 21,805,53340-44 18,789,425 2,898,303 234,212 1,019,997 22,941,93745-49 17,591,630 2,546,075 204,741 921,645 21,264,09150-54 15,714,151 2,096,041 167,053 787,447 18,764,69255-59 12,802,381 1,486,696 121,853 561,736 14,972,66660-64 9,937,023 1,148,349 87,236 423,079 11,595,68765-69 8,246,194 940,743 63,155 335,013 9,585,10570-74 7,649,965 746,660 46,872 264,721 8,708,21875-79 6,624,066 582,553 32,943 194,144 7,433,70680-84 4,791,118 381,413 20,436 117,146 5,310,11385+ 4,130,843 336,182 17,289 86,091 4,570,405

All 234,468,792 37,675,660 3,070,782 12,758,767 287,974,001

*20030-4 15,412,966 3,221,148 231,032 904,133 19,769,2795-9 15,374,759 3,227,441 273,527 899,549 19,775,27610-14 16,435,486 3,553,572 305,255 899,048 21,193,36115-19 16,070,686 3,216,019 295,028 896,736 20,478,46920-24 16,313,731 3,103,903 276,918 1,033,142 20,727,69425-29 15,079,550 2,683,931 234,757 1,169,716 19,167,95430-34 16,389,359 2,790,690 229,293 1,295,302 20,704,64435-39 17,192,410 2,843,132 229,790 1,142,672 21,408,00440-44 18,749,795 2,914,566 236,769 1,061,460 22,962,59045-49 17,954,733 2,635,394 211,958 959,103 21,761,18850-54 15,885,849 2,161,707 172,983 822,872 19,043,41155-59 13,470,025 1,579,623 130,607 613,795 15,794,05060-64 10,383,169 1,183,413 92,139 446,965 12,105,68665-69 8,374,052 953,341 66,525 352,165 9,746,08370-74 7,509,555 755,834 48,965 276,607 8,590,96175-79 6,624,729 587,672 34,800 205,392 7,452,59380-84 4,871,668 393,956 21,862 128,593 5,416,07985+ 4,256,898 342,770 18,859 94,940 4,713,467

All 236,349,420 38,148,112 3,111,067 13,202,190 290,810,789



715

Table M.2Resident population estimates of the U.S.by gender, race, & Hispanic origin; population in thousands

Table M.2Resident population estimates of the U.S.by gender, race, & Hispanic origin; population in thousands

July 1, July 1, July 1, July 1, July 1, July 1, July 1,1990 1991 1992 1993 1994 1995 1996

All racesPopulation 249,622,814 252,980,941 256,514,224 259,918,588 263,125,821 266,278,393 269,394,284Percent of total 100.0 100.0 100.0 100.0 100.0 100.0 100.0Male population 121,713,764 123,416,235 125,247,146 126,970,600 128,597,479 130,215,371 131,807,484Female population 127,909,050 129,564,706 131,267,078 132,947,988 134,528,342 136,063,022 137,586,800

WhitePopulation 209,366,661 211,606,011 213,945,622 216,187,073 218,304,774 220,384,783 222,420,050Percent of total 83.9 83.7 83.4 83.2 83.0 82.8 82.6Male population 102,493,278 103,658,047 104,902,267 106,067,858 107,174,245 108,278,333 109,352,585Female population 106,873,383 107,947,964 109,043,355 110,119,215 111,130,529 112,106,450 113,067,465

BlackPopulation 30,648,345 31,290,743 31,979,982 32,634,735 33,258,981 33,847,306 34,415,478Percent of total 12.3 12.4 12.5 12.6 12.6 12.7 12.8Male population 14,502,886 14,809,739 15,154,311 15,471,443 15,771,864 16,056,540 16,330,618Female population 16,145,459 16,481,004 16,825,671 17,163,292 17,487,117 17,790,766 18,084,860

American Indian, Eskimo, and AleutPopulation 2,058,726 2,126,968 2,202,176 2,282,052 2,361,078 2,441,752 2,534,873Percent of total 0.8 0.8 0.9 0.9 0.9 0.9 0.9Male population 1,020,993 1,055,180 1,092,909 1,132,916 1,172,555 1,213,375 1,260,051Female population 1,037,733 1,071,788 1,109,267 1,149,136 1,188,523 1,228,377 1,274,822

Asian and Pacific IslanderPopulation 7,549,082 7,957,219 8,386,444 8,814,728 9,200,988 9,604,552 10,023,883Percent of total 3.0 3.2 3.3 3.4 3.5 3.6 3.7Male population 3,696,607 3,893,269 4,097,659 4,298,383 4,478,815 4,667,123 4,864,230Female population 3,852,475 4,063,950 4,288,785 4,516,345 4,722,173 4,937,429 5,159,653

HispanicPopulation 22,572,838 23,554,990 24,619,345 25,776,661 26,945,933 28,157,801 29,463,458Percent of total 9.0 9.3 9.6 9.9 10.2 10.6 10.9Male population 11,503,986 12,016,949 12,568,506 13,164,148 13,770,495 14,406,194 15,086,059Female population 11,068,852 11,538,041 12,050,839 12,612,513 13,175,438 13,751,607 14,377,399

Non-HispanicPopulation 227,049,976 229,425,951 231,894,879 234,141,927 236,179,888 238,120,592 239,930,826Percent of total 91.0 90.7 90.4 90.1 89.8 89.4 89.1Male population 110,209,778 111,399,286 112,678,640 113,806,452 114,826,984 115,809,177 116,721,425Female population 116,840,198 118,026,665 119,216,239 120,335,475 121,352,904 122,311,415 123,209,401

CENSUS POPULATIONSM

716

Reference section MCENSUS POPULATIONSMReference section M

Table M.2 (continued)Resident population estimates of the U.S.by gender, race, & Hispanic origin; population in thousands


Table M.2 (continued)Resident population estimates of the U.S.by gender, race, & Hispanic origin; population in thousands

July 1, July 1, July 1, July 1, July 1, July 1, July 1,1997 1998 1999 *2000 *2001 *2002 *2003

All racesPopulation 272,646,925 275,854,104 279,040,168 282,177,838 285,093,870 287,974,001 290,810,789Percent of total 100.0 100.0 100.0 100.0 100.0 100.0 100.0Male population 133,473,526 135,129,904 136,802,873 138,456,540 140,008,573 141,533,415 143,037,290Female population 139,173,399 140,724,200 142,237,295 143,721,298 145,085,297 146,440,586 147,773,499

WhitePopulation 224,553,464 226,648,119 228,687,790 230,597,989 232,543,966 234,468,792 236,349,420Percent of total 82.4 82.2 82.0 81.7 81.6 81.4 81.3Male population 110,482,030 111,599,777 112,695,874 113,725,977 114,795,264 115,846,443 116,875,095Female population 114,071,434 115,048,342 115,991,916 116,872,012 117,748,702 118,622,349 119,474,325

BlackPopulation 35,007,679 35,594,140 36,173,121 36,712,965 37,198,557 37,675,660 38,148,112Percent of total 12.8 12.9 13.0 13.0 13.1 13.1 13.1Male population 16,619,354 16,907,760 17,195,091 17,467,151 17,712,097 17,951,616 18,190,193Female population 18,388,325 18,686,380 18,978,030 19,245,814 19,486,460 19,724,044 19,957,919

American Indian, Eskimo, and AleutPopulation 2,626,475 2,726,036 2,832,761 2,995,371 3,034,055 3,070,782 3,111,067Percent of total 1.0 1.0 1.0 1.1 1.1 1.1 1.1Male population 1,306,151 1,356,530 1,410,781 1,494,149 1,514,025 1,532,452 1,552,954Female population 1,320,324 1,369,506 1,421,980 1,501,222 1,520,030 1,538,330 1,558,113

Asian and Pacific IslanderPopulation 10,459,307 10,885,809 11,346,496 11,871,513 12,317,292 12,758,767 13,202,190Percent of total 3.8 4.0 4.1 4.2 4.3 4.4 4.5Male population 5,065,991 5,265,837 5,501,127 5,769,263 5,987,187 6,202,904 6,419,048Female population 5,393,316 5,619,972 5,845,369 6,102,250 6,330,105 6,555,863 6,783,142

HispanicPopulation 30,895,896 32,382,865 33,937,795 35,650,138 37,061,639 38,488,299 39,899,063Percent of total 11.3 11.7 12.2 12.6 13.0 13.4 13.7Male population 15,833,620 16,612,836 17,436,364 18,347,648 19,096,700 19,851,814 20,599,115Female population 15,062,276 15,770,029 16,501,431 17,302,490 17,964,939 18,636,485 19,299,948

Non-HispanicPopulation 241,751,029 243,471,239 245,102,373 246,527,700 248,032,231 249,485,702 250,911,726Percent of total 88.7 88.3 87.8 87.4 87.0 86.6 86.3Male population 117,639,906 118,517,068 119,366,509 120,108,892 120,911,873 121,681,601 122,438,175Female population 124,111,123 124,954,171 125,735,864 126,418,808 127,120,358 127,804,101 128,473,551


A incidence 05 - USRDS · 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 ... Black 4,876 5,508...

Documents

Transcript of A incidence 05 - USRDS · 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 ... Black 4,876 5,508...